Clustering O 0 0.0089408615604043
of O 0 0.00027372586191631854
missense O 0 0.015239736996591091
mutations O 0 0.0020638343412429094
in O 0 0.0002506733871996403
the O 0 0.0015682127559557557
ataxia B-Disease 1 0.999953031539917
- I-Disease 1 0.9891641736030579
telangiectasia I-Disease 1 0.9983696341514587
gene O 0 0.0015770482132211328
in O 0 0.0001278324198210612
a O 0 0.0015179283218458295
sporadic B-Disease 1 0.5861730575561523
T I-Disease 1 0.998754620552063
- I-Disease 1 0.6506652235984802
cell I-Disease 0 0.24777816236019135
leukaemia I-Disease 1 0.9998964071273804
. O 0 0.0014408674323931336

Ataxia B-Disease 1 0.9995009899139404
- I-Disease 1 0.9661502242088318
telangiectasia I-Disease 1 0.9961153268814087
( O 0 0.004301903303712606
A B-Disease 1 0.9698148965835571
- I-Disease 1 0.9759073853492737
T I-Disease 1 0.9979224801063538
) O 0 0.00018499504949431866
is O 0 0.0002174428227590397
a O 0 0.0010210274485871196
recessive B-Disease 1 0.975874125957489
multi I-Disease 1 0.9937141537666321
- I-Disease 1 0.9920498728752136
system I-Disease 1 0.9448146820068359
disorder I-Disease 1 0.9999871253967285
caused O 1 0.5107424259185791
by O 0 0.0001321049639955163
mutations O 0 0.0006156956660561264
in O 0 5.360479553928599e-05
the O 0 0.00012679131759796292
ATM O 0 0.004542539827525616
gene O 0 0.0010452610440552235
at O 0 0.0005055259098298848
11q22 O 0 0.03882834315299988
- O 0 0.006340284366160631
q23 O 0 0.016452450305223465
( O 0 0.0007107687997631729
ref O 0 0.026953723281621933
. O 0 0.0001279065472772345
3 O 0 0.0004646583693102002
) O 0 0.00029759903554804623
. O 0 0.00042682443745434284

The O 0 0.0016474566655233502
risk O 1 0.6616350412368774
of O 0 0.0005448643933050334
cancer B-Disease 1 0.9999942779541016
, O 0 0.0003697571810334921
especially O 0 0.0027417512610554695
lymphoid B-Disease 1 0.9986476302146912
neoplasias I-Disease 1 0.9399280548095703
, O 0 0.00020775942539330572
is O 0 0.00031699638930149376
substantially O 0 0.014593353495001793
elevated O 1 0.8171883225440979
in O 0 0.00036222796188667417
A B-Disease 1 0.9974101185798645
- I-Disease 1 0.9994786381721497
T I-Disease 1 0.99994957447052
patients O 1 0.9997707009315491
and O 0 0.000186027871677652
has O 0 0.0004970734007656574
long O 0 0.002141940174624324
been O 0 0.00020277610747143626
associated O 0 0.0003107941593043506
with O 0 0.0004136662755627185
chromosomal O 1 0.9538949131965637
instability O 1 0.9587172269821167
. O 0 0.0016459869220852852

By O 0 0.0014204515609890223
analysing O 0 0.04159111902117729
tumour B-Disease 1 0.9998227953910828
DNA O 0 0.003066117875277996
from O 0 0.0006155933369882405
patients O 1 0.9987873435020447
with O 0 0.00039754173485562205
sporadic B-Disease 0 0.4804897606372833
T I-Disease 1 0.9986523985862732
- I-Disease 0 0.0345211885869503
cell I-Disease 0 0.011164041236042976
prolymphocytic I-Disease 1 0.9902488589286804
leukaemia I-Disease 1 0.9998776912689209
( O 0 0.01366337575018406
T B-Disease 1 0.9988119602203369
- I-Disease 0 0.10575764626264572
PLL I-Disease 1 0.9853583574295044
) O 0 0.0002572131052147597
, O 0 0.00013673744979314506
a O 0 0.0007180044776760042
rare O 0 0.011382230557501316
clonal B-Disease 1 0.6675264835357666
malignancy I-Disease 1 0.9985902905464172
with O 0 0.00014411633310373873
similarities O 0 0.0006210573483258486
to O 0 0.00014481419930234551
a O 0 0.0019500106573104858
mature B-Disease 1 0.9934210181236267
T I-Disease 1 0.9994152784347534
- I-Disease 0 0.08673083037137985
cell I-Disease 0 0.020682860165834427
leukaemia I-Disease 1 0.9998641014099121
seen O 0 0.0014412078307941556
in O 0 0.00035562875564210117
A B-Disease 1 0.994878888130188
- I-Disease 1 0.9965633749961853
T I-Disease 1 0.9994947910308838
, O 0 0.00014095350343268365
we O 0 9.110691462410614e-05
demonstrate O 0 0.0005080487462691963
a O 0 0.0001483827509218827
high O 0 0.00025771191576495767
frequency O 0 7.710418867645785e-05
of O 0 3.363320865901187e-05
ATM O 0 0.006664393935352564
mutations O 0 0.0024709946010261774
in O 0 0.0012007183395326138
T B-Disease 1 0.9979300498962402
- I-Disease 0 0.39274922013282776
PLL I-Disease 1 0.9899573922157288
. O 0 0.0015952582471072674

In O 0 0.0007332662935368717
marked O 0 0.0012051636585965753
contrast O 0 0.0006883613532409072
to O 0 7.003667269600555e-05
the O 0 0.0001366008655168116
ATM O 0 0.004982350394129753
mutation O 0 0.001384142553433776
pattern O 0 0.0019650354515761137
in O 0 0.0005596549599431455
A B-Disease 1 0.9928120970726013
- I-Disease 1 0.9953560829162598
T I-Disease 1 0.9992802739143372
, O 0 8.129063644446433e-05
the O 0 5.6461842177668586e-05
most O 0 6.89936859998852e-05
frequent O 0 0.0007305398466996849
nucleotide O 0 0.00019176470232196152
changes O 0 0.0002158681018045172
in O 0 0.00013294962991494685
this O 0 0.0005073528736829758
leukaemia B-Disease 1 0.9999021291732788
were O 0 0.0002808046992868185
missense O 0 0.019780350849032402
mutations O 0 0.004405522253364325
. O 0 0.0009526313515380025

These O 0 0.00030427833553403616
clustered O 0 0.0014977225800976157
in O 0 0.0001139160231105052
the O 0 0.0001302370656048879
region O 0 0.0005136018735356629
corresponding O 0 0.00013423211930785328
to O 0 5.1276132580824196e-05
the O 0 0.000150854088133201
kinase O 0 0.0027645588852465153
domain O 0 0.00017838469648268074
, O 0 5.877772855455987e-05
which O 0 2.3148922991822474e-05
is O 0 6.162697536638007e-05
highly O 0 0.0002652368857525289
conserved O 0 0.00012900750152766705
in O 0 7.590077439090237e-05
ATM O 0 0.004786109551787376
- O 0 0.001314084162004292
related O 0 0.00032232829835265875
proteins O 0 0.00011168311175424606
in O 0 0.00017681358440313488
mouse O 0 0.008007219061255455
, O 0 0.00019479919865261763
yeast O 0 0.0022810441441833973
and O 0 0.00021788131562061608
Drosophila O 0 0.005528745707124472
. O 0 0.0009563640342094004

The O 0 0.000555577629711479
resulting O 0 0.0012917902786284685
amino O 0 0.0006314663914963603
- O 0 0.0031340159475803375
acid O 0 0.0018261470831930637
substitutions O 0 0.0004110001609660685
are O 0 3.2283394830301404e-05
predicted O 0 0.0006651188596151769
to O 0 8.787913247942924e-05
interfere O 0 0.0020817513577640057
with O 0 0.0001937260094564408
ATP O 0 0.09095271676778793
binding O 0 0.0005615481059066951
or O 0 0.00028913054848089814
substrate O 0 0.0029717814177274704
recognition O 0 0.002245622919872403
. O 0 0.0009496422135271132

Two O 0 0.00014345382805913687
of O 0 8.45153845148161e-05
seventeen O 0 0.005704690236598253
mutated O 1 0.7464615702629089
T B-Disease 1 0.9961846470832825
- I-Disease 0 0.01983177475631237
PLL I-Disease 1 0.9410515427589417
samples O 0 0.0005625630146823823
had O 0 0.00029895806801505387
a O 0 0.00038148206658661366
previously O 0 0.0011223397450521588
reported O 0 0.004496804438531399
A B-Disease 1 0.9184834957122803
- I-Disease 1 0.9624375700950623
T I-Disease 1 0.9976757168769836
allele O 0 0.008863016031682491
. O 0 0.0012407823232933879

In O 0 0.0007545746047981083
contrast O 0 0.001366998883895576
, O 0 0.00021189040853641927
no O 0 0.000202847077162005
mutations O 0 0.0006173183210194111
were O 0 3.6250250559533015e-05
detected O 0 0.0011737679596990347
in O 0 5.374606917030178e-05
the O 0 0.00019030857947655022
p53 O 0 0.007511214353144169
gene O 0 0.000836969877127558
, O 0 0.00011055875802412629
suggesting O 0 0.000803327769972384
that O 0 7.596109207952395e-05
this O 0 0.0003404575400054455
tumour B-Disease 1 0.999963641166687
suppressor O 0 0.11817120760679245
is O 0 0.00018557840667199343
not O 0 8.703655475983396e-05
frequently O 0 0.0004994500195607543
altered O 0 0.001087748445570469
in O 0 0.00017381110228598118
this O 0 0.0006820489652454853
leukaemia B-Disease 1 0.9999498128890991
. O 0 0.0012833738001063466

Occasional O 0 0.017690949141979218
missense O 0 0.02750462107360363
mutations O 0 0.0025466380175203085
in O 0 0.00015790879842825234
ATM O 0 0.0021508049685508013
were O 0 3.524720887071453e-05
also O 0 7.731844380032271e-05
found O 0 0.00012761853577103466
in O 0 0.0003449894720688462
tumour B-Disease 1 0.9999561309814453
DNA O 0 0.0009828925831243396
from O 0 0.000240045934333466
patients O 1 0.9998241066932678
with O 0 0.00022875868307892233
B B-Disease 1 0.8570730686187744
- I-Disease 0 0.004710886627435684
cell I-Disease 0 0.002160976640880108
non I-Disease 0 0.011863418854773045
- I-Disease 1 0.99512779712677
Hodgkins I-Disease 1 0.9999927282333374
lymphomas I-Disease 1 0.9993090629577637
( O 0 0.0018721778178587556
B B-Disease 0 0.33603277802467346
- I-Disease 0 0.0037418620195239782
NHL I-Disease 0 0.006078636739403009
) O 0 7.713153900112957e-05
and O 0 6.779203249607235e-05
a O 0 0.0007090673898346722
B B-Disease 0 0.11283213645219803
- I-Disease 0 0.006166077684611082
NHL I-Disease 0 0.011615912429988384
cell O 0 0.002080735983327031
line O 0 0.0012776295188814402
. O 0 0.0007463944493792951

The O 0 0.00042064295848831534
evidence O 0 0.00014432342140935361
of O 0 1.2204100130475126e-05
a O 0 0.00016360377776436508
significant O 0 0.00015062812599353492
proportion O 0 0.00015194489969871938
of O 0 4.11934161093086e-05
loss O 0 0.03799809142947197
- O 0 0.0011065092403441668
of O 0 2.7760726879932918e-05
- O 0 0.00212460127659142
function O 0 0.00033005388104356825
mutations O 0 0.0004806924844160676
and O 0 3.714470221893862e-05
a O 0 0.00022074964363127947
complete O 0 0.00034823024179786444
absence O 0 0.0004380453610792756
of O 0 1.5057596101542003e-05
the O 0 0.0001092611564672552
normal O 0 0.000873057811986655
copy O 0 0.00029495375929400325
of O 0 1.7014393961289898e-05
ATM O 0 0.001595937181264162
in O 0 3.731971446541138e-05
the O 0 7.007662497926503e-05
majority O 0 0.00015767753939144313
of O 0 0.00013888634566683322
mutated O 1 0.9802543520927429
tumours B-Disease 1 0.9998154044151306
establishes O 1 0.6175961494445801
somatic O 0 0.016494834795594215
inactivation O 0 0.018127327784895897
of O 0 3.594316149246879e-05
this O 0 0.00012532294203992933
gene O 0 0.0006695045158267021
in O 0 6.448179919971153e-05
the O 0 0.0002999049611389637
pathogenesis O 1 0.9823859333992004
of O 0 0.0001834836002672091
sporadic B-Disease 1 0.7562972903251648
T I-Disease 1 0.9993970394134521
- I-Disease 1 0.5315245389938354
PLL I-Disease 1 0.9924943447113037
and O 0 0.00021102302707731724
suggests O 0 0.0006729178712703288
that O 0 6.745052814949304e-05
ATM O 0 0.0015063530299812555
acts O 0 0.00017131668573711067
as O 0 0.0002918457321356982
a O 0 0.008976084180176258
tumour B-Disease 1 0.9999147653579712
suppressor O 1 0.6233406662940979
. O 0 0.0010761413723230362

As O 0 0.0006607203395105898
constitutional O 0 0.000847057846840471
DNA O 0 0.000863087538164109
was O 0 0.00028295142692513764
not O 0 4.8817913921084255e-05
available O 0 6.336265505524352e-05
, O 0 6.821035640314221e-05
a O 0 0.0005677313893102109
putative O 0 0.055380795150995255
hereditary O 1 0.9952017068862915
predisposition O 1 0.9984126091003418
to O 0 0.002945502521470189
T B-Disease 1 0.9996979236602783
- I-Disease 0 0.45891159772872925
PLL I-Disease 1 0.9922055602073669
will O 0 0.00021907953487243503
require O 0 0.0007411469705402851
further O 0 0.0004014959849882871
investigation O 0 0.003370200050994754
. O 0 0.0003111285623162985
. O 0 0.0005140076973475516

Myotonic B-Disease 1 0.9998574256896973
dystrophy I-Disease 1 0.9999381303787231
protein O 0 0.009725168347358704
kinase O 0 0.025876924395561218
is O 0 0.0003360023256391287
involved O 0 0.0002648893860168755
in O 0 3.776623998419382e-05
the O 0 6.321140972431749e-05
modulation O 0 0.0005308343097567558
of O 0 2.471043808327522e-05
the O 0 0.00048658318701200187
Ca2 O 0 0.469176322221756
+ O 0 0.04222896322607994
homeostasis O 1 0.9786232709884644
in O 0 0.00201864680275321
skeletal O 1 0.9996143579483032
muscle O 1 0.999025821685791
cells O 0 0.06612434983253479
. O 0 0.0014771493151783943

Myotonic B-Disease 1 0.9999408721923828
dystrophy I-Disease 1 0.9999938011169434
( O 1 0.8731991052627563
DM B-Disease 1 0.9999700784683228
) O 0 0.0004832597333006561
, O 0 0.00010883586946874857
the O 0 0.00010817862494150177
most O 0 0.0004761060990858823
prevalent O 1 0.994515061378479
muscular B-Disease 1 0.9999964237213135
disorder I-Disease 1 0.999994158744812
in O 0 0.0018834216753020883
adults O 1 0.7830390334129333
, O 0 0.00023644017346668988
is O 0 0.0003812724316958338
caused O 0 0.011028929613530636
by O 0 0.00023633605451323092
( O 0 0.001358219888061285
CTG O 1 0.9702366590499878
) O 0 0.0003819489502348006
n O 0 0.0015231595607474446
- O 0 0.001808907836675644
repeat O 0 0.0011404597898945212
expansion O 0 0.0004894874873571098
in O 0 4.083717067260295e-05
a O 0 0.0001664644223637879
gene O 0 0.00025215811911039054
encoding O 0 0.00010954451136058196
a O 0 0.00020392918668221682
protein O 0 0.0008210642263293266
kinase O 0 0.011632351204752922
( O 0 0.001790299080312252
DM B-Disease 1 0.998857855796814
protein O 0 0.0017464193515479565
kinase O 0 0.008392698131501675
; O 0 0.00042004691204056144
DMPK O 1 0.9057750105857849
) O 0 0.0002009223389904946
and O 0 7.127838034648448e-05
involves O 0 0.0007228577160276473
changes O 0 0.00029419068596325815
in O 0 0.00016730443167034537
cytoarchitecture O 0 0.18428541719913483
and O 0 0.0002751151623670012
ion O 0 0.019067859277129173
homeostasis O 1 0.9802287817001343
. O 0 0.0018474479438737035

To O 0 0.0005170590011402965
obtain O 0 0.0006679249345324934
clues O 0 0.0009905899642035365
to O 0 7.466415991075337e-05
the O 0 0.0001272959925699979
normal O 0 0.0011951442575082183
biological O 0 0.0005172098753973842
role O 0 0.00044240441638976336
of O 0 8.081929263425991e-05
DMPK O 1 0.9328442215919495
in O 0 0.00024811248295009136
cellular O 0 0.0028645831625908613
ion O 0 0.006988890469074249
homeostasis O 1 0.9631935954093933
, O 0 0.00018716408521868289
we O 0 6.752608896931633e-05
have O 0 3.319475581520237e-05
compared O 0 0.0001876359892776236
the O 0 0.0001833686837926507
resting O 1 0.9097421765327454
[ O 0 0.018461434170603752
Ca2 O 1 0.51972496509552
+ O 0 0.08914390951395035
] O 0 0.007403826806694269
i O 0 0.0005476194201037288
, O 0 4.332143726060167e-05
the O 0 3.1417395803146064e-05
amplitude O 0 0.0002406426501693204
and O 0 5.956117820460349e-05
shape O 0 0.0011433083564043045
of O 0 7.301179721252993e-05
depolarization O 1 0.7199591398239136
- O 0 0.1811516135931015
induced O 1 0.9741883277893066
Ca2 O 1 0.8085861802101135
+ O 0 0.08336232602596283
transients O 0 0.032155267894268036
, O 0 9.88947504083626e-05
and O 0 2.7818210583063774e-05
the O 0 2.3269418306881562e-05
content O 0 5.966327807982452e-05
of O 0 4.38539354945533e-05
ATP O 0 0.48043230175971985
- O 0 0.0014375847531482577
driven O 0 0.000740828865673393
ion O 0 0.0022570763248950243
pumps O 0 0.009793962351977825
in O 0 0.00039905653102323413
cultured O 0 0.43463459610939026
skeletal O 1 0.9982718229293823
muscle O 1 0.9929600358009338
cells O 0 0.0011470282915979624
of O 0 3.714980630320497e-05
wild O 0 0.000999608775600791
- O 0 0.003820668673142791
type O 0 0.0017128835897892714
and O 0 0.0003636566107161343
DMPK O 1 0.9951106905937195
[ O 0 0.015494058839976788
- O 0 0.044067755341529846
/ O 0 0.04134923964738846
- O 0 0.006064435932785273
] O 0 0.005663908086717129
knockout O 0 0.017831023782491684
mice O 0 0.0229298435151577
. O 0 0.0007624744321219623

In O 0 0.0007786726928316057
vitro O 0 0.004383280873298645
- O 0 0.00788720604032278
differentiated O 0 0.029879270121455193
DMPK O 1 0.982921302318573
[ O 0 0.020554574206471443
- O 0 0.04404495283961296
/ O 0 0.08011917769908905
- O 0 0.006309468299150467
] O 0 0.004337226506322622
myotubes O 0 0.01283574290573597
exhibit O 0 0.0009404070442542434
a O 0 0.0003564802464097738
higher O 0 0.0009180405177175999
resting O 1 0.6331183314323425
[ O 0 0.012883259914815426
Ca2 O 0 0.3109053075313568
+ O 0 0.024927908554673195
] O 0 0.004944721702486277
i O 0 0.0004972307942807674
than O 0 8.975984383141622e-05
do O 0 0.0002510163467377424
wild O 0 0.000731931475456804
- O 0 0.007517329882830381
type O 0 0.0037858819123357534
myotubes O 0 0.25514888763427734
because O 0 0.00016953438171185553
of O 0 1.282463563256897e-05
an O 0 0.00016932288417592645
altered O 0 0.000874656776431948
open O 0 0.0001847688836278394
probability O 0 4.5093420339981094e-05
of O 0 2.6076471840497106e-05
voltage O 0 0.0016190590104088187
- O 0 0.0029942705295979977
dependent O 0 0.0022638740483671427
l O 0 0.05445980280637741
- O 0 0.0035499781370162964
type O 0 0.003546889405697584
Ca2 O 0 0.0317753404378891
+ O 0 0.006757184863090515
and O 0 0.00034294978831894696
Na O 0 0.12294366955757141
+ O 0 0.007205653004348278
channels O 0 0.0011071633780375123
. O 0 0.0008423918625339866

The O 0 0.0014711482217535377
mutant O 0 0.013249550014734268
myotubes O 0 0.07311058044433594
exhibit O 0 0.001524255028925836
smaller O 0 0.00025286542950198054
and O 0 0.00016888223763089627
slower O 0 0.0039314343594014645
Ca2 O 0 0.08466509729623795
+ O 0 0.0073726060800254345
responses O 0 0.0007806081557646394
upon O 0 0.0003497500147204846
triggering O 0 0.004734281450510025
by O 0 0.000327654299326241
acetylcholine O 0 0.24595487117767334
or O 0 0.0004156815411988646
high O 0 0.002214085776358843
external O 0 0.003471134230494499
K O 0 0.22970519959926605
+ O 0 0.022712724283337593
. O 0 0.0008268278324976563

In O 0 0.0005807566922158003
addition O 0 0.00044050964061170816
, O 0 0.00012677267659455538
we O 0 0.0001149808376794681
observed O 0 0.00018553188419900835
that O 0 5.0548023864394054e-05
these O 0 0.00010889014811255038
Ca2 O 1 0.5565379858016968
+ O 0 0.04854602739214897
transients O 0 0.2284618467092514
partially O 0 0.005934544838964939
result O 0 0.0002727283863350749
from O 0 4.3483683839440346e-05
an O 0 8.313392027048394e-05
influx O 0 0.00035831567947752774
of O 0 4.174325295025483e-05
extracellular O 0 0.0061854408122599125
Ca2 O 0 0.05496690422296524
+ O 0 0.0042121149599552155
through O 0 0.0001876125461421907
the O 0 0.0004748961073346436
l O 0 0.4304412305355072
- O 0 0.005530618131160736
type O 0 0.004694692324846983
Ca2 O 0 0.04306524991989136
+ O 0 0.008668680675327778
channel O 0 0.0017591688083484769
. O 0 0.0008800291107036173

Neither O 0 0.003657760564237833
the O 0 0.0001849081163527444
content O 0 0.0002479126851540059
nor O 0 0.0006701560341753066
the O 0 5.9242709539830685e-05
activity O 0 0.0001725600304780528
of O 0 8.337534382008016e-05
Na O 1 0.925374448299408
+ O 0 0.08361484855413437
/ O 0 0.03509688749909401
K O 0 0.015256536193192005
+ O 0 0.010612783953547478
ATPase O 0 0.03329641744494438
and O 0 0.0012586386874318123
sarcoplasmic O 1 0.9873676896095276
reticulum O 1 0.9663276076316833
Ca2 O 1 0.5722483396530151
+ O 0 0.046768005937337875
- O 0 0.008102857507765293
ATPase O 0 0.021093256771564484
are O 0 0.00010138744983123615
affected O 0 0.002120813587680459
by O 0 0.0004252746293786913
DMPK O 1 0.98003089427948
absence O 0 0.010998077690601349
. O 0 0.0015904867323115468

In O 0 0.000929829606320709
conclusion O 0 0.0011770788114517927
, O 0 0.00012763352424371988
our O 0 0.00019495750893838704
data O 0 0.0001430236006854102
suggest O 0 0.000599709281232208
that O 0 0.0002069721231237054
DMPK O 1 0.971627950668335
is O 0 0.00022023434576112777
involved O 0 0.0004032888973597437
in O 0 0.0001400900655426085
modulating O 0 0.009378594346344471
the O 0 9.677354682935402e-05
initial O 0 0.0003290118183940649
events O 0 4.532286402536556e-05
of O 0 3.4251959732500836e-05
excitation O 0 0.011604830622673035
- O 0 0.006202199961990118
contraction O 0 0.010934422723948956
coupling O 0 0.0033324630931019783
in O 0 0.0010547689162194729
skeletal O 1 0.9993107318878174
muscle O 1 0.9983578324317932
. O 0 0.0007518363418057561
. O 0 0.0009413703228347003

Constitutional O 0 0.026247497648000717
RB1 O 1 0.9972087740898132
- O 0 0.03865116462111473
gene O 0 0.003957835026085377
mutations O 0 0.002552686957642436
in O 0 0.0006429528584703803
patients O 1 0.9997196793556213
with O 0 0.00040395051473751664
isolated O 1 0.6616198420524597
unilateral B-Disease 1 0.9622604846954346
retinoblastoma I-Disease 1 0.9993556141853333
. O 0 0.0018449031049385667

In O 0 0.0009005015599541366
most O 0 0.0012416259851306677
patients O 1 0.9993641972541809
with O 0 0.0004956956254318357
isolated O 0 0.371707946062088
unilateral B-Disease 1 0.9727475047111511
retinoblastoma I-Disease 1 0.999836802482605
, O 0 0.00796017237007618
tumor B-Disease 1 0.9998619556427002
development O 0 0.001977697014808655
is O 0 0.00035016442416235805
initiated O 0 0.0025080516934394836
by O 0 0.00013369049702305347
somatic O 0 0.005719238426536322
inactivation O 0 0.005726971197873354
of O 0 1.899568633234594e-05
both O 0 9.305642743129283e-05
alleles O 0 0.0005846810527145863
of O 0 4.513686508289538e-05
the O 0 0.001715244841761887
RB1 O 1 0.998428225517273
gene O 0 0.006358254235237837
. O 0 0.0011293686693534255

However O 0 0.0005792483570985496
, O 0 7.681027636863291e-05
some O 0 2.3509890525019728e-05
of O 0 2.657774166436866e-05
these O 0 0.0002448030572850257
patients O 1 0.9998770952224731
can O 0 0.0005383498501032591
transmit O 0 0.15388040244579315
retinoblastoma B-Disease 1 0.9995593428611755
predisposition O 1 0.9929876923561096
to O 0 0.0001493384625064209
their O 0 0.0001274446549359709
offspring O 0 0.003094560233876109
. O 0 0.0006636821781285107

To O 0 0.00027694785967469215
determine O 0 0.0002195272099925205
the O 0 6.047381248208694e-05
frequency O 0 0.00013072752335574478
and O 0 7.44538483559154e-05
nature O 0 0.00038960238453000784
of O 0 7.300581637537107e-05
constitutional O 0 0.006585190538316965
RB1 O 1 0.9996002316474915
- O 0 0.04474540054798126
gene O 0 0.002394645242020488
mutations O 0 0.0017832875018939376
in O 0 0.0005153550882823765
patients O 1 0.9997016787528992
with O 0 0.0002737177419476211
isolated O 0 0.4665307402610779
unilateral B-Disease 1 0.9311583042144775
retinoblastoma I-Disease 1 0.9996672868728638
, O 0 0.00017577320977579802
we O 0 0.00012986564252059907
analyzed O 0 0.0005971030914224684
DNA O 0 0.00038806942757219076
from O 0 0.00020698791195172817
peripheral O 1 0.9990465044975281
blood O 1 0.9942716360092163
and O 0 0.0004142535326536745
from O 0 0.0019288907060399652
tumor B-Disease 1 0.9999222755432129
tissue O 1 0.9966626763343811
. O 0 0.00147940160240978

The O 0 0.0004233875952195376
analysis O 0 0.0003758604289032519
of O 0 0.00020564434817060828
tumors B-Disease 1 0.9996005892753601
from O 0 0.00020697468426078558
54 O 0 0.0019882055930793285
( O 0 0.0003985599905718118
71 O 0 0.0009913339745253325
% O 0 3.6077468394069e-05
) O 0 5.9826277720276266e-05
of O 0 4.0367776819039136e-05
76 O 0 0.01441797986626625
informative O 1 0.5270893573760986
patients O 1 0.9997510313987732
showed O 0 0.0011209435760974884
loss O 0 0.0013128365390002728
of O 0 4.5721371861873195e-05
constitutional O 0 0.002499018330127001
heterozygosity O 1 0.991489827632904
( O 0 0.01426093652844429
LOH O 1 0.9997164607048035
) O 0 0.0005916641093790531
at O 0 0.0008924764697439969
intragenic O 0 0.2797660231590271
loci O 0 0.011854914017021656
. O 0 0.0009429514175280929

Three O 0 0.00018846597231458873
of O 0 0.00011680356692522764
13 O 0 0.004833864979445934
uninformative O 1 0.9986745119094849
patients O 1 0.9995890259742737
had O 0 0.0008510220795869827
constitutional O 0 0.0010343593312427402
deletions O 0 0.005149556323885918
. O 0 0.0010494256857782602

For O 0 0.0006614536978304386
39 O 0 0.0015656107570976019
randomly O 0 0.0006450132932513952
selected O 0 0.001375172403641045
tumors B-Disease 1 0.999554455280304
, O 0 0.0008048463496379554
SSCP O 1 0.9949294328689575
, O 0 0.0010133571922779083
hetero O 1 0.9903010129928589
- O 0 0.008631360717117786
duplex O 0 0.015879498794674873
analysis O 0 0.00021657584875356406
, O 0 0.00011441930837463588
sequencing O 0 0.00041376237641088665
, O 0 0.00011185641051270068
and O 0 0.00014926400035619736
Southern O 0 0.001290221232920885
blot O 0 0.33763769268989563
analysis O 0 0.0001849532563937828
were O 0 2.8324877348495647e-05
used O 0 7.391324470518157e-05
to O 0 8.396064367843792e-05
identify O 0 0.001130400924012065
mutations O 0 0.002614973345771432
. O 0 0.0007125152042135596

Mutations O 0 0.005084844306111336
were O 0 0.0001342331524938345
detected O 0 0.0022159500513225794
in O 0 0.00014695133722852916
21 O 0 0.0006924209301359951
( O 0 0.0003513059637043625
91 O 0 0.001036760164424777
% O 0 3.0478531698463485e-05
) O 0 5.807631532661617e-05
of O 0 5.4319036280503497e-05
23 O 0 0.01821381412446499
tumors B-Disease 1 0.9999407529830933
with O 0 0.003530637826770544
LOH O 1 0.999862551689148
. O 0 0.0019309002673253417

In O 0 0.000913855736143887
6 O 0 0.001249592867679894
( O 0 0.0003821466816589236
38 O 0 0.00039800870581530035
% O 0 2.9907943826401606e-05
) O 0 5.8759236708283424e-05
of O 0 3.471278614597395e-05
16 O 0 0.004326811525970697
tumors B-Disease 1 0.9999440908432007
without O 0 0.008990776725113392
LOH O 1 0.9999628067016602
, O 0 0.0001385046634823084
one O 0 0.0001166947913588956
mutation O 0 0.0010645665461197495
was O 0 0.00047890402493067086
detected O 0 0.0023068618029356003
, O 0 6.714908522553742e-05
and O 0 4.116346099181101e-05
in O 0 9.006971231428906e-05
9 O 0 0.00046852586092427373
( O 0 0.00021228170953691006
56 O 0 0.0003265768173150718
% O 0 2.0756289814016782e-05
) O 0 4.624080247594975e-05
of O 0 2.4059640054474585e-05
the O 0 0.002174951368942857
tumors B-Disease 1 0.9999828338623047
without O 0 0.02664884552359581
LOH O 1 0.9999551773071289
, O 0 0.0001990420714719221
both O 0 0.00016098530613817275
mutations O 0 0.000908939924556762
were O 0 4.992471804143861e-05
found O 0 0.00048731008428148925
. O 0 0.0005039013340137899

Thus O 0 0.0007996571948751807
, O 0 0.00011129570339107886
a O 0 0.00011801347136497498
total O 0 2.9069296942907386e-05
of O 0 1.6038084140745923e-05
45 O 0 0.0003748481103684753
mutations O 0 0.0006284077535383403
were O 0 3.567243766156025e-05
identified O 0 0.00046979845501482487
in O 0 0.0004704334423877299
tumors B-Disease 1 0.9998214840888977
of O 0 0.00015473563689738512
36 O 0 0.024412056431174278
patients O 1 0.99978107213974
. O 0 0.0010317296255379915

Thirty O 0 0.005782764870673418
- O 0 0.0016858011949807405
nine O 0 8.14433369669132e-05
of O 0 1.6788451830507256e-05
the O 0 0.0001700813154457137
mutations O 0 0.0014061769470572472
- O 0 0.0008648190996609628
including O 0 4.77645626233425e-05
34 O 0 0.0003650413127616048
small O 0 0.0001913971791509539
mutations O 0 0.0006918812869116664
, O 0 8.963813161244616e-05
2 O 0 0.00018347536388318986
large O 0 0.00018655401072464883
structural O 1 0.6245188117027283
alterations O 0 0.00898497924208641
, O 0 0.00017893360927700996
and O 0 0.00024074291286524385
hypermethylation O 1 0.9627746939659119
in O 0 0.0003526178770698607
3 O 0 0.005474194418638945
tumors O 1 0.9999570846557617
- O 0 0.0030059227719902992
were O 0 2.3606542526977137e-05
not O 0 6.86480852891691e-05
detected O 0 0.0007428486132994294
in O 0 3.470755473244935e-05
the O 0 8.107069879770279e-05
corresponding O 0 0.000834415724966675
peripheral O 1 0.9982628226280212
blood O 1 0.9619085192680359
DNA O 0 0.002837744075804949
. O 0 0.0007535118493251503

In O 0 0.0006784687866456807
6 O 0 0.001018998329527676
( O 0 0.0003309717867523432
17 O 0 0.0002661533944774419
% O 0 1.7501657566754147e-05
) O 0 2.730536652961746e-05
of O 0 9.185793715005275e-06
the O 0 0.0002777636400423944
36 O 0 0.003970376215875149
patients O 1 0.9996258020401001
, O 0 0.00011249274393776432
a O 0 0.0005186909693293273
mutation O 0 0.0014913780614733696
was O 0 0.0005468286690302193
detected O 0 0.002285803435370326
in O 0 8.45321555971168e-05
constitutional O 0 0.0003247369022574276
DNA O 0 0.00039774642209522426
, O 0 5.3567848226521164e-05
and O 0 3.7521516787819564e-05
1 O 0 6.708782893838361e-05
of O 0 9.974586646421812e-06
these O 0 4.9103469791589305e-05
mutations O 0 0.0009175189188681543
is O 0 0.00011645113409031183
known O 0 0.0001426320377504453
to O 0 4.0233069739770144e-05
be O 0 4.6240184019552544e-05
associated O 0 0.0001069555728463456
with O 0 0.00013617741933558136
reduced O 0 0.0065506561659276485
expressivity O 1 0.989559531211853
. O 0 0.0013493114383891225

The O 0 0.00039022217970341444
presence O 0 0.0002932763600256294
of O 0 2.7616792067419738e-05
a O 0 0.0003918347938451916
constitutional O 0 0.0006565455114468932
mutation O 0 0.001621981500647962
was O 0 0.0003666788397822529
not O 0 6.589334952877834e-05
associated O 0 7.503760571125895e-05
with O 0 4.214375439914875e-05
an O 0 0.00013783550821244717
early O 0 0.0004651833442039788
age O 0 0.0010370865929871798
at O 0 0.002378621604293585
treatment O 1 0.9994251728057861
. O 0 0.001446214853785932

In O 0 0.0012886555632576346
1 O 0 0.003316764021292329
patient O 1 0.9979838132858276
, O 0 0.0007302496233023703
somatic O 0 0.08878818899393082
mosaicism O 1 0.9952753782272339
was O 0 0.0012852870859205723
demonstrated O 0 0.0012807686580345035
by O 0 5.500098268385045e-05
molecular O 0 0.0003075462591368705
analysis O 0 5.7332894357386976e-05
of O 0 2.0434148609638214e-05
DNA O 0 0.00032446428667753935
and O 0 6.967721128603444e-05
RNA O 0 0.0009091615793295205
from O 0 0.00039629495586268604
peripheral O 1 0.9984476566314697
blood O 1 0.9809818267822266
. O 0 0.0015321711543947458

In O 0 0.0013509251875802875
2 O 0 0.0029159162659198046
patients O 1 0.9973722696304321
without O 0 0.00023072463227435946
a O 0 0.0006067845970392227
detectable O 0 0.006451818626374006
mutation O 0 0.0016821231693029404
in O 0 0.000368487584637478
peripheral O 1 0.9990593791007996
blood O 1 0.9967876672744751
, O 0 0.000925178115721792
mosaicism O 1 0.9949014186859131
was O 0 0.0008178502321243286
suggested O 0 0.0005681265611201525
because O 0 0.00013387957005761564
1 O 0 9.372292697662488e-05
of O 0 1.9509356206981465e-05
the O 0 0.001480701263062656
patients O 1 0.9999814033508301
showed O 1 0.9650317430496216
multifocal O 1 0.9999818801879883
tumors B-Disease 1 0.9999681711196899
and O 0 0.00013995093468111008
the O 0 0.00012294886982999742
other O 0 7.047066901577637e-05
later O 0 0.00042328471317887306
developed O 0 0.009611076675355434
bilateral B-Disease 1 0.5922496318817139
retinoblastoma I-Disease 1 0.999482274055481
. O 0 0.0013435654109343886

In O 0 0.000871555763296783
conclusion O 0 0.0012791026383638382
, O 0 0.00013741437578573823
our O 0 0.0002120502758771181
results O 0 0.00019930090638808906
emphasize O 0 0.0006622819346375763
that O 0 3.0457464163191617e-05
the O 0 0.0001293558452744037
manifestation O 1 0.7961263060569763
and O 0 0.000425612844992429
transmissibility O 1 0.875421941280365
of O 0 0.00022209783492144197
retinoblastoma B-Disease 1 0.9995604157447815
depend O 0 0.0006997946184128523
on O 0 8.149677887558937e-05
the O 0 9.828910697251558e-05
nature O 0 0.00025353828095830977
of O 0 1.0902017493208405e-05
the O 0 6.498880975414068e-05
first O 0 9.414741361979395e-05
mutation O 0 0.0005306407692842185
, O 0 4.7977348003769293e-05
its O 0 6.302800466073677e-05
time O 0 5.5197131587192416e-05
in O 0 7.283662853296846e-05
development O 0 0.0005395200569182634
, O 0 7.106574776116759e-05
and O 0 3.117995584034361e-05
the O 0 3.879110226989724e-05
number O 0 1.7191836377605796e-05
and O 0 3.581280543585308e-05
types O 0 0.00014577469846699387
of O 0 2.976621181005612e-05
cells O 0 0.0033215642906725407
that O 0 4.080891085322946e-05
are O 0 3.917493449989706e-05
affected O 0 0.0032127362210303545
. O 0 0.00017457145440857857
. O 0 0.00046060082968324423

Hereditary B-Disease 1 0.997928261756897
deficiency I-Disease 1 0.9998311996459961
of I-Disease 0 6.693619070574641e-05
the I-Disease 0 0.00017763399227987975
fifth I-Disease 0 0.0007306356565095484
component I-Disease 0 0.0006185013917274773
of I-Disease 0 2.0811428839806467e-05
complement I-Disease 0 0.0009230319992639124
in O 0 0.00028766202740371227
man O 0 0.008738529868423939
. O 0 0.0008102788706310093

I O 0 0.059916745871305466
. O 0 0.002149002393707633

Clinical O 1 0.9974353909492493
, O 0 0.0014595597749575973
immunochemical O 1 0.7866044640541077
, O 0 0.0003108202654402703
and O 0 0.00019862971385009587
family O 0 0.000946617394220084
studies O 0 0.0010423720814287663
. O 0 0.0006440924480557442

The O 0 0.0006120533216744661
first O 0 0.0004204018332529813
recognized O 0 0.0021716756746172905
human O 0 0.004049957729876041
kindred O 1 0.9977401494979858
with O 0 0.0015644148224964738
hereditary B-Disease 1 0.9992402791976929
deficiency I-Disease 1 0.999969482421875
of I-Disease 0 4.2164861952187493e-05
the I-Disease 0 0.0001806465006666258
fifth I-Disease 0 0.0008193600224331021
component I-Disease 0 0.0007208221941255033
of I-Disease 0 3.6681947676697746e-05
complement I-Disease 0 0.002547517418861389
( O 0 0.0012463179882615805
C5 O 1 0.9915545582771301
) O 0 0.0003243696701247245
is O 0 0.00044509494910016656
described O 0 0.0033737346529960632
. O 0 0.0008359197527170181

The O 0 0.0011657553259283304
proband O 0 0.018518313765525818
, O 0 0.0001513706665718928
a O 0 0.0003111724799964577
20 O 0 0.0004229029582347721
- O 0 0.0013841596664860845
year O 0 0.00044433819130063057
- O 0 0.003508227411657572
old O 0 0.0017304543871432543
black O 0 0.008800962008535862
female O 0 0.006133744493126869
with O 1 0.7787947058677673
systemic B-Disease 1 0.9999998807907104
lupus I-Disease 1 0.9999998807907104
erythematosus I-Disease 1 0.9999988079071045
since O 0 0.009281126782298088
age O 0 0.0011713129933923483
11 O 0 0.000847118441015482
, O 0 0.0004697012482210994
lacked O 1 0.9502487778663635
serum O 1 0.9989880919456482
hemolytic O 1 0.9998544454574585
complement O 0 0.0024082164745777845
activity O 0 0.0006489237421192229
, O 0 0.0002757734910119325
even O 0 0.0005049732862971723
during O 0 0.002697312505915761
remission O 1 0.9979196190834045
. O 0 0.0014018741203472018

C5 O 1 0.9760476350784302
was O 0 0.007136089727282524
undetectable O 1 0.972252368927002
in O 0 0.00035465130349621177
her O 0 0.0026766362134367228
serum O 1 0.7882677316665649
by O 0 0.00016562937526032329
both O 0 0.0005118357366882265
immunodiffusion O 1 0.9486081004142761
and O 0 0.0019222887931391597
hemolytic O 1 0.9997522234916687
assays O 0 0.008466248400509357
. O 0 0.0015551360556855798

Other O 0 0.00018022619769908488
complement O 0 0.0009770832257345319
components O 0 0.00042493664659559727
were O 0 5.603701720247045e-05
normal O 0 0.0013198464876040816
during O 0 0.0017374312737956643
remission O 1 0.9990816116333008
of O 0 0.000692324829287827
lupus O 1 0.9999988079071045
, O 0 0.0006659472710452974
but O 0 0.000965531449764967
C1 O 1 0.9994811415672302
, O 0 0.0005341297364793718
C4 O 1 0.9626621603965759
, O 0 0.0007081596995703876
C2 O 1 0.9992181062698364
, O 0 0.000354654184775427
and O 0 0.00037445759517140687
C3 O 1 0.9974886178970337
levels O 0 0.005405838135629892
fell O 0 0.0122499605640769
during O 0 0.00398901104927063
exacerbations O 1 0.9972176551818848
. O 0 0.0018972484394907951

A O 0 0.004937204997986555
younger O 0 0.003053834894672036
half O 0 0.0006833311053924263
- O 0 0.00886374432593584
sister O 0 0.0024133308324962854
, O 0 0.000175872613908723
who O 0 0.0004418937605805695
had O 0 0.0005178111605346203
no O 0 0.0005455339560285211
underlying O 1 0.9991886019706726
disease O 1 0.9999923706054688
, O 0 0.0003035383124370128
was O 0 0.0007822984480299056
also O 0 0.00011657646246021613
found O 0 0.00013326782209333032
to O 0 0.00010409692913526669
lack O 0 0.007888219319283962
immunochemically O 1 0.9848567247390747
detectable O 0 0.19074325263500214
C5 O 1 0.9772005677223206
. O 0 0.001213293755427003

By O 0 0.004809179808944464
hemolytic O 1 0.9993534684181213
assay O 0 0.013649950735270977
, O 0 0.000557745574042201
she O 0 0.0012030252255499363
exhibited O 0 0.0036828138399869204
1 O 0 0.000506338314153254
- O 0 0.0005985415773466229
2 O 0 6.152880087029189e-05
% O 0 8.354902092833072e-06
of O 0 8.076795893430244e-06
the O 0 0.00024026665778364986
normal O 0 0.007493539247661829
serum O 1 0.9885324239730835
C5 O 1 0.9810830354690552
level O 0 0.001192450406961143
and O 0 0.0001659990375628695
normal O 0 0.0011252299882471561
concentrations O 0 0.0005863681435585022
of O 0 1.1222087778151035e-05
other O 0 5.683870767825283e-05
complement O 0 0.0016738190315663815
components O 0 0.002093643182888627
. O 0 0.000945060164667666

C5 O 1 0.9547608494758606
levels O 0 0.0017365497769787908
of O 0 2.9196180548751727e-05
other O 0 7.132849714253098e-05
family O 0 0.0003337712842039764
members O 0 8.22301153675653e-05
were O 0 3.4535802114987746e-05
either O 0 0.000129372623632662
normal O 0 0.000602384505327791
or O 0 7.794934208504856e-05
approximately O 0 0.00017919449601322412
half O 0 0.00027801343821920455
- O 0 0.002465707715600729
normal O 0 0.0010150925954803824
, O 0 0.00012399991101119667
consistent O 0 0.0015161184128373861
with O 0 0.0002908826572820544
autosomal O 1 0.9718056321144104
codominant O 0 0.37068673968315125
inheritance O 0 0.0008014888153411448
of O 0 2.6943362172460184e-05
the O 0 0.0003166997339576483
gene O 0 0.0035880012437701225
determining O 0 0.013363167643547058
C5 B-Disease 1 0.9998419284820557
deficiency I-Disease 1 0.9999916553497314
. O 0 0.0018815464572981

Normal O 1 0.8751897811889648
hemolytic O 1 0.9998821020126343
titers O 1 0.9889147877693176
were O 0 0.0002114046656060964
restored O 0 0.0012936838902533054
to O 0 6.410815694835037e-05
both O 0 0.0002233051782241091
homozygous O 0 0.010177940130233765
C5 B-Disease 1 0.9988021850585938
- I-Disease 1 0.9386049509048462
deficient I-Disease 1 0.9994766116142273
( O 0 0.0029297666624188423
C5D B-Disease 1 0.9986507296562195
) O 0 0.0006269599543884397
sera O 0 0.010957643389701843
by O 0 2.7314950784784742e-05
addition O 0 7.198969251476228e-05
of O 0 2.656788274180144e-05
highly O 0 0.0038100499659776688
purified O 0 0.05255814641714096
human O 0 0.005011125933378935
C5 O 1 0.9865745902061462
. O 0 0.0012251314474269748

In O 0 0.0009638861520215869
specific O 0 0.0016406866488978267
C5 O 1 0.9879565834999084
titrations O 1 0.9561871886253357
, O 0 0.00036166864447295666
however O 0 0.00020768812100868672
, O 0 0.00010394982382422313
it O 0 0.00010264028969686478
was O 0 0.0003028457867912948
noted O 0 0.0002832331520039588
that O 0 3.833158189081587e-05
when O 0 9.664075332693756e-05
limited O 0 0.00014576288231182843
amounts O 0 0.00012682541273534298
of O 0 4.9524460337124765e-05
C5 O 1 0.9769973754882812
were O 0 5.666525612468831e-05
assayed O 0 0.0015288528520613909
in O 0 4.648800313589163e-05
the O 0 5.981047434033826e-05
presence O 0 0.00017479264352004975
of O 0 3.599269257392734e-05
low O 0 0.002765603829175234
dilutions O 0 0.04631789028644562
of O 0 0.00011004968837369233
either O 0 0.0020755345467478037
C5D B-Disease 1 0.9989713430404663
serum O 1 0.9720397591590881
, O 0 0.0002889373863581568
curving O 0 0.004307471215724945
rather O 0 0.00019348750356584787
than O 0 0.00014825772086624056
linear O 0 0.0037592763546854258
dose O 1 0.90172278881073
- O 0 0.0047282204031944275
response O 0 0.0007624380523338914
plots O 0 0.0004451572895050049
were O 0 6.304351700237021e-05
consistently O 0 0.0021043499000370502
obtained O 0 0.00034805102040991187
, O 0 0.00013309407222550362
suggesting O 0 0.0009147905511781573
some O 0 9.998407767852768e-05
inhibitory O 0 0.0028941375203430653
effect O 0 0.0015910532092675567
. O 0 0.0006264735129661858

Further O 0 0.0013026045635342598
studies O 0 0.0005557259428314865
suggested O 0 0.0006190408021211624
that O 0 6.800188566558063e-05
low O 0 0.0015393984504044056
dilutions O 0 0.11800282448530197
of O 0 0.0001647203171160072
C5D B-Disease 1 0.9986894726753235
serum O 1 0.5116215944290161
contain O 0 0.0003656339249573648
a O 0 0.00042309428681619465
factor O 0 0.0012468536151573062
( O 0 0.0003377232060302049
or O 0 0.0001689954660832882
factors O 0 0.00024340800882782787
) O 0 0.0001266413601115346
interfering O 0 0.001531881047412753
at O 0 0.0001761253661243245
some O 0 5.7370034483028576e-05
step O 0 0.001022543990984559
in O 0 0.00016691343626007438
the O 0 0.0008033820195123553
hemolytic O 1 0.9997146725654602
assay O 0 0.003391381585970521
of O 0 0.00014814299356658012
C5 O 1 0.9928268790245056
, O 0 0.0001225130254169926
rather O 0 0.00010594465129543096
than O 0 0.00010280974674969912
a O 0 0.0005600916920229793
true O 0 0.0024621025659143925
C5 O 1 0.9948008060455322
inhibitor O 1 0.651689350605011
or O 0 0.0011782486690208316
inactivator O 1 0.6546581983566284
. O 0 0.0012722760438919067

Of O 0 0.0003947387158405036
clinical O 1 0.9897258877754211
interest O 0 0.00017028869478963315
are O 0 3.7566700484603643e-05
( O 0 0.0001746380585245788
a O 0 0.00021345482673496008
) O 0 4.455873931874521e-05
the O 0 4.998864824301563e-05
documentation O 0 0.0004841145419050008
of O 0 0.0002177087590098381
membranous O 1 0.9997184872627258
glomerulonephritis B-Disease 1 0.9999817609786987
, O 0 0.22472703456878662
vasculitis B-Disease 1 0.9999822378158569
, O 0 0.004829116631299257
and O 0 0.47707515954971313
arthritis B-Disease 1 1.0
in O 0 0.00019469650578685105
an O 0 0.0002171628875657916
individual O 0 0.0008140513091348112
lacking O 1 0.9721460938453674
C5 O 1 0.9973481893539429
( O 0 0.0005407290882430971
and O 0 7.696915417909622e-05
its O 0 0.00017367854889016598
biologic O 0 0.058252379298210144
functions O 0 0.0002073220966849476
) O 0 0.00010249191109323874
, O 0 7.157023355830461e-05
and O 0 7.989989535417408e-05
( O 0 0.000321138504659757
b O 0 0.0012874826788902283
) O 0 5.941261406405829e-05
a O 0 0.0001977481588255614
remarkable O 0 0.0034217152278870344
propensity O 1 0.818606972694397
to O 0 0.001328017795458436
bacterial B-Disease 1 0.9999165534973145
infections I-Disease 1 0.9999847412109375
in O 0 0.0002271115517942235
the O 0 0.00043519848259165883
proband O 1 0.9771725535392761
, O 0 0.000122975223348476
even O 0 0.00013123911048751324
during O 0 0.00018511097005102783
periods O 0 0.00026462788810022175
of O 0 3.375775850145146e-05
low O 0 0.0036171902902424335
- O 0 0.003349245060235262
dose O 0 0.0077571808360517025
or O 0 0.00019629958842415363
alternate O 0 0.0009046802879311144
- O 0 0.006471223197877407
day O 0 0.003421891015022993
corticosteroid O 1 0.9994589686393738
therapy O 1 0.9981504082679749
. O 0 0.001261474913917482

Other O 0 0.0002424380072625354
observations O 0 0.0008168485946953297
indicate O 0 0.0005092703504487872
that O 0 9.610122651793063e-05
the O 0 0.0004165716818533838
C5D B-Disease 1 0.9951950907707214
state O 0 0.00012452660303097218
is O 0 0.00010884022776735947
compatible O 0 0.0004224319418426603
with O 0 7.803323387634009e-05
normal O 0 0.002343841129913926
coagulation O 0 0.17982016503810883
function O 0 0.0002093282964779064
and O 0 3.9876762457424775e-05
the O 0 7.521477527916431e-05
capacity O 0 0.0006473757093772292
to O 0 0.00021341981482692063
mount O 0 0.12804782390594482
a O 0 0.004273491911590099
neutrophilic O 1 0.999175488948822
leukocytosis O 1 0.9979363679885864
during O 0 0.1345990002155304
pyogenic B-Disease 1 0.9995805621147156
infection I-Disease 1 0.9998509883880615
. O 0 0.0007697956752963364
. O 0 0.0010579741792753339

Susceptibility O 1 0.9897666573524475
to O 0 0.056248441338539124
ankylosing B-Disease 1 0.999997615814209
spondylitis I-Disease 1 0.9999988079071045
in O 0 0.004445715807378292
twins O 0 0.387403666973114
: O 0 0.00011417963833082467
the O 0 4.515305772656575e-05
role O 0 0.00023634643002878875
of O 0 3.362006100360304e-05
genes O 0 0.0006738547817803919
, O 0 0.0006739447708241642
HLA O 1 0.9984294772148132
, O 0 0.00015392700152006
and O 0 7.656493107788265e-05
the O 0 0.00026617117691785097
environment O 0 0.003124827751889825
. O 0 0.0008260305039584637

OBJECTIVE O 0 0.007859962992370129
To O 0 0.000272512377705425
determine O 0 0.00025183832622133195
the O 0 8.78700811881572e-05
relative O 0 0.0003742861154023558
effects O 0 0.0015675214817747474
of O 0 4.232281935401261e-05
genetic O 0 0.0015628790715709329
and O 0 0.00013644892896991223
environmental O 0 0.0032989270985126495
factors O 0 0.0003209132410120219
in O 0 0.00033575770794413984
susceptibility O 1 0.9931257963180542
to O 0 0.03747578337788582
ankylosing B-Disease 1 0.9999991655349731
spondylitis I-Disease 1 0.9999995231628418
( O 0 0.01708153262734413
AS B-Disease 0 0.05712325498461723
) O 0 0.0005897237570025027
. O 0 0.0006298221996985376

METHODS O 0 0.006509359460324049
Twins O 0 0.016495730727910995
with O 0 0.00018928557983599603
AS B-Disease 0 0.0011285427026450634
were O 0 4.014936348539777e-05
identified O 0 0.0001834452705224976
from O 0 3.6745004763361067e-05
the O 0 0.00013483788643497974
Royal O 0 0.01002342626452446
National O 1 0.6327322125434875
Hospital O 1 0.9999551773071289
for O 0 0.3947795331478119
Rheumatic B-Disease 1 0.9999996423721313
Diseases I-Disease 1 0.9999868869781494
database O 0 0.010534413158893585
. O 0 0.0009693661704659462

Clinical O 1 0.9969351291656494
and O 0 0.0014435440534725785
radiographic O 1 0.996863842010498
examinations O 0 0.018547076731920242
were O 0 5.331349530024454e-05
performed O 0 0.0003494707343634218
to O 0 0.00013390305684879422
establish O 0 0.00775021081790328
diagnoses O 1 0.9997674822807312
, O 0 0.0009550802642479539
and O 0 0.0702657401561737
disease O 1 0.9999970197677612
severity O 1 0.9994545578956604
was O 0 0.0014253719709813595
assessed O 0 0.003053955500945449
using O 0 8.150424400810152e-05
a O 0 0.0002362774539506063
combination O 0 0.0006767315790057182
of O 0 3.1779269193066284e-05
validated O 0 0.002227005548775196
scoring O 0 0.0003605870879255235
systems O 0 0.006047651171684265
. O 0 0.0008568504708819091

HLA O 1 0.9783411622047424
typing O 0 0.014326144941151142
for O 0 0.0014346691314131021
HLA O 1 0.996239185333252
- O 0 0.00990413036197424
B27 O 0 0.024977846071124077
, O 0 0.0011000202503055334
HLA O 1 0.9927754402160645
- O 0 0.005077483132481575
B60 O 0 0.009111928753554821
, O 0 0.00027804315323010087
and O 0 0.0006127431988716125
HLA O 1 0.9974697828292847
- O 0 0.073802649974823
DR1 O 1 0.9875245094299316
was O 0 0.0007249549380503595
performed O 0 0.00036949836066924036
by O 0 9.187035902868956e-05
polymerase O 0 0.0020281097386032343
chain O 0 0.0016504427185282111
reaction O 0 0.0003804785665124655
with O 0 5.446639988804236e-05
sequence O 0 0.00013557817146647722
- O 0 0.001158379833213985
specific O 0 0.00013325994950719178
primers O 0 0.003864262718707323
, O 0 0.00015206301759462804
and O 0 0.000218977642362006
zygosity O 1 0.653814971446991
was O 0 0.0005641712341457605
assessed O 0 0.0024193122517317533
using O 0 0.00029105774592608213
microsatellite O 0 0.025178221985697746
markers O 0 0.005322696641087532
. O 0 0.000992417917586863

Genetic O 0 0.0054939016699790955
and O 0 0.00027684067026712
environmental O 0 0.001935690175741911
variance O 0 0.00025413872208446264
components O 0 0.0003490465460345149
were O 0 6.084053893573582e-05
assessed O 0 0.0016622109105810523
with O 0 5.66223643545527e-05
the O 0 0.0002605948247946799
program O 0 0.004826280754059553
Mx O 1 0.7706944346427917
, O 0 7.257877587107942e-05
using O 0 3.523178384057246e-05
data O 0 2.983205922646448e-05
from O 0 2.4610089894849807e-05
this O 0 2.706571285671089e-05
and O 0 4.007087409263477e-05
previous O 0 0.00014310448023024946
studies O 0 0.00014646339695900679
of O 0 4.8142064770217985e-05
twins O 0 0.13766628503799438
with O 0 0.000198013469344005
AS B-Disease 0 0.008083350956439972
. O 0 0.0007166147115640342

RESULTS O 0 0.0018687661504372954
Six O 0 0.00020644273899961263
of O 0 6.215857865754515e-05
8 O 0 0.0021183767821639776
monozygotic O 1 0.9671726822853088
( O 0 0.0029249610379338264
MZ O 1 0.9971590042114258
) O 0 0.0007572034373879433
twin O 0 0.008140078745782375
pairs O 0 0.0010756754782050848
were O 0 0.0005459240637719631
disease O 1 0.9998995065689087
concordant O 0 0.282613068819046
, O 0 0.0001874771696748212
compared O 0 0.0002200049493694678
with O 0 4.107432687305845e-05
4 O 0 0.00013994159235153347
of O 0 2.4588718588347547e-05
15 O 0 0.0007108169957064092
B27 O 0 0.022959426045417786
- O 0 0.0034611548762768507
positive O 0 0.002099165692925453
dizygotic O 1 0.599157452583313
( O 0 0.002109165769070387
DZ O 1 0.9813687801361084
) O 0 0.0006812146166339517
twin O 0 0.004020968452095985
pairs O 0 0.0007188921445049345
( O 0 0.0003705026174429804
27 O 0 0.0004342126485425979
% O 0 3.135098813800141e-05
) O 0 5.2802872232859954e-05
and O 0 3.564710641512647e-05
4 O 0 0.00011930231266887859
of O 0 2.2060419723857194e-05
32 O 0 0.0012904246104881167
DZ O 1 0.9895185828208923
twin O 0 0.004981210455298424
pairs O 0 0.00042768544517457485
overall O 0 0.0012263216776773334
( O 0 0.0003735218779183924
12 O 0 0.0002155223919544369
. O 0 5.421817331807688e-05
5 O 0 0.0001718403655104339
% O 0 5.842650352860801e-05
) O 0 0.00023586330644320697
. O 0 0.00041387497913092375

Nonsignificant O 1 0.7712355256080627
increases O 0 0.002194453962147236
in O 0 0.00012004314339719713
similarity O 0 0.0004179505631327629
with O 0 8.968506881501526e-05
regard O 0 0.0006895923870615661
to O 0 0.00019377052376512438
age O 0 0.002515798667445779
at O 0 0.16197538375854492
disease O 1 0.9999899864196777
onset O 1 0.9993933439254761
and O 0 6.706895510433242e-05
all O 0 1.8227281543659046e-05
of O 0 3.717237996170297e-05
the O 0 0.013572587631642818
disease O 1 0.9999957084655762
severity O 1 0.9989404082298279
scores O 0 0.0007273076334968209
assessed O 0 0.0050809672102332115
were O 0 5.310758206178434e-05
noted O 0 0.0008926857262849808
in O 0 0.001181043335236609
disease O 1 0.9999722242355347
- O 1 0.7869446277618408
concordant O 1 0.9757553935050964
MZ O 1 0.9978861212730408
twins O 0 0.047272153198719025
compared O 0 0.001658149529248476
with O 0 0.0007947247358970344
concordant O 1 0.9645273089408875
DZ O 1 0.9973425269126892
twins O 0 0.46922898292541504
. O 0 0.0015635443851351738

HLA O 1 0.9936363697052002
- O 0 0.022787224501371384
B27 O 0 0.01850423775613308
and O 0 0.0003171215648762882
B60 O 0 0.008513227105140686
were O 0 6.641120853601024e-05
associated O 0 0.00017955161456484348
with O 0 0.00012177563621662557
the O 0 0.00125855952501297
disease O 1 0.9999560117721558
in O 0 0.0003498005971778184
probands O 1 0.9114760756492615
, O 0 8.508776227245107e-05
and O 0 3.634655149653554e-05
the O 0 7.420406473102048e-05
rate O 0 0.00017381772340741009
of O 0 0.0001554768969072029
disease O 1 0.9999701976776123
concordance O 0 0.008077182807028294
was O 0 0.000980921322479844
significantly O 0 0.003234133357182145
increased O 0 0.0005044739227741957
among O 0 0.0004536944325082004
DZ O 1 0.9913422465324402
twin O 0 0.005345544777810574
pairs O 0 0.00024546869099140167
in O 0 8.256122237071395e-05
which O 0 6.966193177504465e-05
the O 0 0.00029441769584082067
co O 0 0.25971218943595886
- O 0 0.012134561315178871
twin O 0 0.006293873768299818
was O 0 0.0003741439140867442
positive O 0 0.00041761063039302826
for O 0 0.00010698249388951808
both O 0 0.0003205117827747017
B27 O 0 0.05758196860551834
and O 0 0.001035995432175696
DR1 O 1 0.9949936270713806
. O 0 0.0017426145495846868

Additive O 0 0.011850076727569103
genetic O 0 0.003709155600517988
effects O 0 0.0025772119406610727
were O 0 6.362664862535894e-05
estimated O 0 0.0003265742852818221
to O 0 9.806273737922311e-05
contribute O 0 0.0017882771790027618
97 O 0 0.0007668369798921049
% O 0 1.2455356227292214e-05
of O 0 6.831880909885513e-06
the O 0 7.548653229605407e-05
population O 0 7.943359378259629e-05
variance O 0 0.0005984446033835411
. O 0 0.0006798055255785584

CONCLUSION O 0 0.018833253532648087
Susceptibility O 0 0.0701662003993988
to O 0 0.00040419434662908316
AS B-Disease 0 0.00240927841514349
is O 0 0.0002615778357721865
largely O 0 0.0005381371593102813
genetically O 0 0.000996622839011252
determined O 0 0.0006833538645878434
, O 0 9.562851482769474e-05
and O 0 5.167389099369757e-05
the O 0 0.00010858603491215035
environmental O 0 0.004083964042365551
trigger O 0 0.006652049720287323
for O 0 0.000252638419624418
the O 0 0.0022535191383212805
disease O 1 0.999980092048645
is O 0 0.0010000765323638916
probably O 0 0.0028542554937303066
ubiquitous O 0 0.02151581645011902
. O 0 0.0012109556701034307

HLA O 1 0.9906586408615112
- O 0 0.015180897898972034
B27 O 0 0.007951456122100353
accounts O 0 0.00012812603381462395
for O 0 6.938626029295847e-05
a O 0 0.00017547649622429162
minority O 0 0.00014310135156847537
of O 0 1.0971722076646984e-05
the O 0 0.00012236394104547799
overall O 0 0.001730730989947915
genetic O 0 0.0017431621672585607
susceptibility O 0 0.3686947524547577
to O 0 0.0002746360842138529
AS B-Disease 0 0.0109670115634799
. O 0 0.0007399250171147287

Cell O 0 0.008373034186661243
cycle O 0 0.004000161774456501
- O 0 0.00441485783085227
dependent O 0 0.0021939342841506004
colocalization O 0 0.017032427713274956
of O 0 0.00013938359916210175
BARD1 O 1 0.9918900728225708
and O 0 0.0004610012110788375
BRCA1 O 1 0.9596695899963379
proteins O 0 0.00011538094986462966
in O 0 8.344183152075857e-05
discrete O 0 0.0010563014075160027
nuclear O 0 0.002820973051711917
domains O 0 0.002139471238479018
. O 0 0.0008543174481019378

Germ O 1 0.9826135039329529
- O 0 0.008156904950737953
line O 0 0.0010671238414943218
mutations O 0 0.00048478596727363765
of O 0 3.0491031793644652e-05
the O 0 0.000592196942307055
BRCA1 O 1 0.9969924688339233
gene O 0 0.003996430896222591
predispose O 0 0.1117761880159378
women O 0 0.0003930615202989429
to O 0 0.0001227726461365819
early O 0 0.0016351536614820361
- O 1 0.99444580078125
onset O 1 0.9999377727508545
breast B-Disease 1 0.9999942779541016
and I-Disease 1 0.9874073266983032
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999978542327881
by O 0 0.00021121971076354384
compromising O 0 0.247902512550354
the O 0 0.0002467277809046209
genes O 0 0.0008765114471316338
presumptive O 0 0.4012097716331482
function O 0 0.0005021581309847534
as O 0 0.00025686659500934184
a O 0 0.003835890907794237
tumor B-Disease 1 0.9993650317192078
suppressor O 0 0.31679490208625793
. O 0 0.0011567500187084079

Although O 0 0.0009081409079954028
the O 0 0.0002521335845813155
biochemical O 0 0.003749484894797206
properties O 0 0.0009102285839617252
of O 0 0.00022494529548566788
BRCA1 O 1 0.9980663657188416
polypeptides O 0 0.004938461352139711
are O 0 6.059012594050728e-05
not O 0 0.0001466754183638841
understood O 0 0.0012233443558216095
, O 0 5.402777242125012e-05
their O 0 3.062601899728179e-05
expression O 0 0.0004229449259582907
pattern O 0 0.0015460257418453693
and O 0 0.000113134432467632
subcellular O 0 0.0036073254887014627
localization O 0 0.002790433121845126
suggest O 0 0.000536598265171051
a O 0 0.00026440140209160745
role O 0 0.0006563852657563984
in O 0 0.00024359930830541998
cell O 0 0.0037494294811040163
- O 0 0.0026960966642946005
cycle O 0 0.0012895824620500207
regulation O 0 0.0016585109988227487
. O 0 0.000770932121668011

When O 0 0.005116485990583897
resting O 0 0.4881228804588318
cells O 0 0.003561750752851367
are O 0 0.00010114140604855493
induced O 0 0.20071403682231903
to O 0 0.0002317750040674582
proliferate O 0 0.0064682685770094395
, O 0 8.605815673945472e-05
the O 0 9.957038128050044e-05
steady O 0 0.0023507375735789537
- O 0 0.0011391306761652231
state O 0 9.331190085504204e-05
levels O 0 0.0005464727873913944
of O 0 7.488206756534055e-05
BRCA1 O 1 0.9875683188438416
increase O 0 0.00040858122520148754
in O 0 0.0002046204317593947
late O 0 0.0019517913460731506
G1 O 1 0.6822775602340698
and O 0 6.953065894776955e-05
reach O 0 0.0002115946263074875
a O 0 0.00026006222469732165
maximum O 0 0.0005489768809638917
during O 0 0.001537391566671431
S O 1 0.7329950332641602
phase O 0 0.006721722427755594
. O 0 0.0009096130961552262

Moreover O 0 0.005339030642062426
, O 0 0.00034814164973795414
in O 0 0.0004894430749118328
S O 1 0.558704674243927
phase O 0 0.008549834601581097
cells O 0 0.004251666832715273
, O 0 0.000592837342992425
BRCA1 O 1 0.98434978723526
polypeptides O 0 0.0040492042899131775
are O 0 0.00012363932910375297
hyperphosphorylated O 0 0.049178436398506165
and O 0 0.00018142016779165715
accumulate O 0 0.003304362529888749
into O 0 0.0001576784416101873
discrete O 0 0.002435109345242381
subnuclear O 0 0.22280506789684296
foci O 0 0.05142679065465927
termed O 0 0.21088248491287231
" O 0 0.004717395640909672
BRCA1 O 1 0.9877862930297852
nuclear O 0 0.00947076641023159
dots O 0 0.04881414398550987
. O 0 0.0010335220722481608

" O 0 0.01663655787706375
BRCA1 O 1 0.9955353736877441
associates O 0 0.3903140127658844
in O 0 0.0003357419918756932
vivo O 0 0.0025359748397022486
with O 0 0.00010435275180498138
a O 0 0.0007489238632842898
structurally O 0 0.49495387077331543
related O 0 0.0013757306151092052
protein O 0 0.001877821166999638
termed O 1 0.8934808969497681
BARD1 O 1 0.989974319934845
. O 0 0.0015599398175254464

Here O 0 0.0009608530672267079
we O 0 0.0001923209783853963
show O 0 0.00012974646233487874
that O 0 2.60881133726798e-05
the O 0 6.75386399962008e-05
steady O 0 0.0024876852985471487
- O 0 0.0011566646862775087
state O 0 8.545529271941632e-05
levels O 0 0.0005765175446867943
of O 0 6.847705662949011e-05
BARD1 O 1 0.9959012866020203
, O 0 0.00016003439668565989
unlike O 0 0.0003172285796608776
those O 0 5.297920142766088e-05
of O 0 0.00010389581439085305
BRCA1 O 1 0.9991375207901001
, O 0 0.00020255021809134632
remain O 0 0.0004960113437846303
relatively O 0 0.0004910333664156497
constant O 0 0.000619468919467181
during O 0 0.0012682852102443576
cell O 0 0.0050583784468472
cycle O 0 0.006599202286452055
progression O 1 0.9355477690696716
. O 0 0.0012643268564715981

However O 0 0.002011288655921817
, O 0 0.0008558403351344168
immunostaining O 1 0.5289067625999451
revealed O 0 0.007916963659226894
that O 0 0.0003160573251079768
BARD1 O 1 0.9842847585678101
resides O 0 0.005007361527532339
within O 0 0.0006476681446656585
BRCA1 O 1 0.9926716089248657
nuclear O 0 0.0056628393940627575
dots O 0 0.023082885891199112
during O 0 0.0013849864481016994
S O 0 0.029351141303777695
phase O 0 0.0006285192212089896
of O 0 1.2067925126757473e-05
the O 0 0.00012664678797591478
cell O 0 0.0012261372758075595
cycle O 0 0.0005801707739010453
, O 0 9.00301311048679e-05
but O 0 5.0475769967306405e-05
not O 0 3.687756179715507e-05
during O 0 0.0002401324309175834
the O 0 0.00033019771217368543
G1 O 1 0.9774836301803589
phase O 0 0.005442226305603981
. O 0 0.0006518972804769874

Nevertheless O 0 0.014757218770682812
, O 0 0.00162751495372504
BARD1 O 1 0.7640814185142517
polypeptides O 0 0.0029503717087209225
are O 0 4.324198016547598e-05
found O 0 0.00011940769763896242
exclusively O 0 9.711363964015618e-05
in O 0 3.331386687932536e-05
the O 0 5.024199344916269e-05
nuclear O 0 0.0002833044854924083
fractions O 0 7.891746645327657e-05
of O 0 1.9121986042591743e-05
both O 0 0.0003334297507535666
G1 O 1 0.9831231236457825
- O 0 0.003826824016869068
and O 0 0.00040019163861870766
S O 1 0.615147590637207
- O 0 0.0045494274236261845
phase O 0 0.004862126428633928
cells O 0 0.003331082407385111
. O 0 0.0008181752637028694

Therefore O 0 0.0026851273141801357
, O 0 0.0008629587828181684
progression O 1 0.8530293703079224
to O 0 0.0005247534136287868
S O 1 0.5982919931411743
phase O 0 0.0025821856688708067
is O 0 0.000167594087542966
accompanied O 0 0.00032860651845112443
by O 0 2.077506360365078e-05
the O 0 5.658905502059497e-05
aggregation O 0 0.0004207107122056186
of O 0 4.21225449827034e-05
nuclear O 0 0.005241215694695711
BARD1 O 1 0.6062513589859009
polypeptides O 0 0.003573545254766941
into O 0 0.000890237744897604
BRCA1 O 1 0.9692285060882568
nuclear O 0 0.0062511032447218895
dots O 0 0.03654417768120766
. O 0 0.0010630834149196744

This O 0 0.0006092950934544206
cell O 0 0.0031269092578440905
cycle O 0 0.0027636480517685413
- O 0 0.0034748371690511703
dependent O 0 0.0016424841014668345
colocalization O 0 0.013669174164533615
of O 0 0.00018921609444078058
BARD1 O 1 0.9868766069412231
and O 0 0.0006210056017152965
BRCA1 O 1 0.9937505125999451
indicates O 0 0.0008397974888794124
a O 0 0.0002638549485709518
role O 0 0.0005935791414231062
for O 0 0.0003548561071511358
BARD1 O 1 0.9815612435340881
in O 0 0.0008886986179277301
BRCA1 O 1 0.9981510043144226
- O 1 0.6454212069511414
mediated O 1 0.9675107002258301
tumor B-Disease 1 0.9992939233779907
suppression O 0 0.25612112879753113
. O 0 0.0012619278859347105

Ethnic O 0 0.0007040468626655638
differences O 0 0.00107279303483665
in O 0 0.0002507355238776654
the O 0 0.0008497947710566223
HFE O 1 0.9595582485198975
codon O 0 0.009948007762432098
282 O 0 0.019708843901753426
( O 0 0.004746222402900457
Cys O 1 0.9985451698303223
/ O 1 0.9127894639968872
Tyr O 1 0.991317868232727
) O 0 0.0005916195223107934
polymorphism O 0 0.0030208074022084475
. O 0 0.0010514321038499475

Recent O 0 0.002658272860571742
studies O 0 0.0005310762207955122
have O 0 9.662489173933864e-05
shown O 0 0.0005743826040998101
that O 0 0.0006448632921092212
hereditary B-Disease 1 0.9997683167457581
hemochromatosis I-Disease 1 0.999998927116394
( O 1 0.8164605498313904
HH B-Disease 1 0.9999783039093018
) O 0 0.0004765571793541312
is O 0 0.00027280120411887765
likely O 0 0.0003695563063956797
to O 0 4.8866073484532535e-05
be O 0 7.122911483747885e-05
caused O 0 0.002315344288945198
by O 0 9.164898801827803e-05
homozygosity O 0 0.01255240011960268
for O 0 0.00010868610843317583
a O 0 0.000626252091024071
Cys282Tyr O 0 0.08827619254589081
mutation O 0 0.0009811088675633073
in O 0 0.00011154751700814813
the O 0 0.0005487495800480247
HFE O 1 0.9944814443588257
gene O 0 0.0023140888661146164
located O 0 0.0010517797200009227
4 O 0 0.0012250258587300777
. O 0 0.0008180021541193128

5 O 0 0.006136550102382898
Mb O 1 0.523774266242981
telomeric O 1 0.5537133812904358
to O 0 0.001678192988038063
HLA O 1 0.9936495423316956
- O 0 0.005723507143557072
A O 0 0.002604306908324361
. O 0 0.0008532476495020092

Population O 0 0.0003314845962449908
studies O 0 0.00017191511869896203
of O 0 1.4889312296872959e-05
this O 0 5.3491021390073e-05
polymorphism O 0 0.0006202742224559188
are O 0 3.0839230021229014e-05
facilitated O 0 0.0014275982975959778
by O 0 4.595663631334901e-05
the O 0 7.320156146306545e-05
fact O 0 0.00016959678032435477
that O 0 4.458500552573241e-05
the O 0 0.00018473116506356746
Cys282Tyr O 0 0.3135499954223633
mutation O 0 0.0012902107555419207
creates O 0 0.0016439962200820446
a O 0 0.0011099635157734156
Rsal O 0 0.35866647958755493
restriction O 0 0.0014292295090854168
site O 0 0.0014673405094072223
. O 0 0.000706277322024107

We O 0 0.0006894380785524845
have O 0 0.00010946066322503611
studied O 0 0.00020932851475663483
the O 0 0.00019097626500297338
codon O 0 0.0037014067638665438
282 O 0 0.015293868258595467
( O 0 0.00442858599126339
Cys O 1 0.9975407123565674
/ O 1 0.9208821058273315
Tyr O 1 0.9919959902763367
) O 0 0.00025517132598906755
polymorphism O 0 0.0006674862233921885
in O 0 4.373541014501825e-05
different O 0 1.8914646716439165e-05
ethnic O 0 9.205523383570835e-05
groups O 0 0.00017480163660366088
. O 0 0.0007394379936158657

In O 0 0.0007691518985666335
agreement O 0 0.0007071535219438374
with O 0 0.0001013229921227321
previous O 0 0.0002855209168046713
observations O 0 0.0006731449393555522
the O 0 0.0006244833348318934
Tyr O 1 0.9966955184936523
allele O 0 0.00513174943625927
appeared O 0 0.0009084957418963313
to O 0 0.00011539911793079227
be O 0 0.0001269028289243579
rare O 0 0.0019309810595586896
or O 0 0.00036999446456320584
absent O 0 0.004166786093264818
in O 0 0.0003467694332357496
Asiatic O 1 0.9343220591545105
( O 0 0.000604459026362747
Indian O 0 0.000514113053213805
, O 0 0.00016840978059917688
Chinese O 0 0.0004285416507627815
) O 0 0.00023007461277302355
populations O 0 0.0006278117652982473
. O 0 0.0005341228097677231

The O 0 0.0005982216098345816
highest O 0 0.0017708434024825692
allele O 0 0.00200685509480536
frequency O 0 0.0003542959748301655
( O 0 0.00038921128725633025
7 O 0 0.00031603017123416066
. O 0 4.980782978236675e-05
5 O 0 0.00012480109580792487
% O 0 3.0412944397539832e-05
) O 0 9.585182124283165e-05
was O 0 0.00027920029242523015
found O 0 0.0001521349768154323
in O 0 0.00015011684445198625
Swedes O 0 0.0038523429539054632
. O 0 0.0007303045713342726

Saamis O 0 0.1058429554104805
( O 0 0.0007753488607704639
2 O 0 0.00024880823912099004
% O 0 5.953443906037137e-05
) O 0 0.00011789536802098155
and O 0 0.0001604217104613781
Mordvinians O 0 0.29611268639564514
( O 0 0.00030175631400197744
1 O 0 0.00022955902386456728
. O 0 4.423624704941176e-05
8 O 0 0.00019005472131539136
% O 0 4.174599962425418e-05
) O 0 0.00015442873700521886
had O 0 0.0003415502142161131
significantly O 0 0.001080708927474916
lower O 0 0.0003775774093810469
frequencies O 0 5.405390766100027e-05
of O 0 2.9723467378062196e-05
the O 0 0.0007057451293803751
Tyr O 1 0.9949354529380798
allele O 0 0.012764270417392254
. O 0 0.0016115859616547823

Comparisons O 0 0.0011392198503017426
with O 0 0.0002385585248703137
allele O 0 0.0019046419765800238
frequencies O 0 0.0001876647729659453
based O 0 0.0001434103469364345
on O 0 0.000257243518717587
prevalence O 0 0.36963599920272827
estimates O 0 0.0006911497330293059
of O 0 0.00021448670304380357
HH B-Disease 1 0.9998263716697693
showed O 0 0.0011986945755779743
some O 0 8.03742150310427e-05
disagreements O 0 0.0020633945241570473
with O 0 0.00010793792171170935
the O 0 0.0003492129617370665
RFLP O 0 0.3249237537384033
data O 0 0.00011578456906136125
, O 0 0.00012054522812832147
particularly O 0 0.0005982723087072372
in O 0 0.0002881428808905184
Finns O 0 0.014013505540788174
. O 0 0.0010857658926397562

The O 0 0.0015527433715760708
newly O 0 0.008032985962927341
described O 0 0.014331835322082043
HFE O 1 0.9904352426528931
marker O 0 0.006262867711484432
provides O 0 0.0009283706312999129
a O 0 0.00032695711706764996
new O 0 0.0001398540916852653
approach O 0 0.00037916217115707695
to O 0 3.309865860501304e-05
the O 0 7.291710062418133e-05
screening O 0 0.001986546441912651
of O 0 0.00020186422625556588
HH B-Disease 1 0.9999409914016724
as O 0 0.00013931342982687056
well O 0 9.032981324708089e-05
as O 0 6.431874498957768e-05
studies O 0 7.920907955849543e-05
of O 0 1.2492863788793329e-05
the O 0 0.00011232821270823479
relationship O 0 0.0015593650750815868
between O 0 0.0003050736559089273
the O 0 0.0015711734304204583
HFE O 1 0.998699426651001
Tyr O 1 0.9973245859146118
allele O 0 0.008182517252862453
and O 0 0.0004210086481180042
different O 0 0.0006316411891020834
disorders O 1 0.9999791383743286
including O 0 0.027858754619956017
cancer B-Disease 1 0.9999737739562988

Autosomal B-Disease 1 0.9935833811759949
dominant I-Disease 1 0.9755643010139465
neurohypophyseal I-Disease 1 0.9997177720069885
diabetes I-Disease 1 0.9999992847442627
insipidus I-Disease 1 0.9998970031738281
associated O 0 0.0010569667210802436
with O 0 0.00010875402222154662
a O 0 0.0008253093692474067
missense O 0 0.006031295284628868
mutation O 0 0.0011142456205561757
encoding O 0 0.001016503549180925
Gly23 O 1 0.6760140657424927
- O 0 0.012019581161439419
- O 0 0.01013195514678955
> O 0 0.0160786472260952
Val O 1 0.8564062714576721
in O 0 0.0007478480110876262
neurophysin O 1 0.9819366335868835
II O 1 0.9606201648712158
. O 0 0.0013723175507038832

Autosomal B-Disease 1 0.9826703667640686
dominant I-Disease 1 0.6432755589485168
neurohypophyseal I-Disease 1 0.9986186027526855
diabetes I-Disease 1 0.9999948740005493
insipidus I-Disease 1 0.9998084902763367
( O 0 0.007729270961135626
ADNDI B-Disease 1 0.9953043460845947
) O 0 0.00037021763273514807
is O 0 0.0005000414093956351
an O 0 0.0165169108659029
inherited B-Disease 1 0.9999945163726807
disease I-Disease 1 0.9999996423721313
caused O 1 0.9961142539978027
by O 0 0.0005754236481152475
progressive O 1 0.997260570526123
degeneration O 1 0.9999469518661499
of O 0 7.885321974754333e-05
the O 0 0.0006771986372768879
magnocellular O 1 0.9888585805892944
neurons O 0 0.004604818299412727
of O 0 3.9615388232050464e-05
the O 0 0.00046686676796525717
hypothalamus O 1 0.7261879444122314
leading O 0 0.0007213574717752635
to O 0 0.00013279617996886373
decreased O 0 0.0034891131799668074
ability O 0 0.000574070552829653
to O 0 4.2373823816888034e-05
produce O 0 0.00015431053179781884
the O 0 0.00025899228057824075
hormone O 1 0.6884234547615051
arginine O 0 0.0431060828268528
vasopressin O 1 0.8339710831642151
( O 0 0.004429248161613941
AVP O 1 0.9964545965194702
) O 0 0.0010641944827511907
. O 0 0.0007984624826349318

Affected O 0 0.020249875262379646
individuals O 0 0.0005546791362576187
are O 0 0.00011383273522369564
not O 0 0.00044028504635207355
symptomatic O 1 0.9996596574783325
at O 0 0.0005482009146362543
birth O 0 0.00121872138697654
, O 0 0.00015621946658939123
but O 0 0.0002461056283209473
usually O 0 0.0010446378728374839
develop O 1 0.9989251494407654
diabetes B-Disease 1 0.9999983310699463
insipidus I-Disease 1 0.9998977184295654
at O 0 0.0008244173950515687
1 O 0 0.0007458774489350617
- O 0 0.0030313204042613506
6 O 0 0.0009456280386075377
yr O 0 0.06211556866765022
of O 0 7.174666097853333e-05
age O 0 0.0014015549095347524
. O 0 0.0008130236528813839

The O 0 0.0004738809948321432
genetic O 0 0.0007988216821104288
locus O 0 0.0020342941861599684
of O 0 6.797938112867996e-05
the O 0 0.001330649945884943
disease O 1 0.9999681711196899
is O 0 0.0004410485562402755
the O 0 0.0008665348868817091
AVP O 1 0.9995205402374268
- O 0 0.273057222366333
neurophysin O 1 0.9049164652824402
II O 1 0.8866997361183167
( O 0 0.0017311216797679663
NPII O 1 0.9592640995979309
) O 0 0.00035584039869718254
gene O 0 0.0007114777690730989
, O 0 6.97774812579155e-05
and O 0 0.00011311534035485238
mutations O 0 0.0011692808475345373
that O 0 0.00021792393818031996
cause O 1 0.9524713158607483
ADNDI B-Disease 1 0.9971582889556885
have O 0 0.0001252622460015118
been O 0 0.00011284395441180095
found O 0 5.9877478634007275e-05
in O 0 2.1601435946649872e-05
both O 0 2.2725169401383027e-05
the O 0 5.066021913080476e-05
signal O 0 0.00045632239198312163
peptide O 0 0.0003411222714930773
of O 0 1.4196074516803492e-05
the O 0 0.0002724069054238498
prepro O 1 0.9454750418663025
- O 0 0.30452391505241394
AVP O 1 0.9973708391189575
- O 0 0.02078230120241642
NPII O 0 0.45960795879364014
precursor O 0 0.0029436564072966576
and O 0 0.00015691500448156148
within O 0 0.0004523876414168626
NPII O 1 0.9758970141410828
itself O 0 0.004890074487775564
. O 0 0.0009751273901201785

An O 0 0.0028900590259581804
affected O 0 0.053984809666872025
girl O 0 0.17374752461910248
who O 0 0.0005367420380935073
presented O 0 0.000391551002394408
at O 0 0.00024226008099503815
9 O 0 0.0004324195033404976
months O 0 0.0003650870348792523
of O 0 2.614933873701375e-05
age O 0 0.0004057101032231003
and O 0 0.00016673319623805583
her O 0 0.055744655430316925
similarly O 0 0.19982096552848816
affected O 0 0.3975706398487091
younger O 0 0.022601155564188957
brother O 0 0.004529420752078295
and O 0 0.0001880401832750067
father O 0 0.0010553825413808227
were O 0 2.0467909052968025e-05
all O 0 1.9263688955106772e-05
found O 0 8.44498208607547e-05
to O 0 3.176493919454515e-05
have O 0 3.944999843952246e-05
a O 0 0.00023147003958001733
novel O 0 0.0013774675317108631
missense O 0 0.007453542668372393
mutation O 0 0.002312241354957223
( O 0 0.0008493678760714829
G1758 O 0 0.35924673080444336
- O 0 0.02486206218600273
- O 0 0.013808773830533028
> O 0 0.013523074798285961
T O 0 0.15181829035282135
) O 0 4.3697349610738456e-05
encoding O 0 4.6647652197862044e-05
the O 0 2.9904151233495213e-05
amino O 0 0.00013150947052054107
acid O 0 0.001837488729506731
substitution O 0 0.0012462229933589697
Gly23 O 1 0.6838381290435791
- O 0 0.011975983157753944
- O 0 0.010018781758844852
> O 0 0.01539970375597477
Val O 1 0.5743623971939087
within O 0 0.0009448531782254577
NPII O 1 0.9518098831176758
. O 0 0.0012404696317389607

The O 0 0.0011214702390134335
mutation O 0 0.0032345883082598448
was O 0 0.0010044402442872524
confirmed O 0 0.0009656036272644997
by O 0 9.985706128645688e-05
restriction O 0 0.0011992816580459476
endonuclease O 0 0.029153568670153618
analysis O 0 0.0011172801023349166
. O 0 0.0011065364815294743

A O 0 0.017474090680480003
T1 O 1 0.9839375615119934
- O 0 0.0025792550295591354
weighted O 0 0.0005327829858288169
magnetic O 0 0.0009668399579823017
resonance O 0 0.002849612385034561
imaging O 0 0.014857827685773373
of O 0 3.121548434137367e-05
the O 0 0.00039761560037732124
fathers O 0 0.008358141407370567
pituitary O 1 0.998521625995636
gland O 1 0.9973631501197815
demonstrates O 0 0.01794486865401268
an O 0 0.0011485634604468942
attenuated O 1 0.9791145324707031
posterior O 1 0.9964985847473145
pituitary O 1 0.998717188835144
bright O 1 0.9859204888343811
spot O 0 0.010745497420430183
. O 0 0.0012194726150482893

This O 0 0.0008232939289882779
mutation O 0 0.003904839977622032
may O 0 0.0004936680197715759
be O 0 5.203412001719698e-05
valuable O 0 0.0004082659143023193
for O 0 0.00010356987331761047
developing O 0 0.001867811195552349
models O 0 0.00047747432836331427
of O 0 0.00018550216918811202
dominantly B-Disease 1 0.9979221224784851
inherited I-Disease 1 0.9996932744979858
neurodegeneration I-Disease 1 0.9999737739562988
, O 0 0.000249572069151327
as O 0 8.792841254035011e-05
the O 0 0.00010052642755908892
early O 0 0.00024288454733323306
age O 0 0.00021692262089345604
of O 0 0.00010713173833210021
onset O 1 0.9997628331184387
of O 0 0.0009153572027571499
symptoms O 1 0.9999938011169434
suggests O 0 0.006716718897223473
that O 0 6.526305514853448e-05
this O 0 9.14151532924734e-05
mutation O 0 0.0015883134910836816
may O 0 0.00033782896935008466
be O 0 5.102793511468917e-05
particularly O 0 0.00046231725718826056
deleterious O 0 0.0065063065849244595
to O 0 8.184873877326027e-05
the O 0 0.0003396990359760821
magnocellular O 1 0.991731584072113
neuron O 1 0.9605281949043274
. O 0 0.0004289671196602285
. O 0 0.0008417972130700946

Frequent O 0 0.02232496254146099
inactivation O 0 0.131230890750885
of O 0 0.0011181170120835304
PTEN O 1 0.9995253086090088
/ O 1 0.9803029298782349
MMAC1 O 1 0.990915834903717
in O 0 0.0018462436273694038
primary O 1 0.9968630075454712
prostate B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999973773956299
. O 0 0.0022977173794060946

Sporadic B-Disease 1 0.991578221321106
prostate I-Disease 1 0.9999973773956299
carcinoma I-Disease 1 0.9999942779541016
is O 0 0.0006249853176996112
the O 0 0.00016326687182299793
most O 0 0.00027444027364254
common O 0 0.010873369872570038
male B-Disease 1 0.70307457447052
cancer I-Disease 1 0.9999842643737793
in O 0 0.00015901587903499603
the O 0 0.00017760350601747632
Western O 0 0.0006031121592968702
world O 0 0.0003618550254032016
, O 0 0.00013831554679200053
yet O 0 0.00011534487566677853
many O 0 9.811999916564673e-06
of O 0 8.317632818943821e-06
the O 0 0.0001006821112241596
major O 0 0.0006050844094716012
genetic O 0 0.0004174126370344311
events O 0 0.00010480599303264171
involved O 0 0.0002647073706611991
in O 0 6.743721314705908e-05
the O 0 0.0001503232488175854
progression O 0 0.05961937457323074
of O 0 2.221934119006619e-05
this O 0 0.00021806774020660669
often O 0 0.053370725363492966
fatal O 1 0.9999935626983643
cancer B-Disease 1 0.9999874830245972
remain O 0 0.0010681311832740903
to O 0 0.00012384250294417143
be O 0 0.00024262645456474274
elucidated O 0 0.07367752492427826
. O 0 0.0005788087728433311

Numerous O 0 0.00542779266834259
cytogenetic O 1 0.9697167277336121
and O 0 0.0009456055122427642
allelotype O 1 0.8833175301551819
studies O 0 0.000803466304205358
have O 0 0.0001790254027582705
reported O 0 0.0013056214665994048
frequent O 0 0.0015974909765645862
loss O 0 0.0015394474612548947
of O 0 8.057121158344671e-05
heterozygosity O 1 0.9491702318191528
on O 0 0.0005016032373532653
chromosomal O 0 0.059143830090761185
arm O 1 0.9887884259223938
10q O 0 0.4762592017650604
in O 0 0.0019841354805976152
sporadic B-Disease 1 0.9983943104743958
prostate I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999967813491821
. O 0 0.00308605027385056

Deletion O 0 0.021165035665035248
mapping O 0 0.004883903544396162
studies O 0 0.0007888711406849325
have O 0 0.00017582267173565924
unambiguously O 0 0.004464970901608467
identified O 0 0.0003621267678681761
a O 0 0.00023561516718473285
region O 0 0.0003830450586974621
of O 0 4.370609894976951e-05
chromosome O 0 0.0021886785980314016
10q23 O 0 0.006994465831667185
to O 0 6.316128565231338e-05
be O 0 3.899100192938931e-05
the O 0 6.574077269760892e-05
minimal O 0 0.0010481906356289983
area O 0 0.00030165567295625806
of O 0 5.98045444348827e-05
loss O 0 0.06576555222272873
. O 0 0.0007313806563615799

A O 0 0.00544656440615654
new O 0 0.002877824939787388
tumor B-Disease 1 0.9987848401069641
suppressor O 0 0.25115522742271423
gene O 0 0.003541385754942894
, O 0 0.0016255929367616773
PTEN O 1 0.9995104074478149
/ O 1 0.9654026031494141
MMAC1 O 1 0.9907299876213074
, O 0 0.00036339223152026534
was O 0 0.0008735428564250469
isolated O 0 0.005501173436641693
recently O 0 0.0011835400946438313
at O 0 0.00011288797395536676
this O 0 3.783285501413047e-05
region O 0 0.00028022544574923813
of O 0 4.285522300051525e-05
chromosome O 0 0.0018155308207497
10q23 O 0 0.011803087778389454
and O 0 8.358565537491813e-05
found O 0 8.767137478571385e-05
to O 0 3.328055754536763e-05
be O 0 4.683790393755771e-05
inactivated O 0 0.002501025563105941
by O 0 3.6734210880240425e-05
mutation O 0 0.0006672139861620963
in O 0 0.0002019578096223995
three O 0 0.03931820020079613
prostate B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999988079071045
cell O 0 0.01885412074625492
lines O 0 0.00230864598415792
. O 0 0.0008163140737451613

We O 0 0.0019669777248054743
screened O 0 0.013526281341910362
80 O 0 0.046403683722019196
prostate B-Disease 1 0.9999903440475464
tumors I-Disease 1 0.9996806383132935
by O 0 0.0003034379333257675
microsatellite O 0 0.013143413700163364
analysis O 0 0.00040461073513142765
and O 0 0.0001844210783019662
found O 0 0.00043186734546907246
chromosome O 0 0.0020840750075876713
10q23 O 0 0.006167983170598745
to O 0 7.506737892981619e-05
be O 0 6.535941065521911e-05
deleted O 0 0.0007465289090760052
in O 0 0.00011543554137460887
23 O 0 0.0011273957788944244
cases O 0 0.0017302879132330418
. O 0 0.0008032351615838706

We O 0 0.0008155520772561431
then O 0 0.00024569020024500787
proceeded O 0 0.00034576651523821056
with O 0 1.5930769222904928e-05
sequence O 0 1.7526343071949668e-05
analysis O 0 3.1492934795096517e-05
of O 0 9.533591764920857e-06
the O 0 0.00021576440485659987
entire O 0 0.1693844199180603
PTEN O 1 0.9996090531349182
/ O 1 0.7585787177085876
MMAC1 O 1 0.9394384026527405
coding O 0 0.005807914771139622
region O 0 0.0013653698842972517
and O 0 0.00019942218204960227
tested O 0 0.004008057992905378
for O 0 0.00014596901019103825
homozygous O 0 0.0015383008867502213
deletion O 0 0.0015598951140418649
with O 0 0.0001166313886642456
new O 0 0.0005494661163538694
intragenic O 0 0.3515563905239105
markers O 0 0.0008723579812794924
in O 0 5.5727603466948494e-05
these O 0 3.241626836825162e-05
23 O 0 0.0006106275832280517
cases O 0 0.0005411898018792272
with O 0 0.00024384749121963978
10q23 O 0 0.3680594861507416
loss O 0 0.0033745209220796824
of O 0 0.00017915808712132275
heterozygosity O 1 0.973313570022583
. O 0 0.0014371522702276707

The O 0 0.000275918428087607
identification O 0 0.00012273869651835412
of O 0 1.347536363027757e-05
the O 0 9.446531475987285e-05
second O 0 0.00039346865378320217
mutational O 0 0.023956311866641045
event O 0 0.0003815133241005242
in O 0 9.41785765462555e-05
10 O 0 0.0002772371517494321
( O 0 0.00024038602714426816
43 O 0 0.0005785644170828164
% O 0 0.0001557812502142042
) O 0 0.0015699429204687476
tumors B-Disease 1 0.9999232292175293
establishes O 1 0.9956278800964355
PTEN O 1 0.9995361566543579
/ O 1 0.942879855632782
MMAC1 O 1 0.7907783389091492
as O 0 0.00013755439431406558
a O 0 0.00020474589837249368
main O 0 0.0003451735246926546
inactivation O 0 0.006925632245838642
target O 0 0.00018512227688916028
of O 0 5.339077688404359e-05
10q O 0 0.27026045322418213
loss O 0 0.015058858320116997
in O 0 0.0012942570028826594
sporadic B-Disease 1 0.997977077960968
prostate I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999986886978149
. O 0 0.0007787948125042021
. O 0 0.0008626200724393129

Risk O 0 0.36718878149986267
reversals O 0 0.011943196877837181
in O 0 0.0004748271021526307
predictive O 0 0.03684046119451523
testing O 0 0.1524176299571991
for O 0 0.1947258710861206
Huntington B-Disease 1 0.9999922513961792
disease I-Disease 1 0.9999947547912598
. O 0 0.002109627705067396

The O 0 0.00031958631007000804
first O 0 0.00025535287568345666
predictive O 0 0.007646659389138222
testing O 0 0.01042850874364376
for O 0 0.009049121290445328
Huntington B-Disease 1 0.9999854564666748
disease I-Disease 1 0.9999940395355225
( O 0 0.002693675924092531
HD B-Disease 1 0.9614176154136658
) O 0 0.00021505478071048856
was O 0 0.00023745997168589383
based O 0 4.6282977564260364e-05
on O 0 3.426545299589634e-05
analysis O 0 9.402028808835894e-05
of O 0 3.894711335306056e-05
linked O 0 0.009232476353645325
polymorphic O 0 0.05736507102847099
DNA O 0 0.0010164492996409535
markers O 0 0.0009492776589468122
to O 0 5.5964123021112755e-05
estimate O 0 0.0003094005223829299
the O 0 6.872064841445535e-05
likelihood O 0 0.0005846337298862636
of O 0 2.51335932262009e-05
inheriting O 0 0.4377458989620209
the O 0 0.00021650519920513034
mutation O 0 0.0022178487852215767
for O 0 0.0007053827284835279
HD B-Disease 1 0.891913890838623
. O 0 0.0011103609576821327

Limits O 0 0.0012024592142552137
to O 0 0.00012843136209994555
accuracy O 0 0.00033897554385475814
included O 0 8.493640052620322e-05
recombination O 0 0.0005214868579059839
between O 0 8.063900168053806e-05
the O 0 0.00017614585522096604
DNA O 0 0.000652478716801852
markers O 0 0.000718786905054003
and O 0 5.883818448637612e-05
the O 0 0.00015865966270212084
mutation O 0 0.0018410226330161095
, O 0 0.00024196993035729975
pedigree O 0 0.021799122914671898
structure O 0 0.0012643268564715981
, O 0 0.0001419134350726381
and O 0 8.5130610386841e-05
whether O 0 0.0002595147816464305
DNA O 0 0.0002800461952574551
samples O 0 0.00011999438720522448
were O 0 1.9760453142225742e-05
available O 0 8.865803829394281e-05
from O 0 8.938333485275507e-05
family O 0 0.0005372205632738769
members O 0 0.00025387207278981805
. O 0 0.000671435846015811

With O 0 0.0002745088713709265
direct O 0 0.00029422491206787527
tests O 0 0.0005815315525978804
for O 0 0.00010846331133507192
the O 0 0.00041078979847952724
HD B-Disease 1 0.8894904851913452
mutation O 0 0.0013335351832211018
, O 0 0.00012918352149426937
we O 0 8.577336848247796e-05
have O 0 5.249385139904916e-05
assessed O 0 0.0006810626364313066
the O 0 2.2795104086981155e-05
accuracy O 0 0.0001284711470361799
of O 0 1.77606925717555e-05
results O 0 0.00022732497018296272
obtained O 0 0.00016488281835336238
by O 0 0.00011658324365271255
linkage O 0 0.006388635840266943
approaches O 0 0.0020067780278623104
when O 0 0.0004233238287270069
requested O 0 0.0006546813528984785
to O 0 6.03438493271824e-05
do O 0 0.00012260126823093742
so O 0 6.14941818639636e-05
by O 0 2.5035420549102128e-05
the O 0 0.00011901789548574015
test O 0 0.0009941809112206101
individuals O 0 0.0003912096144631505
. O 0 0.0006601211498491466

For O 0 0.0004688504268415272
six O 0 0.00023114672512747347
such O 0 4.353517579147592e-05
individuals O 0 0.00014919741079211235
, O 0 9.504451008979231e-05
there O 0 8.381617226405069e-05
was O 0 0.00023717351723462343
significant O 0 0.00031349685741588473
disparity O 0 0.004117289558053017
between O 0 0.0001273071684408933
the O 0 0.000290980824502185
tests O 0 0.002115534385666251
. O 0 0.000443868717411533

Three O 0 0.0005072184139862657
went O 0 0.0005920581170357764
from O 0 0.00012985551438760012
a O 0 0.0006782114505767822
decreased O 0 0.06341894716024399
risk O 0 0.021343164145946503
to O 0 6.707810098305345e-05
an O 0 0.00017159967683255672
increased O 0 0.0014270084211602807
risk O 0 0.23004001379013062
, O 0 6.679667421849445e-05
while O 0 4.8738558689365163e-05
in O 0 4.018314939457923e-05
another O 0 0.00013972638407722116
three O 0 6.17319019511342e-05
the O 0 0.00021896780526731163
risk O 1 0.7679786682128906
was O 0 0.0016512712463736534
decreased O 0 0.03280014917254448
. O 0 0.0010412783594802022

Knowledge O 0 0.0016102729132398963
of O 0 7.433841528836638e-05
the O 0 0.00028931887936778367
potential O 0 0.001208778820000589
reasons O 0 0.0004054313467349857
for O 0 6.811974890297279e-05
these O 0 2.6017205527750775e-05
changes O 0 0.00021647903486154974
in O 0 9.894277172861621e-05
results O 0 0.000192618666915223
and O 0 5.702318958356045e-05
impact O 0 0.00036192353582009673
of O 0 1.872522807389032e-05
these O 0 9.295373456552625e-05
risk O 1 0.5635161399841309
reversals O 0 0.017349744215607643
on O 0 0.0002724906080402434
both O 0 0.0005571526126004755
patients O 1 0.9998527765274048
and O 0 0.00011450947204139084
the O 0 0.0003963308990933001
counseling O 1 0.9941039681434631
team O 0 0.0006586333620361984
can O 0 7.469934644177556e-05
assist O 0 0.0005335934110917151
in O 0 4.3396561522968113e-05
the O 0 4.5423417759593576e-05
development O 0 0.00021528640354517847
of O 0 2.3273702026926912e-05
strategies O 0 0.0023865799885243177
for O 0 0.00011932996130781248
the O 0 0.0004207566671539098
prevention O 1 0.9982653260231018
and O 0 0.00012407536269165576
, O 0 0.00012522784527391195
where O 0 0.00011083247227361426
necessary O 0 0.0003798622637987137
, O 0 0.0001809702953323722
management O 0 0.010860832408070564
of O 0 3.510086389724165e-05
a O 0 0.0011824944522231817
risk O 0 0.21565064787864685
reversal O 0 0.0042663319036364555
in O 0 7.393418491119519e-05
any O 0 0.00014144992746878415
predictive O 0 0.010362017899751663
testing O 0 0.005393584258854389
program O 0 0.002056701108813286
. O 0 0.0002070345071842894
. O 0 0.0004687950713559985

A O 0 0.006351488176733255
novel O 0 0.004286361858248711
common O 0 0.0025510070845484734
missense O 0 0.01371862180531025
mutation O 0 0.002824801253154874
G301C O 0 0.005300454329699278
in O 0 9.111204417422414e-05
the O 0 0.0002181451127398759
N O 0 0.00620573665946722
- O 0 0.003917238209396601
acetylgalactosamine O 0 0.027978964149951935
- O 0 0.0024310490116477013
6 O 0 0.0010473101865500212
- O 0 0.009355816058814526
sulfate O 1 0.9784019589424133
sulfatase O 1 0.9901639819145203
gene O 0 0.003156464546918869
in O 0 0.0007022235658951104
mucopolysaccharidosis B-Disease 1 0.9863706827163696
IVA I-Disease 1 0.9944798946380615
. O 0 0.0015060831792652607

Mucopolysaccharidosis B-Disease 1 0.9440135359764099
IVA I-Disease 1 0.9916240572929382
( O 0 0.005539983045309782
MPS B-Disease 1 0.9220944046974182
IVA I-Disease 1 0.9985234141349792
) O 0 0.0003176202008035034
is O 0 0.0001980446104425937
an O 0 0.0005357881309464574
autosomal B-Disease 1 0.9990153312683105
recessive I-Disease 1 0.9994727969169617
lysosomal I-Disease 1 0.9997996687889099
storage I-Disease 1 0.9986072182655334
disorder I-Disease 1 0.9999860525131226
caused O 1 0.7740691900253296
by O 0 0.0001967322314158082
a O 0 0.0019542232621461153
genetic B-Disease 0 0.1948082447052002
defect I-Disease 1 0.9976209998130798
in O 0 0.0003484739863779396
N O 0 0.010907135903835297
- O 0 0.005073233041912317
acetylgalactosamine O 0 0.08559328317642212
- O 0 0.002964835148304701
6 O 0 0.0013612003531306982
- O 0 0.010682704858481884
sulfate O 1 0.9840092658996582
sulfatase O 1 0.9936043620109558
( O 0 0.004399621859192848
GALNS O 1 0.9859299063682556
) O 0 0.0007858931785449386
. O 0 0.0007029084954410791

In O 0 0.0006673787138424814
previous O 0 0.000573153723962605
studies O 0 0.0006108233937993646
, O 0 0.000127657491248101
we O 0 0.00010205315629718825
have O 0 4.2207302612951025e-05
found O 0 7.963677489897236e-05
two O 0 4.014442674815655e-05
common O 0 0.0007032214780338109
mutations O 0 0.0019030310213565826
in O 0 0.00026055981288664043
Caucasians O 0 0.399718314409256
and O 0 0.0001748583308653906
Japanese O 0 0.0009362933924421668
, O 0 0.0002762113290373236
respectively O 0 0.0009744429844431579
. O 0 0.0008386867702938616

To O 0 0.0011340912897139788
characterize O 0 0.013155256398022175
the O 0 0.0005755119491368532
mutational O 0 0.17807923257350922
spectrum O 0 0.0019028009846806526
in O 0 5.765758760389872e-05
various O 0 1.8679105778574012e-05
ethnic O 0 4.1439510823693126e-05
groups O 0 5.392467573983595e-05
, O 0 0.00010870373080251738
mutations O 0 0.0004728134081233293
in O 0 4.815909778699279e-05
the O 0 0.00025933748111128807
GALNS O 1 0.9775558114051819
gene O 0 0.000990794855169952
in O 0 0.00028802428278140724
Colombian O 0 0.01977587677538395
MPS B-Disease 1 0.9889821410179138
IVA I-Disease 1 0.9999114274978638
patients O 1 0.999896764755249
were O 0 0.00025702972197905183
investigated O 0 0.2500856816768646
, O 0 0.0002099931734846905
and O 0 0.0001277412666240707
genetic O 0 0.0011845254339277744
backgrounds O 0 0.0007160829263739288
were O 0 5.457772203953937e-05
extensively O 0 0.001365120173431933
analyzed O 0 0.0006416912656277418
to O 0 5.2233135647838935e-05
identify O 0 0.0003234623873140663
racial O 0 0.0003005768230650574
origin O 0 4.0795137465465814e-05
, O 0 5.1898783567594364e-05
based O 0 5.601446537184529e-05
on O 0 0.00011221815657336265
mitochondrial O 0 0.0011655132984742522
DNA O 0 0.000767366960644722
( O 0 0.00033840269315987825
mtDNA O 0 0.0009349874453619123
) O 0 0.0003458975988905877
lineages O 0 0.0014098280807957053
. O 0 0.0006913803517818451

Three O 0 0.0011660708114504814
novel O 0 0.005444833543151617
missense O 0 0.025045091286301613
mutations O 0 0.005556326359510422
never O 0 0.002343542641028762
identified O 0 0.0004737373092211783
previously O 0 0.00021568992815446109
in O 0 3.804279549513012e-05
other O 0 2.852735087799374e-05
populations O 0 0.00017795557505451143
and O 0 4.709965651272796e-05
found O 0 8.953091310104355e-05
in O 0 4.3228825234109536e-05
16 O 0 0.0001043426018441096
out O 0 3.413489685044624e-05
of O 0 3.157023820676841e-05
19 O 0 0.0012435237877070904
Colombian O 0 0.006805675104260445
MPS B-Disease 1 0.8563393950462341
IVA I-Disease 1 0.9987407326698303
unrelated O 0 0.006289171986281872
alleles O 0 0.001673232764005661
account O 0 0.00022771737712901086
for O 0 0.000431439169915393
84 O 0 0.007333812769502401
. O 0 0.0009458126733079553

2 O 0 0.0005836276686750352
% O 0 3.6141209420748055e-05
of O 0 2.403845064691268e-05
the O 0 0.0002352739538764581
alleles O 0 0.00128283747471869
in O 0 0.0001032797372317873
this O 0 9.900004806695506e-05
study O 0 0.000933360424824059
. O 0 0.0004994695773348212

The O 0 0.0017505483701825142
G301C O 0 0.0341305136680603
and O 0 0.0004965640837326646
S162F O 0 0.01835552603006363
mutations O 0 0.0010420612525194883
account O 0 0.00016664467693772167
for O 0 0.00022521331266034395
68 O 0 0.0031107142567634583
. O 0 0.0006931227399036288

4 O 0 0.001238490454852581
% O 0 0.00010750382352853194
and O 0 0.00017824901442509145
10 O 0 0.0006697045173496008
. O 0 0.0006817110697738826

5 O 0 0.0006371899507939816
% O 0 4.61874769825954e-05
of O 0 3.770535113289952e-05
mutations O 0 0.0014587227487936616
, O 0 0.0001548572618048638
respectively O 0 0.00023046012211125344
, O 0 9.16664648684673e-05
whereas O 0 0.00025097373872995377
the O 0 7.079383794916794e-05
remaining O 0 0.00031990918796509504
F69V O 1 0.7843384742736816
is O 0 0.00011626939522102475
limited O 0 0.00023003469686955214
to O 0 4.8595240514259785e-05
a O 0 0.00018712053133640438
single O 0 0.00045374396722763777
allele O 0 0.00463884836062789
. O 0 0.0008408151916228235

The O 0 0.0014340721536427736
skewed O 0 0.007886700332164764
prevalence O 0 0.06797277182340622
of O 0 0.000111528264824301
G301C O 0 0.029364217072725296
in O 0 0.00015242683002725244
only O 0 0.00025761264259926975
Colombian O 0 0.028141360729932785
patients O 1 0.9995715022087097
and O 0 0.0002018640370806679
haplotype O 0 0.008928168565034866
analysis O 0 0.00015639609773643315
by O 0 5.19178865943104e-05
restriction O 0 0.0003350203623995185
fragment O 0 0.0009644079254940152
length O 0 0.00043350044870749116
polymorphisms O 0 0.0009381517884321511
in O 0 0.0001373581908410415
the O 0 0.0004954604082740843
GALNS O 1 0.9915607571601868
gene O 0 0.0019760297145694494
suggest O 0 0.0005272057023830712
that O 0 0.00015103444457054138
G301C O 0 0.009260455146431923
originated O 0 0.0004504022654145956
from O 0 9.115974535234272e-05
a O 0 0.0004767694335896522
common O 0 0.0012868604389950633
ancestor O 0 0.0026481281965970993
. O 0 0.0011727118398994207

Investigation O 0 0.005398065783083439
of O 0 6.193296576384455e-05
the O 0 0.0002666033979039639
genetic O 0 0.0008637970895506442
background O 0 0.000268276606220752
by O 0 4.3497369915712625e-05
means O 0 0.00016322685405611992
of O 0 2.9076561986585148e-05
mtDNA O 0 0.000688923813868314
lineages O 0 0.0005840999074280262
indicate O 0 0.0003108812670689076
that O 0 4.7202713176375255e-05
all O 0 5.3931722504785284e-05
our O 0 0.002136026741936803
patients O 1 0.9993940591812134
are O 0 3.516911237966269e-05
probably O 0 0.00022506887034978718
of O 0 2.0561679775710218e-05
native O 0 0.00035051730810664594
American O 0 0.0011893881019204855
descent O 0 0.005743713118135929

Low O 0 0.0028868550434708595
frequency O 0 0.000427297898568213
of O 0 0.00022090732818469405
BRCA1 O 1 0.9933739900588989
germline O 0 0.2553947865962982
mutations O 0 0.001061774673871696
in O 0 0.00013907371612731367
45 O 0 0.0009742813999764621
German O 1 0.9821783900260925
breast B-Disease 1 0.9999983310699463
/ I-Disease 1 0.9999599456787109
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999979734420776
families O 0 0.002513657556846738
. O 0 0.0011075758375227451

In O 0 0.0002795800974126905
this O 0 7.95255255070515e-05
study O 0 0.0003507261862978339
we O 0 0.00014662690227851272
investigated O 0 0.0026675097178667784
45 O 0 0.0008064692956395447
German O 1 0.939974308013916
breast B-Disease 1 0.9999983310699463
/ I-Disease 1 0.9999524354934692
ovarian I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999980926513672
families O 0 0.0008326619281433523
for O 0 0.0006658933125436306
germline O 1 0.95711350440979
mutations O 0 0.0013503566151484847
in O 0 0.00013726377801503986
the O 0 0.0008513732464052737
BRCA1 O 1 0.9989542961120605
gene O 0 0.004042840097099543
. O 0 0.000771098886616528

We O 0 0.0005693120765499771
identified O 0 0.00043983955401927233
four O 0 0.0001748029753798619
germline O 0 0.04422633722424507
mutations O 0 0.0006848722696304321
in O 0 0.00013462116476148367
three O 0 0.002640846185386181
breast B-Disease 1 0.9999992847442627
cancer I-Disease 1 0.9999951124191284
families O 0 0.0001571434986544773
and O 0 5.6061606301227584e-05
in O 0 0.0001735939586069435
one O 0 0.010561564937233925
breast B-Disease 1 0.9999990463256836
- I-Disease 1 0.9999744892120361
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999997615814209
family O 0 0.0063430252484977245
. O 0 7.232403731904924e-05
among O 0 3.175106758135371e-05
these O 0 1.6256952221738175e-05
were O 0 3.1246432627085596e-05
one O 0 0.00021746290440205485
frameshift O 1 0.5341361165046692
mutation O 0 0.001126870047301054
, O 0 0.00011624378385022283
one O 0 0.0001436432939954102
nonsense O 0 0.0064369309693574905
mutation O 0 0.000973423186223954
, O 0 7.678793190279976e-05
one O 0 8.426222484558821e-05
novel O 0 0.0008861615206114948
splice O 0 0.006392950192093849
site O 0 0.0011786168906837702
mutation O 0 0.0009777229279279709
, O 0 6.239797949092463e-05
and O 0 6.816411769250408e-05
one O 0 0.00023480785603169352
missense O 0 0.011541077867150307
mutation O 0 0.0035063226241618395
. O 0 0.0006897080456838012

The O 0 0.0016431192634627223
missense O 0 0.016203489154577255
mutation O 0 0.002355244243517518
was O 0 0.0005894831265322864
also O 0 0.00011607352644205093
found O 0 0.00012931146193295717
in O 0 0.00011176833504578099
2 O 0 0.0006342296837829053
. O 0 0.0005626938072964549

8 O 0 0.0007149768644012511
% O 0 3.249887959100306e-05
of O 0 1.4355057828652207e-05
the O 0 0.00011854016338475049
general O 0 0.0003376496606506407
population O 0 5.573967064265162e-05
, O 0 0.00010205042781308293
suggesting O 0 0.0008472242043353617
that O 0 4.683870429289527e-05
it O 0 8.49836360430345e-05
is O 0 0.0003111374389845878
not O 0 0.0010783056495711207
disease O 1 0.9999728202819824
associated O 0 0.001128210686147213
. O 0 0.0006763390265405178

The O 0 0.0006440802244469523
average O 0 0.0013255322119221091
age O 0 0.001035509048961103
of O 0 0.000750351173337549
disease O 1 0.9999978542327881
onset O 1 0.9997807145118713
in O 0 0.0002560508728493005
those O 0 0.00020210168440826237
families O 0 0.0011979303089901805
harbouring O 1 0.9893524050712585
causative O 1 0.9526064991950989
mutations O 0 0.0033652945421636105
was O 0 0.0005048931925557554
between O 0 0.0002600329462438822
32 O 0 0.001477259211242199
. O 0 0.0006665358087047935

3 O 0 0.0014023535186424851
and O 0 0.0003574459988158196
37 O 0 0.002375466749072075
. O 0 0.0009969889651983976

4 O 0 0.0020404993556439877
years O 0 0.0007021459750831127
, O 0 0.00021962812752462924
whereas O 0 0.000699682510457933
the O 0 0.00028115080203861
family O 0 0.0019300495041534305
harbouring O 1 0.6960917115211487
the O 0 0.0006098438170738518
missense O 0 0.014605332165956497
mutation O 0 0.0016497697215527296
had O 0 0.00023945614520926028
an O 0 0.00013795476115774363
average O 0 0.0007728519267402589
age O 0 0.00032762272167019546
of O 0 9.426689211977646e-05
onset O 1 0.9973363280296326
of O 0 0.00016720396524760872
51 O 0 0.007595054339617491
. O 0 0.0010902544017881155

2 O 0 0.003122700145468116
years O 0 0.0019428806845098734
. O 0 0.0012224289821460843

These O 0 0.0005527114262804389
findings O 0 0.002433488145470619
show O 0 0.000714215449988842
that O 0 0.00045197774306870997
BRCA1 O 1 0.9929931163787842
is O 0 0.00041268084896728396
implicated O 0 0.008042593486607075
in O 0 4.102179445908405e-05
a O 0 0.00010400503379059955
small O 0 9.467408381169662e-05
fraction O 0 0.0007215796504169703
of O 0 0.0006528398371301591
breast B-Disease 1 0.9999994039535522
/ I-Disease 1 0.9999780654907227
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999991655349731
families O 0 0.0009006027248688042
suggesting O 0 0.0018770314054563642
the O 0 0.00012667456758208573
involvement O 0 0.0013378678122535348
of O 0 3.5096745705232024e-05
another O 0 0.0012439376441761851
susceptibility O 1 0.9620405435562134
gene O 0 0.004428560845553875
( O 0 0.001402878318913281
s O 0 0.23028568923473358
) O 0 0.001184194115921855

Paternal O 0 0.1368432193994522
transmission O 0 0.25092005729675293
of O 0 0.013506629504263401
congenital B-Disease 1 0.9999996423721313
myotonic I-Disease 1 0.9999974966049194
dystrophy I-Disease 1 0.9999988079071045
. O 0 0.017748432233929634

We O 0 0.0008878615335561335
report O 0 0.0005866801948286593
a O 0 0.0004141875833738595
rare O 0 0.0027712988667190075
case O 0 0.0007980212103575468
of O 0 0.00015651111607439816
paternally O 1 0.998316764831543
transmitted O 1 0.9990085959434509
congenital B-Disease 1 0.9999990463256836
myotonic I-Disease 1 0.999997615814209
dystrophy I-Disease 1 0.9999991655349731
( O 1 0.9870342016220093
DM B-Disease 1 0.9999842643737793
) O 0 0.0020613200031220913
. O 0 0.0011009842855855823

The O 0 0.0011429154546931386
proband O 0 0.01934526301920414
is O 0 0.00029007013654336333
a O 0 0.00042188126826658845
23 O 0 0.0007596944342367351
year O 0 0.0006528012454509735
old O 0 0.006328807678073645
, O 0 0.002515480387955904
mentally B-Disease 1 0.9999674558639526
retarded I-Disease 1 0.9997847676277161
male O 0 0.04354589059948921
who O 1 0.9284451007843018
suffers O 1 0.9999959468841553
severe O 1 0.9999949932098389
muscular B-Disease 1 0.9999967813491821
weakness I-Disease 1 0.9998559951782227
. O 0 0.003938349895179272

He O 0 0.003675884800031781
presented O 0 0.0022947415709495544
with O 0 0.002627721754834056
respiratory O 1 0.9999963045120239
and O 0 0.0008414692129008472
feeding O 1 0.6034037470817566
difficulties O 1 0.6213009357452393
at O 0 0.0015648462576791644
birth O 0 0.004500658717006445
. O 0 0.0008972445502877235

His O 0 0.0027192269917577505
two O 0 0.001156118931248784
sibs O 1 0.998571515083313
suffer O 1 0.9990968704223633
from O 0 0.0020912683103233576
childhood O 1 0.9995354413986206
onset O 1 0.9999439716339111
DM B-Disease 1 0.9999803304672241
. O 0 0.004440484568476677

Their O 0 0.0007399556925520301
late O 0 0.0020696891006082296
father O 0 0.0016420556930825114
had O 0 0.00024063483579084277
the O 0 0.00015151160187087953
adult O 0 0.0014805191894993186
type O 0 0.004018573556095362
of O 0 0.00033351362799294293
DM B-Disease 1 0.9999843835830688
, O 0 0.0003740709798876196
with O 0 0.00032475736225023866
onset O 1 0.9986432194709778
around O 0 0.0003801172715611756
30 O 0 0.0007964850519783795
years O 0 0.0007140919333323836
. O 0 0.0006549727404490113

Only O 0 0.000182580784894526
six O 0 0.0001247399195563048
other O 0 3.706879942910746e-05
cases O 0 0.0003169426054228097
of O 0 4.347290450823493e-05
paternal O 0 0.06664532423019409
transmission O 0 0.47266077995300293
of O 0 0.003983887378126383
congenital B-Disease 1 0.9999998807907104
DM I-Disease 1 0.9999978542327881
have O 0 0.0007039204356260598
been O 0 0.0007889223052188754
reported O 0 0.004255374893546104
recently O 0 0.004981294274330139
. O 0 0.000506100885104388

We O 0 0.00103825016412884
review O 0 0.0009533782140351832
the O 0 0.00021411769557744265
sex O 0 0.0012611030833795667
related O 0 0.001434278441593051
effects O 0 0.004990157205611467
on O 0 0.0004176934598945081
transmission O 0 0.1311749964952469
of O 0 0.0020441184751689434
congenital B-Disease 1 0.9999986886978149
DM I-Disease 1 0.9999895095825195
. O 0 0.004017239902168512

Decreased O 0 0.07106278091669083
fertility O 0 0.0322539322078228
of O 0 9.866133768809959e-05
males O 0 0.0016018395544961095
with O 0 0.0005403681425377727
adult O 1 0.6386467218399048
onset O 1 0.9999176263809204
DM B-Disease 1 0.9999758005142212
and O 0 0.00046995567390695214
contraction O 0 0.007629945408552885
of O 0 3.6887373425997794e-05
the O 0 0.00026682260795496404
repeat O 0 0.008286659605801105
upon O 0 0.0004786349891219288
male O 0 0.0011524156434461474
transmission O 0 0.0036730917636305094
contribute O 0 0.0011687863152474165
to O 0 4.0711849578656256e-05
the O 0 7.099677895894274e-05
almost O 0 0.0002861116954591125
absent O 0 0.0019722352735698223
occurrence O 0 0.0010320775909349322
of O 0 6.473958637798205e-05
paternal O 0 0.052938029170036316
transmission O 0 0.3277202248573303
of O 0 0.0032515903003513813
congenital B-Disease 1 0.9999991655349731
DM I-Disease 1 0.9999860525131226
. O 0 0.004437226802110672

Also O 0 0.00045346617116592824
the O 0 0.00014231048407964408
fathers O 0 0.0003981183981522918
of O 0 2.6096149667864665e-05
the O 0 0.00044397026067599654
reported O 0 0.10723023861646652
congenitally O 1 0.9990143775939941
affected O 0 0.041272733360528946
children O 0 0.0010784504702314734
showed O 0 0.0007874178700149059
, O 0 9.831582428887486e-05
on O 0 0.00012398383114486933
average O 0 0.0007122504757717252
, O 0 0.00039841941907070577
shorter O 0 0.009421400725841522
CTG O 1 0.9525968432426453
repeat O 0 0.00445232167840004
lengths O 0 0.0013938877964392304
and O 0 0.00011642048048088327
hence O 0 0.0011195355327799916
less O 0 0.011712378822267056
severe O 1 0.9999904632568359
clinical O 1 0.9999781847000122
symptoms O 1 0.9999876022338867
than O 0 0.00015381883713416755
the O 0 0.00023984872677829117
mothers O 0 0.031113717705011368
of O 0 6.493484397651628e-05
children O 0 0.0400775782763958
with O 0 0.14156636595726013
congenital B-Disease 1 0.9999996423721313
DM I-Disease 1 0.9999929666519165
. O 0 0.0041908579878509045

We O 0 0.0009051173692569137
conclude O 0 0.002443314529955387
that O 0 0.00013076444156467915
paternal O 0 0.005166696384549141
transmission O 0 0.04047109931707382
of O 0 0.0018677988555282354
congenital B-Disease 1 0.9999994039535522
DM I-Disease 1 0.9999972581863403
is O 0 0.0015563960187137127
rare O 0 0.006514988839626312
and O 0 0.00021140910394024104
preferentially O 0 0.004308788105845451
occurs O 0 0.0006480133743025362
with O 0 0.0002971822104882449
onset O 1 0.9989205598831177
of O 0 0.0005582082667388022
DM B-Disease 1 0.9999537467956543
past O 0 0.0008347528637386858
30 O 0 0.00039715992170386016
years O 0 0.000148027203977108
in O 0 5.762076398241334e-05
the O 0 0.00020325538935139775
father O 0 0.0036299920175224543
. O 0 0.0003248077991884202
. O 0 0.0005704184295609593

The O 0 0.0060499790124595165
RB1 O 1 0.990480363368988
gene O 0 0.003899657865986228
mutation O 0 0.001295490306802094
in O 0 0.00011326677486067638
a O 0 0.0006278874934650958
child O 0 0.015476778149604797
with O 0 0.0013071687426418066
ectopic B-Disease 1 0.9995624423027039
intracranial I-Disease 1 0.9999428987503052
retinoblastoma I-Disease 1 0.999691367149353
. O 0 0.0032708286307752132

The O 0 0.0050353966653347015
RB1 O 1 0.9929733276367188
gene O 0 0.005436365958303213
mutation O 0 0.0027979984879493713
was O 0 0.0010290801292285323
investigated O 0 0.003675504121929407
in O 0 0.00012595573207363486
a O 0 0.0008330619311891496
child O 0 0.027632059529423714
with O 0 0.0011812149314209819
ectopic B-Disease 1 0.9997132420539856
intracranial I-Disease 1 0.9999353885650635
retinoblastoma I-Disease 1 0.9994187355041504
using O 0 0.0003282586403656751
DNA O 0 0.000581076426897198
obtained O 0 0.00011517188249854371
from O 0 4.3692183680832386e-05
both O 0 9.177098399959505e-05
the O 0 0.000492954277433455
pineal B-Disease 1 0.9963296055793762
and I-Disease 0 0.001881952048279345
retinal I-Disease 1 0.9999041557312012
tumours I-Disease 1 0.9998552799224854
of O 0 0.00010485816892469302
the O 0 0.00258974963799119
patient O 1 0.9998036026954651
. O 0 0.001067213830538094

A O 0 0.006661073304712772
nonsense O 0 0.01299242302775383
mutation O 0 0.0023807722609490156
in O 0 0.00039254911825992167
exon O 0 0.008706049993634224
17 O 0 0.000891498290002346
( O 0 0.0004511839069891721
codon O 0 0.002163410885259509
556 O 0 0.008431618101894855
) O 0 0.0001149953095591627
of O 0 3.8344995118677616e-05
the O 0 0.0011181882582604885
RB1 O 1 0.998613715171814
gene O 0 0.0026930291205644608
was O 0 0.0005190188530832529
found O 0 0.00016789237270131707
to O 0 5.88080620218534e-05
be O 0 5.476290243677795e-05
present O 0 0.0001329110818915069
homozygously O 0 0.02128607966005802
in O 0 4.525927943177521e-05
both O 0 6.280619709286839e-05
the O 0 0.000349358277162537
retinal B-Disease 1 0.9993720650672913
and I-Disease 0 0.0002098318509524688
the I-Disease 0 0.001757784397341311
pineal I-Disease 1 0.9991094470024109
tumours I-Disease 1 0.9996742010116577
. O 0 0.0022276942618191242

The O 0 0.0005835943738929927
same O 0 0.000415761984186247
mutation O 0 0.0021386221051216125
was O 0 0.0005003311089240015
present O 0 0.0003828478802461177
heterozygously O 0 0.0955980196595192
in O 0 6.788758037146181e-05
the O 0 0.00010128260328201577
DNA O 0 0.000309302587993443
from O 0 3.433014717302285e-05
the O 0 7.19169620424509e-05
constitutional O 0 0.00034182192757725716
cells O 0 0.0003829160123132169
of O 0 1.975619488803204e-05
the O 0 0.0007980752852745354
patient O 1 0.9998296499252319
, O 0 0.0002949796325992793
proving O 0 0.29846352338790894
it O 0 5.5540542234666646e-05
to O 0 3.54737821908202e-05
be O 0 2.704419421206694e-05
of O 0 3.4885219065472484e-05
germline O 0 0.4148974120616913
origin O 0 0.00022144636022858322
. O 0 0.000653209222946316

The O 0 0.000788758450653404
initial O 0 0.0023168339394032955
mutation O 0 0.002596271224319935
was O 0 0.0006124862702563405
shown O 0 0.0003128331445623189
to O 0 4.849566539633088e-05
have O 0 5.42189009138383e-05
occurred O 0 0.00024877765099518
in O 0 5.98447113588918e-05
the O 0 0.0003042963508050889
paternally O 0 0.06750772148370743
derived O 0 0.0030423877760767937
RB1 O 1 0.9951016306877136
allele O 0 0.015224968083202839
. O 0 0.0017529481556266546

The O 0 0.00124406220857054
mutation O 0 0.0024329416919499636
is O 0 0.00018573791021481156
in O 0 6.7358480009716e-05
an O 0 0.0001084627874661237
area O 0 0.00017160801507998258
of O 0 1.1523582543304656e-05
the O 0 9.384634904563427e-05
gene O 0 0.0003323956916574389
that O 0 1.9183649783371948e-05
encodes O 0 0.00024004730221349746
the O 0 6.1412611103151e-05
protein O 0 0.00037418759893625975
- O 0 0.0010393764823675156
binding O 0 0.0003133549471385777
region O 0 0.0006041243905201554
known O 0 0.00022658793022856116
as O 0 0.00010486107203178108
the O 0 0.000265950191533193
pocket O 0 0.17935222387313843
region O 0 0.0006675320328213274
and O 0 0.00012410922499839216
has O 0 0.0003220705548301339
been O 0 0.00018002920842263848
detected O 0 0.0011566432658582926
in O 0 3.917732465197332e-05
other O 0 3.7407295167213306e-05
cases O 0 0.0007828824454918504
of O 0 0.00016896483430173248
retinoblastoma B-Disease 1 0.9998143315315247
. O 0 0.0004510798607952893
. O 0 0.0007406058139167726

Low O 0 0.0043795183300971985
levels O 0 0.0009626673418097198
of O 0 6.477825081674382e-05
beta O 0 0.007172058802098036
hexosaminidase O 0 0.08120014518499374
A O 0 0.0015173228457570076
in O 0 0.00024288176791742444
healthy O 0 0.44797930121421814
individuals O 0 0.00027466434403322637
with O 0 0.0004229182959534228
apparent O 1 0.993757963180542
deficiency O 1 0.9999722242355347
of O 0 5.061251067672856e-05
this O 0 0.00021354378259275109
enzyme O 0 0.004969053901731968
. O 0 0.0008347902330569923

Appreciable O 0 0.029457146301865578
beta O 0 0.011047199368476868
hexosaminidase O 0 0.02131463773548603
A O 0 0.0019656107760965824
( O 0 0.000551747449208051
hex O 0 0.003371583763509989
A O 0 0.0007721223519183695
) O 0 9.344529826194048e-05
activity O 0 0.0001808091765269637
has O 0 0.0001753331598592922
been O 0 0.0001739505387376994
detected O 0 0.0017821319634094834
in O 0 0.0002558243868406862
cultured O 1 0.9932695031166077
skin O 1 0.9999849796295166
fibroblasts O 1 0.9984337687492371
and O 0 0.24516643583774567
melanoma B-Disease 1 0.9999992847442627
tissue O 1 0.9992600083351135
from O 0 0.00048183061880990863
healthy O 1 0.9737445712089539
individuals O 0 0.00035532526089809835
previously O 0 0.001472983043640852
reported O 0 0.0023539832327514887
as O 0 0.00032382336212322116
having O 0 0.029681894928216934
deficiency B-Disease 1 0.999913215637207
of I-Disease 0 6.504441262222826e-05
hex I-Disease 0 0.010001296177506447
A I-Disease 0 0.0009424539166502655
activity O 0 0.00031989513081498444
indistinguishable O 0 0.001089831697754562
from O 0 3.569333421182819e-05
that O 0 4.504502430791035e-05
of O 0 0.00011353279114700854
patients O 1 0.9999279975891113
with O 0 0.021778125315904617
Tay B-Disease 1 0.9999945163726807
- I-Disease 1 0.9994152784347534
Sachs I-Disease 1 0.9999152421951294
disease I-Disease 1 0.999970555305481
( O 0 0.008591080084443092
TSD B-Disease 1 0.9991623163223267
) O 0 0.001225256361067295
. O 0 0.0008404820109717548

Identification O 0 0.0014299101894721389
and O 0 0.0002786774421110749
quantitation O 0 0.008447452448308468
of O 0 6.666978151770309e-05
hex O 0 0.007877250202000141
A O 0 0.0017286167712882161
, O 0 0.0002658148587215692
amounting O 0 0.0028136293403804302
to O 0 0.00016853137640282512
3 O 0 0.0008157239062711596
. O 0 0.0005336205940693617

5 O 0 0.001372205326333642
% O 0 0.00028921684133820236
- O 0 0.004389307461678982
6 O 0 0.001309528830461204
. O 0 0.0006306169088929892

9 O 0 0.0007452125428244472
% O 0 2.496873275958933e-05
of O 0 1.675988096394576e-05
total O 0 0.00023185901227407157
beta O 0 0.007200227119028568
hexosaminidase O 0 0.08097729831933975
activity O 0 0.00041745122871361673
, O 0 0.00012281704402994365
has O 0 0.00014233980618882924
been O 0 7.68109384807758e-05
obtained O 0 9.364939614897594e-05
by O 0 7.721735164523125e-05
cellulose O 0 0.0141881899908185
acetate O 0 0.028216855600476265
gel O 1 0.933928370475769
electrophoresis O 0 0.02689579874277115
, O 0 0.0007226118468679488
DEAE O 1 0.942254364490509
- O 0 0.004476392641663551
cellulose O 0 0.009818879887461662
ion O 0 0.003849994158372283
- O 0 0.002351968316361308
exchange O 0 0.0009230627329088748
chromatography O 0 0.03807244822382927
, O 0 0.0008296191808767617
radial O 1 0.9857796430587769
immunodiffusion O 1 0.8654465675354004
, O 0 0.00033473045914433897
and O 0 0.0004720217839349061
radioimmunoassay O 1 0.8890054821968079
. O 0 0.0009853114606812596

Previous O 0 0.0028964942321181297
family O 0 0.0016211445908993483
studies O 0 0.0007172210607677698
suggested O 0 0.0007728360942564905
that O 0 4.787446596310474e-05
these O 0 2.4056407710304484e-05
individuals O 0 0.0001719006831990555
may O 0 0.0005947885219939053
be O 0 0.00011798307241406292
compound O 0 0.003468708600848913
heterozygotes O 0 0.02146051824092865
for O 0 7.873569848015904e-05
the O 0 0.00020889482402708381
common O 0 0.003102481598034501
mutant O 0 0.06444985419511795
TSD B-Disease 1 0.9966501593589783
gene O 0 0.0018820274854078889
and O 0 0.00012715077900793403
a O 0 0.0007523544481955469
rare O 0 0.005866987630724907
( O 0 0.0009541051695123315
allelic O 0 0.025451447814702988
) O 0 0.0006608808762393892
mutant O 0 0.005529152229428291
gene O 0 0.0030479624401777983
. O 0 0.0007546775159426033

Thus O 0 0.0010954317403957248
, O 0 0.0001805087667889893
the O 0 0.00018495183030609041
postulated O 0 0.004626871552318335
rate O 0 0.0005759457708336413
mutant O 0 0.004357797093689442
gene O 0 0.0015017068944871426
appears O 0 0.0009437252883799374
to O 0 4.2666910303523764e-05
code O 0 9.670732106314972e-05
for O 0 3.648142592282966e-05
the O 0 5.0129998271586373e-05
expression O 0 0.0001271449582418427
of O 0 1.8167896996601485e-05
low O 0 0.0006037220591679215
amounts O 0 0.00019548113050404936
of O 0 5.022819459554739e-05
hex O 0 0.0120702451094985
A O 0 0.004194280132651329
. O 0 0.0008652370306663215

Heterozygotes O 0 0.3318491578102112
for O 0 0.00043069294770248234
the O 0 0.0005219667800702155
rare O 0 0.03226184472441673
mutant O 0 0.012703998014330864
may O 0 0.0007505979156121612
be O 0 8.936782251112163e-05
indistinguishable O 0 0.002191853942349553
from O 0 0.00019330254872329533
heterozygotes O 0 0.021488728001713753
for O 0 0.00012170633999630809
the O 0 0.0003706638526637107
common O 0 0.010150863789021969
TSD B-Disease 1 0.9975858926773071
mutant O 0 0.01989956758916378
. O 0 0.0015743379481136799

However O 0 0.0011336355237290263
, O 0 0.0002034455828834325
direct O 0 0.00036306530819274485
visualization O 0 0.007433666381984949
and O 0 0.00017114460933953524
quantitation O 0 0.010183182545006275
of O 0 6.530794053105637e-05
hex O 0 0.005720192566514015
A O 0 0.0007054822635836899
by O 0 5.714458166039549e-05
the O 0 0.0001013014480122365
methods O 0 0.0005850136512890458
described O 0 0.0033173030242323875
may O 0 0.0010547306155785918
prevent O 0 0.006235122215002775
false O 0 0.0028002532199025154
- O 0 0.4106738567352295
positive O 0 0.014327355660498142
prenatal O 1 0.9990695118904114
diagnosis O 1 0.9997060894966125
of O 0 0.0004209925828035921
TSD B-Disease 1 0.9994940757751465
in O 0 0.0006116614677011967
fetuses O 0 0.3138987421989441
having O 0 0.0006106350920163095
the O 0 0.00021651883434969932
incomplete O 0 0.0047378623858094215
hex B-Disease 0 0.03896113857626915
A I-Disease 0 0.1826373040676117
deficiency I-Disease 1 0.999848484992981
of O 0 3.76832795154769e-05
the O 0 0.00025067938258871436
type O 0 0.013235596008598804
described O 0 0.0009035750408656895
in O 0 5.9898269682889804e-05
the O 0 0.00011691053077811375
four O 0 0.00031504768412560225
healthy O 0 0.3009432554244995
individuals O 0 0.00196542264893651

The O 0 0.0057512251660227776
tumor B-Disease 1 0.9984708428382874
suppressor O 1 0.7408778071403503
gene O 0 0.013720698654651642
Smad4 O 1 0.9914799928665161
/ O 1 0.7571585178375244
Dpc4 O 0 0.19470040500164032
is O 0 0.00030327108106575906
required O 0 0.00030667902319692075
for O 0 0.0002978295087814331
gastrulation O 1 0.9461799263954163
and O 0 0.00015076796989887953
later O 0 0.0002688942477107048
for O 0 0.0002908283204305917
anterior O 1 0.9991374015808105
development O 0 0.0004912777803838253
of O 0 3.405097595532425e-05
the O 0 0.0006350661860778928
mouse O 0 0.025658806785941124
embryo O 0 0.007904262281954288
. O 0 0.0009662280790507793

Mutations O 0 0.0044002109207212925
in O 0 0.0003463589237071574
the O 0 0.0012337485095486045
SMAD4 O 1 0.9989160299301147
/ O 1 0.9922472238540649
DPC4 O 1 0.9977134466171265
tumor B-Disease 1 0.9988284707069397
suppressor O 0 0.04983426257967949
gene O 0 0.0009614469017833471
, O 0 7.971244485815987e-05
a O 0 0.00017212620878126472
key O 0 0.0004520636866800487
signal O 0 0.0010008384706452489
transducer O 0 0.007100360468029976
in O 0 0.00017231324454769492
most O 0 0.0005341236246749759
TGFbeta O 1 0.9872384071350098
- O 0 0.02699555829167366
related O 0 0.0017071334877982736
pathways O 0 0.00712975487112999
, O 0 8.214093395508826e-05
are O 0 1.527888343844097e-05
involved O 0 0.0001635027292650193
in O 0 3.860698052449152e-05
50 O 0 8.719340257812291e-05
% O 0 3.94355520256795e-05
of O 0 0.0002623398613650352
pancreatic B-Disease 1 0.9999873638153076
cancers I-Disease 1 0.9998960494995117
. O 0 0.0014828275889158249

Homozygous O 0 0.03671537712216377
Smad4 O 1 0.6617526412010193
mutant O 0 0.04325646907091141
mice O 1 0.699449360370636
die O 1 0.6572818160057068
before O 0 0.0006755472277291119
day O 0 0.001151735195890069
7 O 0 0.0012120252940803766
. O 0 0.0007117995410226285

5 O 0 0.0009737876825965941
of O 0 0.00020619960559997708
embryogenesis O 0 0.12252839654684067
. O 0 0.0017645646585151553

Mutant O 0 0.014142743311822414
embryos O 0 0.0012826070887967944
have O 0 0.00013287052570376545
reduced O 0 0.0010277584660798311
size O 0 0.0005410105804912746
, O 0 0.0003528039960656315
fail O 0 0.00876542180776596
to O 0 0.0001387177180731669
gastrulate O 0 0.032019469887018204
or O 0 0.00016961035726126283
express O 0 0.0009322406840510666
a O 0 0.0006702910759486258
mesodermal O 0 0.483944296836853
marker O 0 0.0062679448164999485
, O 0 0.00017228220531251281
and O 0 0.00015819740656297654
show O 0 0.0014597023837268353
abnormal O 1 0.8269933462142944
visceral O 1 0.9818883538246155
endoderm O 1 0.9912961721420288
development O 0 0.0054204147309064865
. O 0 0.0014998818514868617

Growth B-Disease 1 0.7004911303520203
retardation I-Disease 1 0.9988718628883362
of O 0 9.826839959714562e-05
the O 0 0.0009040874429047108
Smad4 O 1 0.9978188276290894
- O 1 0.5262004733085632
deficient O 1 0.9903050661087036
embryos O 0 0.0006895603146404028
results O 0 0.00019681255798786879
from O 0 0.00011358064512023702
reduced O 0 0.0022575517650693655
cell O 0 0.0018310814630240202
proliferation O 0 0.0029167451430112123
rather O 0 0.00011870734306285158
than O 0 0.00011947126040467992
increased O 0 0.0009561808547005057
apoptosis O 0 0.006081826984882355
. O 0 0.0007355458219535649

Aggregation O 0 0.003882960183545947
of O 0 0.00028352931258268654
mutant O 0 0.017983170226216316
Smad4 O 1 0.9565353989601135
ES O 0 0.29016169905662537
cells O 0 0.0010067884577438235
with O 0 9.889795910567045e-05
wild O 0 0.001202683662995696
- O 0 0.0059654442593455315
type O 0 0.004953785799443722
tetraploid O 0 0.07825381308794022
morulae O 1 0.7915855646133423
rescues O 0 0.10313153266906738
the O 0 0.0023258919827640057
gastrulation B-Disease 1 0.9946088790893555
defect I-Disease 1 0.9933018684387207
. O 0 0.002007870702072978

These O 0 0.00026270077796652913
results O 0 0.0006433532107621431
indicate O 0 0.0007739279535599053
that O 0 0.0002919264370575547
Smad4 O 0 0.4752042889595032
is O 0 0.0003069888043683022
initially O 0 0.0003601557982619852
required O 0 0.00012059868458891287
for O 0 3.7266156141413376e-05
the O 0 5.383378083934076e-05
differentiation O 0 0.00027994607808068395
of O 0 1.8449980416335166e-05
the O 0 0.0003515693242661655
visceral O 1 0.981614887714386
endoderm O 1 0.9877110123634338
and O 0 0.00011249585804762319
that O 0 8.297907334053889e-05
the O 0 0.0003707924915943295
gastrulation B-Disease 1 0.9959090948104858
defect I-Disease 1 0.9845557808876038
in O 0 0.00017669510270934552
the O 0 0.0006348513416014612
epiblast O 1 0.9974633455276489
is O 0 0.0005100529524497688
secondary O 0 0.0015732991741970181
and O 0 0.00011933837959077209
non O 0 0.0015135896392166615
- O 0 0.003958993591368198
cell O 0 0.0011836054036393762
autonomous O 0 0.0013702946016564965
. O 0 0.0007060233037918806

Rescued O 0 0.13824717700481415
embryos O 0 0.007686265744268894
show O 0 0.006528295576572418
severe O 1 0.9993743300437927
anterior O 1 0.9993417859077454
truncations O 1 0.6466259956359863
, O 0 0.0004332337703090161
indicating O 0 0.0008499653195030987
a O 0 0.00017676064453553408
second O 0 0.00011079537216573954
important O 0 0.00012347249139565974
role O 0 0.0005365752149373293
for O 0 0.0002790869039017707
Smad4 O 1 0.8743518590927124
in O 0 0.0007201863918453455
anterior O 1 0.9991989731788635
patterning O 1 0.9673793911933899
during O 0 0.004086472559720278
embryogenesis O 1 0.5651249885559082
. O 0 0.00158973119687289

Prevalence O 0 0.4709494411945343
of O 0 0.0003499668091535568
p16 O 1 0.7834550142288208
and O 0 0.0012121316976845264
CDK4 O 1 0.9884264469146729
germline O 1 0.6321755051612854
mutations O 0 0.002081821206957102
in O 0 0.0004044219385832548
48 O 0 0.11599807441234589
melanoma B-Disease 1 0.9999971389770508
- O 1 0.9710178971290588
prone O 1 0.9179244637489319
families O 0 0.0004909327835775912
in O 0 0.00041918069473467767
France O 0 0.005375884007662535
. O 0 0.0011684780474752188

The O 0 0.0031537169124931097
French O 0 0.06568081676959991
Familial B-Disease 1 0.9997414946556091
Melanoma I-Disease 1 0.9999939203262329
Study O 0 0.016733456403017044
Group O 0 0.0015225751558318734
. O 0 0.0008839171496219933

Germline O 1 0.8707855343818665
mutations O 0 0.0035882398951798677
in O 0 0.0002413627807982266
the O 0 0.0006062210304662585
p16 O 1 0.7909821271896362
and O 0 0.0006240621441975236
CDK4 O 1 0.9727967381477356
genes O 0 0.0003573485591914505
have O 0 7.12788532837294e-05
been O 0 0.00014117531827650964
reported O 0 0.00030427833553403616
in O 0 4.253532097209245e-05
a O 0 0.00022217324294615537
subset O 0 0.0012364779831841588
of O 0 0.00036089797504246235
melanoma B-Disease 1 0.9999970197677612
pedigrees O 0 0.28909629583358765
, O 0 0.00023965623404365033
but O 0 0.00016854569548740983
their O 0 0.00014682093751616776
prevalence O 1 0.9699429869651794
is O 0 0.00023581025016028434
not O 0 9.19524027267471e-05
well O 0 0.00018721689411904663
known O 0 0.0007748141069896519
. O 0 0.0006619099876843393

We O 0 0.0009104160126298666
searched O 0 0.001984692644327879
for O 0 9.2128204414621e-05
such O 0 0.0001287074264837429
germline O 0 0.4526504874229431
mutations O 0 0.0008966863388195634
in O 0 0.0001661837159190327
48 O 0 0.002153505338355899
French O 1 0.5580523610115051
melanoma B-Disease 1 0.9999984502792358
- O 1 0.9854588508605957
prone O 1 0.9748924374580383
families O 0 0.0002443625417072326
selected O 0 0.00016222993144765496
according O 0 7.168779120547697e-05
to O 0 3.409962300793268e-05
two O 0 3.0511713703162968e-05
major O 0 0.0004967248532921076
criteria O 0 0.0005993381491862237
families O 0 0.00012756405340041965
with O 0 4.9749633035389706e-05
at O 0 0.0001794210256775841
least O 0 0.00012347815209068358
three O 0 6.37108096270822e-05
affected O 0 0.001060645328834653
members O 0 0.00014948534953873605
( O 0 0.0004301162844058126
n O 0 0.0015948937507346272
= O 0 0.001422810135409236
20 O 0 0.0002828179276548326
) O 0 0.00011109023034805432
or O 0 0.00010715667303884402
families O 0 9.132924606092274e-05
with O 0 5.870944005437195e-05
two O 0 6.39202116872184e-05
affected O 0 0.0017279611201956868
members O 0 8.464443817501888e-05
, O 0 5.054252687841654e-05
one O 0 2.7852929633809254e-05
of O 0 1.081220580090303e-05
them O 0 6.993842544034123e-05
affected O 0 0.0011282041668891907
before O 0 9.42711194511503e-05
the O 0 4.432577043189667e-05
age O 0 9.398409019922838e-05
of O 0 1.880853778857272e-05
50 O 0 0.00031417247373610735
( O 0 0.0004812848928850144
n O 0 0.0015533993719145656
= O 0 0.0019622675608843565
28 O 0 0.0005170486401766539
) O 0 8.79993021953851e-05
, O 0 5.720149783883244e-05
and O 0 4.915027238894254e-05
one O 0 6.972427217988297e-05
additional O 0 0.0004755989648401737
minor O 0 0.027854014188051224
criterion O 0 0.01216316781938076
. O 0 0.0009595535229891539

Sixteen O 0 0.0038215420208871365
different O 0 0.0004892514552921057
p16 O 1 0.8700493574142456
germline O 1 0.8363920450210571
mutations O 0 0.0016377181746065617
were O 0 5.5047523346729577e-05
found O 0 0.00014038263179827482
in O 0 0.00010402408224763349
21 O 0 0.0004139191296417266
families O 0 0.00016024576325435191
, O 0 7.376565190497786e-05
while O 0 9.796021186048165e-05
one O 0 0.0002653972478583455
germline O 0 0.33723390102386475
mutation O 0 0.0024783185217529535
, O 0 0.00038989423774182796
Arg24His O 1 0.7956506609916687
, O 0 0.00023819146736059338
was O 0 0.0004985753912478685
detected O 0 0.0018030412029474974
in O 0 8.955517114372924e-05
the O 0 0.0005044277640990913
CDK4 O 1 0.9913222789764404
gene O 0 0.0035016792826354504
. O 0 0.0007879087934270501

The O 0 0.000321388739394024
frequency O 0 0.000285269517917186
of O 0 0.00010514944733586162
p16 O 0 0.20053701102733612
gene O 0 0.0014167837798595428
mutation O 0 0.0007003185455687344
in O 0 4.170608735876158e-05
our O 0 0.00011256410653004423
sample O 0 0.00016284242155961692
( O 0 0.00017632870003581047
44 O 0 0.00021810809266753495
% O 0 3.305560312583111e-05
) O 0 6.747078441549093e-05
is O 0 5.4653555707773194e-05
among O 0 3.494495103950612e-05
the O 0 8.09305056463927e-05
highest O 0 0.0011432431638240814
rates O 0 0.0005714425933547318
yet O 0 0.0005005199927836657
reported O 0 0.0006630299612879753
and O 0 7.781617023283616e-05
the O 0 0.00021036311227362603
CDK4 O 1 0.9536752104759216
mutation O 0 0.000650593894533813
is O 0 5.4097476095194e-05
the O 0 6.080365346861072e-05
second O 0 0.00019568104471545666
mutation O 0 0.000969048123806715
detected O 0 0.0014657658757641912
in O 0 6.956049764994532e-05
this O 0 0.00011725060176104307
gene O 0 0.0014489602763205767
worldwide O 0 0.0014965812442824244
. O 0 0.0008772691944614053

In O 0 0.0007747662020847201
summary O 0 0.00106094463262707
, O 0 0.00015755956701468676
our O 0 0.0002475198998581618
results O 0 0.0002826486306730658
show O 0 0.0002957743126899004
frequent O 0 0.001422917121089995
involvement O 0 0.0009920935845002532
of O 0 2.777521513053216e-05
the O 0 0.0005002471734769642
p16 O 1 0.8855767250061035
gene O 0 0.0032405743841081858
in O 0 0.0010976949706673622
familial B-Disease 1 0.9998832941055298
melanoma I-Disease 1 0.9999970197677612
and O 0 0.0002578040584921837
confirm O 0 0.000563605222851038
the O 0 4.458398689166643e-05
role O 0 0.00017093388305511326
of O 0 1.803848317649681e-05
the O 0 0.000360633188392967
CDK4 O 1 0.9708629250526428
gene O 0 0.0010775342816486955
as O 0 0.0003496480348985642
a O 0 0.028299950063228607
melanoma B-Disease 1 0.9999934434890747
- O 0 0.35487842559814453
predisposing O 0 0.21691372990608215
gene O 0 0.002341636922210455
. O 0 0.0002927656751126051
. O 0 0.0006276901112869382

Progression O 0 0.1435701549053192
of O 0 0.0002932584611698985
somatic O 0 0.07469341158866882
CTG O 1 0.979540228843689
repeat O 0 0.005113193299621344
length O 0 0.0007839541067369282
heterogeneity O 0 0.0027404660359025
in O 0 0.00010346189810661599
the O 0 0.0002883993147406727
blood O 1 0.9904142022132874
cells O 0 0.014168540947139263
of O 0 0.0015269453870132565
myotonic B-Disease 1 0.9999990463256836
dystrophy I-Disease 1 0.9999996423721313
patients O 1 0.9999572038650513
. O 0 0.003097963286563754

The O 0 0.000488310819491744
genetic O 0 0.0009254113538190722
basis O 0 0.00026683404576033354
of O 0 0.0008583033340983093
myotonic B-Disease 1 0.9999922513961792
dystrophy I-Disease 1 0.9999988079071045
( O 1 0.9109029173851013
DM B-Disease 1 0.9999881982803345
) O 0 0.00035355566069483757
is O 0 9.024113387567922e-05
the O 0 5.076225716038607e-05
expansion O 0 0.00036525886389426887
of O 0 2.719227813940961e-05
an O 0 0.000756420602556318
unstable O 1 0.9964777827262878
CTG O 1 0.9824784994125366
repeat O 0 0.0033535787370055914
in O 0 7.956443732837215e-05
the O 0 0.00016828134539537132
34 O 0 0.0007586946594528854
UTR O 0 0.0075342729687690735
of O 0 5.305999729898758e-05
the O 0 0.000799411500338465
DM B-Disease 1 0.9996765851974487
protein O 0 0.0015278354985639453
kinase O 0 0.0070532276295125484
gene O 0 0.0008801683434285223
on O 0 0.00016473619325552136
chromosome O 0 0.0018559995805844665
19 O 0 0.0011004729894921184
. O 0 0.0004846478987019509

One O 0 0.00019349119975231588
of O 0 2.66218794422457e-05
the O 0 0.00012590832193382084
principal O 0 0.0006779865361750126
features O 0 9.106860670726746e-05
of O 0 4.156751310802065e-05
the O 0 0.0011989491758868098
DM B-Disease 1 0.9999439716339111
mutation O 0 0.0024117252323776484
is O 0 0.00019019359024241567
an O 0 0.00026459054788574576
extraordinarily O 1 0.6796880960464478
high O 0 0.0011713565327227116
level O 0 0.00038593276985920966
of O 0 8.468117448501289e-05
somatic O 0 0.3010227680206299
mosaicism O 1 0.9946111440658569
, O 0 0.000276307255262509
due O 0 0.000519386085215956
to O 0 7.715950050624087e-05
an O 0 0.0001789151574485004
extremely O 0 0.025469455868005753
high O 0 0.001230128575116396
degree O 0 0.0005207175854593515
of O 0 5.00017122249119e-05
somatic O 0 0.024293767288327217
instability O 0 0.004176322836428881
both O 0 8.210443775169551e-05
within O 0 9.44939602049999e-05
and O 0 6.030415534041822e-05
between O 0 0.00011513366916915402
different O 0 0.0001229328045155853
tissues O 0 0.4892641007900238
. O 0 0.0011500425171107054

This O 0 0.0010578990913927555
instability O 0 0.017406612634658813
appears O 0 0.002415548777207732
to O 0 0.00011076886585215107
be O 0 7.41267649573274e-05
biased O 0 0.0008696846780367196
towards O 0 0.00019853182311635464
further O 0 0.00017118964751716703
expansion O 0 0.0005568499909713864
and O 0 5.5519041779916734e-05
continuous O 0 0.0004531952436082065
throughout O 0 9.161193884210661e-05
the O 0 5.7730707339942455e-05
life O 0 0.00011368509876774624
of O 0 9.18144087336259e-06
an O 0 8.944541332311928e-05
individual O 0 0.00015235257160384208
, O 0 0.0001127800642279908
features O 0 0.00015540396270807832
that O 0 4.494380482356064e-05
could O 0 0.00010799660958582535
be O 0 3.553933493094519e-05
associated O 0 5.435240746010095e-05
with O 0 2.9901526431785896e-05
the O 0 8.422992686973885e-05
progressive O 0 0.009461237117648125
nature O 0 0.0007101507508195937
of O 0 6.430721987271681e-05
the O 0 0.014007789082825184
disease O 1 0.9999884366989136
. O 0 0.0011078919051215053

Although O 0 0.001036343863233924
increasing O 0 0.0006030118674971163
measured O 0 0.001077749882824719
allele O 0 0.002192677929997444
size O 0 0.0005930843180976808
between O 0 0.0009619724005460739
patients O 1 0.999805748462677
clearly O 0 0.0009120934410020709
correlates O 0 0.001432810677215457
with O 0 4.986676140106283e-05
an O 0 0.0001635492080822587
increased O 0 0.0013179585803300142
severity O 1 0.9977207779884338
of O 0 0.00023081239487510175
symptoms O 1 0.9999864101409912
and O 0 0.00010715176176745445
an O 0 0.0001883488439489156
earlier O 0 0.0005183652392588556
age O 0 0.0003350580227561295
of O 0 9.403166768606752e-05
onset O 1 0.9997698664665222
, O 0 0.00017806727555580437
this O 0 7.125662523321807e-05
correlation O 0 0.0006959980819374323
is O 0 0.00011597395496210083
not O 0 4.340115992818028e-05
precise O 0 0.0002256003936054185
and O 0 9.041521843755618e-05
measured O 0 0.0007783114560879767
allele O 0 0.0021123618353158236
length O 0 0.0006663345266133547
cannot O 0 0.000380131445126608
be O 0 2.5844103220151737e-05
used O 0 2.7891737772733904e-05
as O 0 3.340685725561343e-05
an O 0 7.508921407861635e-05
accurate O 0 0.0004953626776114106
predictor O 0 0.003804548177868128
of O 0 3.103874405496754e-05
age O 0 0.0004406053922139108
of O 0 0.00018099683802574873
onset O 1 0.9995606541633606
. O 0 0.0018607978709042072

In O 0 0.00041788662201724946
order O 0 0.0001619881804799661
to O 0 8.784502279013395e-05
further O 0 0.00032977902446873486
characterize O 0 0.004354006145149469
the O 0 0.00021575987921096385
dynamics O 0 0.011934922076761723
of O 0 0.0007078979397192597
DM B-Disease 1 0.9999624490737915
CTG O 1 0.9928860068321228
repeat O 0 0.03895382955670357
somatic O 0 0.014962300658226013
instability O 0 0.009741715155541897
, O 0 0.0001964076072908938
we O 0 0.0001357271830784157
have O 0 6.69356741127558e-05
studied O 0 0.0002838386863004416
repeat O 0 0.0013224126305431128
length O 0 0.00024234835291281343
changes O 0 9.577306627761573e-05
over O 0 5.424346454674378e-05
time O 0 0.00011170249490533024
in O 0 0.0004904004745185375
111 O 1 0.9876798391342163
myotonic B-Disease 1 0.9999972581863403
dystrophy I-Disease 1 0.9999997615814209
patients O 1 0.9999772310256958
with O 0 0.0004875609593000263
varying O 0 0.011619288474321365
clinical O 1 0.9998601675033569
severity O 1 0.9995385408401489
and O 0 0.0010652629425749183
CTG O 1 0.9967259168624878
repeat O 0 0.003228795947507024
size O 0 0.00014946781448088586
over O 0 4.53808534075506e-05
time O 0 2.5599814762244932e-05
intervals O 0 8.970404451247305e-05
of O 0 1.8909884602180682e-05
1 O 0 0.00043849213398061693
- O 0 0.0018212452996522188
7 O 0 0.0003390534548088908
years O 0 0.00037060907925479114
. O 0 0.0004440173215698451

We O 0 0.0009992150589823723
have O 0 0.00013723289885092527
found O 0 0.00011934749636566266
a O 0 0.0001631750346859917
direct O 0 0.0002236503642052412
progression O 0 0.007406147196888924
of O 0 1.882811739051249e-05
the O 0 0.0001190910188597627
size O 0 0.00041962103568948805
heterogeneity O 0 0.0023409577552229166
over O 0 0.00010435463627800345
time O 0 0.00010075184400193393
related O 0 0.0005136964609846473
to O 0 0.00016321208386216313
initial O 0 0.0028023323975503445
CTG O 1 0.9879307746887207
repeat O 0 0.0035041377414017916
size O 0 0.00023283307382371277
and O 0 6.894225225551054e-05
the O 0 7.178349187597632e-05
time O 0 0.00010227917664451525
interval O 0 0.0005971927312202752
and O 0 0.00010716352699091658
always O 0 0.0004166900471318513
biased O 0 0.001247813575901091
towards O 0 0.0003352986241225153
further O 0 0.0003169761330354959
expansion O 0 0.002623578766360879
. O 0 0.0007200072868727148

Attempts O 0 0.0024514752440154552
to O 0 0.00025407885550521314
mathematically O 0 0.001573291840031743
model O 0 0.0004569418088067323
the O 0 0.00020963668066542596
dynamics O 0 0.005842682905495167
have O 0 0.00016597197100054473
proved O 0 0.001834354130551219
only O 0 0.00014066617586649954
partially O 0 0.0063963462598621845
successful O 0 0.0008451890316791832
suggesting O 0 0.0008797930786386132
that O 0 3.085806019953452e-05
individual O 0 6.264098192332312e-05
specific O 0 0.00018318953516427428
genetic O 0 0.0016927440883591771
and O 0 0.0006029480136930943
/ O 1 0.9457516074180603
or O 0 0.00028040073812007904
environmental O 0 0.0025960179045796394
factors O 0 0.00017575193487573415
also O 0 6.865816976642236e-05
play O 0 6.575801671715453e-05
a O 0 0.00022885204816702753
role O 0 0.000715885020326823
in O 0 0.00042923667933791876
somatic O 0 0.05716562271118164
mosaicism O 1 0.9916057586669922
. O 0 0.00041444823727943003
. O 0 0.0007413423154503107

Aspartylglucosaminuria B-Disease 1 0.9615882039070129
among O 0 0.001040073810145259
Palestinian O 0 0.005239261779934168
Arabs O 0 0.004518053028732538
. O 0 0.0011922460980713367

Aspartylglucosaminuria B-Disease 1 0.9918314814567566
( O 0 0.013751515187323093
AGU B-Disease 1 0.9997022747993469
) O 0 0.0004807997611351311
is O 0 0.00025698001263663173
a O 0 0.0008302858332172036
rare O 1 0.5221030712127686
disorder B-Disease 1 0.9997438788414001
of I-Disease 0 0.00016945356037467718
glycoprotein I-Disease 1 0.9965865612030029
metabolism I-Disease 1 0.990311861038208
caused O 0 0.08505632728338242
by O 0 0.00015923148021101952
the O 0 0.0010519420029595494
deficiency B-Disease 1 0.9999079704284668
of I-Disease 0 4.604253263096325e-05
the I-Disease 0 0.0004502941155806184
lysosomal I-Disease 1 0.9936688542366028
enzyme I-Disease 0 0.008604248985648155
aspartylglucosaminidase I-Disease 1 0.9276125431060791
( O 0 0.002519747940823436
AGA O 1 0.9920840263366699
) O 0 0.0007053454173728824
. O 0 0.0006281999521888793

AGU B-Disease 1 0.9997095465660095
is O 0 0.004762598313391209
inherited O 1 0.9885016679763794
as O 0 0.0003980688634328544
an O 0 0.0022975674364715815
autosomal O 1 0.9991962313652039
recessive O 1 0.9979748129844666
trait O 1 0.5699657797813416
and O 0 0.00031587504781782627
occurs O 0 0.0005962616996839643
with O 0 5.591648368863389e-05
a O 0 0.0002908075402956456
high O 0 0.0004945287946611643
frequency O 0 0.0001022116921376437
in O 0 6.354630750138313e-05
Finland O 0 0.00042527279583737254
because O 0 0.0001244483864866197
of O 0 2.666288855834864e-05
a O 0 0.0009333533816970885
founder O 0 0.014646757394075394
effect O 0 0.0015897303819656372
. O 0 0.00056397111620754

While O 0 0.0014478283701464534
very O 0 0.001616965513676405
few O 0 0.002139269607141614
patients O 1 0.9996680021286011
with O 0 0.001192801515571773
AGU B-Disease 1 0.999956488609314
have O 0 0.0002168808423448354
been O 0 0.00022540667850989848
reported O 0 0.0005801934166811407
from O 0 7.290486246347427e-05
non O 0 0.0007704410818405449
- O 0 0.0013864262728020549
Finnish O 0 0.0012357044033706188
origin O 0 7.423647912219167e-05
, O 0 0.0003077897126786411
we O 0 0.0031793280504643917
diagnosed O 1 0.999987006187439
the O 0 0.0014829017454758286
disorder O 1 0.9999533891677856
in O 0 0.0006501426105387509
8 O 0 0.007846440188586712
patients O 1 0.9997561573982239
originating O 0 0.0007146981661207974
from O 0 0.0002280439657624811
3 O 0 0.0008111270144581795
unrelated O 0 0.004294226877391338
families O 0 0.0002742799697443843
, O 0 0.00010431493865326047
all O 0 4.6595101593993604e-05
Palestinian O 0 0.0013424487551674247
Arabs O 0 0.0005753956502303481
from O 0 6.545434007421136e-05
the O 0 0.00010510633001103997
region O 0 0.0005442254478111863
of O 0 7.803538755979389e-05
Jerusalem O 0 0.0055787768214941025
. O 0 0.0007538982317782938

The O 0 0.005142625886946917
clinical O 1 0.9995705485343933
diagnosis O 1 0.9998911619186401
of O 0 0.0010787021601572633
AGU B-Disease 1 0.9999709129333496
is O 0 0.0010551034938544035
often O 0 0.0004945407272316515
difficult O 0 0.0017388417618349195
, O 0 0.00010274232045048848
in O 0 5.6762659369269386e-05
particular O 0 0.00012114038690924644
early O 0 0.00012699386570602655
in O 0 4.2475377995288e-05
the O 0 8.208846702473238e-05
course O 0 0.0009647001861594617
of O 0 3.701966124936007e-05
the O 0 0.0022098149638623
disease O 1 0.9999861717224121
, O 0 9.49131790548563e-05
and O 0 3.203083178959787e-05
most O 0 3.187588299624622e-05
of O 0 2.4790568204480223e-05
the O 0 0.002057805424556136
patients O 1 0.999981164932251
are O 0 0.0006181413191370666
diagnosed O 1 0.9999949932098389
after O 0 0.0004340893356129527
the O 0 9.23852639971301e-05
age O 0 0.00019035015429835767
of O 0 3.765475412365049e-05
5 O 0 0.0007661409326829016
years O 0 0.0007559290970675647
. O 0 0.0006170509732328355

However O 0 0.0014281213516369462
, O 0 0.000441497570136562
since O 0 0.0008550300262868404
these O 0 0.00031778193078935146
patients O 1 0.9994274377822876
excrete O 0 0.18549862504005432
early O 0 0.0001855612499639392
large O 0 8.710006659384817e-05
amounts O 0 0.000191848463146016
of O 0 5.430650708149187e-05
aspartylglucosamine O 1 0.681531548500061
in O 0 0.00030374154448509216
urine O 0 0.017651217058300972
, O 0 0.0001827307278290391
biochemical O 0 0.003411856247112155
screening O 0 0.0027199499309062958
is O 0 0.0001525271509308368
easy O 0 0.0005577037809416652
by O 0 0.00021733481844421476
urine O 0 0.01849338784813881
chromatography O 0 0.36908191442489624
. O 0 0.0004251025093253702
. O 0 0.0007641896372660995

Detection O 0 0.007037146016955376
of O 0 0.0001278928975807503
heterozygous O 0 0.00306860264390707
carriers O 0 0.0019419258460402489
of O 0 7.065886893542483e-05
the O 0 0.001428083167411387
ataxia B-Disease 1 0.9998874664306641
- I-Disease 1 0.9841635823249817
telangiectasia I-Disease 1 0.9979338645935059
( O 0 0.0012634708546102047
ATM O 0 0.005882222671061754
) O 0 0.0002933440264314413
gene O 0 0.0009728946606628597
by O 0 0.0003148477408103645
G2 O 1 0.9951398372650146
phase O 0 0.0059759607538580894
chromosomal O 0 0.010510502383112907
radiosensitivity O 0 0.05846671760082245
of O 0 0.0002313138247700408
peripheral O 1 0.9998412132263184
blood O 1 0.999545156955719
lymphocytes O 1 0.9985374212265015
. O 0 0.0018171300180256367

In O 0 0.005329204257577658
ataxia B-Disease 1 0.9997673630714417
- I-Disease 1 0.9790217876434326
telangiectasia I-Disease 1 0.9986453652381897
( O 0 0.004876102786511183
A B-Disease 1 0.9948205947875977
- I-Disease 1 0.9973129630088806
T I-Disease 1 0.9996501207351685
) O 0 0.0013428643578663468
patients O 1 0.9989508390426636
, O 0 0.00017526930605527014
mutations O 0 0.000515647407155484
in O 0 4.6922035835450515e-05
a O 0 0.00020375016902107745
single O 0 0.000269700976787135
gene O 0 0.0009085710044018924
, O 0 0.00013471386046148837
ATM O 0 0.002473820699378848
, O 0 9.95091613731347e-05
result O 0 0.00022004503989592195
in O 0 0.000179635506356135
an O 0 0.0068605574779212475
autosomal B-Disease 1 0.999946117401123
recessive I-Disease 1 0.9999610185623169
syndrome I-Disease 1 0.9999994039535522
that O 0 0.0004781785246450454
embraces O 0 0.012909762561321259
a O 0 0.00041929158032871783
variety O 0 0.00035693010431714356
of O 0 0.00010056236351374537
clinical O 1 0.9993798732757568
features O 0 0.0005784673849120736
and O 0 0.00041641166899353266
manifests O 1 0.9686772227287292
extreme O 0 0.13609248399734497
radiosensitivity O 1 0.7689332962036133
and O 0 7.821679901098832e-05
a O 0 0.00029545981669798493
strong O 0 0.0005785998073406518
pre O 0 0.009283569641411304
- O 0 0.011257811449468136
disposition O 0 0.061632804572582245
to O 0 0.0010728890774771571
malignancy B-Disease 1 0.9991165995597839
. O 0 0.0012463643215596676

Heterozygotes O 0 0.07532177120447159
for O 0 0.0002808949211612344
the O 0 0.00032612780341878533
ATM O 0 0.0092868497595191
gene O 0 0.0011778402840718627
have O 0 7.101811206666753e-05
no O 0 0.00015593953139614314
clinical O 0 0.38598304986953735
expression O 0 0.00023223421885631979
of O 0 8.855673513608053e-05
A B-Disease 1 0.9986931681632996
- I-Disease 1 0.9980948567390442
T I-Disease 1 0.9997301697731018
but O 0 0.00045680461334995925
may O 0 0.0018585179932415485
be O 0 0.0012004736345261335
cancer B-Disease 1 0.9999767541885376
prone O 0 0.35350459814071655
with O 0 0.00010221813136013225
a O 0 0.0003994887229055166
moderate O 0 0.0025790329091250896
increase O 0 0.0002141987788490951
in O 0 9.337012306787074e-05
in O 0 0.00022608468134421855
vitro O 0 0.008329587057232857
radiosensitivity O 1 0.8796459436416626
. O 0 0.0013431714614853263

We O 0 0.0009462959133088589
performed O 0 0.0010982612147927284
a O 0 0.0011797279585152864
blind O 0 0.23503808677196503
chromosomal O 0 0.005075209774076939
analysis O 0 0.0004864690999966115
on O 0 0.0007633900968357921
G2 O 1 0.998454213142395
- O 0 0.008305136114358902
phase O 0 0.0067305718548595905
lymphocytes O 1 0.5970025062561035
from O 0 0.00011403556709410623
7 O 0 0.0006629045237787068
unrelated O 0 0.012848751619458199
A B-Disease 1 0.9962246417999268
- I-Disease 1 0.9984366297721863
T I-Disease 1 0.9998406171798706
patients O 1 0.9994682669639587
, O 0 0.00022897210146766156
13 O 0 0.0008481013937853277
obligate O 0 0.29548534750938416
A B-Disease 1 0.984877347946167
- I-Disease 1 0.9929967522621155
T I-Disease 1 0.9994193315505981
heterozygotes O 1 0.6936097741127014
( O 0 0.00040964281652122736
parents O 0 0.0002621853200253099
of O 0 3.125692091998644e-05
the O 0 0.0010386072099208832
patients O 1 0.9998499155044556
) O 0 0.00014137467951513827
, O 0 7.941548392409459e-05
and O 0 7.052558794384822e-05
14 O 0 0.00027250510174781084
normal O 0 0.0005966881290078163
controls O 0 0.0005964105948805809
following O 0 0.0005314208101481199
X O 0 0.01389614399522543
- O 0 0.002365486929193139
irradiation O 0 0.0037194599863141775
with O 0 0.00014151590585242957
1 O 0 0.001078503904864192
Gy O 0 0.3372325897216797
in O 0 0.00010493370064068586
order O 0 0.00010452552669448778
to O 0 7.949716382427141e-05
evaluate O 0 0.0024858948308974504
this O 0 7.918726623756811e-05
cytogenetic O 0 0.01267551351338625
method O 0 0.0001678461121628061
as O 0 7.892536814324558e-05
a O 0 0.0002378234057687223
tool O 0 0.0012087777722626925
for O 0 0.00010918732004938647
detection O 0 0.0018218540353700519
of O 0 7.212354830699041e-05
ATM O 0 0.020236030220985413
carriers O 0 0.014822949655354023
. O 0 0.0011692028492689133

Both O 0 0.002225548028945923
A B-Disease 1 0.9476209878921509
- I-Disease 1 0.9900152087211609
T I-Disease 1 0.9991220831871033
homozygotes O 1 0.9737294316291809
and O 0 0.0005657702567987144
heterozygotes O 0 0.40276849269866943
showed O 0 0.0017643109895288944
significantly O 0 0.0018804973224177957
increased O 0 0.000364148203516379
levels O 0 0.000788411998655647
of O 0 0.00013273325748741627
radiation O 1 0.9995788931846619
- O 1 0.9407675862312317
induced O 1 0.996504545211792
chromatid O 1 0.9971380233764648
damage O 1 0.6705305576324463
relative O 0 0.0003419242275413126
to O 0 6.40468206256628e-05
that O 0 3.8413920265156776e-05
of O 0 3.216808909201063e-05
normal O 0 0.002479982329532504
controls O 0 0.002660373691469431
. O 0 0.0010320345172658563

These O 0 0.00021859275875613093
results O 0 0.000442509597633034
show O 0 0.0002693427668418735
that O 0 8.788801642367616e-05
the O 0 0.0005403223331086338
G2 O 1 0.9988551139831543
- O 0 0.007838581688702106
phase O 0 0.0045813689939677715
chromosomal O 0 0.011007542721927166
radiosensitivity O 0 0.12072116136550903
assay O 0 0.002302794950082898
can O 0 8.372015145141631e-05
be O 0 2.076759483315982e-05
used O 0 2.3938411686685868e-05
for O 0 2.1109381123096682e-05
the O 0 4.9701498937793076e-05
detection O 0 0.000924615073017776
of O 0 6.792715430492535e-05
A B-Disease 1 0.9975467324256897
- I-Disease 1 0.9962539672851562
T I-Disease 1 0.9987275004386902
heterozygotes O 1 0.5577751994132996
. O 0 0.001019719522446394

In O 0 0.0009008456254377961
combination O 0 0.0032667769119143486
with O 0 0.00020120454428251833
molecular O 0 0.0013864097418263555
genetic O 0 0.0007385245407931507
analyses O 0 0.0004915863974019885
, O 0 8.288337994599715e-05
this O 0 7.575803465442732e-05
test O 0 0.0007867293898016214
may O 0 0.00014372302393894643
be O 0 8.34115326142637e-06
of O 0 3.698731688928092e-06
value O 0 3.543564525898546e-05
in O 0 4.456702299648896e-05
studies O 0 0.0001336000277660787
of O 0 4.429006003192626e-05
familial B-Disease 1 0.9989380240440369
and I-Disease 0 0.0008574507664889097
sporadic I-Disease 1 0.9058154225349426
cancers I-Disease 1 0.9998334646224976
aimed O 0 0.0013526612892746925
at O 0 0.00032193277729675174
determination O 0 0.0012068696087226272
of O 0 1.7969219697988592e-05
the O 0 0.0001047393525368534
potential O 0 0.0006161098717711866
involvement O 0 0.0013334245886653662
of O 0 5.6932334700832143e-05
ATM O 0 0.11377841979265213
mutations O 0 0.005047166720032692
in O 0 0.0014235635753720999
tumor B-Disease 1 0.9999686479568481
risk O 1 0.833259105682373
or O 0 0.00048118532868102193
development O 0 0.001962910173460841
. O 0 0.00035680594737641513
. O 0 0.0006536921137012541

Ataxia B-Disease 1 0.9998015761375427
- I-Disease 1 0.9890011548995972
telangiectasia I-Disease 1 0.997477114200592
: O 0 0.0006295922794379294
identification O 0 0.00023405188403557986
and O 0 9.538225276628509e-05
detection O 0 0.0015858308179304004
of O 0 8.05092349764891e-05
founder O 0 0.05479717254638672
- O 0 0.0031441403552889824
effect O 0 0.00046318626846186817
mutations O 0 0.00046358376857824624
in O 0 6.002600639476441e-05
the O 0 0.00014487399312201887
ATM O 0 0.007429325487464666
gene O 0 0.000778928108047694
in O 0 0.00010197610390605405
ethnic O 0 0.00019612390315160155
populations O 0 0.0014406251721084118
. O 0 0.0010965003166347742

To O 0 0.000386848725611344
facilitate O 0 0.0009008431225083768
the O 0 0.0001728751085465774
evaluation O 0 0.0028758293483406305
of O 0 5.287996827973984e-05
ATM O 0 0.0303080752491951
heterozygotes O 0 0.21495263278484344
for O 0 0.00022965861717239022
susceptibility O 0 0.34231236577033997
to O 0 0.00012977317965123802
other O 0 0.0002668208326213062
diseases O 1 0.9999616146087646
, O 0 0.00013603866682387888
such O 0 0.00012829352635890245
as O 1 0.5729234218597412
breast B-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999983310699463
, O 0 0.00018025764438789338
we O 0 0.00011638530850177631
have O 0 5.0380163884256035e-05
attempted O 0 0.0002882231492549181
to O 0 2.8620435841730796e-05
define O 0 0.00032027901033870876
the O 0 6.70707449899055e-05
most O 0 0.0001255646930076182
common O 0 0.0006514622364193201
mutations O 0 0.00044339720625430346
and O 0 2.2043614080757834e-05
their O 0 2.3447933926945552e-05
frequencies O 0 0.0001640177215449512
in O 0 0.0006390266353264451
ataxia B-Disease 1 0.999923586845398
- I-Disease 1 0.9614499807357788
telangiectasia I-Disease 1 0.998954176902771
( O 0 0.003011424094438553
A B-Disease 1 0.9928520321846008
- I-Disease 1 0.9927377104759216
T I-Disease 1 0.999232292175293
) O 0 0.0007015359587967396
homozygotes O 0 0.09274818003177643
from O 0 0.00012197357136756182
10 O 0 0.0001940041984198615
ethnic O 0 0.00015424596494995058
populations O 0 0.0010795019334182143
. O 0 0.0008638061699457467

Both O 0 0.0010856795124709606
genomic O 0 0.003227831097319722
mutations O 0 0.0012841037241742015
and O 0 7.27468723198399e-05
their O 0 5.7123332226183265e-05
effects O 0 0.0016280543059110641
on O 0 0.00014167492918204516
cDNA O 0 0.001399600994773209
were O 0 0.0001247066247742623
characterized O 0 0.08559851348400116
. O 0 0.0013357060961425304

Protein O 0 0.004192551132291555
- O 0 0.004779782146215439
truncation O 0 0.006376485340297222
testing O 0 0.0007691430510021746
of O 0 1.7728301827446558e-05
the O 0 0.00013445706281345338
entire O 0 0.0015108940424397588
ATM O 0 0.004736016038805246
cDNA O 0 0.0037259843666106462
detected O 0 0.004591940436512232
92 O 0 0.003879151539877057
( O 0 0.0006233298336155713
66 O 0 0.0015978910960257053
% O 0 0.0001310185471083969
) O 0 0.0004022945649921894
truncating O 0 0.05395839735865593
mutations O 0 0.001419251086190343
in O 0 0.00016659684479236603
140 O 0 0.0021155504509806633
mutant O 0 0.005551069509238005
alleles O 0 0.005845247767865658
screened O 0 0.00766131654381752
. O 0 0.001094572595320642

The O 0 0.00119207170791924
haplotyping O 0 0.27448323369026184
of O 0 0.00032856359030120075
patients O 1 0.9997791647911072
with O 0 0.00017094530630856752
identical O 0 0.001175254350528121
mutations O 0 0.0021044679451733828
indicates O 0 0.0005504768341779709
that O 0 3.8709396903868765e-05
almost O 0 6.135476724011824e-05
all O 0 7.51809602661524e-06
of O 0 6.521216619148618e-06
these O 0 2.0998510080971755e-05
represent O 0 0.00017017766367644072
common O 0 0.000638417259324342
ancestry O 0 0.0002687661035452038
and O 0 9.923124162014574e-05
that O 0 9.480563312536106e-05
very O 0 0.0005188427167013288
few O 0 0.0005657769506797194
spontaneously O 0 0.04768190532922745
recurring O 1 0.8821665048599243
ATM O 0 0.040456246584653854
mutations O 0 0.0041534798219799995
exist O 0 0.0007807553629390895
. O 0 0.0007326349150389433

Assays O 0 0.007508036680519581
requiring O 0 0.002903183689340949
minimal O 0 0.001239562756381929
amounts O 0 0.0001990325836231932
of O 0 3.934926280635409e-05
genomic O 0 0.001535687013529241
DNA O 0 0.00048714104923419654
were O 0 3.0019440600881353e-05
designed O 0 0.0003504820342641324
to O 0 5.368280835682526e-05
allow O 0 0.00028858246514573693
rapid O 0 0.005653659347444773
screening O 0 0.001458774204365909
for O 0 8.670346142025664e-05
common O 0 0.00047596293734386563
ethnic O 0 0.0003746938018593937
mutations O 0 0.004582752473652363
. O 0 0.0009601328056305647

These O 0 0.0003006183251272887
rapid O 0 0.008379644714295864
assays O 0 0.0026147556491196156
detected O 0 0.005610850173979998
mutations O 0 0.0008705303189344704
in O 0 0.00010607657895889133
76 O 0 0.0012318221852183342
% O 0 2.395355113549158e-05
of O 0 4.93319530505687e-05
Costa O 0 0.011777687817811966
Rican O 0 0.006411486770957708
patients O 1 0.9990358352661133
( O 0 0.0003236338961869478
3 O 0 0.0003439894353505224
) O 0 7.178225496318191e-05
, O 0 4.651457129511982e-05
50 O 0 5.114637315273285e-05
% O 0 1.0926289178314619e-05
of O 0 2.6362971766502596e-05
Norwegian O 0 0.008603004738688469
patients O 1 0.9994924068450928
( O 0 0.00033009261824190617
1 O 0 0.00032222631853073835
) O 0 7.807357178535312e-05
, O 0 4.671576607506722e-05
25 O 0 6.350794865284115e-05
% O 0 1.336402419838123e-05
of O 0 3.949099118472077e-05
Polish O 1 0.8929327130317688
patients O 1 0.9996694326400757
( O 0 0.00040032569086179137
4 O 0 0.00042049080366268754
) O 0 7.997062493814155e-05
, O 0 4.242832801537588e-05
and O 0 2.6531473849900067e-05
14 O 0 9.563708590576425e-05
% O 0 1.1570207789191045e-05
of O 0 2.9375059966696426e-05
Italian O 0 0.1423775553703308
patients O 1 0.9998834133148193
( O 0 0.00035720126470550895
1 O 0 0.0003145896771457046
) O 0 7.079586066538468e-05
, O 0 3.765870496863499e-05
as O 0 3.2859759812708944e-05
well O 0 5.0151611503679305e-05
as O 0 8.743959915591404e-05
in O 0 0.00029176619136705995
patients O 1 0.9990115165710449
of O 0 0.00011635434202617034
Amish O 1 0.6046122908592224
/ O 1 0.5055732131004333
Mennonite O 0 0.013884002342820168
and O 0 0.0002203654294135049
Irish O 0 0.0013982673408463597
English O 0 0.0007177608786150813
backgrounds O 0 0.002864144742488861
. O 0 0.0010247011668980122

Additional O 0 0.0018798260716721416
mutations O 0 0.0017915997887030244
were O 0 5.539047924685292e-05
observed O 0 0.0002207302750321105
in O 0 8.534495282219723e-05
Japanese O 0 0.0005504479049704969
, O 0 0.00025150529108941555
Utah O 0 0.002120099263265729
Mormon O 0 0.0008027193835005164
, O 0 0.00013528838462661952
and O 0 0.00018870315398089588
African O 0 0.0015333534684032202
American O 0 0.003271469147875905
patients O 1 0.9995101690292358
. O 0 0.0008637493592686951

These O 0 0.000234753213590011
assays O 0 0.0011992473155260086
should O 0 0.00020219785801600665
facilitate O 0 0.0010340746957808733
screening O 0 0.002103260951116681
for O 0 0.000341759150614962
A B-Disease 1 0.991293728351593
- I-Disease 1 0.9954040050506592
T I-Disease 1 0.9995261430740356
heterozygotes O 0 0.08621332794427872
in O 0 9.056233830051497e-05
the O 0 0.00013718512491323054
populations O 0 0.00046250366722233593
studied O 0 0.0006350770709104836
. O 0 0.000256804603850469
. O 0 0.000569696887396276

The O 0 0.004021192900836468
von B-Disease 1 0.9021626710891724
Hippel I-Disease 1 0.9974817633628845
- I-Disease 1 0.9855561852455139
Lindau I-Disease 1 0.9987425208091736
tumor I-Disease 1 0.9996024966239929
suppressor O 0 0.1954631209373474
gene O 0 0.0014112506760284305
is O 0 0.0001597377413418144
required O 0 0.0001956088381120935
for O 0 0.00015424052253365517
cell O 0 0.001342881005257368
cycle O 0 0.0010410075774416327
exit O 0 0.0022941245697438717
upon O 0 0.001002093660645187
serum O 1 0.971210777759552
withdrawal O 0 0.012623545713722706
. O 0 0.0011610930087044835

The O 0 0.0011076312512159348
inactivation O 0 0.01183821726590395
of O 0 7.557115895906463e-05
the O 0 0.0008976462995633483
von B-Disease 1 0.9473228454589844
Hippel I-Disease 1 0.9977927207946777
- I-Disease 0 0.49303945899009705
Lindau I-Disease 1 0.9946466088294983
( I-Disease 0 0.004986739717423916
VHL I-Disease 1 0.9995349645614624
) I-Disease 0 0.004315136466175318
tumor I-Disease 1 0.9996829032897949
suppressor O 1 0.9320364594459534
gene O 0 0.008866467513144016
predisposes O 1 0.9958739876747131
affected O 0 0.0032180699054151773
individuals O 0 0.00011918894597329199
to O 0 9.625053644413128e-05
the O 0 0.0005207245121710002
human O 1 0.9910995364189148
VHL B-Disease 1 0.9999927282333374
cancer I-Disease 1 0.9999992847442627
syndrome I-Disease 1 0.9999982118606567
and O 0 0.00026269524823874235
is O 0 0.0002973386726807803
associated O 0 0.0002573774254415184
with O 0 0.00033897103276103735
sporadic B-Disease 1 0.9937304258346558
renal I-Disease 1 0.9999983310699463
cell I-Disease 1 0.9955992698669434
carcinomas I-Disease 1 0.999942421913147
( O 0 0.04577020928263664
RCC B-Disease 1 0.9999308586120605
) O 0 0.0007349649677053094
and O 0 0.0009343178826384246
brain B-Disease 1 0.9997233748435974
hemangioblastomas I-Disease 1 0.982154130935669
. O 0 0.0008934439392760396

VHL O 1 0.9870930314064026
- O 0 0.014275972731411457
negative O 0 0.0035346513614058495
786 O 0 0.3680603504180908
- O 0 0.010272870771586895
0 O 0 0.0035925235133618116
RCC B-Disease 1 0.9986127614974976
cells O 0 0.002320829313248396
are O 0 8.257263107225299e-05
tumorigenic O 0 0.04294108599424362
in O 0 0.00047053792513906956
nude O 0 0.48633280396461487
mice O 0 0.019173700362443924
which O 0 7.334550173254684e-05
is O 0 0.00014215086412150413
suppressed O 0 0.0011767890537157655
by O 0 4.885722228209488e-05
the O 0 0.00025388444191776216
reintroduction O 0 0.012420720420777798
of O 0 0.0003293761983513832
VHL B-Disease 1 0.9981195330619812
. O 0 0.0020559534896165133

Remarkably O 0 0.33767932653427124
, O 0 0.0003411993966437876
this O 0 0.00014420031220652163
occurs O 0 0.0005414204206317663
without O 0 0.00018148869276046753
affecting O 0 0.0021625349763780832
the O 0 0.0001400772453052923
growth O 0 0.0006774320499971509
rate O 0 0.00017334286530967802
and O 0 0.00012414352386258543
cell O 0 0.0012605637311935425
cycle O 0 0.0006849610945209861
profile O 0 0.0006694436306133866
of O 0 1.7291509720962495e-05
these O 0 7.693246880080551e-05
cells O 0 0.001124995294958353
in O 0 0.00011540615378180519
culture O 0 0.0009145100484602153
. O 0 0.0008000188390724361

The O 0 0.0024473813828080893
786 O 0 0.157165989279747
- O 0 0.005416223779320717
0 O 0 0.0008219569572247565
cell O 0 0.0009640725911594927
line O 0 0.0005929057369939983
, O 0 0.00014353716687764972
like O 0 0.0003894536930602044
many O 0 0.0008282338385470212
cancer B-Disease 1 0.9999854564666748
cells O 0 0.005724262446165085
, O 0 0.00022708818141836673
fails O 0 0.010694725438952446
to O 0 7.1285518060904e-05
exit O 0 0.0009273571777157485
the O 0 9.15456548682414e-05
cell O 0 0.001104729133658111
cycle O 0 0.0010871211998164654
upon O 0 0.000994677422568202
serum O 1 0.9747769832611084
withdrawal O 0 0.010914308950304985
. O 0 0.0011390320723876357

Here O 0 0.0012953076511621475
, O 0 0.00023069052258506417
it O 0 9.960304305423051e-05
is O 0 0.00010265301534673199
shown O 0 0.00017289008246734738
that O 0 3.484970875433646e-05
reintroduction O 0 0.0009952033869922161
of O 0 1.0380267667642329e-05
the O 0 0.00015377369709312916
wild O 0 0.0010797132272273302
- O 0 0.021248433738946915
type O 0 0.0168939046561718
VHL B-Disease 1 0.9968982934951782
gene O 0 0.002450545085594058
restores O 0 0.0037467177025973797
the O 0 8.7829859694466e-05
ability O 0 0.0009325266582891345
of O 0 0.000207293254788965
VHL O 1 0.9998100399971008
- O 1 0.9365194439888
negative O 0 0.3707527220249176
RCC B-Disease 1 0.9999746084213257
cancer I-Disease 1 0.9999686479568481
cells O 0 0.002525502583011985
to O 0 9.92265049717389e-05
exit O 0 0.0010266330791637301
the O 0 0.0001423050562152639
cell O 0 0.0011156050022691488
cycle O 0 0.0010820316383615136
and O 0 0.00032362030469812453
enter O 0 0.005696743726730347
G0 O 1 0.9972801208496094
/ O 0 0.3017813265323639
quiescence O 0 0.05083734169602394
in O 0 0.00039351332816295326
low O 0 0.007248036563396454
serum O 1 0.900924026966095
. O 0 0.0011990349739789963

Both O 0 0.0036907270550727844
VHL O 1 0.997421145439148
- O 0 0.0126211978495121
positive O 0 0.00200836593285203
and O 0 0.000669939792715013
VHL O 1 0.9992535710334778
- O 0 0.10722049325704575
negative O 0 0.007232914213091135
RCC B-Disease 1 0.9993799924850464
cells O 0 0.004347121808677912
exit O 0 0.0016943949740380049
the O 0 0.00019673974020406604
cell O 0 0.0012544050114229321
cycle O 0 0.0007765888585709035
by O 0 0.00015950290253385901
contact O 0 0.0030275241006165743
inhibition O 0 0.005902718752622604
. O 0 0.0010027430253103375

The O 0 0.00220078625716269
cyclin O 0 0.16583506762981415
- O 0 0.005391387734562159
dependent O 0 0.0034280719701200724
kinase O 0 0.014056064188480377
inhibitor O 0 0.04974706843495369
, O 0 0.0005316147580742836
p27 O 1 0.6880167126655579
, O 0 0.00028261172701604664
accumulates O 0 0.019108125939965248
upon O 0 0.001037193345837295
serum O 1 0.9655968546867371
withdrawal O 0 0.0025679082609713078
, O 0 6.211988511495292e-05
only O 0 1.911571598611772e-05
in O 0 3.155019294354133e-05
the O 0 5.435784987639636e-05
presence O 0 0.0003234000760130584
of O 0 0.0001755966804921627
VHL B-Disease 1 0.9995939135551453
, O 0 0.00018798105884343386
as O 0 9.635531750973314e-05
a O 0 0.00017999589908868074
result O 0 8.011182944756001e-05
of O 0 1.1852087482111529e-05
the O 0 0.00011320781777612865
stabilization O 0 0.005295285023748875
of O 0 2.0388231860124506e-05
the O 0 0.0001731837837724015
protein O 0 0.0010380216408520937
. O 0 0.0005671159015037119

We O 0 0.0007850398542359471
propose O 0 0.001784212072379887
that O 0 4.0336570236831903e-05
the O 0 6.111605034675449e-05
loss O 0 0.0007856839220039546
of O 0 4.052865915582515e-05
wild O 0 0.0017900902312248945
- O 0 0.06102939695119858
type O 0 0.04603426530957222
VHL B-Disease 1 0.9973376393318176
gene O 0 0.0019404395716264844
results O 0 0.0002268073003506288
in O 0 5.5620788771193475e-05
a O 0 0.0002510288031771779
specific O 0 0.0003252298920415342
cellular O 0 0.007256289944052696
defect O 1 0.9844849109649658
in O 0 0.0004964101244695485
serum O 1 0.9915838241577148
- O 0 0.0037729479372501373
dependent O 0 0.0009054865804500878
growth O 0 0.0008473976631648839
control O 0 0.0008212331449612975
, O 0 0.00013203670096118003
which O 0 0.00011542299034772441
may O 0 0.001860473770648241
initiate O 1 0.7304638028144836
tumor B-Disease 1 0.9996465444564819
formation O 0 0.018815604969859123
. O 0 0.001046246150508523

This O 0 0.0005654430133290589
is O 0 0.000693966809194535
corrected O 0 0.006467254366725683
by O 0 4.0080660255625844e-05
the O 0 9.365154255647212e-05
reintroduction O 0 0.002847990021109581
of O 0 3.51233575202059e-05
wild O 0 0.0018145458307117224
- O 0 0.08223293721675873
type O 0 0.0615316666662693
VHL B-Disease 1 0.998671293258667
, O 0 0.0014547276077792048
implicating O 1 0.9782997369766235
VHL B-Disease 1 0.9972357153892517
as O 0 0.00021949036454316229
the O 0 0.00019478119793348014
first O 0 0.0008111100760288537
tumor B-Disease 1 0.9994490742683411
suppressor O 0 0.01617385447025299
involved O 0 0.0002806805423460901
in O 0 3.867795749101788e-05
the O 0 5.621942182187922e-05
regulation O 0 0.00028165787807665765
of O 0 3.3722619264153764e-05
cell O 0 0.0018603747012093663
cycle O 0 0.001092891558073461
exit O 0 0.0014437722275033593
, O 0 6.903942266944796e-05
which O 0 3.354019281687215e-05
is O 0 8.232866821344942e-05
consistent O 0 0.00038421794306486845
with O 0 4.562032700050622e-05
its O 0 0.0002434103371342644
gatekeeper O 1 0.8499104976654053
function O 0 0.00039745497633703053
in O 0 0.000208459488931112
the O 0 0.0016114800237119198
kidney O 1 0.9999760389328003
. O 0 0.0005681254551745951
. O 0 0.0007522548548877239

Piebaldism B-Disease 1 0.9940347075462341
with O 0 0.0052675288170576096
deafness B-Disease 1 0.9999639987945557
: O 0 0.0005260484758764505
molecular O 0 0.0007898904732428491
evidence O 0 0.00015155004803091288
for O 0 0.00012084376066923141
an O 0 0.0007949398132041097
expanded O 1 0.5581169128417969
syndrome O 1 0.999988317489624
. O 0 0.0017861385131254792

In O 0 0.0006171638960950077
a O 0 0.0009800138650462031
South O 0 0.0013827616348862648
African O 0 0.0015801303088665009
girl O 0 0.008057305589318275
of O 0 0.00014348406693898141
Xhosa O 1 0.9791545271873474
stock O 0 0.00936465710401535
with O 0 0.0009496575803495944
severe O 1 0.999825656414032
piebaldism B-Disease 1 0.9966821074485779
and O 0 0.004490196239203215
profound O 1 0.9998319149017334
congenital O 1 0.9999997615814209
sensorineural B-Disease 1 0.9999967813491821
deafness I-Disease 1 0.9999972581863403
we O 0 0.0012340036919340491
identified O 0 0.0006578947650268674
a O 0 0.0005029758904129267
novel O 0 0.0014344858936965466
missense O 0 0.00340507784858346
substitution O 0 0.00035398287582211196
at O 0 0.00020096813386771828
a O 0 0.00031637141364626586
highly O 0 0.0006134818540886045
conserved O 0 0.00026665785117074847
residue O 0 0.0015252967132255435
in O 0 4.226332748658024e-05
the O 0 0.00010338092397432774
intracellular O 0 0.0032883984968066216
kinase O 0 0.00207395083270967
domain O 0 0.00010648906754795462
of O 0 2.5353867386002094e-05
the O 0 0.0005459298263303936
KIT O 1 0.993029773235321
proto O 1 0.9587598443031311
- O 0 0.04048112779855728
oncogene O 1 0.7614112496376038
, O 0 0.0007877796306274831
R796G O 0 0.034532301127910614
. O 0 0.0011913399212062359

Though O 0 0.006049537565559149
auditory B-Disease 1 0.9414139986038208
anomalies I-Disease 1 0.6162327527999878
have O 0 0.00016946389223448932
been O 0 0.00019637223158497363
observed O 0 0.0002967439650092274
in O 0 0.00017023626423906535
mice O 0 0.005476775113493204
with O 0 0.00015006244939286262
dominant O 0 0.008279201574623585
white O 0 0.2730480432510376
spotting O 1 0.9832632541656494
( O 0 0.004412238486111164
W O 1 0.9947527647018433
) O 0 0.0002961244899779558
due O 0 0.0007103890529833734
to O 0 0.0003576798480935395
KIT O 1 0.9963909983634949
mutations O 0 0.0071315341629087925
, O 0 0.001812852919101715
deafness B-Disease 1 0.9999936819076538
is O 0 0.0003576222516130656
not O 0 0.00010837109584826976
typical O 0 0.0010655350051820278
in O 0 0.00024077850684989244
human O 0 0.0037585925310850143
piebaldism B-Disease 1 0.9654607772827148
. O 0 0.0010539783397689462

Thus O 0 0.0008276168373413384
, O 0 0.00016062236682046205
the O 0 0.00019480404444038868
occurrence O 0 0.004171054344624281
of O 0 0.00045533699449151754
sensorineural B-Disease 1 0.9999603033065796
deafness I-Disease 1 0.999994158744812
in O 0 0.0006046699127182364
this O 0 0.0004905842943117023
patient O 1 0.9991986155509949
extends O 0 0.008131059817969799
considerably O 0 0.002157748444005847
the O 0 0.00010217945236945525
phenotypic O 0 0.0018582844641059637
range O 0 0.00030050918576307595
of O 0 5.243125997367315e-05
piebaldism B-Disease 1 0.9324219822883606
due O 0 0.0009822240099310875
to O 0 0.00030272972071543336
KIT O 1 0.9905197620391846
gene O 0 0.0014055704232305288
mutation O 0 0.0009503740002401173
in O 0 0.00011711125262081623
humans O 0 0.001413724385201931
and O 0 0.0002860331442207098
tightens O 1 0.5435912013053894
the O 0 0.0004337650316301733
clinical O 1 0.9897629022598267
similarity O 0 0.0007613954949192703
between O 0 0.00024520859005860984
piebaldism B-Disease 0 0.27148979902267456
and O 0 3.939259477192536e-05
the O 0 3.875260517816059e-05
various O 0 3.322090924484655e-05
forms O 0 0.0006644697277806699
of O 0 0.0010219139512628317
Waardenburg B-Disease 1 0.9999961853027344
syndrome I-Disease 1 0.9999971389770508
. O 0 0.0009319369564764202
. O 0 0.0009189130505546927

Cycloheximide O 0 0.1408160775899887
facilitates O 0 0.006848546676337719
the O 0 0.0002138638956239447
identification O 0 0.00026846773107536137
of O 0 6.094146010582335e-05
aberrant O 0 0.01522525493055582
transcripts O 0 0.0007284972816705704
resulting O 0 0.0004729428037535399
from O 0 8.802607044344768e-05
a O 0 0.00045068468898534775
novel O 0 0.001548454980365932
splice O 0 0.011102274060249329
- O 0 0.0037313802167773247
site O 0 0.0007186646689660847
mutation O 0 0.0009850148344412446
in O 0 0.0002946839085780084
COL17A1 O 1 0.6414676308631897
in O 0 0.0002829667937476188
a O 0 0.002527038101106882
patient O 1 0.998502254486084
with O 0 0.0010749978246167302
generalized O 1 0.9984875917434692
atrophic B-Disease 1 0.9999784231185913
benign I-Disease 1 0.9998785257339478
epidermolysis I-Disease 1 0.9998921155929565
bullosa I-Disease 1 0.9989748001098633
. O 0 0.00805819034576416

Patients O 1 0.9990725517272949
with O 0 0.0020971728954464197
generalized O 1 0.9974345564842224
atrophic B-Disease 1 0.9999711513519287
benign I-Disease 1 0.9999198913574219
epidermolysis I-Disease 1 0.999953031539917
bullosa I-Disease 1 0.9998106360435486
often O 0 0.0017827783012762666
show O 0 0.000724052544683218
decreased O 0 0.0033569771330803633
expression O 0 0.00033930744393728673
of O 0 0.00010094561730511487
type O 1 0.990392804145813
XVII O 1 0.9998960494995117
collagen O 1 0.9990220069885254
, O 0 0.00020214311371091753
a O 0 0.0004152262699790299
transmembrane O 0 0.004476116504520178
hemidesmosomal O 0 0.008507899008691311
protein O 0 0.0002712471759878099
encoded O 0 0.00016299202980007976
by O 0 0.00032965641003102064
COL17A1 O 1 0.9537186622619629
. O 0 0.0013943325029686093

This O 0 0.00040742880082689226
report O 0 0.0005863535916432738
documents O 0 0.00017748009122442454
a O 0 0.0004451479180715978
novel O 0 0.0015510560479015112
splice O 0 0.011071978136897087
- O 0 0.003281669458374381
site O 0 0.0005969969788566232
mutation O 0 0.0009799639228731394
in O 0 0.00021359387028496712
COL17A1 O 1 0.908912718296051
in O 0 0.00024082533491309732
a O 0 0.0016460518818348646
patient O 1 0.9973354935646057
with O 0 0.000987163046374917
generalized O 1 0.9981868863105774
atrophic B-Disease 1 0.9999785423278809
benign I-Disease 1 0.9999301433563232
epidermolysis I-Disease 1 0.9999094009399414
bullosa I-Disease 1 0.9997766613960266
, O 0 0.001112135243602097
and O 0 0.0003251077432651073
applies O 0 0.0010073008015751839
a O 0 0.00040631252340972424
new O 0 0.00029046117560938
methodology O 0 0.0011373372981324792
to O 0 7.120481313904747e-05
define O 0 0.0005992295918986201
and O 0 9.776993101695552e-05
characterize O 0 0.0042735980823636055
the O 0 9.962336480384693e-05
resulting O 0 0.000706171675119549
mRNA O 0 0.0005665551871061325
splice O 0 0.00830922182649374
variants O 0 0.002651902614161372
. O 0 0.001242238562554121

Mutational O 0 0.07020492851734161
analysis O 0 0.0005972776561975479
of O 0 0.0002142888552043587
COL17A1 O 1 0.9584371447563171
identified O 0 0.0010220813564956188
a O 0 0.00105396774597466
maternally O 0 0.3509194850921631
inherited O 1 0.9888033270835876
G O 1 0.6504903435707092
- O 0 0.004879706539213657
to O 0 0.0005090143531560898
- O 0 0.2882436215877533
T O 1 0.9880800843238831
transversion O 0 0.008894163183867931
at O 0 0.0002035789075307548
the O 0 0.0001330293744103983
- O 0 0.0010359585285186768
1 O 0 0.00012185999366920441
position O 0 0.00014368604752235115
of O 0 3.3557149436092004e-05
exon O 0 0.008531979285180569
32 O 0 0.001115037128329277
. O 0 0.0005735160084441304

This O 0 0.0007887282990850508
acceptor O 0 0.02136840857565403
splice O 0 0.026237504556775093
- O 0 0.006477102637290955
site O 0 0.001037763780914247
mutation O 0 0.000792234088294208
led O 0 0.00018691759032662958
to O 0 3.9502967410953715e-05
the O 0 7.211817865027115e-05
formation O 0 0.001037313835695386
of O 0 4.761866512126289e-05
aberrant O 0 0.17212964594364166
transcripts O 0 0.0007321191369555891
present O 0 0.00017716274305712432
at O 0 0.00037013718974776566
extremely O 0 0.013711061328649521
low O 0 0.0032949536107480526
levels O 0 0.0030806518625468016
. O 0 0.0006512563559226692

Based O 0 0.0004261479480192065
on O 0 0.00013098458293825388
our O 0 0.0002208443620475009
recent O 0 0.0005053585628047585
finding O 0 0.0009232012089341879
that O 0 0.00038358583697117865
cycloheximide O 1 0.9694119691848755
stabilized O 1 0.9832760095596313
mutant O 0 0.01480212900787592
COL17A1 O 1 0.8027271628379822
transcripts O 0 0.001644984120503068
in O 0 0.0003873725363519043
keratinocytes O 0 0.37888190150260925
homozygous O 0 0.0017890791641548276
for O 0 0.0001837088930187747
a O 0 0.0017354318406432867
frameshift O 1 0.9376361966133118
mutation O 0 0.0016121200751513243
, O 0 6.313484482234344e-05
the O 0 7.766515773255378e-05
effects O 0 0.0006106275832280517
of O 0 1.6058424080256373e-05
the O 0 0.0002830153389368206
splice O 0 0.016943689435720444
- O 0 0.004143877886235714
site O 0 0.0007736347615718842
mutation O 0 0.0004614432982634753
on O 0 6.278116052271798e-05
splicing O 0 0.00048395214253105223
of O 0 8.74867255333811e-05
COL17A1 O 1 0.910775363445282
transcripts O 0 0.000649371650069952
were O 0 3.0193401471478865e-05
determined O 0 0.0002442327968310565
using O 0 0.00011164785973960534
reverse O 0 0.002873810473829508
transcriptase O 0 0.011567392386496067
polymerase O 0 0.002544816816225648
chain O 0 0.0013507180847227573
reaction O 0 0.0002891501353587955
of O 0 1.4666463357571047e-05
total O 0 0.00014370970893651247
RNA O 0 0.0008441572426818311
from O 0 0.0002604957262519747
keratinocytes O 0 0.10375716537237167
incubated O 0 0.0032114065252244473
for O 0 0.0003320156247355044
2 O 0 0.0010894263396039605
. O 0 0.0007443863432854414

5 O 0 0.002436059294268489
h O 0 0.005137916654348373
in O 0 9.138935274677351e-05
the O 0 0.0001175583602162078
presence O 0 0.00039171508979052305
or O 0 0.00019055407028645277
absence O 0 0.0006142508937045932
of O 0 3.4547625546110794e-05
10 O 0 0.0006339982501231134
microg O 0 0.256293386220932
cycloheximide O 0 0.03482448682188988
per O 0 0.0007169385207816958
ml O 0 0.07834096997976303
. O 0 0.0012722319224849343

Using O 0 0.0003995976585429162
this O 0 0.00015279848594218493
approach O 0 0.001102042500860989
, O 0 0.0001518089120509103
an O 0 0.00033693164004944265
abnormally O 1 0.8661250472068787
spliced O 0 0.005485998000949621
transcript O 0 0.0036136035341769457
was O 0 0.00038610686897300184
identified O 0 0.00013448605022858828
that O 0 1.3352736459637526e-05
contains O 0 2.2898815586813726e-05
an O 0 4.4594147766474634e-05
extra O 0 0.00034464497002772987
264 O 0 0.0015969882952049375
bases O 0 0.00032824580557644367
upstream O 0 0.0015170382102951407
from O 0 0.0001361824688501656
exon O 0 0.004580833949148655
32 O 0 0.00046636280603706837
, O 0 9.683291136752814e-05
resulting O 0 0.0005321288481354713
in O 0 0.00014630219084210694
a O 0 0.0013961928198114038
premature O 1 0.9420318603515625
termination O 0 0.11080136150121689
codon O 0 0.004277918022125959
27 O 0 0.0020603076554834843
bp O 0 0.017111940309405327
downstream O 0 0.0020632590167224407
from O 0 0.00013995426706969738
the O 0 0.00035291185486130416
cryptic O 0 0.04852860048413277
splice O 0 0.017184551805257797
site O 0 0.0032694980036467314
. O 0 0.0009558830643072724

Three O 0 0.0002957523101940751
other O 0 0.00014034865307621658
splice O 0 0.006442346144467592
variants O 0 0.0008351610158570111
, O 0 0.00010406576620880514
including O 0 3.9530812500743195e-05
one O 0 6.34492389508523e-05
derived O 0 8.141056605381891e-05
from O 0 3.737370570888743e-05
the O 0 0.00010377322905696929
skipping O 0 0.002370749833062291
of O 0 4.8303616495104507e-05
exon O 0 0.008257774636149406
32 O 0 0.0005359904607757926
, O 0 0.00010323778406018391
were O 0 5.461781256599352e-05
also O 0 0.0002181679883506149
identified O 0 0.0008355945465154946
. O 0 0.00036394689232110977

These O 0 0.00016800397133920342
results O 0 0.0003598575131036341
indicate O 0 0.00028534134617075324
the O 0 0.00012758790398947895
usefulness O 0 0.00836460292339325
of O 0 0.00011991717474302277
cycloheximide O 1 0.9988844990730286
treatment O 1 0.9991550445556641
in O 0 0.00017129283514805138
evaluating O 0 0.004518680740147829
the O 0 0.0002176494017476216
abnormal O 0 0.005388823337852955
processing O 0 0.00017657852731645107
of O 0 2.097409378620796e-05
mRNA O 0 0.00023148194304667413
due O 0 0.0002985502069350332
to O 0 0.00011448403529357165
splice O 0 0.007147044409066439
- O 0 0.0028486561495810747
site O 0 0.0008399912039749324
mutations O 0 0.0009212431614287198
, O 0 0.00013147699064575136
because O 0 0.0004895264864899218
( O 0 0.0003857216506730765
i O 0 0.0008981373975984752
) O 0 0.00014578150876332074
aberrant O 0 0.004350693430751562
splicing O 0 0.0008816225454211235
often O 0 0.00027537569985724986
generates O 0 0.0014523530844599009
a O 0 0.0013361284509301186
premature O 1 0.7533491253852844
termination O 0 0.06407607346773148
codon O 0 0.003394058207049966
, O 0 0.0003286212158855051
( O 0 0.0007125508273020387
ii O 0 0.010370803996920586
) O 0 0.00018885433382820338
transcripts O 0 0.0005063239950686693
with O 0 0.00027224209043197334
premature O 1 0.9824692010879517
termination O 1 0.7138223648071289
codons O 0 0.003641634713858366
can O 0 0.00022175164485815912
occur O 0 0.0003386639873497188
at O 0 0.0002608026552479714
low O 0 0.0020176058169454336
or O 0 0.0008289412944577634
undetectable O 1 0.9922490119934082
levels O 0 0.002412660513073206
due O 0 0.000789498386438936
to O 0 0.00021283903333824128
nonsense O 0 0.0049967579543590546
- O 0 0.0021062716841697693
mediated O 0 0.00206902832724154
mRNA O 0 0.00027933393721468747
decay O 0 0.0012023583985865116
, O 0 0.00018082177848555148
and O 0 0.00016376955318264663
( O 0 0.0007850077818147838
iii O 0 0.017053861171007156
) O 0 7.136195927159861e-05
the O 0 6.358826067298651e-05
levels O 0 0.0002592506934888661
of O 0 9.09226764633786e-06
these O 0 2.213292827946134e-05
transcripts O 0 0.0004417040618136525
can O 0 5.7352197472937405e-05
be O 0 3.3838463423307985e-05
increased O 0 0.00022368044301401824
by O 0 0.0001959386863745749
cycloheximide O 0 0.25159478187561035
. O 0 0.0009199230698868632

A O 0 0.005088159814476967
deletion O 0 0.010108860209584236
mutation O 0 0.0033919878769665956
in O 0 0.00041221908759325743
COL17A1 O 1 0.8030067086219788
in O 0 0.0001454065350117162
five O 0 0.00022907624952495098
Austrian O 0 0.0027372129261493683
families O 0 0.0004527716082520783
with O 0 0.0010440616169944406
generalized O 1 0.997384250164032
atrophic B-Disease 1 0.9999374151229858
benign I-Disease 1 0.9998001456260681
epidermolysis I-Disease 1 0.9997788071632385
bullosa I-Disease 1 0.9985818862915039
represents O 0 0.0037906363140791655
propagation O 0 0.000845622387714684
of O 0 3.081820977968164e-05
an O 0 0.0003736100043170154
ancestral O 0 0.006255500949919224
allele O 0 0.008654996752738953
. O 0 0.0011283966014161706

Patients O 1 0.9995689988136292
with O 0 0.0029365457594394684
generalized O 1 0.9960169196128845
atrophic B-Disease 1 0.9999703168869019
benign I-Disease 1 0.9998878240585327
epidermolysis I-Disease 1 0.999847412109375
bullosa I-Disease 1 0.9996296167373657
, O 0 0.0009494965197518468
a O 0 0.000859919236972928
usually O 0 0.0004749733197968453
nonlethal O 0 0.021428551524877548
form O 0 0.00048546044854447246
of O 0 0.00035148151800967753
junctional B-Disease 1 0.9990552067756653
epidermolysis I-Disease 1 0.9997578263282776
bullosa I-Disease 1 0.9990948438644409
, O 0 0.0008771037682890892
have O 0 0.0003620156494434923
generalized O 0 0.0699416771531105
blistering B-Disease 1 0.9882558584213257
, O 0 0.006083689164370298
nail B-Disease 1 0.9999629259109497
dystrophy I-Disease 1 0.9999961853027344
, O 0 0.11073063313961029
patchy B-Disease 1 0.9999196529388428
alopecia I-Disease 1 0.9999979734420776
, O 0 0.00591603247448802
and O 0 0.04289926588535309
dental B-Disease 1 0.9999932050704956
abnormalities I-Disease 1 0.9991140961647034
. O 0 0.0017360516358166933

Skin B-Disease 1 0.999930739402771
fragility I-Disease 1 0.9973897337913513
in O 0 0.0004055710742250085
most O 0 0.0003995868028141558
cases O 0 0.002921808511018753
is O 0 0.0002142868033843115
due O 0 0.000569602707400918
to O 0 8.866886491887271e-05
mutations O 0 0.0004083363164681941
in O 0 3.555465809768066e-05
the O 0 0.00014141216524876654
gene O 0 0.0012116573052480817
encoding O 0 0.001269561587832868
type O 0 0.4032244086265564
XVII O 1 0.9996621608734131
collagen O 1 0.9991979002952576
( O 0 0.0038331844843924046
COL17A1 O 1 0.9901054501533508
) O 0 0.0007006319938227534
. O 0 0.0005922229029238224

Recently O 0 0.013823644258081913
, O 0 0.0002561106812208891
we O 0 0.0002188567741541192
reported O 0 0.000740886724088341
five O 0 0.00015030890062917024
Austrian O 0 0.0020870205480605364
families O 0 0.00047495681792497635
with O 0 0.0008043218986131251
generalized O 1 0.9975605010986328
atrophic B-Disease 1 0.9999661445617676
benign I-Disease 1 0.9999347925186157
epidermolysis I-Disease 1 0.9999433755874634
bullosa I-Disease 1 0.9997156262397766
who O 0 0.0017550019547343254
share O 0 0.0002720093762036413
the O 0 0.00021712540183216333
same O 0 0.0007475689635612071
COL17A1 O 1 0.9854259490966797
mutation O 0 0.005585396662354469
. O 0 0.0007120661321096122

Affected O 0 0.01425112783908844
individuals O 0 0.00028438615845516324
in O 0 0.00010932421719189733
three O 0 8.23901646072045e-05
families O 0 0.00016311451327055693
are O 0 4.17126138927415e-05
homozygous O 0 0.0012380853295326233
for O 0 0.00022593037283513695
4003delTC O 0 0.27514809370040894
, O 0 0.00014297314919531345
whereas O 0 0.0003251706366427243
those O 0 3.422508598305285e-05
in O 0 4.621324478648603e-05
two O 0 5.1803403039230034e-05
others O 0 0.00022049594554118812
are O 0 8.133654046105221e-05
compound O 0 0.011826536618173122
heterozygotes O 1 0.6285971999168396
. O 0 0.001214247546158731

To O 0 0.0004986603744328022
determine O 0 0.000601323670707643
if O 0 0.0002190569939557463
the O 0 8.430273010162637e-05
occurrence O 0 0.0017106053419411182
of O 0 6.865632894914597e-05
4003delTC O 0 0.12772473692893982
in O 0 0.00015711714513599873
these O 0 7.634067151229829e-05
unrelated O 0 0.0030152190010994673
families O 0 0.0003775421646423638
signifies O 0 0.003706309013068676
propagation O 0 0.00030678894836455584
of O 0 1.8106216884916648e-05
an O 0 0.0001986533752642572
ancestral O 0 0.002237487817183137
allele O 0 0.0023606466129422188
or O 0 0.0002743249060586095
a O 0 0.0011612324742600322
mutational O 1 0.8233625888824463
hot O 0 0.025172879919409752
spot O 0 0.0027538349386304617
, O 0 0.00029086184804327786
haplotypes O 0 0.0024294238537549973
were O 0 3.393007136764936e-05
determined O 0 0.00032872307929210365
for O 0 6.801484414609149e-05
polymorphisms O 0 0.0006325412541627884
both O 0 6.302956899162382e-05
within O 0 0.00014120613923296332
and O 0 0.00037578982301056385
flanking O 1 0.9437655210494995
COL17A1 O 1 0.9881606101989746
. O 0 0.0014952935744076967

Five O 0 0.0017403076635673642
intragenic O 0 0.037383195012807846
polymorphisms O 0 0.0021663671359419823
were O 0 5.4394306062022224e-05
chosen O 0 0.00014190180809237063
based O 0 7.540530350524932e-05
on O 0 0.00010553820902714506
their O 0 0.00021392200142145157
informativeness O 1 0.6679916977882385
. O 0 0.0011895999778062105

One O 0 0.00017456478963140398
of O 0 1.919601891131606e-05
these O 0 4.315205296734348e-05
, O 0 0.00012886401964351535
not O 0 8.35418322822079e-05
previously O 0 0.0005764315137639642
reported O 0 0.0008863942348398268
, O 0 0.00017514901992399246
was O 0 0.0008030238677747548
2988 O 0 0.026656663045287132
A O 0 0.0013199326349422336
or O 0 0.0004992215544916689
C O 0 0.0054363044910132885
that O 0 7.896112947491929e-05
introduces O 0 0.0010666277958080173
a O 0 0.00017923617269843817
new O 0 0.00016247003804892302
restriction O 0 0.0003870292566716671
site O 0 0.00055247254204005
for O 0 0.00035268443753011525
Eco0109 O 0 0.4915367364883423
I O 0 0.013486319221556187
. O 0 0.0007267824839800596

All O 0 0.00034650968154892325
the O 0 0.0007612397894263268
4003delTC O 0 0.04393027350306511
alleles O 0 0.002917305566370487
showed O 0 0.0006125184590928257
the O 0 0.00013036552991252393
same O 0 0.00019756800611503422
haplotype O 0 0.007018052972853184
for O 0 5.210353992879391e-05
these O 0 2.8399721486493945e-05
five O 0 0.00026297944714315236
polymorphic O 0 0.02118910290300846
markers O 0 0.005783790722489357
. O 0 0.0009969704551622272

Fourteen O 0 0.006086423061788082
microsatellite O 0 0.02619442716240883
polymorphisms O 0 0.0027471098583191633
were O 0 5.42446032341104e-05
selected O 0 0.00015743971744086593
based O 0 8.379475184483454e-05
on O 0 8.218433504225686e-05
their O 0 8.591097866883501e-05
high O 0 0.002331317402422428
heterozygosity O 0 0.07893011718988419
and O 0 5.598509233095683e-05
their O 0 4.322944369050674e-05
location O 0 0.00021948284120298922
within O 0 0.00026092203916050494
10q23 O 0 0.057696498930454254
- O 0 0.009155471809208393
q25 O 0 0.021695327013731003
near O 0 0.004929564893245697
COL17A1 O 1 0.8744226694107056
. O 0 0.0014716119039803743

Three O 0 0.0004207550664432347
families O 0 0.0003926765057258308
shared O 0 0.0008651990792714059
microsatellite O 0 0.015436606481671333
polymorphisms O 0 0.003010914195328951
covering O 0 0.00329977716319263
at O 0 0.00035017888876609504
most O 0 0.00022348367201630026
19 O 0 0.0009464293252676725
cM O 0 0.004761651158332825
, O 0 0.00014750346599612385
whereas O 0 0.00045503448927775025
the O 0 0.00010554585605859756
others O 0 0.00021302867389749736
shared O 0 0.00017247219511773437
smaller O 0 0.00016989880532491952
regions O 0 0.0003275618073530495
consistent O 0 0.0009332471527159214
with O 0 0.00014426482084672898
cross O 0 0.0019231396727263927
- O 0 0.0008587909396737814
over O 0 6.264277908485383e-05
events O 0 7.957520574564114e-05
during O 0 0.00025213262415491045
passage O 0 0.0002572940429672599
of O 0 1.6983447494567372e-05
this O 0 8.852903556544334e-05
mutation O 0 0.0007554142503067851
through O 0 0.0001313888787990436
several O 0 0.00015349504246842116
generations O 0 0.001618548994883895
. O 0 0.0007683662115596235

These O 0 0.0003094294515904039
results O 0 0.0007196937222033739
indicate O 0 0.0007609588792547584
that O 0 0.00022418283333536237
4003delTC O 0 0.022583043202757835
occurs O 0 0.0004644400905817747
on O 0 8.199083822546527e-05
a O 0 0.00024612442939542234
single O 0 0.00031611757003702223
ancestral O 0 0.0027527513448148966
allele O 0 0.00401870533823967
. O 0 0.0003457980346865952
. O 0 0.0007517381454817951

The O 0 0.0032034439500421286
haptoglobin O 1 0.9512308239936829
- O 0 0.012079819105565548
gene O 0 0.002078141551464796
deletion O 0 0.003345147706568241
responsible O 0 0.0020821066573262215
for O 0 0.0006397682591341436
anhaptoglobinemia B-Disease 1 0.8702736496925354
. O 0 0.0010611314792186022

We O 0 0.0006613257573917508
have O 0 9.22432736842893e-05
found O 0 0.00010002346243709326
an O 0 0.0001382952177664265
allelic O 0 0.008025242947041988
deletion O 0 0.0014076627558097243
of O 0 4.391080801724456e-05
the O 0 0.0005982863367535174
haptoglobin O 1 0.9912109375
( O 0 0.0013712540967389941
Hp O 0 0.29514050483703613
) O 0 0.00023949315072968602
gene O 0 0.00038649520138278604
from O 0 3.4201038943137974e-05
an O 0 8.629103831481189e-05
individual O 0 0.00019516136671882123
with O 0 0.00042374958866275847
anhaptoglobinemia B-Disease 1 0.9641559720039368
. O 0 0.001075527397915721

The O 0 0.0031203378457576036
Hp O 1 0.614786684513092
gene O 0 0.003006008919328451
cluster O 0 0.0019773845560848713
consists O 0 0.0001566781720612198
of O 0 2.8764088710886426e-05
coding O 0 0.001746790949255228
regions O 0 0.0001477502373745665
of O 0 1.578367482579779e-05
the O 0 0.00015062368765939027
alpha O 0 0.0015524558257311583
chain O 0 0.001019125571474433
and O 0 9.397565736435354e-05
beta O 0 0.0013234748039394617
chain O 0 0.00048584581236355007
of O 0 1.9416478608036414e-05
the O 0 0.00040650161099620163
haptoglobin O 1 0.9288960695266724
gene O 0 0.0028882469050586224
( O 0 0.0007621823460794985
Hp O 0 0.08125220239162445
) O 0 7.970203296281397e-05
and O 0 1.810745925467927e-05
of O 0 9.044711077876855e-06
the O 0 0.00014512590132653713
alpha O 0 0.0015079372096806765
chain O 0 0.0008908341405913234
and O 0 0.00010423588537378237
beta O 0 0.0012856371467933059
chain O 0 0.00036387366708368063
of O 0 1.6064781448221765e-05
the O 0 0.0003273061302024871
haptoglobin O 1 0.9838585257530212
- O 0 0.004753480199724436
related O 0 0.001319593284279108
gene O 0 0.0022369578946381807
( O 0 0.0010716102551668882
Hpr O 1 0.9807822704315186
) O 0 0.00026787223760038614
, O 0 0.00012047328345943242
in O 0 0.0001196526427520439
tandem O 0 0.002512098988518119
from O 0 9.945916826836765e-05
the O 0 0.0002496791712474078
5 O 0 0.0008933187928050756
side O 0 0.003001754404976964
. O 0 0.0009641354554332793

Southern O 0 0.012884017080068588
blot O 1 0.5148977041244507
and O 0 0.0005871354951523244
PCR O 0 0.005727429874241352
analyses O 0 0.0011005528504028916
have O 0 0.00015122091281227767
indicated O 0 0.0006937981233932078
that O 0 2.1563726477324963e-05
the O 0 4.2210482206428424e-05
individual O 0 9.865513857221231e-05
with O 0 0.00014981997082941234
anhaptoglobinemia B-Disease 1 0.6503961682319641
was O 0 0.0004656804958358407
homozygous O 0 0.0008202852914109826
for O 0 6.322094122879207e-05
the O 0 0.00018565289792604744
gene O 0 0.001245786901563406
deletion O 0 0.0016325985779985785
and O 0 8.282980707008392e-05
that O 0 4.5552860683528706e-05
the O 0 0.0001411867415299639
gene O 0 0.0013109721476212144
deletion O 0 0.0016854191198945045
was O 0 0.000279170460999012
included O 0 6.0399866924853995e-05
at O 0 0.00013751281949225813
least O 0 8.697971497895196e-05
from O 0 5.894876812817529e-05
the O 0 0.00016795530973467976
promoter O 0 0.008421976119279861
region O 0 0.0006410078494809568
of O 0 7.967704004840925e-05
Hp O 0 0.453298419713974
to O 0 0.00040180128416977823
Hpr O 1 0.9568246603012085
alpha O 0 0.0014505402650684118
but O 0 0.00013227510498836637
not O 0 7.807752263033763e-05
to O 0 0.0002525840245652944
Hpr O 1 0.9516736268997192
beta O 0 0.006575344130396843
( O 0 0.0011621852172538638
Hpdel O 0 0.28868186473846436
) O 0 0.0005933342617936432
. O 0 0.0005804141983389854

In O 0 0.0006670257425867021
addition O 0 0.0004588652227539569
, O 0 0.00015818381507415324
we O 0 0.0001055498723872006
found O 0 9.770626638783142e-05
seven O 0 7.717568951193243e-05
individuals O 0 8.688397065270692e-05
with O 0 0.00012181501369923353
hypohaptoglobinemia B-Disease 0 0.49465513229370117
in O 0 9.420570859219879e-05
three O 0 9.062126628123224e-05
families O 0 0.0002448878076393157
, O 0 0.00012211101420689374
and O 0 7.26867510820739e-05
the O 0 0.00016937521286308765
genotypes O 0 0.004204113502055407
of O 0 1.6048779798438773e-05
six O 0 6.260539521463215e-05
of O 0 1.1464874660305213e-05
the O 0 7.00398741173558e-05
seven O 0 0.00014890832244418561
individuals O 0 7.865750376367941e-05
were O 0 2.1813832063344307e-05
found O 0 0.0001107479547499679
to O 0 8.729838737053797e-05
be O 0 0.0003185715468134731
Hp2 O 1 0.9875823259353638
/ O 0 0.4925391674041748
Hpdel O 0 0.43088498711586
. O 0 0.0010037916945293546

The O 0 0.001964171649888158
phenotypes O 0 0.021768413484096527
and O 0 0.00040603417437523603
genotypes O 0 0.013041254132986069
in O 0 5.4462554544443265e-05
one O 0 2.2824340703664348e-05
of O 0 6.197805305419024e-06
these O 0 1.5146934856602456e-05
three O 0 4.0803930460242555e-05
families O 0 0.00010959821520373225
showed O 0 0.0003581441123969853
the O 0 0.00011156666005263105
father O 0 0.0007662427378818393
to O 0 6.640423816861585e-05
be O 0 0.00014572174404747784
hypohaptoglobinemic B-Disease 0 0.1629514843225479
( O 0 0.0006148518295958638
Hp2 O 0 0.1336500346660614
) O 0 0.00023436053015757352
and O 0 0.00026719248853623867
Hp2 O 1 0.9876460433006287
/ O 0 0.48310258984565735
Hpdel O 0 0.18114760518074036
, O 0 0.0001391328842146322
the O 0 0.00015598590834997594
mother O 0 0.0009697104105725884
to O 0 7.193067722255364e-05
be O 0 0.0001622947456780821
Hp2 O 0 0.06304788589477539
- O 0 0.001163053442724049
1 O 0 0.0002590278163552284
and O 0 0.00033240712946280837
Hp1 O 1 0.9859547019004822
/ O 0 0.17210814356803894
Hp2 O 0 0.035128042101860046
, O 0 4.987085412722081e-05
one O 0 1.2665996109717526e-05
of O 0 7.261434802785516e-06
the O 0 6.180753553053364e-05
two O 0 4.449241532711312e-05
children O 0 0.00020957054221071303
to O 0 6.0263395425863564e-05
be O 0 0.00013211870100349188
hypohaptoglobinemic B-Disease 0 0.0682092159986496
( O 0 0.0008102584397420287
Hp2 O 0 0.2003106027841568
) O 0 0.00022934899607207626
and O 0 0.00033096165861934423
Hp2 O 1 0.989382803440094
/ O 0 0.23082631826400757
Hpdel O 0 0.2536599636077881
, O 0 9.394420339958742e-05
and O 0 3.142677451251075e-05
the O 0 4.891760181635618e-05
other O 0 6.568607204826549e-05
child O 0 0.0013485315721482038
to O 0 9.006352775031701e-05
be O 0 0.00017399812350049615
Hp1 O 0 0.13086427748203278
and O 0 0.00037704186979681253
Hp1 O 1 0.9945765733718872
/ O 0 0.4222247004508972
Hpdel O 0 0.3012833595275879
, O 0 0.00017287328955717385
showing O 0 0.0005980710848234594
an O 0 0.00031227865838445723
anomalous O 0 0.0804256796836853
inheritance O 0 0.0015798828098922968
of O 0 0.00013084850797895342
Hp O 1 0.9874317646026611
phenotypes O 0 0.011500135064125061
in O 0 0.00014857077621854842
the O 0 0.00038129970198497176
child O 0 0.009207246825098991
with O 0 0.0005787751288153231
Hp1 O 1 0.9624807834625244
. O 0 0.0011394779430702329

The O 0 0.0035451671574264765
Hp2 O 1 0.9914379715919495
/ O 1 0.8449305891990662
Hpdel O 0 0.2736656069755554
individuals O 0 0.00030929609783925116
had O 0 0.000276920385658741
an O 0 0.00015915663971100003
extremely O 0 0.0027695773169398308
low O 0 0.0008305676165036857
level O 0 0.0004275664105080068
of O 0 8.439209341304377e-05
Hp O 1 0.844494104385376
( O 0 0.00068793969694525
mean O 0 0.003030990483239293
+ O 0 0.024921391159296036
/ O 0 0.0130769619718194
- O 0 0.003654810832813382
SD O 0 0.019024642184376717
= O 0 0.00206428999081254
0 O 0 0.0006247053970582783
. O 0 0.0003314747882541269
049 O 1 0.8357609510421753
+ O 0 0.018969444558024406
/ O 0 0.007712882477790117
- O 0 0.0014313420979306102
0 O 0 0.00034281983971595764
. O 0 0.00026027849526144564
043 O 0 0.1454113870859146
mg O 1 0.7999604940414429
/ O 0 0.021367710083723068
ml O 0 0.01381324790418148
; O 0 0.00022059518960304558
n O 0 0.0010526858968660235
= O 0 0.0012109673116356134
6 O 0 0.00038374995347112417
) O 0 7.619549433002248e-05
, O 0 4.589935269905254e-05
compared O 0 0.00011155028187204152
with O 0 2.3763297576806508e-05
the O 0 7.924005331005901e-05
level O 0 0.0004842451598960906
( O 0 0.00016303086886182427
1 O 0 0.00021153007401153445
. O 0 8.689150854479522e-05
64 O 0 0.0007210760377347469
+ O 0 0.009300346486270428
/ O 0 0.005956578068435192
- O 0 0.0010355031117796898
1 O 0 0.0002421792596578598
. O 0 0.00019685777078848332
07 O 0 0.09936228394508362
mg O 1 0.9101592302322388
/ O 0 0.02408624067902565
ml O 0 0.009827378205955029
) O 0 9.922414756147191e-05
obtained O 0 0.00011985475430265069
from O 0 0.00010407836816739291
52 O 0 0.0019727852195501328
healthy O 1 0.6031299233436584
volunteers O 0 0.005935923662036657
having O 0 0.003479602513834834
phenotype O 1 0.7208821177482605
Hp2 O 0 0.4435127079486847
, O 0 0.0001681568828644231
whereas O 0 0.0005094119114801288
the O 0 0.0003189033595845103
serum O 1 0.9824218153953552
Hp O 0 0.027758508920669556
level O 0 0.00017629220383241773
of O 0 8.041994078666903e-06
an O 0 5.643859185511246e-05
individual O 0 0.00013782328460365534
with O 0 0.0003916420682799071
Hp1 O 1 0.9955146908760071
/ O 0 0.45949146151542664
Hpdel O 0 0.29355940222740173
was O 0 0.0012560543837025762
0 O 0 0.001085494877770543
. O 0 0.0006755698123015463

50 O 0 0.005998242646455765
mg O 1 0.9802758693695068
/ O 0 0.35024139285087585
ml O 0 0.026097726076841354
, O 0 0.0001484167150920257
which O 0 4.455440284800716e-05
was O 0 0.0001232504000654444
approximately O 0 7.431042467942461e-05
half O 0 4.2392250179545954e-05
the O 0 4.7174904466373846e-05
level O 0 0.00027495334506966174
of O 0 5.7874734920915216e-05
Hp O 0 0.1751539558172226
in O 0 0.00020856226910836995
control O 0 0.0015695018228143454
sera O 0 0.015291692689061165
from O 0 0.0001119144435506314
the O 0 0.00030134516418911517
Hp1 O 0 0.40783053636550903
phenotype O 0 0.03371267020702362
( O 0 0.00031755477539263666
1 O 0 0.00026950432220473886
. O 0 0.00010451366688357666
26 O 0 0.0008411654271185398
+ O 0 0.007414964027702808
/ O 0 0.003757760627195239
- O 0 0.0008462612167932093
0 O 0 0.00019947692635469139
. O 0 7.528516289312392e-05
33 O 0 0.0015587653033435345
mg O 1 0.5704692602157593
/ O 0 0.019906125962734222
ml O 0 0.012683821842074394
; O 0 0.00018418877152726054
n O 0 0.0010638715466484427
= O 0 0.001300670555792749
9 O 0 0.00034383998718112707
) O 0 6.637960905209184e-05
, O 0 5.8590812841430306e-05
showing O 0 0.0004444381920620799
a O 0 0.0007200398831628263
gene O 0 0.00318388594314456
- O 0 0.009041954763233662
dosage O 0 0.4044709801673889
effect O 0 0.002650186885148287
. O 0 0.0010346934432163835

The O 0 0.0005038311355747283
other O 0 0.00020000965741928667
allele O 0 0.0055598365142941475
( O 0 0.0011401342926546931
Hp2 O 0 0.051907461136579514
) O 0 6.819975533289835e-05
of O 0 1.1728070603567176e-05
individuals O 0 0.00012820656411349773
with O 0 0.0004893963341601193
Hp2 O 1 0.9979460835456848
/ O 1 0.9074601531028748
Hpdel O 1 0.9290942549705505
was O 0 0.0005935477674938738
found O 0 0.00015522654575761408
to O 0 5.155692997504957e-05
have O 0 4.9227623094338924e-05
, O 0 4.027303293696605e-05
in O 0 3.9152379031293094e-05
all O 0 3.96150462620426e-05
exons O 0 0.001514608971774578
, O 0 0.00017408441635780036
no O 0 0.00018796705990098417
mutation O 0 0.00067657302133739
, O 0 6.037516868673265e-05
by O 0 5.0694052333710715e-05
DNA O 0 0.0005844403640367091
sequencing O 0 0.001274644979275763
. O 0 0.0006872621015645564

On O 0 0.00020221945305820554
the O 0 6.502927863039076e-05
basis O 0 2.948052679130342e-05
of O 0 1.2124924069212284e-05
the O 0 0.0001271833898499608
present O 0 0.00019148841965943575
study O 0 0.00042220973409712315
, O 0 6.619907799176872e-05
the O 0 7.018730684649199e-05
mechanism O 0 0.0005057666567154229
of O 0 5.8722711401060224e-05
anhaptoglobinemia B-Disease 1 0.7639490365982056
and O 0 5.140744542586617e-05
the O 0 5.638339280267246e-05
mechanism O 0 0.00045911900815553963
of O 0 4.398734017740935e-05
anomalous O 0 0.46399736404418945
inheritance O 0 0.002111433306708932
of O 0 0.00021359285165090114
Hp O 1 0.9951836466789246
phenotypes O 0 0.018067199736833572
were O 0 8.969593909569085e-05
well O 0 0.00028496235609054565
explained O 0 0.003621104173362255
. O 0 0.0007668304024264216

However O 0 0.000902429863344878
, O 0 0.00013841383042745292
the O 0 8.022742258617654e-05
mechanism O 0 0.0007491243304684758
of O 0 0.00011857498611789197
hypohaptoglobinemia B-Disease 1 0.9655418992042542
remains O 0 0.0054247016087174416
unknown O 0 0.003633680986240506

ATM O 0 0.02990281768143177
mutations O 0 0.005314419977366924
and O 0 0.0005591587978415191
phenotypes O 0 0.11402653902769089
in O 0 0.0023666643537580967
ataxia B-Disease 1 0.9999681711196899
- I-Disease 1 0.9936079978942871
telangiectasia I-Disease 1 0.9986263513565063
families O 0 0.0005393385072238743
in O 0 0.00011281373008387163
the O 0 0.00022080478083807975
British O 0 0.0014806241961196065
Isles O 0 0.005157041363418102
: O 0 8.814803004497662e-05
expression O 0 0.00011488242307677865
of O 0 2.2591997549170628e-05
mutant O 0 0.002090031746774912
ATM O 0 0.0014177934499457479
and O 0 6.027540803188458e-05
the O 0 0.00018139075837098062
risk O 1 0.711855411529541
of O 0 0.0007358830189332366
leukemia B-Disease 1 0.9999997615814209
, O 1 0.9617218375205994
lymphoma B-Disease 1 1.0
, O 0 0.025376122444868088
and O 1 0.5180100202560425
breast B-Disease 1 0.9999988079071045
cancer I-Disease 1 0.9999902248382568
. O 0 0.0015820408007130027

We O 0 0.0007983125979080796
report O 0 0.00048283248906955123
the O 0 9.602848149370402e-05
spectrum O 0 0.0008711062255315483
of O 0 5.540009806281887e-05
59 O 0 0.0022998321801424026
ATM O 0 0.005358043126761913
mutations O 0 0.0012436191318556666
observed O 0 0.0007943529635667801
in O 0 0.0009028397034853697
ataxia B-Disease 1 0.9998396635055542
- I-Disease 1 0.9794289469718933
telangiectasia I-Disease 1 0.9984837174415588
( O 0 0.003318366128951311
A B-Disease 1 0.9941456317901611
- I-Disease 1 0.9964591860771179
T I-Disease 1 0.9996084570884705
) O 0 0.0011475004721432924
patients O 1 0.9981995820999146
in O 0 8.097790851024911e-05
the O 0 0.00030326470732688904
British O 0 0.0028513381257653236
Isles O 0 0.025768274441361427
. O 0 0.0014045238494873047

Of O 0 0.0003474768018350005
51 O 0 0.00474539352580905
ATM O 0 0.016079749912023544
mutations O 0 0.0025619282387197018
identified O 0 0.00038456456968560815
in O 0 8.683675696374848e-05
families O 0 0.0001733463432174176
native O 0 0.00010750711226137355
to O 0 6.660934741375968e-05
the O 0 0.0001690990902716294
British O 0 0.0012081606546416879
Isles O 0 0.006944785360246897
, O 0 0.00018926266056951135
11 O 0 0.0004421541525516659
were O 0 9.938426956068724e-05
founder O 0 0.006572999060153961
mutations O 0 0.0009104879572987556
, O 0 6.76326744724065e-05
and O 0 3.7071415135869756e-05
2 O 0 5.2371848141774535e-05
of O 0 5.178657829674194e-06
these O 0 2.6734433049568906e-05
11 O 0 0.0005469040479511023
conferred O 0 0.04129694029688835
a O 0 0.002409765962511301
milder O 1 0.997532844543457
clinical O 1 0.9990052580833435
phenotype O 0 0.12236204743385315
with O 0 6.67994754621759e-05
respect O 0 0.00025802585878409445
to O 0 0.00013729911006521434
both O 0 0.0006531311082653701
cerebellar B-Disease 1 0.9999061822891235
degeneration I-Disease 1 0.9999747276306152
and O 0 0.00033950433135032654
cellular O 0 0.004380377009510994
features O 0 0.0007533807656727731
. O 0 0.0007386868237517774

We O 0 0.0008207810460589826
report O 0 0.0004780536110047251
, O 0 7.381744217127562e-05
in O 0 6.062191096134484e-05
two O 0 0.00011871889000758529
A B-Disease 1 0.9716572761535645
- I-Disease 1 0.9930182695388794
T I-Disease 1 0.9989014863967896
families O 0 0.00019482891366351396
, O 0 6.813766958657652e-05
an O 0 0.0001502891245763749
ATM O 0 0.004516128916293383
mutation O 0 0.0016061601927503943
( O 0 0.0006223212694749236
7271T O 0 0.03222140297293663
- O 0 0.005349361803382635
- O 0 0.004280486144125462
> O 0 0.007844390347599983
G O 0 0.010267511010169983
) O 0 0.00015655021707061678
that O 0 8.846575656207278e-05
may O 0 0.00027876405511051416
be O 0 4.0157137846108526e-05
associated O 0 4.210298720863648e-05
with O 0 1.7677572031971067e-05
an O 0 9.00590603123419e-05
increased O 0 0.0009587287786416709
risk O 1 0.8139806389808655
of O 0 0.0008585495525039732
breast B-Disease 1 0.999998927116394
cancer I-Disease 1 0.999988317489624
in O 0 0.00023908840375952423
both O 0 0.0005299426848068833
homozygotes O 1 0.9910200238227844
and O 0 0.0005825901171192527
heterozygotes O 1 0.7897863388061523
( O 0 0.00047467867261730134
relative O 0 0.0005749851115979254
risk O 0 0.015377862378954887
12 O 0 0.00027383313863538206
. O 0 7.290228677447885e-05
7 O 0 0.0004622392589226365
; O 0 0.000260417495155707
P O 0 0.030536621809005737
= O 0 0.002366139553487301
. O 0 0.0002657170407474041
0025 O 1 0.8791516423225403
) O 0 0.00022296479437500238
, O 0 8.365765825146809e-05
although O 0 6.8281551648397e-05
there O 0 3.3618005545577034e-05
is O 0 9.004575986182317e-05
a O 0 0.0002953040529973805
less O 0 0.0018041519215330482
severe O 1 0.9998955726623535
A B-Disease 1 0.9989274144172668
- I-Disease 1 0.9989470839500427
T I-Disease 1 0.9996800422668457
phenotype O 0 0.02729886956512928
in O 0 4.030746276839636e-05
terms O 0 5.687514567398466e-05
of O 0 8.217979484470561e-06
the O 0 0.0001347944198641926
degree O 0 0.0014307299861684442
of O 0 0.0003460920415818691
cerebellar B-Disease 1 0.9999517202377319
degeneration I-Disease 1 0.9999749660491943
. O 0 0.0029532993212342262

This O 0 0.0006284461705945432
mutation O 0 0.003599757794290781
( O 0 0.0011477409861981869
7271T O 0 0.09687528014183044
- O 0 0.011368963867425919
- O 0 0.006824296899139881
> O 0 0.00643933517858386
G O 0 0.005691905971616507
) O 0 8.95041084731929e-05
also O 0 3.614027809817344e-05
allows O 0 6.26164983259514e-05
expression O 0 7.246182940434664e-05
of O 0 1.2758739103446715e-05
full O 0 0.00043595206807367504
- O 0 0.0010632787598297
length O 0 0.0002630722301546484
ATM O 0 0.0015731959138065577
protein O 0 0.00020079422392882407
at O 0 0.00014936951629351825
a O 0 0.00021331098105292767
level O 0 0.0004876081657130271
comparable O 0 0.0006254900945350528
with O 0 6.43535386188887e-05
that O 0 9.806854359339923e-05
in O 0 0.0002507752215024084
unaffected O 1 0.7238125801086426
individuals O 0 0.0005287330131977797
. O 0 0.0007591521134600043

In O 0 0.0004497773770708591
addition O 0 0.0003065226483158767
, O 0 9.32411930989474e-05
we O 0 4.486244506551884e-05
have O 0 3.006046790687833e-05
studied O 0 0.0002761629002634436
18 O 0 0.00045226968359202147
A B-Disease 1 0.9964060187339783
- I-Disease 1 0.9992503523826599
T I-Disease 1 0.9999464750289917
patients O 1 0.9997106194496155
, O 0 8.627195347798988e-05
in O 0 6.66756895952858e-05
15 O 0 0.000241728950641118
families O 0 0.00018702831584960222
, O 0 0.00023082428378984332
who O 0 0.0023208027705550194
developed O 1 0.9966440200805664
leukemia B-Disease 1 0.9999994039535522
, O 1 0.5760834217071533
lymphoma B-Disease 1 0.9999998807907104
, O 0 0.005207599140703678
preleukemic O 1 0.9984856247901917
T O 1 0.9994895458221436
- O 0 0.02229209803044796
cell O 0 0.002807057462632656
proliferation O 0 0.03623555973172188
, O 0 0.0008276554872281849
or O 1 0.8801225423812866
Hodgkin B-Disease 1 0.9999998807907104
lymphoma I-Disease 1 0.9999998807907104
, O 0 0.0005779903731308877
mostly O 0 0.0003696962376125157
in O 0 0.0006843020673841238
childhood O 1 0.9972862005233765
. O 0 0.0013432479463517666

A O 0 0.0030931541696190834
wide O 0 0.0008283750503323972
variety O 0 0.00025406648637726903
of O 0 6.650144496234134e-05
ATM O 0 0.020462291315197945
mutation O 0 0.0022132019512355328
types O 0 0.0003672557068057358
, O 0 9.825088636716828e-05
including O 0 0.00012134398275520653
missense O 0 0.009638785384595394
mutations O 0 0.0007881994242779911
and O 0 7.099881622707471e-05
in O 0 0.00018075332627631724
- O 0 0.0048842839896678925
frame O 0 0.002528242766857147
deletions O 0 0.0015687175327911973
, O 0 0.00012549955863505602
were O 0 4.032957076560706e-05
seen O 0 0.000399790849769488
in O 0 0.00011291694681858644
these O 0 0.0003086883807554841
patients O 1 0.9997346997261047
. O 0 0.0007347072241827846

We O 0 0.0006411715876311064
also O 0 0.00013646690058521926
show O 0 9.808583854464814e-05
that O 0 2.2751710275770165e-05
25 O 0 3.901804666384123e-05
% O 0 5.788064754597144e-06
of O 0 1.0409918104414828e-05
all O 0 0.00011191338126081973
A B-Disease 1 0.9980517625808716
- I-Disease 1 0.9989219903945923
T I-Disease 1 0.9999303817749023
patients O 1 0.9988829493522644
carried O 0 0.0002877256483770907
in O 0 0.00021908435155637562
- O 0 0.003364504547789693
frame O 0 0.0022308719344437122
deletions O 0 0.001986189279705286
or O 0 0.0005643346812576056
missense O 0 0.01232871226966381
mutations O 0 0.0012906576739624143
, O 0 5.957935718470253e-05
many O 0 2.0106190277147107e-05
of O 0 1.407842955813976e-05
which O 0 3.691245728987269e-05
were O 0 2.578979365353007e-05
also O 0 7.255704258568585e-05
associated O 0 8.297100430354476e-05
with O 0 2.160147596441675e-05
expression O 0 0.00016598305955994874
of O 0 2.9647173505509272e-05
mutant O 0 0.002769193844869733
ATM O 0 0.003936407156288624
protein O 0 0.0011621906887739897
. O 0 0.0007617289084009826

The O 0 0.0022364510223269463
DMPK O 1 0.8573319315910339
gene O 0 0.0025552960578352213
of O 0 0.00036813365295529366
severely O 1 0.999640703201294
affected O 1 0.9978658556938171
myotonic B-Disease 1 0.9999969005584717
dystrophy I-Disease 1 0.9999995231628418
patients O 1 0.9999597072601318
is O 0 0.004019835032522678
hypermethylated O 1 0.9898492097854614
proximal O 1 0.9706061482429504
to O 0 0.00013779384607914835
the O 0 0.00016602865071035922
largely O 0 0.0009005681495182216
expanded O 0 0.0034509922843426466
CTG O 1 0.9671897888183594
repeat O 0 0.015094964765012264
. O 0 0.001052464242093265

Using O 0 0.0011471605394035578
methylation O 0 0.002648231340572238
- O 0 0.003311500186100602
sensitive O 0 0.0024987771175801754
restriction O 0 0.0008477338124066591
enzymes O 0 0.0007033038418740034
, O 0 0.00020174685050733387
we O 0 0.00020531048357952386
characterized O 0 0.0026231459341943264
the O 0 0.00010201831901213154
methylation O 0 0.00039868749445304275
pattern O 0 0.0005353371961973608
on O 0 7.634147186763585e-05
the O 0 9.003072773339227e-05
5 O 0 0.00022261470439843833
side O 0 0.00029949552845209837
of O 0 1.937463639478665e-05
the O 0 0.00044359121238812804
CTG O 1 0.9855996370315552
repeat O 0 0.002513466402888298
in O 0 0.00013562939420808107
the O 0 0.0003843941376544535
DMPK O 1 0.878922700881958
gene O 0 0.000531330646481365
of O 0 3.258789001847617e-05
normal O 0 0.0011645910562947392
individuals O 0 0.00013527779083233327
and O 0 0.00013010151451453567
of O 0 0.00019428835366852582
patients O 1 0.999982476234436
affected O 1 0.7932859659194946
with O 0 0.06418375670909882
myotonic B-Disease 1 0.9999958276748657
dystrophy I-Disease 1 0.9999988079071045
, O 0 0.0009130804101005197
showing O 0 0.001243343111127615
expansions O 0 0.00147730833850801
of O 0 3.2818017643876374e-05
the O 0 0.00040214695036411285
repetitive O 0 0.3941822946071625
sequence O 0 0.0008575496613048017
. O 0 0.00101986073423177

The O 0 0.0012337698135524988
gene O 0 0.002338593127205968
segment O 0 0.0017491523176431656
analyzed O 0 0.0006273204344324768
corresponds O 0 0.00029330767574720085
to O 0 5.8857767726294696e-05
the O 0 0.0001489568967372179
genomic O 0 0.004224260337650776
SacI O 0 0.39129966497421265
- O 0 0.0052510895766317844
HindIII O 0 0.013315447606146336
fragment O 0 0.0012933642137795687
carrying O 0 0.0006536460132338107
exons O 0 0.0027753235772252083
11 O 0 0.0011668201768770814
- O 0 0.0025722598657011986
15 O 0 0.0006009199423715472
. O 0 0.0005340983625501394

There O 0 0.0006400929996743798
is O 0 0.0004912899457849562
constitutive O 0 0.010589945130050182
methylation O 0 0.0008125322638079524
in O 0 0.00023043245892040431
intron O 0 0.06378742307424545
12 O 0 0.00028045260114595294
at O 0 0.0001341675961157307
restriction O 0 0.0001881036878330633
sites O 0 6.225260585779324e-05
of O 0 3.6102144804317504e-05
SacII O 1 0.6909219622612
and O 0 0.0002743314253166318
HhaI O 0 0.07960868626832962
, O 0 0.00020502859842963517
localized O 0 0.0027937470003962517
1 O 0 0.0002776661713141948
, O 0 0.00019859621534124017
159 O 0 0.0035817113239318132
- O 0 0.0013631642796099186
1 O 0 0.000210587473702617
, O 0 0.00010741529695224017
232 O 0 0.003050088882446289
bp O 0 0.007022842299193144
upstream O 0 0.000717449001967907
of O 0 3.380988346179947e-05
the O 0 0.0005215674173086882
CTG O 1 0.9790416359901428
repeat O 0 0.005267213564366102
, O 0 0.00015976684517227113
whereas O 0 0.0003860382130369544
most O 0 9.305430285166949e-05
, O 0 0.0001354576088488102
if O 0 0.00010779761942103505
not O 0 1.795510615920648e-05
all O 0 5.607520506600849e-06
, O 0 1.5137244190555066e-05
of O 0 3.938596819352824e-06
the O 0 3.518108860589564e-05
other O 0 1.97392455447698e-05
sites O 0 6.994309660512954e-05
of O 0 4.812999031855725e-05
SacII O 1 0.9586651921272278
, O 0 0.0004142452380619943
HhaI O 0 0.3058335781097412
, O 0 0.00024681174545548856
and O 0 0.00025399410515092313
HpaII O 0 0.15286187827587128
in O 0 9.13028561626561e-05
this O 0 7.48208913137205e-05
region O 0 0.0007808837108314037
are O 0 8.17424152046442e-05
unmethylated O 0 0.06609565019607544
, O 0 0.00018987902149092406
in O 0 0.00014237320283427835
normal O 0 0.0012247902341187
individuals O 0 9.093721746467054e-05
and O 0 5.012063411413692e-05
most O 0 6.543006020365283e-05
of O 0 4.9335998483002186e-05
the O 0 0.0015082232421264052
patients O 1 0.9997648596763611
. O 0 0.0007541727391071618

In O 0 0.000254524260526523
a O 0 0.00014767672109883279
number O 0 1.6976355254882947e-05
of O 0 4.586338036460802e-05
young O 0 0.07564004510641098
and O 0 0.0020679770968854427
severely O 1 0.9998524188995361
affected O 1 0.9933603405952454
patients O 1 0.9999313354492188
, O 0 0.00020969945762772113
however O 0 0.00013208176824264228
, O 0 6.69622968416661e-05
complete O 0 0.00024233030853793025
methylation O 0 0.00010654461948433891
of O 0 6.161501914903056e-06
these O 0 1.943559618666768e-05
restriction O 0 0.0002346147084608674
sites O 0 0.00011399686627555639
was O 0 0.00022593769244849682
found O 0 8.772657747613266e-05
in O 0 6.735989154549316e-05
the O 0 0.00029240528238005936
mutated O 0 0.01605876162648201
allele O 0 0.0076408288441598415
. O 0 0.0012262994423508644

In O 0 0.0002785730466712266
most O 0 9.57968077273108e-05
of O 0 3.4868819057010114e-05
these O 0 0.00020392413716763258
patients O 1 0.9998636245727539
, O 0 0.00011643225298030302
the O 0 0.00019450392574071884
onset O 1 0.9982262253761292
of O 0 8.578449342167005e-05
the O 0 0.13831202685832977
disease O 1 0.999997615814209
was O 1 0.9886842370033264
congenital O 1 0.9999958276748657
. O 0 0.0024945244658738375

Preliminary O 0 0.0023270933888852596
in O 0 0.0007926313555799425
vivo O 0 0.016822848469018936
footprinting O 1 0.6093019843101501
data O 0 0.00015213483129628003
gave O 0 0.0003016637056134641
evidence O 0 9.188832336803898e-05
for O 0 8.453650661977008e-05
protein O 0 0.0006401280988939106
- O 0 0.001930191065184772
DNA O 0 0.000461664138128981
contact O 0 0.0006259576184675097
in O 0 8.789447019807994e-05
normal O 0 0.000864375033415854
genes O 0 0.00020390545250847936
at O 0 0.00022028623789083213
an O 0 0.0003370874037500471
Sp1 O 1 0.935766875743866
consensus O 0 0.0003513183619361371
binding O 0 0.00029554712818935513
site O 0 0.0002487785823177546
upstream O 0 0.0005476267542690039
of O 0 3.127236777800135e-05
the O 0 0.0006008732598274946
CTG O 1 0.9897435307502747
repeat O 0 0.003488091751933098
and O 0 7.080072100507095e-05
for O 0 7.149682642193511e-05
a O 0 0.00020356610184535384
significant O 0 0.00026406205142848194
reduction O 0 0.0005005605053156614
of O 0 8.899011845642235e-06
this O 0 2.9424938475131057e-05
interaction O 0 0.000179125796421431
in O 0 0.0001241410500369966
cells O 0 0.0009198967018164694
with O 0 0.0001184940556413494
a O 0 0.0017600632272660732
hypermethylated O 1 0.9696551561355591
DMPK O 1 0.991486668586731
gene O 0 0.002612495794892311
. O 0 0.00024272479640785605
. O 0 0.0006024253088980913

The O 0 0.007756161503493786
hemochromatosis B-Disease 1 0.9999179840087891
gene O 0 0.004180063959211111
product O 0 0.0009776409715414047
complexes O 0 0.00215860060416162
with O 0 9.235046309186146e-05
the O 0 0.00032832653960213065
transferrin O 1 0.9010963439941406
receptor O 0 0.0028632895555347204
and O 0 0.00022959733905736357
lowers O 0 0.047071076929569244
its O 0 0.00012172573042334989
affinity O 0 0.0008810120052658021
for O 0 0.0001928408455569297
ligand O 0 0.004211782943457365
binding O 0 0.001398349180817604
. O 0 0.0007644729921594262

We O 0 0.001773944590240717
recently O 0 0.004166232421994209
reported O 0 0.0007431820849888027
the O 0 8.944481669459492e-05
positional O 0 0.001681977417320013
cloning O 0 0.0009528247755952179
of O 0 1.8706399714574218e-05
a O 0 0.0004046307585667819
candidate O 0 0.000884179025888443
gene O 0 0.0018215402960777283
for O 0 0.001458219368942082
hereditary B-Disease 1 0.999751627445221
hemochromatosis I-Disease 1 0.9999963045120239
called O 1 0.7438910603523254
HFE O 1 0.9983590245246887
. O 0 0.002259255154058337

The O 0 0.0011618840508162975
gene O 0 0.0020793075673282146
product O 0 0.0006062666070647538
, O 0 0.00010175890201935545
a O 0 0.00015682225057389587
member O 0 8.264392818091437e-05
of O 0 1.2416930985637009e-05
the O 0 0.00022019048628862947
major O 0 0.004936487879604101
histocompatibility O 1 0.9994316697120667
complex O 0 0.011148334480822086
class O 0 0.010130406357347965
I O 0 0.3221771717071533
- O 0 0.0030890016350895166
like O 0 0.00020840084471274167
family O 0 0.0003635070752352476
, O 0 0.00012699386570602655
was O 0 0.00025052763521671295
found O 0 7.062162330839783e-05
to O 0 2.2667467419523746e-05
have O 0 2.7586707801674493e-05
a O 0 0.00027389710885472596
mutation O 0 0.0013122351374477148
, O 0 0.0004523363313637674
Cys O 1 0.9886869192123413
- O 0 0.004228996112942696
282 O 0 0.00868139322847128
- O 0 0.006985294632613659
- O 0 0.0063531892374157906
> O 0 0.01425931602716446
Tyr O 1 0.9839291572570801
( O 0 0.001363674527965486
C282Y O 0 0.01585840806365013
) O 0 0.00019533485465217382
, O 0 9.67219821177423e-05
in O 0 6.979797763051465e-05
85 O 0 0.0005424630944617093
% O 0 2.8817516067647375e-05
of O 0 8.179615542758256e-05
patient O 1 0.9977498650550842
chromosomes O 0 0.0018109288066625595
. O 0 0.0009216013713739812

This O 0 0.0006300443201325834
mutation O 0 0.0026105099823325872
eliminates O 0 0.003972656559199095
the O 0 0.0001746440539136529
ability O 0 0.0011686438228935003
of O 0 0.00012199298362247646
HFE O 1 0.9969209432601929
to O 0 0.00023870095901656896
associate O 0 0.002060468541458249
with O 0 0.00026231459924019873
beta2 O 1 0.9222302436828613
- O 0 0.010669872164726257
microglobulin O 0 0.15770749747753143
( O 0 0.0008494669455103576
beta2m O 0 0.05012197047472
) O 0 0.00021280777582433075
and O 0 0.00019517549662850797
prevents O 0 0.0211483221501112
cell O 0 0.004485664423555136
- O 0 0.00376424053683877
surface O 0 0.0025211817119270563
expression O 0 0.0018634062726050615
. O 0 0.0008864938281476498

A O 0 0.0027268959674984217
second O 0 0.0006558800232596695
mutation O 0 0.0017205741023644805
that O 0 0.00010753684910014272
has O 0 0.00018741158419288695
no O 0 0.00011056762014050037
effect O 0 0.00042231418774463236
on O 0 0.00029962806729599833
beta2m O 1 0.8774872422218323
association O 0 0.03752637654542923
, O 0 0.000676049618050456
H63D O 1 0.9946160912513733
, O 0 0.00019398143922444433
was O 0 0.00025033089332282543
found O 0 6.77770294714719e-05
in O 0 2.964397572213784e-05
eight O 0 5.812407107441686e-05
out O 0 3.749407915165648e-05
of O 0 2.8953818400623277e-05
nine O 0 0.000985126942396164
patients O 1 0.9990012049674988
heterozygous O 0 0.0013531354488804936
for O 0 0.00010602136899251491
the O 0 0.0004055397876072675
C282Y O 0 0.08767557144165039
mutant O 0 0.009789669886231422
. O 0 0.001123290043324232

In O 0 0.00036906005698256195
this O 0 0.00012913696991745383
report O 0 0.0005157712730579078
, O 0 9.307028085459024e-05
we O 0 0.00010067068797070533
demonstrate O 0 0.0005303212092258036
in O 0 0.00013360842422116548
cultured O 0 0.011003089137375355
293 O 0 0.03401319310069084
cells O 0 0.007469928823411465
overexpressing O 1 0.980786919593811
wild O 0 0.0021306918933987617
- O 0 0.006928807590156794
type O 0 0.0026658533606678247
or O 0 0.0005819518701173365
mutant O 0 0.009617092087864876
HFE O 1 0.9174997806549072
proteins O 0 0.0001480513601563871
that O 0 3.7130048440303653e-05
both O 0 4.9734309868654236e-05
the O 0 0.00013995773042552173
wild O 0 0.0009008998167701066
- O 0 0.006252596154808998
type O 0 0.002191247884184122
and O 0 0.0004680205602198839
H63D O 1 0.9893174767494202
HFE O 1 0.9692595601081848
proteins O 0 0.00037119482294656336
form O 0 0.0005971145001240075
stable O 0 0.013230577111244202
complexes O 0 0.001984851434826851
with O 0 9.267211862606928e-05
the O 0 0.00041735515696927905
transferrin O 1 0.9609892964363098
receptor O 0 0.00963362492620945
( O 0 0.0017935504438355565
TfR O 1 0.9838480353355408
) O 0 0.0008991358336061239
. O 0 0.0010196489747613668

The O 0 0.00137341080699116
C282Y O 0 0.02535886876285076
mutation O 0 0.0023678140714764595
nearly O 0 0.0013479884946718812
completely O 0 0.0038258936256170273
prevents O 0 0.006130553781986237
the O 0 0.0001790301757864654
association O 0 0.0018416045932099223
of O 0 3.787082459894009e-05
the O 0 0.0004217232344672084
mutant O 0 0.008685925044119358
HFE O 1 0.9006683826446533
protein O 0 0.0005531006609089673
with O 0 0.00017994818335864693
the O 0 0.0009883586317300797
TfR O 1 0.9847276210784912
. O 0 0.0013509882846847177

Studies O 0 0.0012894277460873127
on O 0 0.0003654270840343088
cell O 0 0.003067001234740019
- O 0 0.0035000836942344904
associated O 0 0.00047715945402160287
transferrin O 0 0.13178224861621857
at O 0 0.0005088501493446529
37 O 0 0.001322148717008531
degrees O 0 0.0015577867161482573
C O 0 0.006343284621834755
suggest O 0 0.0002761565847322345
that O 0 4.8104338929988444e-05
the O 0 0.00024054927052929997
overexpressed O 0 0.3310268819332123
wild O 0 0.001447748625651002
- O 0 0.00796867161989212
type O 0 0.0058664558455348015
HFE O 1 0.974768340587616
protein O 0 0.000685261155012995
decreases O 0 0.0012145853834226727
the O 0 8.399090438615531e-05
affinity O 0 0.0005092118517495692
of O 0 3.307449151179753e-05
the O 0 0.00045994625543244183
TfR O 1 0.9821321964263916
for O 0 0.0008349501877091825
transferrin O 1 0.9838009476661682
. O 0 0.0014034262858331203

The O 0 0.004197993781417608
overexpressed O 1 0.699582576751709
H63D O 1 0.9188864231109619
protein O 0 0.0015957866562530398
does O 0 0.0004918212071061134
not O 0 6.329320603981614e-05
have O 0 3.623189695645124e-05
this O 0 2.8718806788674556e-05
effect O 0 0.00031421618768945336
, O 0 6.33520248811692e-05
providing O 0 0.0003603583900257945
the O 0 5.939782568020746e-05
first O 0 6.154000584501773e-05
direct O 0 0.0001173561904579401
evidence O 0 9.625172970118001e-05
for O 0 5.560796125791967e-05
a O 0 0.0002456019283272326
functional O 0 0.0009169146069325507
consequence O 0 0.0009667961276136339
of O 0 3.8361897168215364e-05
the O 0 0.0006239991053007543
H63D O 1 0.9924387335777283
mutation O 0 0.005027686711400747
. O 0 0.0009786781156435609

Addition O 0 0.0005657980218529701
of O 0 0.00011270071263425052
soluble O 0 0.21177439391613007
wild O 0 0.0025664493441581726
- O 0 0.09031763672828674
type O 0 0.2938842475414276
HFE O 1 0.99863201379776
/ O 1 0.9055389761924744
beta2m O 1 0.573810338973999
heterodimers O 0 0.14239172637462616
to O 0 0.00043213783646933734
cultured O 0 0.017285194247961044
cells O 0 0.0025150664150714874
also O 0 0.00019236061780247837
decreased O 0 0.0037570835556834936
the O 0 0.00015595128934364766
apparent O 0 0.0024309498257935047
affinity O 0 0.0005922234850004315
of O 0 2.7208152459934354e-05
the O 0 0.0004034844459965825
TfR O 1 0.9512860774993896
for O 0 0.00011083753634011373
its O 0 0.0002212637773482129
ligand O 0 0.002507563913241029
under O 0 0.0004433095164131373
steady O 0 0.008012334816157818
- O 0 0.0026228888891637325
state O 0 0.00018557645671535283
conditions O 0 0.0014410456642508507
, O 0 7.150542660383508e-05
both O 0 6.121276237536222e-05
in O 0 0.000169550214195624
293 O 0 0.023146705701947212
cells O 0 0.001302669057622552
and O 0 0.000132206900161691
in O 0 0.0004948642454110086
HeLa O 1 0.9892949461936951
cells O 0 0.005745790898799896
. O 0 0.0005856839125044644

Furthermore O 0 0.004123455844819546
, O 0 0.00024129833036568016
at O 0 0.0003056955465581268
4 O 0 0.0004455937014427036
degrees O 0 0.0011302103521302342
C O 0 0.0032083659898489714
, O 0 3.5439428756944835e-05
the O 0 5.834376497659832e-05
added O 0 0.0005054370267316699
soluble O 0 0.0069026220589876175
complex O 0 0.0012088767252862453
of O 0 0.00030407129088416696
HFE O 1 0.9992951154708862
/ O 1 0.8929963111877441
beta2m O 0 0.08145757019519806
inhibited O 0 0.005557612515985966
binding O 0 0.00033694636658765376
of O 0 9.444658644497395e-05
transferrin O 1 0.8204280138015747
to O 0 0.0007268233457580209
HeLa O 1 0.9796460270881653
cell O 0 0.005364494398236275
TfR O 1 0.9101635813713074
in O 0 0.00018425550661049783
a O 0 0.0006940772873349488
concentration O 0 0.004975820425897837
- O 0 0.0040931301191449165
dependent O 0 0.00161045475397259
manner O 0 0.002426528139039874
. O 0 0.0011636618291959167

Scatchard O 0 0.020961401984095573
plots O 0 0.0008168641943484545
of O 0 2.498394860594999e-05
these O 0 2.7096501071355306e-05
data O 0 9.108789527090266e-05
indicate O 0 0.00025071349227800965
that O 0 3.6245721275918186e-05
the O 0 0.00011877426732098684
added O 0 0.0010933246230706573
heterodimer O 0 0.07588180899620056
substantially O 0 0.006083574146032333
reduced O 0 0.0005593746900558472
the O 0 7.076109613990411e-05
affinity O 0 0.0007281373837031424
of O 0 0.00014140125131234527
TfR O 1 0.9889786839485168
for O 0 0.0010900747729465365
transferrin O 1 0.9567310214042664
. O 0 0.001771091134287417

These O 0 0.00021691601432394236
results O 0 0.0005673039704561234
establish O 0 0.0009387883474119008
a O 0 0.0005780468345619738
molecular O 0 0.0017415075562894344
link O 0 0.0028484747745096684
between O 0 0.00055618432816118
HFE O 1 0.9934927821159363
and O 0 9.539080929243937e-05
a O 0 0.0001787715737009421
key O 0 0.00030293819145299494
protein O 0 0.000226153657422401
involved O 0 0.00033514268579892814
in O 0 0.0001850643748184666
iron O 1 0.7511390447616577
transport O 0 0.0036515307147055864
, O 0 0.00019322423031553626
the O 0 0.0004206032899674028
TfR O 1 0.9902576208114624
, O 0 0.00018417331739328802
and O 0 7.968091085786e-05
raise O 0 0.0006203126395121217
the O 0 0.00010083315282827243
possibility O 0 0.00074121163925156
that O 0 8.481297845719382e-05
alterations O 0 0.0013801844324916601
in O 0 5.279290417092852e-05
this O 0 6.037240382283926e-05
regulatory O 0 0.0028489488177001476
mechanism O 0 0.0012057774001732469
may O 0 0.00031690846662968397
play O 0 6.930413655936718e-05
a O 0 0.00018020300194621086
role O 0 0.00044674400123767555
in O 0 0.00013330938236322254
the O 0 0.0004290528013370931
pathogenesis O 1 0.9992417097091675
of O 0 0.0008425643900409341
hereditary B-Disease 1 0.9999682903289795
hemochromatosis I-Disease 1 0.9999983310699463
. O 0 0.002315024845302105
. O 0 0.0011536743259057403

Genomic O 0 0.004086859989911318
organization O 0 0.0009124593925662339
of O 0 6.854289676994085e-05
the O 0 0.0014902756083756685
UBE3A O 1 0.9982208609580994
/ O 1 0.9187049865722656
E6 O 1 0.9763848185539246
- O 0 0.03317219018936157
AP O 0 0.006228749640285969
gene O 0 0.001165890833362937
and O 0 0.0002133797388523817
related O 0 0.002756741363555193
pseudogenes O 0 0.050961777567863464
. O 0 0.001245449879206717

The O 0 0.0027293930761516094
UBE3A O 1 0.754788875579834
gene O 0 0.001433688448742032
encodes O 0 0.0007965523400343955
the O 0 0.0004466679529286921
E6 O 1 0.6615839600563049
- O 0 0.00684466864913702
AP O 0 0.0032134205102920532
ubiquitin O 0 0.005196664482355118
- O 0 0.0014929608441889286
protein O 0 0.00042760162614285946
ligase O 0 0.0032954327762126923
and O 0 0.00013531625154428184
has O 0 0.0005380173679441214
recently O 0 0.001544678583741188
been O 0 0.00013074847811367363
shown O 0 0.00014851198648102582
to O 0 6.45212858216837e-05
be O 0 0.00016384122136514634
mutated O 0 0.10272670537233353
in O 0 0.06347661465406418
Angelman B-Disease 1 0.9999991655349731
syndrome I-Disease 1 1.0
patients O 1 0.9999861717224121
who O 0 0.0044549903832376
lack O 0 0.12081566452980042
15q11 O 1 0.9829786419868469
- O 0 0.0318690724670887
q13 O 0 0.01709703728556633
deletions O 0 0.001860117889009416
or O 0 0.0004124134429730475
chromosome O 0 0.002774635097011924
15 O 0 0.0013513092417269945
paternal O 0 0.13847529888153076
uniparental B-Disease 1 0.9974935054779053
disomy I-Disease 1 0.9737971425056458
. O 0 0.002345639280974865

Previous O 0 0.007119190413504839
UBE3A O 1 0.8835357427597046
cDNA O 0 0.004384379833936691
analysis O 0 0.0005575967952609062
has O 0 0.00039411024772562087
shown O 0 0.00034033620613627136
a O 0 0.00032717917929403484
coding O 0 0.0021672071889042854
region O 0 0.0004288358613848686
of O 0 2.72597826551646e-05
approximately O 0 0.0004172526823822409
2 O 0 0.0008825145778246224
. O 0 0.0006579887703992426

6 O 0 0.0037480457685887814
kb O 0 0.006431499030441046
and O 0 0.00015161420742515475
a O 0 0.000593391596339643
3 O 0 0.0009521145839244127
- O 0 0.0041740466840565205
untranslated O 0 0.014395933598279953
region O 0 0.0019097586628049612
( O 0 0.0008399427752010524
UTR O 0 0.013820219784975052
) O 0 9.864215098787099e-05
of O 0 5.0109545554732904e-05
< O 0 0.009114708751440048
50 O 0 0.0006469403160735965
bp O 0 0.0167078860104084
, O 0 0.0002704917860683054
whereas O 0 0.000458679161965847
Northern O 0 0.000400140299461782
analysis O 0 0.00019331747898831964
has O 0 0.0002319297636859119
indicated O 0 0.0004365700588095933
mRNA O 0 9.566079097567126e-05
sizes O 0 8.919091487769037e-05
of O 0 2.4004410079214722e-05
5 O 0 0.0006922216271050274
- O 0 0.002506291726604104
8 O 0 0.0007300853612832725
kb O 0 0.009942213073372841
. O 0 0.0008307686075568199

We O 0 0.0006432930822484195
have O 0 9.0392553829588e-05
analyzed O 0 0.0004646871821023524
additional O 0 0.00024155846040230244
cDNA O 0 0.0018910194048658013
clones O 0 0.0019844509661197662
and O 0 5.519786282093264e-05
provide O 0 0.00020967067393939942
evidence O 0 6.972174742259085e-05
for O 0 4.117362914257683e-05
an O 0 6.904896872583777e-05
additional O 0 0.00023503630654886365
0 O 0 0.0007417055894620717
. O 0 0.00035625515738502145

5 O 0 0.0015674395253881812
kb O 0 0.00354370241984725
of O 0 6.255669723032042e-05
5 O 0 0.0008507427992299199
- O 0 0.0032836131285876036
UTR O 0 0.01318388618528843
and O 0 0.00016705464804545045
> O 0 0.0029263366013765335
2 O 0 0.00025134108727797866
kb O 0 0.0017565765883773565
of O 0 4.402931153890677e-05
3 O 0 0.0009385228040628135
- O 0 0.006713385693728924
UTR O 0 0.03638438507914543
. O 0 0.001076863263733685

We O 0 0.0007024116930551827
have O 0 0.00010017513704951853
established O 0 0.00013331077934708446
the O 0 8.503942081006244e-05
genomic O 0 0.0009183781803585589
organization O 0 0.0008379134815186262
of O 0 0.00010398065205663443
UBE3A O 1 0.9930141568183899
and O 0 5.0833226850954816e-05
the O 0 4.202379932394251e-05
sequence O 0 4.896627433481626e-05
of O 0 5.622306707664393e-05
intron O 1 0.7409704327583313
- O 0 0.009217440150678158
exon O 0 0.011007833294570446
borders O 0 0.0032475220505148172
. O 0 0.0011751591227948666

We O 0 0.0008450279710814357
have O 0 0.00012674948084168136
also O 0 0.00012911160592921078
mapped O 0 0.0007470249547623098
two O 0 3.6970657674828544e-05
highly O 0 0.0009471382945775986
homologous O 0 0.002403177786618471
processed O 0 0.0010457559255883098
pseudogenes O 0 0.013773693703114986
, O 0 0.000930044858250767
UBE3AP1 O 1 0.9799882173538208
and O 0 0.0005072339554317296
UBE3AP2 O 1 0.9222155213356018
, O 0 0.00011847687710542232
to O 0 6.0752758145099506e-05
chromosomes O 0 0.00021286706032697111
2 O 0 0.0001878004550235346
and O 0 5.8474932302488014e-05
21 O 0 0.0003575942537281662
, O 0 0.00010912019206443802
respectively O 0 0.00023033953038975596
, O 0 8.821160736260936e-05
and O 0 6.3017250795383e-05
determined O 0 0.0003268430882599205
their O 0 5.9219666582066566e-05
genomic O 0 0.0017367027467116714
organization O 0 0.0025404850021004677
. O 0 0.0010762519668787718

These O 0 0.0002724998921621591
results O 0 0.0005277092568576336
will O 0 0.00010378886508988217
form O 0 9.341954137198627e-05
the O 0 3.772455602302216e-05
basis O 0 3.894102337653749e-05
for O 0 4.770120358443819e-05
studies O 0 0.00011240385356359184
of O 0 2.597927232272923e-05
mutation O 0 0.001140653039328754
and O 0 0.00012584707292262465
imprinting O 0 0.021498434245586395
of O 0 0.0002537721593398601
UBE3A O 1 0.996800422668457
. O 0 0.001983314286917448

Mutation O 0 0.011321250349283218
spectrum O 0 0.005206277593970299
and O 0 0.000772228348068893
genotype O 0 0.34294435381889343
- O 0 0.02136164903640747
phenotype O 0 0.023128941655158997
analyses O 0 0.001222700928337872
in O 0 0.0015224860981106758
Cowden B-Disease 1 0.9999600648880005
disease I-Disease 1 0.99997878074646
and O 0 0.002883065026253462
Bannayan B-Disease 1 0.9995406866073608
- I-Disease 1 0.9987412095069885
Zonana I-Disease 1 0.9998797178268433
syndrome I-Disease 1 0.9999890327453613
, O 0 0.0007320517906919122
two O 0 0.0010124427499249578
hamartoma B-Disease 1 0.9995785355567932
syndromes I-Disease 1 0.9995806813240051
with O 0 0.002563424874097109
germline O 1 0.9968900084495544
PTEN O 1 0.9981088638305664
mutation O 0 0.010518609546124935
. O 0 0.0010924115777015686

The O 0 0.008172906935214996
tumour B-Disease 1 0.9998427629470825
suppressor O 1 0.970792829990387
gene O 0 0.029857009649276733
PTEN O 1 0.9945620894432068
, O 0 0.0002191307139582932
which O 0 5.940337723586708e-05
maps O 0 0.0003051620733458549
to O 0 0.00022589591389987618
10q23 O 0 0.029358474537730217
. O 0 0.0008219416486099362

3 O 0 0.0010784139158204198
and O 0 0.00013018528989050537
encodes O 0 0.0007226748275570571
a O 0 0.0004552423197310418
403 O 0 0.0031610438600182533
amino O 0 0.00027105098706670105
acid O 0 0.0018707170384004712
dual O 0 0.0011492595076560974
specificity O 0 0.0017852969467639923
phosphatase O 0 0.13363158702850342
( O 0 0.00040162555524148047
protein O 0 0.0009293672628700733
tyrosine O 0 0.008127122186124325
phosphatase O 1 0.5965284705162048
; O 0 0.0005713088903576136
PTPase O 0 0.35967013239860535
) O 0 0.0002550040080677718
, O 0 0.00012640500790439546
was O 0 0.0004327090282458812
shown O 0 0.0003861158911604434
recently O 0 0.0006241912487894297
to O 0 3.290309541625902e-05
play O 0 4.670578709919937e-05
a O 0 0.00019471471023280174
broad O 0 0.002562690991908312
role O 0 0.0008854669285938144
in O 0 0.0004051253490615636
human O 0 0.06855469942092896
malignancy B-Disease 1 0.9996101260185242
. O 0 0.0015793999191373587

Somatic O 1 0.5898970365524292
PTEN O 1 0.9927697777748108
deletions O 0 0.007348699029535055
and O 0 0.0002422896504867822
mutations O 0 0.0007843194180168211
were O 0 3.210339855286293e-05
observed O 0 0.00026356932357884943
in O 0 0.00017897931684274226
sporadic B-Disease 1 0.606924831867218
breast I-Disease 1 0.9999858140945435
, I-Disease 0 0.011286552995443344
brain I-Disease 1 0.9999833106994629
, I-Disease 0 0.49580296874046326
prostate I-Disease 1 0.9999996423721313
and I-Disease 1 0.9861654043197632
kidney I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999986886978149
cell O 0 0.01261082198470831
lines O 0 0.000542850757483393
and O 0 6.915222911629826e-05
in O 0 8.016241918085143e-05
several O 0 0.0001399851025780663
primary O 0 0.02461862936615944
tumours B-Disease 1 0.99986732006073
such O 0 0.0001061933726305142
as O 0 0.007381687872111797
endometrial B-Disease 1 0.999980092048645
carcinomas I-Disease 1 0.9999847412109375
, O 1 0.9949656128883362
malignant B-Disease 1 0.9999998807907104
melanoma I-Disease 1 1.0
and O 1 0.994814395904541
thyroid B-Disease 1 0.9999997615814209
tumours I-Disease 1 0.9999840259552002
. O 0 0.003874673042446375

In O 0 0.0006727569852955639
addition O 0 0.000872054195497185
, O 0 0.0011935969814658165
PTEN O 1 0.9983914494514465
was O 0 0.0006823230069130659
identified O 0 0.00026194247766397893
as O 0 5.618593058898114e-05
the O 0 0.00016251248598564416
susceptibility O 0 0.05553065612912178
gene O 0 0.0007538204081356525
for O 0 0.0001708120253169909
two O 0 0.0010471531422808766
hamartoma B-Disease 1 0.9998326301574707
syndromes I-Disease 1 0.9999818801879883
Cowden B-Disease 1 0.9999873638153076
disease I-Disease 1 0.99998939037323
( O 0 0.0019669292960315943
CD B-Disease 0 0.021906653419137
; O 0 0.0008462470723316073
MIM O 1 0.9981685876846313
158350 O 0 0.04658093675971031
) O 0 0.00031185674015432596
and O 0 0.0002581144217401743
Bannayan B-Disease 1 0.7935372591018677
- I-Disease 0 0.025011887773871422
Zonana I-Disease 1 0.9863743782043457
( I-Disease 0 0.0015380783006548882
BZS I-Disease 0 0.20239010453224182
) I-Disease 0 0.00034352191141806543
or I-Disease 0 0.0007626836886629462
Ruvalcaba I-Disease 1 0.9969758987426758
- I-Disease 0 0.4837954044342041
Riley I-Disease 1 0.9871954917907715
- I-Disease 1 0.9011021852493286
Smith I-Disease 1 0.9903744459152222
syndrome I-Disease 1 0.9999828338623047
( O 0 0.012062867172062397
MIM O 1 0.9989482760429382
153480 O 1 0.8384947776794434
) O 0 0.0009715890628285706
. O 0 0.0009744827984832227

Constitutive O 0 0.06297581642866135
DNA O 0 0.0018655253807082772
from O 0 0.00022189103765413165
37 O 0 0.001092313788831234
CD B-Disease 0 0.001404338632710278
families O 0 0.00028234184719622135
and O 0 0.0001807757216738537
seven O 0 0.0009367663878947496
BZS B-Disease 1 0.8677458167076111
families O 0 0.0006648380658589303
was O 0 0.0007080767536535859
screened O 0 0.002618161728605628
for O 0 0.0007110703736543655
germline O 1 0.983959972858429
PTEN O 1 0.9964663982391357
mutations O 0 0.00721746077761054
. O 0 0.0010553086176514626

PTEN O 1 0.9896872639656067
mutations O 0 0.004208949860185385
were O 0 8.467608859064057e-05
identified O 0 0.00021652833675034344
in O 0 3.9656504668528214e-05
30 O 0 0.00010298263077856973
of O 0 1.9107257685391232e-05
37 O 0 0.0008734962320886552
( O 0 0.00029289801022969186
81 O 0 0.001157883438281715
% O 0 4.808049197890796e-05
) O 0 0.00015773648920003325
CD B-Disease 0 0.001170203322544694
families O 0 0.00019070548296440393
, O 0 0.00010249474871670827
including O 0 0.00010655884398147464
missense O 0 0.004670002963393927
and O 0 0.00017528283933643252
nonsense O 0 0.005347246304154396
point O 0 0.0005497505771927536
mutations O 0 0.0013149110600352287
, O 0 0.00011688633821904659
deletions O 0 0.0012932440731674433
, O 0 0.00013935434981249273
insertions O 0 0.0020965998992323875
, O 0 0.00011843937681987882
a O 0 0.000803859846200794
deletion O 0 0.01029258407652378
/ O 0 0.018518297001719475
insertion O 0 0.004195937421172857
and O 0 0.00023084189160726964
splice O 0 0.009421476162970066
site O 0 0.0020807557739317417
mutations O 0 0.002969686407595873
. O 0 0.00070924375904724

These O 0 0.00035135552752763033
mutations O 0 0.001118697109632194
were O 0 3.483774344203994e-05
scattered O 0 0.00020902174583170563
over O 0 9.761351975612342e-05
the O 0 9.762906847754493e-05
entire O 0 0.0009459992870688438
length O 0 0.0004888491239398718
of O 0 0.0001583356352057308
PTEN O 1 0.9978888630867004
, O 0 0.00011742067727027461
with O 0 3.116580774076283e-05
the O 0 6.248027057154104e-05
exception O 0 0.0001518341014161706
of O 0 6.7107525865139905e-06
the O 0 4.729048669105396e-05
first O 0 7.449731492670253e-05
, O 0 7.881413330323994e-05
fourth O 0 0.0003928002843167633
and O 0 9.057676652446389e-05
last O 0 0.00088759686332196
exons O 0 0.004945462103933096
. O 0 0.000748000864405185

A O 0 0.005151892080903053
hot O 0 0.008740697987377644
spot O 0 0.003378882072865963
for O 0 0.0008032782934606075
PTEN O 1 0.9925994873046875
mutation O 0 0.001350044272840023
in O 0 0.00013590643357019871
CD B-Disease 0 0.0015397415263578296
was O 0 0.0003991799894720316
identified O 0 0.00025164891849271953
in O 0 6.84113911120221e-05
exon O 0 0.003104591276496649
5 O 0 0.00015353912021964788
that O 0 2.5681119950604625e-05
contains O 0 6.181837670737877e-05
the O 0 0.0001946365664480254
PTPase O 0 0.058226678520441055
core O 0 0.0013885912485420704
motif O 0 0.000964990584179759
, O 0 5.606053309747949e-05
with O 0 3.783877400564961e-05
13 O 0 0.00012488869833759964
of O 0 1.6298119589919224e-05
30 O 0 0.0003458552237134427
( O 0 0.0001811152760637924
43 O 0 0.0003307787119410932
% O 0 4.732291927211918e-05
) O 0 0.00015006016474217176
CD B-Disease 0 0.0020911996252834797
mutations O 0 0.000834865088108927
identified O 0 0.00022255530348047614
in O 0 6.338821549434215e-05
this O 0 0.00013469060650095344
exon O 0 0.012334531173110008
. O 0 0.0008532123756594956

Seven O 0 0.0006048462819308043
of O 0 6.259256042540073e-05
30 O 0 0.0007836657459847629
( O 0 0.00039106662734411657
23 O 0 0.0004305003967601806
% O 0 3.678132270579226e-05
) O 0 6.63499886286445e-05
were O 0 1.329627866653027e-05
within O 0 4.0281829569721594e-05
the O 0 0.00011014302435796708
core O 0 0.001378048793412745
motif O 0 0.0014665464404970407
, O 0 9.556669829180464e-05
the O 0 7.512008596677333e-05
majority O 0 0.0002100056008202955
( O 0 0.00011752338468795642
five O 0 3.969298268202692e-05
of O 0 1.3088842933939304e-05
seven O 0 0.00010831952386070043
) O 0 3.546992229530588e-05
of O 0 1.063755826180568e-05
which O 0 5.694938954547979e-05
were O 0 8.113480726024136e-05
missense O 0 0.011013861745595932
mutations O 0 0.0016783494502305984
, O 0 0.00023768015671521425
possibly O 0 0.001149858464486897
pointing O 0 0.0008120779530145228
to O 0 3.42396815540269e-05
the O 0 5.3035615565022454e-05
functional O 0 0.00043105072109028697
significance O 0 0.00015902164159342647
of O 0 2.1547486539930105e-05
this O 0 0.0001195473741972819
region O 0 0.0018825085135176778
. O 0 0.00044224399607628584

Germline O 1 0.9853663444519043
PTEN O 1 0.9955957531929016
mutations O 0 0.0046086907386779785
were O 0 9.594437142368406e-05
identified O 0 0.00020726321963593364
in O 0 2.893791679525748e-05
four O 0 2.2241280021262355e-05
of O 0 1.4525056940328795e-05
seven O 0 0.00024385772121604532
( O 0 0.0004364643828012049
57 O 0 0.001198177458718419
% O 0 0.00010792598914122209
) O 0 0.0007856726879253983
BZS B-Disease 1 0.7669550776481628
families O 0 0.0007467099349014461
studied O 0 0.0015324776759371161
. O 0 0.0008315662271343172

Interestingly O 0 0.05059150233864784
, O 0 0.0003724639827851206
none O 0 0.0002258907479699701
of O 0 1.6756108379922807e-05
these O 0 7.077067857608199e-05
mutations O 0 0.0010594234336167574
was O 0 0.0002670504036359489
observed O 0 0.00020337810565251857
in O 0 6.591334386030212e-05
the O 0 0.00026061717653647065
PTPase O 1 0.5784226655960083
core O 0 0.0032204906456172466
motif O 0 0.00591540802270174
. O 0 0.0010085850954055786

It O 0 0.0006559106986969709
is O 0 0.00026614626403898
also O 0 8.265346696134657e-05
worthy O 0 0.0005696556763723493
of O 0 1.4761910279048607e-05
note O 0 0.000227039898163639
that O 0 2.290715929120779e-05
a O 0 0.0001378571760142222
single O 0 0.00013214601494837552
nonsense O 0 0.002254364313557744
point O 0 0.00041634385706856847
mutation O 0 0.0012139363680034876
, O 0 0.000244090348132886
R233X O 0 0.019534127786755562
, O 0 0.00011204749898752198
was O 0 0.00018590250692795962
observed O 0 0.00016744584718253464
in O 0 5.821893864776939e-05
the O 0 0.00026020852965302765
germline O 1 0.5502355694770813
DNA O 0 0.0004178662784397602
from O 0 5.14249513798859e-05
two O 0 9.05622509890236e-05
unrelated O 0 0.003972373437136412
CD B-Disease 0 0.001574814785271883
families O 0 0.0002005431888392195
and O 0 0.00011817968334071338
one O 0 0.0005134830134920776
BZS B-Disease 1 0.9518865942955017
family O 0 0.0025072635617107153
. O 0 0.0008116415701806545

Genotype O 1 0.9033185243606567
- O 0 0.26669034361839294
phenotype O 0 0.10198425501585007
studies O 0 0.00038710248190909624
were O 0 3.480029045022093e-05
not O 0 5.22184964211192e-05
performed O 0 0.00016861576295923442
on O 0 4.570101373246871e-05
this O 0 2.4937675334513187e-05
small O 0 9.92278364719823e-05
group O 0 0.0001635682419873774
of O 0 9.083928307518363e-05
BZS B-Disease 1 0.9828398823738098
families O 0 0.0012690935982391238
. O 0 0.0012955347774550319

However O 0 0.0021890567149966955
, O 0 0.0009885120671242476
genotype O 0 0.20752553641796112
- O 0 0.017098119482398033
phenotype O 0 0.01792876049876213
analysis O 0 0.0006382277933880687
inthe O 0 0.018651792779564857
group O 0 0.00024498984566889703
of O 0 4.748403443954885e-05
CD B-Disease 0 0.0031019060406833887
families O 0 0.00038930628215894103
revealed O 0 0.0014651037054136395
two O 0 5.447403964353725e-05
possible O 0 0.0002973701630253345
associations O 0 0.0003422820009291172
worthy O 0 0.001191363320685923
of O 0 3.3256095775868744e-05
follow O 0 0.0005075022927485406
- O 0 0.0009924963815137744
up O 0 8.294726285384968e-05
in O 0 7.660377741558477e-05
independent O 0 0.00023057263751979917
analyses O 0 0.0013613401679322124
. O 0 0.0005725836963392794

The O 0 0.00047925315448082983
first O 0 0.0002983174636028707
was O 0 0.0006118669407442212
an O 0 0.0003352612548042089
association O 0 0.010027552954852581
noted O 0 0.00034178083296865225
in O 0 4.304888716433197e-05
the O 0 5.3945295803714544e-05
group O 0 5.7004159316420555e-05
of O 0 1.887504186015576e-05
CD B-Disease 0 0.0023345451336354017
families O 0 0.0004643675056286156
with O 0 0.016521867364645004
breast B-Disease 1 0.9999972581863403
disease I-Disease 1 0.9999767541885376
. O 0 0.0021887088660150766

A O 0 0.0029349655378609896
correlation O 0 0.001760551705956459
was O 0 0.0004314272082410753
observed O 0 0.0001737812563078478
between O 0 6.592654244741425e-05
the O 0 0.00021078412828501314
presence O 0 0.00142372096888721
/ O 0 0.014165512286126614
absence O 0 0.0007725183968432248
of O 0 4.757826900458895e-05
a O 0 0.0032712705433368683
PTEN O 1 0.997334897518158
mutation O 0 0.0010547969723120332
and O 0 5.651398896588944e-05
the O 0 9.232783486368135e-05
type O 0 0.0037882057949900627
of O 0 0.00024159577151294798
breast O 1 0.9999734163284302
involvement O 1 0.6731802821159363
( O 0 0.003212274983525276
unaffected O 1 0.991675853729248
versus O 1 0.9094045758247375
benign O 1 0.9995287656784058
versus O 1 0.9917563199996948
malignant O 1 0.9999730587005615
) O 0 0.0016458075260743499
. O 0 0.0011922073317691684

Specifically O 0 0.001423715497367084
and O 0 9.183848305838183e-05
more O 0 0.00010225869482383132
directly O 0 0.00030235302983783185
, O 0 0.00010260799172101542
an O 0 0.0002275010192533955
association O 0 0.012480264529585838
was O 0 0.000351119990227744
also O 0 4.697979602497071e-05
observed O 0 7.04792037140578e-05
between O 0 1.993228761421051e-05
the O 0 3.003854362759739e-05
presence O 0 9.002437582239509e-05
of O 0 2.8342683435766958e-05
a O 0 0.003875265596434474
PTEN O 1 0.9992128610610962
mutation O 0 0.07805562019348145
and O 0 0.1943945735692978
malignant B-Disease 1 0.9999994039535522
breast I-Disease 1 0.9999990463256836
disease I-Disease 1 0.9999947547912598
. O 0 0.0032768938690423965

Secondly O 0 0.05644144490361214
, O 0 0.0003140059707220644
there O 0 0.00014074103091843426
appeared O 0 0.0005273693823255599
to O 0 6.640278297709301e-05
be O 0 5.473001147038303e-05
an O 0 0.00018964272749144584
interdependent O 0 0.4663064777851105
association O 0 0.007622374687343836
between O 0 0.00034180530929006636
mutations O 0 0.0012998447054997087
upstream O 0 0.0014733393909409642
and O 0 6.447048508562148e-05
within O 0 7.783991895848885e-05
the O 0 0.0002078684192383662
PTPase O 0 0.3983663022518158
core O 0 0.0011880173115059733
motif O 0 0.001166992005892098
, O 0 7.379464659607038e-05
the O 0 6.85837003402412e-05
core O 0 0.0007727741613052785
motif O 0 0.0005215028068050742
containing O 0 5.994860839564353e-05
the O 0 5.170730946701951e-05
majority O 0 0.00010083420784212649
of O 0 5.483888526214287e-05
missense O 0 0.017032857984304428
mutations O 0 0.001276051509194076
, O 0 9.005073661683127e-05
and O 0 5.8938763686455786e-05
the O 0 7.419260509777814e-05
involvement O 0 0.0008965889574028552
of O 0 1.560650343890302e-05
all O 0 4.8075540689751506e-05
major O 0 0.0012981619220227003
organ O 0 0.2940789759159088
systems O 0 0.010485141538083553
( O 0 0.000541828980203718
central O 0 0.00116518244612962
nervous O 1 0.9967947602272034
system O 0 0.0053488872945308685
, O 0 0.0027446707244962454
thyroid O 1 0.9999973773956299
, O 0 0.06843194365501404
breast O 1 0.9999901056289673
, O 0 0.15601718425750732
skin O 1 0.9999966621398926
and O 1 0.5951058864593506
gastrointestinal O 1 0.9999980926513672
tract O 1 0.9999171495437622
) O 0 0.0017308834940195084
. O 0 0.0010880548506975174

However O 0 0.0010200788965448737
, O 0 0.00013056807802058756
these O 0 2.9259368602652103e-05
observations O 0 0.00044093525502830744
would O 0 0.0001799409801606089
need O 0 0.0002985661558341235
to O 0 4.6206860133679584e-05
be O 0 7.299230492208153e-05
confirmed O 0 0.00029174587689340115
by O 0 2.9461076337611303e-05
studying O 0 0.00017112142813857645
a O 0 9.047809726325795e-05
larger O 0 6.4411862695124e-05
number O 0 9.977069566957653e-06
of O 0 2.513822073524352e-05
CD B-Disease 0 0.003179621184244752
families O 0 0.000557093124371022
. O 0 0.0006444805185310543

Molecular O 0 0.054948996752500534
defects O 1 0.9957823753356934
leading O 0 0.0007118121720850468
to O 0 9.762813715497032e-05
human O 0 0.0006381101557053626
complement B-Disease 0 0.005851397290825844
component I-Disease 1 0.9031851887702942
C6 I-Disease 1 0.9999667406082153
deficiency I-Disease 1 0.9999903440475464
in O 0 0.0002656597935128957
an O 0 0.0003191360447090119
African O 0 0.0025096030440181494
- O 0 0.00907223578542471
American O 0 0.0005716375890187919
family O 0 0.001657931599766016
. O 0 0.0009500812739133835

Complement B-Disease 0 0.017411064356565475
component I-Disease 1 0.7242876887321472
C6 I-Disease 1 0.9998939037322998
deficiency I-Disease 1 0.9999877214431763
( O 0 0.006308502983301878
C6D B-Disease 1 0.9969710111618042
) O 0 0.0009465424809604883
was O 0 0.007876487448811531
diagnosed O 1 0.9998962879180908
in O 0 9.554965799907222e-05
a O 0 0.0003670556761790067
16 O 0 0.0004573628248181194
- O 0 0.0014604901662096381
year O 0 0.0004794587439391762
- O 0 0.001732318545691669
old O 0 0.0007733749807812274
African O 0 0.0008217925787903368
- O 0 0.002150143962353468
American O 0 0.00045345703256316483
male O 0 0.0017522239359095693
with O 0 0.005478380713611841
meningococcal B-Disease 1 0.9999779462814331
meningitis I-Disease 1 0.9999806880950928
. O 0 0.002645560074597597

The O 0 0.00800537969917059
patients O 1 0.9996058344841003
father O 0 0.002219704445451498
and O 0 0.0001308153005084023
two O 0 0.00012346213043201715
brothers O 0 0.0016592020401731133
also O 0 0.0002442505210638046
had O 0 0.0010219226824119687
C6D B-Disease 1 0.9821131825447083
, O 0 0.00010821597243193537
but O 0 7.758921128697693e-05
gave O 0 0.00018540614109952003
no O 0 7.054192974464968e-05
history O 0 0.00015156882000155747
of O 0 0.00016975209291558713
meningitis B-Disease 1 0.999994158744812
or O 0 0.0005889586755074561
other O 0 0.0004264705930836499
neisserial B-Disease 1 0.9987174272537231
infection I-Disease 1 0.9998176693916321
. O 0 0.001456753583624959

By O 0 0.00021716849005315453
using O 0 0.0003276530478615314
exon O 0 0.007161388639360666
- O 0 0.001016707974486053
specific O 0 0.00014569188351742923
polymerase O 0 0.0019874072168022394
chain O 0 0.00218638451769948
reaction O 0 0.0015335037605836987
( O 0 0.0007206738810054958
PCR O 0 0.005549211986362934
) O 0 0.00047795637510716915
/ O 0 0.003860762109979987
single O 0 0.00023992829665075988
- O 0 0.0017434865003451705
strand O 0 0.0013718289555981755
conformation O 0 0.0017690842505544424
polymorphism O 0 0.0009690509177744389
as O 0 0.0001356200809823349
a O 0 0.00043111847480759025
screening O 0 0.001728783012367785
step O 0 0.00035368360113352537
and O 0 2.7529151338967495e-05
nucleotide O 0 5.3920251957606524e-05
sequencing O 0 0.0001003322031465359
of O 0 1.6719845007173717e-05
target O 0 0.0004080071812495589
exons O 0 0.0018007768085226417
, O 0 0.00012261574738658965
we O 0 0.00012713442265521735
determined O 0 0.00033739625359885395
that O 0 4.209431426716037e-05
the O 0 0.00012934757978655398
proband O 0 0.04069335758686066
was O 0 0.00031171165755949914
a O 0 0.0003896192356478423
compound O 0 0.0023993318900465965
heterozygote O 0 0.008618724532425404
for O 0 0.00013727294572163373
two O 0 0.00038885045796632767
C6 O 1 0.9981561303138733
gene O 0 0.004941726569086313
mutations O 0 0.003501542843878269
. O 0 0.0007219090475700796

The O 0 0.0005763162043876946
first O 0 0.0003623761294875294
, O 0 0.0003469230141490698
1195delC O 0 0.009701134636998177
located O 0 0.0004482559743337333
in O 0 0.00010943342203972861
exon O 0 0.004215652123093605
7 O 0 0.00037301337579265237
, O 0 0.00010564413241809234
is O 0 9.705468255560845e-05
a O 0 0.0002896520309150219
novel O 0 0.0009276253404095769
mutation O 0 0.0007797047728672624
, O 0 6.01828214712441e-05
while O 0 6.382866558851674e-05
the O 0 5.47170166100841e-05
second O 0 0.0001862372737377882
, O 0 0.00015937289572320879
1936delG O 0 0.005763956345617771
in O 0 0.00014264945639297366
exon O 0 0.003617721376940608
12 O 0 0.0003582016215659678
, O 0 0.00012019767018500715
has O 0 0.00019757289555855095
been O 0 0.0001216367309098132
described O 0 0.0005815924960188568
before O 0 0.00019730070198420435
to O 0 0.00015487794007640332
cause O 0 0.17907659709453583
C6D B-Disease 1 0.8976011872291565
in O 0 0.00013733447121921927
an O 0 0.00032058850047178566
unrelated O 0 0.008834068663418293
African O 0 0.001738368533551693
- O 0 0.003852562280371785
American O 0 0.00030927106854505837
individual O 0 0.0007674255175516009
. O 0 0.0011016043135896325

Both O 0 0.0008840914233587682
mutations O 0 0.0024565435014665127
result O 0 0.0006570816040039062
in O 0 0.0005824729450978339
premature O 1 0.9931840300559998
termination O 1 0.7982836961746216
codons O 0 0.008125819265842438
and O 0 0.0009403666481375694
C6 O 1 0.9960935711860657
null O 0 0.016942616552114487
alleles O 0 0.00902603194117546
. O 0 0.001335979555733502

Allele O 0 0.022421905770897865
- O 0 0.004683622624725103
specific O 0 0.0005357677582651377
PCR O 0 0.0071518030017614365
indicated O 0 0.0014420272782444954
that O 0 6.593088619410992e-05
the O 0 0.0002208742662332952
probands O 0 0.028576286509633064
two O 0 0.00016120144573505968
brothers O 0 0.0017405975377187133
also O 0 0.0005306372186169028
inherited O 1 0.9009912610054016
the O 0 0.00035809935070574284
1195delC O 0 0.14227671921253204
mutation O 0 0.0009724513511173427
from O 0 6.127291999291629e-05
their O 0 0.00010815553105203435
heterozygous O 0 0.003705796552821994
mother O 0 0.0022750727366656065
and O 0 0.00013167796714697033
the O 0 0.0003198066842742264
1936delG O 0 0.22239065170288086
mutation O 0 0.0011622305028140545
from O 0 7.730944344075397e-05
their O 0 0.00015312051982618868
homozygous O 0 0.006094978656619787
father O 0 0.002637126250192523
. O 0 0.00035027842386625707
. O 0 0.0007036571623757482

PAX6 O 1 0.9816008806228638
mutations O 0 0.020983567461371422
reviewed O 0 0.010201395489275455
. O 0 0.0012906877091154456

Mutations O 0 0.01318507082760334
in O 0 0.0012198492186143994
PAX6 O 1 0.9977412223815918
are O 0 9.711372695164755e-05
responsible O 0 0.0013679279945790768
for O 0 0.00025653469492681324
human O 0 0.005388348363339901
aniridia B-Disease 1 0.9981173276901245
and O 0 0.00013043118815403432
have O 0 7.792651740601286e-05
also O 0 6.472859968198463e-05
been O 0 0.00010402438056189567
found O 0 0.00011971005005761981
in O 0 0.00028044270584359765
patients O 1 0.9999181032180786
with O 0 0.0010218389797955751
Peters B-Disease 1 0.9997877478599548
anomaly I-Disease 1 0.9987800717353821
, O 0 0.0012540377210825682
with O 0 0.45694980025291443
congenital B-Disease 1 0.9999997615814209
cataracts I-Disease 1 0.9999990463256836
, O 0 0.0007907241815701127
with O 0 0.000988586456514895
autosomal B-Disease 1 0.9991542100906372
dominant I-Disease 1 0.983391284942627
keratitis I-Disease 1 0.9999383687973022
, O 0 0.0004757351998705417
and O 0 0.0002368553396081552
with O 0 0.0006688148132525384
isolated B-Disease 1 0.9309321045875549
foveal I-Disease 1 0.9979022741317749
hypoplasia I-Disease 1 0.9994889497756958
. O 0 0.0030356324277818203

No O 0 0.0011236330028623343
locus O 0 0.0035326231736689806
other O 0 5.908496314077638e-05
than O 0 0.00025704342988319695
chromosome O 0 0.002918490208685398
11p13 O 0 0.016649451106786728
has O 0 0.0005581851000897586
been O 0 0.00048370863078162074
implicated O 0 0.32408377528190613
in O 0 0.000448841747129336
aniridia B-Disease 1 0.998310923576355
, O 0 0.00032774798455648124
and O 0 0.0005740809720009565
PAX6 O 1 0.9983325600624084
is O 0 0.0003559121396392584
clearly O 0 0.0004972374299541116
the O 0 9.069915540749207e-05
major O 0 0.0005807467387057841
, O 0 0.00011838676437037066
if O 0 0.00013575876073446125
not O 0 3.27557027048897e-05
only O 0 4.1407438402529806e-05
, O 0 0.00015947474457789212
gene O 0 0.0013921194477006793
responsible O 0 0.0026034677866846323
. O 0 0.0007592450128868222

Twenty O 0 0.003395581152290106
- O 0 0.0016752826049923897
eight O 0 0.00012231062282808125
percent O 0 0.0001646787131903693
of O 0 5.226413122727536e-05
identified O 0 0.002703001955524087
PAX6 O 1 0.9968683123588562
mutations O 0 0.0018106418428942561
are O 0 0.00015892524970695376
C O 1 0.6142675876617432
- O 0 0.21988224983215332
T O 1 0.9604899287223816
changes O 0 0.0003395121020730585
at O 0 0.0005412955651991069
CpG O 0 0.013111494481563568
dinucleotides O 0 0.03303452581167221
, O 0 0.00011428965080995113
20 O 0 8.198371506296098e-05
% O 0 1.6660538676660508e-05
are O 0 1.701897053862922e-05
splicing O 0 0.0006140872137621045
errors O 0 0.0009985303040593863
, O 0 0.00010094340541400015
and O 0 4.176675065536983e-05
more O 0 3.946967626689002e-05
than O 0 5.133787635713816e-05
30 O 0 0.00011870474554598331
% O 0 1.6543299352633767e-05
are O 0 2.57054234680254e-05
deletion O 0 0.0019054970471188426
or O 0 0.00026858036289922893
insertion O 0 0.006038445979356766
events O 0 0.0006862260634079576
. O 0 0.0012035868130624294

There O 0 0.0006153261056169868
is O 0 0.0004377840377856046
a O 0 0.0011549757327884436
noticeably O 0 0.18426068127155304
elevated O 0 0.19802120327949524
level O 0 0.00039352383464574814
of O 0 3.402864604140632e-05
mutation O 0 0.000861991080455482
in O 0 7.990507583599538e-05
the O 0 0.00013123061216901988
paired O 0 0.001153572229668498
domain O 0 0.00020432505698408931
compared O 0 0.00024636153830215335
with O 0 4.6286466385936365e-05
the O 0 8.564392192056403e-05
rest O 0 0.00023160337877925485
of O 0 2.3708020307822153e-05
the O 0 0.00029327356605790555
gene O 0 0.002779571106657386
. O 0 0.0006017911946401

Increased O 0 0.0026928537990897894
mutation O 0 0.0017782762879505754
in O 0 0.00011682439071591944
the O 0 0.0002985479077324271
homeodomain O 0 0.036030832678079605
is O 0 0.00018148279923480004
accounted O 0 0.0003211584116797894
for O 0 6.960336759220809e-05
by O 0 6.660528015345335e-05
the O 0 0.00034927987144328654
hypermutable O 0 0.2741721570491791
CpG O 0 0.018905682489275932
dinucleotide O 0 0.020105596631765366
in O 0 0.00044608820462599397
codon O 0 0.005534989293664694
240 O 0 0.006910654716193676
. O 0 0.0013819639571011066

Very O 0 0.0017836007755249739
nearly O 0 0.000988894491456449
all O 0 0.00013344023318495601
mutations O 0 0.001868430059403181
appear O 0 0.000587447255384177
to O 0 0.00017370306886732578
cause O 0 0.09445305913686752
loss O 0 0.0011926445877179503
of O 0 1.1502294910314959e-05
function O 0 0.00012417620746418834
of O 0 1.8139398889616132e-05
the O 0 0.00026822005747817457
mutant O 0 0.004420998506247997
allele O 0 0.002008778741583228
, O 0 9.957238216884434e-05
and O 0 3.720387758221477e-05
more O 0 4.773860928253271e-05
than O 0 5.7711717090569437e-05
80 O 0 0.00017447445134166628
% O 0 1.830340079322923e-05
of O 0 2.46946783590829e-05
exonic O 0 0.10889334976673126
substitutions O 0 0.0005754022276960313
result O 0 0.0003880125004798174
in O 0 0.00022573572641704232
nonsense O 0 0.021565306931734085
codons O 0 0.007418257184326649
. O 0 0.0009418506524525583

In O 0 0.000564341142307967
a O 0 0.0007399134337902069
gene O 0 0.0007624003337696195
with O 0 5.895708818570711e-05
such O 0 9.015925752464682e-05
extraordinarily O 1 0.937646746635437
high O 0 0.0014726436929777265
sequence O 0 0.00014907793956808746
conservation O 0 0.0020222351886332035
throughout O 0 0.0001998003717744723
evolution O 0 0.0004120448138564825
, O 0 0.00010511595610296354
there O 0 7.434500730596483e-05
are O 0 7.387603545794263e-05
presumed O 0 0.0037336761597543955
undiscovered O 0 0.0513421855866909
missense O 0 0.019636904820799828
mutations O 0 0.0018448829650878906
, O 0 8.242615876952186e-05
these O 0 2.83886183751747e-05
are O 0 3.3832333429018036e-05
hypothesized O 0 0.002153618959710002
to O 0 4.546970740193501e-05
exist O 0 6.144665530882776e-05
in O 0 6.196386675583199e-05
as O 0 0.00023711177345830947
- O 0 0.005671421531587839
yet O 0 0.0009725587442517281
unidentified O 0 0.009339054115116596
phenotypes O 0 0.015940643846988678
. O 0 0.0003818957775365561
. O 0 0.0008324621012434363

Genetic O 0 0.011247243732213974
heterogeneity O 0 0.01489032432436943
and O 0 0.0005935584777034819
penetrance O 0 0.13693617284297943
analysis O 0 0.00017041816317941993
of O 0 3.1661231332691386e-05
the O 0 0.0006695556221529841
BRCA1 O 1 0.9980984330177307
and O 0 0.000894442608114332
BRCA2 O 1 0.9941567182540894
genes O 0 0.0018288028659299016
in O 0 0.01041661761701107
breast B-Disease 1 0.9999985694885254
cancer I-Disease 1 0.9999943971633911
families O 0 0.0023582715075463057
. O 0 0.0011404699180275202

The O 1 0.6311240196228027
Breast B-Disease 1 0.9999972581863403
Cancer I-Disease 1 0.9999959468841553
Linkage O 1 0.9671832919120789
Consortium O 0 0.02513258159160614
. O 0 0.0014938055537641048

The O 0 0.00034422005410306156
contribution O 0 0.0011335128219798207
of O 0 0.00023910299933049828
BRCA1 O 1 0.9980499744415283
and O 0 0.0015721358358860016
BRCA2 O 1 0.9991028308868408
to O 0 0.018820559605956078
inherited B-Disease 1 0.9999963045120239
breast I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999996423721313
was O 0 0.007211473770439625
assessed O 0 0.01390837412327528
by O 0 0.00010951317381113768
linkage O 0 0.006425938103348017
and O 0 0.00015762689872644842
mutation O 0 0.000874136108905077
analysis O 0 0.00017387823027092963
in O 0 0.00017176993424072862
237 O 0 0.010261597111821175
families O 0 0.00019196172070223838
, O 0 4.0503702621208504e-05
each O 0 1.3470955309458077e-05
with O 0 2.9040149456704967e-05
at O 0 0.00011634990369202569
least O 0 7.837492739781737e-05
four O 0 7.933123561087996e-05
cases O 0 0.0007556817145086825
of O 0 0.00041940450319088995
breast B-Disease 1 0.9999994039535522
cancer I-Disease 1 0.9999943971633911
, O 0 8.330588025273755e-05
collected O 0 8.574982348363847e-05
by O 0 0.0001611974585102871
the O 0 0.1614225208759308
Breast B-Disease 1 0.9999996423721313
Cancer I-Disease 1 0.9999972581863403
Linkage O 1 0.9321459531784058
Consortium O 0 0.030593927949666977
. O 0 0.0012473156675696373

Families O 0 0.0016314851818606257
were O 0 0.00010379094601375982
included O 0 9.935488924384117e-05
without O 0 0.00011599386198213324
regard O 0 0.00023799308110028505
to O 0 4.109359724679962e-05
the O 0 8.88048525666818e-05
occurrence O 0 0.002884197747334838
of O 0 0.0002573663950897753
ovarian B-Disease 1 0.9999809265136719
or I-Disease 0 0.0013230261392891407
other I-Disease 0 0.0007492271834053099
cancers I-Disease 1 0.9997630715370178
. O 0 0.0014582588337361813

Overall O 0 0.042409442365169525
, O 0 0.01063504721969366
disease O 1 0.9999674558639526
was O 0 0.0041369847021996975
linked O 0 0.008875108323991299
to O 0 0.00037601706571877003
BRCA1 O 1 0.9857763648033142
in O 0 6.716720235999674e-05
an O 0 0.00011881345562869683
estimated O 0 0.00037913958658464253
52 O 0 0.0003951655235141516
% O 0 1.5295023331418633e-05
of O 0 1.712178891466465e-05
families O 0 0.00023734613205306232
, O 0 0.00021559183369390666
to O 0 0.0003805741434916854
BRCA2 O 1 0.9879322648048401
in O 0 9.983610652852803e-05
32 O 0 0.0002226427459390834
% O 0 2.8448619559640065e-05
of O 0 2.971949834318366e-05
families O 0 0.00027041780413128436
, O 0 0.0001021867647068575
and O 0 7.196861406555399e-05
to O 0 0.00010054645099444315
neither O 0 0.0007755850092507899
gene O 0 0.00036402602563612163
in O 0 5.961703573120758e-05
16 O 0 0.00018019817071035504
% O 0 3.318633753224276e-05
( O 0 0.0001374783314531669
95 O 0 0.0003762391861528158
% O 0 4.27866616519168e-05
confidence O 0 0.0016517712501809
interval O 0 0.0030993004329502583
[ O 0 0.012433605268597603
CI O 1 0.9918053150177002
] O 0 0.003909669350832701
6 O 0 0.0003605666570365429
% O 0 7.243563595693558e-05
- O 0 0.0011532414937391877
28 O 0 0.00029672952950932086
% O 0 3.545037907315418e-05
) O 0 0.00011194947001058608
, O 0 0.0001441601780243218
suggesting O 0 0.001563228783197701
other O 0 0.0001767336652847007
predisposition O 1 0.9509566426277161
genes O 0 0.0012286811834201217
. O 0 0.0008068313472904265

The O 0 0.0005447976291179657
majority O 0 0.0006673700991086662
( O 0 0.00044479971984401345
81 O 0 0.0008582886075600982
% O 0 3.301782635389827e-05
) O 0 4.981148595106788e-05
of O 0 2.9395907404250465e-05
the O 0 0.00982092134654522
breast B-Disease 1 0.999998927116394
- I-Disease 1 0.9999494552612305
ovarian I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999978542327881
families O 0 0.0005804204847663641
were O 0 7.525968976551667e-05
due O 0 0.0010445818770676851
to O 0 0.0003836418327409774
BRCA1 O 1 0.9986107349395752
, O 0 8.412926399614662e-05
with O 0 5.291593697620556e-05
most O 0 0.00010810294770635664
others O 0 0.00022795569384470582
( O 0 0.00021361363178584725
14 O 0 0.0001843106874730438
% O 0 4.162967888987623e-05
) O 0 0.00014851268497295678
due O 0 0.0008555639069527388
to O 0 0.0006247346173040569
BRCA2 O 1 0.996820330619812
. O 0 0.0010182609548792243

Conversely O 0 0.01337403617799282
, O 0 0.0001990978780668229
the O 0 7.327859930228442e-05
majority O 0 7.245222514029592e-05
of O 0 1.6668165699229576e-05
families O 0 0.0001471710711484775
with O 0 0.000108054700831417
male B-Disease 0 0.0011513063218444586
and I-Disease 0 0.0007515883771702647
female I-Disease 1 0.990135133266449
breast I-Disease 1 0.9999992847442627
cancer I-Disease 1 0.9999953508377075
were O 0 9.813271753955632e-05
due O 0 0.0019092379370704293
to O 0 0.0006555282161571085
BRCA2 O 1 0.997114896774292
( O 0 0.0007717851549386978
76 O 0 0.00257839891128242
% O 0 0.00011497107334434986
) O 0 0.0003681006492115557
. O 0 0.0005510752089321613

The O 0 0.0005815831245854497
largest O 0 0.0011492375051602721
proportion O 0 0.0009464906179346144
( O 0 0.0004998993827030063
67 O 0 0.001082681235857308
% O 0 4.400592661113478e-05
) O 0 5.8378824178362265e-05
of O 0 1.6768881323514506e-05
families O 0 0.0002589009527582675
due O 0 0.00035489280708134174
to O 0 5.743566362070851e-05
other O 0 3.661173832369968e-05
genes O 0 0.00028778708656318486
was O 0 0.0003305785357952118
found O 0 0.00011681157775456086
in O 0 5.1243034249637276e-05
families O 0 7.040295167826116e-05
with O 0 2.9812323191436008e-05
four O 0 4.264596282155253e-05
or O 0 5.660092938342132e-05
five O 0 6.928291986696422e-05
cases O 0 0.00037181994412094355
of O 0 0.00010136434866581112
female O 1 0.9933673739433289
breast B-Disease 1 0.9999988079071045
cancer I-Disease 1 0.9999867677688599
only O 0 0.00036133918911218643
. O 0 0.0008170891087502241

These O 0 0.0002489603648427874
estimates O 0 0.0006881337612867355
were O 0 6.400083657354116e-05
not O 0 0.0001929138379637152
substantially O 0 0.007686293683946133
affected O 0 0.0013491669669747353
either O 0 0.00010497682524146512
by O 0 4.5909506297903135e-05
changing O 0 0.0006295749335549772
the O 0 0.0003693632606882602
assumed O 0 0.007107947953045368
penetrance O 0 0.448326975107193
model O 0 0.001264767604880035
for O 0 0.000636392564047128
BRCA1 O 1 0.9969301819801331
or O 0 0.00018291847663931549
by O 0 4.942773375660181e-05
including O 0 7.654660294065252e-05
or O 0 0.00032734390697441995
excluding O 0 0.0030397854279726744
BRCA1 O 1 0.9958209991455078
mutation O 0 0.0020796628668904305
data O 0 0.00038792521809227765
. O 0 0.000678522395901382

Among O 0 0.0004999539814889431
those O 0 0.00017299267346970737
families O 0 0.0006149655673652887
with O 0 0.0020549772307276726
disease O 1 0.9999872446060181
due O 0 0.005540046375244856
to O 0 0.0004899215418845415
BRCA1 O 1 0.9986502528190613
that O 0 6.522385956486687e-05
were O 0 3.793987343669869e-05
tested O 0 0.0013679020339623094
by O 0 1.2514279660535976e-05
one O 0 1.4761262718820944e-05
of O 0 7.434583494614344e-06
the O 0 0.00010191951878368855
standard O 0 0.0008116438984870911
screening O 0 0.0019098315387964249
methods O 0 0.00035656997351907194
, O 0 0.00025297998217865825
mutations O 0 0.0007662956486456096
were O 0 5.069912731414661e-05
detected O 0 0.0011650703381747007
in O 0 3.5431723517831415e-05
the O 0 7.887998799560592e-05
coding O 0 0.0012891085352748632
sequence O 0 9.170966950478032e-05
or O 0 0.0001322398311458528
splice O 0 0.002050532726570964
sites O 0 7.578129589091986e-05
in O 0 3.7125231756363064e-05
an O 0 0.0001033338121487759
estimated O 0 0.0004531411686912179
63 O 0 0.0008831231971271336
% O 0 6.502841279143468e-05
( O 0 0.00026352007989771664
95 O 0 0.0007388452650047839
% O 0 0.00017396328621543944
CI O 1 0.9881904125213623
51 O 0 0.0012694110628217459
% O 0 0.00010345321061322466
- O 0 0.0020977857057005167
77 O 0 0.0014432980678975582
% O 0 9.204531670548022e-05
) O 0 0.0003050527011509985
. O 0 0.00047432203427888453

The O 0 0.000760384020395577
estimated O 0 0.0014521026751026511
sensitivity O 0 0.005333189386874437
was O 0 0.0004982116515748203
identical O 0 0.00021449899941217154
for O 0 4.975603587809019e-05
direct O 0 0.00012980685278307647
sequencing O 0 0.0003352491185069084
and O 0 5.7944100262830034e-05
other O 0 4.548375363810919e-05
techniques O 0 0.00140331347938627
. O 0 0.0006688788416795433

The O 0 0.0020735354628413916
penetrance O 0 0.25116783380508423
of O 0 0.0004985439591109753
BRCA2 O 1 0.9968819618225098
was O 0 0.0006601953646168113
estimated O 0 0.00027850133483298123
by O 0 5.436350329546258e-05
maximizing O 0 0.0031996730249375105
the O 0 0.00029075733618810773
LOD O 1 0.5272889137268066
score O 0 0.0002619352308101952
in O 0 0.0005923736607655883
BRCA2 O 1 0.9973478317260742
- O 0 0.01692304201424122
mutation O 0 0.0015054624527692795
families O 0 0.00020575104281306267
, O 0 5.723511640098877e-05
over O 0 6.950321403564885e-05
all O 0 4.385025749797933e-05
possible O 0 0.0007533617899753153
penetrance O 0 0.23439203202724457
functions O 0 0.0009045699844136834
. O 0 0.0009358528768643737

The O 0 0.0006541757611557841
estimated O 0 0.0010450596455484629
cumulative O 0 0.005274749360978603
risk O 0 0.4710491895675659
of O 0 0.0006633791490457952
breast B-Disease 1 0.9999957084655762
cancer I-Disease 1 0.999967098236084
reached O 0 0.0010045465314760804
28 O 0 0.0006497598369605839
% O 0 6.972686242079362e-05
( O 0 0.0003246007254347205
95 O 0 0.0010274951346218586
% O 0 0.00023616349790245295
CI O 1 0.9914069175720215
9 O 0 0.0007207078160718083
% O 0 8.520987466908991e-05
- O 0 0.0010956533951684833
44 O 0 0.0001782660256139934
% O 0 3.475289486232214e-05
) O 0 6.910495721967891e-05
by O 0 4.885144517174922e-05
age O 0 0.0002792114391922951
50 O 0 0.00023605881142430007
years O 0 0.00024940987350419164
and O 0 0.00012145024084020406
84 O 0 0.0012648471165448427
% O 0 7.014803122729063e-05
( O 0 0.00032692847889848053
95 O 0 0.0010781268356367946
% O 0 0.00020814132585655898
CI O 1 0.9826801419258118
43 O 0 0.0007558974321000278
% O 0 7.905228267190978e-05
- O 0 0.0009318174561485648
95 O 0 0.00030540773877874017
% O 0 2.971252797578927e-05
) O 0 6.309012678684667e-05
by O 0 5.941476410953328e-05
age O 0 0.00037821164005436003
70 O 0 0.000742111646104604
years O 0 0.0008402741514146328
. O 0 0.0006658906931988895

The O 0 0.00327100302092731
corresponding O 1 0.7936811447143555
ovarian B-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999984502792358
risks O 1 0.8869094848632812
were O 0 0.00015896008699201047
0 O 0 0.0010871232952922583
. O 0 0.0006300354143604636

4 O 0 0.0012574358843266964
% O 0 0.0001742531603667885
( O 0 0.00044301609159447253
95 O 0 0.0009701446979306638
% O 0 0.00016731544747017324
CI O 1 0.9361882209777832
0 O 0 0.00041650421917438507
% O 0 5.9273905208101496e-05
- O 0 0.0006915810517966747
1 O 0 0.00011877844372065738
% O 0 1.9995684851892292e-05
) O 0 4.6164313971530646e-05
by O 0 3.778497193707153e-05
age O 0 0.00018208511755801737
50 O 0 0.0001493850431870669
years O 0 0.00015818985411897302
and O 0 6.811032653786242e-05
27 O 0 0.0004317886778153479
% O 0 4.432243076735176e-05
( O 0 0.00024097553978208452
95 O 0 0.0008010719902813435
% O 0 0.00021646519599016756
CI O 1 0.9721280932426453
0 O 0 0.0004115203337278217
% O 0 7.531144365202636e-05
- O 0 0.0010604655835777521
47 O 0 0.0003977183368988335
% O 0 3.9482176362071186e-05
) O 0 7.281183206941932e-05
by O 0 5.919335308135487e-05
age O 0 0.0004092337912879884
70 O 0 0.0006608985713683069
years O 0 0.000727154896594584
. O 0 0.000656394986435771

The O 0 0.001437139930203557
lifetime O 1 0.6913081407546997
risk O 1 0.9484320282936096
of O 0 0.00226420140825212
breast B-Disease 1 0.9999992847442627
cancer I-Disease 1 0.999996542930603
appears O 0 0.005366693250834942
similar O 0 0.00016820966266095638
to O 0 6.852720980532467e-05
the O 0 0.00020313759159762412
risk O 1 0.7191945314407349
in O 0 0.0006279952940531075
BRCA1 O 1 0.9996852874755859
carriers O 0 0.058290764689445496
, O 0 0.0001434957084711641
but O 0 7.971456943778321e-05
there O 0 4.0020539017859846e-05
was O 0 0.00012734116171486676
some O 0 2.8120355636929162e-05
suggestion O 0 0.0006345077999867499
of O 0 2.358145320613403e-05
a O 0 0.0008061957778409123
lower O 0 0.0581037700176239
risk O 1 0.5682474970817566
in O 0 0.0007990546873770654
BRCA2 O 1 0.9984676241874695
carriers O 0 0.012896958738565445
< O 0 0.009201125241816044
50 O 0 0.00024591872352175415
years O 0 0.0001609056635061279
of O 0 4.6382836444536224e-05
age O 0 0.0016199396923184395
. O 0 0.0008394426549784839

Eye B-Disease 1 0.9974199533462524
movement I-Disease 0 0.011944306083023548
abnormalities I-Disease 1 0.9914496541023254
correlate O 0 0.0068114083260297775
with O 0 0.00048419114318676293
genotype O 0 0.23125608265399933
in O 0 0.0007933665183372796
autosomal O 1 0.9952496290206909
dominant O 1 0.9523536562919617
cerebellar B-Disease 1 0.9999067783355713
ataxia I-Disease 1 0.9999580383300781
type I-Disease 1 0.9981440305709839
I I-Disease 1 0.9734771251678467
. O 0 0.0008482702542096376

We O 0 0.001364073483273387
compared O 0 0.0020609137136489153
horizontal O 0 0.013250823132693768
eye O 1 0.9919909834861755
movements O 0 0.001604303251951933
( O 0 0.0015372860943898559
visually O 0 0.16203828155994415
guided O 0 0.02045447565615177
saccades O 1 0.9889773726463318
, O 0 0.0010037858737632632
antisaccades O 0 0.07595855742692947
, O 0 0.0001814579009078443
and O 0 0.00013721117284148932
smooth O 0 0.006318880710750818
pursuit O 0 0.0039877151139080524
) O 0 9.967412916012108e-05
in O 0 7.869727414799854e-05
control O 0 0.0007219339022412896
subjects O 0 0.000881813233718276
( O 0 0.0004601668333634734
n O 0 0.0014075461076572537
= O 0 0.0014545785961672664
14 O 0 0.00043905494385398924
) O 0 0.00019346832414157689
and O 0 0.00021583041234407574
patients O 1 0.9983723759651184
with O 0 3.0529907235177234e-05
three O 0 3.589356492739171e-05
forms O 0 0.00012646794493775815
of O 0 8.657572470838204e-05
autosomal O 1 0.997389018535614
dominant O 1 0.7572123408317566
cerebellar B-Disease 1 0.9999172687530518
ataxias I-Disease 1 0.9973248243331909
type I-Disease 1 0.9696623086929321
I I-Disease 1 0.9787142872810364
spinocerebellar B-Disease 1 0.9992617964744568
ataxias I-Disease 0 0.24048976600170135
1 I-Disease 0 0.00040272410842590034
and I-Disease 0 0.00010327629570383579
2 I-Disease 0 0.0004911762080155313
( O 0 0.0005680664326064289
SCA1 B-Disease 0 0.3893963098526001
, O 0 0.00017525696603115648
n O 0 0.001426428323611617
= O 0 0.0018201398197561502
11 O 0 0.00048452685587108135
; O 0 0.00023428990971297026
SCA2 B-Disease 0 0.2062825709581375
, O 0 0.00019239768153056502
n O 0 0.0009375630179420114
= O 0 0.001018711132928729
10 O 0 0.00016825889179017395
) O 0 0.0001371774123981595
and O 0 0.0003457611019257456
SCA3 B-Disease 1 0.9991029500961304
/ O 1 0.6911319494247437
Machado B-Disease 1 0.8148946762084961
- I-Disease 0 0.31416624784469604
Joseph I-Disease 0 0.4149496555328369
disease I-Disease 1 0.999852180480957
( O 0 0.00213065929710865
MJD B-Disease 1 0.9977263808250427
) O 0 0.0004500657960306853
( O 0 0.00044062684173695743
n O 0 0.001729000243358314
= O 0 0.0019190107705071568
16 O 0 0.0004741638549603522
) O 0 0.00023414137831423432
. O 0 0.0004552423197310418

In O 0 0.001773090218193829
SCA1 B-Disease 1 0.8676922917366028
, O 0 0.0005969338235445321
saccade O 0 0.030561290681362152
amplitude O 0 0.001166212954558432
was O 0 0.0009684731485322118
significantly O 0 0.002238335320726037
increased O 0 0.00039249236579053104
, O 0 0.0001156247963081114
resulting O 0 0.0009523019543848932
in O 0 0.00034234250779263675
hypermetria B-Disease 1 0.9705571532249451
. O 0 0.0009118692250922322

The O 0 0.0009179058251902461
smooth O 0 0.013212715275585651
pursuit O 0 0.011298679746687412
gain O 0 0.0021937901619821787
was O 0 0.0021644155494868755
decreased O 0 0.05147677659988403
. O 0 0.001000950112938881

In O 0 0.0019167172722518444
SCA2 B-Disease 1 0.6448046565055847
, O 0 0.0005882405675947666
saccade O 0 0.05035007372498512
velocity O 0 0.003346855053678155
was O 0 0.00201925216242671
markedly O 0 0.2718796133995056
decreased O 0 0.021304814144968987
. O 0 0.0009205025853589177

The O 0 0.0002458455855958164
percentage O 0 0.0002206991339335218
of O 0 3.359467882546596e-05
errors O 0 0.0020497855730354786
in O 0 0.00035430846037343144
antisaccades O 1 0.9449740052223206
was O 0 0.0008325763046741486
greatly O 0 0.0032913396134972572
increased O 0 0.00028677479713223875
and O 0 0.00010006619413616136
was O 0 0.0004586507275234908
significantly O 0 0.002048073336482048
correlated O 0 0.0013961871154606342
with O 0 0.00018914611428044736
age O 0 0.006292245350778103
at O 0 0.200613871216774
disease O 1 0.9999899864196777
onset O 1 0.9994580149650574
. O 0 0.002233208389952779

In O 0 0.000591139541938901
addition O 0 0.00041414491715840995
, O 0 0.00013433763524517417
a O 0 0.0002848159638233483
correlation O 0 0.0006440397119149566
between O 0 0.00023297453299164772
smooth O 0 0.01018650084733963
pursuit O 0 0.005673303734511137
gain O 0 0.0004970855661667883
and O 0 3.422335794311948e-05
the O 0 3.8017085898900405e-05
number O 0 2.4732386009418406e-05
of O 0 8.970849739853293e-05
trinucleotide O 1 0.9891562461853027
repeats O 0 0.005073069129139185
was O 0 0.00115007977001369
found O 0 0.0007334509282372892
. O 0 0.0006832671933807433

In O 0 0.0044732848182320595
SCA3 B-Disease 1 0.9953016042709351
, O 0 0.0017992790089920163
gaze B-Disease 1 0.6364362835884094
- I-Disease 0 0.04195541515946388
evoked I-Disease 0 0.24034206569194794
nystagmus I-Disease 1 0.9981521964073181
was O 0 0.0008736422751098871
often O 0 0.0002085254673147574
present O 0 0.0001423664070898667
as O 0 0.0002039968385361135
was O 0 0.0011705528013408184
saccade O 1 0.6894590854644775
hypometria O 0 0.045862890779972076
and O 0 0.00026236087433062494
smooth O 0 0.010663884691894054
pursuit O 0 0.007905119098722935
gain O 0 0.0019250737968832254
was O 0 0.0024796496145427227
markedly O 1 0.8171896934509277
decreased O 0 0.05069294571876526
. O 0 0.0010888029355555773

Three O 0 0.0006783613935112953
major O 0 0.0016524663660675287
criteria O 0 0.0015607867389917374
, O 0 0.00033361034002155066
saccade O 0 0.036346957087516785
amplitude O 0 0.0014318423345685005
, O 0 0.000524998817127198
saccade O 0 0.05216560140252113
velocity O 0 0.0015908773057162762
, O 0 0.00013226161536294967
and O 0 6.91209061187692e-05
presence O 0 0.0002519019471947104
of O 0 0.00010545510303927585
gaze B-Disease 1 0.9016291499137878
- I-Disease 0 0.05679600313305855
evoked I-Disease 0 0.09349456429481506
nystagmus I-Disease 1 0.9920468330383301
, O 0 0.00024626104277558625
permitted O 0 0.0002104784653056413
the O 0 0.0001400750916218385
correct O 0 0.0024029111955314875
assignment O 0 0.0019385425839573145
of O 0 2.158584538847208e-05
90 O 0 0.00023987842723727226
% O 0 1.7282542103203014e-05
of O 0 2.0362484065117314e-05
the O 0 0.000344006170053035
SCA1 B-Disease 1 0.9847095608711243
, O 0 0.00010939753701677546
90 O 0 0.00016781329759396613
% O 0 1.4533717148879077e-05
of O 0 1.575600435899105e-05
the O 0 0.0003260665980633348
SCA2 B-Disease 1 0.9891194105148315
, O 0 0.00012903158494737
and O 0 7.670743070775643e-05
93 O 0 0.000901177991181612
% O 0 2.1403737264336087e-05
of O 0 2.4069786377367564e-05
the O 0 0.0012256549671292305
patients O 1 0.9998908042907715
with O 0 0.00044544084812514484
SCA3 B-Disease 1 0.9985070824623108
to O 0 9.289401350542903e-05
their O 0 8.346603135578334e-05
genetically O 0 0.0035270461812615395
confirmed O 0 0.017529353499412537
patient O 1 0.9983783960342407
group O 0 0.00032929834560491145
and O 0 0.00011884507694048807
, O 0 0.00014452310279011726
therefore O 0 0.0002499366528354585
, O 0 0.0002361679944442585
may O 0 0.000797429820522666
help O 0 0.001875119749456644
orient O 0 0.034148357808589935
diagnoses O 1 0.9609881639480591
of O 0 0.00016511928697582334
SCA1 B-Disease 1 0.9976122379302979
, O 0 0.0008553958614356816
SCA2 B-Disease 1 0.9854031801223755
, O 0 0.00027124120970256627
and O 0 0.0004559293738566339
SCA3 B-Disease 1 0.9984816908836365
at O 0 0.0005104369483888149
early O 0 0.0007603325648233294
clinical O 1 0.8908595442771912
stages O 0 0.0009037085110321641
of O 0 7.575024210382253e-05
the O 0 0.004612901248037815
diseases O 1 0.9999599456787109
. O 0 0.0005000674282200634
. O 0 0.0008395030163228512

Genetic O 0 0.0018891807412728667
basis O 0 0.00014506184379570186
and O 0 0.00014945940347388387
molecular O 0 0.0014911110047250986
mechanism O 0 0.005322404205799103
for O 0 0.07276551425457001
idiopathic B-Disease 1 0.9999994039535522
ventricular I-Disease 1 0.9999839067459106
fibrillation I-Disease 1 0.9999874830245972
. O 0 0.004755247849971056

Ventricular B-Disease 1 0.9995172023773193
fibrillation I-Disease 1 0.9996449947357178
causes O 0 0.17115412652492523
more O 0 0.0002282425411976874
than O 0 0.00016258656978607178
300 O 0 0.000866051996126771
, O 0 0.00024854435469023883
000 O 0 0.0029109350871294737
sudden O 0 0.18854586780071259
deaths O 0 0.0016680163098499179
each O 0 4.409821849549189e-05
year O 0 0.00019302863802295178
in O 0 6.420983845600858e-05
the O 0 0.00029217341216281056
USA O 0 0.014207237400114536
alone O 0 0.0023546393495053053
. O 0 0.0008199234143830836

In O 0 0.0004115487972740084
approximately O 0 0.000505331321619451
5 O 0 0.0005203292239457369
- O 0 0.0010187760926783085
12 O 0 9.180503548122942e-05
% O 0 8.762407560425345e-06
of O 0 9.052184395841323e-06
these O 0 3.0915882234694436e-05
cases O 0 0.0006590808043256402
, O 0 5.090992635814473e-05
there O 0 3.9779341022949666e-05
are O 0 2.173940447391942e-05
no O 0 0.0003351526102051139
demonstrable O 1 0.9985731840133667
cardiac O 1 0.999947190284729
or O 0 0.001276228460483253
non O 1 0.511006236076355
- O 1 0.9984751343727112
cardiac O 1 0.9999408721923828
causes O 0 0.04519622027873993
to O 0 6.817042594775558e-05
account O 0 7.07398503436707e-05
for O 0 7.087671110639349e-05
the O 0 0.0001414253783877939
episode O 0 0.0009418605477549136
, O 0 8.377085760002956e-05
which O 0 4.07253646699246e-05
is O 0 0.000102087804407347
therefore O 0 0.00024003698490560055
classified O 0 0.015798091888427734
as O 0 0.006187149323523045
idiopathic B-Disease 1 0.9999963045120239
ventricular I-Disease 1 0.9999547004699707
fibrillation I-Disease 1 0.9999816417694092
( O 0 0.06320493668317795
IVF B-Disease 1 0.9985128045082092
) O 0 0.0010565831325948238
. O 0 0.0009723525145091116

A O 0 0.002470986684784293
distinct O 0 0.0007659737602807581
group O 0 0.0005048553575761616
of O 0 0.0003703851834870875
IVF B-Disease 1 0.999943733215332
patients O 1 0.9999568462371826
has O 0 0.0010030861012637615
been O 0 0.00019275298109278083
found O 0 9.551123366691172e-05
to O 0 3.6713270674226806e-05
present O 0 5.367610356188379e-05
with O 0 5.8886176702799276e-05
a O 0 0.0007811639807187021
characteristic O 0 0.025311196222901344
electrocardiographic O 1 0.9858339428901672
pattern O 0 0.011891992762684822
. O 0 0.001472862670198083

Because O 0 0.0006564422510564327
of O 0 2.2824253392172977e-05
the O 0 7.89456971688196e-05
small O 0 8.524563600076362e-05
size O 0 0.00012088341463822871
of O 0 1.387190968671348e-05
most O 0 0.00012317804794292897
pedigrees O 0 0.0022084685042500496
and O 0 5.933147622272372e-05
the O 0 0.00014617112174164504
high O 0 0.00328130298294127
incidence O 1 0.9641457796096802
of O 0 0.0001259226119145751
sudden B-Disease 1 0.9991781115531921
death I-Disease 0 0.10182487219572067
, O 0 0.00018711606389842927
however O 0 0.0001632161292945966
, O 0 0.00011654866102617234
molecular O 0 0.0007966301636770368
genetic O 0 0.0004920186474919319
studies O 0 0.00023119102115742862
of O 0 0.00012319728557486087
IVF B-Disease 1 0.9989822506904602
have O 0 0.00016639538807794452
not O 0 0.00012175845040474087
yet O 0 0.0003653037711046636
been O 0 0.0002835238992702216
done O 0 0.0013396342983469367
. O 0 0.0005560411373153329

Because O 0 0.04271039739251137
IVF B-Disease 1 0.9984201192855835
causes O 1 0.9986118078231812
cardiac O 1 0.9999029636383057
rhythm O 1 0.9561491012573242
disturbance O 1 0.9933695793151855
, O 0 0.0004144140693824738
we O 0 0.0003344064170960337
investigated O 0 0.005371592007577419
whether O 0 0.0004985843552276492
malfunction O 0 0.2051270753145218
of O 0 3.532403570716269e-05
ion O 0 0.0018819109536707401
channels O 0 0.00036234644358046353
could O 0 0.0004594896163325757
cause O 0 0.0845755785703659
the O 0 0.0008401028462685645
disorder O 1 0.9999443292617798
by O 0 0.00011880608508363366
studying O 0 0.0006569529650732875
mutations O 0 0.0005736302118748426
in O 0 8.138409612001851e-05
the O 0 0.0005571643123403192
cardiac O 1 0.9996414184570312
sodium O 0 0.008843165822327137
channel O 0 0.0026596311945468187
gene O 0 0.005000675562769175
SCN5A O 1 0.9302371740341187
. O 0 0.001540722674690187

We O 0 0.0009302983526140451
have O 0 0.00019560306100174785
now O 0 0.0003099549503531307
identified O 0 0.00031440649763680995
a O 0 0.0004215234948787838
missense O 0 0.005906021222472191
mutation O 0 0.0011485142167657614
, O 0 0.00013196104555390775
a O 0 0.0006770451436750591
splice O 0 0.019602371379733086
- O 0 0.010259964503347874
donor O 0 0.0064057293348014355
mutation O 0 0.0017655928386375308
, O 0 0.0001450164709240198
and O 0 0.0001534562761662528
a O 0 0.001399588887579739
frameshift O 1 0.6680397987365723
mutation O 0 0.0010848958045244217
in O 0 7.274618110386655e-05
the O 0 0.00013671396300196648
coding O 0 0.0021166158840060234
region O 0 0.0007396790315397084
of O 0 8.907948358682916e-05
SCN5A O 1 0.9690400958061218
in O 0 0.000255393999395892
three O 0 0.00043360047857277095
IVF B-Disease 1 0.9901476502418518
families O 0 0.0010701952269300818
. O 0 0.0009969448437914252

We O 0 0.0005558396223932505
show O 0 0.00023787103418726474
that O 0 5.0311125960433856e-05
sodium O 0 0.0006345516885630786
channels O 0 0.00011050364264519885
with O 0 4.840815381612629e-05
the O 0 0.00026038920623250306
missense O 0 0.013658948242664337
mutation O 0 0.005161038134247065
recover O 1 0.6033408641815186
from O 0 0.00025682957493700087
inactivation O 0 0.05698090046644211
more O 0 0.00019848566444125026
rapidly O 0 0.002132997615262866
than O 0 0.00012595669250003994
normal O 0 0.0007969202124513686
and O 0 4.590105891111307e-05
that O 0 4.664017978939228e-05
the O 0 0.00025172284222207963
frameshift O 1 0.9076144099235535
mutation O 0 0.0023358692415058613
causes O 0 0.005369498394429684
the O 0 0.00015805536531843245
sodium O 0 0.0014817394549027085
channel O 0 0.00026069401064887643
to O 0 5.34649079781957e-05
be O 0 7.489206473110244e-05
non O 0 0.0008946999441832304
- O 0 0.0026927778962999582
functional O 0 0.002445568097755313
. O 0 0.0006861063884571195

Our O 0 0.0010612397454679012
results O 0 0.0004159587842877954
indicate O 0 0.00037114243605174124
that O 0 8.402015373576432e-05
mutations O 0 0.000991137931123376
in O 0 0.0003628974955063313
cardiac O 1 0.9998892545700073
ion O 0 0.007932919077575207
- O 0 0.0031926212832331657
channel O 0 0.0005131028592586517
genes O 0 0.00018981783068738878
contribute O 0 0.000704784004483372
to O 0 6.053791003068909e-05
the O 0 0.00016404369671363384
risk O 0 0.013060282915830612
of O 0 0.00011256367724854499
developing O 1 0.8812565803527832
IVF B-Disease 1 0.9975367784500122
. O 0 0.0004855930746998638
. O 0 0.0007635279907844961

Molecular O 0 0.007618004456162453
heterogeneity O 0 0.010529016144573689
in O 0 0.0007743883179500699
mucopolysaccharidosis B-Disease 1 0.9868584871292114
IVA I-Disease 1 0.9938862919807434
in O 0 0.0002330227434867993
Australia O 0 0.00040658185025677085
and O 0 0.00014191180525813252
Northern O 0 0.0008517237729392946
Ireland O 0 0.0004451186687219888
: O 0 0.00015060330042615533
nine O 0 0.0002076237869914621
novel O 0 0.00099592050537467
mutations O 0 0.0008609293727204204
including O 0 0.0001077477791113779
T312S O 0 0.14906556904315948
, O 0 0.0001358082372462377
a O 0 0.00031108970870263875
common O 0 0.0008446773863397539
allele O 0 0.002537468448281288
that O 0 0.00021243072114884853
confers O 0 0.10612298548221588
a O 0 0.003543224185705185
mild O 1 0.9992842078208923
phenotype O 1 0.9534006118774414
. O 0 0.001415669801644981

Mucopolysaccharidosis B-Disease 1 0.951555609703064
IVA I-Disease 1 0.990549623966217
( O 0 0.0051145004108548164
MPS B-Disease 1 0.9210838079452515
IVA I-Disease 1 0.9992608428001404
) O 0 0.000451501487987116
is O 0 0.00032524598645977676
an O 0 0.0007480910280719399
autosomal B-Disease 1 0.9987443685531616
recessive I-Disease 1 0.9992372989654541
lysosomal I-Disease 1 0.9997844099998474
storage I-Disease 1 0.9989712238311768
disorder I-Disease 1 0.9999935626983643
caused O 1 0.9258342385292053
by O 0 0.00017981920973397791
a O 0 0.0022333611268550158
genetic B-Disease 0 0.2483622133731842
defect I-Disease 1 0.998840868473053
in O 0 0.00030999191221781075
N O 0 0.010947044938802719
- O 0 0.004827444441616535
acetylgalactosamine O 0 0.04200458154082298
- O 0 0.002800420857965946
6 O 0 0.001140987267717719
- O 0 0.010126711800694466
sulfate O 1 0.9855127930641174
sulfatase O 1 0.9940616488456726
( O 0 0.003089901991188526
GALNS O 1 0.972224771976471
) O 0 0.0008706331718713045
. O 0 0.0007056798785924911

Previous O 0 0.0017469341401010752
studies O 0 0.0006327275768853724
of O 0 0.00017290688992943615
patients O 1 0.9992458820343018
from O 0 0.00012313082697801292
a O 0 0.0006968852248974144
British O 0 0.0013882409548386931
- O 0 0.0027252458967268467
Irish O 0 0.0003897382994182408
population O 0 5.4728032409911975e-05
showed O 0 0.00037810008507221937
that O 0 4.9143811338581145e-05
the O 0 0.00019641322433017194
I113F O 0 0.02104722149670124
mutation O 0 0.0009696031338535249
is O 0 7.735185499768704e-05
the O 0 4.053036172990687e-05
most O 0 6.602342909900472e-05
common O 0 0.00030489772325381637
single O 0 0.00027568938094191253
mutation O 0 0.0016866743098944426
among O 0 0.0006006371113471687
MPS B-Disease 1 0.9956151247024536
IVA I-Disease 1 0.9999845027923584
patients O 1 0.9998854398727417
and O 0 0.00023091434559319168
produces O 0 0.01621747948229313
a O 0 0.04485674947500229
severe O 1 0.9999473094940186
clinical O 1 0.9997958540916443
phenotype O 1 0.9913265109062195
. O 0 0.0017241562018170953

We O 0 0.0009696669294498861
studied O 0 0.0009091880056075752
mutations O 0 0.0007607210427522659
in O 0 8.004936535144225e-05
the O 0 0.0002622303436510265
GALNS O 1 0.9739634394645691
gene O 0 0.0005990186473354697
from O 0 8.969405462266877e-05
23 O 0 0.000650269677862525
additional O 0 0.0009134135907515883
MPS B-Disease 1 0.9810302257537842
IVA I-Disease 1 0.9998468160629272
patients O 1 0.999442994594574
( O 0 0.0004768643993884325
15 O 0 0.00022335992252919823
from O 0 5.343606244423427e-05
Australia O 0 0.00018429030023980886
, O 0 8.089825132628903e-05
8 O 0 0.00015972144319675863
from O 0 5.6045031669782475e-05
Northern O 0 0.0004933169111609459
Ireland O 0 0.00043478922452777624
) O 0 9.924759797286242e-05
, O 0 4.830721081816591e-05
with O 0 5.4101707064546645e-05
various O 0 0.00018796975200530142
clinical O 1 0.9991356730461121
phenotypes O 1 0.7977107167243958
( O 0 0.0038500530645251274
severe O 1 0.9998263716697693
, O 0 0.0003071837709285319
16 O 0 0.0004294294340070337
cases O 0 0.0009247079724445939
; O 0 0.00012900812726002187
intermediate O 0 0.00757942209020257
, O 0 0.0001325498742517084
4 O 0 0.0004965970292687416
cases O 0 0.001364700379781425
; O 0 0.0004025310918223113
mild O 1 0.9991084933280945
, O 0 0.0002368882851442322
3 O 0 0.0005744433146901429
cases O 0 0.001668515964411199
) O 0 0.00038800857146270573
. O 0 0.0006682299426756799

We O 0 0.000812580285128206
found O 0 0.00024980062153190374
two O 0 6.640265928581357e-05
common O 0 0.0006656001205556095
mutations O 0 0.0006644029053859413
that O 0 3.445705078775063e-05
together O 0 4.794423148268834e-05
accounted O 0 0.0003294283233117312
for O 0 6.595295417355374e-05
32 O 0 0.00013332780508790165
% O 0 9.434193998458795e-06
of O 0 1.0140767699340358e-05
the O 0 0.00014538948016706854
44 O 0 0.0006490802625194192
unrelated O 0 0.0043316069059073925
alleles O 0 0.0022061653435230255
in O 0 0.0002498299290891737
these O 0 0.0004277645202819258
patients O 1 0.9997957348823547
. O 0 0.0008243233314715326

One O 0 0.0004585405986290425
is O 0 0.00030573172261938453
the O 0 0.00030248650000430644
T312S O 0 0.02384815737605095
mutation O 0 0.0014529034961014986
, O 0 0.00010553911852184683
a O 0 0.0004499036876950413
novel O 0 0.001429402269423008
mutation O 0 0.0014581407885998487
found O 0 0.00021450922940857708
exclusively O 0 0.00048809064901433885
in O 0 0.0009136146400123835
milder O 1 0.9992479681968689
patients O 1 0.9997522234916687
. O 0 0.0014569388004019856

The O 0 0.00035812699934467673
other O 0 6.847894110251218e-05
is O 0 0.00012838028487749398
the O 0 0.00014033808838576078
previously O 0 0.0006091638351790607
described O 0 0.0020579425618052483
I113F O 0 0.010835658758878708
that O 0 0.00010853468120330945
produces O 0 0.0019378637662157416
a O 0 0.004398139659315348
severe O 1 0.9997269511222839
phenotype O 1 0.9673746824264526
. O 0 0.0014958953252062201

The O 0 0.0016995773185044527
I113F O 0 0.022808047011494637
and O 0 0.0004161438555456698
T312S O 0 0.012898876331746578
mutations O 0 0.0008840833907015622
accounted O 0 0.0003750127216335386
for O 0 0.00011467010335763916
8 O 0 0.0004317162383813411
( O 0 0.0002011295291595161
18 O 0 0.00011173829989274964
% O 0 2.4924886020016856e-05
) O 0 7.331990491366014e-05
and O 0 6.750522152287886e-05
6 O 0 0.00042921415297314525
( O 0 0.00019526132382452488
14 O 0 0.00015706648991908878
% O 0 1.802111728466116e-05
) O 0 4.459844421944581e-05
of O 0 2.3836879336158745e-05
44 O 0 0.0008029105956666172
unrelated O 0 0.005269492976367474
alleles O 0 0.0033270036801695824
, O 0 0.0003367334429640323
respectively O 0 0.0010395635617896914
. O 0 0.0009194069425575435

The O 0 0.0007961398805491626
relatively O 0 0.002214994980022311
high O 0 0.0028141094371676445
residual O 0 0.04564056918025017
GALNS O 1 0.9806601405143738
activity O 0 0.000847801158670336
seen O 0 0.0007068536942824721
when O 0 0.00018129013187717646
the O 0 0.00016548653366044164
T312S O 0 0.010725175030529499
mutant O 0 0.0023633339442312717
cDNA O 0 0.0023842325899749994
is O 0 0.0005505397566594183
overexpressed O 0 0.020978102460503578
in O 0 0.0002514065126888454
mutant O 0 0.0035095647908747196
cells O 0 0.0012071459786966443
provides O 0 0.0004882660578005016
an O 0 0.00011544093285920098
explanation O 0 0.0006445555482059717
for O 0 0.00012024190800730139
the O 0 0.000627672066912055
mild O 1 0.9998459815979004
phenotype O 1 0.9929624199867249
in O 0 0.0008981210994534194
patients O 1 0.9996917247772217
with O 0 0.00010346435738028958
this O 0 0.00016997657075989991
mutation O 0 0.002958906814455986
. O 0 0.0006844627787359059

The O 0 0.0004006924282293767
distribution O 0 0.0002517199900466949
and O 0 6.820203270763159e-05
relative O 0 0.0001291501394007355
frequencies O 0 5.021717879571952e-05
of O 0 1.993099613173399e-05
the O 0 0.00032390860724262893
I113F O 0 0.04003293439745903
and O 0 0.00034299527760595083
T312S O 0 0.03455289453268051
mutations O 0 0.0010185576975345612
in O 0 0.00012209330452606082
Australia O 0 0.0004352389369159937
corresponded O 0 0.0010974203469231725
to O 0 6.608945113839582e-05
those O 0 4.997106589144096e-05
observed O 0 0.0002595281694084406
in O 0 0.000103464160929434
Northern O 0 0.0006164354854263365
Ireland O 0 0.0003031866508536041
and O 0 4.0780199924483895e-05
are O 0 1.1280490070930682e-05
unique O 0 8.089701441349462e-05
to O 0 2.8517233658931218e-05
these O 0 1.234587216458749e-05
two O 0 2.874829078791663e-05
populations O 0 0.00024488172493875027
, O 0 0.00011121910938527435
suggesting O 0 0.0010657594539225101
that O 0 4.278270716895349e-05
both O 0 7.913184526842088e-05
mutations O 0 0.000645049789454788
were O 0 4.0443108446197584e-05
probably O 0 0.00044293462997302413
introduced O 0 0.0001481246144976467
to O 0 5.698757740901783e-05
Australia O 0 0.00016853894339874387
by O 0 6.674051110167056e-05
Irish O 0 0.0007631119224242866
migrants O 0 0.0003947422665078193
during O 0 0.00028149521676823497
the O 0 0.00014614296378567815
19th O 0 0.0006923763430677354
century O 0 0.0006440341821871698
. O 0 0.0009529287344776094

Haplotype O 0 0.040233928710222244
analysis O 0 0.0005928523023612797
using O 0 0.00036131800152361393
6 O 0 0.0012573045678436756
RFLPs O 0 0.022542208433151245
provides O 0 0.0005704181385226548
additional O 0 9.673534077592194e-05
data O 0 4.469560371944681e-05
that O 0 3.3120570151368156e-05
the O 0 0.0001810852554626763
I113F O 0 0.019438963383436203
mutation O 0 0.0011563932057470083
originated O 0 0.0003476562269497663
from O 0 8.523092401446775e-05
a O 0 0.0005019882810302079
common O 0 0.0015119999879971147
ancestor O 0 0.0024122465401887894
. O 0 0.000748179794754833

The O 0 0.00039944268064573407
other O 0 0.00012049442011630163
9 O 0 0.0009989099344238639
novel O 0 0.002012992976233363
mutations O 0 0.0013908982509747148
identified O 0 0.00037708753370679915
in O 0 8.898702071746811e-05
these O 0 0.00010773853136925027
23 O 0 0.0053376625292003155
patients O 1 0.9991156458854675
were O 0 1.4432407624553889e-05
each O 0 1.7673830370767973e-05
limited O 0 0.0001451750285923481
to O 0 3.3177886507473886e-05
a O 0 0.0002088516193907708
single O 0 0.0003389198100194335
family O 0 0.0012675737962126732
. O 0 0.0007942614029161632

These O 0 0.00010791107342811301
data O 0 9.763968409970403e-05
provide O 0 0.0002242952905362472
further O 0 0.00013558696082327515
evidence O 0 9.788859460968524e-05
for O 0 0.00011589977657422423
extensive O 0 0.0037227447610348463
allelic O 0 0.027273332700133324
heterogeneity O 0 0.008533221669495106
in O 0 0.0007677624234929681
MPS B-Disease 1 0.888556718826294
IVA I-Disease 1 0.998931348323822
in O 0 0.000535821367520839
British O 0 0.005859452299773693
- O 1 0.5843950510025024
Irish O 0 0.0219311211258173
patients O 1 0.9995998740196228
and O 0 0.00012409299961291254
provide O 0 0.00034576651523821056
evidence O 0 9.740737004904076e-05
for O 0 3.4400869481032714e-05
their O 0 4.197229281999171e-05
transmission O 0 0.0015551820397377014
to O 0 6.312207551673055e-05
Australia O 0 0.00016015789879020303
by O 0 0.0001083812239812687
British O 0 0.0012012566439807415
- O 0 0.0034135461319237947
Irish O 0 0.0008964847074821591
migrants O 0 0.000683613820001483
. O 0 0.0002468086895532906
. O 0 0.000446092220954597

Identification O 0 0.0008779290365055203
of O 0 0.0001249602937605232
constitutional O 0 0.004352387972176075
WT1 O 1 0.9982514977455139
mutations O 0 0.005282884929329157
, O 0 0.0003072291729040444
in O 0 0.0007183808484114707
patients O 1 0.9999126195907593
with O 0 0.0008015285129658878
isolated O 1 0.9965611100196838
diffuse B-Disease 1 0.9998651742935181
mesangial I-Disease 1 0.9999943971633911
sclerosis I-Disease 1 0.9999997615814209
, O 0 0.0006123696221038699
and O 0 9.090670937439427e-05
analysis O 0 0.0002246402727905661
of O 0 0.0001452730648452416
genotype O 1 0.9910101890563965
/ O 1 0.9673098921775818
phenotype O 0 0.0511806420981884
correlations O 0 0.0007628480088897049
by O 0 3.150623888359405e-05
use O 0 5.2917803259333596e-05
of O 0 2.424255944788456e-05
a O 0 0.0007135592750273645
computerized O 0 0.029975008219480515
mutation O 0 0.002917713485658169
database O 0 0.0018348782323300838
. O 0 0.0008811480947770178

Constitutional O 0 0.0020925994031131268
mutations O 0 0.0011179402936249971
of O 0 5.750889249611646e-05
the O 0 0.0009695930639281869
WT1 O 1 0.9965822100639343
gene O 0 0.001058541820384562
, O 0 8.354724559467286e-05
encoding O 0 0.0002685102226678282
a O 0 0.0007572218892164528
zinc O 0 0.3682631552219391
- O 0 0.004002723842859268
finger O 0 0.010706325992941856
transcription O 0 0.0007956242188811302
factor O 0 0.001091094920411706
involved O 0 0.0010557681089267135
in O 0 0.0018357953522354364
renal O 1 0.9999936819076538
and O 0 0.001840461976826191
gonadal O 1 0.9985780715942383
development O 0 0.0015024979365989566
, O 0 8.292108395835385e-05
are O 0 1.569998130435124e-05
found O 0 8.083023567451164e-05
in O 0 6.927624781383201e-05
most O 0 0.00045323235099203885
patients O 1 0.999847412109375
with O 0 0.000870929507073015
Denys B-Disease 1 0.9994637370109558
- I-Disease 1 0.9962621331214905
Drash I-Disease 1 0.9993139505386353
syndrome I-Disease 1 0.9999949932098389
( O 0 0.02647286467254162
DDS B-Disease 1 0.9999361038208008
) O 0 0.0005594306858256459
, O 0 0.00033410079777240753
or O 0 0.003690785262733698
diffuse B-Disease 1 0.9998489618301392
mesangial I-Disease 1 0.9999924898147583
sclerosis I-Disease 1 0.9999998807907104
( O 0 0.4713876247406006
DMS B-Disease 1 0.999890923500061
) O 0 0.0003763457352761179
associated O 0 0.00027944421162828803
with O 0 0.0002654481213539839
pseudohermaphroditism B-Disease 1 0.9929364323616028
and O 0 0.0006628357223235071
/ O 1 0.9560526013374329
or O 0 0.008802422322332859
Wilms B-Disease 1 0.9999618530273438
tumor I-Disease 1 0.9998173117637634
( O 0 0.003810259746387601
WT B-Disease 1 0.9929012656211853
) O 0 0.0011082845740020275
. O 0 0.0008885766146704555

Most O 0 0.0015079488512128592
mutations O 0 0.007804722059518099
in O 0 0.003527909517288208
DDS B-Disease 1 0.9999891519546509
patients O 1 0.9998670816421509
lie O 0 0.002974777715280652
in O 0 0.0001517280179541558
exon O 0 0.007159730419516563
8 O 0 0.00034166520345024765
or O 0 0.0001845654915086925
exon O 0 0.0036859677638858557
9 O 0 0.0003232823219150305
, O 0 9.014825627673417e-05
encoding O 0 0.0004432321584317833
zinc O 0 0.048281725496053696
finger O 0 0.045914772897958755
2 O 0 0.0006534389685839415
or O 0 0.0005546881584450603
zinc O 1 0.7119807600975037
finger O 0 0.48384109139442444
3 O 0 0.0006291358731687069
, O 0 0.00011142270523123443
respectively O 0 0.00015347749285865575
, O 0 3.845008905045688e-05
with O 0 5.090798367746174e-05
a O 0 0.00041220354614779353
hot O 0 0.006564286537468433
spot O 0 0.002342646475881338
( O 0 0.0006839740672148764
R394W O 0 0.009594932198524475
) O 0 0.0001649767073104158
in O 0 0.00018124414782505482
exon O 0 0.008578207343816757
9 O 0 0.0015764341223984957
. O 0 0.0005615247646346688

We O 0 0.0004983083344995975
analyzed O 0 0.000566598551813513
a O 0 0.00012459132994990796
series O 0 0.00010553136235103011
of O 0 4.7648733016103506e-05
24 O 0 0.0012146441731601954
patients O 1 0.9990628361701965
, O 0 0.00010509240382816643
10 O 0 0.00015834890655241907
with O 0 0.00022874667774885893
isolated B-Disease 1 0.9323244690895081
DMS I-Disease 1 0.9995064735412598
( O 0 0.003529458772391081
IDMS B-Disease 1 0.9988724589347839
) O 0 0.0003295367059763521
, O 0 0.00014759055920876563
10 O 0 0.00028352823574095964
with O 0 0.0005555532989092171
DDS B-Disease 1 0.9999195337295532
, O 0 0.00017617037519812584
and O 0 9.036841947818175e-05
4 O 0 0.0005217964062467217
with O 0 0.000590645126067102
urogenital B-Disease 1 0.9998306035995483
abnormalities I-Disease 1 0.999530553817749
and O 0 0.0025071760173887014
/ O 1 0.9769179821014404
or O 0 0.002494906773790717
WT B-Disease 1 0.9905341863632202
. O 0 0.001727047492749989

We O 0 0.0024083605967462063
report O 0 0.004017014522105455
WT1 O 1 0.9562975764274597
heterozygous O 0 0.007201522123068571
mutations O 0 0.0017588003538548946
in O 0 0.00031017340370453894
16 O 0 0.002383061219006777
patients O 1 0.9996209144592285
, O 0 0.0001331142702838406
4 O 0 0.00022385390184354037
of O 0 4.1029230487765744e-05
whom O 0 0.001398730673827231
presented O 0 0.0010430580005049706
with O 0 0.000952976755797863
IDMS B-Disease 1 0.9991587400436401
. O 0 0.0015478337882086635

One O 0 0.0005674971616826952
male O 0 0.000689324748236686
and O 0 0.0001312884414801374
two O 0 0.00020617619156837463
female O 0 0.11352568864822388
IDMS B-Disease 1 0.9999196529388428
patients O 1 0.9998745918273926
with O 0 0.0028375578112900257
WT1 O 1 0.9992656111717224
mutations O 0 0.4511871039867401
underwent O 1 0.999685525894165
normal O 0 0.07783997803926468
puberty O 1 0.9854516386985779
. O 0 0.0013606882421299815

Two O 0 0.0009133561979979277
mutations O 0 0.0035389168187975883
associated O 0 0.0007098023197613657
with O 0 0.000516353698913008
IDMS B-Disease 1 0.9992967844009399
are O 0 2.6915573471342213e-05
different O 0 1.7696140275802463e-05
from O 0 6.66091509629041e-05
those O 0 0.00011444747360656038
described O 0 0.011192945763468742
in O 0 0.006787057500332594
DDS B-Disease 1 0.9999920129776001
patients O 1 0.9998308420181274
. O 0 0.0016852137632668018

No O 0 0.007059524767100811
WT1 O 1 0.9912915229797363
mutations O 0 0.002585700713098049
were O 0 7.94328298070468e-05
detected O 0 0.0012197850737720728
in O 0 3.773819116759114e-05
the O 0 0.00010830557584995404
six O 0 0.000325717031955719
other O 0 0.0006603857618756592
IDMS B-Disease 1 0.9999734163284302
patients O 1 0.9999359846115112
, O 0 0.00039675270090810955
suggesting O 0 0.0031180514488369226
genetic O 0 0.0008080331026576459
heterogeneity O 0 0.0037451910320669413
of O 0 7.500913488911465e-05
this O 0 0.003597709583118558
disease O 1 0.9999773502349854
. O 0 0.0015083467587828636

We O 0 0.001771686365827918
analyzed O 0 0.006847388111054897
genotype O 1 0.556477963924408
/ O 0 0.4903385639190674
phenotype O 0 0.04589672014117241
correlations O 0 0.0014627276686951518
, O 0 6.628997653024271e-05
on O 0 4.4670461647911e-05
the O 0 2.704414328036364e-05
basis O 0 1.659531881159637e-05
of O 0 7.94211882748641e-06
the O 0 7.320372969843447e-05
constitution O 0 0.00011857745994348079
of O 0 2.4415710868197493e-05
a O 0 0.0017727222293615341
WT1 O 1 0.991586446762085
mutation O 0 0.0013065955135971308
database O 0 0.0002928332251030952
of O 0 7.469549018424004e-05
84 O 0 0.011544973589479923
germ O 1 0.9964348077774048
- O 0 0.010912971571087837
line O 0 0.0010951964650303125
mutations O 0 0.0007052334840409458
, O 0 5.786177280242555e-05
to O 0 4.686202737502754e-05
compare O 0 0.00033367236028425395
the O 0 3.3536132832523435e-05
distribution O 0 7.894817827036604e-05
and O 0 8.925021393224597e-05
type O 0 0.0007527518318966031
of O 0 3.854275564663112e-05
mutations O 0 0.0012357113882899284
, O 0 6.847901386208832e-05
according O 0 6.193332228576764e-05
to O 0 3.5893357562599704e-05
the O 0 9.11155148060061e-05
different O 0 0.0003155918384436518
symptoms O 1 0.9999215602874756
. O 0 0.0011627975618466735

This O 0 0.000533514772541821
demonstrated O 0 0.0025720323901623487
( O 0 0.0003854850947391242
1 O 0 0.0003109476820100099
) O 0 8.798990165814757e-05
the O 0 0.00012580619659274817
association O 0 0.001733884448185563
between O 0 0.00017022732936311513
mutations O 0 0.0006851027137599885
in O 0 0.00010896047751884907
exons O 0 0.001422242377884686
8 O 0 0.00033265058300457895
and O 0 0.00010924950038315728
9 O 0 0.0005863485857844353
and O 0 0.0004900937201455235
DMS B-Disease 1 0.9980997443199158
; O 0 0.00023115640215110034
( O 0 0.00025230864412151277
2 O 0 0.000339185498887673
) O 0 0.00014939316315576434
among O 0 0.00037311826599761844
patients O 1 0.9993731379508972
with O 0 0.0008546594181098044
DMS B-Disease 1 0.9996898174285889
, O 0 0.00011467184958746657
a O 0 0.00016522117948625237
higher O 0 0.00011607342457864434
frequency O 0 5.592565503320657e-05
of O 0 3.511103932396509e-05
exon O 0 0.005788514390587807
8 O 0 0.000540527340490371
mutations O 0 0.0005731569835916162
among O 0 0.00012379337567836046
46 O 0 0.0016864367062225938
, O 0 0.0012980808969587088
XY O 1 0.9986308217048645
patients O 1 0.9994600415229797
with O 0 0.00027911990764550865
female O 0 0.002059078775346279
phenotype O 0 0.0937391072511673
than O 0 0.0001092869060812518
among O 0 0.00019672623602673411
46 O 0 0.002572164172306657
, O 0 0.0018868065671995282
XY O 1 0.9991278052330017
patients O 1 0.9993864297866821
with O 0 0.00018308285507373512
sexual O 0 0.002455976093187928
ambiguity O 0 0.003541247919201851
or O 0 0.0007445286028087139
male O 0 0.004213931038975716
phenotype O 1 0.851795494556427
; O 0 0.00016350240912288427
and O 0 0.00010252289939671755
( O 0 0.0003205429238732904
3 O 0 0.0002931086637545377
) O 0 7.745067705400288e-05
statistically O 0 0.00023959044483490288
significant O 0 0.00017931209004018456
evidence O 0 0.0001246511092176661
that O 0 5.870989116374403e-05
mutations O 0 0.0004948817077092826
in O 0 7.827074296073988e-05
exons O 0 0.002213359111919999
8 O 0 0.0003551747649908066
and O 0 0.000113073387183249
9 O 0 0.0005111311911605299
preferentially O 0 0.001579403760842979
affect O 0 0.0005863100523129106
amino O 0 8.97906647878699e-05
acids O 0 0.0001214620569953695
with O 0 2.8876442229375243e-05
different O 0 2.9483673642971553e-05
functions O 0 0.00024036402464844286
. O 0 0.0002605963090900332
. O 0 0.0006740398239344358

The O 0 0.003765842644497752
185delAG O 1 0.8077127933502197
BRCA1 O 1 0.978824257850647
mutation O 0 0.004060816951096058
originated O 0 0.0007531442097388208
before O 0 0.00018345611169934273
the O 0 7.399765308946371e-05
dispersion O 0 0.0010296930558979511
of O 0 2.270522054459434e-05
Jews O 0 0.000127128601889126
in O 0 5.734268052037805e-05
the O 0 9.558365127304569e-05
diaspora O 0 0.00031815055990591645
and O 0 9.517492435406893e-05
is O 0 0.0001437727769371122
not O 0 7.223215652629733e-05
limited O 0 0.0004558081564027816
to O 0 0.00023919783416204154
Ashkenazim O 0 0.11158286035060883
. O 0 0.0009426604956388474

The O 0 0.0016354526160284877
185delAG O 0 0.0442008450627327
mutation O 0 0.004050923511385918
in O 0 0.0007945403340272605
BRCA1 O 1 0.997894823551178
is O 0 0.0006454418762587011
detected O 0 0.0036141069140285254
in O 0 0.0001836680603446439
Ashkenazi O 0 0.011919648386538029
Jews O 0 0.00025213335175067186
both O 0 0.00018988264491781592
in O 0 0.0013040592893958092
familial B-Disease 1 0.9999589920043945
breast I-Disease 1 0.9999980926513672
and I-Disease 1 0.9970523118972778
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999990463256836
and O 0 0.00020627155026886612
in O 0 0.0001311533123953268
the O 0 0.0002133408997906372
general O 0 0.0007854222203604877
population O 0 0.0002956136013381183
. O 0 0.0006939654122106731

All O 0 0.0011037761578336358
tested O 0 0.041617948561906815
Ashkenazi O 0 0.05780590698122978
mutation O 0 0.00378889380954206
carriers O 0 0.0020993035286664963
share O 0 0.00016678409883752465
the O 0 0.00010384786583017558
same O 0 0.00025560351787135005
allelic O 0 0.02328161522746086
pattern O 0 0.002801094902679324
at O 0 0.0005880387616343796
the O 0 0.0008461253601126373
BRCA1 O 1 0.9900537729263306
locus O 0 0.018154151737689972
. O 0 0.0015768808079883456

Our O 0 0.0013706223107874393
previous O 0 0.0006596778403036296
study O 0 0.0006501332973130047
showed O 0 0.0004659153346437961
that O 0 5.182687164051458e-05
this O 0 0.00012045077164657414
Ashkenazi O 0 0.1543908715248108
mutation O 0 0.0016870993422344327
also O 0 0.00015636102762073278
occurs O 0 0.00045701698400080204
in O 0 0.00012101361789973453
Iraqi O 0 0.0008450238965451717
Jews O 0 0.00011629555228864774
with O 0 8.025711576920003e-05
a O 0 0.0004575625353027135
similar O 0 0.000780054135248065
allelic O 0 0.06116723641753197
pattern O 0 0.0096765561029315
. O 0 0.0016422871267423034

We O 0 0.0007264888845384121
extended O 0 0.0005790874129161239
our O 0 0.00017556501552462578
analysis O 0 0.00010665328591130674
to O 0 4.347431240603328e-05
other O 0 4.086335320607759e-05
non O 0 0.0012148988898843527
- O 0 0.0036254951264709234
Ashkenazi O 0 0.006544214207679033
subsets O 0 0.0008593942038714886
354 O 0 0.0028312692884355783
of O 0 3.9283611840801314e-05
Moroccan O 0 0.0008762425859458745
origin O 0 8.636018901597708e-05
, O 0 0.0002101061400026083
200 O 0 0.0009277760400436819
Yemenites O 0 0.2492029368877411
and O 0 0.00021755935449618846
150 O 0 0.0007818751619197428
Iranian O 0 0.0009157267049886286
Jews O 0 0.0007475035381503403
. O 0 0.0009405611199326813

Heteroduplex O 0 0.07352302223443985
analysis O 0 0.0006722964462824166
complemented O 0 0.0018851442728191614
by O 0 3.912461033905856e-05
direct O 0 0.00014442556130234152
DNA O 0 0.00030509690986946225
sequencing O 0 0.0003170583222527057
of O 0 8.850364247336984e-05
abnormally O 1 0.985630452632904
migrating O 0 0.0029399176128208637
bands O 0 0.0005812994204461575
were O 0 0.00011732218990800902
employed O 0 0.002283162670210004
. O 0 0.000769911624956876

Four O 0 0.0002285049413330853
of O 0 3.5019413189729676e-05
Moroccan O 0 0.0007698260596953332
origin O 0 8.188862557290122e-05
( O 0 0.00024276901967823505
1 O 0 0.00020611094078049064
. O 0 4.258333865436725e-05
1 O 0 0.00011070677282987162
% O 0 2.9860295398975722e-05
) O 0 6.437028787331656e-05
and O 0 3.1449355446966365e-05
none O 0 0.0001454238808946684
of O 0 1.4829159226792399e-05
the O 0 0.0002928148314822465
Yemenites O 1 0.9800711274147034
or O 0 0.0002886419533751905
Iranians O 0 0.000609405105933547
was O 0 0.0002492679050192237
a O 0 0.00026707787765190005
carrier O 0 0.0018600736511871219
of O 0 2.3514936401625164e-05
the O 0 0.0003852369845844805
185delAG O 0 0.25891411304473877
mutation O 0 0.004174374975264072
. O 0 0.0007718428387306631

BRCA1 O 1 0.9828888177871704
allelic O 0 0.06313224881887436
patterns O 0 0.0013429935788735747
were O 0 8.157297997968271e-05
determined O 0 0.00047695168177597225
for O 0 5.555505777010694e-05
four O 0 2.714993570407387e-05
of O 0 7.3698720370884985e-06
these O 0 1.9043949578190222e-05
individuals O 0 6.822662544436753e-05
and O 0 3.337024099892005e-05
for O 0 7.146356074372306e-05
12 O 0 0.00019108736887574196
additional O 0 0.00019569802680052817
non O 0 0.0012942119501531124
- O 0 0.009546640329062939
Ashkenazi O 0 0.030325666069984436
185delAG O 0 0.06382619589567184
mutation O 0 0.0027419647667557
carriers O 0 0.009533294476568699
who O 0 0.0017744158394634724
had O 0 0.48995643854141235
breast B-Disease 1 0.999996542930603
/ I-Disease 1 0.9998983144760132
ovarian I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999973773956299
. O 0 0.002547251060605049

Six O 0 0.00241168518550694
non O 0 0.004554991144686937
- O 0 0.01825861632823944
Ashkenazi O 0 0.017623374238610268
individuals O 0 0.00017591792857274413
shared O 0 0.0002701618941500783
the O 0 0.0002588164934422821
common O 0 0.005615023896098137
Ashkenazi O 1 0.8865761756896973
haplotype O 0 0.10058839619159698
, O 0 0.00014853777247481048
four O 0 0.00011053863272536546
had O 0 0.00025993032613769174
a O 0 0.00032462022500112653
closely O 0 0.0005558673292398453
related O 0 0.0010935746831819415
pattern O 0 0.0015712634194642305
, O 0 9.319087985204533e-05
and O 0 5.239417077973485e-05
the O 0 0.00013784509792458266
rest O 0 0.000741952215321362
( O 0 0.0003126453375443816
n O 0 0.0013545633992180228
= O 0 0.0013682161225005984
6 O 0 0.0003069800150115043
) O 0 8.600671571912244e-05
displayed O 0 0.0003844088059850037
a O 0 0.0004403945931699127
distinct O 0 0.002374319825321436
BRCA1 O 1 0.9930375218391418
allelic O 0 0.07699122279882431
pattern O 0 0.012369650416076183
. O 0 0.0015831016935408115

We O 0 0.0009725713171064854
conclude O 0 0.0019843121990561485
that O 0 8.439458906650543e-05
the O 0 0.0003580887569114566
185delAG O 1 0.8121158480644226
BRCA1 O 1 0.9866387844085693
mutation O 0 0.002227147575467825
occurs O 0 0.00042507966281846166
in O 0 7.010262925177813e-05
some O 0 0.0001038650079863146
non O 0 0.0037079027388244867
- O 0 0.022519420832395554
Ashkenazi O 0 0.02305031754076481
populations O 0 0.00044350564712658525
at O 0 0.0003412984369788319
rates O 0 0.00048003674601204693
comparable O 0 0.0006853433442302048
with O 0 6.053813922335394e-05
that O 0 8.580405119573697e-05
of O 0 9.825031884247437e-05
Ashkenazim O 1 0.547779381275177
. O 0 0.0015575397992506623

The O 0 0.0004379577003419399
majority O 0 0.00022002343030180782
of O 0 6.979132740525529e-05
Jewish O 0 0.001460519153624773
185delAG O 1 0.6694460511207581
mutation O 0 0.004179420880973339
carriers O 0 0.003143893787637353
have O 0 6.944424967514351e-05
a O 0 0.00033330509904772043
common O 0 0.001390320248901844
allelic O 0 0.07831656187772751
pattern O 0 0.0045386385172605515
, O 0 0.00029669670038856566
supporting O 0 0.0008839318179525435
the O 0 0.0002844775444827974
founder O 0 0.00807469617575407
effect O 0 0.0006520619499497116
notion O 0 0.0008533375803381205
, O 0 0.0001448473340133205
but O 0 0.00014387027476914227
dating O 0 0.0003136765444651246
the O 0 0.00010785026825033128
mutations O 0 0.00036420568358153105
origin O 0 2.4316212147823535e-05
to O 0 2.7743364626076072e-05
an O 0 8.17140462459065e-05
earlier O 0 0.0002621445746626705
date O 0 7.959843060234562e-05
than O 0 6.495869456557557e-05
currently O 0 0.0002460376126691699
estimated O 0 0.0007363418699242175
. O 0 0.0005602529854513705

However O 0 0.0007860508630983531
, O 0 9.842210420174524e-05
the O 0 8.984496525954455e-05
different O 0 6.693848263239488e-05
allelic O 0 0.013397487811744213
pattern O 0 0.002866907510906458
at O 0 0.0005078889662399888
the O 0 0.0007096839253790677
BRCA1 O 1 0.9955880641937256
locus O 0 0.003996592480689287
even O 0 0.00015543717017862946
in O 0 4.252927828929387e-05
some O 0 5.4947351600276306e-05
Jewish O 0 0.0006284958217293024
mutation O 0 0.002911960706114769
carriers O 0 0.008390151895582676
, O 0 0.00021980662131682038
might O 0 0.00043875834671780467
suggest O 0 0.0003150344709865749
that O 0 3.965181895182468e-05
the O 0 0.00015464035095646977
mutation O 0 0.0011521215783432126
arose O 0 0.0011545132147148252
independently O 0 0.00040360522689297795
. O 0 0.0002550871577113867
. O 0 0.0006117436569184065

Crystal O 0 0.05268969014286995
structure O 0 0.0009441848960705101
of O 0 8.011229510884732e-05
the O 0 0.001968732802197337
hemochromatosis B-Disease 1 0.9999440908432007
protein O 0 0.01290114875882864
HFE O 1 0.9970679879188538
and O 0 0.0002244991628685966
characterization O 0 0.002236653584986925
of O 0 1.9115788745693862e-05
its O 0 0.00010355733684264123
interaction O 0 0.0004419080796651542
with O 0 0.00031847861828282475
transferrin O 1 0.9454402923583984
receptor O 0 0.007074117194861174
. O 0 0.0010284254094585776

HFE O 1 0.9787790179252625
is O 0 0.0018443485023453832
an O 0 0.0014620847068727016
MHC O 1 0.9865146279335022
- O 0 0.00288151646964252
related O 0 0.0003498125879559666
protein O 0 0.00018768248264677823
that O 0 4.665726373787038e-05
is O 0 9.503036562819034e-05
mutated O 0 0.0011501532280817628
in O 0 6.488458893727511e-05
the O 0 0.00042892724741250277
iron B-Disease 1 0.9995390176773071
- I-Disease 1 0.9989998936653137
overload I-Disease 1 0.9998878240585327
disease I-Disease 1 0.9999961853027344
hereditary B-Disease 1 0.9998965263366699
hemochromatosis I-Disease 1 0.9999966621398926
. O 0 0.007506110705435276

HFE O 1 0.9322715401649475
binds O 0 0.007408390752971172
to O 0 0.0005793579621240497
transferrin O 1 0.7585852146148682
receptor O 0 0.009635708294808865
( O 0 0.0014144622255116701
TfR O 1 0.9728699326515198
) O 0 0.0001973112375708297
and O 0 8.968917973106727e-05
reduces O 0 0.002400062046945095
its O 0 0.00010646388545865193
affinity O 0 0.0008835188928060234
for O 0 0.0002574042300693691
iron O 1 0.7806314826011658
- O 0 0.003175863064825535
loaded O 0 0.001891137333586812
transferrin O 0 0.2979459762573242
, O 0 0.0009194327285513282
implicating O 1 0.9595062136650085
HFE O 1 0.9959672689437866
in O 0 0.0008919162210077047
iron O 1 0.9902530908584595
metabolism O 1 0.9661674499511719
. O 0 0.0016232188791036606

The O 0 0.0009684759424999356
2 O 0 0.0015055370749905705
. O 0 0.0008772796718403697

6 O 0 0.0035287379287183285
A O 0 0.0030243275687098503
crystal O 0 0.01862046867609024
structure O 0 0.0012556567089632154
of O 0 0.00027498300187289715
HFE O 1 0.9989131689071655
reveals O 0 0.006623024120926857
the O 0 0.00015376503870356828
locations O 0 0.00028273326461203396
of O 0 0.00026626940234564245
hemochromatosis B-Disease 1 0.9999721050262451
mutations O 0 0.004499693401157856
and O 0 0.00020301852782722563
a O 0 0.0024067824706435204
patch O 1 0.9990912675857544
of O 0 0.0001407991658197716
histidines O 1 0.9169694781303406
that O 0 8.158371929312125e-05
could O 0 0.00011243215703871101
be O 0 3.3484684536233544e-05
involved O 0 0.0002218570007244125
in O 0 0.00017848849529400468
pH O 1 0.6002505421638489
- O 0 0.00341433915309608
dependent O 0 0.0009938739240169525
interactions O 0 0.0011400490766391158
. O 0 0.0008146200561895967

We O 0 0.0007983255200088024
also O 0 0.0002134645910700783
demonstrate O 0 0.0011072650086134672
that O 0 0.00030253466684371233
soluble O 1 0.5992481708526611
TfR O 1 0.9869441986083984
and O 0 0.0011081700213253498
HFE O 1 0.9955427050590515
bind O 0 0.003008156083524227
tightly O 0 0.0008309650584124029
at O 0 0.00018560868920758367
the O 0 0.00011007770081050694
basic O 0 0.0008631059317849576
pH O 0 0.0045024859718978405
of O 0 1.8323660697205923e-05
the O 0 0.00022400419402401894
cell O 0 0.001936255837790668
surface O 0 0.0028009454254060984
, O 0 0.00011781445209635422
but O 0 6.90963861416094e-05
not O 0 3.6551591620082036e-05
at O 0 0.00011180245201103389
the O 0 0.00018366087169852108
acidic O 0 0.4711923897266388
pH O 0 0.014314325526356697
of O 0 6.643939559580758e-05
intracellular O 0 0.017153283581137657
vesicles O 0 0.07802420854568481
. O 0 0.0013823674526065588

TfR O 1 0.9544408321380615
HFE O 1 0.9639686942100525
stoichiometry O 0 0.029725225642323494
( O 0 0.001295296591706574
2 O 0 0.0005297349416650832
1 O 0 0.0004221537965349853
) O 0 0.00020579458214342594
differs O 0 0.0013763057067990303
from O 0 0.00042856449726969004
TfR O 1 0.9388970136642456
transferrin O 0 0.29488062858581543
stoichiometry O 0 0.013107101432979107
( O 0 0.0006515531567856669
2 O 0 0.00045499761472456157
2 O 0 0.00037745971349067986
) O 0 0.00011870066373376176
, O 0 8.9619068603497e-05
implying O 0 0.00097237853333354
a O 0 9.52081463765353e-05
different O 0 1.1035827810701448e-05
mode O 0 0.00019106532272417098
of O 0 1.380305093334755e-05
binding O 0 0.0003822722064796835
for O 0 0.00042950399802066386
HFE O 1 0.996756374835968
and O 0 0.0003734026104211807
transferrin O 1 0.9364451169967651
to O 0 0.0006048664799891412
TfR O 1 0.9870566129684448
, O 0 0.0002028488233918324
consistent O 0 0.0006796212983317673
with O 0 6.480437878053635e-05
our O 0 0.00030669302213937044
demonstration O 0 0.001957563916221261
that O 0 0.00041740425513125956
HFE O 1 0.9911885261535645
, O 0 0.000775475986301899
transferrin O 1 0.7562198638916016
, O 0 0.00028904262580908835
and O 0 0.0003495265555102378
TfR O 1 0.9656627774238586
form O 0 0.0005520230624824762
a O 0 0.0009500359301455319
ternary O 0 0.024693943560123444
complex O 0 0.009413380175828934
. O 0 0.0015935486881062388

Identification O 0 0.0006750043830834329
of O 0 3.966475196648389e-05
three O 0 0.0001964512630365789
novel O 0 0.0014836618211120367
mutations O 0 0.0008475842769257724
and O 0 5.655512723024003e-05
a O 0 0.00019268662435933948
high O 0 0.0002998726849909872
frequency O 0 4.766227721120231e-05
of O 0 1.120212436944712e-05
the O 0 0.0001808634988265112
Arg778Leu O 1 0.6902144551277161
mutation O 0 0.001237189513631165
in O 0 0.00021101138554513454
Korean O 1 0.5175846219062805
patients O 1 0.9998250603675842
with O 0 0.0026428918354213238
Wilson B-Disease 1 0.9994708895683289
disease I-Disease 1 0.9999599456787109
. O 0 0.001396089093759656

Four O 0 0.0010976461926475167
mutations O 0 0.004383593797683716
- O 0 0.0076464274898171425
- O 0 0.005390006583184004
R778L O 0 0.010199536569416523
, O 0 0.00032804650254547596
A874V O 0 0.010739690624177456
, O 0 0.0003429030766710639
L1083F O 0 0.00819470826536417
, O 0 0.00013830617535859346
and O 0 0.00013602894614450634
2304delC O 0 0.06775903701782227
- O 0 0.0018114977283403277
- O 0 0.0004651547351386398
in O 0 3.258997094235383e-05
the O 0 0.00010627532174112275
copper O 0 0.006025244016200304
- O 0 0.001419808715581894
transporting O 0 0.0019604249391704798
enzyme O 0 0.001599075854755938
, O 0 0.0005271878326311707
P O 0 0.05887508764863014
- O 0 0.003991753328591585
type O 0 0.003511012764647603
ATPase O 0 0.26211729645729065
( O 0 0.0014703304041177034
ATP7B O 1 0.9046140313148499
) O 0 0.00017756946908775717
, O 0 6.720994133502245e-05
were O 0 3.4341250284342095e-05
identified O 0 0.0002881758555304259
in O 0 0.00019658035307656974
Korean O 0 0.46648192405700684
Patients O 1 0.9998992681503296
with O 0 0.002435254165902734
Wilson B-Disease 1 0.9996140599250793
disease I-Disease 1 0.9999794960021973
. O 0 0.001436614547856152

Arg778Leu O 1 0.6407418847084045
, O 0 0.00035654750536195934
the O 0 0.00013851681433152407
most O 0 0.00022017538140062243
frequently O 0 0.0009361810516566038
reported O 0 0.0008786353282630444
mutation O 0 0.00023366056848317385
of O 0 9.935634807334282e-06
this O 0 6.708865839755163e-05
enzyme O 0 0.0009983258787542582
, O 0 0.00010919784108409658
was O 0 0.00022494573204312474
found O 0 5.8045196055900306e-05
in O 0 2.7825428333017044e-05
six O 0 5.418338696472347e-05
of O 0 2.4734556063776836e-05
eight O 0 0.0007942462689243257
unrelated O 1 0.8826353549957275
patients O 1 0.9998422861099243
studied O 0 0.0006323284469544888
, O 0 7.717656990280375e-05
an O 0 0.00012260173389222473
allele O 0 0.0010715245734900236
frequency O 0 0.00011562855070224032
of O 0 5.40128858119715e-05
37 O 0 0.0016389614902436733
. O 0 0.0007343912147916853

5 O 0 0.0009314570343121886
% O 0 0.00010136503260582685
, O 0 0.00011375580652384087
which O 0 8.547029574401677e-05
is O 0 0.00018684452516026795
considerably O 0 0.0020159464329481125
higher O 0 0.00022220269602257758
than O 0 4.5176704588811845e-05
those O 0 3.6515015381155536e-05
in O 0 7.009768160060048e-05
other O 0 6.569985271198675e-05
Asian O 0 0.0014229482039809227
populations O 0 0.0011314436560496688
. O 0 0.0007762131281197071

The O 0 0.0006480207084678113
novel O 0 0.001083624316379428
single O 0 0.0002683441271074116
nucleotide O 0 0.0006105850334279239
deletion O 0 0.003993378486484289
, O 0 0.00036093307426199317
2304delC O 0 0.027375757694244385
, O 0 0.00016407509974669665
was O 0 0.0003230019938200712
found O 0 0.0001243335718754679
in O 0 8.887439616955817e-05
one O 0 0.0004108403227292001
patient O 1 0.998432457447052
. O 0 0.0006577877793461084

Since O 0 0.0015239734202623367
a O 0 0.0005519938422366977
mutation O 0 0.0010989896254613996
at O 0 0.00023042454267852008
cDNA O 0 0.002083995845168829
nucleotide O 0 0.0019828348886221647
2302 O 1 0.738457441329956
( O 0 0.0018190692644566298
2302insC O 0 0.043650493025779724
) O 0 0.00037313252687454224
had O 0 0.00044127818546257913
been O 0 0.000284568959614262
previously O 0 0.000506174226757139
described O 0 0.0008069713367149234
, O 0 5.8431513025425375e-05
this O 0 2.7128455258207396e-05
region O 0 0.00021553575061261654
of O 0 2.7522615710040554e-05
the O 0 0.0004237041575834155
ATP7B O 1 0.9973107576370239
gene O 0 0.0030259843915700912
may O 0 0.0006866306648589671
be O 0 0.00014540889242198318
susceptible O 0 0.35123690962791443
to O 0 0.0002028977614827454
gene O 0 0.0031078511383384466
rearrangements O 0 0.1557939350605011
causing O 1 0.9975149631500244
Wilson B-Disease 1 0.9990658164024353
disease I-Disease 1 0.9999792575836182
. O 0 0.001694503123871982

Disruption O 0 0.007972683757543564
of O 0 6.489919906016439e-05
splicing O 0 0.0012120866449549794
regulated O 0 0.0008575120009481907
by O 0 0.00010782475874293596
a O 0 0.0009868508204817772
CUG O 1 0.8727884292602539
- O 0 0.0014767542015761137
binding O 0 0.0004520807124208659
protein O 0 0.0011247253278270364
in O 0 0.0023067358415573835
myotonic B-Disease 1 0.9999773502349854
dystrophy I-Disease 1 0.9999955892562866
. O 0 0.005805374588817358

Myotonic B-Disease 1 0.9999287128448486
dystrophy I-Disease 1 0.9999933242797852
( O 1 0.9044641852378845
DM B-Disease 1 0.9999603033065796
) O 0 0.001148229232057929
is O 0 0.0004881601780653
caused O 0 0.004362442530691624
by O 0 0.0001275900867767632
a O 0 0.0012441071448847651
CTG O 1 0.8959077000617981
expansion O 0 0.0009338484378531575
in O 0 7.374729466391727e-05
the O 0 0.00011250443640165031
3 O 0 0.000345050502801314
untranslated O 0 0.006080327555537224
region O 0 0.00040411268128082156
of O 0 5.957629036856815e-05
the O 0 0.00206506229005754
DM B-Disease 1 0.9999034404754639
gene O 0 0.005234581883996725
. O 0 0.0010215801885351539

One O 0 0.0006417343392968178
model O 0 0.0018464800668880343
of O 0 0.0009669075952842832
DM B-Disease 1 0.9999903440475464
pathogenesis O 1 0.9995032548904419
suggests O 0 0.0029719562735408545
that O 0 0.00012533464177977294
RNAs O 0 0.0028747946489602327
from O 0 5.403674367698841e-05
the O 0 8.230104140238836e-05
expanded O 0 0.0005919977556914091
allele O 0 0.0008717214222997427
create O 0 0.00020037443027831614
a O 0 0.0002462593838572502
gain O 0 0.0007362180040217936
- O 0 0.0008535989327356219
of O 0 3.1817296985536814e-05
- O 0 0.0016840555472299457
function O 0 0.0002409401786280796
mutation O 0 0.0005210133967921138
by O 0 3.2439031201647595e-05
the O 0 0.00010635593207553029
inappropriate O 0 0.0016928697004914284
binding O 0 0.00012813019566237926
of O 0 1.1450460988271516e-05
proteins O 0 9.815031080506742e-05
to O 0 9.311182657256722e-05
the O 0 0.00045924002188257873
CUG O 1 0.9624744653701782
repeats O 0 0.008650767616927624
. O 0 0.001351020997390151

Data O 0 0.0005198348080739379
presented O 0 0.0010352111421525478
here O 0 0.00021178153110668063
indicate O 0 0.0002593807294033468
that O 0 2.205766213592142e-05
the O 0 6.352843047352508e-05
conserved O 0 0.00039133569225668907
heterogeneous O 0 0.005958260968327522
nuclear O 0 0.0066329073160886765
ribonucleoprotein O 1 0.9789164066314697
, O 0 0.0006033831741660833
CUG O 0 0.16369092464447021
- O 0 0.0012417901307344437
binding O 0 0.0003512473194859922
protein O 0 0.0008116106619127095
( O 0 0.0011092382483184338
CUG O 1 0.9917703866958618
- O 0 0.01720132678747177
BP O 0 0.46720075607299805
) O 0 0.00022637845540884882
, O 0 0.00016865339421201497
may O 0 0.0004983359249308705
mediate O 0 0.002701827324926853
the O 0 0.0002008964802371338
trans O 0 0.017756471410393715
- O 0 0.001405460643582046
dominant O 0 0.0005985330208204687
effect O 0 0.00014694881974719465
of O 0 1.473111205996247e-05
the O 0 0.00013848695380147547
RNA O 0 0.0020602538716048002
. O 0 0.0005617619026452303

CUG O 1 0.9892237186431885
- O 0 0.30791687965393066
BP O 1 0.6817067265510559
was O 0 0.0005311290733516216
found O 0 0.00011289734538877383
to O 0 3.6403787817107514e-05
bind O 0 0.0005053045460954309
to O 0 4.4834432628704235e-05
the O 0 0.00026110565522685647
human O 0 0.3524656295776367
cardiac O 1 0.9999876022338867
troponin O 1 0.9999089241027832
T O 1 0.9979578256607056
( O 0 0.0014293438289314508
cTNT O 0 0.03891080617904663
) O 0 0.0003679231449496001
pre O 0 0.0025516331661492586
- O 0 0.002487062942236662
messenger O 0 0.0029443546663969755
RNA O 0 0.00051004538545385
and O 0 7.2432667366229e-05
regulate O 0 0.0008887028670869768
its O 0 0.0001508424466010183
alternative O 0 0.0007523397216573358
splicing O 0 0.00248702522367239
. O 0 0.0010662029962986708

Splicing O 0 0.002478297334164381
of O 0 0.00018832620116882026
cTNT O 0 0.06907887756824493
was O 0 0.001996195875108242
disrupted O 0 0.05810796841979027
in O 0 0.003146110801026225
DM B-Disease 1 0.9999872446060181
striated O 1 0.9993744492530823
muscle O 1 0.9977019429206848
and O 0 0.0003374454390723258
in O 0 0.00027218941249884665
normal O 0 0.0039027114398777485
cells O 0 0.00223683868534863
expressing O 0 0.002112792106345296
transcripts O 0 0.0006076095742173493
that O 0 0.00010907660180237144
contain O 0 0.001048581674695015
CUG O 1 0.9845806956291199
repeats O 0 0.006213166750967503
. O 0 0.0010735997930169106

Altered O 0 0.005635091103613377
expression O 0 0.0004813343985006213
of O 0 5.348592094378546e-05
genes O 0 0.0005365583929233253
regulated O 0 0.0025647394359111786
posttranscriptionally O 0 0.026651281863451004
by O 0 0.0005041849799454212
CUG O 1 0.989159882068634
- O 0 0.022506829351186752
BP O 0 0.40506914258003235
therefore O 0 0.0006234741886146367
may O 0 0.0006955379503779113
contribute O 0 0.005348047707229853
to O 0 0.002319708000868559
DM B-Disease 1 0.9999691247940063
pathogenesis O 1 0.9987678527832031
. O 0 0.0005833310424350202
. O 0 0.0006678348872810602

Identification O 0 0.0005674284184351563
of O 0 5.5700944358250126e-05
a O 0 0.0010071853175759315
novel O 0 0.002542750211432576
nonsense O 0 0.010147294960916042
mutation O 0 0.0010756718693301082
and O 0 6.464952457463369e-05
a O 0 0.00026005750987678766
missense O 0 0.0017457453068345785
substitution O 0 0.00018369486497249454
in O 0 7.494664896512404e-05
the O 0 0.0003521264297887683
vasopressin O 1 0.9805527329444885
- O 0 0.07704468071460724
neurophysin O 1 0.8413299322128296
II O 0 0.42907169461250305
gene O 0 0.0005353169981390238
in O 0 3.971744445152581e-05
two O 0 5.263736238703132e-05
Spanish O 0 0.0006039954023435712
kindreds O 0 0.033129721879959106
with O 0 0.0013560618972405791
familial B-Disease 1 0.9995549321174622
neurohypophyseal I-Disease 1 0.9993926286697388
diabetes I-Disease 1 0.9999948740005493
insipidus I-Disease 1 0.9997686743736267
. O 0 0.005312235560268164

Familial B-Disease 1 0.9988147020339966
neurohypophyseal I-Disease 1 0.9986061453819275
diabetes I-Disease 1 0.999996542930603
insipidus I-Disease 1 0.999876856803894
( O 0 0.020182117819786072
FNDI B-Disease 1 0.998997151851654
) O 0 0.00025668952730484307
is O 0 0.0001903873635455966
an O 0 0.0006395730888471007
autosomal B-Disease 1 0.9992029070854187
dominant I-Disease 1 0.9985644221305847
disease I-Disease 1 0.9999990463256836
caused O 1 0.9971367120742798
by O 0 0.0018150890246033669
deficiency O 1 0.9999864101409912
in O 0 0.00022778035781811923
the O 0 0.0009171705460175872
antidiuretic O 1 0.9924773573875427
hormone O 1 0.9743229746818542
arginine O 0 0.12587174773216248
vasopressin O 1 0.8965744376182556
( O 0 0.002173108048737049
AVP O 1 0.9836386442184448
) O 0 7.826723594916984e-05
encoded O 0 4.527037526713684e-05
by O 0 6.071164534660056e-05
the O 0 0.0006133169517852366
AVP O 1 0.9964196681976318
- O 0 0.023634204640984535
neurophysin O 1 0.6450384855270386
II O 1 0.9213626384735107
( O 0 0.002557086991146207
AVP O 1 0.9981651902198792
- O 0 0.030511783435940742
NPII O 1 0.5210497975349426
) O 0 0.00033582522883079946
gene O 0 0.0009536970756016672
on O 0 0.00027246150420978665
chromosome O 0 0.0033217263408005238
20p13 O 0 0.02531762234866619
. O 0 0.0008879884844645858

In O 0 0.0006289854063652456
this O 0 0.00015732311294414103
study O 0 0.0005118839908391237
, O 0 9.131365368375555e-05
we O 0 9.937971481122077e-05
analyzed O 0 0.00038481689989566803
two O 0 4.206545781926252e-05
families O 0 0.00017914407362695783
with O 0 0.00024431341444142163
FNDI B-Disease 1 0.9614630937576294
using O 0 7.692843792028725e-05
direct O 0 0.00018409147742204368
automated O 0 0.0019311557989567518
fluorescent O 0 0.007166125811636448
, O 0 0.00015957529831212014
solid O 0 0.0016002707416191697
phase O 0 0.0017185629112645984
, O 0 0.00011081989214289933
single O 0 0.00032317324075847864
- O 0 0.0015377794625237584
stranded O 0 0.0014537028037011623
DNA O 0 0.00013455378939397633
sequencing O 0 0.0001549216394778341
of O 0 4.328183422330767e-05
PCR O 0 0.00912565365433693
- O 0 0.006686798296868801
amplified O 0 0.012777520343661308
AVP O 1 0.9959702491760254
- O 0 0.03152703121304512
NPII O 1 0.7159700989723206
DNA O 0 0.002569253323599696
. O 0 0.0007091850275173783

In O 0 0.00026003862149082124
one O 0 6.84502738295123e-05
of O 0 2.084686821035575e-05
the O 0 0.0001906144170789048
families O 0 0.00041343073826283216
, O 0 0.0002618201251607388
affected O 0 0.0028562787920236588
individuals O 0 0.00019378328579477966
presented O 0 0.0005622166790999472
a O 0 0.0006116742733865976
novel O 0 0.0017878551734611392
nonsense O 0 0.005385607481002808
mutation O 0 0.0011024257401004434
in O 0 0.00012708762369584292
exon O 0 0.0025674353819340467
3 O 0 9.270304872188717e-05
of O 0 9.37610002438305e-06
the O 0 0.00011964305303990841
gene O 0 0.0005149553762748837
, O 0 4.717382398666814e-05
consisting O 0 7.791797543177381e-05
in O 0 0.00013175296771805733
a O 0 0.0009719566442072392
G O 0 0.04712548851966858
to O 0 0.0006129146204330027
T O 1 0.9591715931892395
transition O 0 0.0011150253703817725
at O 0 0.00032379990443587303
nucleotide O 0 0.0008563256124034524
2101 O 0 0.4644305408000946
, O 0 0.00015608799003530294
which O 0 5.021612741984427e-05
produces O 0 0.0006006673793308437
a O 0 0.000247084884904325
stop O 0 0.0006518447771668434
signal O 0 0.0004451704444363713
in O 0 0.00012693503231275827
codon O 0 0.0020696171559393406
82 O 0 0.003235652344301343
( O 0 0.0013539984356611967
Glu O 1 0.9860426783561707
) O 0 0.00024340266827493906
of O 0 0.00010483556252438575
NPII O 1 0.9864314198493958
. O 0 0.0010105323744937778

The O 0 0.0027469792403280735
premature O 1 0.9602031111717224
termination O 0 0.1734263151884079
eliminates O 0 0.00551916379481554
part O 0 0.0002913539356086403
of O 0 3.784180444199592e-05
the O 0 0.0005502496496774256
C O 0 0.30247780680656433
- O 0 0.005486455745995045
terminal O 0 0.00644896412268281
domain O 0 0.0002037134690908715
of O 0 7.832756818970665e-05
NPII O 1 0.9663720726966858
, O 0 8.210232044802979e-05
including O 0 4.311959492042661e-05
a O 0 0.00030681645148433745
cysteine O 0 0.0014111525379121304
residue O 0 0.0021022502332925797
in O 0 0.00013295316603034735
position O 0 0.0005107790930196643
85 O 0 0.001250731060281396
, O 0 0.00012095777492504567
which O 0 5.698111272067763e-05
could O 0 0.000129162086523138
be O 0 3.91141657019034e-05
involved O 0 0.00013493048027157784
in O 0 4.1958286601584405e-05
the O 0 0.00013306060282047838
correct O 0 0.002005636226385832
folding O 0 0.0028409785591065884
of O 0 3.981983900303021e-05
the O 0 0.0007009158725850284
prohormone O 1 0.9907536506652832
. O 0 0.0017398205818608403

In O 0 0.0003224033280275762
the O 0 0.0001637505047256127
second O 0 0.00037186723784543574
family O 0 0.0004405289946589619
, O 0 0.0001112556055886671
a O 0 0.00046620279317721725
G279A O 0 0.005573298782110214
substitution O 0 0.000389072549296543
at O 0 0.0002088563924189657
position O 0 0.0004793367115780711
- O 0 0.0005620800657197833
1 O 0 5.3014173317933455e-05
of O 0 6.029658379702596e-06
the O 0 5.542076178244315e-05
signal O 0 0.0007250834023579955
peptide O 0 0.0012037035776302218
was O 0 0.00026223360328003764
observed O 0 0.00015598353638779372
in O 0 6.128531094873324e-05
all O 0 7.220914994832128e-05
affected O 0 0.003951180726289749
individuals O 0 0.000500136986374855
. O 0 0.0007630981272086501

This O 0 0.0009023929014801979
missense O 0 0.011980273760855198
mutation O 0 0.0020014941692352295
, O 0 0.0002251164842164144
which O 0 0.0002185246121371165
replaces O 1 0.7229366898536682
Ala O 1 0.9915214776992798
with O 0 0.0007557648350484669
Thr O 1 0.9974468946456909
, O 0 0.0002845464332494885
is O 0 0.00028701304108835757
frequent O 0 0.005125960800796747
among O 0 0.0019973721355199814
FNDI B-Disease 1 0.9999324083328247
patients O 1 0.9998866319656372
and O 0 0.0001580218959134072
is O 0 0.00023385336680803448
thought O 0 0.0003722086257766932
to O 0 5.66772032470908e-05
reduce O 0 0.0007426511729136109
the O 0 6.396202661562711e-05
efficiency O 0 0.0005852729082107544
of O 0 4.845143121201545e-05
cleavage O 0 0.028321608901023865
by O 0 0.00016107237024698406
signal O 0 0.002841549925506115
peptidases O 0 0.05197155848145485
. O 0 0.0004891981952823699
. O 0 0.0006859386339783669

Genetic O 0 0.003134101163595915
heterogeneity O 0 0.004251644480973482
of O 0 0.00021987663058098406
Saethre B-Disease 1 0.9989514350891113
- I-Disease 1 0.9971885085105896
Chotzen I-Disease 1 0.9991287589073181
syndrome I-Disease 1 0.9999910593032837
, O 0 0.00033547673956491053
due O 0 0.0009713044273667037
to O 0 0.00022053865541238338
TWIST O 0 0.08271637558937073
and O 0 0.0005941309500485659
FGFR O 1 0.993084192276001
mutations O 0 0.0043479762971401215
. O 0 0.0008176748524419963

Thirty O 0 0.006504907738417387
- O 0 0.004444867372512817
two O 0 0.00025610384182073176
unrelated O 0 0.053664181381464005
patients O 1 0.998927652835846
with O 0 8.397601050091907e-05
features O 0 0.00021696730982512236
of O 0 0.00013343426689971238
Saethre B-Disease 1 0.9988508224487305
- I-Disease 1 0.9968538880348206
Chotzen I-Disease 1 0.999332845211029
syndrome I-Disease 1 0.9999951124191284
, O 0 0.0002423566475044936
a O 0 0.000982022495009005
common O 0 0.006640344858169556
autosomal B-Disease 1 0.9973832964897156
dominant I-Disease 1 0.6962291598320007
condition I-Disease 1 0.9992876648902893
of O 0 0.0005174687248654664
craniosynostosis B-Disease 1 0.9999778270721436
and O 0 0.12079167366027832
limb B-Disease 1 0.9999351501464844
anomalies I-Disease 1 0.9856583476066589
, O 0 0.00017562262655701488
were O 0 4.6383098379010335e-05
screened O 0 0.0008186619379557669
for O 0 0.00011147798068122938
mutations O 0 0.0008705063373781741
in O 0 0.00018630338308867067
TWIST O 0 0.22294631600379944
, O 0 0.0008256802684627473
FGFR2 O 1 0.9913949370384216
, O 0 0.0005107932374812663
and O 0 0.0005987001932226121
FGFR3 O 1 0.9794685244560242
. O 0 0.0010941107757389545

Nine O 0 0.001713089062832296
novel O 0 0.001763771753758192
and O 0 0.00026034453185275197
three O 0 0.00045214060810394585
recurrent O 1 0.997365415096283
TWIST O 1 0.8101855516433716
mutations O 0 0.002302615437656641
were O 0 6.783840217394754e-05
found O 0 0.00017792300786823034
in O 0 0.00011018861550837755
12 O 0 0.000563693349249661
families O 0 0.0005612379754893482
. O 0 0.0006561720510944724

Seven O 0 0.0011607855558395386
families O 0 0.00027409300673753023
were O 0 4.771835665451363e-05
found O 0 9.615282760933042e-05
to O 0 4.6177610784070566e-05
have O 0 4.82919167552609e-05
the O 0 0.00026018350035883486
FGFR3 O 1 0.9935085773468018
P250R O 0 0.03696390613913536
mutation O 0 0.0009776437655091286
, O 0 7.818167796358466e-05
and O 0 4.0350303606828675e-05
one O 0 5.8050623920280486e-05
individual O 0 0.00012092859105905518
was O 0 0.00032499709050171077
found O 0 0.00010312748054275289
to O 0 4.631344199879095e-05
have O 0 6.824042066000402e-05
an O 0 0.0003714222402777523
FGFR2 O 1 0.9618445634841919
VV269 O 0 0.035187799483537674
- O 0 0.004163266159594059
270 O 0 0.0053400383330881596
deletion O 0 0.007881537079811096
. O 0 0.0010942521039396524

To O 0 0.00036112393718212843
date O 0 0.00021053809905424714
, O 0 7.398855086648837e-05
our O 0 0.00018441228894516826
detection O 0 0.0012493475805968046
rate O 0 0.0001392641570419073
for O 0 0.00017943147395271808
TWIST O 0 0.07154468446969986
or O 0 0.0009610219858586788
FGFR O 1 0.9279332160949707
mutations O 0 0.0011445399140939116
is O 0 0.00017958978423848748
68 O 0 0.0004914908786304295
% O 0 2.192390638811048e-05
in O 0 7.916212052805349e-05
our O 0 0.0012189261615276337
Saethre B-Disease 1 0.9971576929092407
- I-Disease 1 0.9977432489395142
Chotzen I-Disease 1 0.9996894598007202
syndrome I-Disease 1 0.9999985694885254
patients O 1 0.9999370574951172
, O 0 0.00010873296560021117
including O 0 6.158079486340284e-05
our O 0 0.0005147380288690329
five O 0 0.0007847826927900314
patients O 1 0.9998295307159424
elsewhere O 0 0.001390442019328475
reported O 0 0.001404261915013194
with O 0 0.0002637263969518244
TWIST O 0 0.22180868685245514
mutations O 0 0.004141033161431551
. O 0 0.0010303603485226631

More O 0 0.0002974404487758875
than O 0 0.00013286697503644973
35 O 0 0.0003722916590049863
different O 0 6.743097765138373e-05
TWIST O 0 0.01721983775496483
mutations O 0 0.0013601918471977115
are O 0 3.836079849861562e-05
now O 0 0.0002674356510397047
known O 0 0.0001588585728313774
in O 0 4.829173121834174e-05
the O 0 9.123758354689926e-05
literature O 0 0.00033432195778004825
. O 0 0.000428337836638093

The O 0 0.0005849653971381485
most O 0 0.000289176037767902
common O 0 0.0012852419167757034
phenotypic O 0 0.00813047494739294
features O 0 0.0004028161056339741
, O 0 0.00012277041969355196
present O 0 7.319932774407789e-05
in O 0 3.0219123800634407e-05
more O 0 2.6219055143883452e-05
than O 0 3.468472641543485e-05
a O 0 0.00010908877447945997
third O 0 7.607555744471028e-05
of O 0 2.8294158255448565e-05
our O 0 0.0032981589902192354
patients O 1 0.9996212720870972
with O 0 0.0002746290119830519
TWIST O 0 0.23101948201656342
mutations O 0 0.0014983031433075666
, O 0 0.00012089656229363754
are O 0 7.121933595044538e-05
coronal B-Disease 1 0.6785266995429993
synostosis I-Disease 0 0.2184598296880722
, O 0 0.00031136241159401834
brachycephaly B-Disease 0 0.2274906188249588
, O 0 0.0003143336798530072
low B-Disease 0 0.12864187359809875
frontal I-Disease 1 0.9998747110366821
hairline I-Disease 1 0.9999945163726807
, O 0 0.003976031672209501
facial B-Disease 1 0.9999051094055176
asymmetry I-Disease 1 0.9908924102783203
, O 0 0.007345826365053654
ptosis B-Disease 1 0.9999274015426636
, O 0 0.002360563026741147
hypertelorism B-Disease 1 0.9991212487220764
, O 0 0.0005328383995220065
broad B-Disease 0 0.10495433211326599
great I-Disease 0 0.010140295140445232
toes I-Disease 1 0.99613356590271
, O 0 0.00046589889097958803
and O 0 0.00047249917406588793
clinodactyly B-Disease 1 0.8814276456832886
. O 0 0.0009664273238740861

Significant O 0 0.0035469902213662863
intra O 0 0.06788450479507446
- O 0 0.009593921713531017
and O 0 0.00040086437365971506
interfamilial O 0 0.07103153318166733
phenotypic O 0 0.007495603058487177
variability O 0 0.002952429000288248
is O 0 0.00017839763313531876
present O 0 0.00010353600373491645
for O 0 0.00015731666644569486
either O 0 0.0006198397604748607
TWIST O 0 0.06969982385635376
mutations O 0 0.003974325023591518
or O 0 0.0011037561343982816
FGFR O 1 0.993626594543457
mutations O 0 0.005727405659854412
. O 0 0.0009405557648278773

The O 0 0.0008811900625005364
overlap O 0 0.002206340664997697
in O 0 0.0006219230708666146
clinical O 1 0.9937735199928284
features O 0 0.0002796585322357714
and O 0 6.962659972487018e-05
the O 0 0.00011866535351146013
presence O 0 0.00038894684985280037
, O 0 6.986990047153085e-05
in O 0 3.8171845517354086e-05
the O 0 5.539196354220621e-05
same O 0 7.935007306514308e-05
genes O 0 0.000130544911371544
, O 0 2.832511927408632e-05
of O 0 1.209883157571312e-05
mutations O 0 0.00035508687142282724
for O 0 2.4433205908280797e-05
more O 0 3.433928213780746e-05
than O 0 6.106397631810978e-05
one O 0 0.0002056141383945942
craniosynostotic B-Disease 1 0.9893585443496704
condition I-Disease 1 0.9845696091651917
- O 0 0.0009375673835165799
such O 0 3.4576005418784916e-05
as O 0 0.0003468185313977301
Saethre B-Disease 1 0.9108813405036926
- I-Disease 0 0.010598783381283283
Chotzen I-Disease 0 0.10861428081989288
, I-Disease 0 0.0004573906771838665
Crouzon I-Disease 0 0.35360613465309143
, I-Disease 0 0.00047904488747008145
and I-Disease 0 0.0013608490116894245
Pfeiffer I-Disease 1 0.9995719790458679
syndromes I-Disease 1 0.9995174407958984
- O 0 0.0025115255266427994
support O 0 0.00017964646394830197
the O 0 0.00013160781236365438
hypothesis O 0 0.0016364683397114277
that O 0 0.00015560178144369274
TWIST O 0 0.02305782586336136
and O 0 0.0002526488096918911
FGFRs O 0 0.15288129448890686
are O 0 1.5816025552339852e-05
components O 0 9.682690142653883e-05
of O 0 8.00797624833649e-06
the O 0 7.576085772598162e-05
same O 0 0.00012514740228652954
molecular O 0 0.0010275733657181263
pathway O 0 0.0013911640271544456
involved O 0 0.00020607457554433495
in O 0 4.079875361640006e-05
the O 0 9.442389273317531e-05
modulation O 0 0.002503451192751527
of O 0 0.000400344782974571
craniofacial O 1 0.9999873638153076
and O 0 0.004315306898206472
limb O 1 0.9998177886009216
development O 0 0.002032885327935219
in O 0 0.0003054924891330302
humans O 0 0.003011089051142335
. O 0 0.00026906223502010107
. O 0 0.0006869033095426857

Mutation O 0 0.0042085181921720505
analysis O 0 0.0004142284451518208
of O 0 0.00047453955630771816
UBE3A O 1 0.9994045495986938
in O 1 0.8826730847358704
Angelman B-Disease 1 0.999998927116394
syndrome I-Disease 1 0.9999998807907104
patients O 1 0.9999402761459351
. O 0 0.0030151286628097296

Angelman B-Disease 1 0.999988317489624
syndrome I-Disease 1 0.9999988079071045
( O 0 0.00877305306494236
AS B-Disease 0 0.02515692450106144
) O 0 0.0002791558508761227
is O 0 0.0003035930567421019
caused O 0 0.005085023585706949
by O 0 0.00015266305126715451
chromosome O 0 0.0032290462404489517
15q11 O 0 0.20099730789661407
- O 0 0.00813695602118969
q13 O 0 0.008395572192966938
deletions O 0 0.0010736591648310423
of O 0 5.252313712844625e-05
maternal O 0 0.005822249222546816
origin O 0 0.00012529078230727464
, O 0 0.00018012209329754114
by O 0 0.0002855941711459309
paternal O 0 0.09459516406059265
uniparental B-Disease 1 0.9970760345458984
disomy I-Disease 1 0.982079267501831
( O 0 0.006202497519552708
UPD B-Disease 1 0.997529923915863
) O 0 0.00047669713967479765
15 O 0 0.00035885325632989407
, O 0 0.00013442206545732915
by O 0 0.0002565894683357328
imprinting O 1 0.9776501655578613
defects O 1 0.9992272853851318
, O 0 0.00016316647815983742
and O 0 6.782236596336588e-05
by O 0 8.914363570511341e-05
mutations O 0 0.0008100352133624256
in O 0 0.00013420471805147827
the O 0 0.000848737545311451
UBE3A O 1 0.996996283531189
gene O 0 0.005726373288780451
. O 0 0.0010908538242802024

UBE3A O 0 0.4661410450935364
encodes O 0 0.002931782975792885
a O 0 0.0010448655812069774
ubiquitin O 0 0.008876027539372444
- O 0 0.0019179261289536953
protein O 0 0.0005333668668754399
ligase O 0 0.0028352756053209305
and O 0 0.00014400959480553865
shows O 0 0.0008782665827311575
brain O 1 0.9990511536598206
- O 0 0.003422570414841175
specific O 0 0.0004297267587389797
imprinting O 0 0.06976351141929626
. O 0 0.001156418351456523

Here O 0 0.0014919646782800555
we O 0 0.0007898866897448897
describe O 0 0.0067209708504378796
UBE3A O 1 0.9613330960273743
coding O 0 0.013900398276746273
- O 0 0.00686979666352272
region O 0 0.001946002128534019
mutations O 0 0.0019229925237596035
detected O 0 0.002380269579589367
by O 0 0.0001609372702660039
SSCP O 0 0.3682557940483093
analysis O 0 0.00023101143597159535
in O 0 0.00016975242760963738
13 O 0 0.0006468280917033553
AS B-Disease 0 0.001979256048798561
individuals O 0 0.00021831199410371482
or O 0 0.0003607352846302092
families O 0 0.0006262090755626559
. O 0 0.0008407303248532116

Two O 0 0.0003331247135065496
identical O 0 0.0013903520302847028
de O 0 0.00466538593173027
novo O 0 0.008626926690340042
5 O 0 0.0012185019440948963
- O 0 0.00458837253972888
bp O 0 0.013937545008957386
duplications O 0 0.0031908280216157436
in O 0 0.00020794710144400597
exon O 0 0.005598243325948715
16 O 0 0.00035614188527688384
were O 0 7.566533895442262e-05
found O 0 0.0004687535110861063
. O 0 0.0005835999618284404

Among O 0 0.0003466375346761197
the O 0 0.00010055594611912966
other O 0 5.417790816863999e-05
11 O 0 0.0003039846196770668
unique O 0 0.0004325792833697051
mutations O 0 0.0011822286760434508
, O 0 0.00010532034502830356
8 O 0 0.000184416159754619
were O 0 2.2718602849636227e-05
small O 0 0.0001370303361909464
deletions O 0 0.0013252079952508211
or O 0 0.00027283112285658717
insertions O 0 0.00314894737675786
predicted O 0 0.0012257577618584037
to O 0 0.00019151053857058287
cause O 0 0.10019764304161072
frameshifts O 0 0.48746538162231445
, O 0 0.0001274525566259399
1 O 0 0.00021223917428869754
was O 0 0.00016552172019146383
a O 0 0.00018577474111225456
mutation O 0 0.00035857080365531147
to O 0 3.880179065163247e-05
a O 0 0.00022717544925399125
stop O 0 0.0009285069536417723
codon O 0 0.0009398311376571655
, O 0 9.130634134635329e-05
1 O 0 0.00018900944269262254
was O 0 0.00023648684145882726
a O 0 0.0003272858739364892
missense O 0 0.004971747752279043
mutation O 0 0.0008826723205856979
, O 0 9.916293493006378e-05
and O 0 7.605691644130275e-05
1 O 0 0.00024560847668908536
was O 0 0.0002651976828929037
predicted O 0 0.0005826736451126635
to O 0 6.272155587794259e-05
cause O 0 0.0019309628987684846
insertion O 0 0.0014557379763573408
of O 0 3.2735217246226966e-05
an O 0 0.00035743205808103085
isoleucine O 0 0.4221246540546417
in O 0 0.00012309630983509123
the O 0 0.00017303141066804528
hect O 0 0.009219801053404808
domain O 0 0.00021758048387710005
of O 0 3.2420968636870384e-05
the O 0 0.0005048905732110143
UBE3A O 1 0.9784205555915833
protein O 0 0.0005665670614689589
, O 0 0.00010112319432664663
which O 0 2.136246439476963e-05
functions O 0 8.975462696980685e-05
in O 0 0.000184138523763977
E2 O 0 0.03762080520391464
binding O 0 0.0004753567627631128
and O 0 0.00022020094911567867
ubiquitin O 0 0.007367297075688839
transfer O 0 0.0008994296076707542
. O 0 0.0006566312513314188

Eight O 0 0.0005641470197588205
of O 0 5.046528167440556e-05
the O 0 0.0003624264500103891
cases O 0 0.0023929907474666834
were O 0 0.00016561061784159392
familial O 1 0.9930196404457092
, O 0 0.00020021131786052138
and O 0 0.0001019755145534873
five O 0 0.00011408919817768037
were O 0 8.363301458302885e-05
sporadic O 0 0.00487375445663929
. O 0 0.0009572082781232893

In O 0 0.0006075073615647852
two O 0 0.00037479866296052933
familial O 1 0.9936214089393616
cases O 0 0.0030063174199312925
and O 0 0.00014917436055839062
one O 0 0.00021179465693421662
sporadic O 0 0.007696972228586674
case O 0 0.0029895752668380737
, O 0 0.0006112476694397628
mosaicism O 1 0.9852297902107239
for O 0 0.0010135092306882143
UBE3A O 1 0.9965242743492126
mutations O 0 0.003622666234150529
was O 0 0.0006172653520479798
detected O 0 0.002321226056665182
in O 0 5.038487506681122e-05
the O 0 0.00014933945203665644
mother O 0 0.0011549928458407521
of O 0 2.7998870791634545e-05
three O 0 0.00018252352310810238
AS B-Disease 0 0.03502240404486656
sons O 0 0.004297916311770678
, O 0 0.00010333854152122512
in O 0 7.632873166585341e-05
the O 0 0.00016512528236489743
maternal O 0 0.01407293975353241
grandfather O 0 0.0012555783614516258
of O 0 2.0249739463906735e-05
two O 0 7.075683970469981e-05
AS B-Disease 0 0.0014812977751716971
first O 0 0.00017398320778738707
cousins O 0 0.0014653988182544708
, O 0 0.00010719081183196977
and O 0 5.025099380873144e-05
in O 0 5.126024188939482e-05
the O 0 0.00011330944107612595
mother O 0 0.0010536249028518796
of O 0 2.7555761334951967e-05
an O 0 0.0006524815107695758
AS B-Disease 1 0.59706050157547
daughter O 0 0.29751598834991455
. O 0 0.0010120508959516883

The O 0 0.00023667993082199246
frequencies O 0 0.0001265199389308691
with O 0 6.580870831385255e-05
which O 0 5.079741822555661e-05
we O 0 0.00015161652117967606
detected O 0 0.0014248833758756518
mutations O 0 0.0003863747406285256
were O 0 2.6273120965925045e-05
5 O 0 0.00020509565365500748
( O 0 0.00019514704763423651
14 O 0 0.00018773834744933993
% O 0 2.4088936697808094e-05
) O 0 3.514346099109389e-05
of O 0 1.6579229850322008e-05
35 O 0 0.0002731824934016913
in O 0 0.0001176977893919684
sporadic O 0 0.00264029111713171
cases O 0 0.0008701091283001006
and O 0 0.00011796216131187975
8 O 0 0.0003639704955276102
( O 0 0.00016301423602271825
80 O 0 0.00017403182573616505
% O 0 1.630446240596939e-05
) O 0 2.9068465664749965e-05
of O 0 1.0378465958638117e-05
10 O 0 0.00022810135851614177
in O 0 0.0002998171839863062
familial O 1 0.9991552829742432
cases O 0 0.016763484105467796
. O 0 0.0003446035843808204
. O 0 0.0006830764468759298

The O 0 0.00817702803760767
hemochromatosis B-Disease 1 0.9996880292892456
845 O 1 0.9833072423934937
G O 1 0.760445773601532
- O 0 0.007945545017719269
- O 0 0.0028916303999722004
> O 0 0.0017589360941201448
A O 0 0.0004506894329097122
and O 0 0.0001421210472472012
187 O 0 0.0033116338308900595
C O 0 0.01089764479547739
- O 0 0.004543902352452278
- O 0 0.00414068391546607
> O 0 0.007099546492099762
G O 0 0.011857058852910995
mutations O 0 0.0016024818178266287
: O 0 0.0004227455356158316
prevalence O 0 0.23655040562152863
in O 0 0.0002540645655244589
non O 0 0.004534206818789244
- O 0 0.034997325390577316
Caucasian O 0 0.22269676625728607
populations O 0 0.0018280430231243372
. O 0 0.0007752662058919668

Hemochromatosis B-Disease 1 0.9994159936904907
, O 0 0.0018167432863265276
the O 0 0.003943154588341713
inherited B-Disease 1 0.9999198913574219
disorder I-Disease 1 0.9999837875366211
of I-Disease 0 0.00023877814237494022
iron I-Disease 1 0.999461829662323
metabolism I-Disease 1 0.9914491772651672
, O 0 0.0004041041829623282
leads O 0 0.002540992572903633
, O 0 0.00030397562659345567
if O 0 0.0014514010399580002
untreated O 1 0.9994514584541321
, O 0 0.00014388920681085438
to O 0 0.00018516639829613268
progressive O 1 0.842937171459198
iron B-Disease 1 0.998941957950592
overload I-Disease 1 0.9994786381721497
and O 0 0.0014207859057933092
premature B-Disease 1 0.9983974099159241
death I-Disease 0 0.02246229723095894
. O 0 0.0009902837919071317

The O 0 0.007742932066321373
hemochromatosis B-Disease 1 0.999826967716217
gene O 0 0.018558597192168236
, O 0 0.0015639098128303885
HFE O 1 0.9990155696868896
, O 0 0.0007213451899588108
recently O 0 0.007850470952689648
has O 0 0.00031936183222569525
been O 0 0.00016178566147573292
identified O 0 0.00026535094366408885
, O 0 5.757945473305881e-05
and O 0 5.259953104541637e-05
characterization O 0 0.0014188976492732763
of O 0 1.5314932170440443e-05
this O 0 0.00010785870108520612
gene O 0 0.0010009448742493987
has O 0 0.0001895552413770929
shown O 0 0.00015903075109235942
that O 0 2.2675510990666226e-05
it O 0 2.1320822270354256e-05
contains O 0 3.3460004488006234e-05
two O 0 3.604307858040556e-05
mutations O 0 0.0003911011153832078
that O 0 2.476306508469861e-05
result O 0 7.502859807573259e-05
in O 0 3.529884634190239e-05
amino O 0 0.00015216296014841646
acid O 0 0.0015577697195112705
substitutions O 0 0.0005960754351690412
- O 0 0.001262434059754014
cDNA O 0 0.0014387557748705149
nucleotides O 0 0.0019270336488261819
845 O 0 0.04165171831846237
G O 0 0.027985427528619766
- O 0 0.004468690138310194
- O 0 0.0026166753377765417
> O 0 0.0023864645045250654
A O 0 0.0009722035028971732
( O 0 0.0004005910304840654
C282Y O 0 0.005469346884638071
) O 0 9.496948769083247e-05
and O 0 9.58399468800053e-05
187 O 0 0.003503306768834591
C O 0 0.0097842738032341
- O 0 0.0031264680437743664
- O 0 0.0035521446261554956
> O 0 0.006341023836284876
G O 0 0.011596410535275936
( O 0 0.001171911251731217
H63D O 1 0.8982788920402527
) O 0 0.0005226177745498717
. O 0 0.0006660100189037621

Although O 0 0.02018599398434162
hemochromatosis B-Disease 1 0.9998698234558105
is O 0 0.0012357821688055992
common O 0 0.0011315973242744803
in O 0 0.0004324684268794954
Caucasians O 1 0.6291194558143616
, O 0 0.00031224230770021677
affecting O 0 0.018130822107195854
> O 0 0.019041214138269424
= O 0 0.002943075727671385
1 O 0 0.0011641285382211208
/ O 0 0.004902208689600229
300 O 0 0.00026141107082366943
individuals O 0 5.1406903367023915e-05
of O 0 2.300670530530624e-05
northern O 0 0.0003956102591473609
European O 0 0.0002219422603957355
origin O 0 6.82493846397847e-05
, O 0 0.00012262909149285406
it O 0 0.00012030798097839579
has O 0 0.00024299572396557778
not O 0 7.463440852006897e-05
been O 0 0.00012727436842396855
recognized O 0 0.00027825290453620255
in O 0 6.241713708732277e-05
other O 0 8.427652937825769e-05
populations O 0 0.00102867535315454
. O 0 0.0007030020351521671

The O 0 0.0005588561180047691
present O 0 0.00033443636493757367
study O 0 0.00038483523530885577
used O 0 0.00013302278239279985
PCR O 0 0.0019033425487577915
and O 0 8.314206934301183e-05
restriction O 0 0.0006529985112138093
- O 0 0.0023005676921457052
enzyme O 0 0.0009300147066824138
digestion O 0 0.004040505737066269
to O 0 4.043092121719383e-05
analyze O 0 0.00028800172731280327
the O 0 1.962980422831606e-05
frequency O 0 4.3182353692827746e-05
of O 0 1.2941574823344126e-05
the O 0 0.00037263715057633817
845 O 1 0.749049186706543
G O 0 0.03223753720521927
- O 0 0.0034284552093595266
- O 0 0.001636255532503128
> O 0 0.0017887332942336798
A O 0 0.0004587416769936681
and O 0 0.00019013484416063875
187 O 0 0.0045563834719359875
C O 0 0.012394051998853683
- O 0 0.00581276835873723
- O 0 0.004665372893214226
> O 0 0.006165253929793835
G O 0 0.007586232386529446
mutations O 0 0.0010094528552144766
in O 0 0.0003833316150121391
HLA O 1 0.9929007291793823
- O 0 0.001957218162715435
typed O 0 0.0008393611060455441
samples O 0 0.00023652223171666265
from O 0 0.00013913023576606065
non O 0 0.001940988120622933
- O 0 0.007097318768501282
Caucasian O 0 0.012157507240772247
populations O 0 0.0002829125733114779
, O 0 0.00010234561341349036
comprising O 0 0.0003603391523938626
Australian O 0 0.0015674976166337729
Aboriginal O 0 0.003227682551369071
, O 0 0.00021486845798790455
Chinese O 0 0.0004259310953784734
, O 0 0.0001688609627308324
and O 0 0.00027856745873577893
Pacific O 0 0.00454714335501194
Islanders O 0 0.008191403932869434
. O 0 0.0007129009463824332

Results O 0 0.0017147869803011417
showed O 0 0.0006323363049887121
that O 0 9.276654600398615e-05
the O 0 0.0003012667584698647
845 O 1 0.7641379833221436
G O 0 0.23011720180511475
- O 0 0.008301421999931335
- O 0 0.003655151231214404
> O 0 0.0028569535352289677
A O 0 0.0011956015368923545
mutation O 0 0.0014093596255406737
was O 0 0.00024448535987176
present O 0 5.995163883198984e-05
in O 0 4.856735540670343e-05
these O 0 2.3996628442546353e-05
populations O 0 0.0003035719273611903
( O 0 0.00017255476268474013
allele O 0 0.000570156960748136
frequency O 0 0.00013968149141874164
0 O 0 0.00022795438417233527
. O 0 3.22355299431365e-05
32 O 0 0.00015654588059987873
% O 0 2.984221646329388e-05
) O 0 9.461947774980217e-05
, O 0 8.241640898631886e-05
and O 0 7.604972779517993e-05
, O 0 0.00015328970039263368
furthermore O 0 0.0007183993584476411
, O 0 9.868430061032996e-05
it O 0 8.869187149684876e-05
was O 0 0.0003734575875569135
always O 0 0.0003507689980324358
seen O 0 0.00040668336441740394
in O 0 0.0001054438398568891
conjunction O 0 0.0023716276045888662
with O 0 0.0008113083895295858
HLA O 1 0.997209370136261
haplotypes O 0 0.008854507468640804
common O 0 0.0008185878396034241
in O 0 0.00038859806954860687
Caucasians O 0 0.3955114483833313
, O 0 0.0001890519924927503
suggesting O 0 0.0015400757547467947
that O 0 0.0002331205178052187
845 O 1 0.7362121343612671
G O 0 0.37395086884498596
- O 0 0.010534720495343208
- O 0 0.005436515435576439
> O 0 0.004934690427035093
A O 0 0.0016702977009117603
may O 0 0.0005785390385426581
have O 0 6.275776104303077e-05
been O 0 8.877809159457684e-05
introduced O 0 0.00012673207675106823
into O 0 3.9032191125443205e-05
these O 0 2.8376436603139155e-05
populations O 0 0.00032311040558852255
by O 0 0.00024284030951093882
Caucasian O 0 0.4202021062374115
admixture O 0 0.14255622029304504
. O 0 0.0022418226581066847

187 O 0 0.02089342102408409
C O 0 0.03740454837679863
- O 0 0.008943257853388786
- O 0 0.005604803096503019
> O 0 0.006755079608410597
G O 0 0.0063030715100467205
was O 0 0.0002558019768912345
present O 0 7.222678686957806e-05
at O 0 9.348335879622027e-05
an O 0 0.00010060783824883401
allele O 0 0.0007400417234748602
frequency O 0 0.00010284818563377485
of O 0 4.263559094397351e-05
2 O 0 0.0010761895682662725
. O 0 0.0006667327834293246

68 O 0 0.003986131865531206
% O 0 8.559101115679368e-05
in O 0 7.658653339603916e-05
the O 0 8.714359864825383e-05
two O 0 7.201179687399417e-05
populations O 0 0.0004007226089015603
analyzed O 0 0.0014241669559851289
( O 0 0.0004220914270263165
Australian O 0 0.001221750397235155
Aboriginal O 0 0.002272255951538682
and O 0 0.00012941988825332373
Chinese O 0 0.0005141373258084059
) O 0 0.00041299962322227657
. O 0 0.0005616664420813322

In O 0 0.0005236032302491367
the O 0 0.0003271542373113334
Australian O 0 0.0016785803018137813
Aboriginal O 0 0.001971912570297718
samples O 0 0.0005576594267040491
, O 0 0.00032696680864319205
187 O 0 0.004833853337913752
C O 0 0.015410720370709896
- O 0 0.005079899448901415
- O 0 0.00428029103204608
> O 0 0.006973668467253447
G O 0 0.008142049424350262
was O 0 0.00028630762244574726
found O 0 9.099734597839415e-05
to O 0 3.7684894778067246e-05
be O 0 5.464688365464099e-05
associated O 0 0.0001829324319260195
with O 0 0.00037935940781608224
HLA O 1 0.997619092464447
haplotypes O 0 0.009292270988225937
common O 0 0.000977305811829865
in O 0 0.0004616826481651515
Caucasians O 1 0.8916001319885254
, O 0 0.00028869343805126846
suggesting O 0 0.0016034357249736786
that O 0 5.790907744085416e-05
it O 0 5.4468946473207325e-05
was O 0 0.00023092509945854545
introduced O 0 0.0002407922875136137
by O 0 0.00010804687917698175
recent O 0 0.0013255639933049679
admixture O 0 0.04043316841125488
. O 0 0.0017185646574944258

In O 0 0.0003446586197242141
the O 0 0.0001475306344218552
Chinese O 0 0.00024940987350419164
samples O 0 0.00036109640495851636
analyzed O 0 0.0006897778366692364
, O 0 0.0002359172940487042
187 O 0 0.004508431069552898
C O 0 0.011019446887075901
- O 0 0.005058179143816233
- O 0 0.004162028431892395
> O 0 0.006336452905088663
G O 0 0.006054115016013384
was O 0 0.0003588226391002536
present O 0 0.00014207159983925521
in O 0 0.0001449486007913947
association O 0 0.0017780918860808015
with O 0 6.195234891492873e-05
a O 0 0.00022078353504184633
wide O 0 0.0005252587725408375
variety O 0 0.0002705802908167243
of O 0 0.00015199634071905166
HLA O 1 0.9994770884513855
haplotypes O 0 0.006981181912124157
, O 0 0.00011017001088475809
showing O 0 0.00038290777592919767
this O 0 7.717216067248955e-05
mutation O 0 0.0004890486598014832
to O 0 5.277291711536236e-05
be O 0 5.119512206874788e-05
widespread O 0 0.00042411088361404836
and O 0 0.0001149794043158181
likely O 0 0.0003721067914739251
to O 0 8.395808254135773e-05
predate O 0 0.002425071317702532
the O 0 4.5015389332547784e-05
more O 0 8.9921428298112e-05
genetically O 0 0.0008789749117568135
restricted O 0 0.001273887581191957
845 O 1 0.5702080726623535
G O 0 0.41349008679389954
- O 0 0.008886877447366714
- O 0 0.003684618044644594
> O 0 0.0034639863297343254
A O 0 0.0016485063824802637
mutation O 0 0.002523585921153426
. O 0 0.0006003789603710175

Genotype O 1 0.8437277674674988
- O 0 0.03581159561872482
phenotype O 0 0.042580991983413696
correlations O 0 0.005338600371032953
in O 0 0.002438642317429185
attenuated B-Disease 1 0.9986922144889832
adenomatous I-Disease 1 0.999980092048645
polyposis I-Disease 1 0.9999735355377197
coli I-Disease 1 0.9995587468147278
. O 0 0.004733285401016474

Germ O 1 0.9899641871452332
- O 0 0.007858780212700367
line O 0 0.001037614420056343
mutations O 0 0.00043909953092224896
of O 0 3.3736003388185054e-05
the O 0 0.0010375244310125709
tumor B-Disease 1 0.9997877478599548
suppressor O 1 0.8741570711135864
APC O 1 0.9298563599586487
are O 0 0.00016103274538181722
implicated O 0 0.39043673872947693
in O 0 0.0021543444599956274
attenuated B-Disease 1 0.9987776875495911
adenomatous I-Disease 1 0.9999898672103882
polyposis I-Disease 1 0.9999828338623047
coli I-Disease 1 0.9998438358306885
( O 0 0.09189874678850174
AAPC B-Disease 1 0.9997255206108093
) O 0 0.0005063648568466306
, O 0 0.0001484118984080851
a O 0 0.0006436678231693804
variant O 0 0.014603368937969208
of O 0 0.0005559844430536032
familial B-Disease 1 0.999976396560669
adenomatous I-Disease 1 0.9999904632568359
polyposis I-Disease 1 0.9999912977218628
( O 1 0.5035849213600159
FAP B-Disease 1 0.9992765784263611
) O 0 0.0023290240205824375
. O 0 0.0013241675915196538

AAPC B-Disease 1 0.9971420168876648
is O 0 0.0010981441009789705
recognized O 0 0.0005729245604015887
by O 0 4.2735970055218786e-05
the O 0 0.00012059925211360678
occurrence O 0 0.0015062839956954122
of O 0 8.690394315635785e-05
< O 0 0.02690912038087845
100 O 0 0.0015539918094873428
colonic B-Disease 1 0.9979653358459473
adenomas I-Disease 1 0.9944429993629456
and O 0 0.00017238606233149767
a O 0 0.0006178845651447773
later O 0 0.0010298676788806915
onset O 1 0.9994207620620728
of O 0 0.010522987693548203
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999984502792358
( O 0 0.0015922171296551824
age O 0 0.0016496964963153005
> O 0 0.01317533478140831
40 O 0 0.0005371898296289146
years O 0 0.0006364234141074121
) O 0 0.0003552206326276064
. O 0 0.0004979109507985413

The O 0 0.0005013369373045862
aim O 0 0.0011376081965863705
of O 0 3.39258331223391e-05
this O 0 7.779725274303928e-05
study O 0 0.0004360705497674644
was O 0 0.00026240161969326437
to O 0 0.0001716666156426072
assess O 0 0.040362726897001266
genotype O 0 0.19819679856300354
- O 0 0.015114819630980492
phenotype O 0 0.027447856962680817
correlations O 0 0.004086875822395086
in O 0 0.0015865935711190104
AAPC B-Disease 1 0.9990590214729309
families O 0 0.002613834338262677
. O 0 0.0015802732668817043

By O 0 0.00030115508707240224
protein O 0 0.0011031911708414555
- O 0 0.002819259185343981
truncation O 0 0.007097617723047733
test O 0 0.0015288309659808874
( O 0 0.0007717714761383832
PTT O 0 0.024592628702521324
) O 0 0.00022515385353472084
assay O 0 0.000901011866517365
, O 0 5.94273951719515e-05
the O 0 7.810723764123395e-05
entire O 0 0.0008819219656288624
coding O 0 0.001691152690909803
region O 0 0.00036826773430220783
of O 0 3.2178279070649296e-05
the O 0 0.000557310355361551
APC B-Disease 1 0.9898527264595032
gene O 0 0.0020092662889510393
was O 0 0.0006792463827878237
screened O 0 0.0018123429035767913
in O 0 0.00019744577002711594
affected O 0 0.0024537653662264347
individuals O 0 0.00022296266979537904
from O 0 0.00040607480332255363
11 O 0 0.019972091540694237
AAPC B-Disease 1 0.9995641112327576
kindreds O 1 0.6265829801559448
, O 0 0.00030295003671199083
and O 0 8.421642996836454e-05
their O 0 9.68643871601671e-05
phenotypic O 0 0.004469196777790785
differences O 0 0.0011500102700665593
were O 0 0.00021641564671881497
examined O 0 0.18774953484535217
. O 0 0.000802353082690388

Five O 0 0.002153659937903285
novel O 0 0.007619677577167749
germ O 1 0.9936343431472778
- O 0 0.02603810839354992
line O 0 0.0046644252724945545
APC B-Disease 1 0.9030669927597046
mutations O 0 0.0016971209552139044
were O 0 5.783634333056398e-05
identified O 0 0.0003480238374322653
in O 0 0.00013761394075118005
seven O 0 0.0007680422277189791
kindreds O 0 0.23748984932899475
. O 0 0.0010953351156786084

Mutations O 0 0.006249027792364359
were O 0 0.00010591464524623007
located O 0 0.0003485323104541749
in O 0 4.836943844566122e-05
three O 0 2.4545304768253118e-05
different O 0 1.0485341590538155e-05
regions O 0 8.650466770632192e-05
of O 0 2.341395156690851e-05
the O 0 0.000436615024227649
APC B-Disease 1 0.9701226353645325
gene O 0 0.001227236702106893
( O 0 0.0002711688575800508
1 O 0 0.00023529978352598846
) O 0 7.361372990999371e-05
at O 0 8.710887050256133e-05
the O 0 8.513385546393692e-05
5 O 0 0.00026922134566120803
end O 0 0.00042607297655195
spanning O 0 0.0011620500590652227
exons O 0 0.0012787299929186702
4 O 0 0.00025683865533210337
and O 0 5.430567398434505e-05
5 O 0 0.00018935903790406883
, O 0 8.274178981082514e-05
( O 0 0.00013626404688693583
2 O 0 0.00013413437409326434
) O 0 4.548228025669232e-05
within O 0 7.440827903337777e-05
exon O 0 0.0031350876670330763
9 O 0 0.00035281997406855226
, O 0 9.879116259980947e-05
and O 0 8.510755287716165e-05
( O 0 0.00021577982988674194
3 O 0 0.00019395149138290435
) O 0 4.901594002149068e-05
at O 0 7.311554509215057e-05
the O 0 9.620712808100507e-05
3 O 0 0.0005228819791227579
distal O 0 0.3382379114627838
end O 0 0.00032256069243885577
of O 0 2.340359060326591e-05
the O 0 0.00037134645390324295
gene O 0 0.002936967182904482
. O 0 0.0006960272439755499

Variability O 0 0.005206865258514881
in O 0 0.0001050313949235715
the O 0 8.430852176388726e-05
number O 0 8.182204328477383e-05
of O 0 0.0006643016822636127
colorectal B-Disease 1 0.9999996423721313
adenomas I-Disease 1 0.9999656677246094
was O 0 0.002587004564702511
most O 0 0.0002975998795591295
apparent O 0 0.005914168432354927
in O 0 9.889201464829966e-05
individuals O 0 0.00012061880261171609
with O 0 0.00010622061381582171
mutations O 0 0.0006535922293551266
in O 0 6.886537448735908e-05
region O 0 0.0005613422836177051
1 O 0 0.00022460815671365708
, O 0 0.00012130718096159399
and O 0 0.0003448959323577583
upper O 1 0.9993164539337158
- O 1 0.9988549947738647
gastrointestinal O 1 0.9999585151672363
manifestations O 1 0.8306729197502136
were O 0 0.00014835389447398484
more O 0 0.00044038830674253404
severe O 1 0.9995999932289124
in O 0 0.0002849922457244247
them O 0 0.00020364936790429056
. O 0 0.0008130930946208537

In O 0 0.0005274145514704287
individuals O 0 0.00020419653446879238
with O 0 0.00014357287727762014
mutations O 0 0.0007216538651846349
in O 0 7.750195800326765e-05
either O 0 0.0001694819948170334
region O 0 0.0006532748229801655
2 O 0 0.00024913702509365976
or O 0 0.0001091085359803401
region O 0 0.00040646246634423733
3 O 0 0.00015889568021520972
, O 0 4.23147102992516e-05
the O 0 5.093634172226302e-05
average O 0 0.00019950300338678062
number O 0 2.3909000447019935e-05
of O 0 0.00010492608998902142
adenomas B-Disease 1 0.9986080527305603
tended O 0 0.002171427709981799
to O 0 0.00011822318629128858
be O 0 8.829322905512527e-05
lower O 0 0.0005529006011784077
than O 0 5.6115943152690306e-05
those O 0 3.329306491650641e-05
in O 0 5.4589068895438686e-05
individuals O 0 0.00010017953172791749
with O 0 7.666341116419062e-05
mutations O 0 0.0006486136699095368
in O 0 8.638884901301935e-05
region O 0 0.0007536310004070401
1 O 0 0.00029231776716187596
, O 0 0.00012631391291506588
although O 0 0.0002571588847786188
age O 0 0.0006991979316808283
at O 0 0.002504477510228753
diagnosis O 1 0.9999200105667114
was O 0 0.0010085947578772902
similar O 0 0.0006624438101425767
. O 0 0.0006444528698921204

In O 0 0.0014595065731555223
all O 0 0.0010983680840581656
AAPC B-Disease 1 0.9981526732444763
kindreds O 0 0.05135010927915573
, O 0 0.0002357540506636724
a O 0 0.0002906301524490118
predominance O 0 0.0032268508803099394
of O 0 0.00011342261859681457
right O 0 0.43129095435142517
- O 1 0.9929057359695435
sided O 1 0.9989287257194519
colorectal B-Disease 1 0.9999982118606567
adenomas I-Disease 1 0.9998496770858765
and O 0 0.02881835773587227
rectal B-Disease 1 0.999969482421875
polyp I-Disease 1 0.9999209642410278
sparing O 1 0.9702082872390747
was O 0 0.0018148188246414065
observed O 0 0.0016308545600622892
. O 0 0.00100425083655864

No O 0 0.007869398221373558
desmoid B-Disease 1 0.995486319065094
tumors I-Disease 1 0.9997758269309998
were O 0 0.00013743220188189298
found O 0 0.00018859973351936787
in O 0 9.349628089694306e-05
these O 0 0.00014737372111994773
kindreds O 0 0.48620525002479553
. O 0 0.0009741727844811976

Our O 0 0.0008586174226365983
data O 0 0.00022463835193775594
suggest O 0 0.0006408074987120926
that O 0 0.00010201626719208434
, O 0 0.00021721278608310968
in O 0 0.0007366141071543097
AAPC B-Disease 1 0.9993327260017395
families O 0 0.0004499847418628633
, O 0 6.511169340228662e-05
the O 0 4.3698302761185914e-05
location O 0 8.912519115256146e-05
of O 0 2.2257194359553978e-05
the O 0 0.0006872194935567677
APC B-Disease 1 0.9953444600105286
mutation O 0 0.007509621325880289
may O 0 0.002200461458414793
partially O 0 0.009545219130814075
predict O 0 0.0017053547780960798
specific O 0 0.00032283851760439575
phenotypic O 0 0.00707150436937809
expression O 0 0.0026584246661514044
. O 0 0.0010771115776151419

This O 0 0.00043841422302648425
should O 0 0.0003182115324307233
help O 0 0.0003464137262199074
in O 0 4.651439667213708e-05
the O 0 6.30039066891186e-05
design O 0 0.0005172916571609676
of O 0 0.00011106162855867296
tailored O 1 0.9837379455566406
clinical O 1 0.999778687953949
- O 1 0.6060894131660461
management O 0 0.11966902017593384
protocols O 0 0.002393546048551798
in O 0 5.1931358029833063e-05
this O 0 4.43543067376595e-05
subset O 0 0.0010769987711682916
of O 0 0.0003343349671922624
FAP B-Disease 1 0.9999526739120483
patients O 1 0.9998303651809692
. O 0 0.0004364939231891185
. O 0 0.0008417502976953983

Wilms B-Disease 1 0.9996535778045654
' I-Disease 1 0.75514817237854
tumor I-Disease 1 0.9962815642356873
1 O 0 0.0007008243119344115
and O 0 0.00035360391484573483
Dax O 1 0.7516188025474548
- O 0 0.0020232456736266613
1 O 0 0.0003966173972003162
modulate O 0 0.005714733153581619
the O 0 0.00037683863774873316
orphan O 0 0.3366173207759857
nuclear O 0 0.0038908952847123146
receptor O 0 0.008408981375396252
SF O 1 0.9902223348617554
- O 0 0.0015711437445133924
1 O 0 0.00018318202637601644
in O 0 0.00010277427645632997
sex O 0 0.0009715348714962602
- O 0 0.0017659359145909548
specific O 0 0.0002806157572194934
gene O 0 0.0015661243814975023
expression O 0 0.0012837453978136182
. O 0 0.000804788141977042

Products O 0 0.002117779338732362
of O 0 0.0001685733295744285
steroidogenic O 1 0.9820168614387512
factor O 0 0.0013064342783764005
1 O 0 0.0007246043533086777
( O 0 0.0009523260523565114
SF O 1 0.9884569644927979
- O 0 0.0015017027035355568
1 O 0 0.00027227425016462803
) O 0 0.00018201135389972478
and O 0 0.0005065685836598277
Wilms B-Disease 1 0.9999053478240967
tumor I-Disease 1 0.9986255168914795
1 O 0 0.001206065877340734
( O 0 0.001836952636949718
WT1 O 1 0.9936103224754333
) O 0 0.0002067541645374149
genes O 0 0.00010859101166715845
are O 0 1.299689756706357e-05
essential O 0 0.0004650749615393579
for O 0 0.0002130812790710479
mammalian O 0 0.005971597507596016
gonadogenesis O 0 0.2303887903690338
prior O 0 0.00047400794574059546
to O 0 0.0001619847898837179
sexual O 0 0.0019384025363251567
differentiation O 0 0.005353478714823723
. O 0 0.000992853892967105

In O 0 0.0011975413653999567
males O 0 0.002435791539028287
, O 0 0.00124315544962883
SF O 1 0.9956402778625488
- O 0 0.0038003972731530666
1 O 0 0.0005650434759445488
participates O 0 0.0022131495643407106
in O 0 0.0001398540916852653
sexual O 0 0.0008811383740976453
development O 0 0.0006175186717882752
by O 0 8.07197138783522e-05
regulating O 0 0.0014607793418690562
expression O 0 0.0001872972643468529
of O 0 2.282194691360928e-05
the O 0 0.00030820700339972973
polypeptide O 0 0.012867660261690617
hormone O 1 0.9415897727012634
Mullerian O 1 0.9936515092849731
inhibiting O 0 0.23379570245742798
substance O 1 0.9852876663208008
( O 0 0.004962838254868984
MIS O 1 0.9959510564804077
) O 0 0.0007388167432509363
. O 0 0.0008891788311302662

Here O 0 0.0010375704150646925
, O 0 0.00026644792524166405
we O 0 0.00026184809394180775
show O 0 0.0005354261957108974
that O 0 0.0006088712834753096
WT1 O 1 0.9867706298828125
- O 0 0.0187106691300869
KTS O 1 0.8176244497299194
isoforms O 0 0.00257859262637794
associate O 0 0.003468397306278348
and O 0 0.000529915967490524
synergize O 1 0.7397658824920654
with O 0 0.0009339743410237134
SF O 1 0.9945574998855591
- O 0 0.002291097305715084
1 O 0 0.00022287765750661492
to O 0 8.59641659189947e-05
promote O 0 0.0016083820955827832
MIS O 1 0.9727932214736938
expression O 0 0.0017142676515504718
. O 0 0.000835718004964292

In O 0 0.001026106532663107
contrast O 0 0.003676112275570631
, O 0 0.0018537280848249793
WT1 O 1 0.9976361989974976
missense O 0 0.03317167982459068
mutations O 0 0.0022487391252070665
, O 0 0.00016935131861828268
associated O 0 0.00022870981774758548
with O 0 0.000145071666338481
male B-Disease 0 0.001894841087050736
pseudohermaphroditism I-Disease 1 0.9978097081184387
in O 0 0.0012941195163875818
Denys B-Disease 1 0.9994631409645081
- I-Disease 1 0.9970272183418274
Drash I-Disease 1 0.9995469450950623
syndrome I-Disease 1 0.9999932050704956
, O 0 0.0007624231511726975
fail O 0 0.019707148894667625
to O 0 0.0002830501471180469
synergize O 1 0.9227254986763
with O 0 0.0009422895382158458
SF O 1 0.9977644681930542
- O 0 0.004321104846894741
1 O 0 0.0007554790354333818
. O 0 0.0004799873859155923

Additionally O 0 0.0031508307438343763
, O 0 0.0002698380558285862
the O 0 0.00045291450805962086
X O 0 0.03294231742620468
- O 0 0.003872229717671871
linked O 0 0.0017965013394132257
, O 0 0.00016793256509117782
candidate O 0 0.0011679738527163863
dosage O 1 0.8001709580421448
- O 0 0.0035128952004015446
sensitive O 0 0.0033047713804990053
sex O 0 0.0018417483661323786
- O 0 0.004093433730304241
reversal O 0 0.008212443441152573
gene O 0 0.0018543211044743657
, O 0 0.00037111787241883576
Dax O 1 0.9169424772262573
- O 0 0.0022618218790739775
1 O 0 0.000363941362593323
, O 0 0.00024003448197618127
antagonizes O 0 0.049260832369327545
synergy O 0 0.0071641928516328335
between O 0 0.0009066188358701766
SF O 1 0.9920421242713928
- O 0 0.0029592826031148434
1 O 0 0.00040197197813540697
and O 0 0.00044933706521987915
WT1 O 1 0.9971756935119629
, O 0 0.0001764635817380622
most O 0 8.191425149561837e-05
likely O 0 0.00021158374147489667
through O 0 4.8812333261594176e-05
a O 0 0.0001002927019726485
direct O 0 0.00012452054943423718
interaction O 0 0.00038390408735722303
with O 0 0.00046659004874527454
SF O 1 0.9978582262992859
- O 0 0.003674533450976014
1 O 0 0.0006498805596493185
. O 0 0.00044336041901260614

We O 0 0.0015553648117929697
propose O 0 0.005630294792354107
that O 0 0.0006772864726372063
WT1 O 1 0.989597737789154
and O 0 0.0007665400044061244
Dax O 1 0.96036297082901
- O 0 0.003818915691226721
1 O 0 0.0005411572637967765
functionally O 0 0.005399732384830713
oppose O 0 0.00043698539957404137
each O 0 2.766183933999855e-05
other O 0 4.185650323051959e-05
in O 0 0.00022290676133707166
testis O 1 0.8161842823028564
development O 0 0.0011116190580651164
by O 0 0.0003987021336797625
modulating O 1 0.7879413366317749
SF O 1 0.9943011999130249
- O 0 0.004844885319471359
1 O 0 0.0010067729745060205
- O 0 0.004174954257905483
mediated O 0 0.013640505261719227
transactivation O 0 0.08082547038793564
. O 0 0.0005366673576645553
. O 0 0.0008773528970777988

A O 0 0.005907982122153044
mouse O 0 0.012801633216440678
model O 0 0.0015164694050326943
for O 0 0.002512158825993538
Prader B-Disease 1 0.9999791383743286
- I-Disease 1 0.9993165731430054
Willi I-Disease 1 0.9999724626541138
syndrome I-Disease 1 0.9999868869781494
imprinting O 1 0.9726731181144714
- O 0 0.11662139743566513
centre O 0 0.007093485444784164
mutations O 0 0.0042114583775401115
. O 0 0.0007459440384991467

Imprinting O 0 0.02586842142045498
in O 0 0.0004397804441396147
the O 0 0.000735592795535922
15q11 O 0 0.12631836533546448
- O 0 0.007033554371446371
q13 O 0 0.00856001302599907
region O 0 0.0007670442573726177
involves O 0 0.0008729171822778881
an O 0 0.00029987728339619935
imprinting O 0 0.039744600653648376
centre O 0 0.0062693944200873375
( O 0 0.001348423771560192
IC O 1 0.8929365873336792
) O 0 0.00019456347217783332
, O 0 8.384959073737264e-05
mapping O 0 0.0005902888369746506
in O 0 7.419642497552559e-05
part O 0 0.0002236213767901063
to O 0 7.438883767463267e-05
the O 0 0.0001724445610307157
promoter O 0 0.005890781059861183
and O 0 9.09356604097411e-05
first O 0 0.00015425978926941752
exon O 0 0.0038913169410079718
of O 0 0.00015311979223042727
SNRPN O 1 0.9867571592330933
. O 0 0.001100859371945262

Deletion O 0 0.006105989217758179
of O 0 0.00010200041288044304
this O 0 0.0005454273195937276
IC O 1 0.9685249924659729
abolishes O 0 0.07126988470554352
local O 0 0.0005059175891801715
paternally O 0 0.0166478268802166
derived O 0 0.00035036043846048415
gene O 0 0.0007430107798427343
expression O 0 0.00023702385078649968
and O 0 9.341206168755889e-05
results O 0 0.0005288991960696876
in O 0 0.0010637143859639764
Prader B-Disease 1 0.9999804496765137
- I-Disease 1 0.9995207786560059
Willi I-Disease 1 0.9999754428863525
syndrome I-Disease 1 0.9999945163726807
( O 0 0.19017431139945984
PWS B-Disease 1 0.9999184608459473
) O 0 0.0018818634562194347
. O 0 0.0009601768106222153

We O 0 0.0005068090977147222
have O 0 8.259106107288972e-05
created O 0 0.0001862916542449966
two O 0 9.458493150305003e-05
deletion O 0 0.004388112109154463
mutations O 0 0.00151042640209198
in O 0 0.0003500330785755068
mice O 0 0.16904033720493317
to O 0 0.0004256473621353507
understand O 0 0.11776570230722427
PWS B-Disease 1 0.9998183846473694
and O 0 0.0001361396280117333
the O 0 8.078046812443063e-05
mechanism O 0 0.0004087380657438189
of O 0 3.7638525100192055e-05
this O 0 0.0003137390303891152
IC O 1 0.9802687764167786
. O 0 0.0008894534548744559

Mice O 1 0.8336572647094727
harbouring O 1 0.9133711457252502
an O 0 0.0014778007753193378
intragenic O 1 0.8130735158920288
deletion O 0 0.009914863854646683
in O 0 0.0005239492165856063
Snrpn O 1 0.7839468121528625
are O 0 0.0001462404034100473
phenotypically O 1 0.7446015477180481
normal O 0 0.00246579316444695
, O 0 0.00017732751439325511
suggesting O 0 0.0012480035657063127
that O 0 8.55252510518767e-05
mutations O 0 0.0005291614215821028
of O 0 5.475971556734294e-05
SNRPN O 1 0.9911869168281555
are O 0 2.9355094739003107e-05
not O 0 5.4690040997229517e-05
sufficient O 0 0.0007986206910572946
to O 0 0.000473081658128649
induce O 1 0.96855628490448
PWS B-Disease 1 0.9997497200965881
. O 0 0.002215077169239521

Mice O 0 0.021583981812000275
with O 0 0.0001540576631668955
a O 0 0.0003674236359074712
larger O 0 0.0004613753699231893
deletion O 0 0.003028543433174491
involving O 0 0.0006283425027504563
both O 0 0.00024613147252239287
Snrpn O 0 0.12112439423799515
and O 0 0.00015208477270789444
the O 0 0.0005406035925261676
putative O 1 0.9742516875267029
PWS O 1 0.9999485015869141
- O 1 0.6730660796165466
IC O 1 0.9599515795707703
lack O 0 0.001353306113742292
expression O 0 0.00023274360864888877
of O 0 2.317361577297561e-05
the O 0 0.0003159006591886282
imprinted O 0 0.060388218611478806
genes O 0 0.0012413895456120372
Zfp127 O 0 0.42610490322113037
( O 0 0.0011238096049055457
mouse O 0 0.009743954055011272
homologue O 0 0.01450029481202364
of O 0 0.00017693366680759937
ZNF127 O 1 0.9747743606567383
) O 0 0.0005100407870486379
, O 0 0.0005983267910778522
Ndn O 1 0.9848470687866211
and O 0 0.00036153075052425265
Ipw O 1 0.7238106727600098
, O 0 0.0002594974939711392
and O 0 0.00016358539869543165
manifest O 0 0.005522166378796101
several O 0 0.00031336123356595635
phenotypes O 0 0.04028137028217316
common O 0 0.005395690444856882
to O 0 0.0064429049380123615
PWS B-Disease 1 0.9999661445617676
infants O 1 0.9983318448066711
. O 0 0.002309322590008378

These O 0 0.00016365777992177755
data O 0 0.00018695644394028932
demonstrate O 0 0.0009295913041569293
that O 0 3.512952389428392e-05
both O 0 2.6658282877178863e-05
the O 0 3.9585665945196524e-05
position O 0 9.927088831318542e-05
of O 0 1.602298107172828e-05
the O 0 0.000279824947938323
IC O 1 0.9653580188751221
and O 0 7.640709372935817e-05
its O 0 0.00010326525807613507
role O 0 0.00046603396185673773
in O 0 5.003505066270009e-05
the O 0 7.461163477273658e-05
coordinate O 0 0.0009197241743095219
expression O 0 0.00015399730182252824
of O 0 1.6647927623125724e-05
genes O 0 0.00021668987756129354
is O 0 8.271692786365747e-05
conserved O 0 0.00023113659699447453
between O 0 0.0002062717394437641
mouse O 0 0.007697587832808495
and O 0 0.00016238873649854213
human O 0 0.0006552016129717231
, O 0 0.00011612113303272054
and O 0 6.0603015299420804e-05
indicate O 0 0.00022551417350769043
that O 0 4.557454667519778e-05
the O 0 0.00010876656597247347
mouse O 0 0.004039186052978039
is O 0 0.00012255988258402795
a O 0 0.00024585542269051075
suitable O 0 0.0011152935912832618
model O 0 0.0005420844536274672
system O 0 0.0004737549461424351
in O 0 6.797465175623074e-05
which O 0 4.085602631676011e-05
to O 0 8.84977271198295e-05
investigate O 0 0.0014638297725468874
the O 0 9.334688365925103e-05
molecular O 0 0.0005944088334217668
mechanisms O 0 0.0003728654410224408
of O 0 4.5898999815108255e-05
imprinting O 0 0.027941636741161346
in O 0 7.466330862371251e-05
this O 0 4.747556886286475e-05
region O 0 0.000270420394372195
of O 0 2.007453986152541e-05
the O 0 0.00019065983360633254
genome O 0 0.0027994278352707624
. O 0 0.00023861564113758504
. O 0 0.000562842411454767

Mutations O 0 0.0021009084302932024
of O 0 3.9953767554834485e-05
the O 0 0.0002825793926604092
ATM O 0 0.008935674093663692
gene O 0 0.0019446838414296508
detected O 0 0.0031066122464835644
in O 0 0.00022136718325782567
Japanese O 0 0.037586163729429245
ataxia B-Disease 1 0.9999825954437256
- I-Disease 1 0.9994639754295349
telangiectasia I-Disease 1 0.9999539852142334
patients O 1 0.9999251365661621
: O 0 0.00033420149702578783
possible O 0 0.0002820260124281049
preponderance O 0 0.00282036024145782
of O 0 1.624173455638811e-05
the O 0 0.0001067876146407798
two O 0 0.00014381403161678463
founder O 0 0.011796805076301098
mutations O 0 0.0027258936315774918
4612del165 O 0 0.0254727341234684
and O 0 0.00048710996634326875
7883del5 O 0 0.17048287391662598
. O 0 0.0007917012553662062

The O 0 0.0010409062961116433
ATM O 0 0.009584754705429077
( O 0 0.0015149940736591816
A O 1 0.9161272644996643
- O 1 0.9646944999694824
T O 1 0.9985864162445068
, O 0 0.00030951324151828885
mutated O 0 0.004937563557177782
) O 0 0.00018016966350842267
gene O 0 0.0005390825099311769
on O 0 0.00013323515304364264
human O 0 0.0012109085218980908
chromosome O 0 0.00518526416271925
11q22 O 0 0.041024304926395416
. O 0 0.0011364715173840523

3 O 0 0.0027517774142324924
has O 0 0.0012982496991753578
recently O 0 0.002146210754290223
been O 0 0.00017873459728434682
identified O 0 0.00020179648709017783
as O 0 4.019464540760964e-05
the O 0 9.402280556969345e-05
gene O 0 0.0004975782940164208
responsible O 0 0.00034016958670690656
for O 0 7.400337199214846e-05
the O 0 0.00032187445322051644
human O 1 0.722971498966217
recessive B-Disease 1 0.9998983144760132
disease I-Disease 1 0.9999973773956299
ataxia B-Disease 1 0.9999858140945435
- I-Disease 1 0.9976154565811157
telangiectasia I-Disease 1 0.9997404217720032
( O 0 0.005344832316040993
A B-Disease 1 0.9968829154968262
- I-Disease 1 0.99411940574646
T I-Disease 1 0.9989253878593445
) O 0 0.0005517331883311272
. O 0 0.0005427312571555376

In O 0 0.00043971967534162104
order O 0 0.00011528736649779603
to O 0 5.0616996304597706e-05
define O 0 0.00038296286948025227
the O 0 7.630100299138576e-05
types O 0 0.00044733163667842746
of O 0 0.0002302387438248843
disease O 1 0.9999865293502808
- O 0 0.14457057416439056
causing O 0 0.01890992745757103
ATM O 0 0.004465148784220219
mutations O 0 0.0007708542398177087
in O 0 0.00012025097385048866
Japanese O 0 0.002857235027477145
A B-Disease 1 0.998103141784668
- I-Disease 1 0.999508261680603
T I-Disease 1 0.9999376535415649
patients O 1 0.9996071457862854
as O 0 0.00010666935850167647
well O 0 0.00010368025687057525
as O 0 9.078299626708031e-05
to O 0 8.663602056913078e-05
look O 0 0.0005219463491812348
for O 0 0.00010431196278659627
possible O 0 0.0007838894962333143
mutational O 0 0.3161354064941406
hotspots O 0 0.009826513938605785
, O 0 0.00028719176771119237
reverse O 0 0.0023690499365329742
- O 0 0.001350492238998413
transcribed O 0 0.00045882651465944946
RNA O 0 0.0003504984197206795
derived O 0 0.00011780468048527837
from O 0 0.00012506829807534814
ten O 0 0.0008507488528266549
patients O 1 0.9970861077308655
belonging O 0 0.0004149906453676522
to O 0 6.417777331080288e-05
eight O 0 0.0002389790170127526
unrelated O 0 0.0031547965481877327
Japanese O 0 0.004360897466540337
A B-Disease 1 0.9971005320549011
- I-Disease 1 0.997418999671936
T I-Disease 1 0.9996154308319092
families O 0 0.0003062270116060972
was O 0 0.0003438863204792142
analyzed O 0 0.0005141819128766656
for O 0 8.270762918982655e-05
mutations O 0 0.00042926735477522016
by O 0 3.374423977220431e-05
the O 0 0.00015525777416769415
restriction O 0 0.001431249431334436
endonuclease O 0 0.03165175020694733
fingerprinting O 0 0.004165599122643471
method O 0 0.0010097181657329202
. O 0 0.0010264614829793572

As O 0 0.0009422097355127335
has O 0 0.0006351419142447412
been O 0 0.0003751808253582567
reported O 0 0.0007388181402347982
by O 0 7.953970634844154e-05
others O 0 0.0002973843365907669
, O 0 0.00012203976075397804
mutations O 0 0.0003829814959317446
that O 0 2.843082620529458e-05
lead O 0 0.00011547671601874754
to O 0 0.00011256163998041302
exon O 0 0.007923625409603119
skipping O 0 0.008172412402927876
or O 0 0.0007151557947508991
premature O 0 0.20860402286052704
protein O 0 0.0006546048680320382
truncation O 0 0.004353167023509741
were O 0 4.834296487388201e-05
also O 0 0.0001058349953382276
predominant O 0 0.0007283171871677041
in O 0 0.00015110963431652635
our O 0 0.0010394585551694036
mutants O 0 0.01857181079685688
. O 0 0.0008198180003091693

Six O 0 0.0008610404911451042
different O 0 0.00012816805974580348
mutations O 0 0.0009351608459837735
were O 0 4.130922752665356e-05
identified O 0 0.00021958208526484668
on O 0 5.4427302529802546e-05
12 O 0 7.040375930955634e-05
of O 0 1.164059813163476e-05
the O 0 0.00021647800167556852
16 O 0 0.0011753881117329001
alleles O 0 0.005112562794238329
examined O 0 0.016022462397813797
. O 0 0.001297587063163519

Four O 0 0.0003933107655029744
were O 0 0.00011295980220893398
deletions O 0 0.0014362424844875932
involving O 0 0.00044929207069799304
a O 0 0.000333049101755023
loss O 0 0.0006639570347033441
of O 0 1.2168954526714515e-05
a O 0 0.00024575955467298627
single O 0 0.00028459064196795225
exon O 0 0.005620132200419903
exon O 0 0.004691261798143387
7 O 0 0.0004270120116416365
, O 0 0.00016342512390110642
exon O 0 0.0028702712152153254
16 O 0 0.0002968319458886981
, O 0 0.00016497592150699347
exon O 0 0.004152065608650446
33 O 0 0.0008350583957508206
or O 0 0.00033182610059157014
exon O 0 0.008901678025722504
35 O 0 0.0016477610915899277
. O 0 0.0008774356683716178

The O 0 0.0006481720483861864
others O 0 0.00031430102535523474
were O 0 3.560195182217285e-05
minute O 0 0.00040792045183479786
deletions O 0 0.002103182952851057
, O 0 0.00030856599914841354
4649delA O 0 0.010399959050118923
in O 0 0.00032177011598832905
exon O 0 0.006586672738194466
33 O 0 0.0009405176970176399
and O 0 0.00021895821555517614
7883del5 O 0 0.011481795459985733
in O 0 0.0002336732723051682
exon O 0 0.009895196184515953
55 O 0 0.0027106839697808027
. O 0 0.000779199821408838

The O 0 0.0020158705301582813
mutations O 0 0.006036499980837107
4612del165 O 0 0.025686992332339287
and O 0 0.00035149959148839116
7883del5 O 0 0.012018952518701553
were O 0 4.8830672312760726e-05
found O 0 9.234905883204192e-05
in O 0 2.987031803058926e-05
more O 0 3.5543067497201264e-05
than O 0 4.458492185221985e-05
two O 0 5.630081795970909e-05
unrelated O 0 0.0017047604778781533
families O 0 0.00023312342818826437
; O 0 7.751237717457116e-05
44 O 0 0.00017492251936346292
% O 0 4.0410683141089976e-05
( O 0 0.00019881216576322913
7 O 0 0.00011360675125615671
of O 0 1.3726783436140977e-05
16 O 0 0.00021435647795442492
) O 0 3.454011675785296e-05
of O 0 1.0367534741817508e-05
the O 0 0.00016080688510555774
mutant O 0 0.0028481283225119114
alleles O 0 0.0009235887555405498
had O 0 0.00011582320439629257
one O 0 1.8835749870049767e-05
of O 0 9.772078556125052e-06
the O 0 0.00010545439727138728
two O 0 0.00014703346823807806
mutations O 0 0.002587391994893551
. O 0 0.0006102267070673406

The O 0 0.0016240290133282542
4612del165 O 0 0.031223798170685768
mutations O 0 0.0012569549726322293
in O 0 6.050299634807743e-05
three O 0 3.6246587114874274e-05
different O 0 2.3008811695035547e-05
families O 0 8.713611896382645e-05
were O 0 1.3388171282713301e-05
all O 0 1.55479610839393e-05
ascribed O 0 0.0005909981555305421
to O 0 4.018920662929304e-05
the O 0 0.0001227531029144302
same O 0 0.0004113819159101695
T O 1 0.9948217868804932
- O 0 0.004535253159701824
- O 0 0.002004311652854085
> O 0 0.0013968164566904306
A O 0 0.0003341287956573069
substitution O 0 0.00018261368677485734
at O 0 0.00013728758494835347
the O 0 0.00014931836631149054
splice O 0 0.00721417460590601
donor O 0 0.003947657998651266
site O 0 0.0010644150897860527
in O 0 0.00032857456244528294
intron O 0 0.16570939123630524
33 O 0 0.0048989527858793736
. O 0 0.0010064634261652827

Microsatellite O 0 0.07387853413820267
genotyping O 0 0.02723889984190464
around O 0 0.0004193031636532396
the O 0 0.00036250537959858775
ATM O 0 0.0067105721682310104
locus O 0 0.005284277722239494
also O 0 0.00040988775435835123
indicated O 0 0.0011957586975768209
that O 0 6.874018436064944e-05
a O 0 0.00037331038038246334
common O 0 0.0013692654902115464
haplotype O 0 0.0452272929251194
was O 0 0.0003712413599714637
shared O 0 0.000157641145051457
by O 0 3.650429061963223e-05
the O 0 0.00014682683104183525
mutant O 0 0.0030450846534222364
alleles O 0 0.0010565952397882938
in O 0 0.00016615820641163737
both O 0 0.00032673930400051177
mutations O 0 0.0034335139207541943
. O 0 0.0008455095230601728

This O 0 0.0004653263895306736
suggests O 0 0.0010135897900909185
that O 0 4.1365208744537085e-05
these O 0 1.9290493582957424e-05
two O 0 9.972279076464474e-05
founder O 0 0.019618459045886993
mutations O 0 0.002157440409064293
may O 0 0.000363516912329942
be O 0 5.799142309115268e-05
predominant O 0 0.0007060646894387901
among O 0 0.00014132198703009635
Japanese O 0 0.0010251319035887718
ATM O 0 0.008857391774654388
mutant O 0 0.008498375304043293
alleles O 0 0.006075137760490179
. O 0 0.0009360856493003666

W474C O 0 0.024650879204273224
amino O 0 0.0009650559513829648
acid O 0 0.004153873771429062
substitution O 0 0.0012439946876838803
affects O 0 0.00878103356808424
early O 0 0.00014343715156428516
processing O 0 9.762441186467186e-05
of O 0 1.1155057109135669e-05
the O 0 0.0001172139382106252
alpha O 0 0.0008654558914713562
- O 0 0.00046823653974570334
subunit O 0 0.00014330017438624054
of O 0 3.6565539630828425e-05
beta O 0 0.005948561709374189
- O 0 0.003276493400335312
hexosaminidase O 0 0.012263065204024315
A O 0 0.0006783704739063978
and O 0 9.969674283638597e-05
is O 0 0.00017816474428400397
associated O 0 0.0003052333777304739
with O 0 0.0005621840246021748
subacute O 1 0.9999371767044067
G B-Disease 1 0.8990111351013184
( I-Disease 0 0.0021192841231822968
M2 I-Disease 1 0.9671032428741455
) I-Disease 0 0.001025813864544034
gangliosidosis I-Disease 0 0.1649363487958908
. O 0 0.001017121598124504

Mutations O 0 0.006718437187373638
in O 0 0.0003192979493178427
the O 0 0.0011214569676667452
HEXA O 1 0.9951580166816711
gene O 0 0.0013222415000200272
, O 0 6.924004992470145e-05
encoding O 0 0.0001300535222981125
the O 0 8.243314368883148e-05
alpha O 0 0.0007449112017638981
- O 0 0.00041298818541690707
subunit O 0 0.00017713588022161275
of O 0 2.4923127057263628e-05
beta O 0 0.0033813624177128077
- O 0 0.002389763481914997
hexosaminidase O 0 0.008144140243530273
A O 0 0.0013173391344025731
( O 0 0.0004949347348883748
Hex O 0 0.004758622497320175
A O 0 0.0008843049872666597
) O 0 8.99279402801767e-05
, O 0 6.30891663604416e-05
that O 0 5.308221443556249e-05
abolish O 0 0.0021385063882917166
Hex O 0 0.0028724772855639458
A O 0 0.0008131659124046564
enzyme O 0 0.0015092173125594854
activity O 0 0.002057468518614769
cause O 1 0.9980223178863525
Tay B-Disease 1 0.9999892711639404
- I-Disease 1 0.9984545707702637
Sachs I-Disease 1 0.9998257756233215
disease I-Disease 1 0.999964714050293
( O 0 0.004868502728641033
TSD B-Disease 1 0.999265730381012
) O 0 0.00033767244894988835
, O 0 0.00021775941422674805
the O 0 0.0007636811933480203
fatal O 1 0.9997708201408386
infantile B-Disease 1 0.9990003705024719
form I-Disease 0 0.0005418711225502193
of I-Disease 0 0.00016470806440338492
G I-Disease 1 0.7272250652313232
( I-Disease 0 0.001475321827456355
M2 I-Disease 1 0.9627801179885864
) I-Disease 0 0.000535537488758564
gangliosidosis I-Disease 0 0.09500845521688461
, I-Disease 0 0.00027945489273406565
Type I-Disease 0 0.0032853770535439253
1 I-Disease 0 0.0008409842266701162
. O 0 0.0005703080678358674

Less O 0 0.01200497429817915
severe O 1 0.999444305896759
, O 0 0.005925314035266638
subacute O 1 0.9999350309371948
( O 0 0.017603863030672073
juvenile O 1 0.9992533326148987
- O 1 0.8554735779762268
onset O 1 0.9985260367393494
) O 0 0.0005947649478912354
and O 0 0.0014152748044580221
chronic O 1 0.9999969005584717
( O 0 0.0028012068942189217
adult O 0 0.221873477101326
- O 1 0.9566541910171509
onset O 1 0.9990113973617554
) O 0 0.00024214091536123306
variants O 0 0.00048077866085805
are O 0 5.563150261878036e-05
characterized O 0 0.008388211950659752
by O 0 7.780690066283569e-05
a O 0 0.0005421193200163543
broad O 0 0.007716197054833174
spectrum O 0 0.0029856509063392878
of O 0 0.00015446997713297606
clinical O 1 0.9997466206550598
manifestations O 1 0.9828804135322571
and O 0 0.0001333882100880146
are O 0 4.3698015360860154e-05
associated O 0 0.0001785511412890628
with O 0 7.185711729107425e-05
residual O 0 0.0034895804710686207
levels O 0 0.0004360566090326756
of O 0 3.403951632208191e-05
Hex O 0 0.005545950029045343
A O 0 0.0012661253567785025
enzyme O 0 0.0017648771172389388
activity O 0 0.0009861380094662309
. O 0 0.0006965395295992494

We O 0 0.0011897365329787135
identified O 0 0.001133374753408134
a O 0 0.0019881734624505043
1422 O 1 0.9811078906059265
G O 0 0.21511733531951904
- O 0 0.007796834222972393
- O 0 0.0044722845777869225
> O 0 0.0065257353708148
C O 0 0.004597941413521767
( O 0 0.00022342060401570052
amino O 0 0.00029475189512595534
acid O 0 0.004073823802173138
W474C O 0 0.008188102394342422
) O 0 8.945138688432053e-05
substitution O 0 0.00013966789992991835
in O 0 3.366652163094841e-05
the O 0 3.3383897971361876e-05
first O 0 5.475841317093e-05
position O 0 0.00015006632020231336
of O 0 3.551951522240415e-05
exon O 0 0.003826478961855173
13 O 0 0.00024715365725569427
of O 0 5.9978512581437826e-05
HEXA O 1 0.9734241366386414
of O 0 4.379112579044886e-05
a O 0 0.0005650618113577366
non O 0 0.0019201309187337756
- O 0 0.003421633969992399
Jewish O 0 0.0009407843463122845
proband O 0 0.21029841899871826
who O 0 0.0011862014653161168
manifested O 0 0.313088595867157
a O 0 0.0030552027747035027
subacute O 1 0.9995631575584412
variant O 0 0.010480453260242939
of O 0 0.00022213722695596516
G B-Disease 1 0.8579061627388
( I-Disease 0 0.0019029324175789952
M2 I-Disease 1 0.9816492199897766
) I-Disease 0 0.0009405656601302326
gangliosidosis I-Disease 1 0.6087372899055481
. O 0 0.0009632398723624647

On O 0 0.00032443864620290697
the O 0 0.000257265055552125
second O 0 0.0008209625375457108
maternally O 0 0.1457604169845581
inherited O 1 0.8894346952438354
allele O 0 0.004243128001689911
, O 0 0.00015656498726457357
we O 0 0.00012188193795736879
identified O 0 0.00023531660553999245
the O 0 0.00023215652618091553
common O 0 0.13360869884490967
infantile O 1 0.9999793767929077
disease O 1 0.999993085861206
- O 0 0.2886851131916046
causing O 0 0.10458134114742279
4 O 0 0.0009094267152249813
- O 0 0.004465002100914717
bp O 0 0.015081705525517464
insertion O 0 0.005386562552303076
, O 0 0.0006804891745559871
+ O 0 0.059677500277757645
TATC O 1 0.9735368490219116
1278 O 1 0.6522901654243469
, O 0 0.00023788145335856825
in O 0 0.0002358743513468653
exon O 0 0.010343898087739944
11 O 0 0.0015677871415391564
. O 0 0.0007918039336800575

Pulse O 0 0.04851048067212105
- O 0 0.009703682735562325
chase O 0 0.0035637719556689262
analysis O 0 0.0002247555530630052
using O 0 0.0003688548458740115
proband O 1 0.5335515141487122
fibroblasts O 0 0.27351266145706177
revealed O 0 0.0018375086365267634
that O 0 4.896002064924687e-05
the O 0 0.00016609387239441276
W474C O 0 0.008695118129253387
- O 0 0.0008492707274854183
containing O 0 0.0001685095194261521
alpha O 0 0.0011794986203312874
- O 0 0.0011732068378478289
subunit O 0 0.0007567100110463798
precursor O 0 0.0017080731922760606
was O 0 0.00036589615046977997
normally O 0 0.0004820282047148794
synthesized O 0 0.0005682072369381785
, O 0 9.095509449252859e-05
but O 0 8.515545778209344e-05
not O 0 8.374114258913323e-05
phosphorylated O 0 0.0019044317305088043
or O 0 0.00016797131684143096
secreted O 0 0.0015080322045832872
, O 0 9.255977056454867e-05
and O 0 5.789074566564523e-05
the O 0 0.00024355470668524504
mature O 0 0.16543221473693848
lysosomal O 1 0.965393602848053
alpha O 0 0.002685477025806904
- O 0 0.0021419688127934933
subunit O 0 0.0008023691480048001
was O 0 0.0005845084087923169
not O 0 0.0002610461669974029
detected O 0 0.005681266542524099
. O 0 0.0007668625912629068

When O 0 0.0012938360450789332
the O 0 0.0004347272333689034
W474C O 0 0.012609408237040043
- O 0 0.0010759137803688645
containing O 0 0.00021528148499783128
alpha O 0 0.001230924972333014
- O 0 0.0012913511600345373
subunit O 0 0.0007843661587685347
was O 0 0.0009186294046230614
transiently O 0 0.032629773020744324
co O 0 0.005730991251766682
- O 0 0.0011758607579395175
expressed O 0 0.00014335536980070174
with O 0 2.8392869353410788e-05
the O 0 8.131124923238531e-05
beta O 0 0.0013776171253994107
- O 0 0.00043884929618798196
subunit O 0 0.00016360504378098994
to O 0 3.862370067508891e-05
produce O 0 0.0002229042147519067
Hex O 0 0.0038586135488003492
A O 0 0.0011143321171402931
( O 0 0.0005573156522586942
alphabeta O 0 0.033862438052892685
) O 0 0.00025756991817615926
in O 0 0.0004186815058346838
COS O 1 0.9855044484138489
- O 0 0.002256527543067932
7 O 0 0.0004364057385828346
cells O 0 0.0005655623972415924
, O 0 4.3177740735700354e-05
the O 0 0.000123939142213203
mature O 0 0.004650600720196962
alpha O 0 0.0010506820399314165
- O 0 0.0009193613659590483
subunit O 0 0.00041368071106262505
was O 0 0.0002073893410852179
present O 0 0.00010961879888782278
, O 0 8.433424955001101e-05
but O 0 5.129139026394114e-05
its O 0 7.099861250026152e-05
level O 0 0.00046044238843023777
was O 0 0.00018904298485722393
much O 0 0.00015208651893772185
lower O 0 0.00047795387217774987
than O 0 3.7427635106723756e-05
that O 0 2.730260712269228e-05
from O 0 5.405158663052134e-05
normal O 0 0.0009765071445144713
alpha O 0 0.0015563826309517026
- O 0 0.0017505533760413527
subunit O 0 0.0011266306973993778
transfections O 0 0.017133725807070732
, O 0 0.00019507503020577133
although O 0 0.0001676049578236416
higher O 0 0.00022340613941196352
than O 0 6.508828664664179e-05
in O 0 9.497239079792053e-05
those O 0 0.00013542830129154027
cells O 0 0.001926718046888709
transfected O 0 0.012980107218027115
with O 0 4.110704321647063e-05
an O 0 0.0001777090219547972
alpha O 0 0.0013040804769843817
- O 0 0.0014469890156760812
subunit O 0 0.0008140233694575727
associated O 0 0.00046843322343192995
with O 0 0.0009575397707521915
infantile O 1 0.9997261166572571
TSD B-Disease 1 0.9984898567199707
. O 0 0.0030713374726474285

Furthermore O 0 0.0034046084620058537
, O 0 0.0001638457615626976
the O 0 0.00011623701720964164
precursor O 0 0.0011598715791478753
level O 0 0.00021052885858807713
of O 0 1.490509748691693e-05
the O 0 0.00018678860215004534
W474C O 0 0.011713855899870396
alpha O 0 0.0014254410052672029
- O 0 0.0011288471287116408
subunit O 0 0.0005328175611793995
was O 0 0.0003618874470703304
found O 0 0.00011747733515221626
to O 0 7.59168469812721e-05
accumulate O 0 0.0018844482256099582
in O 0 4.168946543359198e-05
comparison O 0 0.0001829933316912502
to O 0 2.925780790974386e-05
the O 0 6.951978866709396e-05
normal O 0 0.0009077810100279748
alpha O 0 0.001154690864495933
- O 0 0.0014222851023077965
subunit O 0 0.0009360406547784805
precursor O 0 0.005424483213573694
levels O 0 0.003637422574684024
. O 0 0.0008977382676675916

We O 0 0.0007654469227418303
conclude O 0 0.001712265657261014
that O 0 8.196800627047196e-05
the O 0 0.0003991191042587161
1422 O 1 0.9885791540145874
G O 0 0.21111154556274414
- O 0 0.011162972077727318
- O 0 0.005483625456690788
> O 0 0.004999508149921894
C O 0 0.0038623011205345392
mutation O 0 0.000494759064167738
is O 0 7.914234447525814e-05
the O 0 9.188753028865904e-05
cause O 0 0.001350216451101005
of O 0 4.487952173803933e-05
Hex B-Disease 0 0.03765932098031044
A I-Disease 0 0.05593490973114967
enzyme I-Disease 1 0.9889260530471802
deficiency I-Disease 1 0.9999841451644897
in O 0 0.000338313722750172
the O 0 0.0008159143035300076
proband O 1 0.9461556077003479
. O 0 0.0013753373641520739

The O 0 0.001001594471745193
resulting O 0 0.0040158722549676895
W474C O 0 0.015142726711928844
substitution O 0 0.001384737086482346
clearly O 0 0.002317726844921708
interferes O 0 0.018419045954942703
with O 0 0.00016967828560154885
alpha O 0 0.0016562232049182057
- O 0 0.00117672944907099
subunit O 0 0.0003305590071249753
processing O 0 0.00043223408283665776
, O 0 0.00013891866547055542
but O 0 9.520396997686476e-05
because O 0 0.00011780299246311188
the O 0 6.247228884603828e-05
base O 0 0.0005280892364680767
substitution O 0 0.0005778741324320436
falls O 0 0.0055092317052185535
at O 0 0.00010984879190800712
the O 0 5.091851926408708e-05
first O 0 5.249800597084686e-05
position O 0 0.00013847151421941817
of O 0 3.202856896677986e-05
exon O 0 0.006567567586898804
13 O 0 0.0004749144718516618
, O 0 0.00017984458827413619
aberrant O 0 0.008343428373336792
splicing O 0 0.0016454010037705302
may O 0 0.00046215063775889575
also O 0 8.169021748472005e-05
contribute O 0 0.0009904701728373766
to O 0 0.00012153585703345016
Hex B-Disease 0 0.017016004770994186
A I-Disease 0 0.09933508187532425
deficiency I-Disease 1 0.9999257326126099
in O 0 0.00018359770183451474
this O 0 0.00023828644771128893
proband O 1 0.7883262634277344
. O 0 0.00028602551901713014
. O 0 0.0005022072582505643

Two O 0 0.0005043647834099829
frequent O 0 0.00746095459908247
missense O 0 0.026574870571494102
mutations O 0 0.008223787881433964
in O 0 0.004783221986144781
Pendred B-Disease 1 0.9999234676361084
syndrome I-Disease 1 0.9999986886978149
. O 0 0.003118104999884963

Pendred B-Disease 1 0.9996324777603149
syndrome I-Disease 1 0.9999974966049194
is O 0 0.006337672472000122
an O 0 0.16515246033668518
autosomal B-Disease 1 0.9999808073043823
recessive I-Disease 1 0.9999865293502808
disorder I-Disease 1 0.9999992847442627
characterized O 1 0.9987516403198242
by O 0 0.0010680666891857982
early O 0 0.37767961621284485
childhood O 1 0.9999685287475586
deafness B-Disease 1 0.9999995231628418
and O 1 0.7936433553695679
goiter B-Disease 1 0.9999982118606567
. O 0 0.003666174365207553

A O 0 0.0018445082241669297
century O 0 0.00031839418807066977
after O 0 0.00040923303458839655
its O 0 0.00012333245831541717
recognition O 0 0.0008050830219872296
as O 0 0.000352032802766189
a O 0 0.047456759959459305
syndrome O 1 0.9999910593032837
by O 0 0.0005386202828958631
Vaughan O 1 0.9590844511985779
Pendred O 1 0.9557725191116333
, O 0 0.0003360151022206992
the O 0 0.001401438843458891
disease O 1 0.9999727010726929
gene O 0 0.00630167918279767
( O 0 0.0016912908758968115
PDS O 1 0.9974532723426819
) O 0 0.0002984443271998316
was O 0 0.0004366597277112305
mapped O 0 0.0012748518493026495
to O 0 0.00017307614325545728
chromosome O 0 0.0027438225224614143
7q22 O 0 0.08683962374925613
- O 0 0.011817067861557007
q31 O 0 0.029190855100750923
. O 0 0.0007589115994051099

1 O 0 0.0012679601786658168
and O 0 0.00028999437927268445
, O 0 0.00030427658930420876
recently O 0 0.0018057654378935695
, O 0 8.377541234949604e-05
found O 0 5.446260911412537e-05
to O 0 2.312253309355583e-05
encode O 0 0.0002106868923874572
a O 0 0.0006871619261801243
putative O 0 0.026649009436368942
sulfate O 1 0.9870045781135559
transporter O 1 0.9465649127960205
. O 0 0.0021173027344048023

We O 0 0.0008380420040339231
performed O 0 0.0008772433502599597
mutation O 0 0.0005555919487960637
analysis O 0 6.824782758485526e-05
of O 0 3.027814454981126e-05
the O 0 0.0007796171703375876
PDS B-Disease 1 0.9993815422058105
gene O 0 0.0031061824411153793
in O 0 0.0006590393022634089
patients O 1 0.999504804611206
from O 0 0.00022159864602144808
14 O 0 0.0014219852164387703
Pendred B-Disease 1 0.6285460591316223
families O 0 0.0003657311899587512
originating O 0 0.000535226718056947
from O 0 0.00010110130097018555
seven O 0 0.000175731343915686
countries O 0 7.408428791677579e-05
and O 0 0.00011337332398397848
identified O 0 0.0004559433145914227
all O 0 8.129978232318535e-05
mutations O 0 0.0024706830736249685
. O 0 0.0006914021796546876

The O 0 0.0007459824555553496
mutations O 0 0.0011726844822987914
include O 0 9.76327937678434e-05
three O 0 4.7102439566515386e-05
single O 0 0.0001860974298324436
base O 0 0.0007381087634712458
deletions O 0 0.0010471426649019122
, O 0 9.929077350534499e-05
one O 0 9.620869241189212e-05
splice O 0 0.004165444988757372
site O 0 0.0008877465152181685
mutation O 0 0.0007747130002826452
and O 0 0.00010248653416056186
10 O 0 0.0004788869118783623
missense O 0 0.00969688966870308
mutations O 0 0.003278361400589347
. O 0 0.0005989061901345849

One O 0 0.0014943975256755948
missense O 0 0.016176629811525345
mutation O 0 0.0041973344050347805
( O 0 0.0011762931244447827
L236P O 0 0.05941598489880562
) O 0 0.0002696857845876366
was O 0 0.0003535069990903139
found O 0 0.00010560212831478566
in O 0 5.173640965949744e-05
a O 0 0.0003243474056944251
homozygous O 0 0.0009403634467162192
state O 0 5.857797077624127e-05
in O 0 7.385497156064957e-05
two O 0 0.00010017303429776803
consanguineous O 0 0.43340256810188293
families O 0 0.0002943941217381507
and O 0 7.883727812441066e-05
in O 0 8.56822298374027e-05
a O 0 0.00029450104921124876
heterozygous O 0 0.0007166447467170656
state O 0 4.976073250873014e-05
in O 0 3.836515315924771e-05
five O 0 7.469407137250528e-05
additional O 0 0.0002592573582660407
non O 0 0.0024624611251056194
- O 0 0.022305862978100777
consanguineous O 0 0.10614781826734543
families O 0 0.001146603375673294
. O 0 0.000880188075825572

Another O 0 0.004222399555146694
missense O 0 0.018588028848171234
mutation O 0 0.005049295723438263
( O 0 0.0010354656260460615
T416P O 0 0.03236832469701767
) O 0 0.0002230102982139215
was O 0 0.00031938013853505254
found O 0 8.953415817813948e-05
in O 0 5.052884080214426e-05
a O 0 0.00026237714337185025
homozygous O 0 0.0009431734797544777
state O 0 6.128437235020101e-05
in O 0 7.464978261850774e-05
one O 0 9.595589654054493e-05
family O 0 0.00022685015574097633
and O 0 5.828059511259198e-05
in O 0 7.799997547408566e-05
a O 0 0.00041415158193558455
heterozygous O 0 0.0010050011333078146
state O 0 7.49314931454137e-05
in O 0 6.732663314323872e-05
four O 0 0.00011968139733653516
families O 0 0.0005029221647419035
. O 0 0.0006094843847677112

Pendred B-Disease 1 0.9902558922767639
patients O 1 0.9986007809638977
in O 0 0.00020178186241537333
three O 0 0.0001987011346500367
non O 0 0.004022542852908373
- O 0 0.066079281270504
consanguineous O 0 0.22272008657455444
families O 0 0.0002795318723656237
were O 0 3.952598854084499e-05
shown O 0 0.00026977062225341797
to O 0 7.083138189045712e-05
be O 0 0.00012528683873824775
compound O 0 0.0030947867780923843
heterozygotes O 0 0.03939227759838104
for O 0 0.00036211955011822283
L236P O 0 0.06600389629602432
and O 0 0.0005306670209392905
T416P O 0 0.05388038977980614
. O 0 0.0010506469989195466

In O 0 0.00026282528415322304
total O 0 0.00011971587809966877
, O 0 0.00011777132021961734
one O 0 6.449778447858989e-05
or O 0 6.048592331353575e-05
both O 0 1.8122696928912774e-05
of O 0 1.1014190022251569e-05
these O 0 4.074248863616958e-05
mutations O 0 0.0004684175946749747
were O 0 2.081456477753818e-05
found O 0 5.9781395975733176e-05
in O 0 3.114305582130328e-05
nine O 0 3.95407660107594e-05
of O 0 1.1454404557298403e-05
the O 0 0.00019999554206151515
14 O 0 0.0006839356501586735
families O 0 0.00045502017019316554
analyzed O 0 0.0028786405455321074
. O 0 0.0007703559822402894

The O 0 0.0003958996385335922
identification O 0 0.0002469895116519183
of O 0 3.222907253075391e-05
two O 0 0.0002428072039037943
frequent O 0 0.05033654719591141
PDS B-Disease 1 0.9985085129737854
mutations O 0 0.0013678290415555239
will O 0 7.029654807411134e-05
facilitate O 0 0.0003748409799300134
the O 0 0.00014919911336619407
molecular O 0 0.03417428955435753
diagnosis O 1 0.9999325275421143
of O 0 0.0010139046935364604
Pendred B-Disease 1 0.9999713897705078
syndrome I-Disease 1 0.9999983310699463
. O 0 0.0028451515827327967

Insertional O 0 0.08696974813938141
mutation O 0 0.002776459092274308
by O 0 0.00020972764468751848
transposable O 0 0.02890552394092083
element O 0 0.0013804072514176369
, O 0 0.0004982964601367712
L1 O 1 0.6688974499702454
, O 0 0.00013904082879889756
in O 0 0.00013347879576031119
the O 0 0.0007376570138148963
DMD B-Disease 1 0.9998940229415894
gene O 0 0.0011829225113615394
results O 0 0.0003122169873677194
in O 0 0.00027339954976923764
X B-Disease 1 0.8515796661376953
- I-Disease 1 0.7481346130371094
linked I-Disease 1 0.9214236736297607
dilated I-Disease 1 0.9996322393417358
cardiomyopathy I-Disease 1 0.9999904632568359
. O 0 0.004980795085430145

X B-Disease 1 0.7439237236976624
- I-Disease 1 0.5297731161117554
linked I-Disease 1 0.8877688646316528
dilated I-Disease 1 0.9996482133865356
cardiomyopathy I-Disease 1 0.999996542930603
( O 0 0.013843173161149025
XLDCM B-Disease 1 0.9968980550765991
) O 0 0.0004881004279013723
is O 0 0.0003131649864371866
a O 0 0.0013183107366785407
clinical O 1 0.9972570538520813
phenotype O 0 0.024957479909062386
of O 0 8.160207653418183e-05
dystrophinopathy B-Disease 1 0.9601271748542786
which O 0 0.00010458864562679082
is O 0 0.00027047787443734705
characterized O 0 0.028578046709299088
by O 0 0.00026191299548372626
preferential O 1 0.9195340275764465
myocardial B-Disease 1 0.9999865293502808
involvement I-Disease 0 0.11555887013673782
without O 0 0.0003210041031707078
any O 0 0.00022438041924033314
overt O 0 0.18553832173347473
clinical O 1 0.9995611310005188
signs O 0 0.1873224824666977
of O 0 0.0008665670175105333
skeletal B-Disease 1 0.9999914169311523
myopathy I-Disease 1 0.9999912977218628
. O 0 0.005117957014590502

To O 0 0.00032664934406057
date O 0 0.00020724999194499105
, O 0 7.530785660492256e-05
several O 0 7.3260634962935e-05
mutations O 0 0.0006446181214414537
in O 0 0.00016781473823357373
the O 0 0.003188041504472494
Duchenne B-Disease 1 0.9999938011169434
muscular I-Disease 1 0.9999963045120239
dystrophy I-Disease 1 0.9999980926513672
gene O 1 0.7112590074539185
, O 0 0.018611880019307137
DMD O 1 0.9999916553497314
, O 0 0.0002844265545718372
have O 0 9.958424925571308e-05
been O 0 0.00016150758892763406
identified O 0 0.0004955196054652333
in O 0 0.00035347987432032824
patients O 1 0.9998239874839783
with O 0 0.00040753348730504513
XLDCM B-Disease 1 0.9981550574302673
, O 0 0.00017481714894529432
but O 0 8.64054964040406e-05
a O 0 0.0002780123904813081
pathogenic O 0 0.0034312144853174686
correlation O 0 0.00025135689065791667
of O 0 1.7281172404182144e-05
these O 0 9.381018753629178e-05
cardiospecific O 1 0.799569308757782
mutations O 0 0.00221848301589489
in O 0 0.0007369048544205725
DMD O 1 0.999916672706604
with O 0 0.00036131334491074085
the O 0 0.0010939394123852253
XLDCM B-Disease 1 0.9988077878952026
phenotype O 1 0.8448266386985779
has O 0 0.0007618824602104723
remained O 0 0.00103358319029212
to O 0 0.00011072219058405608
be O 0 0.0002759163035079837
elucidated O 0 0.04007288068532944
. O 0 0.0007206579903140664

We O 0 0.0011393304448574781
report O 0 0.000597332778852433
here O 0 7.64945725677535e-05
the O 0 3.3407526643713936e-05
identification O 0 5.638850780087523e-05
of O 0 1.2127306035836227e-05
a O 0 0.0002925994049292058
unique O 0 0.0006211129948496819
de O 0 0.0036417157389223576
novo O 0 0.009342389181256294
L1 O 0 0.033986710011959076
insertion O 0 0.0023396057076752186
in O 0 0.00012432858056854457
the O 0 0.000387208245228976
muscle O 1 0.9845592379570007
exon O 0 0.008501256816089153
1 O 0 0.0006580554763786495
in O 0 0.0006918199942447245
DMD O 1 0.999897837638855
in O 0 0.00032131216721609235
three O 0 0.0006365198642015457
XLDCM B-Disease 1 0.9995935559272766
patients O 1 0.9993405938148499
from O 0 9.801768464967608e-05
two O 0 9.466235496802256e-05
unrelated O 0 0.00600172346457839
Japanese O 0 0.0014702449552714825
families O 0 0.0011359655763953924
. O 0 0.0010014132130891085

The O 0 0.0006943815969862044
insertion O 0 0.00679289735853672
was O 0 0.0009278932120651007
a O 0 0.0006016486440785229
5 O 0 0.000843921210616827
- O 0 0.0027691384311765432
truncated O 0 0.0046331495977938175
form O 0 0.00015526665083598346
of O 0 3.392887447262183e-05
human O 0 0.001416735234670341
L1 O 0 0.3488432466983795
inversely O 0 0.0011043293634429574
integrated O 0 0.001258083269931376
in O 0 7.77927998569794e-05
the O 0 0.00015521145542152226
5 O 0 0.000626207038294524
- O 0 0.002289416966959834
untranslated O 0 0.006595849525183439
region O 0 0.0005717062158510089
in O 0 9.490159573033452e-05
the O 0 0.00035608760663308203
muscle O 1 0.989303469657898
exon O 0 0.009310605935752392
1 O 0 0.0004957333439961076
, O 0 0.00012104707275284454
which O 0 6.153841968625784e-05
affected O 0 0.0006543722120113671
the O 0 4.470055137062445e-05
transcription O 0 0.00033238172181881964
or O 0 0.00010021363414125517
the O 0 6.943392509128898e-05
stability O 0 0.0006362096755765378
of O 0 2.8788454073946923e-05
the O 0 0.0004894393496215343
muscle O 1 0.987281858921051
form O 0 0.00032405840465798974
of O 0 0.00015619937039446086
dystrophin O 1 0.9975504279136658
transcripts O 0 0.001279211021028459
but O 0 9.357076487503946e-05
not O 0 2.925457010860555e-05
that O 0 1.0787241990328766e-05
of O 0 1.0714569725678302e-05
the O 0 0.0003756301011890173
brain O 1 0.9994785189628601
or O 0 0.00118605000898242
Purkinje O 1 0.9989396929740906
cell O 0 0.003691106103360653
form O 0 0.00047607862506993115
, O 0 0.0002649962261784822
probably O 0 0.0008533765794709325
due O 0 0.0002115401584887877
to O 0 3.416446634219028e-05
its O 0 6.540423783008009e-05
unique O 0 0.0001802868500817567
site O 0 0.0002339086786378175
of O 0 2.480904004187323e-05
integration O 0 0.001739976229146123
. O 0 0.0007357554277405143

We O 0 0.0012506006751209497
speculate O 0 0.002574471291154623
that O 0 3.93039190385025e-05
this O 0 2.4674996893736534e-05
insertion O 0 0.0007592873298563063
of O 0 1.6568783394177444e-05
an O 0 0.0003037305432371795
L1 O 0 0.4591187536716461
sequence O 0 0.00044259909191168845
in O 0 0.0013201097026467323
DMD O 1 0.9999467134475708
is O 0 0.0004825807991437614
responsible O 0 0.0010182405821979046
for O 0 4.637655365513638e-05
some O 0 1.2310965757933445e-05
of O 0 5.56674831386772e-06
the O 0 3.971721889683977e-05
population O 0 2.417666655674111e-05
of O 0 4.4004835217492655e-05
Japanese O 0 0.03534591570496559
patients O 1 0.9998612403869629
with O 0 0.0005755731253884733
XLDCM B-Disease 1 0.9974591135978699
. O 0 0.00036791522870771587
. O 0 0.0005924555007368326

Severe O 1 0.9992945194244385
early O 0 0.016224412247538567
- O 1 0.9946978092193604
onset O 1 0.9998651742935181
obesity B-Disease 1 0.9999790191650391
, O 0 0.10356441140174866
adrenal B-Disease 1 0.9999778270721436
insufficiency I-Disease 1 0.9999819993972778
and O 0 0.020214587450027466
red O 1 0.9990484118461609
hair O 1 0.9998981952667236
pigmentation O 1 0.9999121427536011
caused O 1 0.9830228686332703
by O 0 0.0013123445678502321
POMC O 1 0.9993791580200195
mutations O 0 0.003731062635779381
in O 0 0.0003170616691932082
humans O 0 0.004003720358014107
. O 0 0.0007610810571350157

Sequential O 0 0.004151992965489626
cleavage O 0 0.007095326669514179
of O 0 4.9046189815271646e-05
the O 0 0.00018375233048573136
precursor O 0 0.002567175542935729
protein O 0 0.0009271366288885474
pre O 0 0.004459174815565348
- O 0 0.005022946745157242
pro O 0 0.00518403435125947
- O 0 0.007684511598199606
opiomelanocortin O 0 0.13486412167549133
( O 0 0.0022995672188699245
POMC O 1 0.9820611476898193
) O 0 0.0003536600270308554
generates O 0 0.0012055799597874284
the O 0 0.0006794619839638472
melanocortin O 1 0.8782692551612854
peptides O 0 0.008847655728459358
adrenocorticotrophin O 0 0.23982679843902588
( O 0 0.0023340140469372272
ACTH O 1 0.9884757995605469
) O 0 0.00034530286211520433
, O 0 0.0004409177927300334
melanocyte O 1 0.9902598261833191
- O 0 0.00712669687345624
stimulating O 0 0.397512823343277
hormones O 0 0.043128013610839844
( O 0 0.002722294768318534
MSH O 1 0.9972211122512817
) O 0 0.00038276068517006934
alpha O 0 0.0010714663658291101
, O 0 0.00012441289436537772
beta O 0 0.0010611325269564986
and O 0 7.299661956494674e-05
gamma O 0 0.001203702064231038
as O 0 3.577201277948916e-05
well O 0 3.0901850550435483e-05
as O 0 4.496913970797323e-05
the O 0 0.00017755253065843135
opioid O 1 0.5939041972160339
- O 0 0.002632049610838294
receptor O 0 0.0022650514729321003
ligand O 0 0.004508649464696646
beta O 0 0.009073776192963123
- O 0 0.01623235084116459
endorphin O 1 0.9493187069892883
. O 0 0.001318075810559094

While O 0 0.0005563062732107937
a O 0 0.0004456876195035875
few O 0 0.0002575539401732385
cases O 0 0.0006977999000810087
of O 0 0.0001690559001872316
isolated O 1 0.9947189092636108
ACTH B-Disease 1 0.9999465942382812
deficiency I-Disease 1 0.9999912977218628
have O 0 0.0003493856347631663
been O 0 0.0006010672077536583
reported O 0 0.003311603795737028
( O 0 0.002535497071221471
OMIM O 1 0.9969322681427002
201400 O 0 0.1281072497367859
) O 0 0.00027651197160594165
, O 0 0.00018167983216699213
an O 0 0.0011069540632888675
inherited O 1 0.9997548460960388
POMC O 1 0.9999315738677979
defect O 1 0.9993504881858826
has O 0 0.0009057933930307627
not O 0 0.00015417275426443666
been O 0 0.0002408800064586103
described O 0 0.0011164203751832247
so O 0 0.0004371737304609269
far O 0 0.000755538058001548
. O 0 0.0006503406330011785

Recent O 0 0.0033981846645474434
studies O 0 0.0007429533870890737
in O 0 0.0002563102461863309
animal O 0 0.002896805526688695
models O 0 0.0010612024925649166
elucidated O 0 0.009300152771174908
a O 0 0.00027354375924915075
central O 0 0.00027452819631434977
role O 0 0.00037520224577747285
of O 0 8.936117228586227e-05
alpha O 0 0.008396454155445099
- O 0 0.10767364501953125
MSH O 1 0.994360625743866
in O 0 0.00011031035683117807
the O 0 8.379826613236219e-05
regulation O 0 0.0003078592708334327
of O 0 2.954553929157555e-05
food O 0 0.0009475065744481981
intake O 0 0.002926087472587824
by O 0 3.427293631830253e-05
activation O 0 0.0003924140182789415
of O 0 1.9624561900855042e-05
the O 0 0.0004882390785496682
brain O 1 0.9980854988098145
melanocortin O 1 0.9859185218811035
- O 0 0.0025996665935963392
4 O 0 0.00048446215805597603
- O 0 0.0015854306984692812
receptor O 0 0.0019117220072075725
( O 0 0.0009734983323141932
MC4 O 1 0.9971920847892761
- O 0 0.01066716481000185
R O 0 0.01687278226017952
; O 0 0.00022749775962438434
refs O 0 0.008773147128522396
3 O 0 0.00045401373063214123
- O 0 0.0010331853991374373
5 O 0 0.0001303434110013768
) O 0 3.618686969275586e-05
and O 0 1.837491618061904e-05
the O 0 4.396146323415451e-05
linkage O 0 0.0017668053042143583
of O 0 4.128820000914857e-05
human O 0 0.03232422098517418
obesity B-Disease 1 0.9998424053192139
to O 0 0.00014909188030287623
chromosome O 0 0.0008893644553609192
2 O 0 0.00014140017447061837
in O 0 4.811130929738283e-05
close O 0 0.00029512253240682185
proximity O 0 0.0004931173170916736
to O 0 0.00013028201647102833
the O 0 0.000540371285751462
POMC O 1 0.9966442584991455
locus O 0 0.007242069113999605
, O 0 0.00018562903278507292
led O 0 0.00019654250354506075
to O 0 4.43086501036305e-05
the O 0 6.247949204407632e-05
proposal O 0 0.0003683952381834388
of O 0 1.5982157492544502e-05
an O 0 0.0002521141432225704
association O 0 0.005138426087796688
of O 0 0.0002003524568863213
POMC O 1 0.9993640780448914
with O 0 0.0007751405937597156
human O 0 0.29865166544914246
obesity B-Disease 1 0.9998660087585449
. O 0 0.002118108794093132

The O 0 0.0003512669063638896
dual O 0 0.0013137683272361755
role O 0 0.0006050302181392908
of O 0 0.00010844551434274763
alpha O 0 0.009200421161949635
- O 0 0.07416583597660065
MSH O 1 0.992743968963623
in O 0 0.00025848360382951796
regulating O 0 0.003624778939411044
food O 0 0.0016992657911032438
intake O 0 0.011533686891198158
and O 0 0.00039286597166210413
influencing O 0 0.045376744121313095
hair O 1 0.9994797110557556
pigmentation O 1 0.9996902942657471
predicts O 0 0.16183379292488098
that O 0 0.00012375421647448093
the O 0 0.0003266284766141325
phenotype O 0 0.12027726322412491
associated O 0 0.00027118436992168427
with O 0 0.00012125770444981754
a O 0 0.002047319198027253
defect O 1 0.9958677291870117
in O 0 0.0006411905633285642
POMC O 1 0.9977105855941772
function O 0 0.000731819192878902
would O 0 0.0003178055339958519
include O 0 0.0010004115756601095
obesity B-Disease 1 0.9999362230300903
, O 0 0.0004346292407717556
alteration O 0 0.1675291210412979
in O 0 0.0011097213719040155
pigmentation O 1 0.9999279975891113
and O 0 0.07696618139743805
ACTH B-Disease 1 0.9999731779098511
deficiency I-Disease 1 0.9999852180480957
. O 0 0.002277518156915903

The O 0 0.0007483811932615936
observation O 0 0.003435626393184066
of O 0 9.193399455398321e-05
these O 0 0.0002818308712448925
symptoms O 1 0.9998186230659485
in O 0 0.00019509624689817429
two O 0 0.00018946015916299075
probands O 1 0.9384483695030212
prompted O 0 0.004433188587427139
us O 0 0.0005426505231298506
to O 0 7.494850433431566e-05
search O 0 0.00025794273824431
for O 0 0.00010844789358088747
mutations O 0 0.0006297009531408548
within O 0 9.66260049608536e-05
their O 0 0.0002687689266167581
POMC O 1 0.9972921013832092
genes O 0 0.0014440501108765602
. O 0 0.0007954725297167897

Patient O 1 0.996852457523346
1 O 0 0.0012936501298099756
was O 0 0.0005069714388810098
found O 0 0.00013387751823756844
to O 0 4.1571318433852866e-05
be O 0 4.7442797949770465e-05
a O 0 0.00023961193801369518
compound O 0 0.001967833610251546
heterozygote O 0 0.0051869419403374195
for O 0 4.584606722346507e-05
two O 0 4.088935020263307e-05
mutations O 0 0.000563907262403518
in O 0 0.00014200442819856107
exon O 0 0.0057521299459040165
3 O 0 0.0007234355434775352
( O 0 0.0006694665062241256
G7013T O 0 0.027429871261119843
, O 0 0.00043979426845908165
C7133delta O 0 0.24841967225074768
) O 0 0.00012916010746266693
which O 0 3.21587358484976e-05
interfere O 0 0.0006848331540822983
with O 0 2.933701398433186e-05
appropriate O 0 0.00019470968982204795
synthesis O 0 0.00028125211247242987
of O 0 9.53878989093937e-05
ACTH O 1 0.9964697360992432
and O 0 0.0004207803285680711
alpha O 0 0.00926967803388834
- O 0 0.15026870369911194
MSH O 1 0.9942477941513062
. O 0 0.0012979443417862058

Patient O 1 0.996404767036438
2 O 0 0.0011213704710826278
was O 0 0.0005431353347375989
homozygous O 0 0.0006438267300836742
for O 0 5.86641144764144e-05
a O 0 0.00032367956009693444
mutation O 0 0.0009068296058103442
in O 0 0.00013421034964267164
exon O 0 0.0065649268217384815
2 O 0 0.000626392662525177
( O 0 0.000614203279837966
C3804A O 0 0.011931279674172401
) O 0 0.0002000176755245775
which O 0 0.00023818964837118983
abolishes O 1 0.5389297008514404
POMC O 1 0.9812204837799072
translation O 0 0.0017410044092684984
. O 0 0.0011647219071164727

These O 0 0.00031795434188097715
findings O 0 0.0008217012509703636
represent O 0 0.00010490408021723852
the O 0 5.8560319303069264e-05
first O 0 6.767415470676497e-05
examples O 0 0.00011105462908744812
of O 0 2.9844948585378006e-05
a O 0 0.002337847137823701
genetic B-Disease 0 0.4207625985145569
defect I-Disease 1 0.9984443783760071
within O 0 0.0003769146278500557
the O 0 0.0012567770900204778
POMC O 1 0.997346043586731
gene O 0 0.0016475601587444544
and O 0 8.928502211347222e-05
define O 0 0.000984081532806158
a O 0 0.0007290863431990147
new O 0 0.002907112007960677
monogenic B-Disease 1 0.9995715022087097
endocrine I-Disease 1 0.9998732805252075
disorder I-Disease 1 0.9999227523803711
resulting O 0 0.003663015551865101
in O 0 0.00035130142350681126
early O 0 0.0036552485544234514
- O 1 0.9978139400482178
onset O 1 0.9999352693557739
obesity B-Disease 1 0.9999885559082031
, O 0 0.044984713196754456
adrenal B-Disease 1 0.9999804496765137
insufficiency I-Disease 1 0.9999744892120361
and O 0 0.008791963569819927
red O 1 0.9990022778511047
hair O 1 0.9998865127563477
pigmentation O 1 0.999786913394928
. O 0 0.0007063735392875969
. O 0 0.001107319025322795

A O 0 0.0057776798494160175
European O 0 0.0030995968263596296
multicenter O 0 0.3624652624130249
study O 0 0.0009121213224716485
of O 0 0.0003777405363507569
phenylalanine B-Disease 1 0.9984989166259766
hydroxylase I-Disease 1 0.9992940425872803
deficiency I-Disease 1 0.999990701675415
: O 0 0.0008274646243080497
classification O 0 0.003234833013266325
of O 0 5.1228325901320204e-05
105 O 0 0.002567458664998412
mutations O 0 0.0008914464269764721
and O 0 7.233341602841392e-05
a O 0 0.0002967360778711736
general O 0 0.0003951176186092198
system O 0 0.0007231223280541599
for O 0 0.00027164368657395244
genotype O 0 0.032764025032520294
- O 0 0.0018308182479813695
based O 0 0.00012772530317306519
prediction O 0 0.0014308895915746689
of O 0 0.00011113897198811173
metabolic O 1 0.9964300990104675
phenotype O 1 0.9473076462745667
. O 0 0.0011808734852820635

Phenylketonuria B-Disease 1 0.9988486766815186
( O 0 0.04099636152386665
PKU B-Disease 1 0.9998230338096619
) O 0 0.001110627199523151
and O 0 0.0009436776745133102
mild B-Disease 1 0.9997358918190002
hyperphenylalaninemia I-Disease 1 0.999599039554596
( O 0 0.01972368359565735
MHP B-Disease 1 0.9999477863311768
) O 0 0.0005823435494676232
are O 0 0.0002474212960805744
allelic B-Disease 1 0.9902397394180298
disorders I-Disease 1 0.9999555349349976
caused O 0 0.2732471823692322
by O 0 0.00015727360732853413
mutations O 0 0.0007490187417715788
in O 0 5.408122524386272e-05
the O 0 0.00013820122694596648
gene O 0 0.0010790664236992598
encoding O 0 0.001160954823717475
phenylalanine O 0 0.10051846504211426
hydroxylase O 1 0.909964919090271
( O 0 0.0074510457925498486
PAH O 1 0.9997188448905945
) O 0 0.001231689122505486
. O 0 0.000693330483045429

Previous O 0 0.002301818924024701
studies O 0 0.0009764168644323945
have O 0 0.00016637078078929335
suggested O 0 0.00043729416211135685
that O 0 3.7816404073964804e-05
the O 0 9.029253124026582e-05
highly O 0 0.0015987615333870053
variable O 0 0.003086969954892993
metabolic O 1 0.9719403386116028
phenotypes O 0 0.2419402301311493
of O 0 0.002511174650862813
PAH B-Disease 1 0.9999972581863403
deficiency I-Disease 1 0.999971866607666
correlate O 0 0.3185621500015259
with O 0 0.004527659621089697
PAH O 1 0.999963641166687
genotypes O 1 0.9284482598304749
. O 0 0.0013583590043708682

We O 0 0.0009137243614532053
identified O 0 0.0005469105672091246
both O 0 0.00027711849543266
causative O 0 0.2180403620004654
mutations O 0 0.0036856948863714933
in O 0 0.000708050443790853
686 O 1 0.9961238503456116
patients O 1 0.9996222257614136
from O 0 0.00013335375115275383
seven O 0 0.0003319064271636307
European O 0 0.0006678122445009649
centers O 0 0.0030899650882929564
. O 0 0.0009853752562776208

On O 0 0.0002838392392732203
the O 0 6.005291288602166e-05
basis O 0 2.4847160602803342e-05
of O 0 1.0370648851676378e-05
the O 0 0.00017064726853277534
phenotypic O 0 0.00251667108386755
characteristics O 0 0.0005252552800811827
of O 0 0.00014944486611057073
297 O 1 0.7201352715492249
functionally O 1 0.9842313528060913
hemizygous O 1 0.9975358247756958
patients O 1 0.9996114373207092
, O 0 0.00016312013030983508
105 O 0 0.000541713263373822
of O 0 1.7326850866083987e-05
the O 0 0.0001753080723574385
mutations O 0 0.0007919087656773627
were O 0 2.4805138309602626e-05
assigned O 0 0.00023445617989636958
to O 0 2.2713773432769813e-05
one O 0 1.8316392015549354e-05
of O 0 9.26264237932628e-06
four O 0 9.918762953020632e-05
arbitrary O 0 0.0005472150514833629
phenotype O 0 0.24635562300682068
categories O 0 0.0013679607072845101
. O 0 0.0009510574163869023

We O 0 0.0012770619941875339
proposed O 0 0.001359406509436667
and O 0 0.0002447855658829212
tested O 0 0.003744187531992793
a O 0 0.00019851629622280598
simple O 0 0.0003077723958995193
model O 0 0.0003200327046215534
for O 0 7.730620563961565e-05
correlation O 0 0.0006901595625095069
between O 0 0.00022456704755313694
genotype O 0 0.018542101606726646
and O 0 0.0002658898592926562
phenotypic O 0 0.0068608555011451244
outcome O 0 0.002960992744192481
. O 0 0.0009572264389134943

The O 0 0.0009694605250842869
observed O 0 0.0021493604872375727
phenotype O 0 0.03027259185910225
matched O 0 0.0014911515172570944
the O 0 0.0002442970871925354
predicted O 0 0.004561553709208965
phenotype O 0 0.01314083393663168
in O 0 0.0001292788947466761
79 O 0 0.0009277397184632719
% O 0 1.638939284021035e-05
of O 0 1.5838137187529355e-05
the O 0 0.00023305164359044284
cases O 0 0.0013793986290693283
, O 0 8.185037586372346e-05
and O 0 3.8262012822087854e-05
in O 0 3.3413609344279394e-05
only O 0 2.5033366910065524e-05
5 O 0 0.00011480215471237898
of O 0 5.5640415666857734e-05
184 O 1 0.6510061621665955
patients O 1 0.9996566772460938
was O 0 0.0003514401032589376
the O 0 0.00014925205323379487
observed O 0 0.0008291955455206335
phenotype O 0 0.00809506606310606
more O 0 4.741756129078567e-05
than O 0 5.379457797971554e-05
one O 0 7.28933882783167e-05
category O 0 0.00029878795612603426
away O 0 0.00017424584075342864
from O 0 7.23755729268305e-05
that O 0 0.00010662785643944517
expected O 0 0.0007857022574171424
. O 0 0.0005812171730212867

Among O 0 0.0003950777754653245
the O 0 0.00020431650045793504
seven O 0 0.00036712916335090995
contributing O 0 0.002193174324929714
centers O 0 0.0007006914238445461
, O 0 6.327986193355173e-05
the O 0 6.208127160789445e-05
proportion O 0 0.0003208844573237002
of O 0 0.0001496125478297472
patients O 1 0.9999169111251831
for O 0 0.0001858805335359648
whom O 0 0.0008906394941732287
the O 0 0.0001645421580178663
observed O 0 0.0010871211998164654
phenotype O 0 0.13967184722423553
did O 0 0.00022869542590342462
not O 0 3.326890873722732e-05
match O 0 9.91141569102183e-05
the O 0 9.63678103289567e-05
predicted O 0 0.0017949372995644808
phenotype O 0 0.00820018257945776
was O 0 0.0002786386467050761
4 O 0 0.0002218504378106445
% O 0 5.95175770286005e-05
- O 0 0.0010695257224142551
23 O 0 0.0003880835138261318
% O 0 9.067467181012034e-05
( O 0 0.0006950910319574177
P O 0 0.08129945397377014
< O 0 0.01502874493598938
. O 0 0.00032747999648563564
0001 O 0 0.23464445769786835
) O 0 0.00028681496041826904
, O 0 0.00015978525334503502
suggesting O 0 0.0011605826439335942
that O 0 4.078315760125406e-05
differences O 0 0.00019568047719076276
in O 0 4.4150190660730004e-05
methods O 0 0.00010489008127478883
used O 0 8.101157436612993e-05
for O 0 0.00016503034566994756
mutation O 0 0.0023013975005596876
detection O 0 0.015969226136803627
or O 0 0.001365629374049604
phenotype O 1 0.9803019165992737
classification O 0 0.36518871784210205
may O 0 0.000516013999003917
account O 0 7.717753032920882e-05
for O 0 5.016290378989652e-05
a O 0 0.000156424444867298
considerable O 0 0.00035655160900205374
proportion O 0 0.0002927001041825861
of O 0 0.00011890150926774368
genotype O 1 0.9642042517662048
- O 0 0.23895101249217987
phenotype O 0 0.08365285396575928
inconsistencies O 0 0.012167712673544884
. O 0 0.0011942965211346745

Our O 0 0.0005860866513103247
data O 0 0.00017028447473421693
indicate O 0 0.0003735004866030067
that O 0 0.00010286054748576134
the O 0 0.0010595909552648664
PAH O 1 0.999919056892395
- O 0 0.010202338919043541
mutation O 0 0.002004222944378853
genotype O 0 0.005105727352201939
is O 0 8.967651956481859e-05
the O 0 6.951680552447215e-05
main O 0 0.0002920536499004811
determinant O 0 0.002690444467589259
of O 0 0.00010693925287341699
metabolic O 1 0.9925053119659424
phenotype O 1 0.5905809998512268
in O 0 0.00031491165282204747
most O 0 0.001974327489733696
patients O 1 0.9999464750289917
with O 0 0.3626454174518585
PAH B-Disease 1 0.9999979734420776
deficiency I-Disease 1 0.9999864101409912
. O 0 0.0024243651423603296

In O 0 0.0003783777356147766
the O 0 0.0001813155395211652
present O 0 0.00028586084954440594
study O 0 0.00046942595508880913
, O 0 7.452430872945115e-05
the O 0 9.787618182599545e-05
classification O 0 0.0026100482791662216
of O 0 0.00013507054245565087
105 O 1 0.5250268578529358
PAH O 1 0.9999570846557617
mutations O 0 0.003755329642444849
may O 0 0.0003889462968800217
allow O 0 9.304205741500482e-05
the O 0 5.919301474932581e-05
prediction O 0 0.0008229260565713048
of O 0 1.5054120922286529e-05
the O 0 0.00020437923376448452
biochemical O 0 0.008163658902049065
phenotype O 0 0.019519736990332603
in O 0 0.00024906150065362453
> O 0 0.005666213575750589
10 O 0 0.00025221871328540146
, O 0 0.00016336092085111886
000 O 0 0.0024329558946192265
genotypes O 0 0.022959649562835693
, O 0 0.00013116143236402422
which O 0 6.861156725790352e-05
may O 0 0.00022262404672801495
be O 0 2.9600081688840874e-05
useful O 0 0.00019101466750726104
for O 0 6.296751234913245e-05
the O 0 0.0001587141159689054
management O 0 0.029274936765432358
of O 0 0.0001412407582392916
hyperphenylalaninemia B-Disease 1 0.9984093308448792
in O 0 0.0008420900558121502
newborns O 1 0.9960179924964905
. O 0 0.0012469413923099637

Somatic O 0 0.018164927139878273
instability O 0 0.003649817081168294
of O 0 9.880869038170204e-05
the O 0 0.0009913262911140919
CTG O 1 0.9848688840866089
repeat O 0 0.006263301242142916
in O 0 0.0002860620734281838
mice O 0 0.006778159644454718
transgenic O 0 0.0018025063909590244
for O 0 0.00026050538872368634
the O 0 0.004539646673947573
myotonic B-Disease 1 0.9999902248382568
dystrophy I-Disease 1 0.9999983310699463
region O 0 0.02011864259839058
is O 0 0.0007687759352847934
age O 0 0.0006490177474915981
dependent O 0 0.001284215715713799
but O 0 0.0001537792559247464
not O 0 8.279806206701323e-05
correlated O 0 0.0006624046945944428
to O 0 3.672290040412918e-05
the O 0 6.657955964328721e-05
relative O 0 0.0004339046136010438
intertissue O 0 0.038120780140161514
transcription O 0 0.0011928640305995941
levels O 0 0.0026433225721120834
and O 0 0.0006863130256533623
proliferative O 1 0.9979204535484314
capacities O 0 0.07663988322019577
. O 0 0.0017396738985553384

A O 0 0.009814955294132233
( O 0 0.003002686658874154
CTG O 1 0.9414763450622559
) O 0 0.0005505082081072032
nexpansion O 0 0.007910405285656452
in O 0 0.00010667271999409422
the O 0 0.00016427189984824508
3 O 0 0.0007104190881364048
- O 0 0.002765106735751033
untranslated O 0 0.010420389473438263
region O 0 0.0014329745899885893
( O 0 0.0004650505434256047
UTR O 0 0.011802543886005878
) O 0 7.385575008811429e-05
of O 0 2.2432379410020076e-05
the O 0 0.0005825217813253403
DM O 1 0.9990881681442261
protein O 0 0.0012557710288092494
kinase O 0 0.008206316269934177
gene O 0 0.0018069744110107422
( O 0 0.0006974316202104092
DMPK O 1 0.9303693175315857
) O 0 0.00016370117373298854
is O 0 0.00016324630996678025
responsible O 0 0.0015658836346119642
for O 0 0.0009226423571817577
causing O 1 0.9986693859100342
myotonic B-Disease 1 0.9999891519546509
dystrophy I-Disease 1 0.9999983310699463
( O 1 0.883292555809021
DM B-Disease 1 0.9999574422836304
) O 0 0.0022635769564658403
. O 0 0.0014827246777713299

Major O 0 0.008786547929048538
instability O 0 0.014781352132558823
, O 0 0.00018825689039658755
with O 0 6.960322934901342e-05
very O 0 0.00030023313593119383
large O 0 0.00016612366016488522
expansions O 0 0.001617493573576212
between O 0 0.00011719683243427426
generations O 0 0.0004902443615719676
and O 0 0.00011937333329115063
high O 0 0.0006890862714499235
levels O 0 0.0004974801559001207
of O 0 6.402788130799308e-05
somatic O 0 0.10641853511333466
mosaicism O 1 0.9922852516174316
, O 0 0.00023177676484920084
is O 0 0.00026958322268910706
observed O 0 0.0006611896096728742
in O 0 0.0007037986651994288
patients O 1 0.999640703201294
. O 0 0.000983776873908937

There O 0 0.00044759034062735736
is O 0 0.0002206326462328434
a O 0 0.00032973563065752387
good O 0 0.000557270017452538
correlation O 0 0.000515330524649471
between O 0 0.0001374951098114252
repeat O 0 0.0016456115990877151
size O 0 0.00029288348741829395
( O 0 0.0002469534520059824
at O 0 0.00017579953419044614
least O 0 0.0001686372997937724
in O 0 0.00018673855811357498
leucocytes O 1 0.6047382354736328
) O 0 0.0004680427082348615
, O 0 0.0005936911329627037
clinical O 1 0.9993306398391724
severity O 1 0.9978588223457336
and O 0 0.00011955364607274532
age O 0 0.00046468942309729755
of O 0 0.00016919942572712898
onset O 1 0.9998131394386292
. O 0 0.0015614809235557914

The O 0 0.004429932218044996
trinucleotide O 1 0.9403151869773865
repeat O 0 0.01581733115017414
instability O 0 0.008630352094769478
mechanisms O 0 0.002482052193954587
involved O 0 0.0026581264100968838
in O 0 0.0023291169200092554
DM B-Disease 1 0.9999880790710449
and O 0 0.00022515407181344926
other O 0 0.0001679679553490132
human O 1 0.5206929445266724
genetic B-Disease 1 0.999194324016571
diseases I-Disease 1 0.9999918937683105
are O 0 0.00010495299648027867
unknown O 0 0.0010781381279230118
. O 0 0.0007699599955230951

We O 0 0.0011856852797791362
studied O 0 0.001301298732869327
somatic O 0 0.0051464177668094635
instability O 0 0.002783639822155237
by O 0 9.843504813034087e-05
measuring O 0 0.0020310520194470882
the O 0 0.0008147396729327738
CTG O 1 0.988262951374054
repeat O 0 0.005185695830732584
length O 0 0.0005688250530511141
at O 0 0.0002234670682810247
several O 0 7.840109901735559e-05
ages O 0 0.0003539995232131332
in O 0 5.77332939428743e-05
various O 0 6.889060023240745e-05
tissues O 0 0.010288383811712265
of O 0 6.689834845019504e-05
transgenic O 0 0.010912486352026463
mice O 0 0.0047867074608802795
carrying O 0 0.00041665908065624535
a O 0 0.0009229432325810194
( O 0 0.001785362372174859
CTG O 1 0.9807809591293335
) O 0 0.0006054253317415714
55expansion O 0 0.02330613322556019
surrounded O 0 0.0013515815371647477
by O 0 6.632153235841542e-05
45 O 0 0.00023719387536402792
kb O 0 0.0015529239317402244
of O 0 2.7632493583951145e-05
the O 0 0.00036498651024885476
human O 0 0.08175642788410187
DM B-Disease 1 0.999947190284729
region O 0 0.0014507874147966504
, O 0 9.220967331202701e-05
using O 0 6.932766700629145e-05
small O 0 0.0004500657960306853
- O 0 0.0040670717135071754
pool O 0 0.003537349635735154
PCR O 0 0.008868773467838764
. O 0 0.0009945243364199996

These O 0 0.0008696963195689023
mice O 0 0.040298014879226685
have O 0 0.00013303940067999065
been O 0 0.00016797499847598374
shown O 0 0.000241120345890522
to O 0 7.116448250599205e-05
reproduce O 0 0.0006658324273303151
the O 0 0.00013406146899797022
intergenerational O 0 0.014757414348423481
and O 0 0.00013336900155991316
somatic O 0 0.0035842445213347673
instability O 0 0.0016363748582080007
of O 0 3.189220660715364e-05
the O 0 0.0004109699511900544
55 O 0 0.005522985942661762
CTG O 1 0.9910635948181152
repeat O 0 0.01138238050043583
suggesting O 0 0.0019646401051431894
that O 0 9.476648847339675e-05
surrounding O 0 0.0004138883959967643
sequences O 0 7.94296502135694e-05
and O 0 5.663311458192766e-05
the O 0 0.00018326379358768463
chromatin O 0 0.003707791678607464
environment O 0 0.0011011064052581787
are O 0 4.5126282202545553e-05
involved O 0 0.0004465947567950934
in O 0 0.00022421553148888052
instability O 0 0.01059863343834877
mechanisms O 0 0.00436749029904604
. O 0 0.0011367577826604247

As O 0 0.0005425398121587932
observed O 0 0.00023679730657022446
in O 0 3.9085156458895653e-05
some O 0 1.4217534953786526e-05
of O 0 1.2960397725692019e-05
the O 0 0.00028913881396874785
tissues O 1 0.9615424871444702
of O 0 0.0020813478622585535
DM B-Disease 1 0.9999992847442627
patients O 1 0.9999603033065796
, O 0 0.0001511197187937796
there O 0 5.164841786609031e-05
is O 0 9.252430027117953e-05
a O 0 0.00026280799647793174
tendency O 0 0.0019019824685528874
for O 0 0.0001706329348962754
repeat O 0 0.0035809592809528112
length O 0 0.0007071077707223594
and O 0 0.000297688995487988
somatic O 0 0.019132744520902634
mosaicism O 1 0.7988061308860779
to O 0 8.034594065975398e-05
increase O 0 0.00012937090650666505
with O 0 3.477189238765277e-05
the O 0 7.208228635136038e-05
age O 0 9.423867595614865e-05
of O 0 1.9508648620103486e-05
the O 0 0.0004439842305146158
mouse O 0 0.054337047040462494
. O 0 0.0008615267579443753

Furthermore O 0 0.006067690439522266
, O 0 0.0002758248010650277
we O 0 0.00016758097626734525
observed O 0 0.0002512227219995111
no O 0 6.894685793668032e-05
correlation O 0 0.00023824372328817844
between O 0 6.235093314899132e-05
the O 0 0.00016452130512334406
somatic O 0 0.005254754330962896
mutation O 0 0.0014585775788873434
rate O 0 0.00029167026514187455
and O 0 0.0004153108166065067
tissue O 1 0.9818098545074463
proliferation O 0 0.04387148097157478
capacity O 0 0.0033135684207081795
. O 0 0.0010135048069059849

The O 0 0.0018252712907269597
somatic O 0 0.011800318956375122
mutation O 0 0.0028057736344635487
rates O 0 0.0004629783215932548
in O 0 8.011374302441254e-05
different O 0 6.455710536101833e-05
tissues O 0 0.057918790727853775
were O 0 3.869931970257312e-05
also O 0 8.188105130102485e-05
not O 0 4.399350655148737e-05
correlated O 0 0.0005596933187916875
to O 0 2.758510163403116e-05
the O 0 7.698318222537637e-05
relative O 0 0.0006210058345459402
inter O 0 0.010604074224829674
- O 0 0.01775989681482315
tissue O 0 0.016497023403644562
difference O 0 0.0002054536307696253
in O 0 4.6522462071152404e-05
transcriptional O 0 0.0006310611497610807
levels O 0 0.000245625531533733
of O 0 9.380088158650324e-06
the O 0 5.3179905080469325e-05
three O 0 7.243978325277567e-05
genes O 0 0.0005398461362347007
( O 0 0.0007223584689199924
DMAHP O 1 0.9620937705039978
, O 0 0.0005022773402743042
DMPK O 1 0.86305171251297
and O 0 0.00018897035624831915
59 O 0 0.0014948145253583789
) O 0 0.00017282151384279132
surrounding O 0 0.0006467120838351548
the O 0 0.0003050222003366798
repeat O 0 0.010869811289012432
. O 0 0.00037521743797697127
. O 0 0.000695014197845012

A O 0 0.006763363257050514
novel O 0 0.00557007035240531
missense O 0 0.016075361520051956
mutation O 0 0.003946724347770214
in O 0 0.0007815742865204811
patients O 1 0.9994725584983826
from O 0 0.0003595955204218626
a O 0 0.006431365851312876
retinoblastoma B-Disease 1 0.9995297193527222
pedigree O 1 0.754895031452179
showing O 0 0.0017176730325445533
only O 0 0.00025909574469551444
mild O 1 0.9975605010986328
expression O 0 0.0003706553834490478
of O 0 5.763796070823446e-05
the O 0 0.0039009214378893375
tumor B-Disease 1 0.9999203681945801
phenotype O 1 0.9197568893432617
. O 0 0.001322003430686891

We O 0 0.0006174142472445965
have O 0 6.981901969993487e-05
used O 0 8.409430301981047e-05
single O 0 0.0002100724814226851
strand O 0 0.0019447465892881155
conformation O 0 0.0021507025230675936
polymorphism O 0 0.0007888397085480392
analysis O 0 0.0001547391730127856
to O 0 7.681576244067401e-05
study O 0 0.0002164325851481408
the O 0 9.640420466894284e-05
27 O 0 0.0004904575762338936
exons O 0 0.0008769751293584704
of O 0 4.221317794872448e-05
the O 0 0.0012068056967109442
RB1 O 1 0.9986547231674194
gene O 0 0.0011663527693599463
in O 0 8.7967244326137e-05
individuals O 0 0.00011095439549535513
from O 0 7.281148282345384e-05
a O 0 0.0005064147990196943
family O 0 0.0008454471826553345
showing O 0 0.003514955285936594
mild O 1 0.9976801872253418
expression O 0 0.0003121482441201806
of O 0 4.568145232042298e-05
the O 0 0.0015674635069444776
retinoblastoma B-Disease 1 0.9997003078460693
phenotype O 1 0.9045274257659912
. O 0 0.001322138006798923

In O 0 0.0007075819303281605
this O 0 0.00022900484327692538
family O 0 0.0013745627366006374
affected O 0 0.010052910074591637
individuals O 0 0.0008963029249571264
developed O 1 0.934848427772522
unilateral B-Disease 1 0.9977072477340698
tumors I-Disease 1 0.999982476234436
and O 0 0.00017508490418549627
, O 0 9.071913518710062e-05
as O 0 6.250636943150312e-05
a O 0 0.00013271909847389907
result O 0 0.00012878724373877048
of O 0 2.460422365402337e-05
linkage O 0 0.012315631844103336
analysis O 0 0.00037424571928568184
, O 0 0.0003922245523426682
unaffected O 1 0.7970718145370483
mutation O 0 0.0030588009394705296
carriers O 0 0.0034686413127928972
were O 0 5.554218660108745e-05
also O 0 0.0001068448691512458
identified O 0 0.00019433464331086725
within O 0 5.6655746448086575e-05
the O 0 0.00025369253125973046
pedigree O 0 0.03969171643257141
. O 0 0.0009144595242105424

A O 0 0.0027522328309714794
single O 0 0.00047700945287942886
band O 0 0.0007488110568374395
shift O 0 0.0013062210055068135
using O 0 0.0005645009223371744
SSCP O 1 0.9259438514709473
was O 0 0.000844678608700633
identified O 0 0.00037414266262203455
in O 0 0.00013406286598183215
exon O 0 0.005681929178535938
21 O 0 0.00045244500506669283
which O 0 4.8874229833018035e-05
resulted O 0 0.0004667615285143256
in O 0 8.240470197051764e-05
a O 0 0.0005490548792295158
missense O 0 0.005242304876446724
mutation O 0 0.0008382241940125823
converting O 0 0.000606341811362654
a O 0 0.0020568380132317543
cys O 1 0.9915796518325806
- O 0 0.020714260637760162
- O 0 0.006599880289286375
> O 0 0.006276118103414774
arg O 0 0.010541840456426144
at O 0 0.00019326199253555387
nucleotide O 0 0.00018774783529806882
position O 0 0.0005032084882259369
28 O 0 0.000406341947382316
in O 0 7.978188659762964e-05
the O 0 0.00036833586636930704
exon O 0 0.015452342107892036
. O 0 0.0007791240350343287

The O 0 0.0011464264243841171
mutation O 0 0.0027595292776823044
destroyed O 0 0.0019272243371233344
an O 0 0.00037977646570652723
NdeI O 0 0.054418206214904785
restriction O 0 0.001559500233270228
enzyme O 0 0.0030594670679420233
site O 0 0.0021274236496537924
. O 0 0.0008118837722577155

Analysis O 0 0.0003541960031725466
of O 0 2.5120703867287375e-05
all O 0 5.1803850510623306e-05
family O 0 0.0003045659395866096
members O 0 9.514334669802338e-05
demonstrated O 0 0.000786101445555687
that O 0 4.311462180339731e-05
the O 0 0.00021396219381131232
missense O 0 0.009492507204413414
mutation O 0 0.003802047809585929
co O 0 0.0173657163977623
- O 0 0.005975648760795593
segregated O 0 0.005900039337575436
with O 0 0.0009383278666064143
patients O 1 0.9998327493667603
with O 0 0.0032125136349350214
tumors B-Disease 1 0.9999843835830688
or O 0 0.000631954928394407
who O 0 0.0004289908683858812
, O 0 8.005302515812218e-05
as O 0 7.866966188885272e-05
a O 0 0.00022879203606862575
result O 0 0.00015159323811531067
of O 0 3.428944546612911e-05
linkage O 0 0.009732565842568874
analysis O 0 0.00031239117379300296
had O 0 0.0003378715191502124
been O 0 0.00011719794565578923
predicted O 0 0.0005073985084891319
to O 0 3.70118286809884e-05
carry O 0 0.00016404571942985058
the O 0 0.00024236590252257884
predisposing O 0 0.0790957659482956
mutation O 0 0.004865812137722969
. O 0 0.0007789873634465039

These O 0 9.162530477624387e-05
observations O 0 0.0003221691877115518
point O 0 0.00014162957086227834
to O 0 5.228356531006284e-05
another O 0 0.00017575327365193516
region O 0 0.00029465078841894865
of O 0 2.7741063604480587e-05
the O 0 0.000888547976501286
RB1 O 1 0.9988040924072266
gene O 0 0.001910958788357675
where O 0 0.00017290063260588795
mutations O 0 0.0005935253575444221
only O 0 4.442000135895796e-05
modify O 0 0.001041642390191555
the O 0 3.330373510834761e-05
function O 0 7.052807632135227e-05
of O 0 1.0144404768652748e-05
the O 0 0.00013531779404729605
gene O 0 0.0007258269470185041
and O 0 5.1449373131617904e-05
raise O 0 0.0004152755718678236
important O 0 0.00013795646373182535
questions O 0 0.0003727943985722959
for O 0 0.0001799574529286474
genetic O 0 0.0032783583737909794
counseling O 1 0.9048125147819519
in O 0 0.00014659417502116412
families O 0 0.00015782796253915876
with O 0 8.89949151314795e-05
these O 0 0.00012355091166682541
distinctive O 0 0.03310010954737663
phenotypes O 0 0.09546127915382385
. O 0 0.00047264349996112287
. O 0 0.0009955581044778228

Maternal B-Disease 1 0.5720224380493164
disomy I-Disease 1 0.9642118215560913
and O 0 0.013224463909864426
Prader B-Disease 1 0.9999794960021973
- I-Disease 1 0.9998216032981873
Willi I-Disease 1 0.9999916553497314
syndrome I-Disease 1 0.9999942779541016
consistent O 0 0.008699286729097366
with O 0 0.0003688414581120014
gamete O 1 0.7650197148323059
complementation O 1 0.9845659136772156
in O 0 0.0002351053262827918
a O 0 0.0005801517399959266
case O 0 0.0006797998212277889
of O 0 8.268522651633248e-05
familial O 1 0.9921236634254456
translocation O 0 0.03021538257598877
( O 0 0.000552237790543586
3 O 0 0.00045195617713034153
; O 0 0.00011609322973527014
15 O 0 0.0002795380132738501
) O 0 0.00018525683844927698
( O 0 0.0006001292495056987
p25 O 0 0.3268486559391022
; O 0 0.0003193295851815492
q11 O 0 0.008073920384049416
. O 0 0.00014874072803650051
2 O 0 0.00044532876927405596
) O 0 0.00035103928530588746
. O 0 0.0005085645825602114

Maternal B-Disease 1 0.961142897605896
uniparental I-Disease 1 0.9979903697967529
disomy I-Disease 1 0.9851816296577454
( I-Disease 0 0.008806363679468632
UPD I-Disease 1 0.9984939098358154
) I-Disease 0 0.0004888990079052746
for I-Disease 0 0.00024007156025618315
chromosome I-Disease 0 0.001304035889916122
15 I-Disease 0 0.0002628350630402565
is O 0 9.865466563496739e-05
responsible O 0 0.0006038458086550236
for O 0 5.956225504633039e-05
an O 0 9.88715619314462e-05
estimated O 0 0.0002676953445188701
30 O 0 0.00011048457236029208
% O 0 1.2326543583185412e-05
of O 0 2.0462503016460687e-05
cases O 0 0.0011315494775772095
of O 0 0.00039512707735411823
Prader B-Disease 1 0.9999973773956299
- I-Disease 1 0.9998345375061035
Willi I-Disease 1 0.9999858140945435
syndrome I-Disease 1 0.9999953508377075
( O 0 0.20468319952487946
PWS B-Disease 1 0.9999252557754517
) O 0 0.0018457287224009633
. O 0 0.0010369365336373448

We O 0 0.0010939539643004537
report O 0 0.0004379952442832291
on O 0 8.856332715367898e-05
an O 0 0.00013911710993852466
unusual O 0 0.000940959551371634
case O 0 0.0006292816833592951
of O 0 5.8482688473304734e-05
maternal B-Disease 1 0.8890069127082825
disomy I-Disease 1 0.9333429336547852
15 I-Disease 0 0.0009524240158498287
in O 0 0.0008582451846450567
PWS B-Disease 1 0.9998570680618286
that O 0 0.00015698639617767185
is O 0 0.00012545817298814654
most O 0 7.203673885669559e-05
consistent O 0 0.0006226908299140632
with O 0 9.037290146807209e-05
adjacent O 0 0.0010129064321517944
- O 0 0.001137440325692296
1 O 0 0.00017286420916207135
segregation O 0 0.0007575178169645369
of O 0 2.2226249711820856e-05
a O 0 0.0009473189129494131
paternal O 0 0.041278839111328125
t O 1 0.9160787463188171
( O 0 0.0004175246867816895
3 O 0 0.0003164390509482473
; O 0 8.697423618286848e-05
15 O 0 0.0002780588110908866
) O 0 0.000191045633982867
( O 0 0.0007812491967342794
p25 O 0 0.41864022612571716
; O 0 0.00027916248654946685
q11 O 0 0.0069864955730736256
. O 0 8.676673314766958e-05
2 O 0 0.0001416781742591411
) O 0 4.439722033566795e-05
with O 0 3.775712684728205e-05
simultaneous O 0 0.0006240187212824821
maternal O 0 0.040066611021757126
meiotic O 1 0.9725611209869385
nondisjunction O 0 0.3119499087333679
for O 0 0.0004492205916903913
chromosome O 0 0.0026574258226901293
15 O 0 0.0009646730613894761
. O 0 0.0006640272331424057

The O 0 0.002882925095036626
patient O 1 0.9986792206764221
( O 0 0.0036147884093225002
J O 1 0.9984660148620605
. O 0 0.00020349700935184956
B O 0 0.005965783726423979
. O 0 4.089777576155029e-05
) O 0 3.732669210876338e-05
, O 0 2.972902439069003e-05
a O 0 0.00014341143833007663
17 O 0 0.0004215182561893016
- O 0 0.0013465192168951035
year O 0 0.00040782903670333326
- O 0 0.004266905132681131
old O 0 0.0020088874734938145
white O 0 0.01182635873556137
male O 0 0.0014861340168863535
with O 0 0.0015331343747675419
PWS B-Disease 1 0.9999566078186035
, O 0 0.0005757873877882957
was O 0 0.0005309610860422254
found O 0 0.00012781877012457699
to O 0 4.040047133457847e-05
have O 0 4.23933015554212e-05
47 O 0 0.0003114743158221245
chromosomes O 0 0.00015340608661063015
with O 0 7.660962000954896e-05
a O 0 0.0009726620628498495
supernumerary O 1 0.8763827085494995
, O 0 0.0005709482938982546
paternal O 0 0.0864211916923523
der O 1 0.9885451197624207
( O 0 0.0003945579519495368
15 O 0 0.000154122753883712
) O 0 3.121536428807303e-05
consisting O 0 2.5724379156599753e-05
of O 0 1.2229427738930099e-05
the O 0 0.0001439412299077958
short O 0 0.002354157855734229
arm O 1 0.7357357144355774
and O 0 0.00015701769734732807
the O 0 0.00044317558058537543
proximal O 1 0.9923248291015625
long O 0 0.009547754190862179
arm O 0 0.171226367354393
of O 0 7.405343058053404e-05
chromosome O 0 0.0015024450840428472
15 O 0 0.00026703637558966875
, O 0 0.00012967076327186078
and O 0 0.00036342701059766114
distal O 1 0.9946446418762207
chromosome O 0 0.014677654951810837
arm O 1 0.98430335521698
3p O 1 0.9593448042869568
. O 0 0.002262846799567342

The O 0 0.0029838031623512506
t O 0 0.39265143871307373
( O 0 0.0005030595348216593
3 O 0 0.0004476338508538902
; O 0 0.00010800670861499384
15 O 0 0.0002778724883683026
) O 0 7.886878302088007e-05
was O 0 0.00016668027092237025
present O 0 6.029029827914201e-05
in O 0 4.4022173824487254e-05
the O 0 6.564736395375803e-05
balanced O 0 0.0008569109486415982
state O 0 0.00010698391997721046
in O 0 0.00012477193376980722
the O 0 0.0008670749375596642
patients O 1 0.9999091625213623
father O 0 0.004470639396458864
and O 0 0.00021042910520918667
a O 0 0.0021694637835025787
sister O 0 0.008194115944206715
. O 0 0.0009467125637456775

Fluorescent O 0 0.03162798285484314
in O 0 0.0008214230183511972
situ O 0 0.023808401077985764
hybridization O 0 0.0009633408044464886
analysis O 0 0.0004023275978397578
demonstrated O 0 0.002511396538466215
that O 0 0.00022288529726210982
the O 0 0.0013333738315850496
PWS B-Disease 1 0.9996776580810547
critical O 0 0.011581859551370144
region O 0 0.002612487180158496
resided O 0 0.002520907437428832
on O 0 0.00010546144039835781
the O 0 0.00017474949709139764
derivative O 0 0.002993362257257104
chromosome O 0 0.0013646854786202312
3 O 0 0.0002655144198797643
and O 0 4.3566367821767926e-05
that O 0 3.6672365240519866e-05
there O 0 3.8007841794751585e-05
was O 0 0.0001954947510967031
no O 0 8.911133045330644e-05
deletion O 0 0.0009046001359820366
of O 0 4.184887802693993e-05
the O 0 0.0011804866371676326
PWS B-Disease 1 0.9997852444648743
region O 0 0.0011623301543295383
on O 0 8.647242793813348e-05
the O 0 0.00010116195335285738
normal O 0 0.0009293796611018479
pair O 0 0.0003035678528249264
of O 0 7.012957212282345e-05
15s O 0 0.4367124140262604
present O 0 0.0005727083771489561
in O 0 0.0013500377535820007
J O 1 0.9976639747619629
. O 0 0.0010917562758550048

B O 0 0.3075009286403656
. O 0 0.003048693761229515

Methylation O 0 0.0020621870644390583
analysis O 0 0.00024656736059114337
at O 0 0.000332801224431023
exon O 0 0.0027743868995457888
alpha O 0 0.0002897108206525445
of O 0 1.2611166312126443e-05
the O 0 8.691273251315579e-05
small O 0 0.0004079373611602932
nuclear O 0 0.006442819721996784
ribonucleoprotein O 1 0.9748659133911133
- O 0 0.003702746704220772
associated O 0 0.00041250776848755777
polypeptide O 0 0.004399596713483334
N O 0 0.005280226469039917
( O 0 0.0011107854079455137
SNRPN O 1 0.9606534242630005
) O 0 0.0004072620067745447
gene O 0 0.0008462301339022815
showed O 0 0.0004180007381364703
a O 0 0.00022892448760103434
pattern O 0 0.0007575329509563744
characteristic O 0 0.0002987249754369259
of O 0 1.2251724001544062e-05
only O 0 3.3841013646451756e-05
the O 0 0.0001320533046964556
maternal O 0 0.018671367317438126
chromosome O 0 0.0017411720473319292
15 O 0 0.0005518931429833174
in O 0 0.0006856536492705345
J O 1 0.9972178936004639
. O 0 0.0010212492197751999

B O 0 0.31570687890052795
. O 0 0.002444598125293851

Maternal B-Disease 1 0.7630186080932617
disomy I-Disease 1 0.9403331875801086
was O 0 0.0019086165120825171
confirmed O 0 0.001195346936583519
by O 0 0.00010231624764855951
polymerase O 0 0.0021587980445474386
chain O 0 0.0015422212891280651
reaction O 0 0.00041398743633180857
analysis O 0 0.000122224009828642
of O 0 5.613392568193376e-05
microsatellite O 0 0.012625863775610924
repeats O 0 0.0013838591985404491
at O 0 0.00021376865333877504
the O 0 0.00020226999185979366
gamma O 0 0.007439134642481804
- O 0 0.0038411773275583982
aminobutyric O 0 0.012462286278605461
acid O 0 0.003830099245533347
receptor O 0 0.0028970781713724136
beta3 O 0 0.016391443088650703
subunit O 0 0.002949886256828904
( O 0 0.0016409539384767413
GABRB3 O 1 0.8126189708709717
) O 0 0.000596926431171596
locus O 0 0.008078738115727901
. O 0 0.0011990154162049294

A O 0 0.016916325315833092
niece O 1 0.7251401543617249
( O 0 0.0025973704177886248
B O 0 0.1080544963479042
. O 0 0.00021438040130306035
B O 0 0.0076242112554609776
. O 0 6.44364336039871e-05
) O 0 4.63511714769993e-05
with O 0 3.0240802516345866e-05
45 O 0 0.0001300893782172352
chromosomes O 0 0.0001123124675359577
and O 0 3.4134765883209184e-05
the O 0 9.269898146158084e-05
derivative O 0 0.0013319216668605804
3 O 0 0.0002482203708495945
but O 0 7.463619112968445e-05
without O 0 0.00014841246593277901
the O 0 0.0002602323074825108
der O 1 0.8620794415473938
( O 0 0.00030422379495576024
15 O 0 0.00034701512777246535
) O 0 9.904622856993228e-05
demonstrated O 0 0.0011488971067592502
a O 0 0.0006754912901669741
phenotype O 0 0.026737336069345474
consistent O 0 0.0007155811763368547
with O 0 7.095617183949798e-05
that O 0 8.405629341723397e-05
reported O 0 0.0005808397545479238
for O 0 0.00013854613644070923
haploinsufficiency O 0 0.012350394390523434
of O 0 0.00013902680075261742
distal O 1 0.9945259094238281
3 O 0 0.003137619001790881
p O 0 0.014178723096847534
. O 0 0.0009289047447964549

Uniparental B-Disease 1 0.9991270899772644
disomy I-Disease 1 0.9911119341850281
associated O 0 0.0015728529542684555
with O 0 0.0003367249446455389
unbalanced O 0 0.2747775912284851
segregation O 0 0.004810841288417578
of O 0 9.077900904230773e-05
non O 0 0.005011111497879028
- O 0 0.052731093019247055
Robertsonian O 1 0.5081337094306946
translocations O 0 0.014278235845267773
has O 0 0.0008306665113195777
been O 0 0.0004936327459290624
reported O 0 0.0012397048994898796
previously O 0 0.0005054565845057368
but O 0 0.00014553040091414005
has O 0 0.0001779009326128289
not O 0 4.9046004278352484e-05
, O 0 3.7482714105863124e-05
to O 0 2.951635906356387e-05
our O 0 0.00012367231829557568
knowledge O 0 0.0004232259816490114
, O 0 9.528843656880781e-05
been O 0 8.550151687813923e-05
observed O 0 0.00013617391232401133
in O 0 5.3565294365398586e-05
a O 0 0.0004124360275454819
case O 0 0.0014559805858880281
of O 0 0.0005134095554240048
PWS B-Disease 1 0.9999200105667114
. O 0 0.002235168358311057

Furthermore O 0 0.005758867599070072
, O 0 0.0003367604222148657
our O 0 0.00043765781447291374
findings O 0 0.0007054085726849735
are O 0 1.9809736841125414e-05
best O 0 0.0001185464789159596
interpreted O 0 0.00016859760216902941
as O 0 0.00011641870514722541
true O 0 0.0011231728130951524
gamete O 0 0.048391424119472504
complementation O 1 0.9750117063522339
resulting O 0 0.003146842122077942
in O 0 0.0010632604826241732
maternal B-Disease 1 0.9872294664382935
UPD I-Disease 1 0.9992851614952087
15 I-Disease 0 0.004347854759544134
and O 0 0.0037652417086064816
PWS B-Disease 1 0.9995612502098083

Schwartz B-Disease 1 0.9875974059104919
- I-Disease 1 0.9496351480484009
Jampel I-Disease 1 0.9957962036132812
syndrome I-Disease 1 0.9999549388885498
type I-Disease 0 0.006773525848984718
2 I-Disease 0 0.0005916627123951912
and O 0 0.000492527789901942
Stuve B-Disease 1 0.998043417930603
- I-Disease 1 0.9963955283164978
Wiedemann I-Disease 1 0.9997021555900574
syndrome I-Disease 1 0.9999932050704956
: O 0 0.0002965398016385734
a O 0 0.00047574815107509494
case O 0 0.0008195969858206809
for O 0 0.00016704176960047334
" O 0 0.000746839155908674
lumping O 0 0.03296605497598648
" O 0 0.0010803625918924809
. O 0 0.0007118108333088458

Recent O 0 0.0032080975361168385
studies O 0 0.0008763268124312162
demonstrated O 0 0.0013621598482131958
the O 0 0.0001099071596399881
existence O 0 0.0003147631068713963
of O 0 2.4676406610524282e-05
a O 0 0.0003999261825811118
genetically O 0 0.0008096564561128616
distinct O 0 0.00031655034399591386
, O 0 0.00011197166895726696
usually O 0 0.00019151145534124225
lethal O 0 0.002511492231860757
form O 0 8.38074556668289e-05
of O 0 2.3999742552405223e-05
the O 0 0.0007525488035753369
Schwartz B-Disease 1 0.9981478452682495
- I-Disease 1 0.990954577922821
Jampel I-Disease 1 0.9991865754127502
syndrome I-Disease 1 0.9999910593032837
( O 0 0.014333377592265606
SJS B-Disease 1 0.9992105960845947
) O 0 0.00037490870454348624
of O 0 0.00022779428400099277
myotonia B-Disease 1 0.9996600151062012
and O 0 0.00845539104193449
skeletal B-Disease 1 0.99994957447052
dysplasia I-Disease 1 0.9999850988388062
, O 0 0.00033330509904772043
which O 0 0.00011217909923288971
we O 0 0.0003648000711109489
called O 0 0.006431663408875465
SJS B-Disease 1 0.9990344047546387
type I-Disease 0 0.004617619793862104
2 I-Disease 0 0.0010986527195200324
. O 0 0.0005096984095871449

This O 0 0.0030002635903656483
disorder O 1 0.9997838139533997
is O 0 0.00040994855226017535
reminiscent O 0 0.0015146350488066673
of O 0 5.421698733698577e-05
another O 0 0.0014422594103962183
rare O 1 0.8006040453910828
condition O 1 0.998002827167511
, O 0 0.00017269632371608168
the O 0 0.0006642196094617248
Stuve B-Disease 1 0.9980352520942688
- I-Disease 1 0.9945474863052368
Wiedemann I-Disease 1 0.9995782971382141
syndrome I-Disease 1 0.9999858140945435
( O 0 0.006357419770210981
SWS B-Disease 1 0.9979299306869507
) O 0 0.0002797523920889944
, O 0 8.67844428285025e-05
which O 0 5.2784645959036425e-05
comprises O 0 0.0005086064338684082
campomelia B-Disease 0 0.1440221667289734
at O 0 0.00038708827923983335
birth O 0 0.0012525294441729784
with O 0 0.0009140691254287958
skeletal B-Disease 1 0.999954342842102
dysplasia I-Disease 1 0.9999886751174927
, O 0 0.0067412215285003185
contractures B-Disease 1 0.9996240139007568
, O 0 0.0003749812312889844
and O 0 0.0002287013194290921
early B-Disease 0 0.001007679384201765
death I-Disease 0 0.004635166376829147
. O 0 0.0007398792658932507

To O 0 0.00042099057463929057
test O 0 0.0007332628010772169
for O 0 0.0001557983341626823
possible O 0 0.0007765963091515005
nosologic O 0 0.03905927762389183
identity O 0 0.00033622104092501104
between O 0 0.0002243964554509148
these O 0 0.0004402873746585101
disorders O 1 0.9999830722808838
, O 0 0.00026959789101965725
we O 0 0.0001825014187488705
reviewed O 0 0.0004889106494374573
the O 0 4.533418905339204e-05
literature O 0 6.560982001246884e-05
and O 0 4.3039901356678456e-05
obtained O 0 0.0001172108095488511
a O 0 0.00024004180158954114
follow O 0 0.00022869848180562258
- O 0 0.0003238474309910089
up O 0 2.1502390154637396e-05
of O 0 4.270793397154193e-06
the O 0 3.6082456063013524e-05
only O 0 4.220058326609433e-05
two O 0 8.751101995585486e-05
surviving O 0 0.04191526025533676
patients O 1 0.999700665473938
, O 0 0.0001213533541886136
one O 0 0.00018128148803953081
with O 0 0.0008452542824670672
SJS B-Disease 1 0.9997441172599792
type I-Disease 0 0.002781991148367524
2 I-Disease 0 0.00027763890102505684
at O 0 0.00018409182666800916
age O 0 0.0002574761165305972
10 O 0 0.00014016541535966098
years O 0 0.00012095570127712563
and O 0 5.183992470847443e-05
another O 0 0.00025431273388676345
with O 0 0.0002667664084583521
SWS B-Disease 1 0.9975693821907043
at O 0 0.000604648026637733
age O 0 0.0006669889553450048
7 O 0 0.0007115116459317505
years O 0 0.0006900463486090302
. O 0 0.0005225191125646234

Patients O 1 0.9997790455818176
reported O 0 0.0042726281099021435
as O 0 0.000422084383899346
having O 0 0.004043223802000284
either O 0 0.01463925838470459
neonatal O 1 0.9999874830245972
SJS B-Disease 1 0.9997513890266418
or O 0 0.0037096557207405567
SWS B-Disease 1 0.9900683760643005
presented O 0 0.0007345899357460439
a O 0 0.00027669183327816427
combination O 0 0.0007858152966946363
of O 0 3.3644886570982635e-05
a O 0 0.007441578432917595
severe O 1 0.9999538660049438
, O 0 0.005585792008787394
prenatal O 1 0.9999229907989502
- O 1 0.999245285987854
onset O 1 0.9999526739120483
neuromuscular B-Disease 1 0.9999982118606567
disorder I-Disease 1 0.999992847442627
( O 0 0.0202734787017107
with O 0 0.23359058797359467
congenital B-Disease 1 0.9999995231628418
joint I-Disease 1 0.9996446371078491
contractures I-Disease 1 0.999988317489624
, O 1 0.8061257004737854
respiratory O 1 0.9999973773956299
and O 0 0.0013187036383897066
feeding O 1 0.8296825885772705
difficulties O 1 0.8880795836448669
, O 0 0.0004428341635502875
tendency O 0 0.05672430247068405
to O 0 0.0005941836861893535
hyperthermia B-Disease 1 0.9997981190681458
, O 0 0.00020612803928088397
and O 0 0.00018127734074369073
frequent O 0 0.010422139428555965
death O 0 0.0027443876024335623
in O 0 0.00018749487935565412
infancy O 0 0.22842472791671753
) O 0 8.217140566557646e-05
with O 0 6.236597982933745e-05
a O 0 0.00041034238529391587
distinct O 0 0.001477119978517294
campomelic B-Disease 1 0.9922506213188171
- I-Disease 1 0.9740985035896301
metaphyseal I-Disease 1 0.9958444237709045
skeletal I-Disease 1 0.9997368454933167
dysplasia I-Disease 1 0.9999145269393921
. O 0 0.003452409291639924

The O 0 0.000348030764143914
similarity O 0 0.0004145727143622935
of O 0 4.4096701458329335e-05
the O 0 0.0006348459282889962
clinical O 1 0.9993374943733215
and O 0 0.0006033946992829442
radiographic O 1 0.999406099319458
findings O 0 0.024048171937465668
is O 0 0.0002519867557566613
so O 0 0.0002625167544465512
extensive O 0 0.0023974080104380846
that O 0 0.00010043060319731012
these O 0 0.00030283682281151414
disorders O 1 0.9999849796295166
appear O 0 0.0009272117749787867
to O 0 6.057989958208054e-05
be O 0 4.0421127778245136e-05
a O 0 0.00021914868557360023
single O 0 0.0003522006154526025
entity O 0 0.003630319843068719
. O 0 0.0007390643004328012

The O 0 0.0007486498216167092
follow O 0 0.0008432772592641413
- O 0 0.0014567113248631358
up O 0 0.00013509966083802283
observation O 0 0.0007261649006977677
of O 0 9.864183084573597e-06
an O 0 7.501028449041769e-05
identical O 0 0.000200829075765796
and O 0 5.248548768577166e-05
unique O 0 0.0002346641558688134
pattern O 0 0.0012721045641228557
of O 0 0.00013463835057336837
progressive O 1 0.9998939037322998
bone B-Disease 1 0.9999982118606567
dysplasia I-Disease 1 0.9999877214431763
in O 0 0.0001752178359311074
the O 0 0.00018726706912275404
two O 0 0.00033576885471120477
patients O 1 0.999853253364563
( O 0 0.00027872182545252144
one O 0 0.00017936131916940212
with O 0 0.000677506672218442
SJS B-Disease 1 0.9997631907463074
type I-Disease 0 0.0027452148497104645
2 I-Disease 0 0.0002823655668180436
, O 0 5.554335075430572e-05
one O 0 9.696438792161644e-05
with O 0 0.00033913605147972703
SWS B-Disease 1 0.9967190623283386
) O 0 0.0004223268770147115
surviving O 0 0.0024631056003272533
beyond O 0 0.0028428579680621624
infancy O 0 0.1271081119775772
adds O 0 0.0012226664694026113
to O 0 4.194404391455464e-05
the O 0 6.082127947593108e-05
evidence O 0 8.81341693457216e-05
in O 0 3.710551391122863e-05
favor O 0 8.966659515863284e-05
of O 0 2.6196710678050295e-05
identity O 0 0.001029699807986617
. O 0 0.0008008848526515067

The O 0 0.0009045570041052997
hypothesis O 0 0.003353724256157875
that O 0 0.0006689970614388585
SWS B-Disease 1 0.9973711967468262
and O 0 0.002013163408264518
SJS B-Disease 1 0.999453604221344
type I-Disease 0 0.003089280566200614
2 I-Disease 0 0.00022584336693398654
are O 0 1.8598337192088366e-05
the O 0 0.00013406938523985445
same O 0 0.0007962021045386791
disorder O 1 0.9999514818191528
should O 0 0.00024081890296656638
be O 0 5.1543174777179956e-05
testable O 0 0.0009441497386433184
by O 0 7.40888062864542e-05
molecular O 0 0.0006405470194295049
methods O 0 0.0004006187373306602
. O 0 0.0002498856629244983
. O 0 0.0006351424963213503

A O 0 0.007043846882879734
mouse O 0 0.01056382805109024
model O 0 0.0011185144539922476
of O 0 0.0003827229083981365
severe O 1 0.9999833106994629
von B-Disease 1 0.9999644756317139
Willebrand I-Disease 1 0.9999974966049194
disease I-Disease 1 0.9999996423721313
: O 0 0.10437359660863876
defects O 1 0.9998260140419006
in O 0 0.002581547247245908
hemostasis O 1 0.9999167919158936
and O 0 0.023356573656201363
thrombosis B-Disease 1 0.9999881982803345
. O 0 0.001967262476682663

von B-Disease 1 0.8662742376327515
Willebrand I-Disease 1 0.9957647323608398
factor I-Disease 0 0.010872052051126957
( I-Disease 0 0.004580769222229719
vWf I-Disease 1 0.9935811758041382
) I-Disease 0 0.02972501702606678
deficiency I-Disease 1 0.999992847442627
causes O 1 0.9997327923774719
severe O 1 0.9999915361404419
von B-Disease 1 0.999985933303833
Willebrand I-Disease 1 0.9999967813491821
disease I-Disease 1 0.9999994039535522
in O 0 0.0020613549277186394
humans O 0 0.02598021738231182
. O 0 0.0010525796096771955

We O 0 0.00048149406211450696
generated O 0 0.000289786490611732
a O 0 0.0006279335357248783
mouse O 0 0.005442231427878141
model O 0 0.0004948576097376645
for O 0 0.00019541832443792373
this O 0 0.00032728712540119886
disease O 1 0.9998774528503418
by O 0 6.454276444856077e-05
using O 0 0.0002447069273330271
gene O 0 0.001354787964373827
targeting O 0 0.0011720486218109727
. O 0 0.0006530373357236385

vWf B-Disease 1 0.9679657220840454
- I-Disease 1 0.9575245380401611
deficient I-Disease 1 0.997654914855957
mice O 0 0.07779915630817413
appeared O 0 0.0017578881233930588
normal O 0 0.0019585597328841686
at O 0 0.0005010757013224065
birth O 0 0.0014648812357336283
; O 0 9.614329610485584e-05
they O 0 4.3470827222336084e-05
were O 0 4.1395869629923254e-05
viable O 0 0.0019225047435611486
and O 0 0.00021892729273531586
fertile O 0 0.048159271478652954
. O 0 0.0011700417380779982

Neither O 0 0.048728521913290024
vWf O 1 0.9045780301094055
nor O 0 0.02753172628581524
vWf O 1 0.9428492188453674
propolypeptide O 1 0.866402268409729
( O 0 0.005257674027234316
von B-Disease 1 0.9881253242492676
Willebrand I-Disease 1 0.999751627445221
antigen O 1 0.9969992637634277
II O 1 0.9765303730964661
) O 0 0.0001587610604474321
were O 0 4.680699930759147e-05
detectable O 0 0.0019799426663666964
in O 0 0.00012571598927024752
plasma O 0 0.010732777416706085
, O 0 0.0005854852497577667
platelets O 1 0.9885253310203552
, O 0 0.00023028046416584402
or O 0 0.00041629141196608543
endothelial O 1 0.9146023988723755
cells O 0 0.0005003678379580379
of O 0 1.794616946426686e-05
the O 0 0.0003352721396367997
homozygous O 0 0.007454325444996357
mutant O 0 0.014073521830141544
mice O 0 0.036425210535526276
. O 0 0.0009397182730026543

The O 0 0.0023592342622578144
mutant O 0 0.048753660172224045
mice O 1 0.8487723469734192
exhibited O 1 0.8135367631912231
defects O 1 0.9987403750419617
in O 0 0.0008783959783613682
hemostasis O 1 0.9985252022743225
with O 0 0.00020739686442539096
a O 0 0.001526273787021637
highly O 1 0.5352644920349121
prolonged O 1 0.9997376799583435
bleeding O 1 0.999968409538269
time O 0 0.0005005199927836657
and O 0 0.00037722609704360366
spontaneous O 0 0.4581098258495331
bleeding O 1 0.9999210834503174
events O 0 0.00022851799440104514
in O 0 0.00010101891530212015
approximately O 0 0.00021065234614070505
10 O 0 0.00012402472202666104
% O 0 3.6123808968113735e-05
of O 0 0.00010986629058606923
neonates O 1 0.9974204301834106
. O 0 0.0015182537026703358

As O 0 0.0005140638095326722
in O 0 0.00023234121908899397
the O 0 0.0006637884071096778
human O 0 0.25816217064857483
disease O 1 0.9999603033065796
, O 0 0.00017151166684925556
the O 0 0.0002463669516146183
factor O 0 0.00407140189781785
VIII O 1 0.9859586358070374
level O 0 0.0007455009035766125
in O 0 8.873730257619172e-05
these O 0 0.00010416870645713061
mice O 0 0.020888803526759148
was O 0 0.00044969527516514063
reduced O 0 0.000768975995015353
strongly O 0 0.0003171378921251744
as O 0 6.284747360041365e-05
a O 0 0.00017538580868858844
result O 0 0.00013162614777684212
of O 0 1.1620712029980496e-05
the O 0 0.00012057901767548174
lack O 0 0.0013209618628025055
of O 0 7.261352584464476e-05
protection O 0 0.06356234848499298
provided O 0 0.0007943060481920838
by O 0 0.0004994898336008191
vWf O 1 0.8700262904167175
. O 0 0.0009635069873183966

Defective O 1 0.9986984729766846
thrombosis B-Disease 1 0.9999223947525024
in O 0 0.0017069765599444509
mutant O 0 0.04746897146105766
mice O 0 0.2179102599620819
was O 0 0.0006234628963284194
also O 0 0.0001700242137303576
evident O 0 0.0009572173003107309
in O 0 7.128626748453826e-05
an O 0 0.00011221580643905327
in O 0 0.00020227963977959007
vivo O 0 0.00458328565582633
model O 0 0.0008625296177342534
of O 0 0.0006173612782731652
vascular B-Disease 1 0.9999963045120239
injury I-Disease 1 0.9998160004615784
. O 0 0.0021127015352249146

In O 0 0.0002926434390246868
this O 0 9.626704559195787e-05
model O 0 0.0005402687238529325
, O 0 0.00013750468497164547
the O 0 0.00035066131385974586
exteriorized O 1 0.8052565455436707
mesentery O 1 0.9563935399055481
was O 0 0.0017591386567801237
superfused O 0 0.35187584161758423
with O 0 0.0006754371570423245
ferric O 1 0.9972575306892395
chloride O 0 0.019319817423820496
and O 0 0.00011747385724447668
the O 0 0.00015460790018551052
accumulation O 0 0.004768627695739269
of O 0 0.0001573141198605299
fluorescently O 1 0.9921672940254211
labeled O 1 0.5554763674736023
platelets O 1 0.9903954863548279
was O 0 0.0007840187172405422
observed O 0 0.0004684825544245541
by O 0 0.00023630360374227166
intravital O 0 0.3130056858062744
microscopy O 0 0.02163027413189411
. O 0 0.0012319136876612902

We O 0 0.0011919530807062984
conclude O 0 0.0026525487191975117
that O 0 8.69493669597432e-05
these O 0 9.872025839285925e-05
mice O 0 0.0147557919844985
very O 0 0.0007326244376599789
closely O 0 0.0021099578589200974
mimic O 1 0.9946657419204712
severe O 1 0.9998999834060669
human O 1 0.9918836355209351
von B-Disease 1 0.9999560117721558
Willebrand I-Disease 1 0.9999978542327881
disease I-Disease 1 0.9999991655349731
and O 0 0.0004008640244137496
will O 0 0.00013450169353745878
be O 0 4.0904640627559274e-05
very O 0 9.66377992881462e-05
useful O 0 0.0002077009849017486
for O 0 7.915803871583194e-05
investigating O 0 0.0009861669968813658
the O 0 5.902099292143248e-05
role O 0 0.0003973096900153905
of O 0 9.555011638440192e-05
vWf O 1 0.9257561564445496
in O 0 0.00028594344621524215
normal O 0 0.0063158124685287476
physiology O 1 0.9841920137405396
and O 0 0.000429109059041366
in O 0 0.003707407508045435
disease O 1 0.9999804496765137
models O 0 0.0013594357296824455
. O 0 0.0002588238858152181
. O 0 0.0006466690101660788

Oral O 1 0.9118391871452332
contraceptives O 1 0.866456925868988
and O 0 0.00015632346912752837
the O 0 0.00032160821137949824
risk O 0 0.46523648500442505
of O 0 0.000627246918156743
hereditary B-Disease 1 0.999977707862854
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.999998927116394
. O 0 0.0031609749421477318

Hereditary B-Disease 1 0.9998488426208496
Ovarian I-Disease 1 0.9999991655349731
Cancer I-Disease 1 0.9999990463256836
Clinical O 1 0.9998472929000854
Study O 0 0.01593036949634552
Group O 0 0.0017140629934147
. O 0 0.0009279529331251979

BACKGROUND O 0 0.010733313858509064
Women O 0 0.0012646863469853997
with O 0 0.00021686058607883751
mutations O 0 0.0010973978787660599
in O 0 0.00011451230966486037
either O 0 0.0002606696216389537
the O 0 0.00048717722529545426
BRCA1 O 1 0.9961745738983154
or O 0 0.00032368017127737403
the O 0 0.0006976031581871212
BRCA2 O 1 0.9970757961273193
gene O 0 0.0007754116668365896
have O 0 5.585737380897626e-05
a O 0 0.0003532578411977738
high O 0 0.003603717777878046
lifetime O 1 0.9674782156944275
risk O 1 0.9885439276695251
of O 0 0.004034182522445917
ovarian B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999977350234985
. O 0 0.002397059230133891

Oral O 1 0.967867374420166
contraceptives O 1 0.9939110279083252
protect O 1 0.934826672077179
against O 1 0.8969560265541077
ovarian B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999988079071045
in O 0 0.0003225422406103462
general O 0 0.0008752878638915718
, O 0 0.000136396789457649
but O 0 0.00011437752982601523
it O 0 8.521816198481247e-05
is O 0 0.00011397839261917397
not O 0 6.594585283892229e-05
known O 0 0.0001800666213966906
whether O 0 0.00012100693129468709
they O 0 2.8125909011578187e-05
also O 0 6.303311965893954e-05
protect O 0 0.0013856724835932255
against O 0 0.0002323314838577062
hereditary B-Disease 1 0.6530264616012573
forms I-Disease 0 0.002880120649933815
of I-Disease 0 0.027521710842847824
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
. O 0 0.0019333390519022942

METHODS O 0 0.004265906289219856
We O 0 0.0011265234788879752
enrolled O 0 0.007166817784309387
207 O 0 0.008458070456981659
women O 0 0.0011356776813045144
with O 0 0.0027539764996618032
hereditary B-Disease 1 0.9999463558197021
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999982118606567
and O 0 0.00034612766467034817
161 O 0 0.0016296905232593417
of O 0 1.987304858630523e-05
their O 0 7.61906267143786e-05
sisters O 0 0.0010904527734965086
as O 0 7.54149368731305e-05
controls O 0 0.0004279536078684032
in O 0 8.955926750786602e-05
a O 0 0.000822792702820152
case O 0 0.004123263526707888
- O 0 0.004977766424417496
control O 0 0.0012639318592846394
study O 0 0.0012959751766175032
. O 0 0.0005828916328027844

All O 0 0.00040755915688350797
the O 0 0.0008178338757716119
patients O 1 0.9975782036781311
carried O 0 0.00027593501727096736
a O 0 0.0005767607362940907
pathogenic O 0 0.011566737666726112
mutation O 0 0.0013527662958949804
in O 0 0.00014278785965871066
either O 0 0.0009348868625238538
BRCA1 O 1 0.9910942912101746
( O 0 0.0009870247449725866
179 O 0 0.010514560155570507
women O 0 0.0012247050181031227
) O 0 0.0004297218401916325
or O 0 0.001407745759934187
BRCA2 O 1 0.9959588646888733
( O 0 0.0010659117251634598
28 O 0 0.0014988611219450831
women O 0 0.0008786156540736556
) O 0 0.000511589169036597
. O 0 0.0007548500434495509

The O 0 0.0013716277899220586
control O 0 0.002734282985329628
women O 0 0.0007265995955094695
were O 0 0.00010110255243489519
enrolled O 0 0.0028739527333527803
regardless O 0 0.00024110103549901396
of O 0 3.157102037221193e-05
whether O 0 0.0004235969390720129
or O 0 0.00019358014105819166
not O 0 7.740977889625356e-05
they O 0 5.5905868066474795e-05
had O 0 0.0002326029643882066
either O 0 0.0003119932080153376
mutation O 0 0.002369081601500511
. O 0 0.000475450127851218

Lifetime O 0 0.038496240973472595
histories O 0 0.00256213522516191
of O 0 0.00018677167827263474
oral O 1 0.9933102130889893
- O 1 0.5710792541503906
contraceptive O 1 0.957145094871521
use O 0 0.00013724807649850845
were O 0 4.577337676892057e-05
obtained O 0 0.0001941346563398838
by O 0 0.00011762620124500245
interview O 0 0.0022177749779075384
or O 0 0.00011076443479396403
by O 0 4.4701911974698305e-05
written O 0 0.00010373514669481665
questionnaire O 0 0.0015584611101076007
and O 0 7.090030703693628e-05
were O 0 5.2847404731437564e-05
compared O 0 0.0006864372990094125
between O 0 0.0006073754047974944
patients O 1 0.9998539686203003
and O 0 0.00016368414799217135
control O 0 0.0018891692161560059
women O 0 0.0006868347991257906
, O 0 0.0001969627192011103
after O 0 0.000558169384021312
adjustment O 0 0.00137660454493016
for O 0 7.87788158049807e-05
year O 0 0.00016701244749128819
of O 0 2.906954614445567e-05
birth O 0 0.0010875323787331581
and O 0 0.00017591859796084464
parity O 0 0.013873624615371227
. O 0 0.0013220147229731083

RESULTS O 0 0.002826814306899905
The O 0 0.00036703035584650934
adjusted O 0 0.0033935385290533304
odds O 0 0.005946467164903879
ratio O 0 0.004324351437389851
for O 0 0.38683396577835083
ovarian B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999986886978149
associated O 0 0.0003965651849284768
with O 0 4.396100121084601e-05
any O 0 4.845096555072814e-05
past O 0 7.52197956899181e-05
use O 0 3.908164944732562e-05
of O 0 3.585958620533347e-05
oral O 1 0.9742829203605652
contraceptives O 1 0.9917517304420471
was O 0 0.0011958632385358214
0 O 0 0.0011827648850157857
. O 0 0.0005220270249992609

5 O 0 0.0018141510663554072
( O 0 0.000609849055763334
95 O 0 0.0007582096732221544
percent O 0 0.0003208759007975459
confidence O 0 0.0008099813130684197
interval O 0 0.0005078279646113515
, O 0 8.171280205715448e-05
0 O 0 0.0001419359032297507
. O 0 3.0272371077444404e-05
3 O 0 8.242936746682972e-05
to O 0 3.617331094574183e-05
0 O 0 0.0001925980905070901
. O 0 4.893047662335448e-05
8 O 0 0.00032774361898191273
) O 0 0.00023789415718056262
. O 0 0.0005228295340202749

The O 0 0.002609404968097806
risk O 0 0.2927025258541107
decreased O 0 0.004046828020364046
with O 0 8.679445454617962e-05
increasing O 0 0.0003043665492441505
duration O 0 0.0006807862082496285
of O 0 1.857100687630009e-05
use O 0 0.0003231670707464218
( O 0 0.0007530280272476375
P O 0 0.01075676642358303
for O 0 0.0001441699278075248
trend O 0 0.0011586557375267148
, O 0 0.00022896358859725296
< O 0 0.00505274161696434
0 O 0 0.0004102592938579619
. O 0 0.0001537502248538658
001 O 0 0.019834214821457863
) O 0 0.00011486237053759396
; O 0 3.2851614378159866e-05
use O 0 3.200145874870941e-05
for O 0 4.073060699738562e-05
six O 0 0.00013291272625792772
or O 0 8.194136171368882e-05
more O 0 7.529636786784977e-05
years O 0 0.0002685929066501558
was O 0 0.00025776494294404984
associated O 0 6.687863060506061e-05
with O 0 2.9260932933539152e-05
a O 0 0.0002284927322762087
60 O 0 0.0003047079953830689
percent O 0 0.0004061773361172527
reduction O 0 0.003883502446115017
in O 0 0.00041755312122404575
risk O 1 0.6533167362213135
. O 0 0.0008473452762700617

Oral O 1 0.5527669787406921
- O 0 0.02374887652695179
contraceptive O 1 0.7014038562774658
use O 0 0.0005835804622620344
protected O 0 0.11773859709501266
against O 1 0.5368226766586304
ovarian B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999971389770508
both O 0 0.00011831294978037477
for O 0 0.00012413134390953928
carriers O 0 0.0013328416971489787
of O 0 2.850018790923059e-05
the O 0 0.0006969489040784538
BRCA1 O 1 0.9974685907363892
mutation O 0 0.0030636980663985014
( O 0 0.0004799887537956238
odds O 0 0.0028671317268162966
ratio O 0 0.0005046715377829969
, O 0 8.932693890528753e-05
0 O 0 0.0002056376833934337
. O 0 4.120835001231171e-05
5 O 0 0.00013811323151458055
; O 0 4.583513873512857e-05
95 O 0 0.00033392407931387424
percent O 0 0.0001603726122993976
confidence O 0 0.0005928624887019396
interval O 0 0.00043287669541314244
, O 0 5.752051583840512e-05
0 O 0 0.00014783127699047327
. O 0 2.3698525183135644e-05
3 O 0 6.086049688747153e-05
to O 0 2.711955676204525e-05
0 O 0 0.00014828643179498613
. O 0 4.1002160287462175e-05
9 O 0 0.00024414711515419185
) O 0 5.604471152764745e-05
and O 0 2.3461579985450953e-05
for O 0 7.096544868545607e-05
carriers O 0 0.0009776147780939937
of O 0 2.7244084776612e-05
the O 0 0.0006008899072185159
BRCA2 O 1 0.9937571287155151
mutation O 0 0.0028140388894826174
( O 0 0.000499363464768976
odds O 0 0.002553340047597885
ratio O 0 0.0005674527492374182
, O 0 0.00012004555173916742
0 O 0 0.00029683791217394173
. O 0 5.098965630168095e-05
4 O 0 0.00023749460524413735
; O 0 5.558600969379768e-05
95 O 0 0.00028211314929649234
percent O 0 0.00012889782374259084
confidence O 0 0.0005663780611939728
interval O 0 0.0003908744838554412
, O 0 7.149035081965849e-05
0 O 0 0.00012363283894956112
. O 0 2.4710650905035436e-05
2 O 0 7.202155393315479e-05
to O 0 2.6910107408184558e-05
1 O 0 0.0001280045253224671
. O 0 5.113730003358796e-05
1 O 0 0.0003321061667520553
) O 0 0.00022447414812631905
. O 0 0.00032830180134624243

CONCLUSIONS O 0 0.020296735689044
Oral O 1 0.8353404998779297
- O 0 0.052695341408252716
contraceptive O 1 0.844789445400238
use O 0 0.0003317606169730425
may O 0 0.0005641674506478012
reduce O 0 0.0016223188722506166
the O 0 0.00026597781106829643
risk O 1 0.865459144115448
of O 0 0.002570462180301547
ovarian B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999990463256836
in O 0 0.0003447558847256005
women O 0 0.0008572433143854141
with O 0 0.0002868371084332466
pathogenic O 0 0.31545737385749817
mutations O 0 0.0011993180960416794
in O 0 0.00013936976029071957
the O 0 0.000862349639646709
BRCA1 O 1 0.9983578324317932
or O 0 0.004735962022095919
BRCA2 O 1 0.9961525797843933
gene O 0 0.01631768047809601

A O 0 0.0057146898470819
Japanese O 0 0.0021608162205666304
family O 0 0.0016444636275991797
with O 0 0.0009545451612211764
adrenoleukodystrophy B-Disease 1 0.9996552467346191
with O 0 0.00021846358140464872
a O 0 0.0008122405270114541
codon O 0 0.0033620703034102917
291 O 0 0.009420582093298435
deletion O 0 0.004152560606598854
: O 0 0.0003144805377814919
a O 0 0.0009761229739524424
clinical O 1 0.9966310858726501
, O 0 0.0003134896687697619
biochemical O 0 0.014791528694331646
, O 0 0.0005941258859820664
pathological O 1 0.9977030158042908
, O 0 0.00019590281590353698
and O 0 0.00015828762843739241
genetic O 0 0.002632149728015065
report O 0 0.0014760701451450586
. O 0 0.0006719165830872953

We O 0 0.0008865673444233835
report O 0 0.0005738528561778367
a O 0 0.00038682675221934915
Japanese O 0 0.0008523635915480554
family O 0 0.0012484119506552815
with O 0 0.00180585659109056
adrenoleukodystrophy B-Disease 1 0.9999833106994629
( O 0 0.12922996282577515
ALD B-Disease 1 0.9999582767486572
) O 0 0.00021192395070102066
with O 0 4.8481284466106445e-05
a O 0 0.0001566127612022683
three O 0 6.924203626113012e-05
base O 0 0.0006011212826706469
pair O 0 0.0007443533977493644
deletion O 0 0.003678708104416728
( O 0 0.000727096339687705
delGAG O 0 0.09494288265705109
291 O 0 0.008482777513563633
) O 0 0.00019635427452158183
in O 0 0.000171456893440336
the O 0 0.0020566678140312433
ALD B-Disease 1 0.9999713897705078
gene O 0 0.008966866880655289
. O 0 0.0009746899595484138

A O 0 0.002963304752483964
variety O 0 0.0004642692510969937
of O 0 8.23601585580036e-05
phenotypes O 0 0.008183334954082966
were O 0 3.640201975940727e-05
observed O 0 0.00020300941832829267
within O 0 8.582287409808487e-05
this O 0 0.0001169582610600628
family O 0 0.0011725019430741668
. O 0 0.0008606701157987118

While O 0 0.0009920453885570168
the O 0 0.000740384275559336
proband O 0 0.4208372235298157
( O 0 0.001955385087057948
patient O 1 0.9945948719978333
1 O 0 0.0005650193197652698
) O 0 0.00015223451191559434
was O 0 0.00023789642727933824
classified O 0 0.001276365714147687
as O 0 8.046616858337075e-05
having O 0 0.00039023501449264586
a O 0 0.0003807067696470767
rare O 0 0.003147908952087164
intermediate O 0 0.009905519895255566
type O 0 0.0014906702563166618
of O 0 6.896512786624953e-05
adult O 0 0.4180147051811218
cerebral O 1 0.9999538660049438
and O 0 0.001229499583132565
cerebello O 1 0.9991651773452759
- O 1 0.9918639659881592
brain O 1 0.9992316961288452
stem O 0 0.020393816754221916
forms O 0 0.00038067190325818956
, O 0 0.0001772690302459523
his O 0 0.002995135961100459
younger O 0 0.021286921575665474
brother O 0 0.011390571482479572
( O 0 0.0012759112287312746
patient O 1 0.9952179193496704
2 O 0 0.000448700156994164
) O 0 0.00020557512470986694
and O 0 0.0002546908217482269
nephew O 0 0.28443634510040283
( O 0 0.0009107786463573575
patient O 1 0.9969968795776367
3 O 0 0.00035666805342771113
) O 0 0.0001259593409486115
had O 0 0.0003824222076218575
a O 0 0.004672587849199772
childhood O 1 0.9996310472488403
ALD B-Disease 1 0.9999955892562866
type O 1 0.8510513305664062
. O 0 0.001974312588572502

Another O 0 0.006197329144924879
nephew O 0 0.256982684135437
( O 0 0.002247275086119771
patient O 1 0.9933162331581116
4 O 0 0.0005765018868260086
) O 0 9.594913717592135e-05
of O 0 6.423808372346684e-05
patient O 1 0.9992364645004272
1 O 0 0.0005005786661058664
was O 0 0.0004935546312481165
classified O 0 0.0019452724372968078
as O 0 0.0001083880415535532
having O 0 0.000559781095944345
an O 0 0.00040268327575176954
adolescent O 1 0.9960271120071411
form O 0 0.0014705529902130365
. O 0 0.000775670341681689

The O 0 0.001109426375478506
tau O 0 0.016150623559951782
level O 0 0.0006094559212215245
in O 0 0.00013456055603455752
the O 0 0.0005745993694290519
cerebrospinal O 1 0.9976578950881958
fluid O 1 0.9925107955932617
( O 0 0.003698840271681547
CSF O 1 0.9984663724899292
) O 0 0.0004496352339629084
in O 0 0.00032635018578730524
patient O 1 0.9957815408706665
1 O 0 0.0003931574756279588
was O 0 0.00021002080757170916
as O 0 7.621220720466226e-05
high O 0 0.00030360138043761253
as O 0 3.829800698440522e-05
that O 0 3.443937384872697e-05
of O 0 9.573453280609101e-05
patients O 1 0.9999709129333496
with O 0 0.05384218320250511
Alzheimers B-Disease 1 0.9999983310699463
disease I-Disease 1 0.9999865293502808
( O 0 0.0025140081997960806
AD B-Disease 0 0.028178725391626358
) O 0 0.0005589810898527503
. O 0 0.0006587617681361735

His O 0 0.005198888946324587
brain O 1 0.9875209331512451
magnetic O 0 0.0019467469537630677
resonance O 0 0.006557001732289791
image O 0 0.05614261329174042
( O 0 0.0038228307384997606
MRI O 1 0.9993776679039001
) O 0 0.0004873895086348057
showed O 0 0.002682990627363324
abnormalities B-Disease 1 0.902218759059906
in I-Disease 0 9.845261229202151e-05
the I-Disease 0 0.0002459079260006547
bilateral I-Disease 0 0.1523476094007492
cerebellar I-Disease 1 0.9995062351226807
hemispheres I-Disease 1 0.9566231966018677
and O 0 0.002852402860298753
brain O 1 0.9998832941055298
stem O 0 0.3324287235736847
, O 0 0.00010713981464505196
but O 0 6.924394983798265e-05
not O 0 4.306227492634207e-05
in O 0 9.624924859963357e-05
the O 0 0.0010087302653118968
cerebral O 1 0.9999678134918213
white O 1 0.5858110189437866
matter O 0 0.001034879358485341
, O 0 0.00010554022446740419
where O 0 6.452768866438419e-05
marked O 0 0.00038740391028113663
reductions O 0 0.001161910709924996
of O 0 2.6537722078501247e-05
the O 0 0.0014070568140596151
cerebral O 1 0.9999761581420898
blood O 1 0.9642689824104309
flow O 0 0.0015721118543297052
and O 0 0.0002711073320824653
oxygen O 0 0.24595850706100464
metabolism O 0 0.0879913792014122
were O 0 6.060844680177979e-05
clearly O 0 0.0006418881821446121
demonstrated O 0 0.0010146710556000471
by O 0 0.00013331726950127631
positron O 0 0.10510804504156113
emission O 0 0.007858103141188622
tomography O 0 0.2259870320558548
( O 0 0.0023731195833534002
PET O 1 0.9483059048652649
) O 0 0.0006551304250024259
. O 0 0.0006895746919326484

In O 0 0.003137442981824279
patients O 1 0.9980170726776123
2 O 0 0.0003547498781699687
and O 0 6.393136573024094e-05
3 O 0 0.0001641996786929667
, O 0 6.420139834517613e-05
the O 0 0.00017666240455582738
autopsy O 0 0.29868653416633606
findings O 0 0.002603259403258562
showed O 0 0.002253716578707099
massive O 1 0.5144131183624268
demyelination B-Disease 1 0.9998152852058411
of I-Disease 0 0.00014398034545592964
the I-Disease 0 0.005699493922293186
cerebral I-Disease 1 0.999983549118042
white I-Disease 0 0.349983811378479
matter I-Disease 0 0.0005343066877685487
with O 0 8.690087270224467e-05
sparing O 0 0.007956060580909252
of O 0 2.7652949938783422e-05
the O 0 0.0005385822732932866
U O 1 0.9846455454826355
- O 0 0.03369555622339249
fibers O 1 0.5356317162513733
, O 0 0.00012197949399705976
compatible O 0 0.0003349621838424355
with O 0 3.479763472569175e-05
the O 0 0.00014328336692415178
findings O 0 0.0014454961055889726
of O 0 0.00032694838591851294
childhood O 1 0.999570906162262
ALD B-Disease 1 0.9999905824661255
. O 0 0.0036146182101219893

Oleic O 0 0.11362796276807785
and O 0 0.001343580661341548
erucic O 1 0.5232254862785339
acids O 0 0.0030115186236798763
( O 0 0.0014032083563506603
Lorenzos O 0 0.04823538288474083
Oil O 0 0.0015949344960972667
) O 0 0.00011672908294713125
were O 0 6.297099753282964e-05
administered O 0 0.0024546536151319742
to O 0 0.00022392818937078118
patients O 1 0.9987672567367554
1 O 0 0.00018475971592124552
and O 0 5.9169768064748496e-05
4 O 0 0.0002458033850416541
, O 0 7.937073678476736e-05
but O 0 9.9773402325809e-05
sufficient O 0 0.0007393283303827047
effectiveness O 0 0.11749011278152466
was O 0 0.0004260378482285887
not O 0 0.00011317812459310517
obtained O 0 0.00036146974889561534
. O 0 0.0004745160695165396

The O 0 0.0009595425799489021
findings O 0 0.0015350817702710629
in O 0 9.809041512198746e-05
this O 0 8.205950871342793e-05
family O 0 0.0004923956003040075
suggest O 0 0.0005386002012528479
that O 0 0.00014718342572450638
delGAG291 O 0 0.013901175931096077
is O 0 8.291942504001781e-05
part O 0 8.20277418824844e-05
of O 0 1.281441655009985e-05
the O 0 0.0001835947041399777
cause O 0 0.019643262028694153
of O 0 0.00011435605119913816
Japanese O 0 0.09100844711065292
ALD B-Disease 1 0.9999614953994751
with O 0 0.0004887843388132751
phenotypic O 0 0.0096186688169837
variations O 0 0.0012173013528808951
. O 0 0.0009486488997936249

Moreover O 0 0.007528670132160187
, O 0 0.00026820116909220815
although O 0 0.00010761429439298809
the O 0 4.8166031774599105e-05
scale O 0 0.00023427560518030077
of O 0 1.594219975231681e-05
the O 0 0.0001152533950516954
study O 0 0.0003950993705075234
is O 0 0.0001337522262474522
limited O 0 0.00034364184830337763
, O 0 7.424964132951573e-05
there O 0 4.5211141696199775e-05
is O 0 7.8809549449943e-05
a O 0 0.0002325876703253016
possibility O 0 0.0009121994953602552
that O 0 0.00015919095312710851
PET O 1 0.9482395648956299
can O 0 0.00018692830053623766
detect O 0 0.00420706532895565
an O 0 0.0005966227035969496
insidious B-Disease 1 0.998626708984375
lesion I-Disease 1 0.9996607303619385
which O 0 0.00015752139734104276
is O 0 0.00036520278081297874
undetectable O 1 0.6798627972602844
by O 0 0.00012195995077490807
computed O 0 0.0032569419126957655
tomogram O 0 0.2576971650123596
( O 0 0.0025317564141005278
CT O 1 0.9994120597839355
) O 0 0.000408695952501148
or O 0 0.0006515184068121016
MRI O 1 0.9978552460670471
analysis O 0 0.00021646766981575638
, O 0 7.90079720900394e-05
and O 0 3.105866926489398e-05
that O 0 2.275739643664565e-05
the O 0 4.481010910240002e-05
higher O 0 0.00016350521764252335
level O 0 0.00018542222096584737
of O 0 3.3081618312280625e-05
tau O 0 0.018831035122275352
reflects O 0 0.00042771868174895644
the O 0 5.683220297214575e-05
process O 0 0.00016500754281878471
of O 0 0.00011782781803049147
neuronal B-Disease 1 0.971045196056366
degeneration I-Disease 1 0.9999798536300659
in O 0 0.025222884491086006
ALD B-Disease 1 0.9999872446060181
. O 0 0.003527785651385784

Lorenzos O 0 0.46464940905570984
Oil O 0 0.003366121556609869
should O 0 0.0002480155089870095
be O 0 4.053132943226956e-05
given O 0 4.541076850728132e-05
in O 0 4.1516093915561214e-05
the O 0 8.66261834744364e-05
early O 0 0.0003180152561981231
stage O 0 0.001479991478845477
. O 0 0.00026319114840589464
. O 0 0.000725694524589926

Nonsense O 0 0.022264648228883743
mutation O 0 0.0027421347331255674
in O 0 0.0002324427041457966
exon O 0 0.0038475077599287033
4 O 0 0.00023443045211024582
of O 0 3.260958692408167e-05
human O 0 0.0013379888841882348
complement O 0 0.00697751622647047
C9 O 1 0.9980746507644653
gene O 0 0.0012163519859313965
is O 0 9.521468746243045e-05
the O 0 8.129466732498258e-05
major O 0 0.0007402300834655762
cause O 0 0.0028572690207511187
of O 0 4.866369272349402e-05
Japanese O 0 0.0039573353715240955
complement B-Disease 1 0.6483262181282043
C9 I-Disease 1 0.9997676014900208
deficiency I-Disease 1 0.999932050704956
. O 0 0.002555162413045764

Deficiency B-Disease 1 0.9994300007820129
of I-Disease 0 8.590425568399951e-05
the I-Disease 0 0.0002549648634158075
ninth I-Disease 0 0.002648837398737669
component I-Disease 0 0.0007076335605233908
of I-Disease 0 3.4835455153370276e-05
human I-Disease 0 0.0007180896354839206
complement I-Disease 0 0.0024937535636126995
( O 0 0.0014704199275001884
C9 O 1 0.9982666969299316
) O 0 0.00018435620586387813
is O 0 6.303287955233827e-05
the O 0 6.181826029205695e-05
most O 0 0.000188344536582008
common O 0 0.0055528078228235245
complement B-Disease 1 0.9965943694114685
deficiency I-Disease 1 0.9999969005584717
in O 0 0.00023222516756504774
Japan O 0 0.0010933543089777231
but O 0 0.00022745979367755353
is O 0 0.00019308426999486983
rare O 0 0.0013361742021515965
in O 0 6.11075374763459e-05
other O 0 4.3494092096807435e-05
countries O 0 0.00014497307711280882
. O 0 0.0005804758402518928

We O 0 0.0006352720665745437
studied O 0 0.0003330236650072038
the O 0 7.659047696506605e-05
molecular O 0 0.0003728275769390166
basis O 0 8.448493463220075e-05
of O 0 0.00021810643374919891
C9 B-Disease 1 0.9998934268951416
deficiency I-Disease 1 0.9999418258666992
in O 0 0.0001712876110104844
four O 0 0.00018997299775946885
Japanese O 0 0.024256395176053047
C9 B-Disease 1 0.999872088432312
- I-Disease 1 0.9986924529075623
deficient I-Disease 1 0.9999639987945557
patients O 1 0.9999409914016724
who O 0 0.004430054221302271
had O 0 0.027310708537697792
suffered O 1 0.9999184608459473
from O 0 0.023106085136532784
meningococcal B-Disease 1 0.9999850988388062
meningitis I-Disease 1 0.9999871253967285
. O 0 0.003458611201494932

Direct O 0 0.00048196225543506444
sequencing O 0 0.00038903209497220814
of O 0 8.091815834632143e-05
amplified O 0 0.008111201226711273
C9 O 1 0.9758830666542053
cDNA O 0 0.0023109382018446922
and O 0 0.0001866365782916546
DNA O 0 0.0008239193703047931
revealed O 0 0.001434010686352849
a O 0 0.0003659561334643513
nonsense O 0 0.00258104526437819
substitution O 0 0.0010482376674190164
( O 0 0.0010462251957505941
CGA O 1 0.7022497653961182
- O 0 0.010366836562752724
- O 0 0.006389428861439228
> O 0 0.008361699990928173
TGA O 1 0.6158019304275513
) O 0 0.00014174710668157786
at O 0 0.00017215675325132906
codon O 0 0.0007426256779581308
95 O 0 0.0004798537993337959
in O 0 8.624068868812174e-05
exon O 0 0.002433034358546138
4 O 0 0.0001297530106967315
in O 0 4.561854439089075e-05
the O 0 0.00016454905562568456
four O 0 0.0007607731968164444
C9 B-Disease 1 0.9993964433670044
- I-Disease 1 0.8639731407165527
deficient I-Disease 1 0.9961942434310913
individuals O 0 0.0009373744251206517
. O 0 0.0009228679118677974

An O 0 0.0014681252650916576
allele O 0 0.007752345409244299
- O 0 0.0022372801322489977
specific O 0 0.00029270286904647946
polymerase O 0 0.0029657557606697083
chain O 0 0.003125630086287856
reaction O 0 0.0014503337442874908
system O 0 0.001586356433108449
designed O 0 0.0008448894950561225
to O 0 0.00010491698049008846
detect O 0 0.002249195007607341
exclusively O 0 0.00011049141903640702
only O 0 1.3647526429849677e-05
one O 0 1.7280250176554546e-05
of O 0 9.621090612199623e-06
the O 0 0.0001121650857385248
normal O 0 0.0012250908184796572
and O 0 0.00018736439233180135
mutant O 0 0.003954787272959948
alleles O 0 0.0018810378387570381
indicated O 0 0.0008664432098157704
that O 0 2.2997843188932166e-05
all O 0 1.690715544100385e-05
the O 0 0.00011860483937198296
four O 0 0.00046810018830001354
patients O 1 0.9985307455062866
were O 0 5.289217006065883e-05
homozygous O 0 0.0006980161415413022
for O 0 4.554521729005501e-05
the O 0 0.0001047989062499255
mutation O 0 0.0006790331099182367
in O 0 0.0001254233648069203
exon O 0 0.004233866930007935
4 O 0 0.0002276107989018783
and O 0 4.543555041891523e-05
that O 0 3.36077791871503e-05
the O 0 7.914581510704011e-05
parents O 0 0.0002502979477867484
of O 0 6.653132732026279e-05
patient O 1 0.9988067150115967
2 O 0 0.00034453411353752017
were O 0 9.265029075322673e-05
heterozygous O 0 0.003363374387845397
. O 0 0.0006370970513671637

The O 0 0.0007232509087771177
common O 0 0.001431669807061553
mutation O 0 0.0015604582149535418
at O 0 0.00036401525721885264
codon O 0 0.0015017170226201415
95 O 0 0.0008852158789522946
in O 0 0.0001488540874561295
exon O 0 0.005040327087044716
4 O 0 0.00039925496093928814
might O 0 0.00025530176935717463
be O 0 3.148158066323958e-05
responsible O 0 0.0004170313768554479
for O 0 0.00010544122051214799
most O 0 0.0003533639828674495
Japanese O 0 0.0639360174536705
C9 B-Disease 1 0.9999030828475952
deficiency I-Disease 1 0.999982476234436
. O 0 0.0006979276076890528
. O 0 0.0009012719965539873

BRCA1 O 1 0.9770694375038147
required O 0 0.0006287965807132423
for O 0 0.0001779949525371194
transcription O 0 0.0015525823691859841
- O 0 0.006375023163855076
coupled O 0 0.004928863141685724
repair O 1 0.9846962690353394
of O 0 0.00010384391498519108
oxidative O 1 0.8797581791877747
DNA O 0 0.006330931559205055
damage O 1 0.9426631927490234
. O 0 0.0008514494984410703

The O 0 0.012838057242333889
breast B-Disease 1 0.9999709129333496
and I-Disease 1 0.9132083058357239
ovarian I-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999973773956299
susceptibility O 1 0.9931885004043579
gene O 0 0.009133979678153992
BRCA1 O 1 0.9748115539550781
encodes O 0 0.0014365063980221748
a O 0 0.0009250410948880017
zinc O 0 0.4616645574569702
finger O 0 0.024581128731369972
protein O 0 0.00028415850829333067
of O 0 2.8654656489379704e-05
unknown O 0 0.0005570548237301409
function O 0 0.0010371558601036668
. O 0 0.000747363141272217

Association O 0 0.0047410582192242146
of O 0 6.537442823173478e-05
the O 0 0.0004139543161727488
BRCA1 O 1 0.879795491695404
protein O 0 0.0002705191436689347
with O 0 7.177445513661951e-05
the O 0 0.0002814602921716869
DNA O 0 0.0023047798313200474
repair O 1 0.9902494549751282
protein O 0 0.002623406471684575
Rad51 O 1 0.9878661632537842
and O 0 0.0001891141728265211
changes O 0 0.00019518070621415973
in O 0 4.1123435948975384e-05
the O 0 5.7211647799704224e-05
phosphorylation O 0 9.680363291408867e-05
and O 0 4.779618393513374e-05
cellular O 0 0.0006186789250932634
localization O 0 0.0004523962561506778
of O 0 1.388808414048981e-05
the O 0 0.00010502008080948144
protein O 0 0.000664282008074224
after O 0 0.0009229633142240345
exposure O 0 0.06595630198717117
to O 0 0.00017010320152621716
DNA O 0 0.0017280110623687506
- O 0 0.011875934898853302
damaging O 0 0.057854026556015015
agents O 0 0.0010384273482486606
are O 0 2.733115979935974e-05
consistent O 0 0.0004061905201524496
with O 0 3.9565249608131126e-05
a O 0 0.0002447444712743163
role O 0 0.0005156152765266597
for O 0 0.0003733094781637192
BRCA1 O 1 0.9962246417999268
in O 0 0.0003980307374149561
DNA O 0 0.009407168254256248
repair O 1 0.9980514049530029
. O 0 0.0014014110201969743

Here O 0 0.000994712463580072
, O 0 0.00021939411817584187
it O 0 0.00010556376946624368
is O 0 0.00014993072545621544
shown O 0 0.0002902112319134176
that O 0 0.00013723695883527398
mouse O 0 0.009291501715779305
embryonic O 0 0.020049015060067177
stem O 0 0.23915663361549377
cells O 0 0.08956834673881531
deficient B-Disease 1 0.9992857575416565
in I-Disease 0 0.0009610663400962949
BRCA1 I-Disease 1 0.9982717037200928
are O 0 0.00015777890803292394
defective O 1 0.9838863611221313
in O 0 0.00010774459224194288
the O 0 0.00010358074359828606
ability O 0 0.0006289398297667503
to O 0 3.8232392398640513e-05
carry O 0 0.0001131145836552605
out O 0 7.93170984252356e-05
transcription O 0 0.0008010871824808419
- O 0 0.0030247634276747704
coupled O 0 0.004228265956044197
repair O 1 0.9851369857788086
of O 0 0.00011959983385168016
oxidative O 1 0.6153138279914856
DNA O 0 0.005660181865096092
damage O 1 0.9720665812492371
, O 0 0.000171630599652417
and O 0 9.158626198768616e-05
are O 0 8.607055497122929e-05
hypersensitive O 1 0.9916720986366272
to O 0 0.0003855208051390946
ionizing O 1 0.984207808971405
radiation O 1 0.8346555829048157
and O 0 0.00014357206237036735
hydrogen O 0 0.0029934875201433897
peroxide O 0 0.49229469895362854
. O 0 0.0012180667836219072

These O 0 0.00026960301329381764
results O 0 0.0006266350974328816
suggest O 0 0.0008263819618150592
that O 0 0.0003490332455839962
BRCA1 O 1 0.9960623383522034
participates O 0 0.005332855507731438
, O 0 0.00019674123905133456
directly O 0 0.0002696757728699595
or O 0 0.00020638959540519863
indirectly O 0 0.0015577096492052078
, O 0 7.381906470982358e-05
in O 0 6.183040386531502e-05
transcription O 0 0.0008244189666584134
- O 0 0.0036591177340596914
coupled O 0 0.003266669576987624
repair O 1 0.9698744416236877
of O 0 0.00012685431283898652
oxidative O 1 0.7754180431365967
DNA O 0 0.004350097384303808
damage O 1 0.8607190847396851
. O 0 0.00032032604212872684
. O 0 0.0006161332712508738

Truncation O 0 0.044572267681360245
mutations O 0 0.0032813665457069874
in O 0 0.00020049272279720753
the O 0 0.0004719812422990799
transactivation O 0 0.047191597521305084
region O 0 0.0016732082003727555
of O 0 0.00022392603568732738
PAX6 O 1 0.9980802536010742
result O 0 0.00067802460398525
in O 0 0.00026061516837216914
dominant O 0 0.00803931150585413
- O 0 0.00933342520147562
negative O 0 0.002340866019949317
mutants O 0 0.012605567462742329
. O 0 0.0008297867607325315

PAX6 O 1 0.9848259091377258
is O 0 0.00048499213880859315
a O 0 0.0002543612790759653
transcription O 0 0.000380917132133618
factor O 0 0.0002536811516620219
with O 0 3.07773043459747e-05
two O 0 4.1466708353254944e-05
DNA O 0 0.0004975920892320573
- O 0 0.0007484015077352524
binding O 0 0.00029876374173909426
domains O 0 0.0009743362315930426
( O 0 0.0005791630246676505
paired O 0 0.002938478486612439
box O 0 0.001458501792512834
and O 0 0.00024725220282562077
homeobox O 1 0.5101617574691772
) O 0 0.00011976336099905893
and O 0 5.158747808309272e-05
a O 0 0.0004725304606836289
proline O 0 0.020108100026845932
- O 0 0.0028659862000495195
serine O 0 0.0039871204644441605
- O 0 0.003179976250976324
threonine O 0 0.00953171867877245
( O 0 0.001896715140901506
PST O 1 0.9099563360214233
) O 0 0.0007066001417115331
- O 0 0.0034989183768630028
rich O 0 0.0026895874179899693
transactivation O 0 0.0357067808508873
domain O 0 0.0017325676744803786
. O 0 0.0011522421846166253

PAX6 O 1 0.9961724877357483
regulates O 1 0.9490242004394531
eye O 1 0.996387243270874
development O 0 0.002250076038762927
in O 0 0.0003267197171226144
animals O 0 0.0009657494956627488
ranging O 0 0.0012391206109896302
from O 0 0.00027055214741267264
jellyfish O 0 0.005462389439344406
to O 0 0.00013659449177794158
Drosophila O 0 0.0020062518306076527
to O 0 0.00023944838903844357
humans O 0 0.0020339572802186012
. O 0 0.0006374389631673694

Heterozygous O 0 0.011970456689596176
mutations O 0 0.0016881524352356791
in O 0 0.00016256935487035662
the O 0 0.0003252714523114264
human O 0 0.011941391974687576
PAX6 O 1 0.9991421699523926
gene O 0 0.0023665789049118757
result O 0 0.0002695711445994675
in O 0 7.629161700606346e-05
various O 0 9.387085447087884e-05
phenotypes O 0 0.030588453635573387
, O 0 0.00022666354198008776
including O 0 0.0003339120012242347
aniridia B-Disease 1 0.9985034465789795
, O 0 0.0018966906936839223
Peters B-Disease 1 0.9990507960319519
anomaly I-Disease 1 0.9958305954933167
, O 0 0.0010515181347727776
autosomal B-Disease 1 0.9901567697525024
dominant I-Disease 1 0.7586070895195007
keratitis I-Disease 1 0.9998979568481445
, O 0 0.0008208252256736159
and O 0 0.0015220404602587223
familial B-Disease 1 0.9998181462287903
foveal I-Disease 1 0.9994255304336548
dysplasia I-Disease 1 0.9999700784683228
. O 0 0.0027719158679246902

It O 0 0.0009148520766757429
is O 0 0.0003306352882646024
believed O 0 0.0005183746106922626
that O 0 3.871205626637675e-05
the O 0 0.00015044571773614734
mutated O 0 0.0034147300757467747
allele O 0 0.0014895668718963861
of O 0 0.000157408052473329
PAX6 O 1 0.9951778650283813
produces O 0 0.0011777315521612763
an O 0 0.00022603507386520505
inactive O 0 0.009211615659296513
protein O 0 0.00047263267333619297
and O 0 0.00040100657497532666
aniridia B-Disease 1 0.998668909072876
is O 0 0.000767311779782176
caused O 0 0.08100257068872452
due O 0 0.0009261280065402389
to O 0 0.00021553144324570894
genetic O 0 0.0037051609251648188
haploinsufficiency O 1 0.9599524736404419
. O 0 0.0010160276433452964

However O 0 0.0011622393503785133
, O 0 0.00020201923325657845
several O 0 0.0001695023529464379
truncation O 0 0.02222364768385887
mutations O 0 0.0021713266614824533
have O 0 8.964411972556263e-05
been O 0 9.41678008530289e-05
found O 0 6.465284968726337e-05
to O 0 3.293160261819139e-05
occur O 0 0.000111568791908212
in O 0 4.901262218481861e-05
the O 0 0.0002997397677972913
C O 0 0.07702291011810303
- O 0 0.0037116848398
terminal O 0 0.006133686285465956
half O 0 0.00014762842329218984
of O 0 0.00010728212510002777
PAX6 O 1 0.9991796612739563
in O 0 0.0014725259970873594
patients O 1 0.9998021721839905
with O 0 0.000498566310852766
Aniridia B-Disease 1 0.9983692765235901
resulting O 0 0.0008976972312666476
in O 0 0.0001145859423559159
mutant O 0 0.001052357954904437
proteins O 0 7.292300870176405e-05
that O 0 5.115852036396973e-05
retain O 0 0.0006495483685284853
the O 0 0.00013283836597111076
DNA O 0 0.0006817162502557039
- O 0 0.0010941269574686885
binding O 0 0.0003230814472772181
domains O 0 0.0006168677355162799
but O 0 0.00011233871191507205
have O 0 5.99708546360489e-05
lost O 0 0.000255668128374964
most O 0 2.342301741009578e-05
of O 0 1.59952887770487e-05
the O 0 0.00025603180984035134
transactivation O 0 0.1404540091753006
domain O 0 0.0014180720318108797
. O 0 0.0007760911248624325

It O 0 0.0006876440020278096
is O 0 0.0002729060361161828
not O 0 9.382683492731303e-05
clear O 0 0.000447932630777359
whether O 0 0.00018456883844919503
such O 0 7.391084363916889e-05
mutants O 0 0.016793053597211838
really O 0 0.003253791481256485
behave O 0 0.004569409415125847
as O 0 0.00028014634153805673
loss O 0 0.004494183696806431
- O 0 0.0009698221692815423
of O 0 4.608505332726054e-05
- O 0 0.0026239268481731415
function O 0 0.0005966181633993983
mutants O 0 0.00318081839941442
as O 0 0.00015136344882193953
predicted O 0 0.0016585530247539282
by O 0 0.000290445372229442
haploinsufficiency O 0 0.3719802796840668
. O 0 0.0011400969233363867

Contrary O 0 0.0021116260904818773
to O 0 0.00011102266580564901
this O 0 5.119180423207581e-05
theory O 0 0.0001505349500803277
, O 0 5.5676402553217486e-05
our O 0 0.00010416543955216184
data O 0 8.955789962783456e-05
showed O 0 0.00028010469395667315
that O 0 3.3322568924631923e-05
these O 0 3.3616790460655466e-05
mutants O 0 0.0017952276393771172
are O 0 3.6246448871679604e-05
dominant O 0 0.001616483787074685
- O 0 0.0014144097222015262
negative O 0 0.00037352400249801576
in O 0 0.0002777710324153304
transient O 1 0.514631986618042
transfection O 1 0.8987229466438293
assays O 0 0.0010947638656944036
when O 0 0.00019650949980132282
they O 0 4.121235542697832e-05
are O 0 3.888265564455651e-05
coexpressed O 0 0.007168556097894907
with O 0 0.0001355843705823645
wild O 0 0.0016778047429397702
- O 0 0.02668585069477558
type O 0 0.030574746429920197
PAX6 O 1 0.9956989288330078
. O 0 0.0015877019613981247

We O 0 0.0005882237455807626
found O 0 0.00018232765432912856
that O 0 3.935635322704911e-05
the O 0 0.0001190501352539286
dominant O 0 0.0029223072342574596
- O 0 0.0030146599747240543
negative O 0 0.0005634799017570913
effects O 0 0.0013278307160362601
result O 0 0.00019336929835844785
from O 0 5.498598329722881e-05
the O 0 0.00015413863002322614
enhanced O 0 0.005202381871640682
DNA O 0 0.00038821023190394044
binding O 0 0.00022455677390098572
ability O 0 0.00038109676097519696
of O 0 2.360303005843889e-05
these O 0 0.00012784215505234897
mutants O 0 0.016896668821573257
. O 0 0.0009388806065544486

Kinetic O 0 0.002667743247002363
studies O 0 0.0003000963479280472
of O 0 3.187487891409546e-05
binding O 0 0.0007879515760578215
and O 0 0.00028869949164800346
dissociation O 0 0.11591920256614685
revealed O 0 0.0024282210506498814
that O 0 3.9735172322252765e-05
various O 0 5.501844498212449e-05
truncation O 0 0.01029838528484106
mutants O 0 0.003994388971477747
have O 0 9.780572872841731e-05
3 O 0 0.0003182185173500329
- O 0 0.0011406030971556902
5 O 0 0.00029741012258455157
- O 0 0.0011730906553566456
fold O 0 0.0007569073350168765
higher O 0 0.00021736339840572327
affinity O 0 0.0003460565931163728
to O 0 3.6845427530352026e-05
various O 0 4.560136585496366e-05
DNA O 0 0.0006522219628095627
- O 0 0.0008787617553025484
binding O 0 0.0001514418254373595
sites O 0 6.204155943123624e-05
when O 0 9.142430644715205e-05
compared O 0 0.00012394858640618622
with O 0 4.648025060305372e-05
the O 0 0.00020975625375285745
wild O 0 0.0017375379102304578
- O 0 0.04332268610596657
type O 0 0.07845811545848846
PAX6 O 1 0.9963341951370239
. O 0 0.0019450299441814423

These O 0 0.0003512811672408134
results O 0 0.0004824694769922644
provide O 0 0.0003839962009806186
a O 0 0.0003555358271114528
new O 0 0.00027340895030647516
insight O 0 0.0020814656745642424
into O 0 6.838731496827677e-05
the O 0 8.603747119195759e-05
role O 0 0.0004728791827801615
of O 0 0.00011063069541705772
mutant O 0 0.044187407940626144
PAX6 O 1 0.9968358874320984
in O 0 0.001309358631260693
causing O 1 0.9671197533607483
aniridia B-Disease 1 0.9954032897949219
. O 0 0.000788054836448282
. O 0 0.000820548739284277

Reversal O 0 0.08716953545808792
of O 0 0.002241118811070919
severe O 1 0.9999891519546509
hypertrophic B-Disease 1 0.999998927116394
cardiomyopathy I-Disease 1 0.9999995231628418
and O 0 0.0033961166627705097
excellent O 1 0.9690057039260864
neuropsychologic O 1 0.9098901748657227
outcome O 0 0.0008056045044213533
in O 0 0.0001272946537937969
very B-Disease 0 0.0008657297003082931
- I-Disease 0 0.004422694910317659
long I-Disease 0 0.002013636752963066
- I-Disease 0 0.0023191256914287806
chain I-Disease 0 0.002542046597227454
acyl I-Disease 0 0.015737663954496384
- I-Disease 0 0.007278492208570242
coenzyme I-Disease 0 0.02820269949734211
A I-Disease 0 0.09207883477210999
dehydrogenase I-Disease 1 0.9973401427268982
deficiency I-Disease 1 0.9999207258224487
. O 0 0.002393169328570366

Very B-Disease 0 0.0053218333050608635
- I-Disease 0 0.00690855085849762
long I-Disease 0 0.003050062572583556
- I-Disease 0 0.0030202011112123728
chain I-Disease 0 0.0021989650558680296
acyl I-Disease 0 0.008726171217858791
- I-Disease 0 0.0032354185823351145
coenzyme I-Disease 0 0.007730946410447359
A I-Disease 0 0.0038679775316268206
dehydrogenase I-Disease 1 0.784287691116333
( I-Disease 0 0.0018802037229761481
VLCAD I-Disease 1 0.9979280233383179
) I-Disease 0 0.0030766495037823915
deficiency I-Disease 1 0.9999887943267822
is O 0 0.0005473063210956752
a O 0 0.002596947830170393
disorder O 1 0.9997431635856628
of O 0 8.990650530904531e-05
fatty O 1 0.7882118821144104
acid O 0 0.035683199763298035
beta O 0 0.004544856026768684
oxidation O 0 0.0012877942062914371
that O 0 0.00017462289542891085
reportedly O 0 0.004676539450883865
has O 0 0.00029312176047824323
high O 0 0.0005611684755422175
rates O 0 0.0002583064488135278
of O 0 6.50272995699197e-05
morbidity O 1 0.9981239438056946
and O 0 0.0006369525217451155
mortality O 1 0.9749940633773804
. O 0 0.0012137212324887514

We O 0 0.0006906065973453224
describe O 0 0.0005859832745045424
the O 0 5.254493225947954e-05
outcome O 0 0.00013593015319202095
of O 0 1.2897344277007505e-05
a O 0 0.00028314354130998254
5 O 0 0.00035911230952478945
- O 0 0.001439298503100872
year O 0 0.00039150306838564575
- O 0 0.0025670118629932404
old O 0 0.0015654988819733262
girl O 0 0.10117577016353607
with O 0 0.0017380102071911097
VLCAD B-Disease 1 0.9999496936798096
deficiency I-Disease 1 0.9999977350234985
who O 0 0.0009719599620439112
was O 0 0.00036410641041584313
first O 0 0.00011000195081578568
seen O 0 0.0003573476860765368
at O 0 0.00016178289661183953
5 O 0 0.00018099891894962639
months O 0 0.00028082774952054024
of O 0 2.282377317897044e-05
age O 0 0.0008502860437147319
with O 0 0.003441354725509882
severe O 1 0.9999927282333374
hypertrophic B-Disease 1 0.9999992847442627
cardiomyopathy I-Disease 1 0.9999996423721313
, O 1 0.9108998775482178
hepatomegaly B-Disease 1 0.999991774559021
, O 1 0.7912681102752686
encephalopathy B-Disease 1 0.9999921321868896
, O 0 0.0020337291061878204
and O 0 0.002070331247523427
hypotonia B-Disease 1 0.9993452429771423
. O 0 0.0017904328415170312

Biochemical O 0 0.04336067661643028
studies O 0 0.005439290311187506
indicated O 1 0.933799147605896
VLCAD B-Disease 1 0.9999449253082275
deficiency I-Disease 1 0.9999974966049194
caused O 0 0.4261230528354645
by O 0 0.00013955873146187514
a O 0 0.000796048843767494
stable O 0 0.07473713159561157
yet O 0 0.0014384811511263251
inactive O 0 0.02384195476770401
enzyme O 0 0.0037169484421610832
. O 0 0.00088498491095379

Molecular O 0 0.004307877738028765
genetic O 0 0.0008174091926775873
analysis O 0 0.00015318492660298944
of O 0 6.997225136728957e-05
her O 0 0.03452182188630104
VLCAD O 1 0.9977226853370667
gene O 0 0.0026976140215992928
revealed O 0 0.0029686209745705128
a O 0 0.0010258675320073962
T1372C O 0 0.048393476754426956
( O 0 0.0009764364222064614
F458L O 0 0.02589164674282074
) O 0 0.00041046878322958946
missense O 0 0.00602344237267971
mutation O 0 0.0015102566685527563
and O 0 0.0002183130127377808
a O 0 0.0026728659868240356
1668 O 1 0.9708803296089172
ACAG O 1 0.98764568567276
1669 O 1 0.6284897327423096
splice O 0 0.021935367956757545
site O 0 0.004226864315569401
mutation O 0 0.004844694398343563
. O 0 0.0008714267169125378

After O 0 0.005148234777152538
initial O 0 0.004859556909650564
treatment O 1 0.994944155216217
with O 0 0.00034604931715875864
intravenous O 1 0.9967976212501526
glucose O 0 0.039742399007081985
and O 0 0.0004943489329889417
carnitine O 1 0.9983969330787659
, O 0 0.00028245977591723204
the O 0 0.00048515023081563413
patient O 1 0.9980998635292053
has O 0 0.0003535897412803024
thrived O 0 0.003319842042401433
on O 0 7.960700895637274e-05
a O 0 0.0003731301985681057
low O 0 0.0019651944749057293
- O 0 0.0030274088494479656
fat O 0 0.0029748936649411917
diet O 0 0.002381975296884775
supplemented O 0 0.0007235344965010881
with O 0 8.214062108891085e-05
medium O 0 0.001990868244320154
- O 0 0.0032617254182696342
chain O 0 0.0027680089697241783
triglyceride O 0 0.023488350212574005
oil O 0 0.0019611443858593702
and O 0 0.0006957299192436039
carnitine O 1 0.9949954748153687
and O 0 0.00028421214665286243
avoidance O 1 0.5778164267539978
of O 0 0.00016858473827596754
fasting O 0 0.06613802164793015
. O 0 0.001042508170939982

Her O 0 0.30132222175598145
ventricular O 1 0.999629020690918
hypertrophy O 1 0.9992644190788269
resolved O 0 0.017476825043559074
significantly O 0 0.0026559580583125353
over O 0 0.00017072228365577757
1 O 0 0.0004056739853695035
year O 0 0.00032881018705666065
, O 0 0.00012174929725006223
and O 0 0.00021878456755075604
cognitively O 1 0.9951876401901245
, O 0 0.00022640457609668374
she O 0 0.0004303367459215224
is O 0 8.313384023495018e-05
in O 0 5.310358392307535e-05
the O 0 0.00015691382577642798
superior O 0 0.008041897788643837
range O 0 0.0004410197143442929
for O 0 0.0002059360995190218
age O 0 0.0012164192739874125
. O 0 0.0006626481772400439

Clinical O 1 0.990698516368866
recognition O 0 0.0038188959006220102
of O 0 0.0012299123918637633
VLCAD B-Disease 1 0.9999812841415405
deficiency I-Disease 1 0.9999970197677612
is O 0 0.0004456079623196274
important O 0 0.00026403440278954804
because O 0 0.00020149558258708566
it O 0 3.947765799239278e-05
is O 0 3.406026735319756e-05
one O 0 1.2062448149663396e-05
of O 0 5.658128429786302e-06
the O 0 7.616222865181044e-05
few O 0 0.00038678068085573614
directly O 0 0.004277538042515516
treatable O 1 0.9999802112579346
causes O 1 0.9633732438087463
of O 0 0.0010018779430538416
cardiomyopathy B-Disease 1 0.9999994039535522
in O 0 0.0018665316747501493
children O 0 0.006318728439509869
. O 0 0.000349243578966707
. O 0 0.000890690425876528

Cloning O 0 0.004069368354976177
of O 0 4.2246167140547186e-05
a O 0 0.0003906528581865132
novel O 0 0.0005979927373118699
member O 0 9.719184163259342e-05
of O 0 1.1259779057581909e-05
the O 0 0.00010960426880046725
low O 0 0.0023385577369481325
- O 0 0.003074473701417446
density O 0 0.0011592645896598697
lipoprotein O 1 0.9954023361206055
receptor O 0 0.008682271465659142
family O 0 0.0018028693739324808
. O 0 0.001065899501554668

A O 0 0.00364467385224998
gene O 0 0.0010358652798458934
encoding O 0 0.000345177308190614
a O 0 0.00035680917790159583
novel O 0 0.0008765156380832195
transmembrane O 0 0.0036239195615053177
protein O 0 0.0006562690250575542
was O 0 0.00043833814561367035
identified O 0 0.00022043455101083964
by O 0 2.7358799343346618e-05
DNA O 0 0.0001226992899319157
sequence O 0 2.0857605704804882e-05
analysis O 0 5.269114990369417e-05
within O 0 5.694232459063642e-05
the O 0 0.000311969721224159
insulin B-Disease 1 0.9939607381820679
- I-Disease 1 0.7742928862571716
dependent I-Disease 1 0.8657748103141785
diabetes I-Disease 1 0.9999988079071045
mellitus I-Disease 1 0.9999725818634033
( O 0 0.006439585238695145
IDDM B-Disease 1 0.9934983253479004
) O 0 0.0007713406812399626
locus O 0 0.012919103726744652
IDDM4 O 1 0.8488633036613464
on O 0 0.0006685889093205333
chromosome O 0 0.003705988172441721
11q13 O 0 0.025816230103373528
. O 0 0.0011274596909061074

Based O 0 0.00044308073120191693
on O 0 0.00016296451212838292
its O 0 0.0003055795677937567
chromosomal O 0 0.005009381100535393
position O 0 0.0005814919131807983
, O 0 0.00011924192222068086
this O 0 5.748032344854437e-05
gene O 0 0.0005505782901309431
is O 0 9.482695168117061e-05
a O 0 0.00018317853391636163
candidate O 0 0.0003327771264594048
for O 0 0.00017704976198729128
conferring O 0 0.3660895526409149
susceptibility O 1 0.9859248995780945
to O 0 0.0031205853447318077
diabetes B-Disease 1 0.9999915361404419
. O 0 0.0015376039082184434

The O 0 0.0008765957900322974
gene O 0 0.0020798551850020885
, O 0 0.00043500869651325047
termed O 0 0.009484535083174706
low O 0 0.0026126811280846596
- O 0 0.0023721803445369005
density O 0 0.0008402825333178043
lipoprotein O 1 0.9949771761894226
receptor O 0 0.0024241784121841192
related O 0 0.0005081724957562983
protein O 0 0.000664933177176863
5 O 0 0.0007425845833495259
( O 0 0.0008942094864323735
LRP5 O 1 0.8875575065612793
) O 0 0.0001398530148435384
, O 0 6.902473978698254e-05
encodes O 0 0.0002787837292999029
a O 0 0.00014142469444777817
protein O 0 0.00015011642244644463
of O 0 4.315641490393318e-05
1615 O 0 0.007567551918327808
amino O 0 0.00015924226318020374
acids O 0 0.00017989931802731007
that O 0 2.0495723219937645e-05
contains O 0 4.249951962265186e-05
conserved O 0 0.0001366136275464669
modules O 0 0.0003279336087871343
which O 0 1.494557818659814e-05
are O 0 6.362480235111434e-06
characteristic O 0 0.0001556476199766621
of O 0 9.04321041161893e-06
the O 0 0.00012731128663290292
low O 0 0.0014433353208005428
- O 0 0.0019277215469628572
density O 0 0.0011216775747016072
lipoprotein O 1 0.9987685084342957
( O 0 0.004249051213264465
LDL O 1 0.9996020197868347
) O 0 0.0007360113668255508
receptor O 0 0.004616230260580778
family O 0 0.0012801486300304532
. O 0 0.0007282779552042484

These O 0 0.00020641478477045894
modules O 0 0.0013466218952089548
include O 0 0.00018474807438906282
a O 0 0.00043743301648646593
putative O 0 0.0033217675518244505
signal O 0 0.0008123620063997805
peptide O 0 0.0007483423687517643
for O 0 5.493702701642178e-05
protein O 0 0.00014857997302897274
export O 0 0.000213772538700141
, O 0 0.00010212363122263923
four O 0 0.0001868480903794989
epidermal O 1 0.9910184144973755
growth O 0 0.0011249856324866414
factor O 0 0.0016733425436541438
( O 0 0.0009168324759230018
EGF O 1 0.8444505333900452
) O 0 0.00025180086959153414
repeats O 0 0.00101666955742985
with O 0 0.00010845802898984402
associated O 0 0.0003825942985713482
spacer O 0 0.007897594012320042
domains O 0 0.0008305588853545487
, O 0 0.0002046100707957521
three O 0 0.0004750459920614958
LDL O 1 0.9994300007820129
- O 0 0.007405428681522608
receptor O 0 0.003983378876000643
( O 0 0.0008540407870896161
LDLR O 1 0.842992901802063
) O 0 0.0002684062928892672
repeats O 0 0.0010197879746556282
, O 0 6.089730595704168e-05
a O 0 0.000133371795527637
single O 0 0.00019015443103853613
transmembrane O 0 0.002756033558398485
spanning O 0 0.0012653061421588063
domain O 0 0.00040604223613627255
, O 0 0.00010462565114721656
and O 0 7.364195334957913e-05
a O 0 0.00045767700066789985
cytoplasmic O 0 0.003654046915471554
domain O 0 0.0017509101890027523
. O 0 0.0011035804636776447

The O 0 0.000264462927589193
encoded O 0 0.0001418620377080515
protein O 0 0.00032164622098207474
has O 0 0.0001607193553354591
a O 0 0.00015128697850741446
unique O 0 0.00025723298313096166
organization O 0 0.0006320750690065324
of O 0 0.00010963562817778438
EGF O 1 0.9852330088615417
and O 0 0.0007982737151905894
LDLR O 1 0.9795833230018616
repeats O 0 0.003660024143755436
; O 0 0.0002139842399628833
therefore O 0 0.00030967494240030646
, O 0 0.0003405020397622138
LRP5 O 1 0.936379611492157
likely O 0 0.0005698625463992357
represents O 0 0.0004520242218859494
a O 0 0.00023846278782002628
new O 0 0.00012128891103202477
category O 0 0.00018049241043627262
of O 0 2.3732834961265326e-05
the O 0 0.0005281389458104968
LDLR O 1 0.9957451224327087
family O 0 0.001989097101613879
. O 0 0.000928330875467509

Both O 0 0.0009214348974637687
human O 0 0.0017026551067829132
and O 0 0.0007430993136949837
mouse O 1 0.5580465793609619
LRP5 O 1 0.9950374960899353
cDNAs O 1 0.6662614941596985
have O 0 0.0002654529525898397
been O 0 0.00030622261692769825
isolated O 0 0.0015780081739649177
and O 0 4.7132998588494956e-05
the O 0 5.6023014622041956e-05
encoded O 0 0.00014776545867789537
mature O 0 0.001683751936070621
proteins O 0 7.702592120040208e-05
are O 0 1.910714854602702e-05
95 O 0 0.0002976305258926004
% O 0 2.8467398806242272e-05
identical O 0 0.0002890847681555897
, O 0 0.00012653211888391525
indicating O 0 0.0008634226978756487
a O 0 0.0003788884496316314
high O 0 0.0007964445394463837
degree O 0 0.00032025095424614847
of O 0 3.09035021928139e-05
evolutionary O 0 0.0012618389446288347
conservation O 0 0.007580343633890152
. O 0 0.0002522788126952946
. O 0 0.0005412151222117245

The O 0 0.002341488841921091
APC B-Disease 1 0.6556886434555054
variants O 0 0.0026137970853596926
I1307K O 0 0.011922838166356087
and O 0 0.0002243481285404414
E1317Q O 0 0.010645727626979351
are O 0 6.736419163644314e-05
associated O 0 0.0008028739830479026
with O 0 0.13029871881008148
colorectal B-Disease 1 0.9999998807907104
tumors I-Disease 1 0.9999985694885254
, O 0 0.00045566653716377914
but O 0 0.0001826121297199279
not O 0 7.228121830848977e-05
always O 0 0.00015703789540566504
with O 0 5.6899232731666416e-05
a O 0 0.0003817669057752937
family O 0 0.0006024640169925988
history O 0 0.0005446423892863095
. O 0 0.0007623167475685477

Classical O 0 0.024405350908637047
familial B-Disease 1 0.999786913394928
adenomatous I-Disease 1 0.9999542236328125
polyposis I-Disease 1 0.9999879598617554
( O 0 0.14341755211353302
FAP B-Disease 1 0.9990221261978149
) O 0 0.00037013666587881744
is O 0 0.00018448122136760503
a O 0 0.0005836149211972952
high O 0 0.012259184382855892
- O 1 0.5678294897079468
penetrance O 1 0.9940642714500427
autosomal B-Disease 1 0.9982836246490479
dominant I-Disease 1 0.9949200749397278
disease I-Disease 1 0.9999864101409912
that O 0 0.0004862836794927716
predisposes O 1 0.9949877262115479
to O 0 0.00014817590999882668
hundreds O 0 0.000321440224070102
or O 0 0.00021727534476667643
thousands O 0 0.0009605619125068188
of O 0 0.001577415387146175
colorectal B-Disease 1 0.9999998807907104
adenomas I-Disease 1 0.9999876022338867
and I-Disease 0 0.4314773380756378
carcinoma I-Disease 1 0.9999979734420776
and O 0 0.00019867366063408554
that O 0 0.00010771809320431203
results O 0 0.0002611467498354614
from O 0 0.00020381994545459747
truncating O 0 0.20123860239982605
mutations O 0 0.0010497337207198143
in O 0 0.00011454452032921836
the O 0 0.0006212057778611779
APC B-Disease 1 0.9886841177940369
gene O 0 0.004636671859771013
. O 0 0.0009274414624087512

A O 0 0.005253595765680075
variant O 0 0.010260981507599354
of O 0 0.0004160950193181634
FAP B-Disease 1 0.9996240139007568
is O 0 0.018200144171714783
attenuated B-Disease 1 0.9987881779670715
adenomatous I-Disease 1 0.9999889135360718
polyposis I-Disease 1 0.9999780654907227
coli I-Disease 1 0.9995494484901428
, O 0 0.00038263099850155413
which O 0 9.67456799116917e-05
results O 0 0.000344669766491279
from O 0 0.00028726982418447733
germ O 1 0.9956842660903931
- O 0 0.0034235469065606594
line O 0 0.0005768404225818813
mutations O 0 0.00043675157940015197
in O 0 4.7234687372110784e-05
the O 0 8.900552347768098e-05
5 O 0 0.00019899594190064818
and O 0 4.025141606689431e-05
3 O 0 0.00011997550609521568
regions O 0 7.336761336773634e-05
of O 0 2.3513186533818953e-05
the O 0 0.00045903390855528414
APC B-Disease 1 0.9902313351631165
gene O 0 0.0033145358320325613
. O 0 0.0007732865633442998

Attenuated B-Disease 1 0.9969128370285034
adenomatous I-Disease 1 0.9999840259552002
polyposis I-Disease 1 0.9999884366989136
coli I-Disease 1 0.9999690055847168
patients O 1 0.999885082244873
have O 0 0.00039886884042061865
" O 0 0.0007052304572425783
multiple O 0 0.006989434361457825
" O 0 0.4765309691429138
colorectal B-Disease 1 0.9999986886978149
adenomas I-Disease 1 0.9999150037765503
( O 0 0.0009993802523240447
typically O 0 0.000340617960318923
fewer O 0 0.0003050826780963689
than O 0 7.4699979450088e-05
100 O 0 0.00021175749134272337
) O 0 0.00010996271157637239
without O 0 0.00010700013808673248
the O 0 0.0002162838209187612
florid O 1 0.984807014465332
phenotype O 0 0.020382214337587357
of O 0 6.400486745405942e-05
classical O 0 0.0029359508771449327
FAP B-Disease 1 0.9988584518432617
. O 0 0.002255791099742055

Another O 0 0.0018627091776579618
group O 0 0.00048132287338376045
of O 0 0.0002003199770115316
patients O 1 0.9997846484184265
with O 0 0.00031369959469884634
multiple O 0 0.02302147075533867
adenomas B-Disease 1 0.9994181394577026
has O 0 0.0006317868828773499
no O 0 0.00021824079158250242
mutations O 0 0.0005311781424097717
in O 0 8.739509212318808e-05
the O 0 0.00047260572318919003
APC B-Disease 1 0.9941260814666748
gene O 0 0.0015809625620022416
, O 0 0.00013848577509634197
and O 0 7.723347516730428e-05
their O 0 0.0001652109349379316
phenotype O 1 0.6079554557800293
probably O 0 0.0005022510304115713
results O 0 8.674455602886155e-05
from O 0 3.720352106029168e-05
variation O 0 0.00015824656293261796
at O 0 0.00014511661720462143
a O 0 0.0004651396593544632
locus O 0 0.004046283662319183
, O 0 0.00023882296227384359
or O 0 0.0003331383632030338
loci O 0 0.0038794646970927715
, O 0 0.0001281408331124112
elsewhere O 0 0.00026021944358944893
in O 0 5.893185152672231e-05
the O 0 0.0002163904719054699
genome O 0 0.004647502675652504
. O 0 0.0005987597396597266

Recently O 0 0.013152649626135826
, O 0 0.00037931749830022454
however O 0 0.000174871674971655
, O 0 0.00012326944852247834
a O 0 0.0005880505195818841
missense O 0 0.006272455211728811
variant O 0 0.003923691809177399
of O 0 0.00020483571279328316
APC B-Disease 1 0.9940040707588196
( O 0 0.001500455429777503
I1307K O 0 0.06960233300924301
) O 0 0.00029077258659526706
was O 0 0.00031774863600730896
described O 0 0.0006892323726788163
that O 0 7.735347026027739e-05
confers O 0 0.005244413856416941
an O 0 0.00013943490921519697
increased O 0 0.0016753575764596462
risk O 1 0.9894596338272095
of O 0 0.004864362068474293
colorectal B-Disease 1 0.9999998807907104
tumors I-Disease 1 0.9999982118606567
, O 0 0.0003940938913729042
including O 0 0.00019621988758444786
multiple O 0 0.06895265728235245
adenomas B-Disease 1 0.9996352195739746
, O 0 0.00040763296419754624
in O 0 0.0005937257083132863
Ashkenazim O 1 0.7279992699623108
. O 0 0.0012412018841132522

We O 0 0.00044486249680630863
have O 0 6.118702731328085e-05
studied O 0 0.00010765308979898691
a O 0 6.51981754344888e-05
set O 0 3.514017953420989e-05
of O 0 4.050609641126357e-05
164 O 1 0.5410559773445129
patients O 1 0.9998347759246826
with O 0 0.000554719299543649
multiple O 1 0.9934972524642944
colorectal B-Disease 1 0.9999995231628418
adenomas I-Disease 1 0.9999693632125854
and I-Disease 0 0.01303267665207386
/ I-Disease 1 0.9979556798934937
or I-Disease 0 0.01460487861186266
carcinoma I-Disease 1 0.9999940395355225
and O 0 0.00037467735819518566
analyzed O 0 0.003533497918397188
codons O 0 0.0063086580485105515
1263 O 1 0.5387912392616272
- O 0 0.01365913450717926
1377 O 1 0.5303472876548767
( O 0 0.000973236805293709
exon O 0 0.010137687437236309
15G O 0 0.01975277252495289
) O 0 8.016119681997225e-05
of O 0 1.994761623791419e-05
the O 0 0.000382685917429626
APC B-Disease 1 0.8620100617408752
gene O 0 0.001219974597916007
for O 0 0.00038842158392071724
germ O 1 0.9897679686546326
- O 0 0.0045750024728477
line O 0 0.001209684764035046
variants O 0 0.0012777597876265645
. O 0 0.0007700165151618421

Three O 0 0.002635363955050707
patients O 1 0.9988856911659241
with O 0 0.00017301722255069762
the O 0 0.0004317974962759763
I1307K O 0 0.10524622350931168
allele O 0 0.0025374998804181814
were O 0 9.850285277934745e-05
detected O 0 0.0018205277156084776
, O 0 4.4579312088899314e-05
each O 0 2.423359183012508e-05
of O 0 6.425278843380511e-05
Ashkenazi O 0 0.0825481191277504
descent O 0 0.0036065643653273582
. O 0 0.0011350477579981089

Four O 0 0.0026970880571752787
patients O 1 0.9982507824897766
had O 0 0.0006859020213596523
a O 0 0.0017005120171234012
germ O 1 0.9949394464492798
- O 0 0.007320696022361517
line O 0 0.0017331806011497974
E1317Q O 0 0.022664934396743774
missense O 0 0.006400569342076778
variant O 0 0.003141998080536723
of O 0 9.548399975756183e-05
APC O 1 0.9923511147499084
that O 0 0.00014569687482435256
was O 0 0.0002952491631731391
not O 0 5.419134322437458e-05
present O 0 6.887575727887452e-05
in O 0 8.353035809705034e-05
controls O 0 0.000622503983322531
; O 0 5.353097731131129e-05
one O 0 1.9743181837839074e-05
of O 0 7.894192094681785e-06
these O 0 2.1212623323663138e-05
individuals O 0 0.00011566461762413383
had O 0 0.0001971842721104622
an O 0 0.00010580805246718228
unusually O 0 0.005052261985838413
large O 0 9.029192733578384e-05
number O 0 2.9230197469587438e-05
of O 0 6.81200108374469e-05
metaplastic B-Disease 1 0.9951003193855286
polyps I-Disease 1 0.9733686447143555
of I-Disease 0 4.240785710862838e-05
the I-Disease 0 0.0005932200001552701
colorectum I-Disease 1 0.967373788356781
. O 0 0.001104347174987197

There O 0 0.0005207001813687384
is O 0 0.00023760060139466077
increasing O 0 0.00025183544494211674
evidence O 0 0.0001826850784709677
that O 0 6.637657497776672e-05
there O 0 7.827483932487667e-05
exist O 0 0.0003888608480338007
germ O 1 0.9940959215164185
- O 0 0.0013455194421112537
line O 0 0.0002793384774122387
variants O 0 0.00011514322250150144
of O 0 1.3965568541607354e-05
the O 0 0.0004144605190958828
APC B-Disease 1 0.9840206503868103
gene O 0 0.001108867465518415
that O 0 0.00011455697676865384
predispose O 0 0.009673560969531536
to O 0 3.2275824196403846e-05
the O 0 4.388485831441358e-05
development O 0 0.00031668710289523005
of O 0 8.800390787655488e-05
multiple O 1 0.9963623881340027
colorectal B-Disease 1 0.9999998807907104
adenomas I-Disease 1 0.9999866485595703
and I-Disease 1 0.7256850004196167
carcinoma I-Disease 1 0.9999992847442627
, O 0 0.0004574932099785656
but O 0 0.0001532517053419724
without O 0 0.00013061675417702645
the O 0 0.0002278200990986079
florid O 1 0.9880203604698181
phenotype O 0 0.02913046069443226
of O 0 6.36549957562238e-05
classical O 0 0.0018378777895122766
FAP B-Disease 1 0.9996654987335205
, O 0 0.00016900287300813943
and O 0 7.940374780446291e-05
possibly O 0 0.0004031833668705076
with O 0 7.76162269175984e-05
importance O 0 0.0058607799001038074
for O 1 0.9055623412132263
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
risk O 1 0.983307957649231
in O 0 0.00011186100891791284
the O 0 0.0001775860582711175
general O 0 0.0005603510071523488
population O 0 0.0001472301664762199
. O 0 0.00030540599254891276
. O 0 0.0006866846815682948

Genomic O 0 0.0037829717621207237
structure O 0 0.0006004536990076303
of O 0 4.6139095502439886e-05
the O 0 0.0008525727898813784
human O 1 0.9839513301849365
congenital B-Disease 1 0.9999966621398926
chloride I-Disease 1 0.9999213218688965
diarrhea I-Disease 1 0.9999995231628418
( O 1 0.8930080533027649
CLD B-Disease 1 0.9998979568481445
) O 0 0.0015017511323094368
gene O 0 0.0038312182296067476
. O 0 0.0009635353926569223

Congenital B-Disease 1 0.9999905824661255
chloride I-Disease 1 0.9997428059577942
diarrhea I-Disease 1 0.9999974966049194
( O 1 0.7495669722557068
CLD B-Disease 1 0.9998413324356079
) O 0 0.0010255469242110848
is O 0 0.0005139427958056331
caused O 0 0.004959380719810724
by O 0 7.828723755665123e-05
mutations O 0 0.00047377528971992433
in O 0 4.557793363346718e-05
a O 0 0.00025119446218013763
gene O 0 0.00039384563569910824
which O 0 4.0089453250402585e-05
encodes O 0 0.0008960005361586809
an O 0 0.001130123739130795
intestinal O 1 0.9999029636383057
anion O 1 0.9886660575866699
transporter O 1 0.9689870476722717
. O 0 0.0017203522147610784

We O 0 0.0010364111512899399
report O 0 0.000475672452012077
here O 0 7.581874524476007e-05
the O 0 6.15047974861227e-05
complete O 0 0.0002653294650372118
genomic O 0 0.0004182191623840481
organization O 0 0.0002452859771437943
of O 0 1.837994386733044e-05
the O 0 0.0003938803565688431
human O 0 0.01944946125149727
CLD B-Disease 1 0.9993671774864197
gene O 0 0.0012918617576360703
which O 0 0.00010171971371164545
spans O 0 0.0032330499961972237
approximately O 0 0.0007311307708732784
39kb O 0 0.062097951769828796
, O 0 0.0002034832286881283
and O 0 0.0001247338659595698
comprises O 0 0.0006039614672772586
21 O 0 0.001125182374380529
exons O 0 0.005647496320307255
. O 0 0.0010571535676717758

All O 0 0.0007854215218685567
exon O 0 0.031077587977051735
/ O 0 0.01415683701634407
intron O 0 0.018031328916549683
boundaries O 0 0.0004023802757728845
conform O 0 0.0015185470692813396
to O 0 0.00016908346151467413
the O 0 0.0011285535292699933
GT O 1 0.9944003224372864
/ O 1 0.964992880821228
AG O 1 0.9950112104415894
rule O 0 0.0016346299089491367
. O 0 0.000985139748081565

An O 0 0.0003642967785708606
analysis O 0 0.00012744964624289423
of O 0 3.3314536267425865e-05
the O 0 0.0003606864484027028
putative O 0 0.015900084748864174
promoter O 0 0.00811964925378561
region O 0 0.0005525868618860841
sequence O 0 8.468351734336466e-05
shows O 0 0.00020044473058078438
a O 0 0.0009489955846220255
putative O 0 0.29427558183670044
TATA O 1 0.9961739182472229
box O 0 0.003310549771413207
and O 0 0.00032330822432413697
predicts O 0 0.004561563953757286
multiple O 0 0.0004215568187646568
transcription O 0 0.0005315726739354432
factor O 0 0.0006607971154153347
binding O 0 0.0006793286302126944
sites O 0 0.0004960928345099092
. O 0 0.0006856530089862645

The O 0 0.0006710139568895102
genomic O 0 0.0026978154201060534
structure O 0 0.0015064196195453405
was O 0 0.0006756229558959603
determined O 0 0.0004643785650841892
using O 0 0.00011124626325909048
DNA O 0 0.0002731400600168854
from O 0 3.281441968283616e-05
several O 0 2.509943806217052e-05
sources O 0 5.517839235835709e-05
including O 0 3.1193460017675534e-05
multiple O 0 0.00045719757326878607
large O 0 0.0005042715347371995
- O 0 0.0064498926512897015
insert O 0 0.014995535835623741
libaries O 0 0.01847197115421295
and O 0 0.00013687298633158207
genomic O 0 0.0013077777111902833
DNA O 0 0.0008837992209009826
from O 0 0.00045242649503052235
Finnish O 1 0.9522817730903625
CLD B-Disease 1 0.9999587535858154
patients O 1 0.9998094439506531
and O 0 0.00041406991658732295
controls O 0 0.004034215118736029
. O 0 0.0011555628152564168

Exon O 0 0.03881379961967468
- O 0 0.003895579604431987
specific O 0 0.0003450317890383303
primers O 0 0.0053756567649543285
developed O 0 0.0012975339777767658
in O 0 6.903646135469899e-05
this O 0 5.585002509178594e-05
study O 0 0.0002318534825462848
will O 0 7.017439202172682e-05
facilitate O 0 0.0009757771040312946
mutation O 0 0.0013699658447876573
screening O 0 0.0019236395601183176
studies O 0 0.0002557329717092216
of O 0 0.00010508237755857408
patients O 1 0.9999456405639648
with O 0 0.0002701624180190265
the O 0 0.013755097053945065
disease O 1 0.9999790191650391
. O 0 0.0016761919250711799

Genomic O 0 0.002086821012198925
sequencing O 0 0.00045968982158228755
of O 0 8.158807759173214e-05
a O 0 0.003570734756067395
BAC O 1 0.994414210319519
clone O 1 0.9691421985626221
H O 1 0.9947364926338196
_ O 0 0.002339728409424424
RG364P16 O 0 0.02886180207133293
revealed O 0 0.0018497706623747945
the O 0 8.157570846378803e-05
presence O 0 0.00013730356295127422
of O 0 1.9885143046849407e-05
another O 0 0.0002443375997245312
, O 0 9.847580076893792e-05
highly O 0 0.0008880833629518747
homologous O 0 0.0021520089358091354
gene O 0 0.0005003840196877718
3 O 0 0.00011367674596840516
of O 0 2.772149491647724e-05
the O 0 0.0009940785821527243
CLD B-Disease 1 0.9996029734611511
gene O 0 0.001256025512702763
, O 0 6.601391942240298e-05
with O 0 3.735311474883929e-05
a O 0 0.00022889087267685682
similar O 0 0.00016302014410030097
genomic O 0 0.0009625297971069813
structure O 0 0.001004332210868597
, O 0 0.0002214609266957268
recently O 0 0.002169374842196703
identified O 0 0.0002701389603316784
as O 0 0.00010345182818127796
the O 0 0.0013162795221433043
Pendred B-Disease 1 0.9998871088027954
syndrome I-Disease 1 0.9999963045120239
gene O 0 0.01882767491042614
( O 0 0.0025842327158898115
PDS B-Disease 1 0.9992291927337646
) O 0 0.00042642606422305107
. O 0 0.00021428537729661912
. O 0 0.0004997286596335471

The O 0 0.002812329214066267
APCI1307K O 1 0.9757413268089294
allele O 0 0.023007674142718315
and O 0 0.007479508873075247
cancer B-Disease 1 0.9999842643737793
risk O 0 0.289870947599411
in O 0 0.0001655464875511825
a O 0 0.0006662138621322811
community O 0 0.0009520166204310954
- O 0 0.002056738128885627
based O 0 0.00011435768101364374
study O 0 0.0002596880658529699
of O 0 6.611144635826349e-05
Ashkenazi O 0 0.20175300538539886
Jews O 0 0.0010631795739755034
. O 0 0.0009607212268747389

Mutations O 0 0.009172070771455765
in O 0 0.0006598035688512027
APC O 1 0.9804445505142212
are O 0 0.00024922442389652133
classically O 1 0.9607844352722168
associated O 0 0.001097788568586111
with O 0 0.0020496773067861795
familial B-Disease 1 0.999956488609314
adenomatous I-Disease 1 0.9999867677688599
polyposis I-Disease 1 0.999987006187439
( O 0 0.2508904039859772
FAP B-Disease 1 0.9994749426841736
) O 0 0.00046088325325399637
, O 0 0.0001911950676003471
a O 0 0.0010085904505103827
highly O 1 0.5346093773841858
penetrant O 1 0.9997449517250061
autosomal B-Disease 1 0.9997941851615906
dominant I-Disease 1 0.9983868598937988
disorder I-Disease 1 0.999997615814209
characterized O 1 0.9982226490974426
by O 0 0.0014976469101384282
multiple O 1 0.9977753758430481
intestinal O 1 0.9999979734420776
polyps B-Disease 1 0.9998602867126465
and O 0 0.0003884666075464338
, O 0 0.0004067343834321946
without O 0 0.0009552111732773483
surgical O 1 0.9998692274093628
intervention O 0 0.004904786590486765
, O 0 0.00010908617696259171
the O 0 9.37156000873074e-05
development O 0 0.0025902511551976204
of O 0 0.0031160882208496332
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999984502792358
( O 0 0.008352547883987427
CRC B-Disease 1 0.9978864789009094
) O 0 0.0008585994364693761
. O 0 0.0006435573450289667

APC B-Disease 1 0.927201509475708
is O 0 0.0014240097953006625
a O 0 0.007940728217363358
tumour O 1 0.9998968839645386
- O 0 0.08778536319732666
suppressor O 0 0.0908627137541771
gene O 0 0.0007645422592759132
, O 0 7.587941945530474e-05
and O 0 0.00011723349598469213
somatic O 0 0.013112715445458889
loss O 0 0.04270746558904648
occurs O 0 0.0019611583556979895
in O 0 0.001810933114029467
tumours B-Disease 1 0.9999279975891113
. O 0 0.0017381046200171113

The O 0 0.005157449748367071
germline O 1 0.982379138469696
T O 1 0.9925514459609985
- O 0 0.0028613980393856764
to O 0 0.00019024110224563628
- O 0 0.002172674285247922
A O 0 0.0012271630112081766
transversion O 0 0.0236348919570446
responsible O 0 0.0012182454811409116
for O 0 0.00012327134027145803
the O 0 0.0004860436310991645
APC O 1 0.9010641574859619
I1307K O 0 0.01125283446162939
allele O 0 0.0012785533908754587
converts O 0 0.00023612342192791402
the O 0 0.00016010677791200578
wild O 0 0.0006870309007354081
- O 0 0.0013579981168732047
type O 0 0.00048555139801464975
sequence O 0 6.312574987532571e-05
to O 0 0.00011574990639928728
a O 0 0.001320666284300387
homopolymer O 1 0.9906704425811768
tract O 1 0.9991627931594849
( O 0 0.0044549903832376
A8 O 1 0.9991766810417175
) O 0 0.00029643267043866217
that O 0 0.00011780411296058446
is O 0 0.0003557948803063482
genetically O 0 0.0030479058623313904
unstable O 1 0.9898102283477783
and O 0 0.0002796108019538224
prone O 1 0.5530800819396973
to O 0 0.00025415277923457325
somatic O 0 0.011032622307538986
mutation O 0 0.0035813895519822836
. O 0 0.0007780626183375716

The O 0 0.001714477431960404
I1307K O 0 0.02517881616950035
allele O 0 0.005379960872232914
was O 0 0.0008046063594520092
found O 0 0.00026901040109805763
in O 0 0.00020179802959319204
6 O 0 0.0011931934859603643
. O 0 0.0007028878317214549

1 O 0 0.0009049605578184128
% O 0 9.58968885242939e-05
of O 0 0.00013203141861595213
unselected O 1 0.9113342761993408
Ashkenazi O 0 0.21172253787517548
Jews O 0 0.0005108116893097758
and O 0 0.00015081196033861488
higher O 0 0.000564312154892832
proportions O 0 0.002755923429504037
of O 0 9.55331779550761e-05
Ashkenazim O 1 0.9119333624839783
with O 0 0.00020847977430094033
family O 0 0.0007695581298321486
or O 0 0.0002103508886648342
personal O 0 0.000963123282417655
histories O 0 0.0020056322682648897
of O 0 0.00020984385628253222
CRC B-Disease 1 0.9984423518180847
( O 0 0.0019119404023513198
ref O 0 0.1577724665403366
. O 0 0.0001573837362229824
2 O 0 0.0005608174833469093
) O 0 0.00032917718635872006
. O 0 0.0004021450295113027

To O 0 0.0006259900983422995
evaluate O 0 0.00289422576315701
the O 0 0.00012969772797077894
role O 0 0.0004784201446454972
of O 0 0.00010981351078953594
I1307K O 1 0.8330855965614319
in O 0 0.0014771949499845505
cancer B-Disease 1 0.9999771118164062
, O 0 0.00023456347116734833
we O 0 0.0002655316493473947
genotyped O 0 0.028621088713407516
5 O 0 0.0005982272559776902
, O 0 0.0005770301795564592
081 O 1 0.9667587280273438
Ashkenazi O 0 0.04858911409974098
volunteers O 0 0.0024072632659226656
in O 0 0.00010544243559706956
a O 0 0.0004582709807436913
community O 0 0.0008717634482309222
survey O 0 0.0015079703880473971
. O 0 0.0007851102272979915

Risk O 0 0.06194176897406578
of O 0 0.0003745312860701233
developing O 1 0.9973053932189941
colorectal B-Disease 1 0.9999970197677612
, I-Disease 0 0.0415356382727623
breast I-Disease 1 0.9999724626541138
and I-Disease 0 0.0002785271208267659
other I-Disease 0 0.0003191731811966747
cancers I-Disease 1 0.9995604157447815
were O 0 4.647936293622479e-05
compared O 0 0.0006454815738834441
between O 0 0.00043445630581118166
genotyped O 1 0.9703331589698792
I1307K O 0 0.22460274398326874
carriers O 0 0.0046179634518921375
and O 0 0.0002243410563096404
non O 0 0.002040588529780507
- O 0 0.004550904501229525
carriers O 0 0.0011409563012421131
and O 0 3.63904946425464e-05
their O 0 4.143970727454871e-05
first O 0 0.0002541764988563955
- O 0 0.006136693526059389
degree O 0 0.0015810694312676787
relatives O 0 0.0027133719995617867
. O 0 0.0010149040026590228

Sperm O 0 0.0035969268064945936
DNA O 0 0.000858069455716759
analysis O 0 0.000277703016763553
in O 0 0.0003216213663108647
a O 0 0.005704387091100216
Friedreich B-Disease 1 0.999398946762085
ataxia I-Disease 1 0.9995493292808533
premutation O 1 0.9915388226509094
carrier O 0 0.25376999378204346
suggests O 0 0.0018229669658467174
both O 0 0.00020942153059877455
meiotic O 0 0.3811381459236145
and O 0 0.00014293634740170091
mitotic O 0 0.004914025776088238
expansion O 0 0.001049853628501296
in O 0 0.00013464388030115515
the O 0 0.000572323682717979
FRDA B-Disease 1 0.9883374571800232
gene O 0 0.0038555320352315903
. O 0 0.0008600151049904525

Friedreich B-Disease 1 0.9955570101737976
ataxia I-Disease 1 0.9990748167037964
is O 0 0.002103556180372834
usually O 0 0.0006463468307629228
caused O 0 0.004781866446137428
by O 0 3.54495678038802e-05
an O 0 5.7536530221113935e-05
expansion O 0 0.0003786361194215715
of O 0 3.5856679460266605e-05
a O 0 0.0015430187340825796
GAA O 0 0.172591894865036
trinucleotide O 1 0.8480901122093201
repeat O 0 0.003798095043748617
in O 0 0.00024028039479162544
intron O 0 0.017446864396333694
1 O 0 0.00016460713231936097
of O 0 2.8388942155288532e-05
the O 0 0.000495068496093154
FRDA B-Disease 1 0.9910481572151184
gene O 0 0.0042427172884345055
. O 0 0.0007108454592525959

Occasionally O 0 0.00576584180817008
, O 0 0.00034737325040623546
a O 0 0.0005211952375248075
fully O 0 0.002240705071017146
expanded O 0 0.0011780220083892345
allele O 0 0.0029493565671145916
has O 0 0.0004041263600811362
been O 0 0.00017659907462075353
found O 0 0.00014091776392888278
to O 0 8.196527051040903e-05
arise O 0 0.0010075665777549148
from O 0 6.379932892741635e-05
a O 0 0.0002870655443985015
premutation O 0 0.005063396412879229
of O 0 1.7937907614395954e-05
100 O 0 0.00017930027388501912
or O 0 0.00018907163757830858
less O 0 0.0008054102072492242
triplet O 0 0.15828388929367065
repeats O 0 0.008101011626422405
. O 0 0.0009500431478954852

We O 0 0.0010019210167229176
have O 0 0.00021210283739492297
examined O 0 0.0018350511090829968
the O 0 7.757116691209376e-05
sperm O 0 0.0003637899353634566
DNA O 0 0.00017675677372608334
of O 0 2.528828554204665e-05
a O 0 0.0015527834184467793
premutation O 1 0.9264510869979858
carrier O 0 0.10892604291439056
. O 0 0.001337271649390459

This O 0 0.0009507539798505604
mans O 0 0.01309515256434679
leucocyte O 0 0.03640226274728775
DNA O 0 0.0010214934591203928
showed O 0 0.0005458179512061179
one O 0 0.0001474788732593879
normal O 0 0.0012547677615657449
allele O 0 0.0013528165873140097
and O 0 5.0031474529532716e-05
one O 0 7.139490480767563e-05
allele O 0 0.0005204699118621647
of O 0 2.1601807020488195e-05
approximately O 0 0.0003222339728381485
100 O 0 0.0005029854946769774
repeats O 0 0.005970918107777834
. O 0 0.0008732544374652207

His O 0 0.002510529477149248
sperm O 0 0.0016721212305128574
showed O 0 0.0006960126338526607
an O 0 0.00022080898634158075
expanded O 0 0.0012502678437158465
allele O 0 0.002173523884266615
in O 0 0.0001393477141391486
a O 0 0.00047526066191494465
tight O 0 0.0015979839954525232
range O 0 0.0004435096634551883
centering O 0 0.0016204903367906809
on O 0 8.95201665116474e-05
a O 0 0.00019102195801679045
size O 0 0.00016488674737047404
of O 0 4.1185441659763455e-05
approximately O 0 0.0011318405158817768
320 O 0 0.03294486179947853
trinucleotide O 1 0.7308121919631958
repeats O 0 0.012190548703074455
. O 0 0.0015715836780145764

His O 0 0.009259426966309547
affected O 0 0.09895962476730347
son O 0 0.0214686281979084
has O 0 0.0005105060408823192
repeat O 0 0.001925241551361978
sizes O 0 0.000326137786032632
of O 0 0.00010979172657243907
1040 O 1 0.9488983750343323
and O 0 0.0005237804143689573
540 O 0 0.028329459950327873
. O 0 0.0010566647397354245

These O 0 0.00012393109500408173
data O 0 0.00013544276589527726
suggest O 0 0.00035098561784252524
that O 0 4.566821371554397e-05
expansion O 0 0.0006598846521228552
occurs O 0 0.00027224491350352764
in O 0 4.233093204675242e-05
two O 0 5.357592453947291e-05
stages O 0 0.0006645239773206413
, O 0 5.415404666564427e-05
the O 0 5.0378101150272414e-05
first O 0 0.00010654756624717265
during O 0 0.0005384093383327127
meiosis O 0 0.00282704527489841
followed O 0 0.00015615364827681333
by O 0 4.306946357246488e-05
a O 0 0.00021195021690800786
second O 0 0.0002926629676949233
mitotic O 0 0.00789125170558691
expansion O 0 0.003519016318023205
. O 0 0.0011614685645326972

We O 0 0.0007951617590151727
also O 0 0.00017192740051541477
show O 0 0.0001468280825065449
that O 0 2.5869156161206774e-05
in O 0 3.267633292125538e-05
all O 0 3.782087878789753e-05
informative O 0 0.0036541270092129707
carrier O 0 0.04563949629664421
father O 0 0.0020613365340977907
to O 0 0.00028651682077907026
affected O 0 0.011660136282444
child O 0 0.006357811391353607
transmissions O 0 0.0015644872328266501
, O 0 7.805414497852325e-05
with O 0 3.992326310253702e-05
the O 0 8.726042869966477e-05
notable O 0 0.0001893458393169567
exception O 0 0.000299788051052019
of O 0 2.2678495952277444e-05
the O 0 0.0003117996675428003
premutation O 1 0.930167019367218
carrier O 0 0.008196988143026829
, O 0 6.797335663577542e-05
the O 0 6.843036680947989e-05
expansion O 0 0.0007712748483754694
size O 0 0.0004540877416729927
decreases O 0 0.0020832561422139406
. O 0 0.00021934793039690703
. O 0 0.0005318892654031515

The O 0 0.0013855762081220746
R496H O 0 0.019201144576072693
mutation O 0 0.0014266326325014234
of O 0 8.711618283996359e-05
arylsulfatase O 1 0.8329177498817444
A O 0 0.004242648370563984
does O 0 0.000854969781357795
not O 0 0.0005100531852804124
cause O 1 0.962898850440979
metachromatic B-Disease 1 0.9989055395126343
leukodystrophy I-Disease 1 0.9996974468231201
. O 0 0.0028234259225428104

Deficiency B-Disease 1 0.9994420409202576
of I-Disease 0 0.00030283682281151414
arylsulfatase I-Disease 1 0.8811860084533691
A I-Disease 0 0.005640517920255661
( O 0 0.0018492373637855053
ARSA O 1 0.9951097369194031
) O 0 0.00042699577170424163
enzyme O 0 0.0018799941753968596
activity O 0 0.0017274142010137439
causes O 1 0.9877632260322571
metachromatic B-Disease 1 0.9988848567008972
leukodystrophy I-Disease 1 0.9998667240142822
( O 0 0.02030560001730919
MLD B-Disease 1 0.9990654587745667
) O 0 0.0015490272780880332
. O 0 0.00126610416918993

A O 0 0.0013483070069923997
number O 0 8.781697397353128e-05
of O 0 0.00021829990146216005
ARSA O 1 0.9943418502807617
gene O 0 0.0044605848379433155
mutations O 0 0.002089717425405979
responsible O 0 0.0027116977144032717
for O 0 0.0012887120246887207
MLD B-Disease 1 0.9997648596763611
have O 0 0.0003240889636799693
been O 0 0.0003940572205465287
identified O 0 0.001208771951496601
. O 0 0.0005309862899594009

Recently O 0 0.009203063324093819
, O 0 0.00032458524219691753
the O 0 0.00032278464641422033
R496H O 0 0.012814492918550968
mutation O 0 0.0013428004458546638
of O 0 0.00014057231601327658
ARSA O 1 0.9979904890060425
was O 0 0.0007681769202463329
proposed O 0 0.0004188353777863085
to O 0 3.872501474688761e-05
be O 0 3.531918264343403e-05
a O 0 0.00023497086658608168
cause O 0 0.003689737059175968
of O 0 0.00018024974269792438
MLD B-Disease 1 0.999718964099884
( O 0 0.003003865946084261
Draghia O 1 0.9831545352935791
et O 0 0.027077021077275276
al O 0 0.004451730288565159
. O 0 0.0001327755453530699
, O 0 0.0002628446090966463
1997 O 0 0.0030449528712779284
) O 0 0.0003632998850662261
. O 0 0.0006730268942192197

We O 0 0.001210646703839302
have O 0 0.0003292211040388793
investigated O 0 0.00318844779394567
the O 0 0.0002998177951667458
R496H O 0 0.02213389053940773
mutation O 0 0.001191838295198977
and O 0 7.200561231002212e-05
found O 0 0.00012325217539910227
this O 0 5.769631388830021e-05
mutation O 0 0.0007854181458242238
at O 0 0.00018569204257801175
a O 0 0.00032409821869805455
relatively O 0 0.0006821201532147825
high O 0 0.00047240027924999595
frequency O 0 0.00010617858788464218
in O 0 5.698236054740846e-05
an O 0 0.00010330228542443365
African O 0 0.0002831994497682899
American O 0 0.00015275886107701808
population O 0 7.752094825264066e-05
( O 0 0.0004489983548410237
f O 0 0.0018491483060643077
= O 0 0.0012393455253913999
0 O 0 0.0002803355164360255
. O 0 0.0001188900787383318
09 O 0 0.005845959763973951
, O 0 0.00021094377734698355
n O 0 0.0013986430130898952
= O 0 0.002298471750691533
61 O 0 0.0016133085591718554
subjects O 0 0.0012994076823815703
) O 0 0.0005000865203328431
. O 0 0.0006409724592231214

The O 0 0.003347867401316762
ARSA O 1 0.9876269698143005
enzyme O 0 0.004573964048177004
activity O 0 0.0004997188807465136
in O 0 0.00013506654067896307
subjects O 0 0.00045253211283124983
with O 0 5.7608784118201584e-05
and O 0 7.951278530526906e-05
without O 0 0.00012198414333397523
the O 0 0.00019428427913226187
R496H O 0 0.13668414950370789
mutation O 0 0.0012522281613200903
was O 0 0.0003659405920188874
determined O 0 0.00047813064884394407
and O 0 5.509994298336096e-05
found O 0 0.00012516039714682847
to O 0 5.990797217236832e-05
be O 0 0.0001500530051998794
normal O 0 0.001939814304932952
. O 0 0.0006732026813551784

It O 0 0.0006518509471789002
is O 0 0.00030871693161316216
therefore O 0 0.0004005013033747673
concluded O 0 0.0017609515925869346
that O 0 4.314209581934847e-05
the O 0 0.00015367093146778643
R496H O 0 0.01952235773205757
mutation O 0 0.001359684276394546
of O 0 0.00016537438204977661
ARSA O 1 0.9990645051002502
does O 0 0.0010259505361318588
not O 0 0.0001058918351191096
negatively O 0 0.0008799083298072219
influence O 0 0.00010849112732103094
the O 0 7.743207243038341e-05
activity O 0 0.0002634286356624216
of O 0 0.00013450156257022172
ARSA O 1 0.9990278482437134
and O 0 0.00022904282377567142
is O 0 0.00019106932450085878
not O 0 7.427443779306486e-05
a O 0 0.00044244216405786574
cause O 0 0.01881331205368042
of O 0 0.0005143483285792172
MLD B-Disease 1 0.9994958639144897

Down O 0 0.007862730883061886
- O 0 0.0024022909346967936
regulation O 0 0.0004451106069609523
of O 0 6.455070251831785e-05
transmembrane O 0 0.029728509485721588
carbonic O 1 0.9785329699516296
anhydrases O 1 0.9773162007331848
in O 0 0.008664309047162533
renal B-Disease 1 0.9999978542327881
cell I-Disease 1 0.9974205493927002
carcinoma I-Disease 1 0.9999924898147583
cell O 0 0.0046161930076777935
lines O 0 0.0005516925593838096
by O 0 0.00014796525647398084
wild O 0 0.0015257630730047822
- O 0 0.02986830100417137
type O 0 0.02019643597304821
von B-Disease 1 0.9411748647689819
Hippel I-Disease 1 0.9987205266952515
- I-Disease 1 0.7774249315261841
Lindau I-Disease 1 0.9932301044464111
transgenes O 0 0.3846740126609802
. O 0 0.0014230357483029366

To O 0 0.0014719645259901881
discover O 0 0.005238886456936598
genes O 0 0.000607602356467396
involved O 0 0.0008088775211945176
in O 0 0.0006343983695842326
von B-Disease 1 0.92146235704422
Hippel I-Disease 1 0.9970554113388062
- I-Disease 1 0.6191995143890381
Lindau I-Disease 1 0.996566116809845
( O 0 0.0027006715536117554
VHL B-Disease 1 0.9972746968269348
) O 0 0.0009390353225171566
- O 0 0.00655565969645977
mediated O 0 0.03308667615056038
carcinogenesis O 1 0.9962286949157715
, O 0 0.00025532173458486795
we O 0 0.00034142943331971765
used O 0 0.002372137736529112
renal B-Disease 1 0.9999949932098389
cell I-Disease 1 0.9956353306770325
carcinoma I-Disease 1 0.999992847442627
cell O 0 0.00928742066025734
lines O 0 0.0021319370716810226
stably O 0 0.06347440183162689
transfected O 0 0.0416959747672081
with O 0 0.00023844414681661874
wild O 0 0.001882718177512288
- O 0 0.039654843509197235
type O 0 0.16113558411598206
VHL O 1 0.9986886382102966
- O 0 0.03632214665412903
expressing O 0 0.012480510398745537
transgenes O 1 0.5915270447731018
. O 0 0.001617801608517766

Large O 0 0.001690404023975134
- O 0 0.002292369259521365
scale O 0 0.0009619843331165612
RNA O 0 0.0009352949564345181
differential O 0 0.0016731738578528166
display O 0 0.0007427798700518906
technology O 0 0.0013088324340060353
applied O 0 0.00038276141276583076
to O 0 5.206514470046386e-05
these O 0 3.47287132171914e-05
cell O 0 0.0012456125114113092
lines O 0 0.000539827102329582
identified O 0 0.0003257245116401464
several O 0 0.00010205918806605041
differentially O 0 0.006671312730759382
expressed O 0 0.000449859508080408
genes O 0 0.00025009471573866904
, O 0 7.334438123507425e-05
including O 0 4.0190127037931234e-05
an O 0 0.00024658290203660727
alpha O 0 0.004546396899968386
carbonic O 1 0.9509645104408264
anhydrase O 1 0.9842983484268188
gene O 0 0.0032230170909315348
, O 0 0.0005484764114953578
termed O 1 0.8032901287078857
CA12 O 1 0.9886848330497742
. O 0 0.0014895626809448004

The O 0 0.0004428752581588924
deduced O 0 0.0013719452545046806
protein O 0 0.00027120555751025677
sequence O 0 0.00014859654766041785
was O 0 0.00036282517248764634
classified O 0 0.001079542562365532
as O 0 8.189870277419686e-05
a O 0 0.00020589154155459255
one O 0 0.00011909112799912691
- O 0 0.001730690710246563
pass O 0 0.0008059315732680261
transmembrane O 0 0.010361251421272755
CA O 0 0.02949267067015171
possessing O 0 0.0009557428420521319
an O 0 0.0002544927119743079
apparently O 0 0.00199970998801291
intact O 0 0.001855114591307938
catalytic O 0 0.0013785316841676831
domain O 0 0.0002027739683398977
in O 0 8.000197703950107e-05
the O 0 0.0002091251953970641
extracellular O 0 0.00917103048413992
CA O 1 0.6535536646842957
module O 0 0.019446872174739838
. O 0 0.0009574909345246851

Reintroduced O 0 0.027815062552690506
wild O 0 0.004442937206476927
- O 0 0.02564396895468235
type O 0 0.04585006460547447
VHL B-Disease 1 0.9972629547119141
strongly O 0 0.002620571991428733
inhibited O 0 0.009693121537566185
the O 0 0.00015366141451522708
overexpression O 0 0.0016254560323432088
of O 0 2.3019259970169514e-05
the O 0 0.0002935787779279053
CA12 O 1 0.9799562692642212
gene O 0 0.0007947323028929532
in O 0 0.00011585745232878253
the O 0 0.0006933328113518655
parental O 1 0.9959526062011719
renal B-Disease 1 0.9999991655349731
cell I-Disease 1 0.9977454543113708
carcinoma I-Disease 1 0.999996542930603
cell O 0 0.037948302924633026
lines O 0 0.0023124690633267164
. O 0 0.0009258583886548877

Similar O 0 0.001285844249650836
results O 0 0.00040149234700948
were O 0 4.7514426114503294e-05
obtained O 0 0.0002501858107279986
with O 0 0.00039422145346179605
CA9 O 1 0.9989268183708191
, O 0 0.0001577226648805663
encoding O 0 0.0003172252618242055
another O 0 0.0005914309294894338
transmembrane O 0 0.015310466289520264
CA O 0 0.01396246999502182
with O 0 5.3749965445604175e-05
an O 0 0.00016131676966324449
intact O 0 0.0035841455683112144
catalytic O 0 0.004160131327807903
domain O 0 0.0013817389262840152
. O 0 0.000900749524589628

Although O 0 0.0006913022953085601
both O 0 9.663918172009289e-05
domains O 0 0.00033326190896332264
of O 0 3.170837226207368e-05
the O 0 0.000605180743150413
VHL B-Disease 1 0.9955897331237793
protein O 0 0.0008716160664334893
contribute O 0 0.0013998462818562984
to O 0 8.469094609608874e-05
regulation O 0 0.00047621343401260674
of O 0 8.334529411513358e-05
CA12 O 1 0.9539481401443481
expression O 0 0.000676493626087904
, O 0 0.0001405217917636037
the O 0 0.0002179683797294274
elongin O 0 0.01703839935362339
binding O 0 0.0004090898728463799
domain O 0 0.0005278787575662136
alone O 0 0.001128048519603908
could O 0 0.00036357028875499964
effectively O 0 0.002828233875334263
regulate O 0 0.017620692029595375
CA9 O 1 0.9929088354110718
expression O 0 0.003531072521582246
. O 0 0.0012087920913472772

We O 0 0.0021060812287032604
mapped O 0 0.01230481918901205
CA12 O 1 0.9751541018486023
and O 0 0.001967120449990034
CA9 O 1 0.991628885269165
loci O 0 0.00840562954545021
to O 0 0.0002901193802244961
chromosome O 0 0.0020671957172453403
bands O 0 0.0013318608980625868
15q22 O 0 0.022678956389427185
and O 0 0.0005771885043941438
17q21 O 0 0.0598863884806633
. O 0 0.0013426021905615926

2 O 0 0.0014930682955309749
respectively O 0 0.0006308164447546005
, O 0 0.00024909546482376754
regions O 0 0.0008611968369223177
prone O 0 0.043632738292217255
to O 0 0.00011452574108261615
amplification O 0 0.0013281417777761817
in O 0 8.557680121157318e-05
some O 0 0.00015644558880012482
human O 0 0.06017797812819481
cancers B-Disease 1 0.999622106552124
. O 0 0.0010279425187036395

Additional O 0 0.0012048715725541115
experiments O 0 0.00101461389567703
are O 0 4.358805745141581e-05
needed O 0 0.0004563219554256648
to O 0 4.116742638871074e-05
define O 0 0.0003272352914791554
the O 0 7.859257311793044e-05
role O 0 0.0006217472837306559
of O 0 0.00016359348956029862
CA O 1 0.9965237975120544
IX O 1 0.9984883069992065
and O 0 0.0008567010518163443
CA O 1 0.991692066192627
XII O 1 0.9938179850578308
enzymes O 0 0.00036318888305686414
in O 0 4.8657009756425396e-05
the O 0 6.119409226812422e-05
regulation O 0 0.00040332713979296386
of O 0 3.879239739035256e-05
pH O 0 0.014669365249574184
in O 0 8.338138286489993e-05
the O 0 0.00013630979810841382
extracellular O 0 0.0030485172756016254
microenvironment O 0 0.07328950613737106
and O 0 5.854976552654989e-05
its O 0 0.00010389620729256421
potential O 0 0.0006180420750752091
impact O 0 0.0026939117815345526
on O 0 0.0020686336793005466
cancer B-Disease 1 0.9999750852584839
cell O 0 0.00470631942152977
growth O 0 0.002329743467271328
. O 0 0.0008048145100474358

A O 0 0.003415385726839304
gene O 0 0.0008322697831317782
encoding O 0 0.00017808035772759467
a O 0 0.0003320824180264026
transmembrane O 0 0.00252184527926147
protein O 0 0.0005020485259592533
is O 0 0.000344212370691821
mutated O 0 0.014151821844279766
in O 0 0.0008417366771027446
patients O 1 0.9999661445617676
with O 0 0.463135689496994
diabetes B-Disease 1 1.0
mellitus I-Disease 1 0.9999988079071045
and O 1 0.7531991600990295
optic B-Disease 1 0.9999973773956299
atrophy I-Disease 1 0.9999865293502808
( O 1 0.9712962508201599
Wolfram B-Disease 1 0.9999734163284302
syndrome I-Disease 1 0.999998927116394
) O 0 0.001533568138256669
. O 0 0.001022413489408791

Wolfram B-Disease 1 0.9996116757392883
syndrome I-Disease 1 0.9999932050704956
( O 0 0.2238743156194687
WFS B-Disease 1 0.9997313618659973
; O 0 0.00668664975091815
OMIM O 1 0.9990127086639404
222300 O 1 0.5400100350379944
) O 0 0.0003847456828225404
is O 0 0.000301085616229102
an O 0 0.001275286078453064
autosomal B-Disease 1 0.9993664622306824
recessive I-Disease 1 0.9998176693916321
neurodegenerative I-Disease 1 0.9999909400939941
disorder I-Disease 1 0.9999666213989258
defined O 0 0.0026082785334438086
by O 0 0.00041331586544401944
young O 0 0.3611021935939789
- O 0 0.39189451932907104
onset O 1 0.9975379705429077
non O 0 0.013250966556370258
- O 1 0.8701105713844299
immune O 1 0.9992098808288574
insulin B-Disease 1 0.9982689619064331
- I-Disease 1 0.9802054166793823
dependent I-Disease 1 0.9832747578620911
diabetes I-Disease 1 0.9999992847442627
mellitus I-Disease 1 0.999980092048645
and O 0 0.00847433041781187
progressive O 1 0.9995286464691162
optic B-Disease 1 0.9999889135360718
atrophy I-Disease 1 0.9998493194580078
. O 0 0.0030295627657324076

Linkage O 0 0.017814980819821358
to O 0 0.0003701484820339829
markers O 0 0.001851758104749024
on O 0 0.0004239512200001627
chromosome O 0 0.0055913464166224
4p O 1 0.9768908619880676
was O 0 0.0013142901007086039
confirmed O 0 0.0009078165167011321
in O 0 6.72187888994813e-05
five O 0 0.00017987098544836044
families O 0 0.0005968735204078257
. O 0 0.0006814232910983264

On O 0 0.00024925987236201763
the O 0 5.634356784867123e-05
basis O 0 5.4458349040942267e-05
of O 0 7.98624096205458e-05
meiotic O 1 0.9937146306037903
recombinants O 1 0.996654748916626
and O 0 0.02417057566344738
disease O 1 0.9999932050704956
- O 0 0.4266066253185272
associated O 0 0.0007537753554061055
haplotypes O 0 0.005441953428089619
, O 0 0.00025842987815849483
the O 0 0.0008523960132151842
WFS B-Disease 1 0.9989149570465088
gene O 0 0.001980111701413989
was O 0 0.0005641423631459475
localized O 0 0.003579353215172887
to O 0 0.00019114949100185186
a O 0 0.003362236311659217
BAC O 1 0.9934750199317932
/ O 0 0.38359931111335754
P1 O 1 0.961087167263031
contig O 0 0.008766843006014824
of O 0 3.487320645945147e-05
less O 0 0.0002836555941030383
than O 0 0.0001884025550680235
250 O 0 0.0018237506737932563
kb O 0 0.018348347395658493
. O 0 0.0008469416643492877

Mutations O 0 0.004462516866624355
in O 0 0.00022115960018709302
a O 0 0.000898913131095469
novel O 0 0.0029268052894622087
gene O 0 0.0031545700039714575
( O 0 0.0010325172916054726
WFS1 O 1 0.5610741376876831
) O 0 0.00010281680442858487
encoding O 0 0.00017653629765845835
a O 0 0.0003064522170461714
putative O 0 0.003274583723396063
transmembrane O 0 0.0023982704151421785
protein O 0 0.00029500212986022234
were O 0 2.9630240533151664e-05
found O 0 7.328928768401965e-05
in O 0 3.6996902053942904e-05
all O 0 3.62888204108458e-05
affected O 0 0.0018571808468550444
individuals O 0 0.00012865738244727254
in O 0 0.0002666118089109659
six O 0 0.002115504816174507
WFS B-Disease 1 0.999618411064148
families O 0 0.0007940154173411429
, O 0 0.00015731200983282179
and O 0 7.47545636841096e-05
these O 0 5.017036528442986e-05
mutations O 0 0.0006263878894969821
were O 0 2.5652992917457595e-05
associated O 0 0.00017157431284431368
with O 0 0.00014466498396359384
the O 0 0.009240553714334965
disease O 1 0.9999874830245972
phenotype O 1 0.9769601821899414
. O 0 0.0012334607308730483

WFS1 O 1 0.9691259860992432
appears O 0 0.004178021568804979
to O 0 9.572504495736212e-05
function O 0 0.00030503436573781073
in O 0 0.0001174976205220446
survival O 0 0.010879711247980595
of O 0 6.895362457726151e-05
islet O 1 0.5362212061882019
beta O 0 0.023924535140395164
- O 0 0.006734143011271954
cells O 0 0.0013924675295129418
and O 0 0.00020251197565812618
neurons O 0 0.013846981339156628
. O 0 0.00021055694378446788
. O 0 0.0005415107007138431

Stable O 0 0.013587012887001038
interaction O 0 0.0004223743744660169
between O 0 9.774214413482696e-05
the O 0 7.257807737914845e-05
products O 0 0.0002817731292452663
of O 0 2.4771756216068752e-05
the O 0 0.0005842909449711442
BRCA1 O 1 0.9989005327224731
and O 0 0.0020230377558618784
BRCA2 O 1 0.9994617104530334
tumor B-Disease 1 0.9995612502098083
suppressor O 0 0.025536606088280678
genes O 0 0.00028639170341193676
in O 0 0.00017349682457279414
mitotic O 0 0.010094388388097286
and O 0 0.0006265646661631763
meiotic O 1 0.9888592958450317
cells O 0 0.010637685656547546
. O 0 0.0010778793366625905

BRCA1 O 1 0.9940534234046936
and O 0 0.0024874371010810137
BRCA2 O 1 0.9777452945709229
account O 0 0.00019379473815206438
for O 0 0.00010250422928947955
most O 0 0.00013647366722580045
cases O 0 0.0005252062692306936
of O 0 6.350783223751932e-05
familial O 1 0.9992144107818604
, O 0 0.0006764311692677438
early O 0 0.007248520385473967
onset O 1 0.9999531507492065
breast B-Disease 1 0.9999926090240479
and I-Disease 0 0.029675299301743507
/ I-Disease 1 0.9995843768119812
or I-Disease 1 0.9807358980178833
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.999997615814209
and O 0 0.00011368552804924548
encode O 0 0.00022746543982066214
products O 0 0.00034403588506393135
that O 0 2.6713179977377877e-05
each O 0 3.7846748455194756e-05
interact O 0 0.0009886373300105333
with O 0 0.00032029245630837977
hRAD51 O 0 0.3090532422065735
. O 0 0.000895409903023392

Results O 0 0.0022534183226525784
presented O 0 0.0011721652699634433
here O 0 0.0003230161382816732
show O 0 0.0006797897513024509
that O 0 0.0005375919281505048
BRCA1 O 1 0.9935585856437683
and O 0 0.0012509538792073727
BRCA2 O 1 0.9909052848815918
coexist O 0 0.002031307201832533
in O 0 0.00010497611947357655
a O 0 0.0004154917842242867
biochemical O 0 0.003546410705894232
complex O 0 0.002074381336569786
and O 0 0.00027392638730816543
colocalize O 1 0.6268447637557983
in O 0 0.0004141843819525093
subnuclear O 1 0.7343290448188782
foci O 0 0.01194116659462452
in O 0 0.00026827966212294996
somatic O 0 0.007602058816701174
cells O 0 0.0009559522150084376
and O 0 4.77120338473469e-05
on O 0 4.346573041402735e-05
the O 0 6.384094012901187e-05
axial O 0 0.002567338990047574
elements O 0 7.556741184089333e-05
of O 0 7.048047700664029e-05
developing O 0 0.42850348353385925
synaptonemal O 1 0.9865869879722595
complexes O 0 0.015749264508485794
. O 0 0.0012956296559423208

Like O 0 0.007758891209959984
BRCA1 O 1 0.99440997838974
and O 0 0.0023776914458721876
RAD51 O 1 0.9987781643867493
, O 0 0.003690615063533187
BRCA2 O 1 0.9951960444450378
relocates O 0 0.09443006664514542
to O 0 0.0013508828124031425
PCNA O 1 0.9883246421813965
+ O 0 0.010751469992101192
replication O 0 0.0010516273323446512
sites O 0 0.00020813218725379556
following O 0 0.0003444720059633255
exposure O 0 0.05328231677412987
of O 0 0.00011901087418664247
S O 1 0.9546685814857483
phase O 0 0.006519585847854614
cells O 0 0.0019056085729971528
to O 0 0.0003035626432392746
hydroxyurea O 1 0.9958609938621521
or O 0 0.0021351531613618135
UV O 1 0.9980242252349854
irradiation O 0 0.18973200023174286
. O 0 0.001122053130529821

Thus O 0 0.003210855880752206
, O 0 0.0022746031172573566
BRCA1 O 1 0.9965749382972717
and O 0 0.0012088720686733723
BRCA2 O 1 0.9957641363143921
participate O 0 0.00045140853035263717
, O 0 7.207294402178377e-05
together O 0 5.194195910007693e-05
, O 0 6.860031135147437e-05
in O 0 6.025850962032564e-05
a O 0 0.00045182823669165373
pathway O 0 0.005093439482152462
( O 0 0.0008803117088973522
s O 0 0.01898597553372383
) O 0 0.00012062272435287014
associated O 0 7.430178084177896e-05
with O 0 2.0845993276452646e-05
the O 0 5.104842784930952e-05
activation O 0 0.0003493617696221918
of O 0 1.9732280634343624e-05
double O 0 0.0014523619320243597
- O 0 0.003913555759936571
strand O 0 0.002259791363030672
break O 0 0.0023830635473132133
repair O 1 0.9960044026374817
and O 0 0.0005920750554651022
/ O 0 0.0373801589012146
or O 0 0.0003842160804197192
homologous O 0 0.004502712283283472
recombination O 0 0.004679110366851091
. O 0 0.0012492024106904864

Dysfunction O 1 0.9959815740585327
of O 0 9.902885358314961e-05
this O 0 0.0002666509535629302
pathway O 0 0.005980998743325472
may O 0 0.000516044266987592
be O 0 5.719882756238803e-05
a O 0 0.00018284610996488482
general O 0 0.00038635448436252773
phenomenon O 0 0.000684737169649452
in O 0 4.290904325898737e-05
the O 0 4.965620246366598e-05
majority O 0 6.358268001349643e-05
of O 0 1.7959833712666295e-05
cases O 0 0.0008569917408749461
of O 0 0.00017752411076799035
hereditary B-Disease 1 0.9998518228530884
breast I-Disease 1 0.9999953508377075
and I-Disease 0 0.059459250420331955
/ I-Disease 1 0.9995695948600769
or I-Disease 1 0.9914412498474121
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999986886978149
. O 0 0.0007275295211002231
. O 0 0.0007689184858463705

A O 0 0.006432072725147009
novel O 0 0.004437517374753952
Arg362Ser O 0 0.07276130467653275
mutation O 0 0.00117231416516006
in O 0 0.00010901618225034326
the O 0 0.0002961851714644581
sterol O 1 0.5911259651184082
27 O 0 0.0038577704690396786
- O 0 0.010706528089940548
hydroxylase O 0 0.15255695581436157
gene O 0 0.002967061474919319
( O 0 0.0010140781523659825
CYP27 O 1 0.9621938467025757
) O 0 0.0002394399489276111
: O 0 9.812831558519974e-05
its O 0 9.944512567017227e-05
effects O 0 0.0009372003260068595
on O 0 0.00010800639574881643
pre O 0 0.0008696424774825573
- O 0 0.00047097945935092866
mRNA O 0 0.0001085992917069234
splicing O 0 0.0003500389284454286
and O 0 0.00011879101657541469
enzyme O 0 0.0014129073824733496
activity O 0 0.0008596038678660989
. O 0 0.000744182092603296

A O 0 0.006147562526166439
novel O 0 0.003763493150472641
C O 0 0.005329426843672991
to O 0 8.902036643121392e-05
A O 0 0.0005719874752685428
mutation O 0 0.00043813264346681535
in O 0 5.2919618610758334e-05
the O 0 0.00025005656061694026
sterol O 0 0.30173659324645996
27 O 0 0.0030866325832903385
- O 0 0.009654994122684002
hydroxylase O 0 0.22121889889240265
gene O 0 0.002971747424453497
( O 0 0.0009389163460582495
CYP27 O 1 0.9636362791061401
) O 0 0.00024450354976579547
was O 0 0.00023355834127869457
identified O 0 0.00013611107715405524
by O 0 2.3955606593517587e-05
sequencing O 0 0.0006742972182109952
amplified O 0 0.0037814246024936438
CYP27 O 1 0.918355405330658
gene O 0 0.0008333089062944055
products O 0 0.0003532322880346328
from O 0 0.00010422137711429968
a O 0 0.0013562763342633843
patient O 1 0.9986110925674438
with O 0 0.0006784040597267449
cerebrotendinous B-Disease 1 0.9988647699356079
xanthomatosis I-Disease 1 0.9963536262512207
( O 0 0.0051650009118020535
CTX B-Disease 1 0.9992215633392334
) O 0 0.0011153796222060919
. O 0 0.0008097227546386421

The O 0 0.0012071916135028005
mutation O 0 0.00332098500803113
changed O 0 0.0013427396770566702
the O 0 0.0002723975630942732
adrenodoxin O 0 0.10353419929742813
cofactor O 0 0.012696093879640102
binding O 0 0.0013131614541634917
residue O 0 0.008788545615971088
362Arg O 0 0.022519590333104134
to O 0 0.00043417932465672493
362Ser O 0 0.06037977710366249
( O 0 0.001772768679074943
CGT O 1 0.9671210646629333
362Arg O 0 0.14601781964302063
to O 0 0.0013694154331460595
AGT O 1 0.9989956021308899
362Ser O 0 0.2648226022720337
) O 0 0.0003384746960364282
, O 0 0.00011109118349850178
and O 0 9.711391612654552e-05
was O 0 0.0004397289012558758
responsible O 0 0.002434687688946724
for O 0 0.0007541011436842382
deficiency O 1 0.9999426603317261
in O 0 0.00015835254453122616
the O 0 0.00039965499308891594
sterol O 1 0.912233293056488
27 O 0 0.0028255425859242678
- O 0 0.008610677905380726
hydroxylase O 0 0.04477887600660324
activity O 0 0.00041330489329993725
, O 0 0.00013230009062681347
as O 0 0.0001571839675307274
confirmed O 0 0.0004110281588509679
by O 0 2.112653965014033e-05
expression O 0 7.542291859863326e-05
of O 0 1.859400981629733e-05
mutant O 0 0.0016077574109658599
cDNA O 0 0.0014672629768028855
into O 0 0.0006054963450878859
COS O 1 0.982984185218811
- O 0 0.0035079275257885456
1 O 0 0.0007949042483232915
cells O 0 0.0024853330105543137
. O 0 0.0005427369032986462

Quantitative O 0 0.0038429161068052053
analysis O 0 0.0005884228157810867
showed O 0 0.0006997445016168058
that O 0 4.669941699830815e-05
the O 0 6.561176269315183e-05
expression O 0 0.000220134636037983
of O 0 7.534313044743612e-05
CYP27 O 1 0.6776432394981384
gene O 0 0.000431394757470116
mRNA O 0 0.00014191424997989088
in O 0 9.412488725502044e-05
the O 0 0.00037248493754304945
patient O 1 0.9950222969055176
represented O 0 0.0007307487539947033
52 O 0 0.0034870742820203304
. O 0 0.0007725331815890968

5 O 0 0.0006668897112831473
% O 0 2.7932386728934944e-05
of O 0 2.0386696633067913e-05
the O 0 0.00021599656611215323
normal O 0 0.0024610059335827827
level O 0 0.0017834234749898314
. O 0 0.0006678947829641402

As O 0 0.0004243201401550323
the O 0 0.0002792351588141173
mutation O 0 0.0017268008086830378
occurred O 0 0.000459717441117391
at O 0 0.00016005027282517403
the O 0 9.151449194177985e-05
penultimate O 0 0.002736780559644103
nucleotide O 0 0.00011576126416912302
of O 0 3.061895040445961e-05
exon O 0 0.006543218623846769
6 O 0 0.0011249203234910965
( O 0 0.000513400009367615
- O 0 0.0010021672351285815
2 O 0 0.00010148737783310935
position O 0 0.00010201131226494908
of O 0 2.337740625080187e-05
exon O 0 0.004733921494334936
6 O 0 0.0008219510782510042
- O 0 0.0023367004469037056
intron O 0 0.014366061426699162
6 O 0 0.0006540355389006436
splice O 0 0.0030990750528872013
site O 0 0.0004089440335519612
) O 0 3.704021582962014e-05
of O 0 1.232299291586969e-05
the O 0 0.0001843630598159507
gene O 0 0.0010432284325361252
, O 0 9.97653987724334e-05
we O 0 0.00015038115088827908
hypothesized O 0 0.0022658694069832563
that O 0 4.5001615944784135e-05
the O 0 0.00018801366968546063
mutation O 0 0.0021248741541057825
may O 0 0.0008998831617645919
partially O 0 0.005090816877782345
affect O 0 0.0005358090857043862
the O 0 8.253083797171712e-05
normal O 0 0.0006929903174750507
splicing O 0 0.0005455760983750224
efficiency O 0 0.0010476709576323628
in O 0 0.00014818734780419618
exon O 0 0.005387785844504833
6 O 0 0.0005989638157188892
and O 0 0.00016708156908862293
cause O 0 0.002931763418018818
alternative O 0 0.00043216958874836564
splicing O 0 0.0007777368882670999
elsewhere O 0 0.00038215325912460685
, O 0 7.070457650115713e-05
which O 0 4.038729821331799e-05
resulted O 0 0.0005564875900745392
in O 0 0.00017340121848974377
decreased O 0 0.014913695864379406
transcript O 0 0.0025061985943466425
in O 0 0.00017584883607923985
the O 0 0.0007271073409356177
patient O 1 0.99811851978302
. O 0 0.0010216321097686887

Transfection O 0 0.1714978665113449
of O 0 0.0003568899701349437
constructed O 0 0.004937542602419853
minigenes O 0 0.4161282181739807
, O 0 0.0001537228235974908
with O 0 6.633304292336106e-05
or O 0 0.00011471177276689559
without O 0 8.613763202447444e-05
the O 0 8.842112583806738e-05
mutation O 0 0.0007006360101513565
, O 0 0.00010841326002264395
into O 0 0.00042242894414812326
COS O 1 0.9855417609214783
- O 0 0.002282446948811412
1 O 0 0.00035539118107408285
cells O 0 0.0008242476615123451
confirmed O 0 0.00041822873754426837
that O 0 2.967543332488276e-05
the O 0 0.00017009170551318675
mutant O 0 0.005179333966225386
minigene O 0 0.22300417721271515
was O 0 0.00046002166345715523
responsible O 0 0.0006257660570554435
for O 0 5.0259237468708307e-05
a O 0 0.0001772380928741768
mRNA O 0 0.0002221719769295305
species O 0 0.00016085671086329967
alternatively O 0 0.0010640621185302734
spliced O 0 0.0009657844784669578
at O 0 0.00022373333922587335
an O 0 0.0003708685399033129
activated O 0 0.03863544017076492
cryptic O 0 0.013727735728025436
5 O 0 0.0005055124056525528
splice O 0 0.006075938232243061
site O 0 0.001296261791139841
88 O 0 0.0024604753125458956
bp O 0 0.012439345940947533
upstream O 0 0.00131900270935148
from O 0 5.771304131485522e-05
the O 0 9.037996642291546e-05
3 O 0 0.00019442010670900345
end O 0 0.0002568890922702849
of O 0 6.03904809395317e-05
exon O 0 0.011762136593461037
6 O 0 0.0019049575785174966
. O 0 0.0008315035956911743

Our O 0 0.0007524771499447525
data O 0 0.00016362642054446042
suggest O 0 0.00031417427817359567
that O 0 4.427047315402888e-05
the O 0 0.00017127487808465958
C O 0 0.0044905049726367
to O 0 7.596739305881783e-05
A O 0 0.0007070874562487006
mutation O 0 0.0005483517306856811
at O 0 9.996195149142295e-05
the O 0 8.224776684073731e-05
penultimate O 0 0.0029932118486613035
nucleotide O 0 9.510561358183622e-05
of O 0 3.1049490644363686e-05
exon O 0 0.0030996554996818304
6 O 0 0.000176371555426158
of O 0 1.5230960343615152e-05
the O 0 0.0002863701374735683
CYP27 O 1 0.9893484115600586
gene O 0 0.0007369372178800404
not O 0 6.1386963352561e-05
only O 0 7.576627103844658e-05
causes O 0 0.162286177277565
the O 0 0.0011625781189650297
deficiency B-Disease 1 0.9999470710754395
in I-Disease 0 0.00014064174320083112
the I-Disease 0 0.0003800384874921292
sterol I-Disease 1 0.7759187817573547
27 I-Disease 0 0.0029492052271962166
- I-Disease 0 0.008105886168777943
hydroxylase I-Disease 0 0.03902497887611389
activity I-Disease 0 0.0003842514124698937
, O 0 0.00015673332381993532
but O 0 0.00015908380737528205
also O 0 0.00021896844555158168
partially O 0 0.003830457804724574
leads O 0 0.0004349216469563544
to O 0 6.128635868662968e-05
alternative O 0 0.0003296199720352888
pre O 0 0.0011895993957296014
- O 0 0.00044742817408405244
mRNA O 0 7.456276216544211e-05
splicing O 0 0.00016153239994309843
of O 0 1.922988121805247e-05
the O 0 0.000276031787507236
gene O 0 0.0024674583692103624
. O 0 0.0006337360246106982

To O 0 0.0004316072154324502
our O 0 0.0003345919831190258
knowledge O 0 0.0006514426786452532
, O 0 9.721268725115806e-05
this O 0 3.6176661524223164e-05
is O 0 7.393918349407613e-05
the O 0 6.157339521450922e-05
first O 0 0.0001458557671867311
report O 0 0.00041801194311119616
regarding O 0 0.0003060770104639232
effects O 0 0.0014990494819357991
on O 0 0.00011868776346091181
pre O 0 0.0011248174123466015
- O 0 0.00038250937359407544
mRNA O 0 6.0160098655615e-05
splicing O 0 9.792481432668865e-05
of O 0 1.3389831110544037e-05
a O 0 0.0003236866323277354
mutation O 0 0.00080230797175318
at O 0 0.00014656566781923175
the O 0 0.00014245168131310493
- O 0 0.0010710695059970021
2 O 0 9.190173295792192e-05
position O 0 8.287792297778651e-05
of O 0 1.075595173460897e-05
a O 0 0.0004264490562491119
5 O 0 0.0005387193523347378
splice O 0 0.008492466993629932
site O 0 0.002000839915126562
. O 0 0.0006570055265910923

ATM O 0 0.0498519204556942
germline O 1 0.5811995267868042
mutations O 0 0.002996329450979829
in O 0 0.000345610169460997
classical O 0 0.006857607513666153
ataxia B-Disease 1 0.9999876022338867
- I-Disease 1 0.9995500445365906
telangiectasia I-Disease 1 0.9999195337295532
patients O 1 0.9996849298477173
in O 0 0.0002201094466727227
the O 0 0.00020351192506495863
Dutch O 0 0.0013984472025185823
population O 0 0.000271722674369812
. O 0 0.0007915941532701254

Germline O 1 0.8626381158828735
mutations O 0 0.0027463820297271013
in O 0 0.00012668652925640345
the O 0 0.00023633672390133142
ATM O 0 0.007939660921692848
gene O 0 0.0005573706584982574
are O 0 2.0282734112697653e-05
responsible O 0 0.0008123673615045846
for O 0 0.00020336161833256483
the O 0 0.004263885319232941
autosomal B-Disease 1 0.999957799911499
recessive I-Disease 1 0.9999833106994629
disorder I-Disease 1 0.9999996423721313
ataxia B-Disease 1 0.9999957084655762
- I-Disease 1 0.9989957213401794
telangiectasia I-Disease 1 0.9997851252555847
( O 0 0.009029499255120754
A B-Disease 1 0.9969878792762756
- I-Disease 1 0.9959325194358826
T I-Disease 1 0.9985443353652954
) O 0 0.0006914198747836053
. O 0 0.000668476102873683

In O 0 0.000615110038779676
our O 0 0.0005542368744499981
study O 0 0.0007755616679787636
, O 0 0.00010622668924042955
we O 0 8.376542245969176e-05
have O 0 3.9249349356396124e-05
determined O 0 0.00021506565099116415
the O 0 5.8474317484069616e-05
ATM O 0 0.0021148782689124346
mutation O 0 0.000656132644508034
spectrum O 0 0.0006613213918171823
in O 0 8.677517325850204e-05
19 O 0 0.0003266723651904613
classical O 0 0.0005066888406872749
A B-Disease 1 0.9985023736953735
- I-Disease 1 0.9996558427810669
T I-Disease 1 0.9999783039093018
patients O 1 0.9997801184654236
, O 0 8.461643301416188e-05
including O 0 3.2429536076961085e-05
some O 0 7.258942787302658e-05
immigrant O 0 0.0005416418425738811
populations O 0 0.00036072017974220216
, O 0 9.284017141908407e-05
as O 0 5.465318827191368e-05
well O 0 6.346957525238395e-05
as O 0 7.627924787811935e-05
12 O 0 0.0001081107766367495
of O 0 1.7174972526845522e-05
Dutch O 0 0.0005118869594298303
ethnic O 0 0.00013028176908846945
origin O 0 0.00024564945488236845
. O 0 0.0008040782413445413

Both O 0 0.0001846100203692913
the O 0 0.00012208527186885476
protein O 0 0.0006271818419918418
truncation O 0 0.007052880246192217
test O 0 0.0015851364005357027
( O 0 0.0006313914782367647
PTT O 0 0.028185078874230385
) O 0 9.761826368048787e-05
and O 0 2.8649656087509356e-05
the O 0 6.885828042868525e-05
restriction O 0 0.0007191154290921986
endonuclease O 0 0.06489580869674683
fingerprinting O 0 0.008508864790201187
( O 0 0.0013323455350473523
REF O 1 0.5749468803405762
) O 0 8.971157512860373e-05
method O 0 5.729763870476745e-05
were O 0 1.5196576896414626e-05
used O 0 4.986210115021095e-05
and O 0 4.3010808440158144e-05
compared O 0 0.0001837148447521031
for O 0 4.616850128513761e-05
their O 0 5.481551852426492e-05
detection O 0 0.0032889610156416893
efficiency O 0 0.0018690010765567422
, O 0 0.00019554469326976687
identifying O 0 0.0023319951724261045
76 O 0 0.0015681918011978269
% O 0 3.161512722726911e-05
and O 0 5.3724899771623313e-05
60 O 0 0.00013277768448460847
% O 0 1.16905839604442e-05
of O 0 1.4298465430329088e-05
the O 0 0.00022646891011390835
mutations O 0 0.0013355165719985962
, O 0 0.00016626548313070089
respectively O 0 0.0006589972181245685
. O 0 0.0006432617665268481

Most O 0 0.0055745248682796955
patients O 1 0.9994128942489624
were O 0 7.995003397809342e-05
found O 0 0.00014453910989686847
to O 0 6.585302617168054e-05
be O 0 0.0001579071395099163
compound O 0 0.004769827704876661
heterozygote O 0 0.047437913715839386
. O 0 0.0011939023388549685

Seventeen O 0 0.006965108215808868
mutations O 0 0.00161844864487648
were O 0 3.828719491139054e-05
distinct O 0 0.00015252831508405507
, O 0 3.730448224814609e-05
of O 0 9.016462172439788e-06
which O 0 4.207179517834447e-05
10 O 0 9.158103057416156e-05
were O 0 2.8805481633753516e-05
not O 0 0.00015091295063029975
reported O 0 0.0014314687578007579
previously O 0 0.0008693483541719615
. O 0 0.0006103424238972366

Mutations O 0 0.004996245726943016
are O 0 5.63240610063076e-05
small O 0 0.00027020752895623446
deletions O 0 0.0020782602950930595
or O 0 0.0002859148371499032
point O 0 0.0008339605992659926
mutations O 0 0.002318988787010312
frequently O 0 0.0011858652578666806
affecting O 0 0.00660753482952714
splice O 0 0.013514362275600433
sites O 0 0.0011264989152550697
. O 0 0.001135244034230709

Moreover O 0 0.006192602217197418
, O 0 0.00037974969018250704
a O 0 0.0008125268504954875
16 O 0 0.0010846953373402357
. O 0 0.0006844980525784194

7 O 0 0.004698989912867546
- O 0 0.0059938314370810986
kb O 0 0.006564299110323191
genomic O 0 0.0010492696892470121
deletion O 0 0.0008201016462408006
of O 0 1.692609475867357e-05
the O 0 0.00010405335342511535
3 O 0 0.0002241516049252823
end O 0 0.0001347964716842398
of O 0 1.2315239473537076e-05
the O 0 0.00018574181012809277
gene O 0 0.0009346811566501856
, O 0 8.784828969510272e-05
most O 0 0.000107479230791796
likely O 0 0.00026535597862675786
a O 0 0.00012114073615521193
result O 0 8.577402331866324e-05
of O 0 1.600009090907406e-05
recombination O 0 0.0005287151434458792
between O 0 7.530052971560508e-05
two O 0 6.300336826825514e-05
LINE O 0 0.0011415351182222366
elements O 0 0.00014454557094722986
, O 0 0.0002264488284708932
was O 0 0.0009256749763153493
identified O 0 0.0009238519705832005
. O 0 0.0005867399740964174

The O 0 0.0005523082800209522
most O 0 0.00030509926727972925
frequently O 0 0.0010451150592416525
found O 0 0.0004160363750997931
mutation O 0 0.0010966314002871513
, O 0 0.00012594553118105978
identified O 0 0.00020390661666169763
in O 0 3.788664616877213e-05
three O 0 7.734396058367565e-05
unrelated O 0 0.0026796343736350536
Turkish O 0 0.004540168680250645
A B-Disease 1 0.9947415590286255
- I-Disease 1 0.9963184595108032
T I-Disease 1 0.9995877146720886
individuals O 0 0.00025630806339904666
, O 0 0.00016128583229146898
was O 0 0.00039259716868400574
previously O 0 0.00034808850614354014
described O 0 0.0003276804636698216
to O 0 3.2281979656545445e-05
be O 0 2.9752620321232826e-05
a O 0 0.00021952866518404335
Turkish O 0 0.00173973198980093
A B-Disease 1 0.9492347836494446
- I-Disease 1 0.9936277866363525
T I-Disease 1 0.9991453886032104
founder O 0 0.02256316877901554
mutation O 0 0.004416811745613813
. O 0 0.0009510321542620659

The O 0 0.0003367417957633734
presence O 0 0.0003508129739202559
of O 0 4.7346529754577205e-05
a O 0 0.0014746616361662745
founder O 0 0.03189771994948387
mutation O 0 0.0015018755802884698
among O 0 9.090999810723588e-05
relatively O 0 0.0003645337710622698
small O 0 9.66482111834921e-05
ethnic O 0 6.051222590031102e-05
population O 0 5.343626980902627e-05
groups O 0 5.703433998860419e-05
in O 0 0.00017531943740323186
Western O 0 0.0007535255281254649
Europe O 0 0.000916697084903717
could O 0 0.0003155040030833334
indicate O 0 0.00041886133840307593
a O 0 0.00040007109055295587
high O 0 0.001479641068726778
carrier O 0 0.0034952987916767597
frequency O 0 0.00014768968685530126
in O 0 5.9043002693215385e-05
such O 0 7.379154703812674e-05
communities O 0 0.0008118341211229563
. O 0 0.0007526742992922664

In O 0 0.002774737775325775
patients O 1 0.9956656098365784
of O 0 4.525780968833715e-05
Dutch O 0 0.0006511167157441378
ethnic O 0 0.00010205149737885222
origin O 0 9.70563487499021e-05
, O 0 0.00015663546219002455
however O 0 0.00017521984409540892
, O 0 0.00010466176900081336
no O 0 0.00012182826321804896
significant O 0 0.0005006585852243006
founder O 0 0.007827041670680046
effect O 0 0.0007785020279698074
could O 0 0.0002489793405402452
be O 0 0.00014113345241639763
identified O 0 0.0007374039851129055
. O 0 0.00037979273474775255

The O 0 0.0008898201049305499
observed O 0 0.0011559438426047564
genetic O 0 0.0012011450016871095
heterogeneity O 0 0.002605769084766507
including O 0 6.238601781660691e-05
the O 0 0.00010212187771685421
relative O 0 0.0003098078304901719
high O 0 0.0003966806980315596
percentage O 0 0.00016645471623633057
of O 0 4.333432298153639e-05
splice O 0 0.04221031442284584
- O 0 0.01293489895761013
site O 0 0.001008654828183353
mutations O 0 0.0010458973702043295
had O 0 0.0002032443298958242
no O 0 0.00010214671783614904
reflection O 0 0.0016927318647503853
on O 0 0.00015669476124458015
the O 0 0.0005340526695363224
phenotype O 0 0.3123128116130829
. O 0 0.000910125789232552

All O 0 0.0014135115779936314
patients O 1 0.9983731508255005
manifested O 0 0.0763983279466629
classical O 0 0.00143378262873739
A B-Disease 1 0.996238112449646
- I-Disease 1 0.9952393770217896
T I-Disease 1 0.9992080330848694
and O 0 0.00011280943726887926
increased O 0 0.0005541105638258159
cellular O 0 0.0026083183474838734
radioresistant O 0 0.048487551510334015
DNA O 0 0.0009867016924545169
synthesis O 0 0.0014901806134730577
. O 0 0.0008431579335592687

Determination O 0 0.0033455449156463146
of O 0 3.342231138958596e-05
the O 0 0.00013610445603262633
genomic O 0 0.0007306297193281353
structure O 0 0.0003729873860720545
of O 0 3.148740506730974e-05
the O 0 0.0004715302202384919
COL4A4 O 1 0.994222104549408
gene O 0 0.0006176196038722992
and O 0 3.598877810873091e-05
of O 0 4.3322881538188085e-05
novel O 0 0.009345196187496185
mutations O 0 0.04481147602200508
causing O 1 0.9957770109176636
autosomal B-Disease 1 0.999523401260376
recessive I-Disease 1 0.9999308586120605
Alport I-Disease 1 0.9999926090240479
syndrome I-Disease 1 0.9999983310699463
. O 0 0.006414676550775766

Autosomal B-Disease 1 0.9987414479255676
recessive I-Disease 1 0.9995575547218323
Alport I-Disease 1 0.9999735355377197
syndrome I-Disease 1 0.999992847442627
is O 0 0.0020644119940698147
a O 0 0.004153309855610132
progressive O 1 0.9911453127861023
hematuric B-Disease 1 0.9988307356834412
glomerulonephritis I-Disease 1 0.9998887777328491
characterized O 1 0.9870409965515137
by O 0 0.0017101183766499162
glomerular B-Disease 1 0.999783456325531
basement I-Disease 1 0.9951747059822083
membrane I-Disease 0 0.4183643162250519
abnormalities I-Disease 1 0.9982530474662781
and O 0 0.0001669576740823686
associated O 0 0.0002487050660420209
with O 0 9.179628250421956e-05
mutations O 0 0.000627748086117208
in O 0 7.711727812420577e-05
either O 0 0.0001868766121333465
the O 0 0.00034023920306935906
COL4A3 O 1 0.9934009909629822
or O 0 0.00032211298821493983
the O 0 0.0004495727189350873
COL4A4 O 1 0.98728346824646
gene O 0 0.0008230597013607621
, O 0 4.120830635656603e-05
which O 0 1.786008579074405e-05
encode O 0 0.0001509825960965827
the O 0 0.00015950639499351382
alpha3 O 0 0.10657767951488495
and O 0 0.00037662009708583355
alpha4 O 1 0.9565280079841614
type O 1 0.8259756565093994
IV O 1 0.9994358420372009
collagen O 1 0.9991975426673889
chains O 0 0.008792135864496231
, O 0 0.00040532968705520034
respectively O 0 0.0014517370145767927
. O 0 0.0009527084766887128

To O 0 0.0005575706600211561
date O 0 0.0004541981325019151
, O 0 0.00024389005557168275
mutation O 0 0.0013416997389867902
screening O 0 0.0010656816884875298
in O 0 5.346022226149216e-05
the O 0 6.397087418008596e-05
two O 0 6.020274304319173e-05
genes O 0 0.0003985165385529399
has O 0 0.000553388032130897
been O 0 0.0005353573360480368
hampered O 1 0.9722735285758972
by O 0 6.250565638765693e-05
the O 0 8.08669428806752e-05
lack O 0 0.0004770439409185201
of O 0 2.68227668129839e-05
genomic O 0 0.001193757401779294
structure O 0 0.001108048134483397
information O 0 0.0004960874211974442
. O 0 0.0007320236181840301

We O 0 0.0011674066772684455
report O 0 0.0006308699958026409
here O 0 0.00010428977111587301
the O 0 9.574366413289681e-05
complete O 0 0.00038245937321335077
characterization O 0 0.0014785644598305225
of O 0 2.0987517928006127e-05
the O 0 0.00010772229870781302
48 O 0 0.0004821915354114026
exons O 0 0.0005709422985091805
of O 0 2.2038064344087616e-05
the O 0 0.00035073072649538517
COL4A4 O 1 0.9896067976951599
gene O 0 0.0008220436284318566
, O 0 0.0001011748900054954
a O 0 0.00048275882727466524
comprehensive O 0 0.010685548186302185
gene O 0 0.0013270974159240723
screen O 0 0.0006396060925908387
, O 0 7.563596591353416e-05
and O 0 3.543969796737656e-05
the O 0 6.872694211779162e-05
subsequent O 0 0.00025351892691105604
detection O 0 0.0006989793037064373
of O 0 1.6833631889312528e-05
10 O 0 0.00020219017460476607
novel O 0 0.0007560421945527196
mutations O 0 0.0007304928731173277
in O 0 0.0001881008065538481
eight O 0 0.021844182163476944
patients O 1 0.999996542930603
diagnosed O 1 0.9999985694885254
with O 0 0.026659199967980385
autosomal B-Disease 1 0.9999016523361206
recessive I-Disease 1 0.9999723434448242
Alport I-Disease 1 0.9999974966049194
syndrome I-Disease 1 0.9999985694885254
. O 0 0.006789745297282934

Furthermore O 0 0.006703612394630909
, O 0 0.00034577195765450597
we O 0 0.00021404218568932265
identified O 0 0.00036989504587836564
a O 0 0.00033928026095964015
glycine O 0 0.00170604488812387
to O 0 0.00011086820450145751
alanine O 0 0.003751250682398677
substitution O 0 0.0003626284305937588
in O 0 0.0001143181070801802
the O 0 0.0003948994562961161
collagenous O 1 0.9782504439353943
domain O 0 0.0007323235622607172
that O 0 0.00015930132940411568
is O 0 0.00038609933108091354
apparently O 0 0.002174963941797614
silent O 0 0.0021859081462025642
in O 0 7.051549619063735e-05
the O 0 0.00021153652050998062
heterozygous O 0 0.002608975861221552
carriers O 0 0.002915421035140753
, O 0 0.0001001441924017854
in O 0 0.00016987175331451
11 O 0 0.0010257931426167488
. O 0 0.0004491687286645174

5 O 0 0.0006719117518514395
% O 0 3.35376025759615e-05
of O 0 1.8104767150362022e-05
all O 0 6.821074930485338e-05
control O 0 0.0009594598086550832
individuals O 0 0.00019305369642097503
, O 0 0.0001074833344318904
and O 0 6.731404573656619e-05
in O 0 7.216289668576792e-05
one O 0 6.105646752985194e-05
control O 0 0.00037589232670143247
individual O 0 0.00014906116120982915
homozygous O 0 0.0006818264373578131
for O 0 4.3200932850595564e-05
this O 0 6.781925912946463e-05
glycine O 0 0.003058138070628047
substitution O 0 0.0011096843518316746
. O 0 0.000967003928963095

There O 0 0.0010134624317288399
has O 0 0.0006218478083610535
been O 0 0.0001525900006527081
no O 0 6.533074338221923e-05
previous O 0 0.00010130657028639689
finding O 0 0.0001504544634371996
of O 0 1.4817383089393843e-05
a O 0 0.0002954502124339342
glycine O 0 0.0017550912452861667
substitution O 0 0.0003305340651422739
that O 0 6.56509364489466e-05
is O 0 0.00014937279047444463
not O 0 7.9752215242479e-05
associated O 0 0.00010566287528490648
with O 0 4.8876419896259904e-05
any O 0 0.00015473179519176483
obvious O 0 0.009148553013801575
phenotype O 0 0.3062170445919037
in O 0 0.00027011195197701454
homozygous O 0 0.003413946833461523
individuals O 0 0.0005708623211830854
. O 0 0.0009403370786458254

Founder O 1 0.6689255833625793
BRCA1 O 1 0.9920303821563721
and O 0 0.0011467017466202378
BRCA2 O 1 0.988303542137146
mutations O 0 0.0015466404147446156
in O 0 0.0001611413317732513
French O 0 0.006225834134966135
Canadian O 1 0.8053619265556335
breast B-Disease 1 0.9999957084655762
and I-Disease 1 0.9924136996269226
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999990463256836
families O 0 0.0029415872413665056
. O 0 0.0012165559455752373

We O 0 0.0007135636988095939
have O 0 0.00010917223698925227
identified O 0 0.00019487016834318638
four O 0 4.7679692215751857e-05
mutations O 0 0.0001677584514254704
in O 0 1.3084661986795254e-05
each O 0 1.1645128324744292e-05
of O 0 2.5320476197521202e-05
the O 0 0.01576346904039383
breast B-Disease 1 0.9999984502792358
cancer I-Disease 1 0.9999969005584717
- O 0 0.4929364323616028
susceptibility O 0 0.3728678524494171
genes O 0 0.0007621953845955431
, O 0 0.000634215772151947
BRCA1 O 1 0.9970689415931702
and O 0 0.0006039723521098495
BRCA2 O 1 0.9955875873565674
, O 0 0.00011359169002389535
in O 0 0.00014180713333189487
French O 0 0.0037269792519509792
Canadian O 1 0.9177308678627014
breast B-Disease 1 0.9999983310699463
cancer I-Disease 1 0.999997615814209
and O 1 0.9137652516365051
breast B-Disease 1 0.9999995231628418
/ I-Disease 1 0.9999772310256958
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999986886978149
families O 0 0.0011434467742219567
from O 0 0.0003589114057831466
Quebec O 0 0.1068926751613617
. O 0 0.000973571150097996

To O 0 0.0011507559102028608
identify O 0 0.0038123673293739557
founder O 0 0.025579767301678658
effects O 0 0.008473352529108524
, O 0 0.0002478129754308611
we O 0 0.00023007461277302355
examined O 0 0.002991174580529332
independently O 0 0.0003552279085852206
ascertained O 0 0.007007858715951443
French O 0 0.0030931190121918917
Canadian O 0 0.329021155834198
cancer B-Disease 1 0.9999773502349854
families O 0 0.00020191736984997988
for O 0 4.624635766958818e-05
the O 0 3.543733328115195e-05
distribution O 0 5.2657542255474254e-05
of O 0 1.1003335202985909e-05
these O 0 3.711843237397261e-05
eight O 0 0.00031637141364626586
mutations O 0 0.0023454853799194098
. O 0 0.0005222135805524886

Mutations O 0 0.004722536541521549
were O 0 8.722773782210425e-05
found O 0 0.00015119381714612246
in O 0 9.251601295545697e-05
41 O 0 0.00044172341586090624
of O 0 4.835726213059388e-05
97 O 0 0.00439391890540719
families O 0 0.0008469054009765387
. O 0 0.0010144091211259365

Six O 0 0.0004496622714214027
of O 0 4.467988037504256e-05
eight O 0 0.00032375360024161637
mutations O 0 0.000652249320410192
were O 0 2.6031550078187138e-05
observed O 0 0.00020232168026268482
at O 0 0.00020173646043986082
least O 0 0.00028917219606228173
twice O 0 0.001626225421205163
. O 0 0.0005884503480046988

The O 0 0.005331441294401884
BRCA1 O 1 0.9910734295845032
C4446T O 0 0.17032518982887268
mutation O 0 0.002743133809417486
was O 0 0.00033978474675677717
the O 0 8.609460928710178e-05
most O 0 0.00011067005107179284
common O 0 0.0008774657035246491
mutation O 0 0.0019153356552124023
found O 0 0.00018225186795461923
, O 0 7.964550604810938e-05
followed O 0 0.00017200414731632918
by O 0 0.00010440946789458394
the O 0 0.0010537303751334548
BRCA2 O 1 0.9978935122489929
8765delAG O 0 0.40422698855400085
mutation O 0 0.005853062029927969
. O 0 0.0008927924791350961

Together O 0 0.0005357480840757489
, O 0 0.00015934312250465155
these O 0 5.3627751185558736e-05
mutations O 0 0.0006094459677115083
were O 0 2.410973684163764e-05
found O 0 9.325604332843795e-05
in O 0 5.5685697589069605e-05
28 O 0 0.00020834701717831194
of O 0 2.0691306417575106e-05
41 O 0 0.0012067005736753345
families O 0 0.00022876152070239186
identified O 0 0.0003283547412138432
to O 0 4.4802545744460076e-05
have O 0 7.031620043562725e-05
a O 0 0.0004890304408036172
mutation O 0 0.002050616778433323
. O 0 0.0004888705443590879

The O 0 0.0009258986101485789
odds O 0 0.003102605463936925
of O 0 3.642684532678686e-05
detection O 0 0.0007236110977828503
of O 0 7.055552487145178e-06
any O 0 2.1346864741644822e-05
of O 0 8.50076958158752e-06
the O 0 0.00012792620691470802
four O 0 0.00033388458541594446
BRCA1 O 1 0.9959994554519653
mutations O 0 0.0018110962118953466
was O 0 0.0006921985186636448
18 O 0 0.0006940597086213529
. O 0 0.0006514643901027739

7x O 1 0.974469780921936
greater O 0 0.0009005349711515009
if O 0 0.00021175728761591017
one O 0 5.2664323447970673e-05
or O 0 6.959353777347133e-05
more O 0 7.903479126980528e-05
cases O 0 0.0034050759859383106
of O 0 0.004586503375321627
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.999998927116394
were O 0 6.497368303826079e-05
also O 0 9.081901953322813e-05
present O 0 7.319988799281418e-05
in O 0 8.375966717721894e-05
the O 0 0.00027322262758389115
family O 0 0.001448306953534484
. O 0 0.0008204318583011627

The O 0 0.0006734738126397133
odds O 0 0.0023436229676008224
of O 0 3.6717749026138335e-05
detection O 0 0.0007641721749678254
of O 0 1.084519135474693e-05
any O 0 2.4183676941902377e-05
of O 0 1.4489512977888808e-05
the O 0 0.00021039642160758376
four O 0 0.000805137911811471
BRCA2 O 1 0.9934288859367371
mutations O 0 0.0022389402147382498
was O 0 0.0007540120859630406
5 O 0 0.0010741767473518848
. O 0 0.0007232401985675097

3x O 1 0.6126331686973572
greater O 0 0.001168865361250937
if O 0 0.00021975925483275205
there O 0 2.899249921028968e-05
were O 0 1.118876662076218e-05
at O 0 5.824958498124033e-05
least O 0 4.9778242100728676e-05
five O 0 6.0368543927324936e-05
cases O 0 0.0008828775025904179
of O 0 0.00043818235280923545
breast B-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999955892562866
in O 0 0.00021754794579464942
the O 0 0.0003970762772951275
family O 0 0.0024879174306988716
. O 0 0.0009006208274513483

Interestingly O 0 0.009939064271748066
, O 0 0.00010949782154057175
the O 0 4.782792166224681e-05
presence O 0 0.0001527795393485576
of O 0 4.6920871682232246e-05
a O 1 0.7699088454246521
breast B-Disease 1 0.9999972581863403
cancer I-Disease 1 0.999992847442627
case O 0 0.010755437426269054
< O 0 0.0381917767226696
36 O 0 0.0004261948342900723
years O 0 0.0001522144884802401
of O 0 2.998379204655066e-05
age O 0 0.0007340823067352176
was O 0 0.0005816646153107285
strongly O 0 0.0005924024735577404
predictive O 0 0.0010718461126089096
of O 0 1.4601931979996152e-05
the O 0 5.833425166201778e-05
presence O 0 9.972982661565766e-05
of O 0 6.265117463044589e-06
any O 0 2.1069357899250463e-05
of O 0 7.201218068075832e-06
the O 0 0.0001394168211845681
eight O 0 0.000511840102262795
mutations O 0 0.0027701212093234062
screened O 0 0.004920884966850281
. O 0 0.0007811542600393295

Carriers O 0 0.005915859714150429
of O 0 3.8138659874675795e-05
the O 0 0.0001644334552111104
same O 0 0.0002574545214883983
mutation O 0 0.0014624085742980242
, O 0 8.438227087026462e-05
from O 0 4.2572253732942045e-05
different O 0 2.556546314735897e-05
families O 0 0.00019847770454362035
, O 0 0.00010789922816911712
shared O 0 0.00034908982343040407
similar O 0 0.0006404026644304395
haplotypes O 0 0.008654111996293068
, O 0 0.00018964924674946815
indicating O 0 0.0008482677512802184
that O 0 5.4519256082130596e-05
the O 0 0.0001817673328332603
mutant O 0 0.003351654391735792
alleles O 0 0.0012118025915697217
were O 0 6.278140062931925e-05
likely O 0 0.00029278211877681315
to O 0 3.508981899358332e-05
be O 0 2.845610652002506e-05
identical O 0 8.411370072280988e-05
by O 0 2.9709581212955527e-05
descent O 0 0.00024483338347636163
for O 0 7.612388435518369e-05
a O 0 0.00034757982939481735
mutation O 0 0.0007940601208247244
in O 0 7.620625547133386e-05
the O 0 0.00027504589525051415
founder O 0 0.00544133922085166
population O 0 0.00031364962342195213
. O 0 0.0006534704007208347

The O 0 0.00027287661214359105
identification O 0 0.0002921681443694979
of O 0 8.4250008512754e-05
common O 0 0.038711417466402054
BRCA1 O 1 0.9992749094963074
and O 0 0.0016675313236191869
BRCA2 O 1 0.9979717135429382
mutations O 0 0.0015528823714703321
will O 0 0.0001089653669623658
facilitate O 0 0.0008591869845986366
carrier O 0 0.00614118529483676
detection O 0 0.0014352730941027403
in O 0 0.0001415863516740501
French O 0 0.003032147651538253
Canadian O 1 0.8376302123069763
breast B-Disease 1 0.9999970197677612
cancer I-Disease 1 0.9999986886978149
and O 1 0.9550607204437256
breast B-Disease 1 0.9999996423721313
/ I-Disease 1 0.9999829530715942
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.999998927116394
families O 0 0.004525150638073683
. O 0 0.0011671297252178192

Are O 0 0.0007339934236370027
Dp71 O 0 0.1805262416601181
and O 0 0.000886033580172807
Dp140 O 1 0.9630911946296692
brain O 1 0.9986016154289246
dystrophin O 1 0.9862375259399414
isoforms O 0 0.002244849456474185
related O 0 0.0011175153777003288
to O 0 0.00044663946027867496
cognitive B-Disease 1 0.9936420321464539
impairment I-Disease 1 0.9998987913131714
in O 0 0.1290489137172699
Duchenne B-Disease 1 0.9999974966049194
muscular I-Disease 1 0.9999923706054688
dystrophy I-Disease 1 0.9999959468841553
? O 1 0.9782166481018066

Molecular O 0 0.00893250759691
study O 0 0.0014526662416756153
and O 0 0.00029358212486840785
neuropsychological O 0 0.15615801513195038
analysis O 0 0.00017749024846125394
were O 0 3.164490408380516e-05
performed O 0 0.0002781317161861807
concurrently O 0 0.000669352593831718
on O 0 0.0003008009516634047
49 O 0 0.009662127122282982
patients O 1 0.9997588992118835
with O 0 0.011076201684772968
Duchenne B-Disease 1 0.9999948740005493
muscular I-Disease 1 0.9999957084655762
dystrophy I-Disease 1 0.9999986886978149
( O 1 0.9483093619346619
DMD B-Disease 1 0.9999895095825195
) O 0 0.00045146013144403696
in O 0 8.191252709366381e-05
order O 0 9.633896115701646e-05
to O 0 7.163824193412438e-05
find O 0 0.00032058850047178566
a O 0 0.00029781789635308087
molecular O 0 0.0007161347311921418
explanation O 0 0.0004249313788022846
for O 0 6.538689922308549e-05
the O 0 0.0003085818898398429
cognitive B-Disease 1 0.9941964149475098
impairment I-Disease 1 0.9997971653938293
observed O 0 0.0007041569333523512
in O 0 0.0004301952139940113
most O 0 0.05156774818897247
DMD B-Disease 1 0.9999963045120239
patients O 1 0.999862790107727
. O 0 0.0013652438065037131

Complete O 0 0.0011368877021595836
analysis O 0 0.00018064476898871362
of O 0 4.4543099647853523e-05
the O 0 0.0007616879884153605
dystrophin O 1 0.9962484240531921
gene O 0 0.002486833604052663
was O 0 0.0004780269809998572
performed O 0 0.000317302969051525
to O 0 5.033862908021547e-05
define O 0 0.00039112966624088585
the O 0 7.743413880234584e-05
localization O 0 0.0010146115673705935
of O 0 4.098894351045601e-05
deletions O 0 0.0017733535496518016
and O 0 0.00015580235049128532
duplications O 0 0.003422351088374853
in O 0 0.0001022233918774873
relation O 0 0.000376156676793471
to O 0 7.60988550609909e-05
the O 0 0.0001948434073710814
different O 0 0.0005788810085505247
DMD B-Disease 1 0.9999573230743408
promoters O 0 0.12974481284618378
. O 0 0.0017510466277599335

Qualitative O 0 0.002423713682219386
analysis O 0 0.0001902200747281313
of O 0 4.288097989046946e-05
the O 0 0.0006266153650358319
Dp71 O 1 0.6906218528747559
transcript O 0 0.00330400955863297
and O 0 0.00013213582860771567
testing O 0 0.0007367334910668433
for O 0 3.8367201341316104e-05
the O 0 4.388008528621867e-05
specific O 0 7.316973642446101e-05
first O 0 0.00011627825006144121
exon O 0 0.002593724988400936
of O 0 5.997828338877298e-05
Dp140 O 0 0.008049425669014454
were O 0 3.9478189137298614e-05
also O 0 0.00010140669473912567
carried O 0 0.00022411745158024132
out O 0 0.00022491889831144363
. O 0 0.00046812029904685915

Neuropsychological O 0 0.4731213450431824
analysis O 0 0.0015445682220160961
assessed O 0 0.009506241418421268
verbal O 0 0.008626967668533325
and O 0 0.0007493257289752364
visuospatial O 1 0.9949610233306885
intelligence O 0 0.006542989052832127
, O 0 0.00047285264008678496
verbal O 0 0.00800090841948986
memory O 0 0.014497427269816399
, O 0 0.00019011851691175252
and O 0 0.00012805812002625316
reading O 0 0.00240473379381001
skills O 0 0.014925463125109673
. O 0 0.0010365473572164774

Comparison O 0 0.001350041595287621
of O 0 6.6791006247513e-05
molecular O 0 0.0017948612803593278
and O 0 0.00031005838536657393
psychometric O 1 0.9191572666168213
findings O 0 0.003962548449635506
demonstrated O 0 0.00176258257124573
that O 0 0.00010984124673996121
deletions O 0 0.0012138114543631673
and O 0 9.500463056610897e-05
duplications O 0 0.0026951225008815527
that O 0 5.2438259444897994e-05
were O 0 2.587705421319697e-05
localized O 0 0.003078014124184847
in O 0 8.056398655753583e-05
the O 0 0.00025875383289530873
distal O 1 0.9749889373779297
part O 0 0.00024650865816511214
of O 0 2.4672359359101392e-05
the O 0 0.00023823986703064293
gene O 0 0.0014338428154587746
seemed O 0 0.0010424148058518767
to O 0 4.9775630031945184e-05
be O 0 7.516321784351021e-05
preferentially O 0 0.0019557152409106493
associated O 0 0.0002980058779940009
with O 0 0.00028448840021155775
cognitive B-Disease 1 0.996574878692627
impairment I-Disease 1 0.9996969699859619
. O 0 0.0015078196302056313

Two O 0 0.0007777714054100215
altered O 0 0.006397468503564596
Dp71 O 0 0.02821582928299904
transcripts O 0 0.0005601941957138479
and O 0 5.2250274165999144e-05
two O 0 7.200053369160742e-05
deleted O 0 0.0013632039772346616
Dp140 O 0 0.003808403853327036
DNA O 0 0.00017422523524146527
sequences O 0 2.8882337574032135e-05
were O 0 1.3760455658484716e-05
found O 0 7.218436076072976e-05
in O 0 9.064476762432605e-05
four O 0 0.0005819282960146666
patients O 1 0.9999504089355469
with O 0 0.01589364744722843
severe O 1 0.9999959468841553
cerebral B-Disease 1 0.9999984502792358
dysfunction I-Disease 1 0.9999668598175049
. O 0 0.0036675850860774517

These O 0 0.0004569379088934511
findings O 0 0.002152584260329604
suggest O 0 0.0004153325571678579
that O 0 3.33532843797002e-05
some O 0 2.4787803340586834e-05
sequences O 0 7.896579336374998e-05
located O 0 0.00021689159621018916
in O 0 6.869786011520773e-05
the O 0 0.00022771563089918345
distal O 1 0.8224450945854187
part O 0 0.00026756367878988385
of O 0 2.2135649487609044e-05
the O 0 0.0002095787349389866
gene O 0 0.0008866311400197446
and O 0 7.28688610251993e-05
, O 0 6.872281664982438e-05
in O 0 5.565176979871467e-05
particular O 0 0.00017974824004340917
, O 0 0.00018127213115803897
some O 0 0.00039113208185881376
DMD B-Disease 1 0.9996539354324341
isoforms O 0 0.0008987786713987589
expressed O 0 0.00036103063030168414
in O 0 0.00012754702765960246
the O 0 0.0014195158146321774
brain O 1 0.9999172687530518
may O 0 0.0008776045287959278
be O 0 5.009683809475973e-05
related O 0 0.0002084308653138578
to O 0 4.8581619921606034e-05
the O 0 0.0003143843205180019
cognitive B-Disease 1 0.9974344372749329
impairment I-Disease 1 0.9999172687530518
associated O 0 0.0020444628316909075
with O 0 0.0028064646758139133
DMD B-Disease 1 0.9999842643737793
. O 0 0.0007459507323801517
. O 0 0.0008609145297668874

I1307K O 1 0.5299041271209717
APC O 1 0.9179656505584717
and O 0 0.0009535443969070911
hMLH1 O 0 0.02533440850675106
mutations O 0 0.0009004458552226424
in O 0 9.728595614433289e-05
a O 0 0.0004358490405138582
non O 0 0.001542415702715516
- O 0 0.0025933317374438047
Jewish O 0 0.00026421190705150366
family O 0 0.00037780930870212615
with O 0 0.0003100037283729762
hereditary B-Disease 1 0.9974539875984192
non I-Disease 1 0.9926276803016663
- I-Disease 1 0.9998123049736023
polyposis I-Disease 1 0.9999958276748657
colorectal I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999971389770508
. O 0 0.0025054430589079857

We O 0 0.000770058308262378
describe O 0 0.0009927137289196253
a O 0 0.0006053353426977992
French O 0 0.0015798009699210525
Canadian O 0 0.004084555432200432
hereditary B-Disease 1 0.9964867830276489
non I-Disease 1 0.9933011531829834
- I-Disease 1 0.99986732006073
polyposis I-Disease 1 0.9999986886978149
colorectal I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999988079071045
( O 0 0.4176923632621765
HNPCC B-Disease 1 0.9998561143875122
) O 0 0.0012077050050720572
kindred O 1 0.955525815486908
which O 0 0.00015616601740475744
carries O 0 0.0009213778539560735
a O 0 0.0006537681329064071
novel O 0 0.0025220359675586224
truncating O 0 0.4840099811553955
mutation O 0 0.002997665898874402
in O 0 0.0004739882715512067
hMLH1 O 1 0.5445117354393005
. O 0 0.0012502606259658933

Interestingly O 0 0.01658625528216362
, O 0 0.00035502121318131685
the O 0 0.0004383918712846935
I1307K O 0 0.19482757151126862
APC O 1 0.9035991430282593
polymorphism O 0 0.0013997142668813467
, O 0 0.00013464721268974245
associated O 0 0.00010514262976357713
with O 0 2.408291766187176e-05
an O 0 9.766119910636917e-05
increased O 0 0.0011911834590137005
risk O 1 0.9764429926872253
of O 0 0.008442070335149765
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
, O 0 0.000338141864631325
is O 0 0.00016092283476609737
also O 0 6.318308442132547e-05
present O 0 5.730419798055664e-05
in O 0 6.155919982120395e-05
this O 0 8.610264922026545e-05
family O 0 0.00092330202460289
. O 0 0.0007383374031633139

The O 0 0.0013513267040252686
I1307K O 0 0.020043393597006798
polymorphism O 0 0.0025759718846529722
has O 0 0.00047541470848955214
previously O 0 0.0003962241462431848
only O 0 6.024133472237736e-05
been O 0 0.00015708582941442728
identified O 0 0.00016441279149148613
in O 0 3.44913023582194e-05
individuals O 0 6.237073830561712e-05
of O 0 5.032350600231439e-05
self O 0 0.46920183300971985
- O 0 0.3858720362186432
reported O 0 0.00415684562176466
Ashkenazi O 0 0.022204086184501648
Jewish O 0 0.0009792596101760864
origins O 0 0.0027145887725055218
. O 0 0.0012477468699216843

In O 0 0.0006143369828350842
addition O 0 0.00032681194716133177
, O 0 0.00012193413567729294
in O 0 8.426905696978793e-05
this O 0 8.803420496406034e-05
family O 0 0.000646296888589859
, O 0 0.00015323971456382424
there O 0 0.00012082981993444264
appears O 0 0.0012540987227112055
to O 0 6.44661849946715e-05
be O 0 5.907059312448837e-05
no O 0 9.485599002800882e-05
relationship O 0 0.000742047734092921
between O 0 8.211343811126426e-05
the O 0 0.00022535680909641087
I1307K O 0 0.013116455636918545
polymorphism O 0 0.0006654098979197443
and O 0 5.6889901316026226e-05
the O 0 8.864113624440506e-05
presence O 0 0.0004256359825376421
or O 0 0.00026833798619918525
absence O 0 0.0074362559244036674
of O 0 0.00033849000465124846
cancer B-Disease 1 0.9999924898147583
. O 0 0.00041353938286192715
. O 0 0.0007135978084988892

Identification O 0 0.0005332253058440983
of O 0 3.873963578371331e-05
a O 0 0.0005570342182181776
novel O 0 0.0011627853382378817
mutation O 0 0.0005812622257508337
of O 0 2.3519645765190944e-05
the O 0 0.0003593412693589926
CPO O 0 0.02786867320537567
gene O 0 0.0008155560353770852
in O 0 9.233497257810086e-05
a O 0 0.0005875888746231794
Japanese O 0 0.0037602661177515984
hereditary B-Disease 1 0.9826756715774536
coproporphyria I-Disease 1 0.991890549659729
family O 0 0.004264075309038162
. O 0 0.001241021673195064

Hereditary B-Disease 1 0.975592315196991
coproporphyria I-Disease 1 0.982720673084259
( O 0 0.007319874595850706
HCP B-Disease 1 0.9983491897583008
) O 0 0.00039844089769758284
is O 0 0.0002352353767491877
an O 0 0.000739389332011342
autosomal B-Disease 1 0.9977885484695435
dominant I-Disease 1 0.9951266050338745
disease I-Disease 1 0.9999868869781494
characterized O 1 0.7925912737846375
by O 0 0.0003723887202795595
a O 0 0.0193475391715765
deficiency B-Disease 1 0.9999428987503052
of I-Disease 0 0.00014321136404760182
coproporphyrinogen I-Disease 1 0.9911125302314758
oxidase I-Disease 0 0.12301898747682571
( O 0 0.0010719667188823223
CPO O 0 0.029242202639579773
) O 0 0.00029165661544539034
caused O 0 0.0015058036660775542
by O 0 3.7123390939086676e-05
a O 0 0.0003148900577798486
mutation O 0 0.0007353376713581383
in O 0 6.953676347620785e-05
the O 0 0.00035261252196505666
CPO O 0 0.12124049663543701
gene O 0 0.004024343099445105
. O 0 0.000837683561258018

Only O 0 0.0005290090921334922
11 O 0 0.0006248256540857255
mutations O 0 0.00037823058664798737
of O 0 1.661425812926609e-05
the O 0 0.00017365404346492141
gene O 0 0.0008226491627283394
have O 0 7.804424240021035e-05
been O 0 0.00024986351490952075
reported O 0 0.0019008457893505692
in O 0 0.0011778752086684108
HCP B-Disease 1 0.9998664855957031
patients O 1 0.9997599720954895
. O 0 0.0009789674077183008

We O 0 0.0008280278416350484
report O 0 0.0006187261315062642
another O 0 0.0003631453146226704
mutation O 0 0.0009585757507011294
in O 0 0.00010993168689310551
a O 0 0.0006329278112389147
Japanese O 0 0.0016280898125842214
family O 0 0.0023172309156507254
. O 0 0.0012203314108774066

Polymerase O 0 0.014265027828514576
chain O 0 0.007586641702800989
reaction O 0 0.0028830075170844793
- O 0 0.0028082311619073153
single O 0 0.0003387665201444179
strand O 0 0.0018472808878868818
conformational O 0 0.0014741324121132493
polymorphism O 0 0.0005069062463007867
and O 0 3.652337545645423e-05
direct O 0 7.97632455942221e-05
sequence O 0 7.24364654161036e-05
analyses O 0 0.0005058886599726975
demonstrated O 0 0.0012301714159548283
a O 0 0.0007116154301911592
C O 0 0.011081145144999027
to O 0 0.00026214157696813345
T O 0 0.17467494308948517
substitution O 0 0.00017879185907077044
in O 0 8.960709965322167e-05
exon O 0 0.0019177437061443925
1 O 0 7.696482498431578e-05
of O 0 1.1192289093742147e-05
the O 0 0.0001941944647114724
CPO O 0 0.010598842985928059
gene O 0 0.0004885844537056983
at O 0 9.476883860770613e-05
nucleotide O 0 0.00013733106607105583
position O 0 0.0005544846644625068
85 O 0 0.0011016986100003123
, O 0 0.00012396491365507245
which O 0 6.170612323330715e-05
lies O 0 0.0006167413666844368
in O 0 6.817666871938854e-05
the O 0 0.00021589218522422016
putative O 0 0.01288427785038948
presequence O 0 0.016254205256700516
for O 0 0.00010430140537209809
targeting O 0 0.0005099365371279418
to O 0 0.00020944328571204096
mitochondria O 0 0.0029202529694885015
. O 0 0.0006364635191857815

This O 0 0.00044037066982127726
mutation O 0 0.0010718185221776366
changes O 0 0.00016880157636478543
the O 0 0.00011310983973089606
codon O 0 0.0011422004317864776
for O 0 0.00012422644067555666
glutamine O 0 0.0024425131268799305
to O 0 8.288029493996873e-05
a O 0 0.000431962835136801
termination O 0 0.009929037652909756
codon O 0 0.0009011341608129442
at O 0 0.0001634718501009047
amino O 0 0.00030650157714262605
acid O 0 0.0035070541780442
position O 0 0.0009245185065083206
29 O 0 0.0019258453976362944
. O 0 0.000823275069706142

MaeI O 0 0.06491288542747498
restriction O 0 0.0016688131727278233
analysis O 0 0.000497887609526515
showed O 0 0.0005667187506332994
two O 0 4.02524892706424e-05
other O 0 5.2913863328285515e-05
carriers O 0 0.0019834425766021013
in O 0 8.184646867448464e-05
the O 0 0.0002885758876800537
family O 0 0.0016112745506688952
. O 0 0.001057398971170187

The O 0 0.003152859630063176
C O 1 0.9028388261795044
- O 1 0.7064362168312073
T O 1 0.9790518283843994
mutation O 0 0.001180189778096974
is O 0 0.00015479937428608537
located O 0 0.0002667483640834689
within O 0 8.452715701423585e-05
a O 0 0.0005198035505600274
recently O 0 0.0018385322764515877
proposed O 0 0.0005793286254629493
putative O 0 0.001899031805805862
alternative O 0 0.00032625405583530664
translation O 0 0.00025259729591198266
initiation O 0 0.001697242958471179
codon O 0 0.004208056256175041
( O 0 0.0018386425217613578
TIC O 1 0.9966946840286255
- O 0 0.001788285793736577
1 O 0 0.00023798558686394244
) O 0 7.145791460061446e-05
, O 0 6.460526492446661e-05
supporting O 0 0.0005131138022989035
that O 0 0.00027467875042930245
TIC O 1 0.9974182844161987
- O 0 0.001362146227620542
1 O 0 0.00015898238052614033
is O 0 8.770749991526827e-05
the O 0 0.00014779406774323434
real O 0 0.0017151189967989922
TIC O 1 0.9955360889434814
rather O 0 0.0005574070382863283
than O 0 0.0006933793774805963
TIC O 1 0.997877836227417
- O 0 0.0035112977493554354
2 O 0 0.00045068704639561474
. O 0 0.0002028766757575795
. O 0 0.0004464193480089307

Human B-Disease 0 0.003727799281477928
complement I-Disease 0 0.009226184338331223
factor I-Disease 1 0.6251961588859558
H I-Disease 1 0.9997820258140564
deficiency I-Disease 1 0.9999842643737793
associated O 0 0.02342686988413334
with O 1 0.592782735824585
hemolytic B-Disease 1 0.9999982118606567
uremic I-Disease 1 0.9999985694885254
syndrome I-Disease 1 0.9999974966049194
. O 0 0.0074717034585773945

This O 0 0.0004848363751079887
study O 0 0.0006299684173427522
reports O 0 0.00021388386085163802
on O 0 0.0001127060895669274
six O 0 0.0002340545761398971
cases O 0 0.0010201882105320692
of O 0 0.00026702237664721906
deficiency B-Disease 1 0.9999909400939941
in I-Disease 0 0.00011441178503446281
the I-Disease 0 0.00013298788690008223
human I-Disease 0 0.0005334176821634173
complement I-Disease 0 0.0011308317771181464
regulatory I-Disease 0 0.002858598018065095
protein I-Disease 0 0.0009931542444974184
Factor I-Disease 0 0.006310870870947838
H I-Disease 1 0.9911989569664001
( O 0 0.0016479744808748364
FH O 1 0.9968211650848389
) O 0 9.144619980361313e-05
in O 0 1.7451358871767297e-05
the O 0 2.3051748939906247e-05
context O 0 9.530514944344759e-05
of O 0 6.546557415276766e-05
an O 0 0.33787524700164795
acute B-Disease 1 0.9999988079071045
renal I-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999979734420776
. O 0 0.005172888748347759

Five O 0 0.0002436838549328968
of O 0 3.443756577325985e-05
the O 0 0.0002470573235768825
cases O 0 0.0007418200839310884
were O 0 4.598521991283633e-05
observed O 0 0.0003126870433334261
in O 0 0.00013204713468439877
children O 0 0.0012536997674033046
presenting O 0 0.13850414752960205
with O 1 0.5136775970458984
idiopathic O 1 0.9999995231628418
hemolytic B-Disease 1 0.9999996423721313
uremic I-Disease 1 0.9999997615814209
syndrome I-Disease 1 0.9999995231628418
( O 1 0.9782298803329468
HUS B-Disease 1 0.9999743700027466
) O 0 0.0021044400054961443
. O 0 0.0011163139715790749

Two O 0 0.00010082709195557982
of O 0 3.1034218409331515e-05
the O 0 0.0002657742879819125
children O 0 0.0017662032041698694
exhibited O 0 0.15095150470733643
a O 0 0.007998066954314709
homozygous O 1 0.8810510635375977
deficiency O 1 0.9999699592590332
characterized O 0 0.14961038529872894
by O 0 9.987858356907964e-05
the O 0 0.00013539601059164852
absence O 0 0.0006622396758757532
of O 0 1.9886547306668945e-05
the O 0 0.00021661489154212177
150 O 0 0.0014061018591746688
- O 0 0.004301146138459444
kD O 0 0.015409381128847599
form O 0 0.0001209532783832401
of O 0 4.096909106010571e-05
Factor O 0 0.00429054768756032
H O 1 0.9645758867263794
and O 0 9.614878945285454e-05
the O 0 0.00011387323320377618
presence O 0 0.0004238520050421357
, O 0 0.00015931758389342576
upon O 0 0.000422528013586998
immunoblotting O 0 0.012536062858998775
, O 0 4.6262637624749914e-05
of O 0 1.3798338841297664e-05
the O 0 0.00017006865527946502
42 O 0 0.0018329840386286378
- O 0 0.006597704719752073
kD O 0 0.12300002574920654
Factor O 0 0.003457999788224697
H O 1 0.5195895433425903
- O 0 0.0008147143526002765
like O 0 0.00011277833982603624
protein O 0 0.00026391836581751704
1 O 0 0.000523459049873054
( O 0 0.0009324245620518923
FHL O 1 0.9854744672775269
- O 0 0.0018906070617958903
1 O 0 0.0002520547423046082
) O 0 6.382950959959999e-05
and O 0 5.5136777518782765e-05
other O 0 0.000189221856999211
FH O 1 0.997160792350769
- O 0 0.00219540623947978
related O 0 0.0005714654107578099
protein O 0 0.0008732029818929732
( O 0 0.001017851522192359
FHR O 1 0.9674196243286133
) O 0 0.00043356927926652133
bands O 0 0.001135061727836728
. O 0 0.0009204522357322276

Southern O 0 0.007982533425092697
blot O 0 0.2330171912908554
and O 0 0.00024692449369467795
PCR O 0 0.0016716500977054238
analysis O 0 5.912983033340424e-05
of O 0 1.0778378054965287e-05
DNA O 0 0.00016946291725616902
of O 0 1.8984075722983107e-05
one O 0 0.00031988354749046266
patient O 1 0.9993182420730591
with O 0 0.0006048719515092671
homozygous O 1 0.8379740715026855
deficiency O 1 0.9999774694442749
ruled O 0 0.00204515946097672
out O 0 8.387341222260147e-05
the O 0 5.56945706193801e-05
presence O 0 0.00011325856758048758
of O 0 1.2168791727162898e-05
a O 0 0.000169215229107067
large O 0 0.00014329566329251975
deletion O 0 0.0009328297455795109
of O 0 2.98324284813134e-05
the O 0 0.0007146260468289256
FH O 1 0.9988083839416504
gene O 0 0.0009067739592865109
as O 0 8.77484999364242e-05
the O 0 0.00024494665558449924
underlying O 1 0.9264253973960876
defect O 1 0.998345136642456
for O 0 0.00045041623525321484
the O 0 0.006465047597885132
deficiency O 1 0.9999775886535645
. O 0 0.001618511974811554

The O 0 0.0004502713563852012
other O 0 8.999305282486603e-05
four O 0 0.00017517840024083853
children O 0 0.0005260023172013462
presented O 0 0.0006822854047641158
with O 0 0.0004995397757738829
heterozygous O 0 0.3742842972278595
deficiency O 1 0.9999572038650513
and O 0 0.0004574495542328805
exhibited O 0 0.05900367349386215
a O 0 0.001085401396267116
normal O 0 0.004786448087543249
immunoblotting O 0 0.02896629087626934
pattern O 0 0.0006537321023643017
of O 0 1.2606273230630904e-05
proteins O 0 7.270303467521444e-05
of O 0 4.2776424379553646e-05
the O 0 0.0013925470411777496
FH O 1 0.9994121789932251
family O 0 0.0032684775069355965
. O 0 0.0013106674887239933

Factor B-Disease 0 0.27163195610046387
H I-Disease 1 0.9990590214729309
deficiency I-Disease 1 0.9999343156814575
is O 0 0.00022632839682046324
the O 0 0.00013341060548555106
only O 0 0.0002823806426022202
complement B-Disease 1 0.9923615455627441
deficiency I-Disease 1 0.9999961853027344
associated O 0 0.002147030783817172
with O 0 0.0022790657822042704
HUS B-Disease 1 0.999923586845398
. O 0 0.0021298544015735388

These O 0 0.00015251901641022414
observations O 0 0.000636882206890732
suggest O 0 0.0003487440408207476
a O 0 0.0002553519152570516
role O 0 0.0009380721603520215
for O 0 0.0008985885069705546
FH O 1 0.9993293285369873
and O 0 0.0010330238146707416
/ O 0 0.4624730348587036
or O 0 0.0010299343848600984
FH O 1 0.9959455132484436
receptors O 0 0.0019962491933256388
in O 0 0.00012314444757066667
the O 0 0.0005204076296649873
pathogenesis O 1 0.9994901418685913
of O 0 0.001975794555619359
idiopathic O 1 0.9999973773956299
HUS B-Disease 1 0.999976396560669
. O 0 0.0012319236993789673
. O 0 0.0011287835659459233

Further O 0 0.0006877220002934337
evidence O 0 0.0002011310716625303
for O 0 8.529051410732791e-05
a O 0 0.0002875076897908002
major O 0 0.0005901268450543284
ancient O 0 0.0008744217921048403
mutation O 0 0.03804023563861847
underlying O 1 0.9988652467727661
myotonic B-Disease 1 0.9999948740005493
dystrophy I-Disease 1 0.9999960660934448
from O 0 0.0018525549676269293
linkage O 1 0.7886195778846741
disequilibrium O 1 0.9902984499931335
studies O 0 0.0005021988181397319
in O 0 9.068824874702841e-05
the O 0 0.00013217450759839267
Japanese O 0 0.000705518526956439
population O 0 0.0002581466978881508
. O 0 0.0008171194931492209

The O 0 0.026132160797715187
myotonic B-Disease 1 0.9999693632125854
dystrophy I-Disease 1 0.9999957084655762
( O 1 0.663686990737915
DM B-Disease 1 0.9999223947525024
) O 0 0.0007606818107888103
mutation O 0 0.0011949907056987286
is O 0 0.00017276714788749814
an O 0 0.0005049718311056495
unstable O 1 0.9911230802536011
( O 0 0.002492252504453063
CTG O 1 0.9888294339179993
) O 0 0.00047661809367127717
n O 0 0.0015266663394868374
repeat O 0 0.002067874651402235
, O 0 6.961584585951641e-05
present O 0 5.972202052362263e-05
at O 0 9.940739982994273e-05
a O 0 0.00012101038737455383
copy O 0 0.00013433083950076252
number O 0 6.268524430197431e-06
of O 0 1.6537383999093436e-05
5 O 0 0.00044603401329368353
- O 0 0.0012631748104467988
37 O 0 0.000528129399754107
repeats O 0 0.0009894156828522682
on O 0 0.00015699716459494084
normal O 0 0.0007636254886165261
chromosomes O 0 0.00017258817388210446
but O 0 7.895434828242287e-05
amplified O 0 0.0005206509958952665
to O 0 6.703226245008409e-05
50 O 0 0.0003642747469712049
- O 0 0.0019450122490525246
3000 O 0 0.004346812609583139
copies O 0 0.0002959560079034418
on O 0 0.0010578818619251251
DM B-Disease 1 0.998945415019989
chromosomes O 0 0.0021321377716958523
. O 0 0.0007654064102098346

Previous O 0 0.0020466488786041737
findings O 0 0.0021086791530251503
in O 0 0.00027759396471083164
Caucasian O 0 0.025705743581056595
populations O 0 0.00034716291702352464
of O 0 0.00010896599269472063
a O 0 0.07574259489774704
DM B-Disease 1 0.9999529123306274
founder O 0 0.05552976578474045
chromosome O 0 0.0026708838995546103
raise O 0 0.0009807317983359098
a O 0 0.0003348408790770918
question O 0 0.0003584597143344581
about O 0 0.00012725667329505086
the O 0 9.817913814913481e-05
molecular O 0 0.0005285945371724665
events O 0 0.00012517435243353248
involved O 0 0.0002632412943057716
in O 0 6.683375249849632e-05
the O 0 0.00016644125571474433
expansion O 0 0.002631354844197631
mutation O 0 0.002949634101241827
. O 0 0.00047003227518871427

To O 0 0.0008505989098921418
investigate O 0 0.004920432344079018
whether O 0 0.00047047025873325765
a O 0 0.000533171696588397
founder O 0 0.0034757391549646854
chromosome O 0 0.0008982323342934251
for O 0 0.0001541611272841692
the O 0 0.0014903388218954206
DM B-Disease 1 0.9998819828033447
mutation O 0 0.00341203436255455
exists O 0 0.0004132554167881608
in O 0 6.201447831699625e-05
the O 0 8.85689805727452e-05
Japanese O 0 0.0004680480342358351
population O 0 7.795424608048052e-05
, O 0 0.00013778515858575702
we O 0 0.00024857730022631586
genotyped O 0 0.011164809577167034
families O 0 0.0001830594555940479
using O 0 0.0001633755600778386
polymorphic O 0 0.00974323321133852
markers O 0 0.0017777042230591178
near O 0 0.0007975811022333801
the O 0 0.0003264295810367912
( O 0 0.0015859242994338274
CTG O 1 0.9728003144264221
) O 0 0.0005060463445261121
n O 0 0.0019285428570583463
repeat O 0 0.0036021736450493336
region O 0 0.0014294132124632597
and O 0 0.000336236204020679
constructed O 0 0.0037440701853483915
haplotypes O 0 0.013153664767742157
. O 0 0.0012249198043718934

Six O 0 0.0009356242953799665
different O 0 0.000111270128400065
haplotypes O 0 0.00354586448520422
were O 0 8.77099228091538e-05
found O 0 0.0004653450450859964
and O 0 0.0010115583427250385
DM B-Disease 1 0.9999393224716187
alleles O 0 0.0030834267381578684
were O 0 0.00011325489322189242
always O 0 0.001075168838724494
haplotype O 0 0.027724027633666992
A O 0 0.0027890519704669714
. O 0 0.0009603358921594918

To O 0 0.000447107624495402
find O 0 0.0002708339598029852
an O 0 4.335788617026992e-05
origin O 0 1.6018733731471002e-05
of O 0 1.85839398909593e-05
the O 0 0.00029062069370411336
( O 0 0.0013877975288778543
CTG O 1 0.9778469800949097
) O 0 0.00047162463306449354
n O 0 0.0015832093777135015
repeat O 0 0.003647587960585952
mutation O 0 0.0010814133565872908
and O 0 7.813227421138436e-05
to O 0 0.00010671188647393137
investigate O 0 0.0011152054648846388
the O 0 4.767200516653247e-05
mechanism O 0 0.00022842803446110338
of O 0 1.1945179721806198e-05
the O 0 0.00013034825678914785
expansion O 0 0.0012056947452947497
mutation O 0 0.0005681119509972632
in O 0 5.4750998970121145e-05
the O 0 6.105850479798391e-05
Japanese O 0 0.0002554071834310889
population O 0 3.667169949039817e-05
we O 0 0.00010441285849083215
have O 0 5.110624624649063e-05
studied O 0 0.00031811356893740594
90 O 0 0.0008400832302868366
Japanese O 0 0.005068385973572731
DM B-Disease 1 0.9996477365493774
families O 0 0.0005385717959143221
comprising O 0 0.0005163522437214851
190 O 0 0.003600763389840722
affected O 0 0.0026621418073773384
and O 0 0.00025290451594628394
130 O 0 0.0028097282629460096
unaffected O 0 0.09230705350637436
members O 0 0.0005220525781624019
. O 0 0.0009712058817967772

The O 0 0.0009443414164707065
results O 0 0.0007027906249277294
suggest O 0 0.0004802765906788409
that O 0 6.194495654199272e-05
a O 0 0.0002817701897583902
few O 0 0.00020371697610244155
common O 0 0.0007706815958954394
ancestral O 0 0.0032071045134216547
mutations O 0 0.0012903750175610185
in O 0 0.00011320694466121495
both O 0 0.00025545398239046335
Caucasian O 1 0.6975913643836975
and O 0 0.0002137637638952583
Japanese O 0 0.0008114258525893092
populations O 0 0.00034347022301517427
have O 0 5.811830851598643e-05
originated O 0 0.00018468538473825902
by O 0 2.7858297471539117e-05
expansion O 0 0.00025379727594554424
of O 0 1.5291303498088382e-05
an O 0 0.0002042444102698937
ancestral O 0 0.002695287810638547
n O 0 0.002045161323621869
= O 0 0.00160245131701231
5 O 0 0.0003082340117543936
repeat O 0 0.0012771440669894218
to O 0 0.00010563586693024263
n O 0 0.001479964004829526
= O 0 0.002312907949090004
19 O 0 0.0007539392681792378
- O 0 0.0014038861263543367
37 O 0 0.0008477475494146347
copies O 0 0.0005178787978366017
. O 0 0.0006580232293345034

These O 0 0.00013923534424975514
data O 0 0.00020334745931904763
support O 0 0.0005434181075543165
multistep O 0 0.012925904244184494
models O 0 0.0005361841758713126
of O 0 0.00010278759145876393
triplet O 1 0.6663358807563782
repeat O 0 0.007766691967844963
expansion O 0 0.001178214093670249
that O 0 6.753709021722898e-05
have O 0 5.92550277360715e-05
been O 0 0.000110628578113392
proposed O 0 0.00031519850017502904
for O 0 0.00020201998995617032
both O 0 0.0009496987913735211
DM B-Disease 1 0.9999598264694214
and O 0 0.0011552657233551145
Friedreichs B-Disease 1 0.9947918057441711
ataxia I-Disease 1 0.998259961605072
. O 0 0.0008494944777339697
. O 0 0.001241494668647647

The O 0 0.000441283656982705
molecular O 0 0.0009460975416004658
basis O 0 0.00019552605226635933
of O 0 0.0005129803321324289
C6 B-Disease 1 0.9999918937683105
deficiency I-Disease 1 0.9999927282333374
in O 0 0.0002096398820867762
the O 0 0.0002951202623080462
western O 0 0.0013819127343595028
Cape O 0 0.019314222037792206
, O 0 0.0002550443459767848
South O 0 0.0008602503221482038
Africa O 0 0.0015971092507243156
. O 0 0.0006298471125774086

Deficiency B-Disease 1 0.9994326233863831
of I-Disease 0 7.097594061633572e-05
the I-Disease 0 0.00027895442326553166
sixth I-Disease 0 0.0014450199669227004
component I-Disease 0 0.0008364003151655197
of I-Disease 0 3.460602601990104e-05
human I-Disease 0 0.0009850247297436
complement I-Disease 0 0.0031164702959358692
( O 0 0.0016494060400873423
C6 O 1 0.9983431100845337
) O 0 0.0004234045627526939
has O 0 0.0003410713979974389
been O 0 0.00018532607646193355
reported O 0 0.00039295663009397686
in O 0 3.503878542687744e-05
a O 0 7.712021033512428e-05
number O 0 9.128314559347928e-06
of O 0 1.2460820471460465e-05
families O 0 0.00011702084157150239
from O 0 6.445769395213574e-05
the O 0 0.00016525380488019437
western O 0 0.0012335864594206214
Cape O 0 0.02583383210003376
, O 0 0.00036539731081575155
South O 0 0.0010746209882199764
Africa O 0 0.0019620649982243776
. O 0 0.0008505904115736485

Meningococcal B-Disease 1 0.9999179840087891
disease I-Disease 1 0.9999692440032959
is O 0 0.0027027742471545935
endemic O 0 0.3678659200668335
in O 0 0.00021936693519819528
the O 0 0.0003208242414984852
Cape O 0 0.00620241230353713
and O 0 4.841854388359934e-05
almost O 0 9.300019883085042e-05
all O 0 2.484301512595266e-05
pedigrees O 0 0.0010277506662532687
of O 0 4.3194875615881756e-05
total O 0 0.0017577626276761293
C6 B-Disease 1 0.9999790191650391
deficiency I-Disease 1 0.9999972581863403
( O 0 0.007253466639667749
C6Q0 O 1 0.9973153471946716
) O 0 0.00019085337407886982
have O 0 6.342273991322145e-05
been O 0 0.00019495602464303374
ascertained O 0 0.0035815085284411907
because O 0 0.00030637127929367125
of O 0 0.00023214213433675468
recurrent O 1 0.9999725818634033
disease O 1 0.9999934434890747
. O 0 0.0026511019095778465

We O 0 0.0007170054595917463
have O 0 0.00011067784362239763
sequenced O 0 0.0005399315268732607
the O 0 6.466468767030165e-05
expressed O 0 0.00026402281946502626
exons O 0 0.0007155787898227572
of O 0 3.596078386181034e-05
the O 0 0.0005661675822921097
C6 O 1 0.9982441663742065
gene O 0 0.0012878456618636847
from O 0 8.305411756737158e-05
selected O 0 0.0002628761576488614
cases O 0 0.0005105352611280978
and O 0 5.672694169334136e-05
have O 0 5.076743764220737e-05
found O 0 9.786227747099474e-05
three O 0 7.10915046511218e-05
molecular O 0 0.0032319759484380484
defects O 1 0.9977816939353943
leading O 0 0.0005744937225244939
to O 0 0.00015218168846331537
total O 0 0.0011048538144677877
deficiency O 1 0.9999873638153076
879delG O 1 0.90465247631073
, O 0 0.00016064688679762185
which O 0 6.114823190728202e-05
is O 0 9.840511484071612e-05
the O 0 0.00019581748347263783
common O 0 0.004100893624126911
defect O 1 0.9954285621643066
in O 0 0.0001383730414090678
the O 0 0.00032911691232584417
Cape O 0 0.01591639593243599
and O 0 0.00021992527763359249
hitherto O 0 0.016573410481214523
unreported O 0 0.00849155243486166
, O 0 0.0002581538283266127
and O 0 0.0002671919937711209
1195delC O 0 0.10558870434761047
and O 0 0.0002816363994497806
1936delG O 0 0.1419701874256134
, O 0 9.931815293384716e-05
which O 0 3.436641054577194e-05
have O 0 4.389532114146277e-05
been O 0 0.00010444832150824368
previously O 0 0.00046128235408104956
reported O 0 0.0006953928386792541
in O 0 0.00013886476517654955
African O 0 0.0013679162366315722
- O 0 0.005230357404798269
Americans O 0 0.0008404551772400737
. O 0 0.00046098651364445686

We O 0 0.000950150890275836
also O 0 0.00017931635375134647
show O 0 0.00018990239186678082
that O 0 4.569870725390501e-05
the O 0 0.0001902403892017901
879delG O 0 0.48333898186683655
and O 0 0.00044830256956629455
1195delC O 1 0.9926188588142395
defects O 1 0.9956002235412598
are O 0 5.078845424577594e-05
associated O 0 0.00017889656010083854
with O 0 0.0001925039105117321
characteristic O 1 0.8324453234672546
C6 O 1 0.9999196529388428
/ O 1 0.9872621893882751
C7 O 1 0.9956949949264526
region O 0 0.0025612679310142994
DNA O 0 0.001348789781332016
marker O 0 0.006912756245583296
haplotypes O 0 0.006338951643556356
, O 0 0.0001571120519656688
although O 0 0.00013087783008813858
small O 0 9.751592006068677e-05
variations O 0 0.00017271707474719733
were O 0 4.727172927232459e-05
observed O 0 0.000798412598669529
. O 0 0.0005526890745386481

The O 0 0.002931398106738925
1936delG O 1 0.9495841264724731
defect O 1 0.9838829636573792
was O 0 0.0007018964388407767
observed O 0 0.00027247396064922214
only O 0 4.916354373563081e-05
once O 0 0.0002957218966912478
in O 0 6.762835255358368e-05
the O 0 0.0002485779987182468
Cape O 0 0.025216814130544662
, O 0 9.817370300879702e-05
but O 0 9.90748594631441e-05
its O 0 0.0001688353659119457
associated O 0 0.0007416504085995257
haplotype O 0 0.03206938877701759
could O 0 0.00025440900935791433
be O 0 0.00015425862511619925
deduced O 0 0.0028693105559796095
. O 0 0.0005931125488132238

The O 0 0.0003085744974669069
data O 0 0.0001377981825498864
from O 0 8.676623838255182e-05
the O 0 0.00022304899175651371
haplotypes O 0 0.004332484677433968
indicate O 0 0.00028735719388350844
that O 0 2.7094562028651126e-05
these O 0 1.6724758097552694e-05
three O 0 8.81552550708875e-05
molecular O 0 0.0035331989638507366
defects O 1 0.9913982152938843
account O 0 0.00010551435843808576
for O 0 0.00011579890997381881
the O 0 0.0004194442881271243
defects O 1 0.998299777507782
in O 0 6.4947729697451e-05
all O 0 3.480460509308614e-05
the O 0 0.00026636943221092224
38 O 0 0.003190861316397786
unrelated O 0 0.06697240471839905
C6Q0 O 1 0.9968463778495789
individuals O 0 0.00031208753352984786
we O 0 0.00012222517398186028
have O 0 5.1070150220766664e-05
studied O 0 0.0001985651470022276
from O 0 6.93449837854132e-05
the O 0 0.00029003608506172895
Cape O 0 0.019954020157456398
. O 0 0.0006778204697184265

We O 0 0.0007642278214916587
have O 0 0.00011061011900892481
also O 0 8.388076821574941e-05
observed O 0 0.00018904767057392746
the O 0 0.00020765805675182492
879delG O 0 0.3241378962993622
defect O 0 0.39791375398635864
in O 0 0.00010667525930330157
two O 0 0.00016770373622421175
Dutch O 0 0.02266528829932213
C6 B-Disease 1 0.9999126195907593
- I-Disease 1 0.9917286038398743
deficient I-Disease 1 0.9996137022972107
kindreds O 0 0.11941368877887726
, O 0 0.000272244680672884
but O 0 0.00015666670515201986
the O 0 0.0002466858713887632
879delG O 1 0.8216321468353271
defect O 1 0.8130307197570801
in O 0 0.00015288505528587848
the O 0 0.00045083201257511973
Cape O 0 0.05319681763648987
probably O 0 0.0015126625075936317
did O 0 0.00031045713694766164
not O 0 5.0216509407619014e-05
come O 0 8.388156857108697e-05
from O 0 4.10108441428747e-05
The O 0 0.0001499647623859346
Netherlands O 0 0.0005733110592700541
. O 0 0.0001598712260602042
. O 0 0.0003869412757921964

Complement B-Disease 1 0.917589008808136
C7 I-Disease 1 0.999932050704956
deficiency I-Disease 1 0.9999862909317017
: O 0 0.0006038494757376611
seven O 0 0.0003281153622083366
further O 0 0.0005349013372324407
molecular O 0 0.011071471497416496
defects O 1 0.9979116320610046
and O 0 9.500155283603817e-05
their O 0 0.00012212287401780486
associated O 0 0.0008499872055836022
marker O 0 0.013180405832827091
haplotypes O 0 0.012746628373861313
. O 0 0.0009032514062710106

Seven O 0 0.000617378915194422
further O 0 0.0002682661288417876
molecular O 0 0.0007859524339437485
bases O 0 0.0005309327389113605
of O 0 0.0007697487599216402
C7 B-Disease 1 0.9999945163726807
deficiency I-Disease 1 0.9999969005584717
are O 0 0.00032282958272844553
described O 0 0.011537043377757072
. O 0 0.001088661258108914

All O 0 0.00011600094876484945
these O 0 7.506150723202154e-05
new O 0 0.0005309681291691959
molecular O 0 0.0061738030053675175
defects O 1 0.9915987253189087
involve O 0 0.0007467879331670702
single O 0 0.00028991224826313555
- O 0 0.0009733294718898833
nucleotide O 0 0.0001572007458889857
events O 0 0.00011421699309721589
, O 0 0.0001734271936584264
deletions O 0 0.001014225883409381
and O 0 4.514280954026617e-05
substitutions O 0 0.00026240613078698516
, O 0 3.796831515501253e-05
some O 0 1.874252120614983e-05
of O 0 1.588215491210576e-05
which O 0 0.00011364197416696697
alter O 0 0.0073221963830292225
splice O 0 0.0040839617140591145
sites O 0 0.0001959758810698986
, O 0 0.0001530365989310667
and O 0 0.00014516037481371313
others O 0 0.0006127707310952246
codons O 0 0.004988424479961395
. O 0 0.0008690518443472683

They O 0 0.0002364002721151337
are O 0 3.394383020349778e-05
distributed O 0 0.0002209176600445062
along O 0 0.00023471159511245787
the O 0 0.0006291022873483598
C7 O 1 0.9983304142951965
gene O 0 0.001339378533884883
, O 0 9.696587221696973e-05
but O 0 8.584799797972664e-05
predominantly O 0 0.00013378805306274444
towards O 0 0.00022435840219259262
the O 0 0.00015333268675021827
3 O 0 0.0005999013665132225
end O 0 0.0015067524509504437
. O 0 0.0005707322852686048

All O 0 0.00011123746662633494
were O 0 5.967772449366748e-05
found O 0 0.00018342217663303018
in O 0 0.00017144660523626953
compound O 0 0.005615364294499159
heterozygous O 0 0.0031349402852356434
individuals O 0 0.0006294771446846426
. O 0 0.0008283071801997721

The O 0 0.007000569254159927
C6 O 1 0.9986636638641357
/ O 1 0.9657670259475708
C7 O 1 0.9950852990150452
marker O 0 0.019130410626530647
haplotypes O 0 0.009289140813052654
associated O 0 0.0004047740949317813
with O 0 0.00018635114247445017
most O 0 0.0014665616909042
C7 B-Disease 1 0.9998145699501038
defects I-Disease 1 0.9988895058631897
are O 0 7.604944403283298e-05
tabulated O 0 0.0010524874087423086
. O 0 0.000192311083083041
. O 0 0.000613347627222538

A O 0 0.005579001735895872
genome O 0 0.0057305097579956055
- O 0 0.0022315303795039654
wide O 0 0.0005468651652336121
search O 0 0.00047356713912449777
for O 0 0.0002590797084849328
chromosomal O 0 0.010370602831244469
loci O 0 0.010504433885216713
linked O 0 0.014807678759098053
to O 0 0.0012363378191366792
mental O 1 0.9999574422836304
health O 1 0.9998001456260681
wellness O 1 0.999333918094635
in O 0 0.00022787398484069854
relatives O 0 0.0011391349835321307
at O 0 0.0005255011492408812
high O 0 0.08101342618465424
risk O 1 0.99326092004776
for O 0 0.024778570979833603
bipolar B-Disease 1 0.9999991655349731
affective I-Disease 1 0.9999822378158569
disorder I-Disease 1 0.999980092048645
among O 0 0.00026478938525542617
the O 0 0.0002720222983043641
Old O 0 0.004442010540515184
Order O 0 0.00043436355190351605
Amish O 0 0.007605822756886482
. O 0 0.0006844070740044117

Bipolar B-Disease 1 0.9999725818634033
affective I-Disease 1 0.999774158000946
disorder I-Disease 1 0.9999624490737915
( O 0 0.15324701368808746
BPAD B-Disease 1 0.9998793601989746
; O 0 0.022342847660183907
manic B-Disease 1 0.9999904632568359
- I-Disease 1 0.9997770190238953
depressive I-Disease 1 0.9999973773956299
illness I-Disease 1 0.9999821186065674
) O 0 0.000526242540217936
is O 0 0.00034340177080594003
characterized O 0 0.013328257016837597
by O 0 9.645827230997384e-05
episodes O 0 0.0005386998527683318
of O 0 0.00015918700955808163
mania B-Disease 1 0.9997943043708801
and O 0 0.0016583942342549562
/ O 1 0.9830859899520874
or O 0 0.001728310715407133
hypomania B-Disease 1 0.9992331266403198
interspersed O 0 0.001555729191750288
with O 0 0.00011934954090975225
periods O 0 0.0008511769701726735
of O 0 0.0002629872178658843
depression B-Disease 1 0.9998853206634521
. O 0 0.001415327424183488

Compelling O 0 0.006871931254863739
evidence O 0 0.0006051490199752152
supports O 0 0.0017215030966326594
a O 0 0.00031739106634631753
significant O 0 0.0003699491498991847
genetic O 0 0.0005993429804220796
component O 0 0.0009702403331175447
in O 0 9.636174945626408e-05
the O 0 0.00023791730927769095
susceptibility O 1 0.7456973791122437
to O 0 0.0003917044377885759
develop O 1 0.994236946105957
BPAD B-Disease 1 0.999321460723877
. O 0 0.0015424297889694571

To O 0 0.0005355681641958654
date O 0 0.0003454321122262627
, O 0 0.00015924485342111439
however O 0 0.0002107570180669427
, O 0 0.00016877532470971346
linkage O 0 0.0032297614961862564
studies O 0 0.00019789606449194252
have O 0 5.795415927423164e-05
attempted O 0 0.0003204341628588736
only O 0 2.9881484806537628e-05
to O 0 7.160450331866741e-05
identify O 0 0.0008446946158073843
chromosomal O 0 0.01133481040596962
loci O 0 0.0041257236152887344
that O 0 0.00015298539074137807
cause O 0 0.038047585636377335
or O 0 0.00015675110626034439
increase O 0 0.00027579322340898216
the O 0 0.0002463657583575696
risk O 0 0.05903971567749977
of O 0 0.00017813484009820968
developing O 1 0.6400198340415955
BPAD B-Disease 1 0.998139500617981
. O 0 0.0016747277695685625

To O 0 0.00043925337377004325
determine O 0 0.0005417812499217689
whether O 0 0.00027327524730935693
there O 0 7.1712740464136e-05
could O 0 0.00018181085761170834
be O 0 0.00015719117072876543
protective O 1 0.976590633392334
alleles O 0 0.0015843322034925222
that O 0 0.0001266628532903269
prevent O 0 0.0023567471653223038
or O 0 0.00027622899506241083
reduce O 0 0.002733011497184634
the O 0 0.00020786405366379768
risk O 0 0.021651240065693855
of O 0 9.990906983148307e-05
developing O 1 0.9371986985206604
BPAD B-Disease 1 0.9996808767318726
, O 0 0.00017932472110260278
similar O 0 0.00012909117504023015
to O 0 5.360714567359537e-05
what O 0 0.00010149675654247403
is O 0 8.043946581892669e-05
observed O 0 0.0001317559799645096
in O 0 6.124031642684713e-05
other O 0 0.000205841293791309
genetic B-Disease 1 0.9982787370681763
disorders I-Disease 1 0.999996542930603
, O 0 0.0004437568422872573
we O 0 0.00035423075314611197
used O 0 0.0022100263740867376
mental O 1 0.9999704360961914
health O 1 0.999790608882904
wellness O 1 0.9991905093193054
( O 0 0.0005267172819003463
absence O 0 0.0013202092377468944
of O 0 5.383726966101676e-05
any O 0 0.005179037339985371
psychiatric B-Disease 1 0.999996542930603
disorder I-Disease 1 0.9999837875366211
) O 0 0.00022108960547484457
as O 0 0.00012261293886695057
the O 0 0.00023607525508850813
phenotype O 0 0.06759953498840332
in O 0 6.368407775880769e-05
our O 0 0.0002830636512953788
genome O 0 0.0024577309377491474
- O 0 0.002142402110621333
wide O 0 0.00111115793697536
linkage O 0 0.0077375187538564205
scan O 0 0.006145377177745104
of O 0 1.4912917322362773e-05
several O 0 8.766820974415168e-05
large O 0 0.00043831270886585116
multigeneration O 1 0.6010753512382507
Old O 0 0.0018059872090816498
Order O 0 0.00032757181907072663
Amish O 0 0.004899999126791954
pedigrees O 0 0.006419237237423658
exhibiting O 0 0.013185666874051094
an O 0 0.0005645729834213853
extremely O 1 0.654509961605072
high O 0 0.09333667159080505
incidence O 1 0.9942459464073181
of O 0 0.00041142955888062716
BPAD B-Disease 1 0.9995738863945007
. O 0 0.0017298326129093766

We O 0 0.0008775886381044984
have O 0 0.00016091272118501365
found O 0 0.0001365655625704676
strong O 0 0.00014826649567112327
evidence O 0 0.00011563693260541186
for O 0 7.495407771784812e-05
a O 0 0.0003939975576940924
locus O 0 0.003257239004597068
on O 0 0.0003635919711086899
chromosome O 0 0.0036105334293097258
4p O 1 0.7953019738197327
at O 0 0.0009509994997642934
D4S2949 O 0 0.01244091521948576
( O 0 0.0005976955872029066
maximum O 0 0.0016600401140749454
GENEHUNTER O 1 0.9198636412620544
- O 0 0.003486780682578683
PLUS O 0 0.0021449041087180376
nonparametric O 0 0.008393424563109875
linkage O 0 0.0032238848507404327
score O 0 0.0002336033503524959
= O 0 0.0011454963823780417
4 O 0 0.0002921703562606126
. O 0 0.00010706311877584085
05 O 0 0.01171071082353592
, O 0 0.0003068740770686418
P O 0 0.009912345558404922
= O 0 0.00102270080242306
5 O 0 0.00021894861129112542
. O 0 7.844596257200465e-05
22 O 0 0.0003825756721198559
x O 0 0.0008829701691865921
10 O 0 0.0002765802782960236
( O 0 0.00037254870403558016
- O 0 0.0009934158297255635
4 O 0 0.00025743464357219636
) O 0 0.000137205672217533
; O 0 0.00017729910905472934
SIBPAL O 0 0.24946272373199463
Pempirical O 0 0.009481619112193584
value O 0 0.00018877169350162148
< O 0 0.004297938663512468
3 O 0 0.00033756528864614666
x O 0 0.0009046522900462151
10 O 0 0.00020491289615165442
( O 0 0.0003653244930319488
- O 0 0.0011008399305865169
5 O 0 0.00021964634652249515
) O 0 9.246422996511683e-05
) O 0 7.83886862336658e-05
and O 0 7.18169758329168e-05
suggestive O 0 0.0029719320591539145
evidence O 0 7.776357961120084e-05
for O 0 6.064539047656581e-05
a O 0 0.00031235962524078786
locus O 0 0.0027182896155864
on O 0 0.00032761553302407265
chromosome O 0 0.005776418838649988
4q O 1 0.9969044327735901
at O 0 0.0007256986573338509
D4S397 O 0 0.014157610014081001
( O 0 0.0004018578620161861
maximum O 0 0.0011133633088320494
GENEHUNTER O 1 0.825139045715332
- O 0 0.0019764211028814316
PLUS O 0 0.0015073702670633793
nonparametric O 0 0.005753979552537203
linkage O 0 0.001999431289732456
score O 0 0.0001766053173923865
= O 0 0.0010281320428475738
3 O 0 0.0001604992721695453
. O 0 6.011772347847e-05
29 O 0 0.000442800170276314
, O 0 0.00024341636162716895
P O 0 0.008348148316144943
= O 0 0.0010788522195070982
2 O 0 0.00015815667575225234
. O 0 6.470397056546062e-05
57 O 0 0.0006037128623574972
x O 0 0.000840748252812773
10 O 0 0.00018008310871664435
( O 0 0.00038126466097310185
- O 0 0.0012455785181373358
3 O 0 0.00020428649440873414
) O 0 0.00012157781748101115
; O 0 0.0002366383996559307
SIBPAL O 0 0.12399328500032425
Pempirical O 0 0.009090743958950043
value O 0 0.00022444954083766788
< O 0 0.004073587246239185
1 O 0 0.00030986720230430365
x O 0 0.000868900737259537
10 O 0 0.00020553162903524935
( O 0 0.0002670870453584939
- O 0 0.000946542015299201
3 O 0 0.00019813621474895626
) O 0 8.691687253303826e-05
) O 0 5.560403587878682e-05
that O 0 3.096400178037584e-05
are O 0 3.902995740645565e-05
linked O 0 0.007755482103675604
to O 0 0.0009216931066475809
mental O 1 0.9999420642852783
health O 1 0.9997091889381409
wellness O 1 0.9994558691978455
. O 0 0.001344825141131878

These O 0 0.0004084474639967084
findings O 0 0.0012922665337100625
are O 0 4.29582541983109e-05
consistent O 0 0.0004673073417507112
with O 0 5.482712367665954e-05
the O 0 0.0001372513361275196
hypothesis O 0 0.0007593288901261985
that O 0 3.9438069507014006e-05
certain O 0 0.00012195111048640683
alleles O 0 0.0013242565328255296
could O 0 0.00024191662669181824
prevent O 0 0.002411079593002796
or O 0 0.00030941941076889634
modify O 0 0.010016141459345818
the O 0 0.0004978126380592585
clinical O 1 0.9988081455230713
manifestations O 0 0.2924805283546448
of O 0 0.0002062172716250643
BPAD B-Disease 1 0.999754011631012
and O 0 0.00023193328524939716
perhaps O 0 0.001541143748909235
other O 0 0.00026232886011712253
related O 1 0.6888154149055481
affective B-Disease 1 0.9999241828918457
disorders I-Disease 1 0.9999674558639526
. O 0 0.003649804973974824

Segregation O 0 0.0748833641409874
distortion O 0 0.10334473103284836
in O 0 0.014400847256183624
myotonic B-Disease 1 0.9999768733978271
dystrophy I-Disease 1 0.9999959468841553
. O 0 0.00750784482806921

Myotonic B-Disease 1 0.9999426603317261
dystrophy I-Disease 1 0.9999934434890747
( O 1 0.8333867192268372
DM B-Disease 1 0.9999638795852661
) O 0 0.0006653436576016247
is O 0 0.0002727616811171174
an O 0 0.0006140241166576743
autosomal B-Disease 1 0.9990912675857544
dominant I-Disease 1 0.9963051080703735
disease I-Disease 1 0.9999818801879883
which O 0 0.00011656311835395172
, O 0 8.793880988378078e-05
in O 0 6.046723865438253e-05
the O 0 0.00016417638107668608
typical O 0 0.002788156969472766
pedigree O 0 0.016596127301454544
, O 0 0.00011018441000487655
shows O 0 7.993372128112242e-05
a O 0 0.00019501849601510912
three O 0 0.00010225342703051865
generation O 0 0.0022201859392225742
anticipation O 0 0.006918988190591335
cascade O 0 0.11297005414962769
. O 0 0.001214978750795126

This O 0 0.00044581512338481843
results O 0 0.0008207848877646029
in O 0 0.0011698071612045169
infertility B-Disease 1 0.9998584985733032
and O 1 0.7142914533615112
congenital B-Disease 1 0.9999995231628418
myotonic I-Disease 1 0.9999988079071045
dystrophy I-Disease 1 0.9999990463256836
( O 0 0.17080356180667877
CDM B-Disease 1 0.9987558126449585
) O 0 0.00027449315530247986
with O 0 7.897330942796543e-05
the O 0 0.0002408005530014634
disappearance O 0 0.004987148568034172
of O 0 0.00028160682995803654
DM B-Disease 1 0.999976634979248
in O 0 0.0003760277759283781
that O 0 0.00027464941376820207
pedigree O 0 0.0561133548617363
. O 0 0.0013055556919425726

The O 0 0.0004406545776873827
concept O 0 0.0004446720995474607
of O 0 9.004481398733333e-05
segregation O 0 0.01349694188684225
distortion O 0 0.007621466647833586
, O 0 0.00019627994333859533
where O 0 9.916672570398077e-05
there O 0 5.8480898587731645e-05
is O 0 0.00017530107288621366
preferential O 0 0.0017553087091073394
transmission O 0 0.000831442594062537
of O 0 1.148571027442813e-05
the O 0 6.729183223797008e-05
larger O 0 0.00030976589187048376
allele O 0 0.0018226963002234697
at O 0 0.0003892083477694541
the O 0 0.0014266904909163713
DM B-Disease 1 0.9998100399971008
locus O 0 0.00929093174636364
, O 0 0.0002329623093828559
has O 0 0.0002599055296741426
been O 0 9.144889918388799e-05
put O 0 0.00019064857042394578
forward O 0 0.00018668212578631938
to O 0 6.018218846293166e-05
explain O 0 0.0012366181472316384
partially O 0 0.0036693892907351255
the O 0 0.0002796534390654415
maintenance O 1 0.5687952637672424
of O 0 0.000405288563342765
DM B-Disease 1 0.9999303817749023
in O 0 0.00016662687994539738
the O 0 0.00018210716370958835
population O 0 0.0002259148604935035
. O 0 0.0008538755355402827

In O 0 0.0005188496434129775
a O 0 0.0005810085567645729
survey O 0 0.0006396097014658153
of O 0 0.00023251317907124758
DM B-Disease 1 0.9998953342437744
in O 0 0.00036254237056709826
Northern O 0 0.0011352894362062216
Ireland O 0 0.0006501159514300525
, O 0 0.00026337490999139845
59 O 0 0.002777597401291132
pedigrees O 0 0.005375206004828215
were O 0 0.00018062515300698578
ascertained O 0 0.014782018959522247
. O 0 0.0009429299389012158

Sibships O 0 0.3079538345336914
where O 0 0.000327262154314667
the O 0 0.00010842999472515658
status O 0 0.00021390018810052425
of O 0 9.121839866566006e-06
all O 0 2.4680926799192093e-05
the O 0 9.32845869101584e-05
members O 0 0.00012466133921407163
had O 0 0.0004173444176558405
been O 0 0.00019449465617071837
identified O 0 0.00030132741085253656
were O 0 3.084893978666514e-05
examined O 0 0.001559463911689818
to O 0 2.601879350550007e-05
determine O 0 7.978865323821083e-05
the O 0 5.32126723555848e-05
transmission O 0 0.0008680488099344075
of O 0 4.435439404915087e-05
the O 0 0.0014567702310159802
DM B-Disease 1 0.9999603033065796
expansion O 0 0.002831120975315571
from O 0 0.0003175602469127625
affected O 0 0.007540689315646887
parents O 0 0.0003541602345649153
to O 0 5.47077834198717e-05
their O 0 9.88697720458731e-05
offspring O 0 0.0026483573019504547
. O 0 0.0007558779325336218

Where O 0 0.0007987904828041792
the O 0 0.0005450968747027218
transmitting O 0 0.03341250866651535
parent O 0 0.036120928823947906
was O 0 0.001491182018071413
male O 0 0.0012900959700345993
, O 0 0.0004309118667151779
58 O 0 0.00419752299785614
. O 0 0.0007894622976891696

3 O 0 0.0006276344647631049
% O 0 3.7942692870274186e-05
of O 0 2.4295975890709087e-05
the O 0 0.00024992020917125046
offspring O 0 0.0014523703139275312
were O 0 0.00010430917609483004
affected O 0 0.0029462745878845453
, O 0 9.973495616577566e-05
and O 0 4.930217983201146e-05
in O 0 5.10755053255707e-05
the O 0 7.463412475772202e-05
case O 0 0.0002918312675319612
of O 0 1.904162490973249e-05
a O 0 0.0005199130391702056
female O 0 0.0017887657741084695
transmitting O 0 0.15515999495983124
parent O 0 0.06808602809906006
, O 0 0.0005235675489529967
68 O 0 0.0038721119053661823
. O 0 0.0009791842894628644

7 O 0 0.0016350927762687206
% O 0 0.0001539186341688037
were O 0 0.00017438546638004482
affected O 0 0.005150765646249056
. O 0 0.0008977182442322373

Studies O 0 0.0012895707041025162
on O 0 0.0005379528156481683
meiotic O 1 0.6528769731521606
drive O 0 0.005573552567511797
in O 0 0.0016865507932379842
DM B-Disease 1 0.9999566078186035
have O 0 0.00023896488710306585
shown O 0 0.0003567610401660204
increased O 0 0.000330520560964942
transmission O 0 0.0007222580024972558
of O 0 1.2824880286643747e-05
the O 0 8.090920891845599e-05
larger O 0 0.00040333063225261867
allele O 0 0.0022260798141360283
at O 0 0.0005399449146352708
the O 0 0.001057666726410389
DM B-Disease 1 0.999600350856781
locus O 0 0.007452685385942459
in O 0 0.0005136138643138111
non O 0 0.013425740413367748
- O 1 0.9740461111068726
DM O 1 0.9998637437820435
heterozygotes O 1 0.682656466960907
for O 0 0.0011761642526835203
CTGn O 1 0.8051929473876953
. O 0 0.0014983074506744742

This O 0 0.0003363314608577639
study O 0 0.0006635689060203731
provides O 0 0.000581376429181546
further O 0 0.00013341798330657184
evidence O 0 0.00013230489275883883
that O 0 0.00010076472972286865
the O 0 0.0008509649778716266
DM B-Disease 1 0.9999301433563232
expansion O 0 0.0036034404765814543
tends O 0 0.0019112235167995095
to O 0 9.664001117926091e-05
be O 0 0.0001551839231979102
transmitted O 0 0.003947475925087929
preferentially O 0 0.006881049368530512
. O 0 0.0007503611268475652

Diagnosis O 1 0.9996240139007568
of O 0 0.001998971914872527
hemochromatosis B-Disease 1 0.9999626874923706
. O 0 0.003449526382610202

If O 0 0.018518967553973198
untreated O 1 0.9994809031486511
, O 0 0.018398215994238853
hemochromatosis B-Disease 1 0.9999938011169434
can O 0 0.009282323531806469
cause O 1 0.9988406300544739
serious O 1 0.9998794794082642
illness O 1 0.9999768733978271
and O 0 0.00028978733462281525
early B-Disease 0 0.000788690522313118
death I-Disease 0 0.004812844563275576
, O 0 0.00011827189882751554
but O 0 0.00017526546434964985
the O 0 0.0008484061108902097
disease O 1 0.9999661445617676
is O 0 0.00028031948022544384
still O 0 0.0005679866299033165
substantially O 0 0.0818723738193512
under O 0 0.0056479573249816895
- O 1 0.9988561868667603
diagnosed O 1 0.9999603033065796
. O 0 0.0010361078893765807

The O 0 0.0007918537012301385
cornerstone O 0 0.013821038417518139
of O 0 7.702635775785893e-05
screening O 0 0.007135056424885988
and O 0 0.0001549142471048981
case O 0 0.0012481571175158024
detection O 0 0.001667323405854404
is O 0 5.67823663004674e-05
the O 0 3.626972102210857e-05
measurement O 0 0.00045142462477087975
of O 0 8.660296589368954e-05
serum O 1 0.9856169819831848
transferrin O 1 0.7057362794876099
saturation O 0 0.008298777043819427
and O 0 0.00020308219245634973
the O 0 0.0005075738881714642
serum O 1 0.9473214149475098
ferritin O 1 0.9487537145614624
level O 0 0.0032317363657057285
. O 0 0.0009913604008033872

Once O 0 0.006516625173389912
the O 0 0.001977213192731142
diagnosis O 1 0.9998687505722046
is O 0 0.001104779657907784
suspected O 0 0.009051020257174969
, O 0 0.00044979085214436054
physicians O 1 0.7208177447319031
must O 0 0.00019196630455553532
use O 0 0.00023910436721052974
serum O 1 0.9819498658180237
ferritin O 1 0.9805780649185181
levels O 0 0.003438579384237528
and O 0 0.0007219269755296409
hepatic O 1 0.9999397993087769
iron O 1 0.9958648681640625
stores O 0 0.0017285343492403626
on O 0 0.003044077195227146
liver O 1 0.9999840259552002
biopsy O 1 0.9998244643211365
specimens O 0 0.015167136676609516
to O 0 0.0005121621652506292
assess O 1 0.9815754890441895
patients O 1 0.9992315769195557
for O 0 5.843413600814529e-05
the O 0 7.372682739514858e-05
presence O 0 0.0002602953463792801
of O 0 0.00010608203592710197
iron B-Disease 1 0.9983506202697754
overload I-Disease 1 0.9956243634223938
. O 0 0.001964912284165621

Liver O 1 0.9999299049377441
biopsy O 1 0.999161958694458
is O 0 0.0005352888838388026
also O 0 0.00010861420742003247
used O 0 5.7991921494249254e-05
to O 0 4.2808173020603135e-05
establish O 0 0.00022044485376682132
the O 0 8.03037328296341e-05
presence O 0 0.00037385281757451594
or O 0 0.00020228116773068905
absence O 0 0.0015841525746509433
of O 0 0.00012495684495661408
cirrhosis B-Disease 1 0.9999850988388062
, O 0 0.00031497981399297714
which O 0 0.00010650591866578907
can O 0 0.0004204395227134228
affect O 0 0.37708571553230286
prognosis O 1 0.9999731779098511
and O 0 0.0005711822886951268
management O 1 0.9888816475868225
. O 0 0.0012977742590010166

A O 0 0.004276037681847811
DNA O 0 0.0020190770737826824
- O 0 0.001409743563272059
based O 0 0.00011515343067003414
test O 0 0.00034295357181690633
for O 0 0.00010963698150590062
the O 0 0.0006179935298860073
HFE O 1 0.9975107908248901
gene O 0 0.0012927945936098695
is O 0 0.00013309699716046453
commercially O 0 0.00041582202538847923
available O 0 6.808564648963511e-05
, O 0 4.239111876813695e-05
but O 0 2.8762167858076282e-05
its O 0 3.516847573337145e-05
place O 0 4.1392042476218194e-05
in O 0 6.649497663602233e-05
the O 0 0.0003526256186887622
diagnosis O 1 0.9999364614486694
of O 0 0.0003602457290980965
hemochromatosis B-Disease 1 0.9999960660934448
is O 0 0.0013313370291143656
still O 0 0.0007155525381676853
being O 0 0.0007177492952905595
evaluated O 0 0.019779333844780922
. O 0 0.000538813357707113

Currently O 0 0.0014467011205852032
, O 0 0.00014280325558502227
the O 0 6.809266051277518e-05
most O 0 6.581636262126267e-05
useful O 0 0.0003397534601390362
role O 0 0.00031960339401848614
for O 0 5.778760169050656e-05
this O 0 4.608127346727997e-05
test O 0 0.00033284659730270505
is O 0 5.447559669846669e-05
in O 0 3.1262195989256725e-05
the O 0 9.050010703504086e-05
detection O 0 0.0034258312080055475
of O 0 0.00019520863133948296
hemochromatosis B-Disease 1 0.9999936819076538
in O 0 0.00019596055790316314
the O 0 0.00017633223615121096
family O 0 0.0004590859462041408
members O 0 0.00011107305908808485
of O 0 0.0001208128742291592
patients O 1 0.9997742772102356
with O 0 0.00010697332618292421
a O 0 0.0009095376008190215
proven O 0 0.1879347860813141
case O 0 0.0005896599031984806
of O 0 6.065562047297135e-05
the O 0 0.004799444694072008
disease O 1 0.999977707862854
. O 0 0.0015785123687237501

It O 0 0.00038519492954947054
is O 0 0.00029295944841578603
crucial O 0 0.0018315328052267432
to O 0 0.0017790537094697356
diagnose O 1 0.999970555305481
hemochromatosis B-Disease 1 0.999985933303833
before O 1 0.6503340601921082
hepatic B-Disease 1 0.9999803304672241
cirrhosis I-Disease 1 0.999992847442627
develops O 1 0.9989111423492432
because O 0 0.13423128426074982
phlebotomy O 1 0.9996570348739624
therapy O 1 0.9997424483299255
can O 0 0.0032937258947640657
avert O 1 0.9996030926704407
serious O 1 0.9999756813049316
chronic O 1 0.9999998807907104
disease O 1 0.9999977350234985
and O 0 0.0003727918956428766
can O 0 0.0001582903350936249
even O 0 0.00013442744966596365
lead O 0 0.00016294990200549364
to O 0 0.00010766017658170313
normal O 0 0.0019472778076305985
life O 0 0.0018458595732226968
expectancy O 0 0.25800859928131104
. O 0 0.0003163810761179775
. O 0 0.0005713385762646794

Prevalence O 0 0.05163233354687691
of O 0 0.00013395669520832598
the O 0 0.0009772945195436478
I1307K O 1 0.858849823474884
APC B-Disease 1 0.9798054099082947
gene O 0 0.00502687506377697
variant O 0 0.0054834806360304356
in O 0 0.00017035983910318464
Israeli O 0 0.0006536815199069679
Jews O 0 8.403569518122822e-05
of O 0 1.010368941933848e-05
differing O 0 0.00012423614680301398
ethnic O 0 5.044680438004434e-05
origin O 0 8.602468005847186e-05
and O 0 0.00037710240576416254
risk O 1 0.9987263083457947
for O 1 0.9310619831085205
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999988079071045
. O 0 0.002627117093652487

BACKGROUND O 0 0.019775452092289925
& O 0 0.08515510708093643
AIMS O 0 0.011303378269076347
Israeli O 0 0.0010115476325154305
Jews O 0 0.00010071072756545618
of O 0 2.443339144519996e-05
European O 0 0.00047986110439524055
birth O 0 0.0017516486113891006
, O 0 0.0002629827067721635
i O 0 0.0013733799569308758
. O 0 9.738470544107258e-05
e O 0 0.0006980307516641915
. O 0 5.806972330901772e-05
, O 0 0.0001465505629312247
Ashkenazim O 0 0.00953217875212431
, O 0 9.44471248658374e-05
have O 0 6.274124461924657e-05
the O 0 0.0004666741006076336
highest O 1 0.9977526068687439
colorectal B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999986886978149
incidence O 1 0.9934900999069214
of O 0 4.8209276428679004e-05
any O 0 0.00015485046606045216
Israeli O 0 0.0008011864847503603
ethnic O 0 0.00020656915148720145
group O 0 0.0008945299196057022
. O 0 0.0007035787566564977

The O 0 0.0020610843785107136
I1307K O 0 0.30581560730934143
APC B-Disease 1 0.9749782085418701
gene O 0 0.004507613833993673
variant O 0 0.007140821311622858
was O 0 0.0005306235980242491
found O 0 0.00024631599080748856
in O 0 0.00016771157970651984
6 O 0 0.001242032740265131
. O 0 0.0005934589426033199

1 O 0 0.0005412067985162139
% O 0 3.407374970265664e-05
of O 0 2.0270434106350876e-05
American O 0 0.00029185658786445856
Jews O 0 0.00016973575111478567
, O 0 9.764563583303243e-05
28 O 0 0.00019750565115828067
% O 0 1.2958593288203701e-05
of O 0 3.1476898584514856e-05
their O 0 0.004645274952054024
familial O 1 0.999995231628418
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
cases O 0 0.33827608823776245
, O 0 0.00021134057897143066
but O 0 0.00010999439837178215
not O 0 4.699431519838981e-05
in O 0 6.249873695196584e-05
non O 0 0.0015528093790635467
- O 0 0.003526964457705617
Jews O 0 0.0006719680968672037
. O 0 0.000672000169288367

We O 0 0.0014915684005245566
assessed O 0 0.007128033321350813
the O 0 0.000766214681789279
I1307K O 0 0.4575696289539337
prevalence O 1 0.5494219064712524
in O 0 0.0002856284845620394
Israeli O 0 0.0006475521950051188
Jews O 0 0.00010097787890117615
of O 0 1.1794357305916492e-05
differing O 0 0.00011845473636640236
ethnic O 0 6.118907185737044e-05
origin O 0 7.752286910545081e-05
and O 0 0.0003510642272885889
risk O 1 0.997633695602417
for O 1 0.8345094919204712
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999967813491821
. O 0 0.0028117771726101637

METHODS O 0 0.0038824218790978193
DNA O 0 0.0011526911985129118
samples O 0 0.0004736176924780011
from O 0 0.0001449885603506118
500 O 0 0.001158564118668437
unrelated O 0 0.0013639783719554543
Jews O 0 0.00011373768938938156
of O 0 2.3023188987281173e-05
European O 0 0.00036916069802828133
or O 0 0.00027420176775194705
non O 0 0.0011529162293300033
- O 0 0.0012731349561363459
European O 0 0.00012301828246563673
origin O 0 3.593363726395182e-05
, O 0 5.894337664358318e-05
with O 0 5.7256078434875235e-05
or O 0 0.00010416563600301743
without O 0 7.951885345391929e-05
a O 0 0.0002757777110673487
personal O 0 0.0011316474992781878
and O 0 0.0005142117734067142
/ O 1 0.7045053243637085
or O 0 0.0001935303007485345
family O 0 0.00027820252580568194
history O 0 0.0001960401568794623
of O 0 0.00012818518735002726
neoplasia B-Disease 1 0.9996370077133179
, O 0 0.0002505517622921616
were O 0 8.146384061546996e-05
examined O 0 0.0025296187959611416
for O 0 7.030963024590164e-05
the O 0 0.00023581204004585743
I1307K O 0 0.01840250752866268
variant O 0 0.0017109799664467573
by O 0 4.362544495961629e-05
the O 0 0.00015038374112918973
allele O 0 0.002376556396484375
- O 0 0.0014035532949492335
specific O 0 0.0002486541052348912
oligonucleotide O 0 0.024260899052023888
( O 0 0.002057531150057912
ASO O 1 0.996466875076294
) O 0 0.0004965284024365246
method O 0 0.00079155876301229
. O 0 0.0009865203173831105

RESULTS O 0 0.0024149350356310606
In O 0 0.00019917497411370277
persons O 0 0.0004465079109650105
at O 0 0.0003696463245432824
average O 0 0.002846927149221301
risk O 1 0.992438018321991
for O 1 0.7470797896385193
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999983310699463
, O 0 0.0009317362564615905
I1307K O 0 0.49952632188796997
was O 0 0.0004663072759285569
found O 0 0.0001782242179615423
in O 0 0.00015387460007332265
5 O 0 0.0008111676434054971
. O 0 0.000623086525592953

0 O 0 0.0007066476391628385
% O 0 4.386205182527192e-05
of O 0 3.2897823984967545e-05
120 O 0 0.0005287459352985024
European O 0 0.00040699419332668185
and O 0 0.0002147185441572219
1 O 0 0.0009594981675036252
. O 0 0.0005543979932554066

6 O 0 0.0011651008389890194
% O 0 5.759351552114822e-05
of O 0 4.867218740400858e-05
188 O 0 0.004855090286582708
non O 0 0.0016898448811843991
- O 0 0.001678487635217607
European O 0 0.0003838316770270467
Jews O 0 0.0005210995441302657
( O 0 0.0008951356867328286
P O 0 0.015766724944114685
= O 0 0.0017955079674720764
0 O 0 0.00044210866326466203
. O 0 0.00017515970102977008
08 O 0 0.009671421721577644
) O 0 0.00042872634367085993
. O 0 0.0004299213760532439

It O 0 0.001116170547902584
occurred O 0 0.0018062321469187737
in O 0 0.0003364108270034194
15 O 0 0.0012664636597037315
. O 0 0.0009134579449892044

4 O 0 0.0007753998506814241
% O 0 6.318886880762875e-05
of O 0 5.310004053171724e-05
52 O 0 0.002931992057710886
Ashkenazi O 0 0.03534011170268059
Israelis O 0 0.002828185213729739
with O 0 0.000891595147550106
familial O 1 0.9997795224189758
cancer B-Disease 1 0.9999860525131226
( O 0 0.002651933114975691
P O 0 0.3442326784133911
= O 0 0.0024814268108457327
0 O 0 0.0005287777166813612
. O 0 0.00020091792976018041
02 O 0 0.49027562141418457
) O 0 0.00013826304348185658
and O 0 8.47830597194843e-05
was O 0 0.00034358224365860224
not O 0 8.33727972349152e-05
detected O 0 0.0011636955896392465
in O 0 8.457294461550191e-05
51 O 0 0.0009138488676398993
non O 0 0.0007929561543278396
- O 0 0.001021200674585998
European O 0 0.00018307377467863262
Jews O 0 0.0002346784749533981
at O 0 0.0009911733213812113
increased O 0 0.3327570855617523
cancer B-Disease 1 0.999981164932251
risk O 1 0.9692084789276123
. O 0 0.0009136177250184119

Colorectal B-Disease 1 0.9999222755432129
neoplasia I-Disease 1 0.9991936087608337
occurred O 0 0.01880030706524849
personally O 0 0.1669778823852539
or O 0 0.00021039000421296805
in O 0 5.991437137708999e-05
the O 0 5.62928689760156e-05
families O 0 5.649588638334535e-05
of O 0 1.3912874237576034e-05
13 O 0 0.0002272980782436207
of O 0 3.101750189671293e-05
20 O 0 0.0007901674252934754
Ashkenazi O 0 0.22584417462348938
I1307K O 0 0.06600543111562729
carriers O 0 0.0035319384187459946
, O 0 0.00012125192006351426
8 O 0 0.0001697917323326692
of O 0 2.3876214982010424e-05
whom O 0 0.0009398901602253318
also O 0 0.0001533208560431376
had O 0 0.00018426218593958765
a O 0 0.00029380866908468306
personal O 0 0.0006470059743151069
or O 0 0.00025200715754181147
family O 0 0.0003472355310805142
history O 0 0.00022482842905446887
of O 0 0.00019708144827745855
noncolonic O 1 0.9953435063362122
neoplasia B-Disease 1 0.9977572560310364
. O 0 0.0020133184734731913

CONCLUSIONS O 0 0.00964242685586214
The O 0 0.0017320070182904601
I1307K O 0 0.39355742931365967
APC O 1 0.9697811603546143
variant O 0 0.01616775244474411
may O 0 0.0005443247500807047
represent O 0 0.00013378181029111147
a O 0 0.0007107499404810369
susceptibility O 1 0.7432374358177185
gene O 0 0.002529113320633769
for O 0 0.0015251378063112497
colorectal B-Disease 1 0.9999938011169434
, I-Disease 0 0.0002445093705318868
or I-Disease 0 0.0002256969892187044
other I-Disease 0 0.00010864259820664302
, I-Disease 0 0.0009353510104119778
cancers I-Disease 1 0.9997767806053162
in O 0 0.0003271835157647729
Ashkenazi O 0 0.2649761736392975
Jews O 0 0.0003714348131325096
, O 0 0.00017945711442735046
and O 0 0.0001933906605700031
partially O 0 0.023306332528591156
explains O 0 0.001006106729619205
the O 0 0.0001068222481990233
higher O 0 0.0015394065994769335
incidence O 1 0.9991577863693237
of O 0 0.01576872356235981
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999985694885254
in O 0 0.0003549755201674998
European O 0 0.0012867397163063288
Israelis O 0 0.007925057783722878
. O 0 0.0009251596056856215

Systematic O 0 0.004465406760573387
analysis O 0 0.00048504528240300715
of O 0 0.00016933241568040103
coproporphyrinogen O 1 0.9864330887794495
oxidase O 1 0.7412387728691101
gene O 0 0.015641137957572937
defects O 1 0.9974728226661682
in O 0 0.0008581384900026023
hereditary B-Disease 1 0.9918267726898193
coproporphyria I-Disease 1 0.9910721182823181
and O 0 0.000594590965192765
mutation O 0 0.006926544476300478
update O 0 0.011729931458830833
. O 0 0.001031517400406301

Hereditary B-Disease 1 0.9807149171829224
coproporphyria I-Disease 1 0.9830908179283142
( O 0 0.0066719357855618
HC B-Disease 1 0.9997996687889099
) O 0 0.0007019592449069023
is O 0 0.0005035294452682137
an O 0 0.004578364547342062
acute O 1 0.9999897480010986
hepatic B-Disease 1 0.9999922513961792
porphyria I-Disease 1 0.9999512434005737
with O 0 0.003178424434736371
autosomal O 1 0.9966117739677429
dominant O 0 0.19622085988521576
inheritance O 0 0.4766271710395813
caused O 1 0.8394729495048523
by O 0 0.0006264690891839564
deficient B-Disease 1 0.9979382157325745
activity I-Disease 0 0.0004308271745685488
of I-Disease 0 0.0001232441863976419
coproporphyrinogen I-Disease 1 0.9902148246765137
III I-Disease 1 0.9720773100852966
oxidase I-Disease 0 0.026836371049284935
( O 0 0.0010297116823494434
CPO O 0 0.023675672709941864
) O 0 0.000535199127625674
. O 0 0.0008360297069884837

Clinical O 1 0.9965354204177856
manifestations O 0 0.06732046604156494
of O 0 0.00016598431102465838
the O 0 0.0276899766176939
disease O 1 0.9999887943267822
are O 0 0.0001367806107737124
characterized O 1 0.9625652432441711
by O 0 0.0005832028691656888
acute O 1 0.9999778270721436
attacks O 0 0.007524274289608002
of O 0 0.0010385094210505486
neurological B-Disease 1 0.9999988079071045
dysfunction I-Disease 1 0.9999597072601318
often O 0 0.0032654423266649246
precipitated O 1 0.9946516752243042
by O 0 0.00040311881457455456
drugs O 0 0.39425256848335266
, O 0 0.0004053152515552938
fasting O 0 0.022518906742334366
, O 0 0.0005483801360242069
cyclical O 1 0.9908361434936523
hormonal O 1 0.9656229615211487
changes O 0 0.0013335909461602569
, O 0 0.0010055031161755323
or O 0 0.13417308032512665
infectious B-Disease 1 0.9999867677688599
diseases I-Disease 1 0.9999762773513794
. O 0 0.002134556882083416

Skin O 1 0.9999759197235107
photosensitivity O 1 0.9997472167015076
may O 0 0.013180009089410305
also O 0 0.0002163187018595636
be O 0 8.384022657992318e-05
present O 0 0.00023706907813902944
. O 0 0.0005867402069270611

The O 0 0.0005283434293232858
seven O 0 0.0005004212725907564
exons O 0 0.002128884196281433
, O 0 0.00017551997734699398
the O 0 0.000344039814081043
exon O 0 0.02744024619460106
/ O 0 0.0094607537612319
intron O 0 0.010338845662772655
boundaries O 0 0.00012176670134067535
and O 0 5.643665281240828e-05
part O 0 0.00015105576312635094
of O 0 2.1791023755213246e-05
3 O 0 0.00023746496299281716
noncoding O 0 0.002098537515848875
sequence O 0 2.507580393285025e-05
of O 0 1.4588096746592782e-05
the O 0 0.00025147339329123497
CPO O 0 0.027731318026781082
gene O 0 0.0007633722270838916
were O 0 3.682621172629297e-05
systematically O 0 0.0012965098721906543
analyzed O 0 0.0003945485223084688
by O 0 3.526842556311749e-05
an O 0 0.00017567118629813194
exon O 0 0.007638868410140276
- O 0 0.0014607654884457588
by O 0 0.0001250878704013303
- O 0 0.003209445858374238
exon O 0 0.008929596282541752
denaturing O 0 0.10171817243099213
gradient O 0 0.019681086763739586
gel O 1 0.947746217250824
electrophoresis O 0 0.22235459089279175
( O 0 0.0031595462933182716
DGGE O 1 0.9716675281524658
) O 0 0.0003996235318481922
strategy O 0 0.001327185775153339
followed O 0 0.00012221842189319432
by O 0 2.3862125090090558e-05
direct O 0 7.442162313964218e-05
sequencing O 0 0.00022710354824084789
in O 0 7.480583735741675e-05
seven O 0 0.00033064786111935973
unrelated O 0 0.01642255298793316
heterozygous O 0 0.10061687231063843
HC B-Disease 1 0.9999573230743408
patients O 1 0.9998031258583069
from O 0 0.0003609346167650074
France O 0 0.003341245697811246
, O 0 0.00047327831271104515
Holland O 0 0.019146714359521866
, O 0 0.00013495853636413813
and O 0 0.00013449105608742684
Czech O 0 0.002513276180252433
Republic O 0 0.0010003728093579412
. O 0 0.0008023450500331819

Seven O 0 0.0022121956571936607
novel O 0 0.003652217797935009
mutations O 0 0.0014989468036219478
and O 0 6.854427192592993e-05
two O 0 4.7756362619111314e-05
new O 0 0.0002469713508617133
polymorphisms O 0 0.0019562591332942247
were O 0 0.0001539575168862939
detected O 0 0.009669731371104717
. O 0 0.0009030577493831515

Among O 0 0.0004965965053997934
these O 0 9.997368033509701e-05
mutations O 0 0.0007112675812095404
two O 0 5.391033482737839e-05
are O 0 8.301127672893927e-05
missense O 0 0.007489922922104597
( O 0 0.0009791416814550757
G197W O 0 0.043690718710422516
, O 0 0.0003710412420332432
W427R O 0 0.010037294588983059
) O 0 0.0001267960324184969
, O 0 5.004908234695904e-05
two O 0 2.81907068711007e-05
are O 0 5.727420648327097e-05
nonsense O 0 0.004616096615791321
( O 0 0.0007453254656866193
Q306X O 0 0.023967459797859192
, O 0 0.0002913505886681378
Q385X O 0 0.01059793308377266
) O 0 0.00011240953608648852
, O 0 3.845434548566118e-05
two O 0 1.2762729966198094e-05
are O 0 1.1028326298401225e-05
small O 0 0.0001629273610888049
deletions O 0 0.0019773109816014767
( O 0 0.000722666212823242
662de14bp O 0 0.023288104683160782
; O 0 0.00022678029199596494
1168del3bp O 0 0.01630299724638462
removing O 0 0.0021908425260335207
a O 0 0.00043082761112600565
glycine O 0 0.002375870943069458
at O 0 0.0002555893734097481
position O 0 0.0008246616926044226
390 O 0 0.005795461591333151
) O 0 0.0001423786161467433
, O 0 6.280631350819021e-05
and O 0 2.5739129341673106e-05
one O 0 3.645099786808714e-05
is O 0 5.0798291340470314e-05
a O 0 0.0001730578369461
splicing O 0 0.000942739425227046
mutation O 0 0.0019369915826246142
( O 0 0.0009651478612795472
IVS1 O 1 0.9275016784667969
- O 0 0.006806296296417713
15c O 0 0.0838126540184021
- O 0 0.005368352867662907
- O 0 0.0037197591736912727
> O 0 0.004505094140768051
g O 0 0.0019027809612452984
) O 0 8.673157572047785e-05
which O 0 4.526303746388294e-05
creates O 0 0.0009350231848657131
a O 0 0.00045677245361730456
new O 0 0.000678173906635493
acceptor O 0 0.01839994639158249
splice O 0 0.017355209216475487
site O 0 0.0034309634938836098
. O 0 0.0011580586433410645

The O 0 0.0014356339816004038
pathological O 0 0.1271761804819107
significance O 0 0.0003144817310385406
of O 0 2.3464108380721882e-05
the O 0 0.00015626015374436975
point O 0 0.0006464114994741976
mutations O 0 0.0021806545555591583
G197W O 0 0.016500188037753105
, O 0 0.00027565809432417154
W427R O 0 0.007638153154402971
, O 0 5.820705700898543e-05
and O 0 3.555889998096973e-05
the O 0 7.227915193652734e-05
in O 0 0.00019396741117816418
- O 0 0.007432789541780949
frame O 0 0.004125288687646389
deletion O 0 0.008359351195394993
390delGly O 0 0.030955864116549492
were O 0 9.771549957804382e-05
assessed O 0 0.0018629690166562796
by O 0 3.517068762448616e-05
their O 0 3.807738903560676e-05
respective O 0 0.00023755960864946246
expression O 0 0.0003469869843684137
in O 0 9.89040854619816e-05
a O 0 0.0004139981174375862
prokaryotic O 0 0.0010470140259712934
system O 0 0.0005777186015620828
using O 0 0.00024063415185082704
site O 0 0.0012754956260323524
- O 0 0.0037361301947385073
directed O 0 0.0006464052712544799
mutagenesis O 0 0.02095435932278633
. O 0 0.0011649250518530607

These O 0 0.00039387005381286144
mutations O 0 0.0016436191508546472
resulted O 0 0.0006652158917859197
in O 0 8.583179442211986e-05
the O 0 0.00015920522855594754
absence O 0 0.0025564762763679028
or O 0 0.00019092981528956443
a O 0 0.0004215989902149886
dramatic O 0 0.0019520348869264126
decrease O 0 0.0015469349455088377
of O 0 0.00010804234625538811
CPO O 0 0.070432148873806
activity O 0 0.0014432828174903989
. O 0 0.000886238762177527

The O 0 0.0003390384081285447
two O 0 0.00012735501513816416
polymorphisms O 0 0.0014090279582887888
were O 0 9.017180855153129e-05
localized O 0 0.005997082218527794
in O 0 0.000201608199859038
noncoding O 0 0.0072959293611347675
part O 0 0.00016092651640065014
of O 0 1.5843666915316135e-05
the O 0 0.0001148925002780743
gene O 0 0.0005539141711778939
1 O 0 0.0002284230140503496
) O 0 0.0001021934804157354
a O 0 0.0006494706613011658
C O 0 0.07571066170930862
/ O 0 0.01595141738653183
G O 0 0.005097534973174334
polymorphism O 0 0.0006764188874512911
in O 0 0.00014150052447803319
the O 0 0.0004609140451066196
promotor O 1 0.8739143013954163
region O 0 0.001868225634098053
, O 0 0.00031555749592371285
142 O 0 0.0040365359745919704
bp O 0 0.014716493897140026
upstream O 0 0.0009296878124587238
from O 0 4.1691455407999456e-05
the O 0 8.94292097655125e-05
transcriptional O 0 0.0016469580586999655
initiation O 0 0.0023954110220074654
site O 0 0.0013997801579535007
( O 0 0.0009830358903855085
- O 0 0.008055748417973518
142C O 0 0.046809762716293335
/ O 0 0.025571854785084724
G O 0 0.00623029051348567
) O 0 0.00010907098476309329
, O 0 5.836117634316906e-05
and O 0 5.768294067820534e-05
2 O 0 0.00019824261835310608
) O 0 7.533630559919402e-05
a O 0 0.0002834660408552736
6 O 0 0.0008566145552322268
bp O 0 0.010764146223664284
deletion O 0 0.001773574622347951
polymorphism O 0 0.0006037508137524128
in O 0 6.119554745964706e-05
the O 0 0.00011675733549054712
3 O 0 0.0004413298738654703
noncoding O 0 0.004165985155850649
part O 0 0.00015270178846549243
of O 0 2.5000490495585836e-05
the O 0 0.00034282656270079315
CPO O 0 0.029222669079899788
gene O 0 0.0018870382336899638
, O 0 0.0003727179719135165
574 O 0 0.0674494281411171
bp O 0 0.018752973526716232
downstream O 0 0.0011948966421186924
of O 0 2.2124148017610423e-05
the O 0 0.0001425458467565477
last O 0 0.00024643930373713374
base O 0 0.000152172680827789
of O 0 1.0434875548526179e-05
the O 0 0.0001228662149515003
normal O 0 0.0019773526582866907
termination O 0 0.03379730507731438
codon O 0 0.004723663441836834
( O 0 0.001476528588682413
+ O 0 0.022984616458415985
574 O 0 0.10751354694366455
delATTCTT O 0 0.053799182176589966
) O 0 0.000707576866261661
. O 0 0.0007210767362266779

Five O 0 0.0027390760369598866
intragenic O 1 0.8489445447921753
dimorphisms O 0 0.1974814385175705
are O 0 0.00012910767691209912
now O 0 0.00041874239104799926
well O 0 0.00023091280309017748
characterized O 0 0.05152997747063637
and O 0 0.00010374375415267423
the O 0 0.0001511116570327431
high O 0 0.0010045799426734447
degree O 0 0.00045926589518785477
of O 0 6.740198296029121e-05
allelic O 0 0.04013683646917343
heterogeneity O 0 0.018365494906902313
in O 0 0.0011501344852149487
HC B-Disease 1 0.9998488426208496
is O 0 0.000559269159566611
demonstrated O 0 0.0011483293492347002
with O 0 6.655468314420432e-05
seven O 0 0.00012020661233691499
new O 0 6.498701259260997e-05
different O 0 2.3541033442597836e-05
mutations O 0 0.00030134289409033954
making O 0 6.115261203376576e-05
a O 0 7.109164289431646e-05
total O 0 4.0346611058339477e-05
of O 0 3.375730739207938e-05
nineteen O 0 0.006054539233446121
CPO O 1 0.9213018417358398
gene B-Disease 0 0.03391033411026001
defects I-Disease 1 0.9992853999137878
reported O 0 0.0033926356118172407
so O 0 0.00047433353029191494
far O 0 0.0006051812670193613
. O 0 0.0002789634745568037
. O 0 0.0005748678231611848

Coincidence O 0 0.003182451706379652
of O 0 4.997687938157469e-05
two O 0 0.00016013607091736048
novel O 0 0.0025090326089411974
arylsulfatase O 0 0.2089691013097763
A O 0 0.001761351595632732
alleles O 0 0.0018555348506197333
and O 0 0.00026465460541658103
mutation O 0 0.004143749829381704
459 O 1 0.6185485124588013
+ O 0 0.041625406593084335
1G O 0 0.43297848105430603
> O 0 0.005427319090813398
A O 0 0.000584834604524076
within O 0 9.771613986231387e-05
a O 0 0.0004501494695432484
family O 0 0.0006909462972544134
with O 0 0.0007826705696061254
metachromatic B-Disease 1 0.9993009567260742
leukodystrophy I-Disease 1 0.9998528957366943
: O 0 0.0004747892962768674
molecular O 0 0.0004403660714160651
basis O 0 5.712387428502552e-05
of O 0 5.7676945289131254e-05
phenotypic O 0 0.01732526905834675
heterogeneity O 0 0.043976932764053345
. O 0 0.0019771659281104803

In O 0 0.0005966941243968904
a O 0 0.0006016850820742548
family O 0 0.0004835191648453474
with O 0 9.755890641827136e-05
three O 0 0.00018987142539117485
siblings O 0 0.0020252764225006104
, O 0 9.882622543955222e-05
one O 0 8.297337626572698e-05
developed O 0 0.0011479170061647892
classical O 0 0.0004896032041870058
late O 0 0.006736216135323048
infantile O 1 0.9997267127037048
metachromatic B-Disease 1 0.9991437196731567
leukodystrophy I-Disease 1 0.9998914003372192
( O 0 0.021022526547312737
MLD B-Disease 1 0.9997784495353699
) O 0 0.0007169446907937527
, O 0 0.0006664805696345866
fatal O 1 0.9990866184234619
at O 0 0.00043992194696329534
age O 0 0.0005412527243606746
5 O 0 0.00036639280733652413
years O 0 0.00025216961512342095
, O 0 0.000125493694213219
with O 0 0.00039978892891667783
deficient O 1 0.9995225667953491
arylsulfatase O 1 0.7268865704536438
A O 0 0.0051120067946612835
( O 0 0.0016431770054623485
ARSA O 1 0.9952735304832458
) O 0 0.00017315834702458233
activity O 0 0.00021413770446088165
and O 0 0.00012260056973900646
increased O 0 0.001320050796493888
galactosylsulfatide O 1 0.9642911553382874
( O 0 0.0033690498676151037
GS O 1 0.9976467490196228
) O 0 0.0009010748472064734
excretion O 0 0.01816180720925331
. O 0 0.0010021677007898688

The O 0 0.0003094311396125704
two O 0 8.640376472612843e-05
other O 0 0.0001285448088310659
siblings O 0 0.0039617205038666725
, O 0 0.0003668772696983069
apparently O 0 0.002700596582144499
healthy O 0 0.01133507676422596
at O 0 0.0003562812926247716
12 O 0 0.00039975158870220184
( O 0 0.0002477330854162574
1 O 0 0.0005370191065594554
/ O 0 0.00253631011582911
2 O 0 0.00015751674072816968
) O 0 5.506821253220551e-05
and O 0 6.757387018296868e-05
15 O 0 0.0002515354717615992
years O 0 0.0002000283420784399
, O 0 8.498898387188092e-05
respectively O 0 0.00020652306557167321
, O 0 7.045279198791832e-05
and O 0 5.5875010730233043e-05
their O 0 8.264944335678592e-05
father O 0 0.0033196720760315657
, O 0 0.0003139146720059216
apparently O 0 0.0038136932998895645
healthy O 0 0.04839576408267021
as O 0 0.00010566448327153921
well O 0 0.0001671244390308857
, O 0 0.00026933662593364716
presented O 0 0.002698219381272793
ARSA O 1 0.9955590963363647
and O 0 0.0007993733161129057
GS O 1 0.9947654008865356
values O 0 9.831047646002844e-05
within O 0 4.3048559746239334e-05
the O 0 7.139388617360964e-05
range O 0 0.0005905367434024811
of O 0 0.000423408200731501
MLD B-Disease 1 0.999970555305481
patients O 1 0.9997804760932922
. O 0 0.001273110625334084

Mutation O 0 0.014683524146676064
screening O 0 0.004052349366247654
and O 0 0.0001414652942912653
sequence O 0 0.00020488868176471442
analysis O 0 0.0005153484526090324
disclosed O 0 0.005577412899583578
the O 0 0.00012059775326633826
involvement O 0 0.001206824672408402
of O 0 2.274175494676456e-05
three O 0 0.00010762795136542991
different O 0 0.0002741024363785982
ARSA O 1 0.9978734254837036
mutations O 0 0.0025684856809675694
being O 0 0.00015938840806484222
the O 0 8.882662223186344e-05
molecular O 0 0.0004089401045348495
basis O 0 6.452110392274335e-05
of O 0 7.27506194380112e-05
intrafamilial O 1 0.8867315053939819
phenotypic O 0 0.01785079389810562
heterogeneity O 0 0.031185509636998177
. O 0 0.0017280622851103544

The O 0 0.0023457331117242575
late O 0 0.036931637674570084
infantile O 1 0.9998990297317505
patient O 1 0.9998624324798584
inherited O 1 0.9951289892196655
from O 0 0.00029435931355692446
his O 0 0.0019751458894461393
mother O 0 0.0053230756893754005
the O 0 0.00013954647874925286
frequent O 0 0.003062962554395199
0 O 0 0.0009526118519715965
- O 0 0.0025726023595780134
type O 0 0.0019793992396444082
mutation O 0 0.0027764919213950634
459 O 0 0.18963241577148438
+ O 0 0.022370146587491035
1G O 0 0.31861886382102966
> O 0 0.0071820481680333614
A O 0 0.0009047156781889498
, O 0 0.0001003321012831293
and O 0 5.075804438092746e-05
from O 0 5.997822881909087e-05
his O 0 0.0006637125043198466
father O 0 0.0015265747206285596
a O 0 0.00042475457303225994
novel O 0 0.0009187374962493777
, O 0 0.00012902887829113752
single O 0 0.0004152419278398156
basepair O 0 0.12215511500835419
microdeletion O 0 0.0063318791799247265
of O 0 2.5760416974662803e-05
guanine O 0 0.0007402032497338951
at O 0 0.00011187443305971101
nucleotide O 0 0.0001593882479937747
7 O 0 0.00023081109975464642
in O 0 0.00012289141886867583
exon O 0 0.005216244608163834
1 O 0 0.0006417174590751529
( O 0 0.0007596666691824794
7delG O 0 0.04046156629920006
) O 0 0.0005219493759796023
. O 0 0.0006599211483262479

The O 0 0.0009168857941403985
two O 0 0.0005863675614818931
clinically O 1 0.9912638664245605
unaffected O 0 0.37019801139831543
siblings O 0 0.0024010075721889734
carried O 0 0.00029199410346336663
the O 0 0.0002720983175095171
maternal O 0 0.021094173192977905
mutation O 0 0.007873316295444965
459 O 1 0.9675977230072021
+ O 0 0.17549562454223633
1G O 1 0.9127529859542847
> O 0 0.014636162668466568
A O 0 0.0011723802890628576
and O 0 9.934750414686278e-05
, O 0 7.808913505868986e-05
on O 0 4.8108053306350484e-05
their O 0 5.6806027714628726e-05
paternal O 0 0.0025539351627230644
allele O 0 0.0018535708077251911
, O 0 0.0001216345262946561
a O 0 0.00041043752571567893
novel O 0 0.0011977963149547577
cytosine O 0 0.0026359776966273785
to O 0 0.000203451985726133
thymidine O 0 0.009028126485645771
transition O 0 0.0016800056910142303
at O 0 0.00041315556154586375
nucleotide O 0 0.0010947969276458025
2435 O 0 0.164579376578331
in O 0 0.0004351445531938225
exon O 0 0.008626502938568592
8 O 0 0.0005175116821192205
, O 0 0.00011904627172043547
resulting O 0 0.00030533058452419937
in O 0 4.805972639587708e-05
substitution O 0 0.0001745312038110569
of O 0 6.413457595044747e-05
alanine O 0 0.02393396757543087
464 O 0 0.05036246031522751
by O 0 0.00044564640847966075
valine O 0 0.21737352013587952
( O 0 0.0017323417123407125
A464V O 0 0.07097537815570831
) O 0 0.0006761011900380254
. O 0 0.0007089849095791578

The O 0 0.0011420262744650245
fathers O 0 0.004735616501420736
genotype O 0 0.01830272376537323
thus O 0 0.0008221524767577648
was O 0 0.0026311632245779037
7delG O 1 0.8962727189064026
/ O 0 0.3613576591014862
A464V O 0 0.044005136936903
. O 0 0.001056020613759756

Mutation O 0 0.016555653885006905
A464V O 0 0.0369146466255188
was O 0 0.0008054340723901987
not O 0 0.00011114576045656577
found O 0 0.0001454760058550164
in O 0 0.00016433205746579915
18 O 0 0.0013171108439564705
unrelated O 1 0.9747443795204163
MLD B-Disease 1 0.9999440908432007
patients O 1 0.9997482895851135
and O 0 0.00026782171335071325
50 O 0 0.0005115415551699698
controls O 0 0.002156830858439207
. O 0 0.0007639610557816923

A464V O 0 0.05309572070837021
, O 0 0.0005961602437309921
although O 0 0.0005588109488599002
clearly O 0 0.002308786613866687
modifying O 0 0.20117326080799103
ARSA O 1 0.9976279139518738
and O 0 0.0021333391778171062
GS O 1 0.9996601343154907
levels O 0 0.005533135496079922
, O 0 0.00038444140227511525
apparently O 0 0.0031250074971467257
bears O 0 0.0032990933395922184
little O 0 0.0005249534733593464
significance O 0 0.0004943187814205885
for O 0 0.0004384999047033489
clinical O 1 0.9981208443641663
manifestation O 1 0.8202995657920837
of O 0 0.0003863633028231561
MLD B-Disease 1 0.9998855590820312
, O 0 0.0010239077964797616
mimicking O 0 0.04375085234642029
the O 0 0.0009542614570818841
frequent O 0 0.10656846314668655
ARSA O 1 0.9952585101127625
pseudodeficiency O 1 0.674389123916626
allele O 0 0.015643596649169922
. O 0 0.002005984541028738

Our O 0 0.0016090101562440395
results O 0 0.0007064139936119318
demonstrate O 0 0.0008786303224042058
that O 0 5.329016494215466e-05
in O 0 6.881377339595929e-05
certain O 0 0.00023934979981277138
genetic O 0 0.004325546324253082
conditions O 1 0.9575074911117554
MLD B-Disease 1 0.9998847246170044
- O 0 0.36963576078414917
like O 0 0.0027126416098326445
ARSA O 1 0.9974019527435303
and O 0 0.001436576247215271
GS O 1 0.9974491000175476
values O 0 0.00020434999896679074
need O 0 0.00036179416929371655
not O 0 5.1375442126300186e-05
be O 0 6.327847222564742e-05
paralleled O 0 0.003212891984730959
by O 0 0.00043004759936593473
clinical O 1 0.9999266862869263
disease O 1 0.9999798536300659
, O 0 0.0001662497961660847
a O 0 0.00041160022374242544
finding O 0 0.001280255732126534
with O 0 0.0006063036271370947
serious O 1 0.9990798234939575
diagnostic O 1 0.9988051652908325
and O 0 0.0010529266437515616
prognostic O 1 0.9942495822906494
implications O 0 0.0962027832865715
. O 0 0.001241686288267374

Moreover O 0 0.009347951970994473
, O 0 0.0009294043993577361
further O 0 0.002430760068818927
ARSA O 1 0.9860040545463562
alleles O 0 0.008830578997731209
functionally O 0 0.014931225217878819
similar O 0 0.000505977135617286
to O 0 0.0003723220434039831
A464V O 0 0.09858415275812149
might O 0 0.0005271653062663972
exist O 0 9.145579679170623e-05
which O 0 1.7685159036773257e-05
, O 0 3.116628431598656e-05
together O 0 2.6469835574971512e-05
with O 0 7.891400309745222e-05
0 O 0 0.0006946687935851514
- O 0 0.003119298256933689
type O 0 0.0019348891219124198
mutations O 0 0.0013776773121207952
, O 0 0.0002253449783893302
may O 0 0.0031511427368968725
cause O 1 0.9377540946006775
pathological O 1 0.9995331764221191
ARSA O 1 0.9996949434280396
and O 0 0.004100266378372908
GS O 1 0.9998546838760376
levels O 0 0.0029960405081510544
, O 0 0.00019011979748029262
but O 0 0.00019040876941289753
not O 0 0.00021497276611626148
clinical O 1 0.9975887537002563
outbreak O 1 0.9751944541931152
of O 0 8.352279110113159e-05
the O 0 0.0172842126339674
disease O 1 0.9999818801879883
. O 0 0.000447713682660833
. O 0 0.0009206183603964746

Human O 1 0.9539687633514404
MLH1 O 1 0.9996845722198486
deficiency O 1 0.9999760389328003
predisposes O 1 0.9984865188598633
to O 0 0.004941653925925493
hematological B-Disease 1 0.9996877908706665
malignancy I-Disease 1 0.9998786449432373
and O 0 0.012182994745671749
neurofibromatosis B-Disease 1 0.9999672174453735
type I-Disease 0 0.29282644391059875
1 I-Disease 0 0.0016937467735260725
. O 0 0.0008353313314728439

Heterozygous O 0 0.03946659713983536
germ O 1 0.9573574066162109
- O 0 0.006968855392187834
line O 0 0.0009724299889057875
mutations O 0 0.0006404368323273957
in O 0 5.045199941378087e-05
the O 0 0.00014592504885513335
DNA O 0 0.0018189947586506605
mismatch O 1 0.9814305901527405
repair O 1 0.993229866027832
genes O 0 0.0006130008259788156
lead O 0 0.0005720060435123742
to O 0 0.0007682172581553459
hereditary B-Disease 1 0.9993404746055603
nonpolyposis I-Disease 1 0.9999295473098755
colorectal I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999974966049194
. O 0 0.003348895348608494

The O 0 0.029804762452840805
disease O 1 0.9999489784240723
susceptibility O 1 0.6677961349487305
of O 0 9.337003575637937e-05
individuals O 0 0.0005621432792395353
who O 0 0.0011920796241611242
constitutionally O 0 0.006962057668715715
lack O 0 0.0013057346222922206
both O 0 0.00015472604718524963
wild O 0 0.0012921704910695553
- O 0 0.010435687378048897
type O 0 0.002775877946987748
alleles O 0 0.0018615260487422347
is O 0 0.00040203885873779655
unknown O 0 0.0009013251401484013
. O 0 0.0007149250595830381

We O 0 0.0006853737868368626
have O 0 0.00012502155732363462
identified O 0 0.00020266555657144636
three O 0 5.604610123555176e-05
offspring O 0 0.0005875169881619513
in O 0 0.00013768719509243965
a O 0 0.004568129777908325
hereditary B-Disease 1 0.9993641972541809
nonpolyposis I-Disease 1 0.9999498128890991
colorectal I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999995231628418
family O 0 0.05368351563811302
who O 0 0.0072489455342292786
developed O 1 0.9635047912597656
hematological B-Disease 1 0.9998600482940674
malignancy I-Disease 1 0.9997952580451965
at O 0 0.0006468690116889775
a O 0 0.0005645108758471906
very O 0 0.000586514885071665
early O 0 0.000340416154358536
age O 0 0.0002956322277896106
, O 0 8.427154534729198e-05
and O 0 7.373195694526657e-05
at O 0 0.0001277802512049675
least O 0 4.529529178398661e-05
two O 0 8.912642442737706e-06
of O 0 9.43622762861196e-06
them O 0 5.891774708288722e-05
displayed O 0 0.001145821064710617
signs O 0 0.002758611226454377
of O 0 0.00022174467449076474
neurofibromatosis B-Disease 1 0.9999485015869141
type I-Disease 0 0.05764801427721977
1 I-Disease 0 0.002042860956862569
( O 0 0.0020187371410429478
NF1 B-Disease 1 0.9935001730918884
) O 0 0.0006919188890606165
. O 0 0.0006884449976496398

DNA O 0 0.0013058414915576577
sequence O 0 0.0001538362994324416
analysis O 0 0.0002810556616168469
and O 0 0.00021937697601970285
allele O 0 0.003257381496950984
- O 0 0.0009961094474419951
specific O 0 0.00010162701801164076
amplification O 0 0.0010365750640630722
in O 0 9.859221609076485e-05
two O 0 0.00011603425082284957
siblings O 0 0.0028582350350916386
revealed O 0 0.0029021597001701593
a O 0 0.0008962003048509359
homozygous O 0 0.007597555872052908
MLH1 O 1 0.9807412028312683
mutation O 0 0.005473142955452204
( O 0 0.001233425340615213
C676T O 0 0.15380188822746277
- O 0 0.012159002013504505
- O 0 0.00689318124204874
> O 0 0.01004076935350895
Arg226Stop O 0 0.08274645358324051
) O 0 0.0006516074645332992
. O 0 0.00067951186792925

Thus O 0 0.001008300227113068
, O 0 0.0002490657789167017
a O 0 0.0011507647577673197
homozygous O 0 0.007085222285240889
germ O 1 0.9897053837776184
- O 0 0.017800021916627884
line O 0 0.004093170631676912
MLH1 O 1 0.992730438709259
mutation O 0 0.0038170930929481983
and O 0 0.0004474687739275396
consequent O 1 0.9960173964500427
mismatch O 1 0.9995724558830261
repair O 1 0.9999569654464722
deficiency O 1 0.999983549118042
results O 0 0.0011444598203524947
in O 0 0.0003977289597969502
a O 0 0.00490766204893589
mutator O 1 0.9978420734405518
phenotype O 1 0.9918087124824524
characterized O 1 0.9771466851234436
by O 0 0.00452241487801075
leukemia B-Disease 1 0.9999990463256836
and O 0 0.026974309235811234
/ O 1 0.9993547797203064
or O 1 0.774341881275177
lymphoma B-Disease 1 0.9999997615814209
associated O 0 0.0019186876015737653
with O 0 0.0012199728516861796
neurofibromatosis B-Disease 1 0.9999734163284302
type I-Disease 0 0.06605324894189835
1 I-Disease 0 0.0007621526601724327
. O 0 0.00018917443230748177
. O 0 0.0005260622128844261

Missense O 0 0.04688122868537903
mutations O 0 0.0022771647199988365
in O 0 8.355297904927284e-05
the O 0 6.185741949593648e-05
most O 0 5.74145233258605e-05
ancient O 0 0.00015841882850509137
residues O 0 0.0003717270737979561
of O 0 3.633220330812037e-05
the O 0 0.0008456465438939631
PAX6 O 1 0.9982988238334656
paired O 0 0.003923229873180389
domain O 0 0.0008424504194408655
underlie O 0 0.023080935701727867
a O 0 0.0005028661107644439
spectrum O 0 0.001800675643607974
of O 0 0.00022903190983925015
human O 1 0.9981694221496582
congenital B-Disease 1 0.9999995231628418
eye I-Disease 1 0.9999750852584839
malformations I-Disease 1 0.9998586177825928
. O 0 0.0031379028223454952

Mutations O 0 0.00216180132701993
of O 0 4.899878695141524e-05
the O 0 0.0004796511784661561
human O 0 0.012123594991862774
PAX6 O 1 0.9989218711853027
gene O 0 0.02654142491519451
underlie O 1 0.9967033267021179
aniridia B-Disease 1 0.9993841648101807
( O 0 0.14771489799022675
congenital B-Disease 1 0.9999912977218628
absence I-Disease 0 0.004237557295709848
of I-Disease 0 5.6288896303158253e-05
the I-Disease 0 0.0011802819790318608
iris I-Disease 1 0.9994402527809143
) O 0 0.00018855673260986805
, O 0 0.00010502358782105148
a O 0 0.0004963580286130309
rare O 0 0.006578331813216209
dominant O 0 0.016926558688282967
malformation B-Disease 1 0.9987437129020691
of I-Disease 0 0.00011480171815492213
the I-Disease 0 0.0028279931284487247
eye I-Disease 1 0.9996885061264038
. O 0 0.0014569846680387855

The O 0 0.0006693877512589097
spectrum O 0 0.0027965179178863764
of O 0 0.0003647729172371328
PAX6 O 1 0.9982681274414062
mutations O 0 0.010332735255360603
in O 0 0.001491081202402711
aniridia B-Disease 1 0.9996656179428101
patients O 1 0.9998481273651123
is O 0 0.0003966611984651536
highly O 0 0.0019656284712255
biased O 0 0.0023619607090950012
, O 0 0.00010319733701180667
with O 0 5.9188609156990424e-05
92 O 0 0.0008884370909072459
% O 0 1.3646459592564497e-05
of O 0 1.3906785170547664e-05
all O 0 6.982181366765872e-05
reported O 0 0.001962984912097454
mutations O 0 0.0009374003275297582
leading O 0 0.0005997075932100415
to O 0 0.00019633964984677732
premature O 0 0.23485107719898224
truncation O 0 0.001899120514281094
of O 0 1.810725370887667e-05
the O 0 0.00012495565169956535
protein O 0 0.0005905336583964527
( O 0 0.0005274437135085464
nonsense O 0 0.0036957559641450644
, O 0 0.0001411232224199921
splicing O 0 0.0007037872564978898
, O 0 0.00016280268027912825
insertions O 0 0.0018423673463985324
and O 0 0.00012750567111652344
deletions O 0 0.0013863227795809507
) O 0 8.9411209046375e-05
and O 0 6.844472954981029e-05
just O 0 0.00017853819008450955
2 O 0 0.00010063911759061739
% O 0 1.2891121514257975e-05
leading O 0 0.00011525625450303778
to O 0 1.2755757779814303e-05
substitution O 0 4.310105578042567e-05
of O 0 6.126580501586432e-06
one O 0 4.184325007372536e-05
amino O 0 0.0001456734025850892
acid O 0 0.0012292384635657072
by O 0 6.621662760153413e-05
another O 0 0.0005253164563328028
( O 0 0.0007534432224929333
missense O 0 0.01035820972174406
) O 0 0.0005104716983623803
. O 0 0.0007765844347886741

The O 0 0.001023935736157
extraordinary O 0 0.0037035439163446426
conservation O 0 0.0021669857669621706
of O 0 3.82981525035575e-05
the O 0 0.0004970028530806303
PAX6 O 1 0.9849641919136047
protein O 0 0.0003098852466791868
at O 0 8.438782970188186e-05
the O 0 5.422681351774372e-05
amino O 0 0.00018140354950446635
acid O 0 0.0023221990559250116
level O 0 0.000685361388605088
amongst O 0 0.0009133135317824781
vertebrates O 0 0.0071934061124920845
predicts O 0 0.03164049983024597
that O 0 0.00029491999885067344
pathological O 1 0.9913830161094666
missense O 0 0.06703857332468033
mutations O 0 0.0024894634261727333
should O 0 0.000256130937486887
in O 0 0.00010563022806309164
fact O 0 0.0003375810629222542
be O 0 0.00011772078141802922
common O 0 0.000612806819844991
even O 0 0.00030582965700887144
though O 0 0.00021048028429504484
they O 0 3.258869764977135e-05
are O 0 2.8275573640712537e-05
hardly O 0 0.0013441643677651882
ever O 0 0.00046363769797608256
seen O 0 0.0009689294965937734
in O 0 0.0007972079911269248
aniridia B-Disease 1 0.999459445476532
patients O 1 0.9998001456260681
. O 0 0.0012387518072500825

This O 0 0.00036460792762227356
indicates O 0 0.0007618494564667344
that O 0 4.389234891277738e-05
there O 0 4.369809903437272e-05
is O 0 0.00012830845662392676
a O 0 0.0004935109172947705
heavy O 0 0.011730341240763664
ascertainment O 1 0.962984025478363
bias O 0 0.0014171331422403455
in O 0 4.938274287269451e-05
the O 0 6.692087481496856e-05
selection O 0 0.00030084431637078524
of O 0 0.00011342716607032344
patients O 1 0.9998856782913208
for O 0 0.0009535948629491031
PAX6 O 1 0.9992526173591614
mutation O 0 0.0016097357729449868
analysis O 0 0.00012796778173651546
and O 0 5.013420741306618e-05
that O 0 5.12376609549392e-05
the O 0 0.00025943267974071205
missing O 0 0.016446786001324654
PAX6 O 1 0.9963788390159607
missense O 0 0.05381316691637039
mutations O 0 0.006689250934869051
frequently O 0 0.0030445908196270466
may O 0 0.0035868766717612743
underlie O 1 0.9390658736228943
phenotypes O 0 0.015897883102297783
distinct O 0 0.0009594442672096193
from O 0 0.000517027045134455
textbook O 1 0.9758419990539551
aniridia B-Disease 1 0.994482159614563
. O 0 0.0022637750953435898

Here O 0 0.0007308616186492145
we O 0 0.00016813813999760896
present O 0 0.00015017224359326065
four O 0 0.0002220362366642803
novel O 0 0.006357510108500719
PAX6 O 1 0.9979427456855774
missense O 0 0.02199723944067955
mutations O 0 0.0014797721523791552
, O 0 0.000100030614703428
two O 0 5.6026969105005264e-05
in O 0 0.00023137759126257151
association O 0 0.022664038464426994
with O 0 0.0006579480250366032
atypical O 1 0.9987603425979614
phenotypes O 1 0.7967011332511902
ectopia B-Disease 1 0.9810278415679932
pupillae I-Disease 1 0.9541884064674377
( O 0 0.0016397240106016397
displaced B-Disease 0 0.014871849678456783
pupils I-Disease 0 0.008960012346506119
) O 0 0.0009618505137041211
and O 0 0.0031503187492489815
congenital B-Disease 1 0.9999909400939941
nystagmus I-Disease 1 0.9989140033721924
( O 0 0.0023201818112283945
searching B-Disease 0 0.005206020548939705
gaze I-Disease 0 0.15230797231197357
) O 0 0.00021487193589564413
, O 0 6.814365042373538e-05
and O 0 3.336658119224012e-05
two O 0 2.700290860957466e-05
in O 0 9.966194920707494e-05
association O 0 0.002481096191331744
with O 0 8.83694738149643e-05
more O 0 0.00038175107329152524
recognizable O 0 0.16091498732566833
aniridia B-Disease 1 0.9937485456466675
phenotypes O 0 0.11450933665037155
. O 0 0.001332442625425756

Strikingly O 0 0.028908561915159225
, O 0 0.00021645735250785947
all O 0 3.498970181681216e-05
four O 0 0.00011655544221866876
mutations O 0 0.00042554715764708817
are O 0 1.555768722028006e-05
located O 0 0.00020714863785542548
within O 0 0.00012078916188329458
the O 0 0.0006082584732212126
PAX6 O 1 0.9957067370414734
paired O 0 0.0025465979706496
domain O 0 0.0002678145538084209
and O 0 7.706023461651057e-05
affect O 0 0.0005978733533993363
amino O 0 0.000145030309795402
acids O 0 0.00018603001080919057
which O 0 1.965033334272448e-05
are O 0 1.4790643035667017e-05
highly O 0 0.0002702832571230829
conserved O 0 9.962241892935708e-05
in O 0 3.142539571854286e-05
all O 0 2.529076846258249e-05
known O 0 0.00033229871769435704
paired O 0 0.0011394716566428542
domain O 0 0.00038138494710437953
proteins O 0 0.000377307937014848
. O 0 0.0007336920243687928

Our O 0 0.00122825987637043
results O 0 0.0004719589778687805
support O 0 0.0002638061414472759
the O 0 0.00016156487981788814
hypothesis O 0 0.000888907874468714
that O 0 4.916973193758167e-05
the O 0 7.82904535299167e-05
under O 0 0.00027446329477243125
- O 0 0.0006389181944541633
representation O 0 6.87601204845123e-05
of O 0 4.917141632176936e-05
missense O 0 0.011780518107116222
mutations O 0 0.0018421290442347527
is O 0 0.0003671690938062966
caused O 0 0.014191338792443275
by O 0 0.00035237494739703834
ascertainment O 1 0.991209864616394
bias O 0 0.005063151009380817
and O 0 0.00014728477981407195
suggest O 0 0.0003438115818426013
that O 0 3.219780046492815e-05
a O 0 0.00019116919429507107
substantial O 0 0.0008754889131523669
burden O 0 0.19469445943832397
of O 0 0.0003400815767236054
PAX6 B-Disease 1 0.9999266862869263
- I-Disease 1 0.9969550371170044
related I-Disease 1 0.8326811194419861
disease I-Disease 1 0.9999711513519287
remains O 0 0.003241480328142643
to O 0 0.0001191430346807465
be O 0 0.00014760816702619195
uncovered O 0 0.004826008342206478
. O 0 0.00020756834419444203
. O 0 0.0006040898151695728

The O 0 0.0008888145675882697
chromosomal O 0 0.004584601614624262
order O 0 0.00011018924124073237
of O 0 2.653359842952341e-05
genes O 0 0.0004413107526488602
controlling O 0 0.002524107228964567
the O 0 0.0003703841066453606
major O 0 0.007528516463935375
histocompatibility O 1 0.9984140396118164
complex O 0 0.00437669362872839
, O 0 0.00045871498878113925
properdin O 0 0.45442840456962585
factor O 0 0.0023516931105405092
B O 0 0.17644467949867249
, O 0 0.0002446891739964485
and O 0 0.0004401839687488973
deficiency B-Disease 1 0.999891996383667
of I-Disease 0 1.40087859108462e-05
the I-Disease 0 7.09924497641623e-05
second I-Disease 0 0.0001146903305198066
component I-Disease 0 0.0005857871728949249
of I-Disease 0 2.76180035143625e-05
complement I-Disease 0 0.002162293065339327
. O 0 0.0007081233197823167

The O 0 0.0005473707569763064
relationship O 0 0.0011887431610375643
of O 0 2.7319016226101667e-05
the O 0 0.00016165644046850502
genes O 0 0.0004900934873148799
coding O 0 0.0031103314831852913
for O 0 0.0006529748206958175
HLA O 1 0.9862145781517029
to O 0 9.56372678047046e-05
those O 0 5.5640415666857734e-05
coding O 0 0.001676961430348456
for O 0 0.00034768437035381794
properdin O 0 0.1886230856180191
Factor O 0 0.003931291867047548
B O 0 0.0682736188173294
allotypes O 0 0.05929573252797127
and O 0 0.00020096469961572438
for O 0 0.0006221247022040188
deficiency B-Disease 1 0.9997661709785461
of I-Disease 0 1.4509647371596657e-05
the I-Disease 0 6.080875391489826e-05
second I-Disease 0 0.00011869829177157953
component I-Disease 0 0.00040713761700317264
of I-Disease 0 2.988251253555063e-05
complement I-Disease 0 0.002499394118785858
( O 0 0.0018059303984045982
C2 O 1 0.9987658262252808
) O 0 0.00023893298930488527
was O 0 0.00027963935281150043
studied O 0 0.00018617747991811484
in O 0 5.4699587053619325e-05
families O 0 0.00014887652650941163
of O 0 0.0001683941954979673
patients O 1 0.9999727010726929
with O 0 0.005470867734402418
connective O 1 0.9999669790267944
tissue O 1 0.9999645948410034
disorders O 1 0.9999880790710449
. O 0 0.005227886606007814

Patients O 1 0.9996200799942017
were O 0 0.0001398752792738378
selected O 0 0.000277125887805596
because O 0 0.0001782503823051229
they O 0 2.42372443608474e-05
were O 0 2.5401181119377725e-05
heterozygous O 0 0.0009383735014125705
or O 0 0.0002888029848691076
homozygous O 0 0.005400390364229679
for O 0 0.007314945571124554
C2 B-Disease 1 0.999992847442627
deficiency I-Disease 1 0.9999927282333374
. O 0 0.002393155824393034

12 O 0 0.0010951666627079248
families O 0 0.00033993489341810346
with O 0 0.00016207252338062972
15 O 0 0.0008028299198485911
matings O 0 0.04171173647046089
informative O 0 0.015180847607553005
for O 0 0.026368485763669014
C2 B-Disease 1 0.9999957084655762
deficiency I-Disease 1 0.9999955892562866
were O 0 0.00022876088041812181
found O 0 0.0006200040807016194
. O 0 0.0007484550587832928

Of O 0 0.0002670498797670007
57 O 0 0.0049474528059363365
informative O 0 0.0066876537166535854
meioses O 0 0.0451909601688385
, O 0 0.00012874143430963159
two O 0 4.4697397242998704e-05
crossovers O 0 0.0007238613907247782
were O 0 3.203810047125444e-05
noted O 0 0.00023717034491710365
between O 0 0.00017726294754538685
the O 0 0.0068372758105397224
C2 B-Disease 1 0.9999958276748657
deficiency I-Disease 1 0.9999920129776001
gene O 0 0.002019745297729969
and O 0 0.00016979222709778696
the O 0 0.0010907123796641827
HLA O 1 0.9994868040084839
- O 0 0.09305255115032196
B O 0 0.0159686878323555
gene O 0 0.0005562346195802093
, O 0 5.579317075898871e-05
with O 0 3.2749954698374495e-05
a O 0 0.00019395482377149165
recombinant O 0 0.0011722528142854571
fraction O 0 0.0003202600928489119
of O 0 5.0616083171917126e-05
0 O 0 0.0013836674625054002
. O 0 0.0006554901483468711

035 O 1 0.8639360070228577
. O 0 0.0046614971943199635

A O 0 0.007239539176225662
lod O 0 0.017948836088180542
score O 0 0.00010106438276125118
of O 0 3.0226243325159885e-05
13 O 0 0.0003946388023905456
was O 0 0.0001738886785460636
calculated O 0 0.00018367839220445603
for O 0 0.00013938146003056318
linkage O 0 0.01961594633758068
between O 0 0.005148346535861492
C2 B-Disease 1 0.999990701675415
deficiency I-Disease 1 0.9999943971633911
and O 0 0.0060358792543411255
HLA O 1 0.9996960163116455
- O 0 0.039067529141902924
B O 0 0.005707444157451391
at O 0 0.0001552380999783054
a O 0 0.00015908456407487392
maximum O 0 0.0002238699235022068
likelihood O 0 0.00040491222171112895
value O 0 2.216182110714726e-05
of O 0 8.52791254146723e-06
the O 0 7.50034159864299e-05
recombinant O 0 0.0013458424946293235
fraction O 0 0.0003163738292641938
of O 0 4.790360253537074e-05
0 O 0 0.0013959389179944992
. O 0 0.0006597368628717959

04 O 1 0.778473436832428
. O 0 0.004286591894924641

18 O 0 0.0013429896207526326
families O 0 0.00026717415312305093
with O 0 0.00013446449884213507
21 O 0 0.0007793111726641655
informative O 0 0.002877111081033945
matings O 0 0.010150877758860588
for O 0 0.00015008520858827978
both O 0 0.00022277014795690775
properdin O 0 0.13768284022808075
Factor O 0 0.002987686777487397
B O 0 0.05501528084278107
allotype O 0 0.15424489974975586
and O 0 0.0009461750159971416
HLA O 1 0.9981471300125122
- O 0 0.023429740220308304
B O 0 0.0068457904271781445
were O 0 7.660793926334009e-05
found O 0 0.00043829012429341674
. O 0 0.0005960403941571712

Of O 0 0.00036476110108196735
72 O 0 0.005522839725017548
informative O 0 0.006564504001289606
meioses O 0 0.0903184786438942
, O 0 0.000229068158660084
three O 0 0.00014155448297969997
recombinants O 0 0.06568963080644608
were O 0 5.476295336848125e-05
found O 0 0.00013324760948307812
, O 0 5.463114575832151e-05
giving O 0 0.0002790395519696176
a O 0 0.00018938432913273573
recombinant O 0 0.0008657912258058786
fraction O 0 0.00029908548458479345
of O 0 4.0771607018541545e-05
0 O 0 0.0011649061925709248
. O 0 0.0004859778273385018

042 O 0 0.35678836703300476
. O 0 0.0034538351465016603

A O 0 0.004744271747767925
lod O 0 0.013004432432353497
score O 0 7.068212289595976e-05
of O 0 2.7195650545763783e-05
16 O 0 0.00046375414240173995
between O 0 0.0006801947602070868
HLA O 1 0.998315691947937
- O 0 0.011754865758121014
B O 0 0.008095012977719307
and O 0 0.00017735929577611387
Factor O 0 0.0027386241126805544
B O 0 0.02625330165028572
allotypes O 0 0.02756345458328724
was O 0 0.00036648454261012375
calculated O 0 0.00023941688414197415
at O 0 0.00011276801524218172
a O 0 0.0001240074634552002
maximum O 0 0.00027416046941652894
likelihood O 0 0.0004720734723377973
value O 0 3.0298595447675325e-05
of O 0 8.113404874166008e-06
the O 0 9.406010940438136e-05
recombinant O 0 0.0014272694243118167
fraction O 0 0.0002916686062235385
of O 0 4.672868817579001e-05
0 O 0 0.0010324858594685793
. O 0 0.0005793893942609429

04 O 1 0.9120426177978516
. O 0 0.003251416841521859

A O 0 0.0034480628091841936
crossover O 0 0.0023657302372157574
was O 0 0.0008417836506851017
shown O 0 0.0003288026782684028
to O 0 4.4618951505981386e-05
have O 0 4.1831557609839365e-05
occurred O 0 0.0001872097491286695
between O 0 3.751117765204981e-05
genes O 0 9.755183418747038e-05
for O 0 7.795231067575514e-05
Factor O 0 0.001645697746425867
B O 0 0.014899865724146366
and O 0 0.0005647673970088363
HLA O 1 0.9975484013557434
- O 0 0.015686368569731712
D O 0 0.1407526433467865
, O 0 7.24500059732236e-05
in O 0 8.508353494107723e-05
which O 0 0.0002367699780734256
HLA O 1 0.9984017014503479
- O 0 0.021115845069289207
D O 1 0.8744893074035645
segregared O 0 0.030369732528924942
with O 0 0.0005325175588950515
HLA O 1 0.9953568577766418
- O 0 0.003063279902562499
A O 0 0.0011559448903426528
and O 0 0.0003652473969850689
B O 0 0.0437677763402462
. O 0 0.0006911389646120369

These O 0 0.00020742593915201724
studies O 0 0.00042663715430535376
suggest O 0 0.00028818962164223194
that O 0 2.2471131160273217e-05
the O 0 3.666673001134768e-05
genes O 0 0.0001325311604887247
for O 0 0.0001187145899166353
Factor O 0 0.0035686451010406017
B O 1 0.8342385292053223
and O 0 0.005622531287372112
C2 B-Disease 1 0.9999958276748657
deficiency I-Disease 1 0.9999916553497314
are O 0 6.53141105431132e-05
located O 0 0.0003017557319253683
outside O 0 0.0001418803003616631
those O 0 8.633211837150156e-05
for O 0 0.0004184358986094594
HLA O 1 0.9964902997016907
, O 0 7.832531991880387e-05
that O 0 1.9228524251957424e-05
the O 0 2.4818720703478903e-05
order O 0 3.186478716088459e-05
of O 0 3.157981700496748e-05
genese O 1 0.8000208139419556
is O 0 0.0008318618056364357
HLA O 1 0.9894969463348389
- O 0 0.0016868164530023932
A O 0 0.0007418158347718418
, O 0 0.00027601313195191324
- O 0 0.004028356168419123
B O 0 0.006812891457229853
, O 0 0.00022885532234795392
- O 0 0.008961682207882404
D O 0 0.18108996748924255
, O 0 0.00018659225315786898
Factor O 0 0.0019289302872493863
B O 0 0.10925440490245819
allotype O 1 0.9082902073860168
, O 0 0.013841865584254265
C2 B-Disease 1 0.9999896287918091
deficiency I-Disease 1 0.9999957084655762
, O 0 0.00013336505799088627
that O 0 3.448597635724582e-05
the O 0 7.909903069958091e-05
genes O 0 0.0003591136774048209
coding O 0 0.00490402290597558
for O 0 0.005993081722408533
C2 B-Disease 1 0.9999936819076538
deficiency I-Disease 1 0.9999918937683105
and O 0 0.0005206455243751407
Factor O 0 0.003841463476419449
B O 0 0.027876270934939384
allotypes O 0 0.005936965346336365
are O 0 2.1820718757226132e-05
approximately O 0 0.00017707118240650743
3 O 0 0.00041468971176072955
- O 0 0.0015479369321838021
- O 0 0.0009406570461578667
5 O 0 0.00021142925834283233
centimorgans O 0 0.0036878460086882114
from O 0 6.675152690149844e-05
the O 0 0.0003388075565453619
HLA O 1 0.9952497482299805
- O 0 0.0022451868280768394
A O 0 0.0013038755860179663
and O 0 0.0005348100676201284
HLA O 1 0.9980828762054443
- O 0 0.021781984716653824
B O 0 0.017093205824494362
loci O 0 0.003373401239514351
, O 0 0.00011498379171825945
and O 0 5.060599505668506e-05
that O 0 4.605263166013174e-05
the O 0 0.00010713950177887455
apparent O 0 0.003095238469541073
lack O 0 0.0006430926732718945
of O 0 5.015716305933893e-05
recombinants O 0 0.1265532225370407
between O 0 9.126655641011894e-05
the O 0 0.00016790052177384496
Factor O 0 0.0034167366102337837
B O 0 0.31039220094680786
gene O 0 0.002948837587609887
and O 0 0.004284642171114683
C2 B-Disease 1 0.9999958276748657
deficiency I-Disease 1 0.9999988079071045
gene O 0 0.006645726040005684
suggests O 0 0.0006999499164521694
that O 0 2.523513830965385e-05
these O 0 1.0935526006505825e-05
two O 0 4.6960449253674597e-05
genes O 0 0.0003022296878043562
lie O 0 0.0010672822827473283
in O 0 7.266200555022806e-05
close O 0 0.0004409087705425918
proximity O 0 0.0006527726072818041
to O 0 8.628141222288832e-05
one O 0 0.0001201150516862981
another O 0 0.0005646570352837443
. O 0 0.0006231402512639761

Distribution O 0 0.0007261850405484438
of O 0 0.0001681924914009869
emerin O 0 0.4368162751197815
and O 0 0.0005852286121807992
lamins O 1 0.9844308495521545
in O 0 0.00022287319006863981
the O 0 0.0005674635758623481
heart O 1 0.999131977558136
and O 0 0.00013345615298021585
implications O 0 0.01300362590700388
for O 0 0.0009059052099473774
Emery B-Disease 1 0.9985319375991821
- I-Disease 1 0.9963239431381226
Dreifuss I-Disease 1 0.9999227523803711
muscular I-Disease 1 0.9999688863754272
dystrophy I-Disease 1 0.9999809265136719
. O 0 0.004453019239008427

Emerin O 0 0.10050508379936218
is O 0 0.00034817299456335604
a O 0 0.00035660716821439564
nuclear O 0 0.0008183405734598637
membrane O 0 0.000626461289357394
protein O 0 0.00023401174985338002
which O 0 5.268944369163364e-05
is O 0 0.0001861858181655407
missing O 0 0.0010615895735099912
or O 0 0.0003761027182918042
defective O 1 0.9944936037063599
in O 0 0.0009312490583397448
Emery B-Disease 1 0.9989644289016724
- I-Disease 1 0.9971936941146851
Dreifuss I-Disease 1 0.9999544620513916
muscular I-Disease 1 0.9999833106994629
dystrophy I-Disease 1 0.9999942779541016
( O 0 0.08495670557022095
EDMD B-Disease 1 0.9992533326148987
) O 0 0.0012080605374649167
. O 0 0.000747712270822376

It O 0 0.0005809786962345243
is O 0 0.0001800918544176966
one O 0 5.797107587568462e-05
member O 0 8.743626676732674e-05
of O 0 1.4855144399916753e-05
a O 0 0.0003170339041389525
family O 0 0.0003273826150689274
of O 0 0.00011313249706290662
lamina O 1 0.9997151494026184
- O 0 0.004398041404783726
associated O 0 0.0001429807598469779
proteins O 0 7.408125384245068e-05
which O 0 5.836702257511206e-05
includes O 0 0.00042773454333655536
LAP1 O 1 0.9740518927574158
, O 0 0.0005165452603250742
LAP2 O 1 0.872875452041626
and O 0 0.0006900184671394527
lamin O 1 0.9808897972106934
B O 0 0.11181852221488953
receptor O 0 0.01132519543170929
( O 0 0.003648679703474045
LBR O 1 0.9980736970901489
) O 0 0.0008430873276665807
. O 0 0.0009193386067636311

A O 0 0.002949149115011096
panel O 0 0.0018129425588995218
of O 0 7.786137575749308e-05
16 O 0 0.0013003114145249128
monoclonal O 0 0.037302181124687195
antibodies O 0 0.03571140766143799
( O 0 0.0024520782753825188
mAbs O 1 0.970198392868042
) O 0 0.0004480103380046785
has O 0 0.0003658239438664168
been O 0 0.00018423196161165833
mapped O 0 0.0007089680875651538
to O 0 3.707523865159601e-05
six O 0 4.105772313778289e-05
specific O 0 4.723973324871622e-05
sites O 0 5.392132879933342e-05
throughout O 0 7.907234248705208e-05
the O 0 0.000127931431052275
emerin O 0 0.014090284705162048
molecule O 0 0.0009293078910559416
using O 0 0.00043765970622189343
phage O 0 0.3269210159778595
- O 0 0.0022218197118490934
displayed O 0 0.0006108673987910151
peptide O 0 0.0014341950882226229
libraries O 0 0.0004290662764105946
and O 0 9.670214785728604e-05
has O 0 0.00020793620205949992
been O 0 5.294445509207435e-05
used O 0 5.177056300453842e-05
to O 0 0.00010527525591896847
localize O 0 0.0853840634226799
emerin O 0 0.05650131776928902
in O 0 0.0001760011218721047
human O 0 0.0015633472939953208
and O 0 0.0010852927807718515
rabbit O 1 0.9966545104980469
heart O 1 0.9984511137008667
. O 0 0.0017110025510191917

Several O 0 0.0022498746402561665
mAbs O 0 0.15557311475276947
against O 0 0.0005431421450339258
different O 0 0.00021610305702779442
emerin O 1 0.8704947829246521
epitopes O 0 0.14360420405864716
did O 0 0.0005648664082400501
not O 0 0.00012822869757656008
recognize O 0 0.002141163684427738
intercalated O 0 0.13798578083515167
discs O 0 0.0019352241652086377
in O 0 0.00013958296040073037
the O 0 0.0007924885139800608
heart O 1 0.9997836947441101
, O 0 0.00021570535318460315
though O 0 0.00024356262292712927
they O 0 7.697120599914342e-05
recognized O 0 0.0010940248612314463
cardiomyocyte O 0 0.04178871959447861
nuclei O 0 0.001180340419523418
strongly O 0 0.0005083992145955563
, O 0 7.034926966298372e-05
both O 0 5.558579141506925e-05
at O 0 0.0001679046981735155
the O 0 0.00017190445214509964
rim O 0 0.020876845344901085
and O 0 0.0001456553436582908
in O 0 0.00029877229826524854
intranuclear O 1 0.553006112575531
spots O 0 0.003628138452768326
or O 0 0.00040156408795155585
channels O 0 0.0009432201040908694
. O 0 0.0007000353652983904

A O 0 0.023112237453460693
polyclonal O 1 0.9104222655296326
rabbit O 1 0.9435006976127625
antiserum O 1 0.9380900859832764
against O 0 0.002715551992878318
emerin O 1 0.6886299848556519
did O 0 0.0010394020937383175
recognize O 0 0.0014209941728040576
both O 0 0.00010720696445787326
nuclear O 0 0.0013654915383085608
membrane O 0 0.001390269142575562
and O 0 0.00023049881565384567
intercalated O 1 0.780997633934021
discs O 0 0.004580256063491106
but O 0 0.00018408465257380158
, O 0 0.00013290601782500744
after O 0 0.00032125209691002965
affinity O 0 0.0007299622520804405
purification O 0 0.0020849101711064577
against O 0 0.0001503156527178362
a O 0 0.00045302935177460313
pure O 0 0.001484148669987917
- O 0 0.007737042848020792
emerin O 0 0.01526430994272232
band O 0 0.0002973848895635456
on O 0 7.732478115940467e-05
a O 0 0.0003233319439459592
western O 0 0.0006722480757161975
blot O 1 0.9724669456481934
, O 0 0.00024044036399573088
it O 0 0.0002643313491716981
stained O 1 0.9332365989685059
only O 0 7.54363791202195e-05
the O 0 0.0001313319953624159
nuclear O 0 0.002638119738548994
membrane O 0 0.003369823331013322
. O 0 0.0005673722480423748

These O 0 0.00022192552569322288
results O 0 0.00040730065666139126
would O 0 0.00010697209654608741
not O 0 4.141344106756151e-05
be O 0 3.9177884900709614e-05
expected O 0 0.0002233718550996855
if O 0 0.0002742346841841936
immunostaining O 0 0.03473576158285141
at O 0 0.00046136017772369087
intercalated O 0 0.29127418994903564
discs O 0 0.0019327022600919008
were O 0 3.3885935408761725e-05
due O 0 0.00021457509137690067
to O 0 3.642027877504006e-05
a O 0 0.00010820038733072579
product O 0 0.00014920993999112397
of O 0 2.164791658287868e-05
the O 0 0.0003750493924599141
emerin O 1 0.9693425297737122
gene O 0 0.0013413727283477783
and O 0 9.895399853121489e-05
, O 0 0.00010995433694915846
therefore O 0 0.00015771739708725363
, O 0 5.926022640778683e-05
cast O 0 0.00010020388435805216
some O 0 3.817068136413582e-05
doubt O 0 0.0006017458508722484
upon O 0 0.00015130429528653622
the O 0 0.00016390062228310853
hypothesis O 0 0.0037617951165884733
that O 0 0.0013535756152123213
cardiac B-Disease 1 0.9999854564666748
defects I-Disease 1 0.9997361302375793
in O 0 0.002024403540417552
EDMD B-Disease 1 0.9997988343238831
are O 0 0.00011846851703012362
caused O 0 0.008982012048363686
by O 0 6.870101060485467e-05
absence O 0 0.0009717099601402879
of O 0 5.896017682971433e-05
emerin O 1 0.9079310297966003
from O 0 0.0004134425544179976
intercalated O 1 0.7556332349777222
discs O 0 0.011499342508614063
. O 0 0.0008643796318210661

Although O 0 0.004507001955062151
emerin O 0 0.043504904955625534
was O 0 0.000659828947391361
abundant O 0 0.0005228272639214993
in O 0 7.589650340378284e-05
the O 0 0.0001353388506686315
membranes O 0 0.0038289844524115324
of O 0 9.589279216015711e-05
cardiomyocyte O 1 0.8504305481910706
nuclei O 0 0.0014388305135071278
, O 0 0.00013109804422128946
it O 0 0.00014028092846274376
was O 0 0.00034781615249812603
absent O 0 0.00115123949944973
from O 0 5.2633247833000496e-05
many O 0 8.814458851702511e-05
non O 0 0.002284647896885872
- O 0 0.02350085973739624
myocyte O 1 0.9650153517723083
cells O 0 0.0012965111527591944
in O 0 0.00014126310998108238
the O 0 0.0006980327307246625
heart O 1 0.9992565512657166
. O 0 0.0011281644692644477

This O 0 0.00022756177349947393
distribution O 0 0.00022239364625420421
of O 0 0.00011799771164078265
emerin O 0 0.4947759807109833
was O 0 0.0004825908981729299
similar O 0 0.0001152526238001883
to O 0 4.629392788046971e-05
that O 0 3.097844455623999e-05
of O 0 4.420090772327967e-05
lamin O 1 0.9921858310699463
A O 0 0.0012518203584477305
, O 0 0.00011045696010114625
a O 0 0.0003174252051394433
candidate O 0 0.000715934147592634
gene O 0 0.00041926579433493316
for O 0 7.034631562419236e-05
an O 0 0.0003298110677860677
autosomal O 1 0.7418481707572937
form O 0 0.000560707354452461
of O 0 0.00028211207245476544
EDMD B-Disease 1 0.9997162222862244
. O 0 0.0015125516802072525

In O 0 0.0006507511134259403
contrast O 0 0.0033199370373040438
, O 0 0.0019372965907678008
lamin O 1 0.9986315369606018
B1 O 1 0.9994906187057495
was O 0 0.0017922106198966503
absent O 0 0.0037309490144252777
from O 0 0.0002524780866224319
cardiomyocyte O 0 0.05007017031311989
nuclei O 0 0.0013313267845660448
, O 0 0.00019483410869725049
showing O 0 0.0014829491265118122
that O 0 0.0007744638714939356
lamin O 1 0.9973080158233643
B1 O 1 0.9989370703697205
is O 0 0.00025913160061463714
not O 0 5.331909051164985e-05
essential O 0 0.00024345975543837994
for O 0 7.364904013229534e-05
localization O 0 0.0008333651931025088
of O 0 3.5011635191040114e-05
emerin O 0 0.036556825041770935
to O 0 8.648099901620299e-05
the O 0 0.00021751080930698663
nuclear O 0 0.008303745649755001
lamina O 1 0.9958652257919312
. O 0 0.0011382104130461812

Lamin O 1 0.9961103796958923
B1 O 1 0.9979050159454346
is O 0 0.0005753425066359341
also O 0 0.00019612371397670358
almost O 0 0.0005007347208447754
completely O 0 0.003707083873450756
absent O 0 0.005403826013207436
from O 0 0.0007595916977152228
skeletal O 1 0.9994390606880188
muscle O 1 0.997421383857727
nuclei O 0 0.01090971753001213
. O 0 0.0015513779362663627

In O 0 0.0035290559753775597
EDMD B-Disease 1 0.995743453502655
, O 0 0.00013785243208985776
the O 0 8.672686089994386e-05
additional O 0 0.00023029583098832518
absence O 0 0.0016026130178943276
of O 0 0.00021345482673496008
lamin O 1 0.9993900060653687
B1 O 1 0.9996305704116821
from O 0 0.0012946206843480468
heart O 1 0.9997566342353821
and O 0 0.001463742577470839
skeletal O 1 0.9998086094856262
muscle O 1 0.9991342425346375
nuclei O 0 0.0062209502793848515
which O 0 0.00018161401385441422
already O 0 0.002165443729609251
lack O 0 0.025944991037249565
emerin O 1 0.9927402138710022
may O 0 0.0009348716703243554
offer O 0 0.0004233228100929409
an O 0 0.00012751952453982085
alternative O 0 0.0004105224215891212
explanation O 0 0.0004705401661340147
of O 0 3.0243052606238052e-05
why O 0 0.0012659740168601274
these O 0 6.888994539622217e-05
tissues O 0 0.37622684240341187
are O 0 6.953371484996751e-05
particularly O 0 0.002745503792539239
affected O 0 0.00995646882802248
. O 0 0.00027270993450656533
. O 0 0.0006186712416820228

Genetic O 0 0.002169362735003233
mapping O 0 0.0011724191717803478
of O 0 5.958163092145696e-05
the O 0 0.0005746561218984425
copper B-Disease 1 0.8388321399688721
toxicosis I-Disease 1 0.9950588941574097
locus O 0 0.016508067026734352
in O 0 0.0011988314799964428
Bedlington O 1 0.9932302236557007
terriers O 0 0.3972056806087494
to O 0 0.0003480974701233208
dog O 0 0.07492677867412567
chromosome O 0 0.0014563936274498701
10 O 0 0.00017841141379904002
, O 0 7.736047700745985e-05
in O 0 8.911847544368356e-05
a O 0 0.0004682755970861763
region O 0 0.0016801777528598905
syntenic O 0 0.06591911613941193
to O 0 0.00010020933405030519
human O 0 0.0009483831818215549
chromosome O 0 0.0023244007024914026
region O 0 0.003435600083321333
2p13 O 0 0.1153697744011879
- O 0 0.015158302150666714
p16 O 0 0.08085016906261444
. O 0 0.001318594440817833

Abnormal O 1 0.9895504117012024
hepatic B-Disease 1 0.9995813965797424
copper I-Disease 1 0.8459029197692871
accumulation I-Disease 0 0.1839214265346527
is O 0 0.00048754189629107714
recognized O 0 0.0007305712206289172
as O 0 0.00026832445291802287
an O 0 0.0066437553614377975
inherited B-Disease 1 0.9999691247940063
disorder I-Disease 1 0.9999943971633911
in O 0 0.001300327479839325
man O 0 0.24347415566444397
, O 0 0.0006232335581444204
mouse O 0 0.07466592639684677
, O 0 0.0007539905491285026
rat O 1 0.9880198836326599
and O 0 0.0006007842603139579
dog O 1 0.7795212864875793
. O 0 0.0012933906400576234

The O 0 0.0009450425859540701
major O 0 0.002165897050872445
cause O 0 0.010096604935824871
of O 0 0.00033585450728423893
hepatic B-Disease 1 0.9999291896820068
copper I-Disease 1 0.7905768156051636
accumulation I-Disease 0 0.2864201068878174
in O 0 0.00033826433354988694
man O 0 0.00487801618874073
is O 0 0.0003113689017482102
a O 0 0.001216283650137484
dysfunctional O 1 0.9973462820053101
ATP7B O 1 0.9963106513023376
gene O 0 0.0038929807487875223
, O 0 0.0007850216352380812
causing O 1 0.9960277080535889
Wilson B-Disease 1 0.999263346195221
disease I-Disease 1 0.9999816417694092
( O 0 0.012470570392906666
WD B-Disease 1 0.9989707469940186
) O 0 0.0009667169651947916
. O 0 0.0008296792511828244

Mutations O 0 0.006086630746722221
in O 0 0.000262166082393378
the O 0 0.0005725430091843009
ATP7B O 1 0.9600523114204407
genes O 0 0.00043279974488541484
have O 0 9.002196748042479e-05
also O 0 0.00012142812192905694
been O 0 0.00018863136938307434
demonstrated O 0 0.0013854786520823836
in O 0 0.0002449893800076097
mouse O 0 0.01465636771172285
and O 0 0.0005828581051900983
rat O 1 0.9856207966804504
. O 0 0.000808316224720329

The O 0 0.003093236591666937
ATP7B O 1 0.9834533333778381
gene O 0 0.003451564582064748
has O 0 0.0004556886851787567
been O 0 0.0002032036572927609
excluded O 0 0.0004474623710848391
in O 0 4.532809180091135e-05
the O 0 8.929269097279757e-05
much O 0 0.0006064152112230659
rarer O 1 0.7559126615524292
human O 0 0.005568657536059618
copper B-Disease 1 0.994657039642334
overload I-Disease 1 0.9997817873954773
disease O 1 0.99997878074646
non B-Disease 0 0.022229764610528946
- I-Disease 0 0.4194618761539459
Indian I-Disease 0 0.004760370589792728
childhood I-Disease 1 0.9996188879013062
cirrhosis I-Disease 1 0.9999831914901733
, O 0 0.0008088182075880468
indicating O 0 0.006289204582571983
genetic O 0 0.003608388127759099
heterogeneity O 0 0.04461545869708061
. O 0 0.0014076424995437264

By O 0 0.0005223440821282566
investigating O 0 0.0034235529601573944
the O 0 0.0003807998728007078
common O 0 0.007975044660270214
autosomal O 1 0.9969651103019714
recessive O 1 0.9975627660751343
copper B-Disease 1 0.9972297549247742
toxicosis I-Disease 1 0.9998205304145813
( O 0 0.050421375781297684
CT B-Disease 1 0.9996968507766724
) O 0 0.0006566462107002735
in O 0 0.0006175372982397676
Bedlington O 1 0.9986132383346558
terriers O 1 0.8993403315544128
, O 0 0.00021604681387543678
we O 0 0.00012196449097245932
have O 0 5.0914150051539764e-05
identified O 0 0.00016710722411517054
a O 0 0.0001545804989291355
new O 0 0.0001633029751246795
locus O 0 0.0029462913516908884
involved O 0 0.0007987653370946646
in O 0 0.0011196245905011892
progressive O 1 0.9997351765632629
liver B-Disease 1 0.9999990463256836
disease I-Disease 1 0.9999978542327881
. O 0 0.0031059253960847855

We O 0 0.0016877215821295977
examined O 0 0.006011699326336384
whether O 0 0.0004516539047472179
the O 0 0.000737515336368233
WD B-Disease 1 0.9947082996368408
gene O 0 0.00475193839520216
ATP7B O 1 0.9113239049911499
was O 0 0.0006554475985467434
also O 0 0.00030202456400729716
causative O 0 0.401944637298584
for O 0 0.0009321109973825514
CT B-Disease 1 0.9997106194496155
by O 0 0.000162857337272726
investigating O 0 0.0032444829121232033
the O 0 0.0004962241509929299
chromosomal O 0 0.03694701939821243
co O 0 0.014291900210082531
- O 0 0.002302056411281228
localization O 0 0.0015800251858308911
of O 0 0.00010831064719241112
ATP7B O 1 0.9894744157791138
and O 0 0.00025040344917215407
C04107 O 0 0.009540635161101818
, O 0 9.926946950145066e-05
using O 0 0.0001334364351350814
fluorescence O 0 0.0040487428195774555
in O 0 0.0002544832823332399
situ O 0 0.01831377111375332
hybridization O 0 0.001458632410503924
( O 0 0.0006660367362201214
FISH O 0 0.002342402236536145
) O 0 0.00039427142473869026
. O 0 0.0005112096550874412

C04107 O 0 0.02712264470756054
is O 0 0.0004275189421605319
an O 0 0.0002664550265762955
anonymous O 0 0.0025562902446836233
microsatellite O 0 0.021244920790195465
marker O 0 0.005251438356935978
closely O 0 0.001230092952027917
linked O 0 0.006304027512669563
to O 0 0.0008874547784216702
CT B-Disease 1 0.9986981153488159
. O 0 0.0012511088280007243

However O 0 0.0022764173336327076
, O 0 0.0012622897047549486
BAC O 1 0.968593418598175
clones O 0 0.007076348178088665
containing O 0 0.0009726774296723306
ATP7B O 1 0.8353421092033386
and O 0 0.00030672518187202513
C04107 O 0 0.009727180935442448
mapped O 0 0.0009360322146676481
to O 0 7.4055053119082e-05
the O 0 0.00030147566576488316
canine O 1 0.9714658856391907
chromosome O 0 0.002465027617290616
regions O 0 0.0012652892619371414
CFA22q11 O 1 0.7978121042251587
and O 0 0.0005385981639847159
CFA10q26 O 1 0.6921023726463318
, O 0 0.00015724213153589517
respectively O 0 0.00028772454243153334
, O 0 0.00014016997010912746
demonstrating O 0 0.0021949114743620157
that O 0 0.00032857799669727683
WD B-Disease 1 0.9967120885848999
cannot O 0 0.00048046393203549087
be O 0 0.0001136018690885976
homologous O 0 0.002867035800591111
to O 0 0.0010264174779877067
CT B-Disease 1 0.9978423118591309
. O 0 0.0010424345964565873

The O 0 0.0017476161010563374
copper O 0 0.01829368807375431
transport O 0 0.009491369128227234
genes O 0 0.0028224491979926825
CTR1 O 1 0.976924479007721
and O 0 0.0005122290458530188
CTR2 O 1 0.9439660310745239
were O 0 6.124340870883316e-05
also O 0 0.00010556729102972895
excluded O 0 0.0005606985068880022
as O 0 8.199748117476702e-05
candidate O 0 0.00042069784831255674
genes O 0 0.0003197091573383659
for O 0 0.0006333725759759545
CT B-Disease 1 0.999704897403717
since O 0 0.000364738138159737
they O 0 3.636350447777659e-05
both O 0 7.750410441076383e-05
mapped O 0 0.0017399265198037028
to O 0 0.0004282990994397551
canine O 1 0.9385408759117126
chromosome O 0 0.005420512519776821
region O 0 0.00483457837253809
CFA11q22 O 1 0.7620819807052612
. O 0 0.0012940005399286747

2 O 0 0.0035541262477636337
- O 0 0.0057897139340639114
22 O 0 0.0014852554304525256
. O 0 0.0005989467608742416

5 O 0 0.004771942272782326
. O 0 0.0017404218669980764

A O 0 0.0028438898734748363
transcribed O 0 0.0011688275262713432
sequence O 0 0.0001820156758185476
identified O 0 0.0003377676475793123
from O 0 7.727776392130181e-05
the O 0 0.0002941079728771001
C04107 O 0 0.05079704523086548
- O 0 0.0034968405961990356
containing O 0 0.0009293659240938723
BAC O 1 0.9731745719909668
was O 0 0.000583456945605576
found O 0 0.00012449764471966773
to O 0 3.6473596992436796e-05
be O 0 3.1617088097846135e-05
homologous O 0 0.0005526732420548797
to O 0 3.605342863011174e-05
a O 0 0.0002623458858579397
gene O 0 0.00051809725118801
expressed O 0 0.00018780402024276555
from O 0 8.486224396619946e-05
human O 0 0.0011370254214853048
chromosome O 0 0.0036254730075597763
2p13 O 0 0.15951207280158997
- O 0 0.011355454102158546
p16 O 0 0.029028840363025665
, O 0 0.00011868628644151613
a O 0 0.00027591316029429436
region O 0 0.0006303608533926308
devoid O 0 0.0007572037866339087
of O 0 1.4241473763831891e-05
any O 0 9.97341048787348e-05
positional O 0 0.0027206127997487783
candidate O 0 0.0013840014580637217
genes O 0 0.001138698891736567
. O 0 0.0007164614507928491

Molecular O 0 0.002155655063688755
analysis O 0 0.00016207777662202716
of O 0 3.687101707328111e-05
the O 0 0.0005923007847741246
APC B-Disease 1 0.9720579981803894
gene O 0 0.0010270854691043496
in O 0 0.00016956085164565593
205 O 0 0.004239607602357864
families O 0 0.00038390446570701897
: O 0 0.00030598565354011953
extended O 0 0.0020639796275645494
genotype O 0 0.09577874839305878
- O 0 0.014879260212182999
phenotype O 0 0.02256634458899498
correlations O 0 0.0024507699999958277
in O 0 0.0007532627205364406
FAP B-Disease 1 0.9991568326950073
and O 0 0.00016217764641623944
evidence O 0 0.00011618360440479591
for O 0 5.204270564718172e-05
the O 0 5.8144254580838606e-05
role O 0 0.0003045479243155569
of O 0 5.701578993466683e-05
APC B-Disease 0 0.217344731092453
amino O 0 0.0004070832801517099
acid O 0 0.010494259186089039
changes O 0 0.0018400730332359672
in O 1 0.5636411905288696
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
predisposition O 1 0.9990195035934448
. O 0 0.001993585377931595

BACKGROUND O 0 0.019797665998339653
/ O 0 0.03375731036067009
AIMS O 0 0.004765958525240421
The O 0 0.0002757940092124045
development O 0 0.0028451501857489347
of O 0 0.0035089077427983284
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999961853027344
and O 0 0.00013633162598125637
a O 0 0.0002890464966185391
variable O 0 0.0006110589019954205
range O 0 0.00027297940687276423
of O 0 7.511629519285634e-05
extracolonic O 1 0.9904904365539551
manifestations O 1 0.9727646708488464
in O 0 0.008080128580331802
familial B-Disease 1 0.9999686479568481
adenomatous I-Disease 1 0.9999910593032837
polyposis I-Disease 1 0.999993085861206
( O 1 0.6374585628509521
FAP B-Disease 1 0.9996844530105591
) O 0 0.0005087426980026066
is O 0 0.00010501818178454414
the O 0 5.021277320338413e-05
result O 0 8.629367221146822e-05
of O 0 1.0836207366082817e-05
the O 0 0.00013657337694894522
dominant O 0 0.003174332669004798
inheritance O 0 0.00570390559732914
of O 0 0.0015014417003840208
adenomatous B-Disease 1 0.9999971389770508
polyposis I-Disease 1 0.9999881982803345
coli I-Disease 1 0.9997264742851257
( O 0 0.00979243591427803
APC B-Disease 1 0.9929757118225098
) O 0 0.001046608085744083
gene O 0 0.0034823869355022907
mutations O 0 0.0032570376060903072
. O 0 0.0007036860333755612

In O 0 0.0005023826961405575
this O 0 0.00012200344644952565
study O 0 0.0003887075581587851
, O 0 6.112315895734355e-05
direct O 0 0.00011574272502912208
mutation O 0 0.00028907868545502424
analysis O 0 4.74499465781264e-05
of O 0 1.968045035027899e-05
the O 0 0.00047209556214511395
APC B-Disease 1 0.9940173625946045
gene O 0 0.0012658581836149096
was O 0 0.0003570615081116557
performed O 0 0.00029129840550012887
to O 0 9.972040425054729e-05
determine O 0 0.0008677205187268555
genotype O 0 0.04883761331439018
- O 0 0.007038439158350229
phenotype O 0 0.008992301300168037
correlations O 0 0.0009921328164637089
for O 0 0.00013403259799815714
nine O 0 0.0006452493835240602
extracolonic O 1 0.8624289035797119
manifestations O 0 0.04058516398072243
and O 0 0.00012312144099269062
to O 0 0.00011719170288415626
investigate O 0 0.002202868927270174
the O 0 0.0002557446714490652
incidence O 1 0.9091260433197021
of O 0 0.00013616299838759005
APC B-Disease 1 0.9902017712593079
mutations O 0 0.0018318563234061003
in O 0 0.0003253167087677866
non O 1 0.5935724377632141
- O 1 0.9993891716003418
FAP O 1 0.9999699592590332
colorectal B-Disease 1 0.9999995231628418
cancer I-Disease 1 0.9999951124191284
. O 0 0.002314672339707613

METHODS O 0 0.003263595513999462
The O 0 0.0016137079801410437
APC B-Disease 1 0.9728041887283325
gene O 0 0.0020619879942387342
was O 0 0.0004383621853776276
analysed O 0 0.0012621225323528051
in O 0 0.0002079582045553252
190 O 0 0.004515602253377438
unrelated O 0 0.024974657222628593
FAP B-Disease 1 0.9961523413658142
and O 0 0.0003258971555624157
15 O 0 0.0012436640681698918
non O 0 0.16161276400089264
- O 1 0.9989200830459595
FAP O 1 0.999968409538269
colorectal B-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999986886978149
patients O 1 0.9996961355209351
using O 0 0.0012718986254185438
denaturing O 1 0.9731479287147522
gradient O 0 0.05326366797089577
gel O 1 0.9845302104949951
electrophoresis O 0 0.02043117769062519
, O 0 0.0001258530974155292
the O 0 0.00012033757957397029
protein O 0 0.0005835504271090031
truncation O 0 0.006983945146203041
test O 0 0.0009425580501556396
, O 0 9.557126031722873e-05
and O 0 5.7564688177080825e-05
direct O 0 0.00023240722657646984
sequencing O 0 0.0014195652911439538
. O 0 0.000655387993901968

RESULTS O 0 0.010844334959983826
Chain O 0 0.010642037726938725
terminating O 0 0.022311612963676453
signals O 0 0.0006475490517914295
were O 0 3.360874325153418e-05
only O 0 6.888034840812907e-05
identified O 0 0.00043183501111343503
in O 0 0.00036745937541127205
patients O 1 0.999347984790802
belonging O 0 0.0004630180192179978
to O 0 0.00013154443877283484
the O 0 0.000647770706564188
FAP B-Disease 1 0.9993816614151001
group O 0 0.0008373116725124419
( O 0 0.0009121138718910515
105 O 0 0.020317522808909416
patients O 1 0.9996503591537476
) O 0 0.0004699968849308789
. O 0 0.0006668554269708693

Amino O 0 0.0023227445781230927
acid O 0 0.006436761002987623
changes O 0 0.0003429730422794819
were O 0 5.2719249652000144e-05
identified O 0 0.00030102013261057436
in O 0 9.770002361619845e-05
four O 0 0.0004274806415196508
patients O 1 0.9996091723442078
, O 0 6.484104233095422e-05
three O 0 3.2822805223986506e-05
of O 0 3.053494219784625e-05
whom O 0 0.0007568705477751791
belonged O 0 0.00045779920765198767
to O 0 3.9878701500128955e-05
the O 0 0.0001345778873655945
non O 0 0.0029896406922489405
- O 0 0.3774535059928894
FAP O 1 0.9987264275550842
group O 0 0.0013148661237210035
of O 0 0.004351214971393347
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
patients O 1 0.9999592304229736
. O 0 0.0017784703522920609

Genotype O 1 0.8883680701255798
- O 0 0.15289658308029175
phenotype O 0 0.07964926958084106
correlations O 0 0.002385411411523819
identified O 0 0.0005953520303592086
significant O 0 0.0002813508326653391
differences O 0 0.0005042571574449539
in O 0 9.213382872985676e-05
the O 0 8.460085518890992e-05
nature O 0 0.0004303555760998279
of O 0 3.0415352739510126e-05
certain O 0 0.0005129047785885632
extracolonic O 1 0.9946282505989075
manifestations O 1 0.9849792122840881
in O 0 0.010132353752851486
FAP B-Disease 1 0.9999575614929199
patients O 1 0.9997419714927673
belonging O 0 0.0008584652096033096
to O 0 0.00011681547766784206
three O 0 0.00016783412138465792
mutation O 0 0.0020384397357702255
subgroups O 0 0.002591334283351898
. O 0 0.0007188006420619786

CONCLUSIONS O 0 0.01380789652466774
Extended O 0 0.008320001885294914
genotype O 0 0.3754782974720001
- O 0 0.024079781025648117
phenotype O 0 0.025877568870782852
correlations O 0 0.0011962468270212412
made O 0 0.0001506068801973015
in O 0 9.398855036124587e-05
this O 0 0.0001078089335351251
study O 0 0.0008849502773955464
may O 0 0.00034983688965439796
have O 0 2.6612386136548594e-05
the O 0 3.5445107641862705e-05
potential O 0 0.0002116305404342711
to O 0 3.1180788937490433e-05
determine O 0 8.646401693113148e-05
the O 0 3.65780942956917e-05
most O 0 7.116176857380196e-05
appropriate O 0 0.000586586189456284
surveillance O 0 0.003602363634854555
and O 0 0.0007323797908611596
prophylactic O 1 0.9997757077217102
treatment O 1 0.9998908042907715
regimens O 1 0.9992050528526306
for O 0 0.00042521668365225196
those O 0 0.0008035750361159444
patients O 1 0.9999017715454102
with O 0 0.00022137943597044796
mutations O 0 0.0049013784155249596
associated O 0 0.00040354696102440357
with O 0 0.00029960949905216694
life O 0 0.11360982060432434
threatening O 1 0.997542142868042
conditions O 1 0.6337515711784363
. O 0 0.0014958889223635197

This O 0 0.000504063384141773
study O 0 0.0007075734902173281
also O 0 0.00013001917977817357
provided O 0 0.00021141172328498214
evidence O 0 0.00011941214324906468
for O 0 8.349413110408932e-05
the O 0 0.0001713264937279746
pathological O 1 0.8951367735862732
nature O 0 0.00038316738209687173
of O 0 2.397389107500203e-05
amino O 0 0.0003995050792582333
acid O 0 0.005430424120277166
changes O 0 0.0004275487153790891
in O 0 0.00036139978328719735
APC O 1 0.9687381982803345
associated O 0 0.00023704918567091227
with O 0 0.000116986375360284
both O 0 0.0004005671653430909
FAP B-Disease 1 0.9988391995429993
and O 0 0.00047606462612748146
non O 1 0.5384251475334167
- O 1 0.9996585845947266
FAP O 1 0.9999909400939941
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999997615814209
patients O 1 0.9999597072601318
. O 0 0.0004902053624391556
. O 0 0.0006832392537035048

Inherited B-Disease 1 0.999839186668396
colorectal I-Disease 1 0.9999991655349731
polyposis I-Disease 1 0.9999922513961792
and O 1 0.9631286859512329
cancer B-Disease 1 0.9999967813491821
risk O 0 0.1219862848520279
of O 0 4.683571387431584e-05
the O 0 0.0007544732070527971
APC O 1 0.9938357472419739
I1307K O 0 0.1137804239988327
polymorphism O 0 0.006072299554944038
. O 0 0.0014134981902316213

Germ O 1 0.9838809370994568
- O 0 0.009774263016879559
line O 0 0.0014358361950144172
and O 0 0.0002590384101495147
somatic O 0 0.006060626357793808
truncating O 0 0.03810396045446396
mutations O 0 0.0006814547814428806
of O 0 3.459602521616034e-05
the O 0 0.0005981468711979687
APC B-Disease 1 0.9929900169372559
gene O 0 0.00070705555845052
are O 0 2.5131676011369564e-05
thought O 0 0.0004139526863582432
to O 0 0.00028687651501968503
initiate O 1 0.987800121307373
colorectal B-Disease 1 0.9999960660934448
tumor I-Disease 1 0.9999281167984009
formation O 1 0.724355936050415
in O 0 0.04914277791976929
familial B-Disease 1 0.9999939203262329
adenomatous I-Disease 1 0.9999982118606567
polyposis I-Disease 1 0.9999995231628418
syndrome I-Disease 1 0.9999991655349731
and O 0 0.04473406448960304
sporadic O 1 0.9963352680206299
colorectal O 1 0.9999946355819702
carcinogenesis O 1 0.9993355870246887
, O 0 0.0012398838298395276
respectively O 0 0.0014959422405809164
. O 0 0.0009461623849347234

Recently O 0 0.008142882026731968
, O 0 0.00033110464573837817
an O 0 0.0005630095256492496
isoleucine O 1 0.5862734317779541
- O 0 0.009614414535462856
- O 0 0.004973257426172495
> O 0 0.004615903832018375
lysine O 0 0.005472725722938776
polymorphism O 0 0.0015481050359085202
at O 0 0.0006070113158784807
codon O 0 0.005075640510767698
1307 O 0 0.14539989829063416
( O 0 0.0010593518381938338
I1307K O 0 0.0067467535845935345
) O 0 6.653849413851276e-05
of O 0 1.6714122466510162e-05
the O 0 0.00036056371754966676
APC B-Disease 1 0.9875314831733704
gene O 0 0.0012560089817270637
has O 0 0.00020837185729760677
been O 0 0.00011630685912678018
identified O 0 0.00015741854440420866
in O 0 6.612537981709465e-05
6 O 0 0.00033556693233549595
% O 0 5.010782479075715e-05
- O 0 0.000834551639854908
7 O 0 0.00010410606046207249
% O 0 1.176913247036282e-05
of O 0 1.5702393284300342e-05
the O 0 0.0003296690119896084
Ashkenazi O 0 0.030815571546554565
Jewish O 0 0.0005976443644613028
population O 0 0.000244047972955741
. O 0 0.0008230970706790686

To O 0 0.0010030645644292235
assess O 0 0.005935315974056721
the O 0 0.0002426678838673979
risk O 0 0.0018114271806553006
of O 0 2.0809087800444104e-05
this O 0 0.00010716934775700793
common O 0 0.003201413433998823
APC B-Disease 1 0.9943975210189819
allelic O 0 0.34914499521255493
variant O 0 0.4506685733795166
in O 0 0.00990381371229887
colorectal O 1 0.9999961853027344
carcinogenesis O 1 0.9995477795600891
, O 0 0.00045474054059013724
we O 0 0.0001133201367338188
have O 0 4.777845970238559e-05
analyzed O 0 0.00024257997574750334
a O 0 0.00011509238538565114
large O 0 0.0001430596166756004
cohort O 0 0.001621726667508483
of O 0 6.883530295453966e-05
unselected O 1 0.8646665215492249
Ashkenazi O 0 0.12321559339761734
Jewish O 0 0.0010212570196017623
subjects O 0 0.0023195180110633373
with O 0 0.002454458735883236
adenomatous B-Disease 1 0.9999558925628662
polyps I-Disease 1 0.9996604919433594
and O 0 0.00045881466940045357
. O 0 0.0008290751138702035
or O 1 0.9099029302597046
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999983310699463
, I-Disease 0 0.0001687215844867751
for O 0 0.00016039263573475182
the O 0 0.0005663192132487893
APC O 1 0.9915659427642822
I1307K O 0 0.0483776293694973
polymorphism O 0 0.004857002757489681
. O 0 0.0009151824633590877

The O 0 0.003479814389720559
APC O 1 0.9411632418632507
I1307K O 0 0.03678230196237564
allele O 0 0.005326919257640839
was O 0 0.0007614521309733391
identified O 0 0.0003442374581936747
in O 0 0.0001080149449990131
48 O 0 0.0006383855943568051
( O 0 0.0001990686432691291
10 O 0 9.723679977469146e-05
. O 0 3.051578823942691e-05
1 O 0 0.00010839766036951914
% O 0 2.576366205175873e-05
) O 0 7.555897900601849e-05
of O 0 0.00010942820517811924
476 O 1 0.9898714423179626
patients O 1 0.9994581341743469
. O 0 0.001123080844990909

Compared O 0 0.001492251642048359
with O 0 9.013484668685123e-05
the O 0 8.043601701501757e-05
frequency O 0 0.00012280461669433862
in O 0 4.711946894531138e-05
two O 0 2.8554402888403274e-05
separate O 0 8.81399682839401e-05
population O 0 5.6891527492552996e-05
control O 0 0.0005139726563356817
groups O 0 6.719853263348341e-05
, O 0 0.0001659988920437172
the O 0 0.000615781347732991
APC O 1 0.9787350296974182
I1307K O 0 0.03323664516210556
allele O 0 0.003101811744272709
is O 0 0.00020412972662597895
associated O 0 0.00013812548422720283
with O 0 4.355830969871022e-05
an O 0 0.00011662705219350755
estimated O 0 0.0004220747505314648
relative O 0 0.0003541049954947084
risk O 0 0.004780863877385855
of O 0 4.994452319806442e-05
1 O 0 0.0009857405675575137
. O 0 0.0005907536833547056

5 O 0 0.0036667627282440662
- O 0 0.005232511553913355
1 O 0 0.0013253102079033852
. O 0 0.0007173567428253591

7 O 0 0.003656704444438219
for O 0 0.0025917335879057646
colorectal B-Disease 1 0.999969482421875
neoplasia I-Disease 1 0.9981611371040344
( O 0 0.0013267335016280413
both O 0 0.0005944719887338579
P O 0 0.29964935779571533
= O 0 0.0031690956093370914
. O 0 0.0003998045576736331
01 O 1 0.84464430809021
) O 0 0.0006195143796503544
. O 0 0.0006674915784969926

Furthermore O 0 0.0051735397428274155
, O 0 0.0004062488442286849
compared O 0 0.0006223728414624929
with O 0 0.0003524325438775122
noncarriers O 1 0.7725387811660767
, O 0 0.0009193422156386077
APC O 1 0.9848588109016418
I1307K O 0 0.13578800857067108
carriers O 0 0.004014900885522366
had O 0 0.00019062731007579714
increased O 0 0.00013717218826059252
numbers O 0 3.267069041612558e-05
of O 0 7.514344179071486e-05
adenomas B-Disease 1 0.9997202754020691
and O 0 0.008503266610205173
colorectal B-Disease 1 0.999997615814209
cancers I-Disease 1 0.9995120763778687
per O 0 0.001266059116460383
patient O 1 0.9994220733642578
( O 0 0.0018167832167819142
P O 1 0.5058905482292175
= O 0 0.003776030382141471
. O 0 0.00029372042627073824
03 O 0 0.09044886380434036
) O 0 0.00015326075663324445
, O 0 6.623658555326983e-05
as O 0 3.888599167112261e-05
well O 0 5.9690821217373013e-05
as O 0 0.00011771326535381377
a O 0 0.0005729663535021245
younger O 0 0.004993733484297991
age O 0 0.0013409389648586512
at O 0 0.006009301636368036
diagnosis O 1 0.9998584985733032
. O 0 0.0012491054367274046

We O 0 0.0010086019756272435
conclude O 0 0.002105774125084281
that O 0 8.856036583893001e-05
the O 0 0.00048466119915246964
APC O 1 0.9355783462524414
I1307K O 0 0.0285139549523592
variant O 0 0.007709904573857784
leads O 0 0.0013885503867641091
to O 0 0.0002633263939060271
increased O 0 0.004628689493983984
adenoma B-Disease 1 0.9999203681945801
formation O 0 0.007369633298367262
and O 0 0.0001246429019374773
directly O 0 0.00028346251929178834
contributes O 0 0.003063799813389778
to O 0 6.119245517766103e-05
3 O 0 0.00013689984916709363
% O 0 3.5134009522153065e-05
- O 0 0.0004876251332461834
4 O 0 5.248168235993944e-05
% O 0 5.5749405873939395e-06
of O 0 8.248868653026875e-06
all O 0 0.00015349533350672573
Ashkenazi O 1 0.9939945340156555
Jewish O 1 0.9866384267807007
colorectal B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999967813491821
. O 0 0.0027293635066598654

The O 0 0.0007829786627553403
estimated O 0 0.0011644402984529734
relative O 0 0.0012888984056189656
risk O 0 0.3700549900531769
for O 0 0.000384042679797858
carriers O 0 0.18711823225021362
may O 0 0.0008737034513615072
justify O 0 0.004684365354478359
specific O 0 0.0005498328246176243
clinical O 1 0.9960948824882507
screening O 0 0.0019765133038163185
for O 0 0.00011046697909478098
the O 0 0.00023585589951835573
360 O 0 0.0038353793788701296
, O 0 0.0002424676058581099
000 O 0 0.001337813795544207
Americans O 0 0.0002980422868859023
expected O 0 0.00018738048675004393
to O 0 7.87975950515829e-05
harbor O 0 0.0031297747045755386
this O 0 7.641786942258477e-05
allele O 0 0.0014610625803470612
, O 0 0.00011702630581567064
and O 0 9.311520989285782e-05
genetic O 0 0.0006119125173427165
testing O 0 0.0007385442731902003
in O 0 3.370435661054216e-05
the O 0 4.027552859042771e-05
setting O 0 0.0001853349240263924
of O 0 3.951464532292448e-05
long O 0 0.006459641270339489
- O 0 0.0031145126558840275
term O 0 0.0009312197216786444
- O 0 0.0011507251765578985
outcome O 0 0.0004246904281899333
studies O 0 0.00020801751816179603
may O 0 0.0003264930273871869
impact O 0 0.0020100693218410015
significantly O 0 0.32979828119277954
on O 0 0.22332842648029327
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999991655349731
prevention O 1 0.9991704225540161
in O 0 0.00012831090134568512
this O 0 7.566071872133762e-05
population O 0 0.00016212214541155845
. O 0 0.0006571561680175364

Localization O 0 0.005208713002502918
of O 0 0.00015131122199818492
human O 0 0.004322466906160116
BRCA1 O 1 0.9915135502815247
and O 0 0.00010133574687642977
its O 0 0.0001860216580098495
loss O 0 0.003005268285050988
in O 0 0.00014813874440733343
high O 0 0.005094094667583704
- O 0 0.007096495479345322
grade O 0 0.007802015636116266
, O 0 0.00023572257487103343
non B-Disease 0 0.010338285006582737
- I-Disease 1 0.9911540150642395
inherited I-Disease 1 0.9990488886833191
breast I-Disease 1 0.9999831914901733
carcinomas I-Disease 1 0.9996894598007202
. O 0 0.0026216129772365093

Although O 0 0.0005797368939965963
the O 0 0.00014742767962161452
link O 0 0.0013643178390339017
between O 0 0.00017637998098507524
the O 0 0.00124464463442564
BRCA1 O 1 0.9996497631072998
tumour B-Disease 1 0.9999653100967407
- O 0 0.1194109246134758
suppressor O 0 0.09166122227907181
gene O 0 0.001397334155626595
and O 0 0.000553889840375632
hereditary B-Disease 1 0.9997174143791199
breast I-Disease 1 0.9999969005584717
and I-Disease 1 0.9927452206611633
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
is O 0 0.0006254799081943929
established O 0 0.0003748372255358845
, O 0 8.971996430773288e-05
the O 0 9.003991726785898e-05
role O 0 0.0008341974462382495
, O 0 0.00010029910481534898
if O 0 8.58339190017432e-05
any O 0 2.8728256438625976e-05
, O 0 5.411888923845254e-05
of O 0 6.681495142402127e-05
BRCA1 O 1 0.9963094592094421
in O 0 0.0002349370624870062
non B-Disease 0 0.030858943238854408
- I-Disease 1 0.9844702482223511
familial I-Disease 1 0.999677300453186
cancers I-Disease 1 0.9999043941497803
is O 0 0.0008049514144659042
unclear O 0 0.0020364648662507534
. O 0 0.0005221561877988279

BRCA1 O 1 0.9908435344696045
mutations O 0 0.004161425866186619
are O 0 7.606641884194687e-05
rare O 0 0.0034729130566120148
in O 0 0.0005000057280994952
sporadic B-Disease 1 0.8659428358078003
cancers I-Disease 1 0.9999099969863892
, O 0 0.000292767072096467
but O 0 0.00022378773428499699
loss O 0 0.0056451247073709965
of O 0 0.00013701101124752313
BRCA1 O 1 0.9992538094520569
resulting O 0 0.001336520304903388
from O 0 0.00013357809802982956
reduced O 0 0.0012796401279047132
expression O 0 0.00048279704060405493
or O 0 0.00023496727226302028
incorrect O 0 0.0013799075968563557
subcellular O 0 0.003645746037364006
localization O 0 0.002918174024671316
is O 0 0.00022448698291555047
postulated O 0 0.0011778110638260841
to O 0 2.789924110402353e-05
be O 0 1.7604335880605504e-05
important O 0 5.65599330002442e-05
in O 0 0.0001211543712997809
non B-Disease 0 0.009116776287555695
- I-Disease 1 0.992202877998352
familial I-Disease 1 0.9998206496238708
breast I-Disease 1 0.999993085861206
and I-Disease 1 0.9686890840530396
ovarian I-Disease 1 0.9999996423721313
cancers I-Disease 1 0.9999908208847046
. O 0 0.0032662427984178066

Epigenetic O 0 0.03370943292975426
loss O 0 0.0489283986389637
, O 0 0.00039302671211771667
however O 0 0.0002708094834815711
, O 0 0.00017922524421010166
has O 0 0.0002723897632677108
not O 0 9.338276868220419e-05
received O 0 0.0005921038100495934
general O 0 0.000554505328182131
acceptance O 0 0.003779086284339428
due O 0 0.0007769890362396836
to O 0 0.00010073128214571625
controversy O 0 0.0007514824392274022
regarding O 0 0.00020856206538155675
the O 0 0.0001288924104301259
subcellular O 0 0.0028548152185976505
localization O 0 0.002249418757855892
of O 0 0.00010962183296214789
BRCA1 O 1 0.98460453748703
proteins O 0 0.00021294053294695914
, O 0 0.00011056813673349097
reports O 0 0.0001245956082129851
of O 0 1.4745827684237156e-05
which O 0 6.190239218994975e-05
have O 0 6.807597674196586e-05
ranged O 0 0.0008201429736800492
from O 0 6.819734699092805e-05
exclusively O 0 0.00029612419893965125
nuclear O 0 0.0010039781918749213
, O 0 9.705227421363816e-05
to O 0 0.00016437812882941216
conditionally O 0 0.009946237318217754
nuclear O 0 0.000796594365965575
, O 0 8.559165871702135e-05
to O 0 0.00010917035979218781
the O 0 0.0006739621749147773
ER O 1 0.9986091256141663
/ O 0 0.10286180675029755
golgi O 0 0.2262326329946518
, O 0 0.0001640089467400685
to O 0 0.00011296259617665783
cytoplasmic O 0 0.00329775782302022
invaginations O 0 0.013407171703875065
into O 0 0.0001796308788470924
the O 0 0.00029155376250855625
nucleus O 0 0.005348600447177887
. O 0 0.0008733085705898702

In O 0 0.00036658780300058424
an O 0 0.00024969966034404933
attempt O 0 0.0010178893571719527
to O 0 0.0001769937080098316
resolve O 0 0.005916181486099958
this O 0 7.578057557111606e-05
issue O 0 0.00045549622154794633
, O 0 0.00011773268488468602
we O 0 0.0001063200252247043
have O 0 0.00012249256542418152
comprehensively O 0 0.02491346374154091
characterized O 0 0.01833570934832096
19 O 0 0.0017604285385459661
anti O 0 0.03227453678846359
- O 0 0.3779994547367096
BRCA1 O 1 0.991657555103302
antibodies O 0 0.035544563084840775
. O 0 0.0009884154424071312

These O 0 0.00035698915598914027
reagents O 0 0.010582913644611835
detect O 0 0.006847855634987354
a O 0 0.0011362707009539008
220 O 0 0.0034884363412857056
- O 0 0.0077045150101184845
kD O 0 0.026650624349713326
protein O 0 0.0004680132260546088
localized O 0 0.002453621942549944
in O 0 9.704264084575698e-05
discrete O 0 0.000959093333221972
nuclear O 0 0.002075394382700324
foci O 0 0.004938057623803616
in O 0 0.00010875039151869714
all O 0 0.00012898659042548388
epithelial O 1 0.9683161377906799
cell O 0 0.002090610796585679
lines O 0 0.00036831406760029495
, O 0 6.315803329925984e-05
including O 0 2.9575503504020162e-05
those O 0 5.2096336730755866e-05
derived O 0 0.0003782756975851953
from O 0 0.0012045118492096663
breast B-Disease 1 0.999967098236084
malignancies I-Disease 1 0.9979640245437622
. O 0 0.0018559739692136645

Immunohistochemical O 1 0.9339755773544312
staining O 0 0.121024951338768
of O 0 0.0003404949093237519
human O 1 0.5095937848091125
breast O 1 0.9999681711196899
specimens O 0 0.022988559678196907
also O 0 0.000802813854534179
revealed O 0 0.13386577367782593
BRCA1 O 1 0.9898125529289246
nuclear O 0 0.005403474904596806
foci O 0 0.07690425217151642
in O 0 0.0014491872861981392
benign O 1 0.9999456405639648
breast O 1 0.9999926090240479
, O 0 0.03747374936938286
invasive B-Disease 1 0.9999269247055054
lobular I-Disease 1 0.9999871253967285
cancers I-Disease 1 0.9998700618743896
and O 0 0.0005251446273177862
low B-Disease 0 0.3512289524078369
- I-Disease 1 0.9766186475753784
grade I-Disease 1 0.9920742511749268
ductal I-Disease 1 0.9999185800552368
carcinomas I-Disease 1 0.9995864033699036
. O 0 0.0028726658783853054

Conversely O 0 0.03345872461795807
, O 0 0.0015452639199793339
BRCA1 O 1 0.9831880927085876
expression O 0 0.0011636295821517706
was O 0 0.000927330635022372
reduced O 0 0.001441977801732719
or O 0 0.00043171708239242435
undetectable O 1 0.8366478681564331
in O 0 4.272619844414294e-05
the O 0 4.0751077904133126e-05
majority O 0 6.488954386441037e-05
of O 0 3.239389479858801e-05
high O 0 0.009036371484398842
- O 0 0.0988428145647049
grade O 0 0.201083704829216
, O 0 0.0017791823484003544
ductal B-Disease 1 0.9999822378158569
carcinomas I-Disease 1 0.9998927116394043
, O 0 0.00039186154026538134
suggesting O 0 0.002168632810935378
that O 0 8.325109229190275e-05
absence O 0 0.0015431715874001384
of O 0 0.00013479622430168092
BRCA1 O 1 0.9996689558029175
may O 0 0.0011700399918481708
contribute O 0 0.001784231630153954
to O 0 8.047622395679355e-05
the O 0 0.00024547314387746155
pathogenesis O 1 0.9793461561203003
of O 0 1.6046071323216893e-05
a O 0 0.00014178751735016704
significant O 0 0.0001409532269462943
percentage O 0 0.00016720859275665134
of O 0 0.00010186628060182557
sporadic B-Disease 1 0.9900201559066772
breast I-Disease 1 0.9999940395355225
cancers I-Disease 1 0.9999423027038574
. O 0 0.0006215015309862792
. O 0 0.0010494946036487818

